<SEC-DOCUMENT>0001603978-22-000011.txt : 20220310
<SEC-HEADER>0001603978-22-000011.hdr.sgml : 20220310
<ACCEPTANCE-DATETIME>20220310084731
ACCESSION NUMBER:		0001603978-22-000011
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		82
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220310
DATE AS OF CHANGE:		20220310

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AquaBounty Technologies, Inc.
		CENTRAL INDEX KEY:			0001603978
		STANDARD INDUSTRIAL CLASSIFICATION:	FISHING, HUNTING & TRAPPING [0900]
		IRS NUMBER:				043156167
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36426
		FILM NUMBER:		22727549

	BUSINESS ADDRESS:	
		STREET 1:		TWO CLOCK TOWER PLACE
		STREET 2:		SUITE 395
		CITY:			MAYNARD
		STATE:			MA
		ZIP:			01754
		BUSINESS PHONE:		978-648-6000

	MAIL ADDRESS:	
		STREET 1:		TWO CLOCK TOWER PLACE
		STREET 2:		SUITE 395
		CITY:			MAYNARD
		STATE:			MA
		ZIP:			01754
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>aqb-20211231x10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Inline XBRL document created by Certent Disclosure Management 1.0.0.0-->
<!--Created on: 03/10/2022 13:42:45 PM-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:aqb="http://www.sec.gov/20211231" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <head>
    <title>aqb-20211231x10k</title>
    <meta http-equiv="Content-Type" content="text/html" /></head>
  <body xml:lang="en-US">
    <div style="display:none"><ix:header><ix:hidden><ix:nonFraction id="ct-nonFraction-6843bac4-d396-4fd5-bf64-eaadba0c9281" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-4b105fbd-1e83-4e55-98fe-f75182c28eb1" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-263e3319-a480-4d83-a603-55ac72fed500" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-3fbe7447-b64c-49bf-8eb3-857896bb3d07" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonNumeric name="dei:AmendmentFlag" id="ct-nonNumeric-ae8d33c1-cd01-46e4-bc99-cd2b4eab21f8" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="ct-nonNumeric-89256f51-0667-42c8-90fd-c2b0beb023a5" contextRef="Duration_1_1_2021_To_12_31_2021">FY</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="ct-nonNumeric-a1f5732c-09df-49a1-b51c-5092f4f69710" contextRef="Duration_1_1_2021_To_12_31_2021">0001603978</ix:nonNumeric><ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="ct-nonNumeric-dad54e01-7cbb-49a6-9ef9-26fae263ec17" contextRef="Duration_1_1_2021_To_12_31_2021">Yes</ix:nonNumeric><ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="ct-nonNumeric-1e470b56-62bb-4aa4-976a-9a36f2e03bf9" contextRef="Duration_1_1_2021_To_12_31_2021">Yes</ix:nonNumeric><ix:nonNumeric name="dei:EntityVoluntaryFilers" id="ct-nonNumeric-40a08545-331d-4169-b4c9-e76073a08e6a" contextRef="Duration_1_1_2021_To_12_31_2021">No</ix:nonNumeric><ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" id="ct-nonNumeric-5da46204-68f9-4a13-b58a-944d76156d6a" contextRef="Duration_1_1_2021_To_12_31_2021">No</ix:nonNumeric><ix:nonFraction id="ct-nonFraction-a98151dc-30be-4049-88e4-e8cba4435ef0" name="us-gaap:CommitmentsAndContingencies" contextRef="As_Of_12_31_2020" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-9b6a89d3-0451-4270-8124-ff3ec68f392a" name="us-gaap:CommitmentsAndContingencies" contextRef="As_Of_12_31_2021" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-077f0b32-cba5-4513-adc8-5c7bdc6e843b" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="As_Of_12_31_2020" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-1f41823f-8a95-4a42-aa9f-fe1f629034c2" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="As_Of_12_31_2021" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-6cd9ec42-3e38-47dd-ac50-dd60514278fc" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-473abf1b-b7a8-48ec-9c21-1b576508b93a" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-d18d1eb7-b31b-4410-9c80-ffbc9b77fa38" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-f18e4ffc-3dd2-4c4d-bffc-5e004097cfa6" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-784a336f-4241-46ff-b361-20226944947e" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-1bb6a9e6-5ce4-42f3-b252-6b5d694544b3" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-cb484afc-c85f-4c6f-8d1f-29ef78cae0b0" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-097314e7-11bb-4ca7-9fd6-6cda76fab2db" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-f5bfb904-39d5-41a6-a26b-bcef77051a83" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-4bb53a14-2a93-4e17-a63b-c2cb1c46e424" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-a6a59526-a36d-40a1-bb65-7b1a4df8e865" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-cf4fe521-6340-4877-82ce-2a20e3ddbcd5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-868b5e5a-c34a-420c-ad32-9cbd544962d2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-5c3c08f2-7378-4208-9011-725686935807" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-47847e33-ade6-41f5-b123-5cde2d12e28d" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-b59795ba-7292-4c2b-b223-b9e146873faa" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-0f0c9ec5-d409-41d6-944e-59e4d95411a6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-5098dbc5-42aa-46bc-a709-f0801a283dcd" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-0de592a2-a281-4bcc-b007-54b70b53ad5e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit12" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-0f1e3a82-3c9a-4af7-8079-b11fbf22c4b8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit12" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-2367f287-be72-479c-be0c-a2b3f6b3a182" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit14" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-4fe05951-b99a-4a95-904e-ec454df333b2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit14" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-140e6731-d1c4-4feb-b875-90fdf39442e2" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-7d6a578e-1989-4c3f-b810-b250c9fffb38" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-32f45406-b983-4571-872a-500c6d6fa4ee" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-bdea8e6f-fb6c-48e6-baae-6a051816da74" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-ff28a4a8-4f8d-4747-97e8-7cc1e22f4798" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-2e4c5fba-a84c-4603-9ba3-f3d69a621041" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-48c7b8af-c98c-4e02-9b32-50bbecaa0198" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-ce6ab083-ac06-43a7-8908-c67eeecfcb96" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-8d648ec8-43cb-4fa1-ad25-d93da47c90e9" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-aae32a99-c74d-4fa3-a6ab-7f34f49500b0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-47b3ae23-1792-4d3b-8c42-c4bb6f520a26" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-35042d0c-312c-4986-8548-bc6cd3eb8bc2" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-e8d2e945-1c87-493b-9e7e-e6c30034ab06" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="aqb-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_aqb_A2016EquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqb:A2016EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_23_2021_To_11_23_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aqb:TsAquacultureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-23</xbrli:startDate><xbrli:endDate>2021-11-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_UnitedStatesSubsidiaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:UnitedStatesSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadaSubsidiaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadaSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aqb:TsAquacultureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqb:OfficeFurnitureandEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_RolloBayFarmAndFortuneBayHatcheryMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">aqb:RolloBayFarmAndFortuneBayHatcheryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_New10000MetricTonFarmMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">aqb:New10000MetricTonFarmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_IndianaAquacultureFarmMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">aqb:IndianaAquacultureFarmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqb:OfficeFurnitureandEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqb:OfficeFurnitureandEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_2_8_2021_To_2_8_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_February2021PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqb:February2021PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-08</xbrli:startDate><xbrli:endDate>2021-02-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_14_2020_To_12_14_2020_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_December2020PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqb:December2020PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-14</xbrli:startDate><xbrli:endDate>2020-12-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_1_2020_To_9_30_2020_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_StatementScenarioAxis_aqb_LimitationsOnUseToSection382Member_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">aqb:LimitationsOnUseToSection382Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_1_2019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_New10000MetricTonFarmMember_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_us-gaap_CapitalAdditionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">aqb:New10000MetricTonFarmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:CapitalAdditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:KubotaCanadaLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyAIFGrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_1_2019_srt_RangeAxis_srt_WeightedAverageMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:FishInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:FeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_PackagingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:PackagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:FeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_EggsAndFryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:EggsAndFryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:FishInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_8_20_2021_To_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-20</xbrli:startDate><xbrli:endDate>2021-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2018_To_11_30_2018_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_1_2016_To_2_29_2016_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-02-01</xbrli:startDate><xbrli:endDate>2016-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_31_2025_To_7_31_2025_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-31</xbrli:startDate><xbrli:endDate>2025-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:KubotaCanadaLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyAIFGrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_30_2018_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_29_2016_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_4_27_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_25_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_31_2025_To_7_31_2025_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_VariableRateAxis_aqb_USTreasuryFiveYearMaturitiesInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">aqb:USTreasuryFiveYearMaturitiesInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-31</xbrli:startDate><xbrli:endDate>2025-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CA_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_9_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_1_2020_To_3_31_2020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_DomesticCorporateDebtSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2009_To_1_31_2009_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyAIFGrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2009-01-01</xbrli:startDate><xbrli:endDate>2009-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:KubotaCanadaLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyAIFGrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_12_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_11_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="Unit15"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit14"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit13"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit12"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit1"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
    <div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div>
    <div><div style="text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: bottom;width: 100.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: bottom;width: 100.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 2pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 2pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 14pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 14pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Washington, D.C. 20549</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">_____________________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 18pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Form </span><ix:nonNumeric name="dei:DocumentType" id="ct-nonNumeric-a110ceaa-099b-45a3-85ff-8dee1d36eb33" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">10-K</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 16pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:DocumentAnnualReport" id="ct-nonNumeric-31e89b51-5185-4a54-86ae-f2e46ceca926" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt-sec:boolballotbox"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 16pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9746;</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 16pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonNumeric-89256f51-0667-42c8-90fd-c2b0beb023a5;">fiscal year</span></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> ended </span><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="ct-nonNumeric-d5f50fcd-12a0-4448-a9d5-fc90348a96bf" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt:datemonthdayen"><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="ct-nonNumeric-812b9b51-9e2e-4205-8d01-30beadc493b8" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt:datemonthdayyearen" continuedAt="ct-nonNumeric-812b9b51-9e2e-4205-8d01-30beadc493b8-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">December&#160;31</span></ix:nonNumeric></ix:nonNumeric><ix:continuation id="ct-nonNumeric-812b9b51-9e2e-4205-8d01-30beadc493b8-continuation-0" continuedAt="ct-nonNumeric-812b9b51-9e2e-4205-8d01-30beadc493b8-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, </span></ix:continuation><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="ct-nonNumeric-b80a3b28-d161-404e-8590-f9d69bb4073a" contextRef="Duration_1_1_2021_To_12_31_2021"><ix:continuation id="ct-nonNumeric-812b9b51-9e2e-4205-8d01-30beadc493b8-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2021</span></ix:continuation></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 16pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:DocumentTransitionReport" id="ct-nonNumeric-a773f5d0-e746-40d7-b81a-6beffb7009be" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt-sec:boolballotbox"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 16pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 16pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For the transition period from ________________ to ________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Commission file number: </span><ix:nonNumeric name="dei:EntityFileNumber" id="ct-nonNumeric-acc7b983-fd09-4e97-acb9-6d3e8bf2db4e" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">001-36426</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">_____________________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 22pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityRegistrantName" id="ct-nonNumeric-fa3d5437-a958-4694-abfb-930717430674" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 22pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(Exact name of the registrant as specified in its charter)</span></p><div style="text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;width: 100%;"><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 50.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 50.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 50.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="ct-nonNumeric-71c52b6e-6b3b-41f3-8f87-323d70026c97" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt-sec:stateprovnameen"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Delaware</span></ix:nonNumeric></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 50.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="ct-nonNumeric-b0bd8b31-6d4f-40b4-bd79-22496f732071" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">04-3156167</span></ix:nonNumeric></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 50.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(State or other jurisdiction of</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">incorporation or organization)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 50.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(I.R.S. employer</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">identification no.)</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 3pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="ct-nonNumeric-16425177-367e-445e-a2e9-13780b273bcf" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2 Mill &amp; Main Place</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="ct-nonNumeric-037dbe75-edeb-4ea4-afb7-c8d51cc32cfc" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Suite 395</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 3pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="ct-nonNumeric-e317c2ef-7168-4cdf-aa42-9d30e5a250a9" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Maynard</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="ct-nonNumeric-58d9efcf-c798-4708-9dff-02d3b7ca96be" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt-sec:stateprovnameen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Massachusetts</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="ct-nonNumeric-6abda6c6-2517-47be-a473-088147513ebd" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">01754</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 3pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(</span><ix:nonNumeric name="dei:CityAreaCode" id="ct-nonNumeric-0836a366-74c4-4d98-bab0-3a951fb3f3a1" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">978</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">) </span><ix:nonNumeric name="dei:LocalPhoneNumber" id="ct-nonNumeric-3922f655-0539-474c-a714-6d8924c8d2fc" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">648-6000</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 3pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(Address and telephone number of the registrant&#8217;s principal executive offices)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 3pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Securities registered pursuant to Section&#160;12(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;):</span></p><div style="text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 33.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 33.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 33.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 33.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Title of each class</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 33.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.03in;margin-right: 0.03in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Trading Symbol(s)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 33.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.03in;margin-right: 0.03in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Name of exchange on which registered</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 33.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="ct-nonNumeric-46fa4ecc-f23b-4743-adc0-f4ba715fd4bb" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Common Stock, par value $0.001 per share</span></ix:nonNumeric></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 33.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="ct-nonNumeric-5883bb3b-5c58-42bf-ab85-a7f82099dfb4" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AQB</span></ix:nonNumeric></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 33.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">The </span><ix:nonNumeric name="dei:SecurityExchangeName" id="ct-nonNumeric-9446b8e7-38ee-4215-9fdb-a3db5842951b" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">NASDAQ</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> Stock Market LLC</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 120.0%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 2pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Securities registered pursuant to Section&#160;12(g) of the Act</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">:</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">None</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act of 1933</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;Yes&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonNumeric-5da46204-68f9-4a13-b58a-944d76156d6a;">&#9746;</span></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;Yes&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonNumeric-40a08545-331d-4169-b4c9-e76073a08e6a;">&#9746;</span></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;Yes&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonNumeric-dad54e01-7cbb-49a6-9ef9-26fae263ec17;">&#9746;</span></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;No&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12 months (or such shorter period that the registrant was required to submit such files).</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;Yes&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonNumeric-1e470b56-62bb-4aa4-976a-9a36f2e03bf9;">&#9746;</span></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;No&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Large accelerated filer&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;&#160;&#160;Accelerated filer&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;&#160;&#160;</span><ix:nonNumeric name="dei:EntityFilerCategory" id="ct-nonNumeric-04528bb6-13b2-409c-8b91-31c0dd884f1c" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt-sec:entityfilercategoryen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Non-accelerated filer</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9746;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;&#160;Smaller reporting company&#160;&#160;</span><ix:nonNumeric name="dei:EntitySmallBusiness" id="ct-nonNumeric-e615527b-4a01-4f40-ae59-498c7b149024" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt-sec:boolballotbox"><span style="white-space:pre-wrap; font-family: Segoe UI Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9746;</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;</span><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="ct-nonNumeric-5878db1f-6db4-44a8-9e07-d0d1e8afe999" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt-sec:boolballotbox"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9746;</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#160;&#160;</span><ix:nonNumeric name="dei:EntityExTransitionPeriod" id="ct-nonNumeric-2619b13b-ca35-4d68-8fda-0df67e1a7ae6" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt-sec:boolballotbox"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 1pt;"><span id="_cp_change_4" style="text-decoration: none;"></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span id="_cp_change_3" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="_cp_change_6" style="text-decoration: none;"></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;Yes&#160;&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: Segoe UI Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;No&#160;&#160;</span><ix:nonNumeric name="dei:IcfrAuditorAttestationFlag" id="ct-nonNumeric-e1cdb6fd-0cc3-42d1-9069-94c89d17a0a9" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt:booleanfalse"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: Segoe UI Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9746;</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9744;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><ix:nonNumeric name="dei:EntityShellCompany" id="ct-nonNumeric-d2f1ced6-89d6-463a-98a1-d89610726ccf" contextRef="Duration_1_1_2021_To_12_31_2021" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#9746;</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">At June&#160;30, 2021, the aggregate market value of the 43,685,796 shares of common stock held by non-affiliates of the registrant was approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2e8aa19c-9424-4e7a-9cb6-230bf073fb68" name="dei:EntityPublicFloat" contextRef="As_Of_6_30_2021" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">234.2</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million. At March&#160;9, 2022, the registrant had </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b25f3540-0f64-4a5f-aa6c-625c290099b6" name="dei:EntityCommonStockSharesOutstanding" contextRef="As_Of_3_9_2022" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">71,025,738</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock outstanding.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 1pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 1pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="dei:DocumentsIncorporatedByReferenceTextBlock" id="ct-nonNumeric-0cea20a3-7919-4550-9a50-845b9f2bee44" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Portions of the registrant&#8217;s Proxy Statement for its Annual Meeting of Shareholders to be held on May&#160;17, 2022 (the &#8220;2022 Proxy Statement&#8221;), are incorporated by reference into Part III of this Annual Report on Form&#160;10</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8209;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">K.</span></ix:nonNumeric></p><div style="text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: bottom;width: 100.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: bottom;width: 100.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span id="Section2" style="text-decoration: none;"></span></p></div>
    <div><div class="footerContainer"></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">ANNUAL REPORT ON FORM 10-K</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">FOR THE FISCAL YEAR ENDED DECEMBER&#160;31, 2021</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Table of Contents</span><span id="TableofContents" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">PART I</span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Page</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section5"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 1.</span><span style="white-space:pre-wrap; color: #0000FF;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section5" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Business</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section6" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 1A.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section6" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Risk Factors</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">12</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section7" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 1B.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section7" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Unresolved Staff Comments</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">27</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section8" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 2.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section8" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Properties</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">27</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section9" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 3.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section9" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Legal Proceedings</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">27</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section10" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 4.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section10" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Mine Safety Disclosures</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">27</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">PART II</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section12" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 5.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section12" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">27</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section13" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 6.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section13" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Selected Financial Data</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">27</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section14" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 7.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section14" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">28</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section15" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 7A.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section15" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">33</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section16" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 8.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section16" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Financial Statements and Supplementary Data</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">33</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section17" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 9.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section17" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Changes In and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">33</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section18" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 9A.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section18" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Controls and Procedures</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">33</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section19" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 9B.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section19" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Other Information</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">34</span></p></td></tr><tr style="height: 0.13in;"><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section9C" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 9C.     </span></a><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section9C" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">34</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">PART III</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section21" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 10.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section21" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Directors, Executive Officers and Corporate Governance</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">35</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section22" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 11.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section22" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Executive Compensation</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">35</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section23" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 12.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section23" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">35</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section24" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 13.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section24" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">35</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section25" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 14.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section25" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Principal Accounting Fees and Services</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">35</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">PART IV</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section27" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 15.</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section27" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Exhibits and Financial Statement Schedules</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">36</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 8.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section28" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Item 16.</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section28" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Form 10-K Summary</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">40</span></p></td></tr><tr><td colspan="2" style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 93.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Section29" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">SIGNATURES</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 6.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">40</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span id="Section3" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This Annual Report on Form 10&#8209;K, particularly the sections titled &#8220;Summary,&#8221; &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Business,&#8221; contains forward looking statements. All statements other than present and historical facts and conditions contained in this Annual Report on Form 10&#8209;K, including statements regarding our future results of operations and financial positions, business strategy, plans, and our objectives for future operations, are forward-looking statements. When used in this Annual Report on Form 10&#8209;K, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;is designed to,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;objective,&#8221; &#8220;should,&#8221; or the negative of these and similar expressions identify forward-looking statements. These forward-looking statements include statements that are not historical facts, including statements regarding management&#8217;s expectations for future financial and operational performance and operating expenditures, expected growth, and business outlook; the nature of and progress toward our commercialization plan; the future introduction of our products to consumers; the countries in which we may obtain regulatory approval and the progress toward such approvals; the volume of eggs or fish we may be able to produce; the timeline for our production of saleable fish; the expected advantages of land-based systems over sea cage production; the validity and impact of legal actions; the completion of renovations at our farms; and the establishment of a larger-scale grow-out facility.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have based these forward-looking statements on our current expectations, assumptions, estimates, and projections. While we believe these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks, uncertainties, and other factors, many of which are outside of our control, which could cause our actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by such forward-looking statements. Forward-looking statements in this Annual Report on Form 10&#8209;K include, but are not limited to, statements about:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the an</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ticipated benefits and characteristics of AquaBounty&#8217;s genetically engineered AquAdvantage salmon (&#8220;GE Atlantic salmon&#8221;) product; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the implementation and likelihood of achieving the business plan, future revenue, and operating results; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our plans for (including without limitation, projected costs, locations and third-party involvement) and the timing of the development of new farms and the output of those farms (including our Pioneer, Ohio farm); </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">developments concerning our research projects; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our expectations regarding our ability to successfully enter new markets or develop additional products; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our competitive position and developments and projections relating to our competitors and our industry; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">expectations regarding anticipated operating results; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our cash position and ability to raise additional capital to finance our activities; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the impact of the evolving COVID-19 pandemic (the &#8220;COVID-19 pandemic&#8221;) on our business, operations and financial results, any of which could be significantly impaired by the COVID-19 pandemic; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our ability to protect our intellectual property and other proprietary rights and technologies; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the impact of and our ability to adapt to changes in laws or regulations and policies; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the ability to secure any necessary regulatory approvals to commercialize any products; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the rate and degree of market acceptance of any products developed through the application of bioengineering, including genetically engineered fish; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our ability to retain and recruit key personnel; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the success of any of our future acquisitions or investments; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our expectations regarding the time during which we will be an emerging growth company under the Jumpstart Our Business Startups Act (the &#8220;JOBS Act&#8221;); </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our estimates regarding expenses, future revenue, capital requirements, and needs for additional financing; and </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">other ris</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ks and uncertainties referenced under &#8220;Risk Factors&#8221; below and in any documents incorporated by reference herein. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We caution you that the foregoing list may not contain all of the risks to which the forward-looking statements made in this Annual Report on Form 10&#8209;K are subject. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking </span></p></div>
    <div><div class="footerContainer"></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions, and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included, particularly in the section titled &#8220;Risk Factors,&#8221; that could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments that we may make.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. These forward-looking statements are made only as of the date of this Annual Report on Form 10&#8209;K. We do not undertake and specifically decline any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments unless required by federal securities law. New risks emerge from time to time, and it is not possible for us to predict all such risks.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">i</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span></p></div>
    <div><div class="footerContainer"></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: center;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">SUMMARY OF THE MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-indent: 0.50in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our business is subject to numerous risks and uncertainties that you should be aware of in evaluating our business,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> including those described in the &#8220;Risk Factors&#8221; section in Part I, Item 1A. of this Annual Report on Form 10-K</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. These risks and uncertainties include, but are not limited to, the following:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have a history of net losses and will likely incur future losses and may not achieve or maintain profitability.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our business plans include the need for substantial additional capital and without it we may not be able to implement our strategy as planned or at all.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Ethical, legal, and social concerns about genetically engineered products could limit or prevent the use of our products and limit our revenues.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may have limited success in gaining consumer acceptance of our products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our business is affected by the quality and quantity of the salmon that we harvest.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may experience a significant fish mortality event in our broodstock or our production facilities that could impact the price of our common stock.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">A shutdown, damage to any of our farms, or lack of availability of power, fuel, oxygen, eggs, water, or other key components needed for our operations, could result in our prematurely harvesting fish, a loss of a material percentage of our fish in production, a delay in our commercialization plans, and a material adverse effect on our operations, business results, reputation, and the value of our brands.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Security breaches, cyber-attacks and other disruptions could compromise our information, expose us to fraud or liability, or interrupt our operations, which would cause our business and reputation to suffer.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The successful development of our business depends on our ability to efficiently and cost-effectively produce and sell salmon at large commercial scale.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our ability to generate revenue to support our operations depends on maintaining regulatory approvals for our GE Atlantic salmon and our farm sites and obtaining new approvals for farm sites and the sale of our products in other markets, the receipt of which is uncertain.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We will be required to continue to comply with FDA and foreign regulations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We remain dependent on third parties for the processing, distribution and sale of our products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may be required to write-down the value of our inventory if its net realizable value is less than its accumulated cost at the end of a reporting period.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If our products become contaminated, we may be subject to product liability claims and product recalls, which could adversely affect our financial results and damage our reputation.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The loss of our GE Atlantic salmon broodstock could result in the loss of our commercial technology.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Business, political, or economic disruptions or global health concerns, such as the COVID-19 pandemic, could seriously harm our current or planned business and increase our costs and expenses.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The construction and potential benefits of our new facilities are subject to risks and uncertainties.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Industry volatility can affect our earnings, especially due to fluctuations in commodity prices of salmon.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If we lose key personnel, including key management personnel, or are unable to attract and retain additional personnel, it could delay our commercialization plans or harm our research and development efforts, and we may be unable to sell or develop our own products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The price of our shares of common stock is likely to be volatile.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our share price and our ability to raise additional funds may depend on our success in growing, or our perceived ability to grow, our GE Atlantic salmon successfully and profitably at commercial scale.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Atlantic salmon farming is subject to disease outbreaks, which can increase the cost of production and/or reduce production harvests.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The summary risk factors described above should be read together with the text of the full risk factors below,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in the section entitled &#8220;Risk Factors&#8221; </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and in the other information set forth in this Annual Report on Form 10-K, including our financial statements and the related notes, as well as in other documents that we file with the U.S. Securities and Exchange Commission, or the SEC. If any such risks and uncertainties actually occur, our business, prospects, financial condition and results of operations could be materially and adversely affected. The risks summarized above or described in full below are not the only risks that we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial may also materially adversely affect our business, prospects, financial condition and results of operations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Where You Can Find More Information</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We file with the Securities and Exchange Commission (the &#8220;SEC&#8221;) periodic reports and other information, including our Annual Report on Form 10&#8209;K, quarterly reports on Form 10&#8209;Q, current reports on Form 8&#8209;K, and amendments to those reports. The SEC maintains an internet site at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file, as we do, electronically with the SEC.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">All of these documents are available free of charge on our website, www.aquabounty.com, and will be provided free of charge to any shareholders requesting a copy by writing to: Corporate Secretary, AquaBounty Technologies, Inc., 2&#160;Mill &amp; Main Place, Suite 395, Maynard Massachusetts 01754, Telephone: (978) 648-6000. We use our website as a channel for routine distribution of important information, including news releases, analyst presentations, and financial information. In addition, our website allows investors and other interested persons to sign up to automatically receive e-mail alerts when we post news releases and financial information on our website. The information contained on, or accessible from, our website or in any other report or document we file with or furnish to the SEC is intended to be inactive textual references only, and is not incorporated by reference into this Annual Report on Form 10&#8209;K.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ii</span><span id="Section4" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div>
    <div><div class="footerContainer"></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Part&#160;I</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section5" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;1.&#160;&#160;Business</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Feed a growing world by developing and deploying new aquaculture technologies.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">At AquaBounty, we believe we are a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. Our objective is to ensure the availability of high-quality seafood to meet growing global consumer demand, while addressing critical production constraints in one of the most popular farmed species. We are committed to feeding the world efficiently, sustainably and profitably.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Aquaculture is the farming of aquatic organisms such as fish, shellfish, crustaceans, and aquatic plants. It involves cultivating freshwater or saltwater species under controlled conditions, as an alternative to the commercial harvesting of wild species of aquatic organisms.  According to the Food and Agriculture Organization of the United Nations (&#8220;FAO&#8221;), aquaculture was a $250 billion industry in 2018, and we are targeting the $17 billion salmon farming segment of that industry.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our GE Atlantic salmon is based upon proprietary salmon genetics and grows to harvest size faster than conventional Atlantic salmon. Our salmon was approved for production, sale, and consumption in the United States on November 19, 2015 by the U.S. Food and Drug Administration (&#8220;FDA&#8221;). This was followed by an approval from Health Canada for the production, sale, and consumption of our salmon in Canada on May 19, 2016 and an approval from the National Biosafety Technical Commission for the sale and consumption of our salmon in Brazil on May 12, 2021. Consequently, we have received approvals for our product from what we believe are three of the most respected and rigorous regulatory agencies in the world.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We farm our GE Atlantic salmon in land-based, recirculating aquaculture systems (&#8220;RAS&#8221;), which allow inland fish farms to be established close to major demand centers in a profitable and environmentally sustainable manner. We believe that our 25 years of experience growing salmon in land-based farms, coupled with the unique genetics of our faster-growing GE Atlantic salmon, provides us with a competitive advantage and an opportunity to establish multiple salmon farms throughout North America and the world. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We currently have two salmon farms in production &#8211; a 1,200 metric ton facility in Indiana and a 250 metric ton demonstration facility on Prince Edward Island, Canada. Our plans include the construction of a new 10,000 metric ton farm in Pioneer, Ohio during the next twenty-four months and an additional three to four new 10,000 metric ton farms in North America at sites close to consumer consumption over the next seven-to-ten years. We are also pursuing regulatory approval for our GE Atlantic salmon in Israel and China, with the goal of entering those markets with local partners in the form of joint ventures or licensing arrangements.  Additionally, we plan to utilize our expertise in biotechnology and RAS operations to enter complimentary areas of the aquaculture industry.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our strategy is to continually strengthen our core capabilities, scale our business and pursue growth opportunities. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Market Drivers</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Population Growth Drives Demand for Food Protein</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">According to FAO, the global population is projected to exceed 9 billion people by 2050, or roughly 26% growth over the next 28 years.  Along with this increase is a growing middle class with more disposable income, which is driving increased demand for protein food sources.  And according to FAO, global fish consumption has been growing faster than all other animal protein foods.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Traditional Fisheries Cannot Meet the Demand</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The increased demand for fish protein cannot be satisfied from traditional capture fisheries.  FAO states that over 90% of the world&apos;s fisheries are fully fished or overfished.  Total production from global capture fisheries has been relatively stable since the late-1980s, with catches generally fluctuating between 86 million metric tons and 93 million metric tons per year, reaching 96 million metric tons in 2018.  In contrast, over the same period, aquaculture fish production has grown from 14 million metric tons to a level of 82 million metric tons in 2018 and now accounts for 46% of global fish production.  Feeding the growing population and meeting the demand for fish protein will require aquaculture production to almost double by 2050.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">1</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The chart below depicts the projected gap between supply and demand over the next 28 years.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="aqb-20211231x10kg001.jpg" style="width: 4.953472in; height: 2.793411in" alt="Picture 1" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Source: FAO - The State of World Fisheries and Aquaculture 2020 for actual data</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">through 2018.  Company estimates based on FAO data for projections through 2050.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Salmon Farming</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Atlantic salmon farming is a major industry in the cold-water countries of the northern and southern hemispheres. According to FAO, global tonnage of Atlantic salmon aquaculture production grew by approximately 2% annually between 2015 and 2019, reaching 2.6 million metric tons with a value of over $17 billion. We believe that the aquaculture industry &#8211; and in particular salmon farming &#8211; is  poised for significant growth in the coming years, as the global population expands and consumers seek out high-quality proteins. However, the near-term outlook will continue to be influenced by the COVID-19 pandemic and its impact on both production and demand.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Below is a break-down by major producing country for the time period 2015 through 2019, which is the last year for which data is readily available from FAO.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Worldwide Atlantic Salmon Production by Country (in metric tons)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Country</span></p></td><td style="background: white;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: white;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2015</span></p></td><td style="background: white;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2016</span></p></td><td style="background: white;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2017</span></p></td><td style="background: white;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2018</span></p></td><td style="background: white;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2019</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Norway</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,303,346</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,233,619</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,236,353</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,282,003</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,364,042</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Chile</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">608,546</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">532,225</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">614,180</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">661,138</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">701,984</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">United Kingdom</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">172,146</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">163,135</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">189,707</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">156,025</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">190,500</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Canada</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">121,926</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">123,522</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">120,553</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">123,184</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">118,630</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Faroe Islands</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">80,600</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">83,300</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">86,800</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">78,900</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">95,000</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Australia</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">48,331</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">56,115</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">52,580</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">61,227</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">56,989</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Ireland</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">13,116</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">16,300</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">18,342</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">11,984</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">11,333</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">United States</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">18,719</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">16,185</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">14,685</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">16,107</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">16,491</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">All other</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">14,549</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">22,592</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">25,163</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">35,205</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">60,993</span></p></td></tr><tr><td style="background: white;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 25.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Volume-Worldwide (mt)</span></p></td><td style="background: white;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: white;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,381,279</span></p></td><td style="background: white;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,246,993</span></p></td><td style="background: white;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,358,363</span></p></td><td style="background: white;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,425,773</span></p></td><td style="background: white;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 12.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,615,962</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Source: FAO - Fisheries and Aquaculture Information and Statistics Service - 2/9/2022</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Limitations of Conventional Sea-Cage Salmon Farming</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Conventional salmon aquaculture takes place in large cages (sea cages) in coastal waterways exposed to currents, which can bring a variety of pathogens in contact with the farmed salmon. The presence of pathogens in an uncontrolled environment such as this is a universally accepted fact in human and animal health. Such disease agents in these uncontrolled water currents can result in infection and spread of infection within the captive population. The risks and outcomes of conventional, open sea-cage systems are well established, including the susceptibility to extreme weather conditions, and are often evidenced by outbreaks of a variety of bacterial </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">2</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and viral diseases as well as water fouling and contamination due to algal blooms and similar events. This risk of disease has led to the widespread use of antibiotics, vaccines, and other pharmacological agents.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The most prevalent disease and health management issues are infectious salmon anemia (&#8220;ISA&#8221;) and sea lice. ISA is a viral disease in Atlantic salmon, and outbreaks have occurred in virtually every major salmon farming geography since 1984, including a major event in Chile in 2008 that impacted the country&#8217;s production for three years. There is currently no effective treatment for the disease, and the salmon farming industry relies on health management practices to mitigate its impact.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Sea lice are marine parasites that occur naturally and attach to the skin of Atlantic salmon. Even a few sea lice can increase the likelihood of secondary infections and mortality, and the presence of significant numbers are likely to have adverse effects on fish health and aesthetic appearance. The cost of managing sea lice in sea-cage farming environments can be significant.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Another limitation of the conventional salmon production system is that the farms are not located near the ultimate consumers and thus an additional carbon footprint is created in transporting the fish from its production to its consumption location.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We believe we offer a better, more sustainable alternative to conventional salmon production.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Solution</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Land-Based RAS Production</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The closed, contained, land-based production systems using RAS technology that we use for the grow-out of our fish are less susceptible to the disease-related pressures of conventional salmon farming, because this type of culture system is isolated from the environment. RAS facilities employ sophisticated water treatment technology including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system. In addition, incoming water is similarly filtered and treated prior to entering the system, and water quality is regularly measured as part of the standard procedures. The fish in RAS facilities are generally not vaccinated against typical fish diseases, and no antibiotics, pesticides, or pharmacological agents are typically required. RAS facilities employ effective biosecurity to prevent disease by reducing or eliminating the introduction of pathogens and continuously treating the water to assure optimal fish health. RAS production will allow our fish to be raised in optimized conditions with total control of the water coming in and going out of the system, while recirculating greater than 95% of the water used.  Further, stocking our RAS farms with disease-free eggs from our own hatchery results in a much higher degree of biosecurity and protection from disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition to biosecurity measures to optimize fish health, our farms feature multiple layers of containment designed to prevent escapes.  We have been growing fish in RAS facilities for decades and we have never experienced an escape.  The multiple layers of containment redundancy, coupled with the fact that our salmon are sterile female fish, pose a much-needed solution to raising fresh, healthy seafood in a manner that prevents harming native fish populations.  The method of land-based fish farming that we employ has been promoted by many environmental NGOs and it does not pose a threat to wild salmon populations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have significant experience in operating land-based RAS facilities.  Our operating practices and procedures have been developed and honed over several decades and are geared towards meeting stringent regulatory requirements.  Our experience operating land-based RAS salmon farms enables us to protect both the fish and the environment.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">3</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="aqb-20211231x10kg002.jpg" style="width: 6.362998in; height: 4.010575in" alt="Picture 3" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="aqb-20211231x10kg003.jpg" style="width: 6.822063in; height: 1.051951in" alt="Picture 11" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Our GE Atlantic Salmon</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our GE Atlantic salmon program (&#8220;AquAdvantage&#8221;) began over 30 years ago and is based upon a single, specific molecular modification in our salmon that results in more rapid growth during early development. The result is a genetically engineered Atlantic salmon that can grow to market size faster than a conventional farmed Atlantic salmon.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The original research on the Atlantic salmon was conducted at Memorial University in Newfoundland, Canada, by a team seeking to protect the fish from the effects of the cold waters of the North Atlantic Ocean. They discovered that the single genetic change made by placing a second copy of the salmon growth hormone gene under the control of an alternative genetic promoter (gene switch) from the ocean pout resulted in more consistent levels of growth hormone being released, which accelerated the early stages of the salmon&#8217;s development, a time period when the salmon are more susceptible to disease and mortality. The accelerated growth allows these fish to reach a marketable size sooner. This can reduce farming time in a RAS facility from roughly 26 to 28 months for conventional Atlantic salmon to roughly 18 to 20 months for our salmon.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This accelerated growth has economic and environmental advantages. The faster life cycle from birth to harvesting of our salmon, as compared to conventional salmon, allows it to be produced more economically in contained, land-based RAS farms. Although RAS farms require greater capital investment than the sea cage approach, we believe that the higher costs are offset by more efficient growth and a shorter transportation distance to market.  Compared to conventional salmon grown in a RAS farm with a similar capital investment, we can produce approximately 70% more of our GE Atlantic salmon each year.  Our fish are also 25% more efficient at converting their feed to biomass, which represents a significant cost advantage as feed is the largest variable cost of growing salmon.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">4</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="aqb-20211231x10kg004.jpg" style="width: 6.942027in; height: 3.145711in" alt="Picture 4" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Source: AquaBounty - Management estimates based on current assumptions.  EBITDA is defined as farm operation</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">net income (loss), plus depreciation expense, other income/expense, including interest expense and interest income,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and the provision for income taxes.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Further, with our plan to locate our farms nearer to the major food markets, we expect savings on transportation of the harvested stock, a reduced carbon footprint, and an improved ability to get fresh product to market faster.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Intellectual Property</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our GE Atlantic salmon is based upon a single, specific molecular modification in the fish that results in more rapid growth in early development. The patent for the underlying technology, which had been issued in certain salmon producing countries, expired in August 2013 and we currently hold a global, perpetual, royalty-free, fully paid, sub-licensable, assignable, non-exclusive right to the technology covering genetically engineered salmonid fish that express endogenous growth hormone under the control of a protein gene promoter from an edible fish.  Despite the expiration of the patent for the licensed technology, we believe that the degree of know-how in the molecular modification process and the regulatory timescales associated with approval of genetically engineered fish present significant barriers to entry and a competitive advantage.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We rely on a combination of patent, trademark, and trade secret laws in the United States and applicable foreign jurisdictions, as well as confidentiality procedures and contractual provisions, to protect our proprietary technology, processes, and brand. In December 2015, we were granted a U.S. patent for our molecular sterility system, which renders sterile the progeny of any female fish carrying a defined maternal sterility gene. Subsequently, the maternal sterility patent has been issued in Australia, Brazil, Canada, Chile, Japan, and the Republic of Korea. While the technology described in the sterility system patent is not required under any of our current regulatory approvals, the technology may be desirable in the future to obtain or maintain regulatory approvals.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Regulatory Aspects of Genetically Engineered Fish</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The genetic engineering of food using the tools of modern biotechnology is regulated in the United States by two government organizations, the U.S Department of Agriculture (&#8220;USDA&#8221;) for genetically engineered plants and the FDA for genetically engineered animals.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The regulatory process for genetically engineered food and animal feed is based upon the Coordinated Framework, issued by the Office of Science and Technology Policy in 1986, but the enabling legislation is the Federal Food, Drug, and Cosmetic Act (&#8220;FFDCA&#8221;).  The FDA is also required to determine the environmental impact of a proposed application under the National Environmental Policy Act (&#8220;NEPA&#8221;). In the case of animals intended for food or materials for feed, the FDA process is a pre-approval review followed by an approval if the application is acceptable under the relevant legislation,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">with ongoing oversight following approval.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We opened an Investigational New Animal Drug file for AquAdvantage salmon with the FDA in 1995. At that time, there was no defined regulatory framework for the regulation of bioengineered animals. There were, however, certain studies that were generally </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">5</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">acknowledged to be necessary for an eventual approval process. We commenced work on those studies and began a phased submission of studies to the FDA that ultimately was responsive to each technical section of the New Animal Drug Application (&#8220;NADA&#8221;). These technical sections require submission of studies relating to molecular characterization of the construct; molecular characterization of AquAdvantage salmon lineage; phenotypic characterization of AquAdvantage salmon; a genotypic and phenotypic durability plan; support for environmental, food, and feed safety; and claim validation. The FDA&#8217;s phased review process, which included a cycle of study conduct, submission, review, and acceptance, continued over the period from 1995 to 2010. Following this process, the FDA concluded that AquAdvantage salmon &#8220;is as safe as food from conventional salmon, and that there is a reasonable certainty of no harm from consumption of food&#8221; from AquAdvantage salmon.  On November 19, 2015, the FDA issued an approval letter for the NADA for AquAdvantage salmon, along with a final Environmental Assessment (&#8220;EA&#8221;) and a finding of No Significant Impact on the EA under NEPA.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Regulatory Legal Challenge</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On March 30, 2016, a coalition of non-governmental organizations (&#8220;NGOs&#8221;) filed a complaint in the United States District Court for the Northern District of California against the FDA, the United States Fish and Wildlife Service, and related individuals for their roles in the approval of AquAdvantage salmon.  Subsequently, AquaBounty joined the case as an intervenor to protect our interests.  Shortly thereafter, the Fish and Wildlife Service was dismissed from the case. The NGOs, including the Center for Food Safety and Friends of the Earth, claimed that the FDA had no statutory authority to regulate genetically engineered animals, and, if it did, that the agency failed to adequately analyze and implement measures to mitigate ecological, environmental, and socioeconomic risks that could impact wild salmon and the environment, including the risk that AquAdvantage salmon could escape and threaten endangered wild salmon stocks. In December 2019 the court found that the FDA did have authority/jurisdiction over genetically engineered animals under the FFDCA, and in November 2020, the court remanded the EA to the FDA for further work on its NEPA and Endangered Species Act (&#8220;ESA&#8221;) assessments.  In December 2020, the plaintiffs filed a motion to alter or amend the judgment.  In February 2021, the judge denied that motion. The court&#8217;s decisions do not have a current business impact on AquaBounty&#8217;s egg production on Prince Edward Island, Canada or AquaBounty&#8217;s salmon production in Albany, Indiana. AquaBounty is working with the FDA on the NEPA and ESA regulatory matters. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">On-going Regulatory Requirements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition to the FDA approval of the NADA for AquAdvantage salmon, our operating sites in the United States and on Prince Edward Island, as well as those we plan to operate in the future, must be registered with, and periodically inspected by, the FDA as drug manufacturing establishments. Drug manufacturing establishments that supply FDA-regulated products for use in the United States must comply with the product&#8217;s conditions for approval, whether located in the United States or in a foreign country. Each of our operating sites in Indiana and on Prince Edward Island, is currently registered with the FDA, and the FDA has performed inspections and site visits at each of those facilities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Going forward, we must continue to comply with FDA requirements not only for manufacturing, but also for labeling, advertising, record keeping, and reporting to the FDA of adverse events and other information. We also need to comply with USDA disclosure requirements</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> pertaining to bioengineered foods under </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the National Bioengineered Food Disclosure Law. Failure to comply with these requirements could subject us to administrative or judicial enforcement actions, including but not limited to product seizures, injunctions, civil penalties, criminal prosecution, refusals to approve new products, or withdrawal of existing approvals, as well as increased product liability exposure.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Production of AquAdvantage salmon in the United States also requires compliance with environmental regulations and local site permitting statutes. In addition, every production site for AquAdvantage salmon in the United States requires approval by the FDA of both a Supplemental NADA and satisfaction of corresponding obligations under NEPA, as well as compliance with local permitting requirements for construction of grow-out facilities. We expect that we may incur significant costs to comply with these environmental and regulatory requirements, which could be a multi-year process to complete for each production site, though conducted in parallel with our construction timelines.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Labeling and Disclosure Standard</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There have been surveys cited by various NGOs that indicate that consumers are reluctant to purchase genetically engineered food and that they would like to see labeling in order to avoid it.  Many states reacted to this by enacting genetically engineered food labeling laws.  Consequently, in response to the potential for state-by-state labeling laws, Congress passed the National Bioengineered Food Disclosure Law (&#8220;Disclosure Standard&#8221;) in 2016, which directed USDA to establish a national mandatory standard for disclosing foods that are or may be bioengineered. The Disclosure Standard requires food manufacturers, importers, and certain retailers to ensure bioengineered foods are appropriately disclosed. The Disclosure Standard came into effect on January 1, 2022, but we began complying in 2021 on a voluntary basis when our salmon began to be harvested and sold. </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">6</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In conjunction with the bioengineered disclosure, we also have begun to educate consumers on the benefits of our GE Atlantic salmon versus conventional Atlantic salmon, including its 25% improved feed conversion (meaning less feed is needed to produce the same harvest), a lower carbon footprint due to local production, reduced impact on the environment, reduced exposure of the fish to environmental toxins due to use of land-based aquaculture systems, and reduced reliance on vaccines or antibiotics due to improved biosecurity.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In December 2019, the 2020 Appropriations Act was signed into law, which was reintroduced and passed in 2021, which contained an amendment that requires that any genetically engineered animal approved by FDA prior to the effective date of the Disclosure Standard shall include the words &#8216;&#8216;genetically engineered&#8217;&#8217; prior to the existing acceptable market name. While we believe that this labeling requirement is unnecessary and redundant to the requirement of the Disclosure Standard, we have and will continue to comply with all applicable laws.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our compliance with these laws and regulations may be onerous and could increase our cost of doing business, impact our competitive position relative to our peers or otherwise have an adverse impact on our business, reputation, financial condition and operating results.  For more information about government regulations applicable to our business, refer to &#8220;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Risk Factors</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8221; in Item 1A.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">U.S. Market</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">According to the U.S. Department of Commerce (&#8220;DOC&#8221;), in 2019 the United States imported a record 886 million pounds (402 thousand metric tons) of Atlantic salmon with an aggregate market value of approximately $4.0 billion, or $4.49 per pound. The vast majority of the imported Atlantic salmon originated from Chile, Canada, and Norway. The Atlantic salmon farming industry in the United States contracted significantly beginning in the 1990s in the face of environmental concerns and lower costs of production from foreign sources, notably Chile. According to FAO, a total of only 36 million pounds (16.5 thousand metric tons) of farmed Atlantic salmon was produced in the United States in 2019, representing only 4.0% of the total farmed Atlantic salmon supplied to the country.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Despite intensive public consumer education campaigns promoting its health benefits, seafood consumption in the United States still lags behind other protein sources and trails consumption in overseas markets. According to the USDA, during the period from 2013 to 2018, annual seafood consumption in the United States ranged between 14 and 16 pounds per capita, significantly behind consumption of poultry (70 to 78 pounds), beef (51 to 55 pounds), and pork (43 to 47 pounds). In comparison, according to FAO, average seafood consumption worldwide was 45 pounds per capita in 2018.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Consumer Sentiment Regarding Genetically Engineered Fish</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Though Atlantic salmon is the second most consumed seafood in the United States, activist groups opposing genetically engineered foods have pressured a number of retail food outlets and grocery chains to publicly state that they will not carry genetically engineered salmon.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">However, currently we do not expect that this will have a significant impact on overall consumer demand and product placement in the marketplace generally, and in particular the wholesale marketplace. To date, large wholesalers have not followed the example of these retailers, and we have sold our GE Atlantic salmon from both our Indiana and Prince Edward Island farms since commencing harvesting in May 2021.  We believe that there will be sufficient demand from smaller retailers, wholesalers, and institutional seafood buyers to absorb our projected production. We believe that the FDA approval reinforces the message that our salmon is a safe and nutritious seafood product that is identical to conventional farmed Atlantic salmon.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We believe that consumer sentiment towards genetically engineered foods is evolving.  Based on market research that we commissioned, the top attributes for consumer selection of farm-raised salmon are availability, affordability, freshness, safety, and taste.  According to the poll conducted, 53% of respondents had a first impression of genetically engineered food that was neutral to very positive; 60% were neutral to very likely to purchase genetically engineered products they buy regularly if labeled as such; 70% were neutral to very likely to purchase genetically engineered products they buy regularly if labeled with the USDA Bioengineered Disclosure Symbol; 81% were neutral to very positive to the AquaBounty and our GE Atlantic salmon story and product benefits; and 70% were likely to purchase and try our salmon at least once.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Sales Plan</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The salmon distribution system in the United States is complex and varied. Participants include fishermen, fish farmers, processors, importers, secondary processors, broadline distributors, specialty seafood distributors, brokers, traders, and many different kinds of retail and food service companies. Salmon distribution channels are evolving, with fewer and larger distributors handling an increasing </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">7</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">share of total volume and an increasing share of salmon being sold directly by large fish-farming companies and large wild salmon processors to large retail and food service chains. Our GE Atlantic salmon is currently being sold into this distribution network with an initial focus on seafood distributors and wholesalers.  This is due to our limited supply of fish, which necessitates our being selective in bringing on new customers.  We expect that once our Ohio farm is in commercial operation, we will be able to expand our customer depth and breadth and increase our channel coverage.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As a commodity food item, the price of Atlantic salmon is variable based on the supply and demand for product weekly.  We base our pricing on a published index by Urner Barry, which provides comprehensive market coverage across all major center-of-the-plate food proteins, taking into account differences for fish size and quality.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Competition</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The global Atlantic salmon farming industry includes several very large companies with operations in each of the major producing countries. Consolidation has been evident in the past few years as producers attempt to gain competitive cost advantages while overcoming the regulatory challenges associated with developing new marine farm sites. Major market producers include the following companies: Mowi, Aquachile, Cermaq, Leroy Seafood Group, SalMar, Cooke Aquaculture, and Bakkafrost. According to Kontali, these seven companies accounted for approximately 47% of the Atlantic salmon produced in 2019.  Since salmon is primarily sold as a commodity in the United States, we will compete against these well-established, sea-cage production companies.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition, new entrants to salmon production have emerged that plan to use land-based RAS facilities. A number of projects are either planned, under construction or in operation.  Atlantic Sapphire is operating a ten thousand metric ton facility in Florida, with stated plans to increase production to over 220 thousand metric tons.  Other entrants include Nordic Aquafarms, with plans for facilities in Maine and California, and Whole Oceans and Aquabanq, both with plans for farms in Maine.       </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Operations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Current Production</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We currently have two salmon farms in production &#8211; a refurbished 1,200 metric ton facility in Indiana and a 250 metric ton demonstration facility on Prince Edward Island.  Our first harvests of conventional salmon in Indiana commenced in June 2020 and our first harvests of our GE Atlantic salmon commenced in June 2021 at both of our farms.  At December 31, 2021, we had a total farm biomass of 469 metric tons.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Impact of COVID-19</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although COVID-19 vaccines have become more readily available in the United States and other parts of the world, several variants of the virus continue to spread.  Local governmental authorities in the United States and Canada have issued, and continue to update, directives aimed at minimizing the spread of the virus and the Company continues to monitor its status.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The ultimate impact of the evolving COVID-19 pandemic on our operations will depend on future developments, which cannot be predicted with confidence, and we cannot predict the extent or impact of the extended period of continued business interruption and reduced operations caused by the COVID-19 pandemic or any additional preventative or protective measures taken in response. In connection with the COVID-19 pandemic, we made modifications to our biosecurity procedures at our farm sites in early 2020 to adapt to local requirements and to provide a safe work environment. Our current preventative and protective measures include, but are not limited to, segregating farm workers to specific locations, rotating shifts, and monitoring worker temperatures upon arrival at our facilities. In certain circumstances, we utilized, and continue to utilize, work-from-home arrangements for employees that do not have fish care responsibilities. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As a result of the COVID-19 pandemic, we have experienced delays and cost increases in capital projects, additional challenges in our efforts to meet the capacity expectations at our existing facilities and we continue to experience extended lead times on equipment purchases.  We may continue to experience delays and cost increases on farm construction, purchases of capital equipment and supplies and other materials required in our operations due to vendor shortages and labor shortages. We also expect to continue to be impacted by transportation or other supply chain disruptions to our partners or customers. In addition, we are carefully managing and monitoring the impact of labor shortages on our ability to meet the annual capacity expectations at our existing facilities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We were initially impacted by a reduction in the market price and demand for Atlantic salmon due to the pandemic&#8217;s impact on the food service sector. This had a negative impact on revenue and inventory value, as we were not yet an established vendor and customers appeared reluctant to add a new supplier during a period of depressed demand.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">8</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the second half of 2021, we were impacted by a shortage of labor at our Indiana farm and increased costs for third-party processing and transportation. This had a negative effect on revenue and inventory values and resulted in higher than expected sales costs for the period.  This is expected to continue for the foreseeable future.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We remain focused on maintaining a strong balance sheet, liquidity, and financial flexibility and we continue to monitor developments as we deal with the disruptions and uncertainties from a business and financial perspective related to the evolving COVID-19 pandemic.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">North America Plan</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our longer-term business plan contemplates that we will construct and operate four to five new, land-based RAS farms in North America at locations close to consumer consumption. Our target is to achieve an annual production output of at least 50,000 metric tons within the next seven to ten years.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2021, we selected Pioneer, Ohio as the site location for our first 10,000 metric ton farm.  Based on the engineering design that has been completed, we have estimated that the roughly 479,000 square foot facility will cost between $290 million and $320 million to construct.  We have commenced site construction activities and our targeted timeline for the introduction of our first batch of GE Atlantic salmon eggs is the end of 2023, pending the required facility approval by the FDA.  Our plan to finance the construction of the farm includes both equity and debt components.  In October 2021, the Board of Directors of the Toledo-Lucas County Port Authority approved the issuance of up to $300 million in municipal bonds for our project.  We are currently proceeding with the bond financing and expect to close the transaction in the second quarter of 2022.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The work that we have done to date on the design of the Ohio farm will serve as a template for future farm projects, though we will continue to incorporate the learnings from our current farm operations and our philosophy of continual improvement. The picture below shows a design rendering of the inside of the farm. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="aqb-20211231x10kg005.jpg" style="width: 6.246878in; height: 3.391161in" alt="Picture 5" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">                Source: AquaBounty</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Egg Production</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have scaled-up our egg production capability at our Fortune and Rollo Bay hatcheries on Prince Edward Island and we can now produce over 10 million eyed eggs annually, which is more than our current internal demand.  As there is a shortage of supply of salmon eggs in the market, we have begun to sell our excess conventional salmon eggs and fry to other salmon farmers.  We have also made the decision to increase our egg production capacity over the next several years to 30 million eyed eggs annually, which would be sufficient to stock six 10,000 metric ton farms.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">9</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">International Plans</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">While our primary focus is on North America, we also plan to expand internationally, targeting those markets that are net salmon importers, unable to supply their domestic needs and where we believe we will have success in gaining further regulatory approvals and consumer acceptance.  Once approved in these locations, we plan to commercialize through a combination of partnerships, joint ventures, and licensing arrangements.  Consequently, we have targeted Brazil, Israel and China as potential markets. In Brazil, we have received approval for the sale and consumption of our fish, and we are now seeking to identify a local partner.  In Israel, we have selected a partner and we are preparing our regulatory application.  In China, we have received approval from regulators to conduct field trials and have reviewed the commercial landscape.  Once field trials are underway, we will commence a search for a local partner.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Growth Strategy</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Optimizing Technology and Innovating for the Future</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are exploring the potential development of a range of additional products, including a second generation of our GE Atlantic salmon to help ensure 100% sterility, molecular sterility systems to provide an improved means of sterility for farmed fish, and improved methods for generating genetically engineered fish.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our primary research and development operations are located in our owned hatcheries on Prince Edward Island. As of December 31, 2021, we employed 34 scientists and technicians to oversee our broodstock, as well as the lines of fish we maintain for research and development purposes. In addition, we contract some research activities to third parties.  In the future, we may enter into other partnerships and collaboration agreements to advance our research and development efforts.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="aqb-20211231x10kg006.jpg" style="width: 6.353372in; height: 2.187227in" alt="Picture 10" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Vertical and horizontal integration</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may have multiple opportunities to vertically integrate and strategically increase our value-added capabilities within the seafood industry.  These capabilities can be obtained by building and developing in-house, forming partnerships, direct investment or through acquisition.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">10</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="aqb-20211231x10kg007.jpg" style="width: 6.747222in; height: 2.626882in" alt="Picture 8" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We could also seek to expand our production capabilities in adjacent markets, including:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Di</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">versify into additional high value species such as shrimp, trout, or tuna.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Evaluate</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> markets for inputs and by-products such as animal feed, fish meal and fish oil.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Acquire</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> new production technologies such as cellular aquaculture in the rapidly growing bio-engineered food market.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Human Capital Resources</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We believe in the positive impact that a team-based management structure delivers.  We empower our people by placing decision making power at the team level; driven by those closest to the work.  We provide training opportunities to our teams to continually improve their decision-making skills. Our recent development initiatives included introduction to lean and continuous improvement, leadership coaching skills, and goal setting and coaching performance.  We believe such initiatives ensure our team&#8217;s alignment with our company&#8217;s expectations, and when coupled with our confidence in our people&#8217;s abilities, our team is positioned to succeed. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2021, we had 95 team members, 72 of which were in our farm operations and 11 in research and technical support functions.  As of December 31, 2021, we had 12 corporate team members who provided support to all of our operations and were responsible for the execution of all corporate functions, including executive, operational, finance, information technology, legal, and corporate communications. None of our team members are represented by a labor union, and we consider our employee relations to be good.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We structure our compensation packages to compete for the best talent. Our compensation packages include a competitive base salary and health and wellness benefits, along with a 401(k) retirement plan that includes a Company match.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We made modifications to our biosecurity procedures at our farm sites in response to the COVID-19 pandemic, including segregating farm workers to specific locations, rotating shifts, and monitoring worker temperatures upon arrival at our facilities. In certain circumstances, we utilized, and continue to utilize, work from home arrangements for team members that did not have fish care responsibilities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Recent Events</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2020, we completed a series of public offerings, resulting in the aggregate issuance of 33,028,000 shares of common stock for net proceeds of approximately $104.6 million and we issued 713,449 shares of common stock through the conversion of outstanding warrants for total proceeds of $2.3 million.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2021, we completed a public offering of 14,950,000 shares of common stock for net proceeds of approximately $119.2 million. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2021, we had a balance of $191.2 million in cash and cash equivalents, marketable securities and restricted cash.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">11</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;1A.&#160;&#160;Risk Factors</span><span id="Section6" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following are certain risk factors that could affect our business, financial condition, and results of operations. You should carefully consider the risks described below, together with the other information contained in this Annual Report on Form 10&#8209;K, including our consolidated financial statements and the related notes. We cannot assure you that any of the events discussed in the risk factors below will not occur. These risks could have a material and adverse impact on our business, results of operations, financial condition, or prospects. If that were to happen, the trading price of our common stock could decline, and you could lose all or part of your investment.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This Annual Report on Form 10&#8209;K also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks faced by us described below and elsewhere in this Annual Report on Form 10&#8209;K. See &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; for information relating to these forward-looking statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Risks Relating to our Business and Operations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We have a history of net losses and will likely incur future losses and may not achieve or maintain profitability.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In the period from incorporation to December 31, 2021, we have incurred cumulative net losses of approximately $171&#160;million. These losses reflect our personnel, research and development, production and marketing costs. We have constructed a 250 metric ton annual capacity production facility in Rollo Bay and in 2017 we acquired a facility in Indiana, which has undergone renovations to increase its annual capacity to 1,200 metric tons. We expect revenues to grow modestly in 2022 as we increase our weekly harvesting capability at our Indiana farm.  However, our ability to realize revenues and the timing thereof are not certain, and achieving revenues does not assure that we will become profitable.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Our business plans include the need for substantial additional capital and without it we may not be able to implement our strategy as planned or at all. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0.22in;margin-top: 5pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our strategy depends on our ability to develop and construct additional farms, including our planned Ohio farm. We have not yet begun construction of this farm and its construction, and others in the future, is contingent on a number of significant uncertainties, including those described below. As a result, we may be unable to construct such facilities as planned or at all. We may not be able to obtain the financing necessary to commence construction of our proposed facilities. We estimate that the construction cost for the Ohio farm will range between $290 million and $320 million, although this figure is likely to change as we finalize the design and proceed with construction. We do not have the financial resources required to fully finance the construction of the Ohio farm. We will seek to raise part of these necessary funds through debt financing. We may also need further funding if there are delays in construction or increased construction costs at our proposed construction site in Ohio. We may finance unanticipated construction costs by issuing equity securities or debt. The delay or failure of regulatory bodies to approve our construction plans, disruption and volatility in the financial markets, tighter credit markets and a downturn in the seafood market may negatively impact our ability to obtain financing. We may not have access to the required funding, or funding may not be available to us on acceptable terms.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0.22in;margin-top: 5pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">While we are currently completing the remaining contingencies for the acquisition of the site in Ohio for this farm, if we are unable to secure this location or others for future farms that satisfy our requirements, our business and results of operations would be materially and adversely impacted.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0.22in;margin-top: 5pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may not be able to obtain the approvals and permits that will be necessary in order to construct our facilities as planned. We will need to obtain a number of required permits in connection with the hydrology, construction and operation of our farms, which is often a time-consuming process. If we experience delays in obtaining the required approvals and permits for our farms, our expected construction start date, commercial stocking and first sale of our GE Atlantic salmon may be delayed. If we are unable to obtain the required approvals and permits for our farms, we will not be able to construct the farms. In addition, federal, state and local governmental requirements could substantially increase our costs, which could materially harm our results of operations and financial condition.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0.22in;margin-top: 5pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have encountered cost increases in the expected construction cost of the Ohio farm, and may encounter further unanticipated difficulties and cost overruns in constructing this farm and other future farms. Preparing cost and timing estimates for complex RAS farms is inherently difficult and subject to change based on a number of factors, including site availability and characteristics, design changes, fluctuating costs of materials, labor shortages, the impact of the COVID-19 pandemic, construction delays, dependence on contractors, financing costs, customer requirements and other unexpected complications.  As a </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">12</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0.22in;margin-top: 5pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">result, we may encounter unanticipated difficulties and the construction and development of our proposed farms may be more costly or time-consuming than we anticipate.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0.22in;margin-top: 5pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Delays and defects may cause our costs to increase to a level that would make one or more of our farms too expensive to construct or unprofitable. We may suffer significant delays or cost overruns at our farms that could prevent us from commencing operations as expected as a result of various factors. These factors include shortages of workers or materials, construction and equipment cost escalation, transportation constraints, adverse weather, unforeseen difficulties or labor issues, or changes in political administrations at the federal, state or local levels that result in policy change towards genetically engineered foods in general or our products and farms in particular. Defects in materials or workmanship could also delay the commencement of operations of our planned farms, increase production costs or negatively affect the quality of our products. Due to these or other unforeseen factors, we may not be able to proceed with the construction or operation of our farms in a timely manner or at all.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.22in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Ethical, legal, and social concerns about genetically engineered products could limit or prevent the use of our products and limit our revenues.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.22in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our technologies include the use of genetic engineering. Public perception about the safety and environmental hazards of, and ethical concerns over, genetically engineered products could influence public acceptance of our technologies and products. Activist groups opposing the genetic engineering of organisms have in the past pressured a number of retail food outlets and grocery chains to publicly state that they will not carry genetically engineered Atlantic salmon, and they could file lawsuits to prevent the production and sale of our products. If we are not able to overcome the ethical, legal, and social concerns relating to genetic engineering, products using our technologies may not be accepted in the marketplace, and demand for our products could fall short of what we expect. These concerns could also result in increased expenses, regulatory scrutiny, delays, or other impediments to implementation of our business plan. For example, in January 2021, Representative Don Young of Alaska introduced legislation (HR-273), which was referred to the House Natural Resources Committee. The legislation, if passed, would prohibit our business unless we obtain an exemption from the Department of Commerce&apos;s National Oceanic and Atmospheric Administration, who in consultation with the Fish and Wildlife Service, would need to conduct additional environmental assessments to show &#8220;no significant impact.&#8221; In July 2021, Congressman Young testified before the House Natural Resources Committee&#8217;s sub-committee on Water, Oceans and Wildlife with respect to the legislation but there has not been additional support for the legislation and no further movement on the bill, to date.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The subject of genetically engineered products has received negative publicity, which has aroused public debate. This adverse publicity could lead to lawsuits against the production, distribution, and sale of genetically engineered products; greater regulation of those products; and trade restrictions on their importation. Further, there is a concern that products produced using our technologies could be perceived to cause adverse events, which could also lead to negative publicity.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may have limited success in gaining consumer acceptance of our products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There is an active and vocal group of opponents to genetically engineered products who wish to ban or restrict the technology and who, at a minimum, hope to sway consumer perceptions and acceptance of this technology. Their efforts include regulatory legal challenges and labeling campaigns for genetically engineered products, as well as application of pressure to multiple channels of distribution including, but not limited to distributors, food service operators, and consumer retail outlets seeking a commitment not to carry genetically engineered Atlantic salmon. Consumer acceptance could also be adversely affected if our GE Atlantic salmon were believed to grow to a larger final size than conventional Atlantic salmon. We may not be able to overcome the negative consumer perceptions that these organizations have instilled against our products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Our business is affected by the quality and quantity of the salmon that we harvest.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We sell our products in a highly competitive market.  Our ability to successfully sell our products, and the price that we receive, is highly dependent on the quality of the salmon that we produce.  A number of factors can negatively affect the quality of the salmon that we sell, including the quality of our broodstock, water conditions in our farms, the food and additives consumed by our fish, population levels in the tanks, and the amount of time that it takes to bring a fish to harvest, including transportation and processing. We have experience operating RAS facilities and raising salmon, and while we actively monitor these factors using rigorous standard operating procedures, we cannot always ensure optimal growing conditions.  Although fish grown in RAS production systems are not subject to the disease and parasite issues that can affect salmon grown in ocean pens, there is the potential for organisms that are ubiquitous to freshwater environments to become pathogenic if the fish are subjected to stressful conditions or there is an issue with biomass management. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We maintain high standards for the quality of our product and if we determine that a harvest has not met such standards, we may be required to reduce our inventory and write down the value of the harvest to reflect net realizable value.  Sub-optimal conditions could lead to smaller harvests and or lower quality fish.  Conversely, if we experience better than expected growth rates, we may not be able </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">13</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to process and bring our fish to market in a timely manner, which may result in overcrowding that can cause negative health impacts and/or require culling our fish population.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Further, if our salmon is perceived by the market to be of lower quality than other available sources of salmon or other fish, we may experience reduced demand for our product and may not be able to sell our products at the prices that we expect or at all. For  example, we concluded 2020 with a conventional Atlantic salmon harvest that met our high standards for nutrition, taste and texture. However, unlike our GE Atlantic salmon, the conventional salmon did not achieve the same high level of color consistency, due in part to the maturity of the male population and the quality of the ingredients in the feed. We identified and successfully addressed the source of the color inconsistency in the conventional salmon, and our production plans call for only raising our all-female GE Atlantic salmon moving forward.  However, we reduced the net realizable value of our conventional salmon to $0 as of December 31, 2020 as we decided to donate the entire conventional salmon biomass during the first and second quarters of 2021.  As we continue to expand our operations and build new farms, we potentially may face additional challenges with maintaining the  quality of our products.  We cannot guarantee that we will not face quality issues again in the future, any of which could cause damage to our reputation, and a loss of consumer confidence in our products, which could have a material adverse effect on our business results and the value of our brands.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition, we may be required to recall some of our products if they spoil, become contaminated, are tampered with or are mislabeled. A widespread product recall could result in significant losses due to the costs of a recall, the destruction of product inventory and lost sales due to the unavailability of product for a period of time. Such a product recall also could result in adverse publicity, damage to our reputation, and a loss of consumer confidence in our products, which could have a material adverse effect on our business results and the value of our brands.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.22in;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may experience a significant fish mortality event in our broodstock or our production facilities that could impact the price of our common stock.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.22in;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.22in;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In recent periods, other companies in the land-based aquaculture industry have experienced fish mortality events that resulted in a decline in their share price. It is possible that our operations could experience a significant fish mortality event due to, among other causes, disease, pathogens, human error, intentional malfeasance, a weather event, loss of access to electricity or water, or damage to our farms, or other factors beyond our control.  If we were to have a significant fish mortality event, this could lead to a reduction in production harvests, loss of broodstock, loss of revenue, increased production costs, and public relations damage, the result of which could impact the price of our common stock.   </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">A shutdown, damage to any of our farms, or lack of availability of power, fuel, oxygen, eggs, water, or other key components needed for our operations, could result in our prematurely harvesting fish, a loss of a material percentage of our fish in production, a delay in our commercialization plans, and a material adverse effect on our operations, business results, reputation, and the value of our brands.&#160;&#160; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">At present, we only have farms in Albany, Indiana, and Prince Edward Island, Canada. As an interruption in the power, fuel, oxygen supply, water quality systems, or other critical infrastructure of an aquaculture facility for more than a short period of time can lead to the loss of a large number of fish, any shutdown of or damage to either of our farms&#8212;for example, due to weather or other natural disaster, shortages of key components to our operations due to a pandemic, reduction in water supply, contamination of our aquifers, interruption in services beyond our backup capacity, or human interference&#8212;could require us to prematurely harvest some or all of the fish at that farm or could result in a loss of a material percentage of our fish in production. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We also are dependent on egg availability and being able to ship genetically engineered Atlantic salmon eggs from Canada to the United States for production.&#160; If we had a disruption in our ability to produce our eggs in Canada or ship our eggs to the United States, due to border closings or some other event that would prevent us from importing the eggs to the United States, we would not be able to continue to stock our Indiana Farm with genetically engineered Atlantic salmon eggs.&#160; We cannot guarantee that any of these disruptions might not occur in the future, any of which could cause loss of salmon to sell, damage to our reputation, loss of consumer confidence in our products and company, and lost revenues, all of which could have a material adverse effect on our business results and the value of our brands.</span></p><p dir="ltr" style="font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Security breaches, cyber-attacks and other disruptions could compromise our information, expose us to fraud or liability, or interrupt our operations, which would cause our business and reputation to suffer.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In the ordinary course of our business, we use our servers and networks to store sensitive data, including our proprietary business and financial information; general business information regarding our customers, suppliers, and business partners; and personally identifiable information of our employees; and to operate our farm equipment. The security of our network and the storage and maintenance of sensitive information is critical to our operations. Despite our security measures, our information technology and </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">14</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">infrastructure may be vulnerable to cyber-attacks by hackers or breached due to employee error or malfeasance. A breach of our security could compromise our networks and the information stored on our servers could be accessed, manipulated, publicly disclosed, lost, or stolen.  Any such access, manipulation, disclosure, or loss of information could result in errors in our records, fraudulent use of our financial information or theft of assets, legal claims or proceedings, liability under laws that protect the privacy of personal information, theft of our intellectual property, or damage to our reputation. In addition, our systems could be the subject of denial of service or other interference, which could disrupt our operations and commercial transactions.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition, with the continued automation of our farm operations, there is the possibility of exposure to critical assets or sensitive information loss stemming from a cyber-attack on communication interfaces with outside vendors, which could adversely impact our farm operations.  Any of the foregoing could adversely affect our business, revenues, and competitive position.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">The successful development of our business depends on our ability to efficiently and cost-effectively produce and sell salmon at large commercial scale.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although we have over two decades of experience in successfully raising Atlantic salmon in land-based systems, we have only begun to produce them at commercial scale. Our business plans depend on our ability to increase our production capacity through the development of larger farms. We have limited experience constructing, ramping up, and managing such large, commercial-scale facilities, and we may not have anticipated all of the factors or costs that could affect our production, harvest, sale, and delivery of salmon at such a scale. For example, our salmon may not perform as expected when raised at very large commercial scale, we may encounter operational challenges for which we are unable to identify a workable solution, control deficiencies may surface, our vendors may experience capacity constraints, or our production cost and timeline projections may prove to be inaccurate. Any of these could decrease process efficiency, create delays, and increase our costs. We are also subject to volatility in market demand and prices, such as the disruption to the salmon market and the resulting reduction in market prices for salmon caused by the COVID-19 pandemic.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition, competitive pressures, customer volatility and the possible inability to secure established and ongoing customer partnerships and contracts, may result in a lack of buyers for our fish.  Customers of our fish may not wish to follow our terms and conditions of sale, potentially resulting in a violation of labeling or disclosure laws, improper food handling, nonpayment for product, and similar issues.  The competitive landscape for salmon may create challenges in securing competitive pricing for our salmon to reach our competitive goals.  In addition, it is possible that we may not be able to service our customers to meet their expectations regarding fish quality, ongoing harvest supply availability, order processing fill rate, on time or correct deliveries, potential issues with third party processors, and other factors, which could impact our relationships with customers, our reputation, and our business results.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We remain dependent on third parties for the processing, distribution, and sale of our products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">At present, we rely on third parties to process our fish, deliver them to seafood vendors, and ultimately sell them to consumers. While we carefully select processors or other intermediaries in the supply chain, any failure on their part to maintain quality standards or proper food handling processes could subject us to product liability claims, product recalls, increased scrutiny from regulators, and loss of consumer confidence in the safety and quality of our products. Seafood vendors may reject our products due to their particular product or volume requirements, extract pricing concessions that reduce our margins, or fail to adequately promote and sell our products. Our reliance on third parties could therefore result in a reduction in our revenues, an increase in our costs, delays in commercialization, additional regulatory requirements, or negative public opinion that could impact future sales and growth.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may be required to write-down the value of our inventory if its net realizable value is less than its accumulated cost at the end of a reporting period.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our fish-in-process inventory is a biological asset and is stated on our balance sheet at the lower of cost or net realizable value, where net realizable value is calculated as the estimated market price less the estimated costs of processing, packaging and transportation. Any adjustments to the carrying value of inventory are reported as a component of production costs on our income statement. Such adjustments may be material in any given period and could adversely affect our financial condition and results of operations. Until such time as our net realizable value is consistently in excess of inventory costs, our inventory may be subject to significant market value risk. During the third quarter of 2021, we recognized a $1.5 million charge to reduce the value of our inventory to its net realizable value, based on our current quarter production yields and transportation costs which were higher than our expectations as of the end of the second quarter of 2021.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">15</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">If our products become contaminated, we may be subject to product liability claims and product recalls, which could adversely affect our financial results and damage our reputation.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Food safety issues (both actual and perceived) may have a negative impact on, the reputation of and demand for, our products. In addition to the need to comply with relevant food safety regulations, it is of critical importance that our products are safe and perceived as safe and healthy in all relevant markets. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our products may be subject to contamination by foreign materials or disease-producing organisms or pathogens, such as Listeria monocytogenes, Salmonella and E. coli. These organisms and pathogens are found generally in the environment and there is a risk that one or more, as a result of food processing, could be present in our products. These organisms and pathogens also can be introduced to our products as a result of improper handling at the further-processing, foodservice or consumer level. These risks may be controlled, but may not be eliminated, by adherence to good manufacturing practices and finished product testing. We have little, if any, control over handling procedures once our products have been shipped for distribution. Even an inadvertent shipment of contaminated products may be a violation of law and may lead to increased risk of exposure to product liability claims, increased scrutiny and penalties, including but not limited to, injunctive relief and plant closings, by federal and state regulatory agencies, and adverse publicity, which could exacerbate the associated negative consumer reaction. Any of these occurrences may have an adverse effect on our financial results and the value of our brands. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition, we may be required to recall some of our products if they spoil, become contaminated, are tampered with or are mislabeled. A widespread product recall could result in significant losses due to the costs of a recall, the destruction of product inventory and lost sales due to the unavailability of product for a period of time. Such a product recall also could result in adverse publicity, damage to our reputation, and a loss of consumer confidence in our products, which could have a material adverse effect on our business results and the value of our brands.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">The loss of our GE Atlantic salmon broodstock could result in the loss of our commercial technology.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our GE Atlantic salmon, or more specifically the breeding population of live fish, or broodstock, themselves, is a product of our combined intellectual property, which includes our trade secrets related to creating and maintaining the broodstock. Destruction of our salmon broodstock by whatever means would result in a significant delay to our operations while the broodstock was replenished. Live animals are subject to disease that may, in some cases, prevent or cause delay in the export of fish or eggs to customers. Disease organisms may be present undetected and transferred inadvertently. In addition, our broodstock is kept at a limited number of facilities, and damage to or failure of critical systems at any one of those facilities could lead to the loss of a substantial percentage of our broodstock. Such events may cause loss of revenue, increased costs, or both. The broodstock, however, could be reinstated, in whole or in part, using our technology and stored breeding reserves.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Business, political, or economic disruptions or global health concerns, such as the COVID-19 pandemic, could seriously harm our current or planned business and increase our costs and expenses.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Broad-based business or economic disruptions, political instability, or global health concerns could adversely affect our current or planned production, sale, distribution, research and development, and expansion. For example, the COVID-19 pandemic has continued to spread, and the related adverse public health developments, including orders to shelter-in-place, travel restrictions, and mandated business closures, have adversely affected workforces, organizations, customers, economies, and financial markets globally, leading to an economic downturn and increased market volatility. It has also disrupted the normal operations of many businesses, including ours.&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Global health concerns like the COVID-19 pandemic could in themselves result in social, economic, and labor instability in the countries in which we or the third parties with whom we engage operate. The COVID-19 pandemic and government measures taken in response have also had a significant impact, both direct and indirect, on businesses and commerce, as worker shortages have occurred.  These impacts include the shortage of packaging workers and transportation suppliers that we have experienced, leading to slower and more expensive harvests; supply chains have been disrupted; facilities and production have been suspended; and demand for certain goods and services, such as medical services and supplies, has spiked, while demand for other goods and services, including salmon in the institutional sales chain that includes restaurants, has fallen, with a resulting drop in the prices for those goods and services. We have been impacted by the reduction in food service demand for salmon due to the pandemic in the form of significantly lower than expected sales and a reduction in the value of our inventory. In response to the COVID-19 pandemic, we have provided our administrative employees with the option to work remotely, and we have limited the number of staff in any given area of our farm sites. We have also implemented policies and procedures at our farms to react to any outbreak of the virus.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As a result of the COVID-19 pandemic, we have and may continue to experience disruptions that could severely impact our business, including disruptions or restrictions on our ability to travel, obtain regulatory approvals from the FDA and other regulators, pursue </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">16</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">partnerships and other business transactions, conduct production activities, and make shipments, as well as be impacted by the temporary closure of the facilities of suppliers. While we have taken steps to address the impact of the coronavirus on our operations, we and our service providers have experienced labor and transportation shortages that have slowed the pace and increased the expense of commercial harvests of our products. In addition, labor shortages are creating additional challenges to our efforts to meet the annual harvest expectations at our existing facilities, which has necessitated increased culling to rebalance the biomass of our fish and lower our stocking densities. Though we believe this action will position us to achieve an annual harvest volume of 1,200 metric tons at the farm, we do not expect to reach this level during the next twelve months.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We also cannot presently predict the scope and severity of any additional business shutdowns or disruptions or the future impact on consumer demand. For example, we have been primarily impacted by a reduction in the market price and demand for Atlantic salmon due to the pandemic&#8217;s impact on the food service sector. This had and continues to have a negative impact on our revenue and inventory value. If we or any of the third parties with whom we engage, including suppliers, distributors, service providers, regulators, and overseas business partners, experience additional or continued shutdowns or other disruptions, or consumer demand remains materially reduced, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively impacted, our anticipated revenues could decrease, and our costs and expenses could continue to rise as a result of our efforts to address such disruptions.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition, the trading prices for our common stock and the stock of other biotechnology and food companies have been highly volatile as a result of the COVID-19 pandemic. As a result, we may face difficulties raising capital through sales of our common stock or such sales may be on unfavorable terms. The COVID-19 pandemic continues to rapidly evolve, and the extent to which it may impact our business and planned programs will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease; the duration of the pandemic; travel restrictions and other actions to contain the pandemic or address its impact, such as social distancing and quarantines or lock-downs in the United States, Canada, and other countries; business closures or business disruptions; and the effectiveness of actions taken in the United States, Canada, and other countries to contain and address the disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">The construction and potential benefits of our new facilities are subject to risks and uncertainties.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For any new facility that we build, our ability to complete construction on a timely basis and within budget is subject to a number of risks and uncertainties. In order to complete construction of a new facility, we need to take a significant number of steps and obtain a number of approvals and permits, none of which is assured of attainment.  If we are unable to obtain the required permits, complete construction on schedule, run the facility efficiently, or otherwise achieve the expected benefits of our new facilities, our business could be negatively affected. In addition, when a new facility becomes operational, it may not generate the benefits we expect if demand for the products to be produced by the facility is different from what we had expected or if we do not operate the facility efficiently.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Industry volatility can affect our earnings, especially due to fluctuations in commodity prices of salmon.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Profitability in the salmon industry is materially affected by the commodity price of salmon, and to a lesser extent, alternative proteins. These prices are determined by supply and demand factors and can fluctuate by season. For example, the COVID-19 pandemic impacted market demand for salmon, which resulted in market prices falling by up to 40% for certain product presentations.  Conversely, given the long grow-out cycle for raising salmon, disruptions in production can depress market supply and result in price increases.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">If we lose key personnel, including key management personnel, or are unable to attract and retain additional personnel, it could delay our commercialization plans or harm our research and development efforts, and we may be unable to sell or develop our own products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our success depends substantially on the efforts and abilities or our officers and other key employees. The loss of any key members of our management, or the failure to attract or retain other key employees who possess the requisite expertise for the conduct of our business, could prevent us from developing and commercializing our products and executing on our business strategy. We may not be able to attract or retain qualified employees in the future due to the intense competition for qualified personnel among aquaculture, biotechnology, and other technology-based businesses, or due to the unavailability of personnel with the particular qualifications or experience necessary for our business. For production positions, effective training will be needed for new hires due to the overall lack of industry experience in land-based aquaculture in North America. If we are not able to attract, train, and retain the necessary personnel to accomplish our business objectives, we may experience staffing constraints that could adversely affect our ability to meet the demands of our customers in a timely fashion, adequately staff existing or new production facilities, or support our internal research and development programs. In particular, our production facilities require individuals experienced or trained in RAS-based aquaculture, and our product development programs are dependent on our ability to attract and retain highly skilled scientists. </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">17</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Competition for experienced production staff, scientists, and other technical personnel from numerous companies and academic and other research institutions may limit our ability to attract and retain such personnel on acceptable terms.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Atlantic salmon farming is restricted in certain states.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Concerns regarding the possible environmental impact from our GE Atlantic salmon have led several states to impose legislative and regulatory restrictions or bans on its farming. In addition, some states, such as Alaska, have enacted restrictions on Atlantic salmon farming generally. While we currently believe that many states offer excellent potential sites for our salmon production farms, if additional states adopt similar restrictions, or otherwise prohibit the rearing of our GE Atlantic salmon in those states, the number of potential sites available to us for production farms in the United States could be reduced.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Atlantic salmon farming is subject to disease outbreaks, which can increase the cost of production and/or reduce production harvests.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Salmon farming systems, particularly conventional, open sea-cage systems, are vulnerable to disease introduction and transmission, primarily from the marine environment or adjacent culture systems. The economic impact of disease to these production systems can be significant, as farmers must incur the cost of preventative measures, such as vaccines and antibiotics, and then, if the fish become infected, the cost of lost or reduced harvests.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although we will produce and grow our GE Atlantic salmon in land-based, closed containment facilities, we will still be at risk for potential disease outbreaks. We have implemented biosecurity measures in our facilities intended to prevent or mitigate disease impact, but there can be no assurance that any measures will be 100% effective.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Restrictive covenants in our term loan agreement may restrict our ability to pursue our business strategies.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our term loan agreement with First Farmers Bank and Trust in the amount of $4 million contains certain customary restrictive covenants that limit our ability, including without limitation, to incur additional indebtedness and liens, merge with other companies or consummate certain changes of control, acquire other companies, engage in new lines of business and make certain investments, as well as financial covenants requiring us to maintain certain ratios with respect to our operations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our ability to comply with these covenants may be affected by events beyond our control, and we may not be able to meet those covenants.  A breach of any of these covenants could result in a default under the term loan agreement, which could cause all of the outstanding indebtedness under our term loan to become immediately due and payable.  In that event, we would be required to disclose the default in our public filings, which could have an adverse effect on the price of our shares of common stock.  These covenants could also limit our ability to seek capital through the incurrence of new indebtedness or, if we are unable to meet our obligations, require us to repay any outstanding amounts with sources of capital we may otherwise use to fund our business, operations and strategy.   </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may encounter difficulties managing our growth, which could adversely affect our business.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We could face a period of rapid growth following commercial availability of our products, which may place significant pressure on our management, sales, operational, and financial resources. The execution of our business plan and our future success will depend, in part, on our ability to manage current and planned expansion and on our ability to continue to implement and improve our operational management. Any failure to manage the planned growth may have a significant adverse effect on our business, financial condition, trading performance, and prospects.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may pursue strategic acquisitions and investments that could have an adverse impact on our business if they are unsuccessful.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If appropriate opportunities become available, we may acquire businesses, assets, technologies, or products to enhance our business in the future. In connection with any future acquisitions, we could:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">issue </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">additional</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> equity securities, which would dilute our current shareholders;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">incur </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">substantial</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> debt to fund the acquisitions; or</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">assume </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">significant</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> liabilities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Acquisitions involve numerous risks, including:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">difficulti</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">es integrating the purchased operations, technologies, or products;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">18</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">unanticipated costs and other liabilities;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">diversion of management&#8217;s attention from our core business;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">adverse effects on existing business relationships with current and/or prospective customers and/or suppliers;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">risks associated with entering markets in which we have no or limited prior experience; and</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">potential loss of k</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ey employees.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We do not have extensive experience in managing the integration process, and we may not be able to successfully integrate any businesses, assets, products, technologies, or personnel that we might acquire in the future without a significant expenditure of operating, financial, and management resources. The integration process could divert management time from focusing on operating our business, result in a decline in employee morale, or cause retention issues to arise from changes in compensation, reporting relationships, future prospects, or the direction of the business. Acquisitions also may require us to record goodwill and non-amortizable intangible assets that will be subject to impairment testing on a regular basis and potential periodic impairment charges, incur amortization expenses related to certain intangible assets, and incur large and immediate write-offs and restructuring and other related expenses, all of which could harm our operating results and financial condition. In addition, we may acquire companies that have insufficient internal financial controls, which could impair our ability to integrate the acquired company and adversely impact our financial reporting. If we fail in our integration efforts with respect to any of our acquisitions and are unable to efficiently operate as a combined organization, our business and financial condition may be adversely affected.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We have entered into agreements that require us to pay a significant portion of our future revenue to third parties.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In 2009, we received a grant from the Atlantic Canada Opportunities Agency to fund a research program. A total of C$2.9&#160;million was made available under the grant, and we received the entire amount through December&#160;31, 2015. Once we begin to generate revenue from any of the products from the research program, we must commence repayment of the outstanding loan in the form of a 10% royalty. These payments could negatively impact our ability to support our operations. Revenues from sales of our GE Atlantic salmon are not subject to the royalty.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Our financial condition or results of operations may be adversely affected by international business risks, including exchange rate fluctuation.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The majority of our employees, including our research personnel, are currently located outside of the United States. As a consequence of the international nature of our business, we are exposed to risks associated with international operations. For example, we are based in the United States and present our financial statements in U.S. dollars, and the majority of our cash resources are held in U.S. dollars or in Canadian dollars. Some of our future expenses and revenues are expected to be denominated in currencies other than in U.S. dollars. Other risks include possible governmental restrictions of the movement of funds, limitation of contractual rights, or expropriation of assets without fair compensation. Therefore, movements in exchange rates to translate to foreign currencies and other international operational risks may have a negative impact on our reported results of operations, financial position, and cash flows.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We have received government research grants and loans in the past, but such grants and loans may not be available in the future.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have in the past received government assistance in the form of research grants and loans to partially fund various research projects, including projects involving our GE Atlantic salmon. There can be no assurance that additional government assistance will be available in the future to help offset the cost of our research activities, in which case we would need to fund our research projects entirely from our available cash resources, which may be limited. This could delay progress on future product development and introduction. In addition, we may be subject to audit by the government agencies that provided research assistance to ensure that the funds were used in accordance with the terms of the grant or loan. Any audit of the use of these funds would require the expenditure of funds and result in the diversion of management&#8217;s attention.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.41in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Our ability to use net operating losses and other tax attributes to offset future taxable income may be subject to certain limitations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.41in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In general, under Sections&#160;382 and 383 of the U.S. Tax Code (the &#8220;Code&#8221;), a corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its pre-change net operating losses (&#8220;NOLs&#8221;), tax credits, or other tax attributes to offset future taxable income or taxes. For these purposes, an ownership change generally occurs where the aggregate stock ownership of one or more stockholders or groups of stockholders who owns at least 5% of a corporation&#8217;s stock increases its ownership by more than 50 percentage points over its lowest ownership percentage within a specified testing period. In addition to limitations imposed by the 2017 Tax Cuts and Jobs Act, a portion of our NOLs are subject to substantial limitations arising from previous ownership </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">19</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">changes, and, if we undergo another ownership change, our ability to utilize NOLs could be further limited by Sections&#160;382 and 383 of the Code. In addition, future changes in our stock ownership, many of which are outside of our control, could result in an ownership change under Sections&#160;382 and 383 of the Code. Our NOLs may also be impaired under state law. Accordingly, we may not be able to utilize a material portion of our NOLs. Furthermore, our ability to utilize our NOLs is conditioned upon our attaining profitability and generating U.S. federal and state taxable income.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Risks Relating to Regulated Products</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Our ability to generate revenue to support our operations depends on maintaining regulatory approvals for our GE Atlantic salmon and our farm sites and obtaining new approvals for farm sites and the sale of our products in other markets, the receipt of which is uncertain.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As a genetically engineered animal for human consumption, our GE Atlantic salmon required approval from the FDA in the United States and the Ministers of Health and Environment in Canada before it could be produced, sold, or consumed in those countries. Our FDA approval covers the production of our eggs in our hatchery in Canada and the grow-out of our eggs in our facilities in Indiana and Rollo Bay. FDA approvals will be needed for each additional facility we plan to operate. Additionally, we will require local regulatory approvals in other countries in which we hope to operate. There is no guarantee that we will receive or be able to maintain regulatory approvals from the FDA or other regulatory bodies or that there will not be a significant delay before approval. There is also no guarantee that any approvals granted will not be subject to onerous obligations in relation to matters such as production or labeling, or that any regulator will not require additional data prior to approval, which may be costly and time-consuming to acquire.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other agencies on which our operations may rely is subject to the political process, which is inherently fluid and unpredictable.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Disruptions at the FDA and other agencies may also slow the time necessary for new applications to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, in May 2021, the FDA released its Resiliency Roadmap for FDA Inspectional Oversight, which described the prioritization process for FDA inspections and oversight.  We believe that our GE Atlantic salmon would be treated as a &#8220;tier 2 - higher priority&#8221; product, but not a &#8220;tier 1 - mission critical&#8221; product.  This designation could potentially impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We will be required to continue to comply with FDA and foreign regulations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Even with the approval of our NADA and other regulatory applications for our GE Atlantic salmon, we must continue to comply with FDA and other regulatory requirements not only for manufacturing, but also for labeling, advertising, record keeping, and reporting to the FDA and other regulators of adverse events and other information. Failure to comply with these requirements could subject us to administrative or judicial enforcement actions, including but not limited to product seizures, injunctions, civil penalties, criminal prosecution, refusals to approve new products, or withdrawal of existing approvals, as well as increased product liability exposure, any of which could have a material adverse effect on our business, financial condition, or results of operations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">The markets in which we intend to sell our products are subject to significant regulations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition to our FDA approval for the sale and consumption of our GE Atlantic salmon in the United States, we are also subject to state and local regulations and permitting requirements, which could impact or delay the commercialization and commencement of revenue generation from the sale of our salmon. International sales also are subject to rules and regulations promulgated by regulatory bodies within foreign jurisdictions. There can be no assurance that foreign, state, or local regulatory bodies will approve the sale and consumption of our product in their jurisdiction.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may incur significant costs complying with environmental, health, and safety laws and regulations, and failure to comply with these laws and regulations could expose us to significant liabilities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our operations are subject to a variety of federal, state, local, and international laws and regulations governing, among other matters, the use, generation, manufacture, transportation, international shipment, storage, handling, disposal of, and human exposure to our products in both the United States and overseas, including regulation by governmental regulatory agencies, such as the FDA and the U.S. Environmental Protection Agency. We have incurred, and will continue to incur, capital and operating expenditures and other costs in the ordinary course of our business in complying with these laws and regulations. Additional laws and regulations could be adopted in the future further regulating our business.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">20</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may become subject to increasing regulation, changes in existing regulations, and review of existing regulatory decisions.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Regulations pertaining to genetically engineered animals are still developing and could change from their present state. In addition, new legislation could require new regulatory frameworks, changes in existing regulation, or re-evaluation of prior regulatory decisions. For example, despite the FDA&#8217;s final determination that our GE Atlantic salmon may be sold without being labeled as a genetically engineered product, a provision added to the 2016 Omnibus Appropriations Act required the FDA to issue final guidance for such labeling. The FDA was therefore obligated to maintain an Import Alert starting in January 2016 that prohibited import of our GE Atlantic salmon until such guidance was finalized or the provision was no longer effective. On March 8, 2019, several months after the USDA promulgated its final rule establishing the Disclosure Standard, which included disclosure requirements for bioengineered foods, including our GE Atlantic salmon, the FDA lifted the Import Alert.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Similarly, in July 2017, a bill was introduced in the United States Senate that could have, had it become law, required labeling unique to, as well as re-examination of the environmental assessments used by the FDA in its 2015 approval of the NADA for our GE Atlantic salmon. While this bill was reintroduced in January 2019 without the requirement for re-examination of those environmental assessments, any such legislatively imposed review of a completed regulatory process could result in new restrictions on, or delays in, commercialization of our product in the United States. We could be subject to increasing or more onerous regulatory hurdles as we attempt to commercialize our product, which could require us to incur significant additional capital and operating expenditures and other costs in complying with these laws and regulations. Our regulatory burdens could also increase if our GE Atlantic salmon are found, or believed, to grow to a larger final size than conventional Atlantic salmon.&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition, the 2020 Appropriations Act, which was signed into law in December 2019, contained an amendment that requires that any bioengineered animal approved by FDA prior to the effective date of the Disclosure Standard shall include the words &#8216;&#8216;genetically engineered&#8217;&#8217; prior to the existing acceptable market name. While the Company believes that this labeling requirement is unnecessary and redundant to the requirement of the Disclosure Standard, it will comply with all applicable laws. </span></p><p dir="ltr" style="font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Further, in January 2021, the U.S. House of Representatives introduced HR 273, which would place significant restrictions and regulatory requirements on our business.&#160; This act is currently under review by the House of Representatives&#8217; natural resources committee.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Additional regulatory and lawmaking activity within the United States and abroad could increase our costs and/or delay or prevent the production and sales of our GE Atlantic salmon.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We or regulatory agencies approving of our products may be sued by non-governmental organizations and others who are opposed to the development or commercialization of genetically engineered products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There are many organizations in the United States and elsewhere that are fundamentally opposed to the development of genetically engineered products. These groups have a history of bringing legal action against companies attempting to bring new biotechnology products to market. On December&#160;23, 2013, an application was filed by two NGOs with the Canadian Federal Court seeking judicial review to declare invalid the decision by the Canadian Minister of the Environment to publish in the Canadian Gazette a Significant New Activity Notice (&#8220;SNAN&#8221;) with respect to our GE Atlantic salmon. Though the Canadian Federal Court dismissed this challenge, the petitioners filed an appeal of the ruling, which was subsequently dismissed by the Canadian Federal Court of Appeal on October&#160;21, 2016.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On March 30, 2016, a coalition of non-governmental organizations filed a complaint in the United States District Court for the Northern District of California against the FDA, the United States Fish and Wildlife Service, and related individuals for their roles in the approval of our GE Atlantic salmon.  Subsequently, the Fish and Wildlife Service was dismissed from the case, and AquaBounty joined the case as an intervenor to protect AquaBounty&#8217;s interests. The coalition, including the Center for Food Safety and Friends of the Earth, claims that the FDA had no statutory authority to regulate genetically engineered animals, and, if it did, that the agency failed to analyze and implement measures to mitigate ecological, environmental, and socioeconomic risks that could impact wild salmon and the environment, including the risk that our GE Atlantic salmon could escape and threaten endangered wild salmon stocks. In December 2019 the court found that FDA had authority/jurisdiction over genetically engineered animals and in November 2020,  the judge remanded the Environmental Assessment (the approval) to FDA on National Environmental Protection Act (NEPA) and Endangered Species Act (ESA) grounds.  In April 2021, FDA/US Department of Justice filed a notice of appeal relating to several claims in that case, and subsequently withdrew the appeal, and the date to file appeals in the case has expired.  The court decision from the Northern District of California does not have a current business impact on AquaBounty&#8217;s egg production in Prince Edward Island, Canada, AquaBounty&#8217;s salmon production in Albany, Indiana, or AquaBounty&#8217;s sales of its fish.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">21</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">The term &#8220;genetically engineered&#8221; will need to be included as part of the acceptable market name for our GE Atlantic salmon, and bioengineering disclosures will need to be provided at the retail level, in accordance with USDA regulations. These disclosures could negatively impact consumer acceptance.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Until the passage of the National Bioengineered Food Disclosure Law in July 2016, which contained the requirement to establish the Disclosure Standard, our GE Atlantic salmon did not need to be labeled as containing a bioengineered product, because it had been deemed to be &#8220;substantially equivalent&#8221; to the conventional product. However, because several states either passed or considered new laws specifying varying requirements for labeling products sold at the retail level that contain bioengineered ingredients, the United States Congress passed the National Bioengineered Food Disclosure Law in July 2016, requiring USDA to establish a mandatory standard for disclosing foods that are or may be bioengineered. USDA issued the National Bioengineered Food Disclosure Standard in December 2018. AquaBounty includes the bioengineered logo on its GE Atlantic salmon packaging, in accordance with the Disclosure Standard. In addition, the 2020 Appropriations Act, which was signed into law in December 2019, which was reintroduced and passed in 2021, contained an amendment that requires that any bioengineered animal approved by FDA prior to the effective date of the Disclosure Standard shall include the words &#8216;&#8216;genetically engineered&#8217;&#8217; prior to the existing acceptable market name. While the Company believes that this labeling requirement is unnecessary and redundant to the requirement of the Disclosure Standard, it complies with all applicable laws.  Labeling requirements could cause consumers to view the label as either a warning or as an indication that GE Atlantic salmon is inferior to conventional Atlantic salmon, which could negatively impact consumer acceptance of our product.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Risks Relating to Intellectual Property</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Competitors and potential competitors may develop products and technologies that make ours obsolete or garner greater market share than ours.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We do not believe that we have a direct competitor for bioengineered, growth-enhanced Atlantic salmon. However, the market for Atlantic salmon is dominated by a group of large, multinational corporations with entrenched distribution channels. Our ability to compete successfully will depend on our ability to demonstrate that our GE Atlantic salmon is superior to and/or less expensive than other products available in the market.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain of our competitors may benefit from government support and other incentives that are not available to us. As a result, our competitors may be able to develop competing and/or superior products and compete more aggressively and sustain that competition over a longer period of time than we can. As more companies develop new intellectual property in our markets, a competitor could acquire patent or other rights that may limit our ability to successfully market our product.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.28in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">If our technologies or products are stolen, misappropriated, or reverse engineered, others could use the technologies to produce competing technologies or products.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.28in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Third parties, including our collaborators, contractors, and others involved in our business often have access to, and may require that we grant interests in, our technologies. If our technologies or products were stolen, misappropriated, or reverse engineered, or if we are forced to grant broad interests in our technologies, they could be used by other parties that may be able to reproduce our technologies or products using our technologies for their own commercial gain. If this were to occur, it would be difficult for us to challenge this type of use, especially in countries with limited intellectual property protection. In addition, third parties granted interests in our technologies could seek to prevent or limit our use or commercialization of those technologies based on claims of partial ownership.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Our ability to compete may be negatively impacted if we do not adequately protect our proprietary technologies or if we lose some of our intellectual property rights.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our success depends in part on our ability to obtain patents and maintain adequate protection of our intellectual property in the United States and abroad for our technologies and resultant products and potential products. We have adopted a strategy of seeking patent protection in the United States and abroad with respect to certain of the technologies used in or relating to our products; however, the patent to the technology covering our salmon, which we license under a global, perpetual, royalty-free, non-exclusive license from Genesis Group, Inc., an affiliate of Memorial University of Newfoundland, and an affiliate of the Hospital for Sick Children of Toronto, expired in August 2013. We expect to protect our proprietary technology in regard to our GE Atlantic salmon through a combination of in-house know-how and the deterrence of the regulatory process that would need to be completed for a competing product to be commercialized, which we believe provides us with a competitive advantage. There can be no guarantee that this strategy will be successful.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">22</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We also rely on trade secrets to protect our technologies, particularly in cases when we believe patent protection is not appropriate or obtainable. However, trade secrets are difficult to protect, and we may not be able to adequately protect our trade secrets or other proprietary or licensed information. While we require our employees, academic collaborators, consultants, and other contractors to enter into confidentiality agreements with us, if we cannot maintain the confidentiality of our proprietary and licensed technologies and other confidential information, our ability and that of our licensor to receive patent protection, and our ability to protect valuable information owned or licensed by us may be imperiled.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Enforcing our intellectual property rights may be difficult and unpredictable.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Enforcing our intellectual property rights can be expensive and time consuming, and the outcome of such efforts can be unpredictable. If we were to initiate legal proceedings against a third party to enforce a patent covering one of our technologies, the defendant could counterclaim that our patent is invalid and/or unenforceable or assert that the patent does not cover its manufacturing processes, manufacturing components, or products. Furthermore, in patent litigation in the United States, defendant counterclaims alleging both invalidity and unenforceability are commonplace. Although we may believe that we have conducted our patent prosecution in accordance with the duty of candor and in good faith, the outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. With respect to the validity of our patent rights, we cannot be certain, for example, that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would not be able to exclude others from practicing the inventions claimed therein. Such a loss of patent protection could have a material adverse impact on our business. Even if our patent rights are found to be valid and enforceable, patent claims that survive litigation may not cover commercially valuable products or prevent competitors from importing or marketing products similar to our own, or using manufacturing processes or manufacturing components similar to those used to produce the products using our technologies.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although we believe that we have obtained assignments of patent rights from all inventors, if an inventor did not adequately assign their patent rights to us, a third party could obtain a license to the patent from such inventor. This could preclude us from enforcing the patent against such third party.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may not be able to enforce our intellectual property rights throughout the world.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the United States. Many companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, often do not favor the enforcement of patents and other intellectual property protection, particularly those relating to bioengineering. This could make it difficult for us to stop the infringement of our patents or misappropriation of our other intellectual property rights. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Risks Relating to our Common Stock</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">The price of our shares of common stock is likely to be volatile.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The share price of publicly traded emerging companies can be highly volatile and subject to wide fluctuations. The prices at which our common stock is quoted and the prices which investors may realize will be influenced by a large number of factors, some specific to our company and operations and some that may affect the quoted land-based fish farming industry, the biotechnology sector, or quoted companies generally. These factors could include variations in our operating results, publicity regarding the process of obtaining regulatory approval to commercialize our products, divergence in financial results from analysts&#8217; expectations, changes in earnings estimates by stock market analysts, overall market or sector sentiment, legislative changes in our sector, the performance of our research and development programs, large purchases or sales of our common stock, currency fluctuations, legislative changes in the bioengineering environment, future sales of our common stock or the perception that such sales could occur and general economic conditions. Certain of these events and factors are outside of our control. Stock markets have from time to time experienced severe price and volume fluctuations, which, if recurring, could adversely affect the market prices for our common stock. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section&#160;404 of the Sarbanes-Oxley Act, may reveal deficiencies in our internal controls </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">23</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Ineffective internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our common stock.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">An active trading market for our common stock may not develop or be sustained.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although our common stock is currently traded on The Nasdaq Capital Market, an active trading market for our common stock may not be maintained. If an active market for our common stock is not maintained, it may be difficult for shareholders to sell shares of our common stock. An inactive trading market may impair our ability to raise capital to continue to fund operations by selling shares and may impair our ability to acquire other companies or technologies by using our shares as consideration. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">If securities or industry analysts do not publish research or reports, or publish inaccurate or unfavorable research or reports about our business, our share price and trading volume could decline.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.16in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The U.S. trading market for our shares of common stock depends, in part, on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over these analysts. If we obtain securities or industry analyst coverage, and one or more of the analysts who covers us downgrades our shares of common stock, changes their opinion of our shares, or publishes inaccurate or unfavorable research about our business, our share price would likely decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, demand for our shares of common stock could decrease, and we could lose visibility in the financial markets, which could cause our share price and trading volume to decline.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Our share price and our ability to raise additional funds may depend on our success in growing, or our perceived ability to grow, our GE Atlantic salmon successfully and profitably at commercial scale.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have not yet demonstrated that we can grow our GE Atlantic salmon successfully or profitably at commercial scale. If we are unsuccessful in growing our salmon to harvest size, achieving our quality standards and selling the fish in the market at a profit from our commercial-scale facilities, or are perceived as being unable to do so prior to commercial-scale harvest and sale, we may lose credibility with the investor community and other funding sources, which could negatively impact the price of our common stock and our ability to raise additional funds.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">There can be no assurance that additional funds will be available on a timely basis, on favorable terms, or at all, or that such funds, if raised, would be sufficient to enable us to continue to implement our business strategy.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interests of holders of our common stock will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of holders of our common stock. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, or declaring dividends. If we raise additional funds through government or other third-party funding; marketing and distribution arrangements; or other collaborations, strategic alliances, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates or to grant licenses on terms that may not be favorable to us.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.47in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">There can be no assurance that we will be able to comply with the continued listing standards of the Nasdaq Capital Market.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.47in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Even though our common stock has been listed on the Nasdaq Capital Market, we cannot assure you that we will be able to comply with standards necessary to maintain a listing of our common stock on the Nasdaq Capital Market. Our failure to meet the continuing listing requirements may result in our common stock being delisted from the Nasdaq Capital Market.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We are an &#8220;emerging growth company,&#8221; as well as a &#8220;smaller reporting company,&#8221; and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our shares of common stock less attractive to investors.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including the auditor attestation requirements in the assessment of our internal control over financial reporting under Section&#160;404(b) of the Sarbanes-Oxley Act, compliance with any new requirements adopted by the PCAOB, disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">24</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the requirements of holding advisory &#8220;say-on-pay&#8221; votes on executive compensation and shareholder advisory votes on golden parachute compensation not previously approved. Certain of these reduced reporting requirements and exemptions were also available to us due to the fact that we qualify as a &#8220;smaller reporting company&#8221; under SEC rules. For instance, smaller reporting companies are not required to report regarding management&#8217;s assessment of internal control over financial reporting, are not required to provide a compensation discussion and analysis, are not required to provide a pay-for-performance graph or CEO pay ratio disclosure and may present only two years of audited financial statements and related MD&amp;A disclosure.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Under the JOBS Act, we will remain an emerging growth company until the earliest of (1)&#160;the last day of the fiscal year in which we have more than $1.07&#160;billion in annual revenue; (2)&#160;the date we qualify as a &#8220;large accelerated filer,&#8221; with at least $700.0&#160;million of equity securities held by non-affiliates; (3)&#160;the issuance, in any three-year period, by our company of more than $1.0&#160;billion in non-convertible debt securities; and (4)&#160;December&#160;31, 2023, which is the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement filed under the Securities Act. Under current SEC rules, however, we will continue to qualify as a &#8220;smaller reporting company&#8221; for so long as (i) we have a public float (i.e., the market value of common equity held by non-affiliates) of less than $250 million or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our common stock held by non-affiliates is less than $700 million.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We cannot predict if investors will find our shares of common stock to be less attractive because we may rely on these exemptions. If some investors find our shares of common stock less attractive as a result, there may be a less active trading market for our shares of common stock, and our share price may be more volatile.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Under the JOBS Act, emerging growth companies also can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected to avail ourselves of this exemption from new or revised accounting standards and, therefore, will not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.34in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We may issue preferred stock with terms that could dilute the voting power or reduce the value of our common stock.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.34in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">While we have no specific plan to issue preferred stock, our certificate of incorporation authorizes us to issue, without the approval of our shareholders, one or more series of preferred stock having such designation, relative powers, preferences (including preferences over our common stock respecting dividends and distributions), voting rights, terms of conversion or redemption, and other relative, participating, optional, or other special rights, if any, of the shares of each such series of preferred stock and any qualifications, limitations, or restrictions thereof, as our Board of Directors may determine. The terms of one or more classes or series of preferred stock could dilute the voting power or reduce the value of our common stock. For example, the repurchase or redemption rights or liquidation preferences we could assign to holders of preferred stock could affect the residual value of the common stock.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.25in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Provisions in our corporate documents and Delaware law could have the effect of delaying, deferring, or preventing a change in control of us, even if that change may be considered beneficial by some of our shareholders.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.25in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The existence of some provisions of our certificate of incorporation or our bylaws or Delaware law could have the effect of delaying, deferring, or preventing a change in control of us that a shareholder may consider favorable. These provisions include:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">providin</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">g that the number of members of our board is limited to a range fixed by our by-laws;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">establishing advance notice requirements for nominations of candidates for election to our Board of Directors or for proposing matters that can be acted on by shareholders at shareholder meetings; and</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">authorizing the issuance of &#8220;blank check&#8221; preferred stock, which could be issued by our Board of Directors to issue securities with voting rights </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and thwart a takeover attempt.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.22in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As a Delaware corporation, we are also subject to provisions of Delaware law, including Section 203 of the General Corporation Law of the State of Delaware. Section 203 prevents some shareholders holding more than 15% of our voting stock from engaging in certain business combinations unless the business combination or the transaction that resulted in the shareholder becoming an interested shareholder was approved in advance by our Board of Directors, results in the shareholder holding more than 85% of our voting stock (subject to certain restrictions), or is approved at an annual or special meeting of shareholders by the holders of at least 66 2/3% of our voting stock not held by the shareholder engaging in the transaction. Any provision of our certificate of incorporation or our bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our shareholders to receive a premium for their shares of our common stock and affect the price that some investors are willing to pay for our common stock.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.22in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">25</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">The financial reporting obligations of being a public company in the United States are expensive and time consuming and place significant additional demands on our management.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The obligations of being a public company in the United States place additional demands on our management and require significant expenditures, including costs resulting from public company reporting obligations under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;); the rules and regulations regarding corporate governance practices, including those under the Sarbanes-Oxley Act and the Dodd Frank Wall Street Reform and Consumer Protection Act; and the listing requirements for the Nasdaq Capital Market. Our management and other personnel devote a substantial amount of time to ensure that we comply with all of these requirements. Moreover, despite reforms made possible by the JOBS Act, the reporting requirements, rules, and regulations make some activities more time-consuming and costly. Any changes that we make to comply with these obligations may not be sufficient to allow us to satisfy our obligations as a public company on a timely basis, or at all.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.25in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">These rules and regulations make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. These factors also could make it more difficult for us to attract and retain qualified persons to serve on our Board of Directors, particularly to serve on our Audit Committee and Compensation Committee, or as executive officers.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">We do not anticipate paying cash dividends in the foreseeable future, and, accordingly, shareholders must rely on stock appreciation for any return on their investment.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.13in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have never declared or paid cash dividends on our common stock. We do not anticipate paying cash dividends in the foreseeable future and intend to retain all of our future earnings, if any, to finance the operations, development, and growth of our business. There can be no assurance that we will have sufficient surplus under Delaware law to be able to pay any dividends at any time in the future. As a result, absent payment of dividends, only appreciation of the price of our common stock, which may never occur, will provide a return to shareholders. You may also have to sell some or all of your shares of our common stock in order to generate cash flow from your investment in us.</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">26</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;1B.&#160;&#160;Unresolved Staff Comments</span><span id="Section7" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">None.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section8" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;2.&#160;&#160;Properties</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our corporate headquarters are located in Maynard, Massachusetts, and consist of approximately 3,500 square feet of office space under a lease that expires in March 2023. We own a production grow-out farm in Indiana, which is capable of producing 1,200 metric tons of our fish annually. On Prince Edward Island, Canada, we own a hatchery in Fortune Bay and a salmon farm in Rollo Bay, that consists of a hatchery, a grow-out facility, and a broodstock facility that is currently under construction. We believe that the spaces that we lease and own are sufficient to meet our current and near-term needs. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section9" style="text-decoration: none;"></span><span id="_Hlk94538718" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;3.&#160;&#160;Legal Proceedings</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.25in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are not party to any legal proceedings the outcome of which, we believe, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our future business, consolidated results of operations, cash flows, or financial position. We may, from time to time, be subject to legal proceedings and claims arising from the normal course of business activities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;4.&#160;&#160;Mine Safety Disclosures</span><span id="Section10" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Not applicable.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section11" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Part&#160;II</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section12" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;5.&#160;&#160;Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Market Information</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our common stock is currently traded on the Nasdaq Capital Market under the symbol &#8220;AQB.&#8221; As of March&#160;9, 2022, [71,025,738] shares of our common stock were issued and outstanding.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of March&#160;9, 2022, there were approximately 281 holders of record of our common stock. The actual number of shareholders is greater than this number and includes shareholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees. The transfer agent for our common stock is Computershare Trust Company, N.A.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Dividends</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have never declared or paid any cash dividends on our common stock. We currently intend to retain earnings, if any, to finance the growth and development of our business. We do not expect to pay any cash dividends on our common stock in the foreseeable future. Payment of future dividends, if any, will be at the discretion of our Board of Directors and will depend on our financial condition, results of operations, capital requirements, restrictions contained in current or future financing instruments, provisions of applicable law, and other factors the Board of Directors deems relevant.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Securities Authorized for Issuance Under Equity Compensation Plans</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The information under &#8220;Equity Compensation Plan Information&#8221; to be included in our definitive proxy statement relating to our 2022 annual meeting of stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended December&#160;31, 2021, is incorporated herein by reference.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;6.&#160;&#160;Selected Financial Data</span><span id="Section13" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Not Applicable. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">27</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;7.&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span id="Section14" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes that appear elsewhere in this Annual Report on Form 10&#8209;K. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report on Form 10&#8209;K, particularly in &#8220;Risk Factors.&#8221;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We believe that we are a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. Our lead product is our GE Atlantic salmon, which received FDA approval in 2015 as the first genetically engineered animal available for sale for human consumption. We have commenced commercial activities with operations in the United States and Canada where we have received regulatory approval. We are actively engaged in genetic, genomic, fish health and fish nutrition research, which drive continuous improvement in our operations and may lead to new, disruptive technologies and products that could further expand our competitive offerings.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">COVID-19</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although COVID-19 vaccines have become more readily available in the United States and other parts of the world, several variants of the virus continue to spread.  Local governmental authorities in the United States and Canada have issued, and continue to update, directives aimed at minimizing the spread of the virus and we continue to monitor their status.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The ultimate impact of the evolving COVID-19 pandemic on our operations will depend on future developments, which cannot be predicted with confidence, and we cannot predict the extent or impact of the extended period of continued business interruption and reduced operations caused by the COVID-19 pandemic or any additional preventative or protective measures taken in response.  In connection with the COVID-19 pandemic, we made modifications to our biosecurity procedures at our farm sites in early 2020 to adapt to local requirements and to provide a safe work environment. Our current preventative and protective measures include, but are not limited to, segregating farm workers to specific locations, rotating shifts, and monitoring worker temperatures upon arrival at our facilities. In certain circumstances, we utilized, and continue to utilize, work-from-home arrangements for employees that do not have fish care responsibilities. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Due to the pandemic, we have experienced delays and cost increases in capital projects, additional challenges in our efforts to meet the capacity expectations at our existing facilities and continue to experience extended lead times on equipment purchases.  We may continue to experience delays and cost increases on farm construction, purchases of capital equipment and supplies and other materials required in our operations due to vendor shortages and other labor shortages. We also expect to continue to be impacted by transportation or supply chain disruptions to our partners or customers. In addition, we are carefully managing and monitoring the impact of labor shortages on our ability to meet the annual capacity expectations at our existing facilities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our operations were initially impacted by a reduction in the market price and demand for Atlantic salmon due to the pandemic&#8217;s impact on the food service sector. This had a negative impact on revenue and inventory value, as we were not yet an established vendor and customers appeared reluctant to add a new supplier during a period of depressed demand.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the second half of 2021, we were impacted by a shortage of labor at our Indiana farm and increased costs for third-party processing and transportation. This had a negative effect on revenue and inventory values and resulted in higher than expected sales costs for the period.  We expect this to continue for the foreseeable future.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We remain focused on maintaining a strong balance sheet, liquidity, and financial flexibility and continue to monitor developments as we deal with the disruptions and uncertainties from a business and financial perspective relating to the evolving COVID-19 pandemic. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Financial Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have incurred significant losses since our inception, which we expect to continue for the foreseeable future, and we may never achieve or maintain profitability. We expect to generate product revenue primarily through the sales of our GE Atlantic salmon. We also sell conventional Atlantic salmon, salmon eggs, fry, and byproducts. We expect revenues to grow modestly in 2022, as we increase our weekly harvesting capability at our Indiana farm and as the U.S. economy continues to recover from the COVID-19 pandemic.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We expect our future capital requirements will be substantial, particularly as we continue to develop our business and expand our commercial activities, as discussed in &#8220;Liquidity and Capital Resources&#8221;.  During the next several years, we expect that our working capital requirements and our capital expenditures will increase substantially due to our plans to construct four to five new land-based production farms.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">28</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Product Revenue</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We currently generate product revenue through the sales of our GE Atlantic salmon, conventional Atlantic salmon eggs and fry, and salmon byproducts. We expect revenues to grow modestly in 2022, as we increase our weekly harvesting capability at our Indiana farm.  In the future, we believe that our revenue will depend upon the number and capacity of grow-out farms we have in operation and the market acceptance we achieve.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Production Costs</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Production costs include the labor and related costs to grow out our fish, including feed, oxygen, and other direct costs; overhead; and the cost to process and ship our products to customers. A portion of production costs is absorbed into inventory as fish in process to the extent that these costs do not exceed the net realizable value of the fish biomass. The costs that are not absorbed into inventory, as well as any net realizable inventory value adjustments, are classified as production costs</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. As of December&#160;31, 2021 and 2020, we had sixty-one and forty-three employees, respectively engaged in production activities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Sales and Marketing Expenses</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.44in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our sales and marketing expenses currently include salaries and related costs for our sales personnel and consulting fees for market-related activities.  During 2021, we also included the cost of our conventional salmon donation program. As of December 31, 2021 and 2020, we had one and zero employees, respectively dedicated to sales and marketing.  We expect our sales and marketing expenses to increase as our production output and revenues grow.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Research and Development Expenses</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.09in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2021 and 2020, we employed nineteen and fifteen scientists and technicians, respectively at our facilities on Prince Edward Island to oversee our broodstock of GE Atlantic salmon, as well as the lines of fish we maintain for research and development purposes. We recognize research and development expenses as they are incurred. Our research and development expenses consist primarily of:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 1.00in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">salaries and related overhead expenses for personnel in research, development functions, and brood-stock husbandry;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 1.00in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">fees paid to contract research organizations and consultants who perform research for us;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 1.00in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">costs related to laboratory supplies used in our research and development efforts; and</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 1.00in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">costs related to the operation of our field trials.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">General and Administrative Expenses</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative expenses consist primarily of salaries and related costs for employees in executive, corporate, and finance functions. Other significant general and administrative expenses include corporate governance and public company costs, regulatory affairs, rent and utilities, insurance, and legal services. We had fourteen employees in our general and administrative group at December 31, 2021 and 2020.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Other Income (Expense), Net</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Interest expense includes the interest on our outstanding loans and the amortization of debt issuance costs. Other income (expense) includes bank charges, fees, interest income, miscellaneous gains or losses on asset disposals and realized gains or losses on investments.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Critical Accounting Policies and Estimates</span></p><p dir="ltr" style="font-family: NewsGoth Lt BT;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is based on our consolidated financial statements, which we have prepared in accordance with GAAP. The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues and expenses during the reporting periods. We evaluate these estimates and judgments on an ongoing basis. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Our actual results may differ from these estimates under different assumptions or conditions. While our significant accounting policies are more fully described in Note 2 to our audited consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K, we believe that the following accounting policies and estimates are the most critical for fully understanding and evaluating our financial condition and results of operations. </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">29</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Inventories</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inventories are mainly comprised of feed, eggs and fish in process. Fish in process inventory is measured based on the estimated biomass of fish on hand. We have established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques.  We measure inventory at the lower of cost or net realizable value (&#8220;NRV&#8221;). The NRV calculation contains various estimates and assumptions in regard to the calculation of the biomass, including expected yield, the market value of the biomass and estimated costs of processing and transportation.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The estimates and assumptions used in calculating the NRV can introduce variability in the inventory value from period to period.  This is primarily due to the variability in the market price for salmon; the yield we can achieve in processing and the mix of products sold; and the number and frequency of shipments from our farm to our customers. Each of these factors in the calculation of NRV can change from week to week based on market conditions.  In our estimates, we rely on a combination of our actual experience, along with an estimation of foreseeable trends in the market.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Revenue Recognition</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We generate revenue from the sale of our products.  Revenue is recognized when the customer takes physical control of the goods, in an amount that reflects the transaction price consideration that we expect to receive in exchange for the goods. Revenue excludes any sales tax collected and includes any estimate of future credits.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our revenue can vary from period to period based on the available biomass of fish that are ready to be harvested; our resource capability to harvest, process and ship salmon from our farms; the percentage of fish that meet our quality requirements; and the market price for salmon. Additionally, once our product is received by a customer, it is subject to a quality review before acceptance.  To date, credits issued to customers for quality issues have been negligible, but we will continue to monitor and evaluate our customer quality experience as our shipments increase.  We started harvesting our GE Atlantic salmon in June of 2021 and we are still ramping up our internal harvesting resources and our customer base.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Recent Accounting Pronouncements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We do not expect any recently issued, but not yet effective, accounting standards to have a material effect on our results of operations or financial condition.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Results of Operations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Comparison of the year ended December&#160;31, 2021 to the year ended December&#160;31, 2020.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following table summarizes our results of operations for the years ended December&#160;31, 2021 and 2020, together with the changes in those items in dollars (in thousands) and as a percentage:</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.23in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.45in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Year Ended</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Dollar</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">%</span></p></td></tr><tr style="height: 0.23in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2020</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Change</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Change</span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="4" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Product revenue</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> 1,175</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 128</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 1,047</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 818%</span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating expenses:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Product costs</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> 10,786</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 6,680</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 4,106</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 61%</span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Sales and marketing</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> 1,262</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 533</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 729</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 137%</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> 2,146</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 2,365</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (219)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (9)%</span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> 9,103</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 6,798</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 2,305</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 34%</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating loss</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (22,122)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (16,248)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (5,874)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 36%</span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total other expense</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (201)</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (152)</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (49)</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 32%</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (22,323)</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (16,400)</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (5,923)</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 36%</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Product Revenue</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Product revenue for the year ended December&#160;31, 2021 consisted of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">sales of our GE Atlantic salmon and conventional Atlantic salmon fry and eggs.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> For the comparative period in 2020, revenue included the sale of conventional Atlantic salmon, fry and eggs. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the current year, we began harvesting and selling our GE Atlantic salmon from both our Indiana and Rollo Bay farms.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">30</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Production Costs</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Production costs for the year ended December&#160;31, 2021, were up from the corresponding period in 2020, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">due to production cost increases related to the commencement of harvesting at the Indiana and Rollo Bay farms.  Increases included headcount additions, feed costs and other direct supplies, as well as the costs for processing and transportation to bring our product to market.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The current year includes net realizable inventory value adjustments of $8.0 million based on the market price for salmon, our production yields and external processing and transportation costs.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Costs for 2020 include net realizable inventory value adjustments of $4.2 million and a $1.5 million write-off against the carrying value of the conventional salmon biomass due to management&#8217;s decision to donate substantially all of the conventional salmon to local food charities during Q1 2021.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Sales and Marketing Expenses</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Sales and marketing expenses for the year ended December 31, 2021, were up from the corresponding period in 2020 due to an increase in headcount and promotional expenses related to marketing activities for our salmon. Costs for the period also include a $514 thousand charge related to the donation program of conventional Atlantic salmon to local food charities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Research and Development Expenses</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development expenses for the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">year ended December 31, 2021</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, were down from the corresponding period in 2020 due to an increase in broodstock cost transferred to production costs for related product revenue during the period and a decrease in field trials, offset by increased outside contract service fees and</span><span style="white-space:pre-wrap; color: #000000;font-family: Calibri;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">personnel costs.&#160; During the current period, research activities included feed nutrition trials, discovery research in salmon immunology and work on a genome study to identify genes associated with economically important traits in salmon.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">General and Administrative Expenses</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative expenses for the year ended December 31, 2021, were up from the corresponding period in 2020 due to increases in personnel, outside consulting and advisory fees, auditing fees, insurance costs, and travel, partly offset by decreases in legal fees and stock compensation charges.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Total Other (Income) Expense</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total other (income) expense for 2021 is comprised of interest on debt, bank charges, and interest income. Total other (income) expense for 2020 is comprised of interest on debt, bank charges, interest income, and a net gain on the disposal of assets.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Liquidity and Capital Resources</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Sources of Liquidity</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have incurred losses from operations since our inception in 1991, and, as of December&#160;31, 2021, we had an accumulated deficit of $171&#160;million.  We expect to continue to experience losses from operations for the foreseeable future and we will require substantial additional cash to fund our business plans.  Liquidity has primarily come from equity financings, supplemented by debt transactions.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2020, we completed three public equity offerings totaling 33,028,000 shares of common stock for net proceeds of approximately $104.6 million and we issued 713,449 shares of common stock through the conversion of outstanding warrants for total proceeds of $2.3 million.  During 2021, we completed a public equity offering of 14,950,000 shares of common stock for net proceeds of approximately $119.1&#160;million. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In the future, we expect to use bond issuances to fund the construction of our farms and we may use additional equity issuances to supplement these costs or to fund other growth opportunities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2021, we had $191.2&#160;million in cash and cash equivalents, marketable securities and restricted cash.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our principal contractual commitments include capital expenditure obligations, repayments of debt and related interest, and payments under operating leases. Refer to the notes in our consolidated financial statements for further information about our share capital expenditure commitments (Note 6), debt (Note 7), and lease payment obligations (Note 10).</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">31</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cash Flows</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following table sets forth the significant sources and uses of cash for the periods set forth below (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Year Ended</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Dollar</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">%</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2020</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Change</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Change</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="4" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash provided by (used in):</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating activities</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (20,472)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (14,289)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (6,183)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 43%</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Investing activities</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (107,539)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (3,239)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (104,300)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 3,220%</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Financing activities</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> 121,179</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 111,003</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 10,176</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 9%</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Effect of exchange rate changes on cash</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> 36</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (23)</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 59</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (257)%</span></p></td></tr><tr><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 56.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net increase in cash</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (6,796)</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 93,452</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (100,248)</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 7.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (107)%</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Cash Flows from Operating Activities</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in operating activities during the year ended December&#160;31, 2021, was primarily comprised of our $22.3&#160;million net loss, offset by non-cash depreciation and stock compensation charges of $2.2&#160;million and increased by working capital uses of $349 thousand. Spending on operations increased in 2021 due to increases in production activities at our Rollo Bay and Indiana farm sites and outside consulting and advisory fees. Cash used for working capital was due primarily to increases in receivables and prepaid expenses, partially offset by increases in accounts payable and accrued expenses and a decrease in inventory.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in operating activities during the year ended December&#160;31, 2020, was primarily comprised of our $16.4&#160;million net loss, offset by non-cash depreciation and stock compensation charges of $1.9&#160;million and by working capital sources of $136 thousand. Spending on operations increased in 2020 due to increases in production activities at our Rollo Bay and Indiana farm sites, offset by lower field trial costs related to our demonstration farm in Panama and travel expenses. Cash provided by working capital was due primarily to an increase in accounts payable and accrued liabilities, partially offset by increases in inventory and prepaid expenses.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Cash Flows from Investing Activities</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2021, we used $5.7 million for renovations to our Indiana farm site, construction charges at our Rollo Bay farm site and renovations at our Fortune Bay hatchery, $45 thousand for deposits on equipment purchases and $101.8  million on the purchase of marketable securities. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2020, we used $4.0 million for renovations to our Indiana farm site and for construction charges at our Rollo Bay site, offset by $100&#160;thousand in proceeds from the sale of equipment and $1&#160;million in net proceeds from a settlement agreement. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We expect expenditures on capital projects to increase in future periods as we commence construction of our Ohio farm.  We currently estimate the construction costs to be in the range of $290 million to $320 million, including a reserve for potential contingencies of $30 million.  We expect to finance this project cost through a combination of cash on hand and debt.  Estimating the cost and timing for the completion of this new and complex capital project is inherently difficult and subject to change based on a number of factors, including design changes, fluctuating costs of materials, labor shortages, the impact of the COVID-19 pandemic, construction delays, dependence on contractors, financing costs, customer requirements and unexpected complications.  For more information, see &#8220;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Our business plans include the need for substantial additional capital and without it we may not be able to implement our strategy as planned or at all</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.&#8221;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Cash Flows from Financing Activities</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2021, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">we received approximately $119.1&#160;million in net proceeds from the issuance of shares of common stock in a public equity offering, $1.7 million from the exercise of warrants, and $606 thousand from new debt. This was offset by $272 thousand in debt repayment.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2020, we received approximately $104.6&#160;million in net proceeds from the issuance of shares of common stock in three public equity offerings, $2.3 million from the exercise of warrants, and $4.1 million from the issuance of debt, net of repayments and debt issuance costs.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Future Capital Requirements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In February 2021, we completed an equity raise with net proceeds of $119.1 million and we had $191.2 million of cash, cash equivalents, marketable securities and restricted cash as of December 31, 2021.  While we have experienced net losses and negative cash flows from operations since inception, we believe that we have sufficient cash to meet our requirements for at least the next twelve months from the filing date.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2022, we expect to use approximately $130 million of cash to fund our operations and the first year of construction costs for our Ohio farm.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">32</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In 2020, we entered into a term loan agreement with First Farmers Bank and Trust in the amount of $4 million, which is secured by the assets of our Indiana subsidiary and a corporate guarantee.  The agreement contains certain financial and non-financial covenants, which if not met, could result in an event of default pursuant to the terms of the loan.  The ability of the Indiana subsidiary to meet its debt covenants over the next twelve months is dependent upon its operating performance.   </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Until such time, if ever, as we can generate positive operating cash flows, we may finance our cash needs through a combination of equity offerings, debt financings, government or other third-party funding, strategic alliances, and licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interests of holders of our common stock will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of holders of our common stock. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, or declaring dividends. If we raise additional funds through government or other third-party funding; marketing and distribution arrangements; or other collaborations, strategic alliances, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates or to grant licenses on terms that may not be favorable to us.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If we are unable to generate additional funds in the future through financings, sales of our products, government grants, loans, or from other sources or transactions, we will exhaust our resources and will be unable to maintain our currently planned operations. If we cannot continue as a going concern, our stockholders would likely lose most or all of their investment in us.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;7A.&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span><span id="Section15" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following sections provide quantitative information on our exposure to interest rate risk and foreign currency exchange risk. We make use of sensitivity analyses, which are inherently limited in estimating actual losses in fair value that can occur from changes in market conditions.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Interest Rate Risk</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our primary exposure to market risk is interest rate risk associated with debt financing that we utilize from time to time to fund operations or specific projects. The interest on this debt is usually determined based on a fixed rate and is contractually set in advance. As of December&#160;31, 2021 and 2020, we had $5.8&#160;million and $6.0&#160;million, respectively, in interest-bearing debt instruments on our consolidated balance sheet. All of our interest-bearing debt is at fixed rates, except for our loan with First Farmers&#8217; Bank and Trust which has a rate reset in July 2025.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Foreign Currency Exchange Risk</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our functional currency is the U.S. Dollar. The functional currency of our Canadian subsidiary is the Canadian Dollar, and the functional currency of our U.S. and Brazil subsidiaries is the U.S. Dollar. For the Canadian subsidiary, assets and liabilities are translated at the exchange rates in effect at the balance sheet date, equity accounts are translated at the historical exchange rate, and the income statement accounts are translated at the average rate for each period during the year. Net translation gains or losses are adjusted directly to a separate component of other comprehensive loss within shareholders&#8217; equity.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section16" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;8.&#160;&#160;Financial Statements and Supplementary Data</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The financial statements required by this Item are located beginning on page F-1 of this Annual Report.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section17" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;9.&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">None.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section18" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;9A.  Controls and Procedures</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Evaluation of Disclosure Controls and Procedures</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities and Exchange Act of 1934 is (1)&#160;recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and (2)&#160;accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. As of December&#160;31, 2021 (the &#8220;Evaluation Date&#8221;), our management, with the participation of our Chief Executive Officer </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">33</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934). Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our Chief Executive Officer and Chief Financial Officer have concluded based upon the evaluation described above that, as of the Evaluation Date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Management&#8217;s Report on Internal Control over Financial Reporting</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting for our company. Internal control over financial reporting is defined in Rules&#160;13a-15(f) and 15(d)-15(f) promulgated under the Securities Exchange Act of 1934, as amended, as a process designed by, or under the supervision of, our Chief Executive and Chief Financial Officers and effected by our board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">pertain</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and disposition of our assets;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">provide reasonable assurance that our receipts and expenditures are being made only in accordance with authorization of our management and directors; and</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 6pt;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">provide re</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">asonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Because of inherent limitations, internal controls over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of our internal control over financial reporting as of December&#160;31, 2021. In conducting this evaluation, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013).</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Based upon this evaluation and those criteria, management believes that, as of December&#160;31, 2021, our internal controls over financial reporting were effective.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This Annual Report on Form 10&#8209;K does not include an attestation report of the Company&#8217;s independent registered accounting firm as we are an emerging growth company, as defined under the JOBS Act, and are subject to reduced public company reporting requirements. The JOBS Act provides that an emerging growth company is not required to have the effectiveness of the Company&#8217;s internal control over financial reporting audited by its external auditors for as long as the Company is deemed to be an emerging growth company.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Changes in Internal Control</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There have been no changes in our internal control over financial reporting for the quarter ended December&#160;31, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section19" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;9B.&#160;&#160;Other Information</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">None.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section9C" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Item </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">9C.  Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Not applicable.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 14pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section20" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-size: 14pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 14pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 14pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 14pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">34</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Part&#160;III</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section21" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;10.&#160;&#160;Directors, Executive Officers and Corporate Governance</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The information required by this Item is set forth in our 2022 Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2021, and is incorporated by reference into this Annual Report on Form 10&#8209;K by reference.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;11.&#160;&#160;Executive Compensation</span><span id="Section22" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are an emerging growth company, as defined under the JOBS Act, and are therefore not required to provide certain disclosures regarding executive compensation required of larger public companies or hold a nonbinding advisory vote on executive compensation or obtain stockholder approval of any golden parachute payments not previously approved.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The information required by this Item is set forth in our 2022 Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2021, and is incorporated by reference into this Annual Report on Form 10&#8209;K by reference.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section23" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;12.&#160;&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The information required by this Item is set forth in our 2022 Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2021, and is incorporated by reference into this Annual Report on Form 10&#8209;K by reference.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section24" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;13.&#160;&#160;Certain Relationships and Related Transactions, and Director Independence</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The information required by this Item is set forth in our 2022 Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2021, and is incorporated by reference into this Annual Report on Form 10&#8209;K by reference.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section25" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;14.&#160;&#160;Principal Accounting Fees and Services</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The information required by this Item is set forth in our 2022 Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2021 and is incorporated by reference into this Annual Report on Form 10&#8209;K, for Deloitte &amp; Touche LLP (PCAOB ID No. </span><ix:nonNumeric name="dei:AuditorFirmId" id="ct-nonNumeric-aa2b36db-299d-47e8-b496-9075f6b71067" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">34</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">) and Wolf &amp; Company P.C. (PCAOB ID No. 392).</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section26" style="text-decoration: none;"></span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">35</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Part&#160;IV</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section27" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;15.&#160;&#160;Exhibits and Financial Statement Schedules</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">List of Documents Filed as Part of this Report</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">1. Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following consolidated financial statements are filed herewith in accordance with Item 8 of Part II above:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(i)&#160;&#160;&#160;&#160;</span><a href="#ReportofIndep" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Reports of Independent Registered Public Accounting Firm</span></a><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">s</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(ii)&#160;&#160;&#160;</span><a href="#BS" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Consolidated Balance Sheets</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(iii)&#160;&#160;</span><a href="#IS" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Consolidated Statements of Operations and Comprehensive Loss</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(iv)&#160;&#160;</span><a href="#SE" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Consolidated Statements of Changes in Stockholders&#8217; Equity</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(v)&#160;&#160;&#160;</span><a href="#CF" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Consolidated Statements of Cash Flows</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(vi)&#160;&#160;</span><a href="#Notes" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Notes to Consolidated Financial Statements</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.75in;margin-right: 0;margin-top: 0;text-indent: -0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2. Schedules</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Schedules not listed are omitted because the required information is inapplicable or is presented in the consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">36</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">3. Exhibits</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Exhibit&#160;Number</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Exhibit Description</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex31.htm"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.1*</span><span style="white-space:pre-wrap; color: #0000FF;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Third Amended and Restated Certificate of Incorporation of AquaBounty Technologies, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312517004648/d209058dex31.htm"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.2*</span><span style="white-space:pre-wrap; color: #0000FF;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312517004648/d209058dex31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certificate of Amendment of Third Amended and Restated Bylaws of AquaBounty Technologies, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on January&#160;6, 2017).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex32.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.3*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000005/exhibit3-3.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certificate of Amendment of Third Amended and Restated Certificate of Incorporation of AquaBounty Technologies, Inc. (incorporated by reference to Exhibit 3.3 to the Registrant&#8217;s Registration Statement on Form S-1, filed on January&#160;15, 2020).</span></a></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000133/exhibit31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.4*</span></a></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000133/exhibit31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certificate of Amendment of Third Amended and Restated Certificate of Incorporation of AquaBounty Technologies, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on November 19, 2020).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex32.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.5*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex32.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Amended and Restated Bylaws of AquaBounty Technologies, Inc. (incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex41.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">4.1*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex41.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Specimen Certificate of Common Stock (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312518006673/d489530dex42.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">4.2*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312518006673/d489530dex42.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Specimen Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Registration Statement on Form S-1, filed on January&#160;9, 2018).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000052/exhibit43-2019x12x31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">4.3</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000052/exhibit43-2019x12x31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Description of Registrant&#8217;s securities. (incorporated by reference to Exhibit 4.3 to the Registration&#8217;s Annual Report on Form 10-K, filed on March 10, 2020).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex101.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.1*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex101.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Stock Purchase Agreement, by and between AquaBounty Technologies, Inc. and Intrexon Corporation, dated November&#160;7, 2016 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex102.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.2*&#8224;</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex102.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">AquaBounty Technologies, Inc. 2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex103.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.3*&#8224;</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex103.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Amendment No. 1 to AquaBounty Technologies, Inc. 2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex104.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.4*&#8224;</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex104.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Form of Stock Option Agreement pursuant to AquaBounty Technologies, Inc. 2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex105.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.5*&#8224;</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex105.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Form of Restricted Stock Agreement pursuant to AquaBounty Technologies, Inc. 2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex106.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.6*&#8224;</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex106.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397819000067/exhibit102-2019x05x02.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.7*&#8224;</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397819000067/exhibit102-2019x05x02.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Amendment No. 1 to AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K, filed on May&#160;2. 2019).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000079/exhibit103-2020x04x29.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.8*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000079/exhibit103-2020x04x29.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Amendment No. 2 to AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K, filed on April 29, 2020).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516790896/d275549dex1022.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.9*&#8224;</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516790896/d275549dex1022.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Form of Stock Option Agreement pursuant to AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.22 to the Registrant&#8217;s Registration Statement on Form 10, filed on December&#160;12, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516790896/d275549dex1021.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.10*&#8224;</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516790896/d275549dex1021.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Form of Restricted Stock Agreement pursuant to AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.21 to the Registrant&#8217;s Registration Statement on Form 10, filed on December&#160;12, 2016).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex107.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.11*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex107.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Relationship Agreement, by and between AquaBounty Technologies, Inc. and Intrexon Corporation, dated December&#160;5, 2012 (incorporated by reference to Exhibit 10.7 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex109.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.12*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex109.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Subscription Agreement, by and between AquaBounty Technologies, Inc. and the investors listed therein, dated February&#160;14, 2013 (incorporated by reference to Exhibit 10.9 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1010.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.13*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1010.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Subscription Agreement, by and between AquaBounty Technologies, Inc. and Intrexon Corporation, dated March&#160;5, 2014 (incorporated by reference to Exhibit 10.10 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1011.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.14*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1011.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Subscription Agreement, by and between AquaBounty Technologies, Inc. and Intrexon Corporation, dated June&#160;24, 2015 (incorporated by reference to Exhibit 10.11 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">37</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1012.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.15*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1012.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Promissory Note Purchase Agreement, by and between AquaBounty Technologies, Inc. and Intrexon Corporation, dated February&#160;22, 2016 (incorporated by reference to Exhibit 10.12 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312518306999/d645152dex101.htm"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.16*</span><span style="white-space:pre-wrap; color: #0000FF;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312518306999/d645152dex101.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Form of Warrant Exercise Agreement, by and between AquaBounty Technologies, Inc. and certain holders of its Common Stock Purchase Warrants, dated October&#160;24, 2018 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on October&#160;25, 2018).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1014.htm"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.17*</span><span style="white-space:pre-wrap; color: #0000FF;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"></span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1014.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Agreement, by and among Atlantic Canada Opportunities Agency and AQUA Bounty Canada Inc. and AquaBounty Technologies Inc., dated December&#160;16, 2009 (incorporated by reference to Exhibit 10.14 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/offerletter2018x08x20.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.18*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/offerletter2018x08x20.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Offer Letter dated as of July&#160;10, 2018, from Prince Edward Island Century 2000 Fund Inc. to AQUA Bounty Canada Inc. and accepted by AQUA Bounty Canada Inc. and AquaBounty Technologies, Inc. on August&#160;20, 2018 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;2, 2018).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/promissorynote2018x10x16.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.19*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/promissorynote2018x10x16.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Negotiable Promissory Note dated as of October&#160;16, 2018, issued by AQUA Bounty Canada Inc. in favor of Prince Edward Island Century 2000 Fund Inc. (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;2, 2018).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/collateralmortgage2016x07x26.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.20*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/collateralmortgage2016x07x26.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Collateral Mortgage dated as of July&#160;26, 2016, by and between AQUA Bounty Canada Inc. and Prince Edward Island Century 2000 Fund Inc. (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;2, 2018).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/collateralmortgage2018x10x09.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.21*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/collateralmortgage2018x10x09.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Collateral Mortgage dated as of October&#160;9, 2018, by and between AQUA Bounty Canada Inc. and Prince Edward Island Century 2000 Fund Inc. (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;2, 2018).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/securityagreement2016x07x26.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.22*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/securityagreement2016x07x26.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">General Security Agreement dated as of July&#160;26, 2016, by and between AQUA Bounty Canada Inc. and Prince Edward Island Century 2000 Fund Inc. (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;2, 2018).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/guarantee2018x10x09.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.23*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000064/guarantee2018x10x09.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Guarantee dated as of October&#160;9, 2018, made by AquaBounty Technologies, Inc. in favor of Prince Edward Island Century 2000 Fund Inc. (incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;2, 2018).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000066/wulf-ea2018x11x27.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.24*&#8224;</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397818000066/wulf-ea2018x11x27.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Employment Agreement, by and between Sylvia Wulf and AquaBounty Technologies, Inc., dated November&#160;27. 2018 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on November&#160;28, 2018).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1016.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.25*&#8224;</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1016.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Employment Agreement, by and between David Frank and AquaBounty Technologies, Inc., dated October&#160;1, 2007 (incorporated by reference to Exhibit 10.16 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1017.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.26*&#8224;</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1017.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Employment Agreement, by and between Alejandro Rojas and AquaBounty Technologies, Inc., dated December&#160;30, 2013 (incorporated by reference to Exhibit 10.17 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1019.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.27*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000119312516760799/d275549dex1019.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Intellectual Property License and Full and Final Release among Genesis Group, Inc., HSC Research and Development Partnership and AquaBounty Technologies, Inc., dated February&#160;28, 2014 (incorporated by reference to Exhibit 10.19 to the Registrant&#8217;s Registration Statement on Form 10, filed on November&#160;7, 2016).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397817000049/assetpurchaseagreement.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.28*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397817000049/assetpurchaseagreement.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Asset Purchase Agreement by and between AquaBounty Technologies, Inc. and Bell Fish Company LLC, dated as of June&#160;9, 2017 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August&#160;4, 2017).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/loanandsecurityagreeme.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.29*#</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/loanandsecurityagreeme.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Loan and Security Agreement by and between AquaBounty Farms Indiana LLC and First Farmers Bank and Trust, dated as of July 31, 2020 (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August 6, 2020).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/termnote2020-07x31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.30*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/termnote2020-07x31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Term Note granted by AquaBounty Farms Indiana LLC in favor of First Farmers Bank and Trust, dated as of July 31, 2020 (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August 6, 2020).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/mortgage2020-07x31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.31*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/mortgage2020-07x31.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Mortgage, Assignment of Rents and Leases, Security Agreement, Fixture Filing and Financing Statement granted by AquaBounty Technologies, Inc. in favor of First Farmers Bank and Trust, dated as of July 31, 2020 (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August 6, 2020).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/guarantorsecurityagree.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.31*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/guarantorsecurityagree.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Guarantor Security Agreement by and between AquaBounty Technologies, Inc. and First Farmers Bank and Trust, dated as of July 31, 2020 (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August 6, 2020).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/securedguarantyagreeme.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.32*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/securedguarantyagreeme.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Unconditional and Continuing Secured Guaranty Agreement by and between AquaBounty Technologies, Inc. and First Farmers Bank and Trust, dated as of July 31, 2020 (incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August 6, 2020).</span></a></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">38</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/collateralaccessagreem.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.33*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/collateralaccessagreem.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Collateral Access Agreement by and between AquaBounty Technologies, Inc. and First Farmers Bank and Trust, dated as of July 31, 2020 (incorporated by reference to Exhibit 10.7 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August 6, 2020).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/guarantyagreement2020-.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.34*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/guarantyagreement2020-.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Unconditional and Continuing Guaranty Agreement by and between AquaBounty Farms, Inc. and First Farmers Bank and Trust, dated as of July 31, 2020 (incorporated by reference to Exhibit 10.8 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August 6, 2020).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/environmentalindemnity.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.35*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397820000099/environmentalindemnity.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Environmental Indemnity Agreement by and among AquaBounty Technologies, Inc., AquaBounty Farms Indiana LLC, and First Farmers Bank and Trust, dated as of July 31, 2020 (incorporated by reference to Exhibit 10.9 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on August 6, 2020).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397821000050/aqb-20210630xex10_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.36*</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397821000050/aqb-20210630xex10_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Letter Agreement between AquaBounty Technologies, Inc. and Third Security And its affiliates dated July 30, 2021 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November 4, 2021).</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397821000037/aqb-20210706xex16_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">16.1*</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1603978/000160397821000037/aqb-20210706xex16_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Letter from Wolf &amp; Company, P.C. dated July 6, 2021 (incorporated by reference to Exhibit 16.1 to the Registrant&#8217;s Current Report on Form 8-K, filed July 7, 2021).</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="aqb-20211231xex21_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">21.1</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="aqb-20211231xex21_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">List of Subsidiaries of AquaBounty Technologies, Inc.</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="aqb-20220310xex23_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">23.1</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="aqb-20211231xex23_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Consent of Deloitte &amp; Touche LLP</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="aqb-20211231xex23_2.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">23.2</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0000FF;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="aqb-20211231xex23_2.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Consent of Wolf &amp; Company, P.C.</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="aqb-20211231xex31_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">31.1</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="aqb-20211231xex31_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="aqb-20211231xex31_2.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">31.2</span></a></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="aqb-20211231xex31_2.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><a href="aqb-20211231xex32_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">32.1</span></a></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="aqb-20211231xex32_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.INS</span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL instance document-the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.SCH</span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL taxonomy extension schema document.</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.CAL</span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL taxonomy extension calculation linkbase document.</span></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.DEF</span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL taxonomy extension definition linkbase document.</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.LAB</span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL taxonomy label linkbase document.</span></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.PRE</span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL taxonomy extension presentation linkbase document.</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">104</span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in exhibit 101).</span></p></td></tr><tr><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 12.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 87.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">*Incorporated herein by reference as indicated.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"># Schedules, exhibits, and similar supporting attachments or agreements to the Loan and Security Agreement are omitted pursuant to Item 601(b)(2) of Regulation S-K. The Registrant agrees to furnish a supplemental copy of any omitted schedule or similar attachment to the Securities and Exchange Commission upon request.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8224;Management contract or compensatory plan or arrangement.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The registrant hereby undertakes to file with the Securities and Exchange Commission, upon request, copies of any constituent instruments defining the rights of holders of long-term debt of the registrant or its subsidiaries that have not been filed herewith because the amounts represented thereby are less than 10% of the total assets of the registrant and its&#160;subsidiaries on a consolidated basis.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">39</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item&#160;16.&#160;&#160;Form 10&#8209;K Summary</span><span id="Section28" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Not applicable.&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span id="Section29" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Signatures</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="padding-left: 0;text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 27pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 206.7pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 233.7pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">AQUABOUNTY TECHNOLOGIES, INC.</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 27pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 206.7pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 27pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">By:</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 206.7pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/&#160;Sylvia A. Wulf</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 27pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 206.7pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Sylvia A. Wulf</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 27pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 206.7pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Chief Executive Officer, President, and Director</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Power of Attorney</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David A. Frank and Angela M. Olsen, as his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendment to this Annual Report on Form&#160;10&#8209;K, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated below.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Signature</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Title</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Date</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Sylvia A. Wulf</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td rowspan="2" style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.06in;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">President, Chief Executive Officer and Director (Principal Executive Officer)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Sylvia A. Wulf</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ David A. Frank</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td rowspan="2" style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.06in;margin-right: 0.06in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Chief Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">David A. Frank</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Richard J. Clothier</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Chairman of the Board, Director</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Richard J. Clothier</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Christine St.Clare</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Director</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Christine St.Clare</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Rick Sterling</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Director</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Rick Sterling</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ James C. Turk</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Director</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">James C. Turk</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Alana D. Kirk</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Director</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Alana D. Kirk</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Theodore J. Fisher</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Director</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Theodore J. Fisher</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Ricardo Alvarez</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Director</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March&#160;10, 2022</span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom: solid windowtext 1.0pt;border-left: none;border-right: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 27.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Ricardo Alvarez</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.13in;margin-right: 0.06in;margin-top: 0;text-align: center;text-indent: -0.09in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Gail Sharps Myers</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 52.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Director</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March 10, 2022</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;              Gail Sharps Myers</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">40</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Report of Independent Registered Public Accounting Firm</span><span id="Section30" style="text-decoration: none;"></span><span id="ReportofIndep" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">To the shareholders and the Board of Directors of AquaBounty Technologies, Inc. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Opinion on the Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have audited the accompanying consolidated balance sheet of AquaBounty Technologies, Inc. and subsidiaries (the &quot;Company&quot;) as of December 31, 2021, the related consolidated statements of&#160;operations and comprehensive loss, changes in stockholders&apos; equity, and cash flows, for the year ended December 31, 2021, and the related notes (collectively referred to as the &quot;financial statements&quot;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and the results of its operations and its cash flows for the year ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Basis for Opinion</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">These financial statements are the responsibility of the Company&apos;s management. Our responsibility is to express an opinion on the Company&apos;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ </span><ix:nonNumeric name="dei:AuditorName" id="ct-nonNumeric-2f0d4b42-255b-4527-a6cf-9677e1c9b450" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Deloitte &amp; Touche LLP</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="dei:AuditorLocation" id="ct-nonNumeric-29a3b02c-51b5-413d-9390-fec6562d8331" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Baltimore, Maryland</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March 10, 2022 </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have served as the Company&apos;s auditor since 2021.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">1</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Report of Independent Registered Public Accounting Firm</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">To the Shareholders and the Board of Directors of</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Opinion on the Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have audited the accompanying consolidated balance sheet of AquaBounty Technologies, Inc. (the &#8220;Company&#8221;) as of December 31, 2020, the related consolidated statements of operations and comprehensive loss, changes in stockholders&#8217; equity, and cash flows for the year ended December 31, 2020 and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020, and the results of its operations and its cash flows for the year ended December 31, 2020 in conformity with accounting principles generally accepted in the United States of America.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Basis for Opinion</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provide a reasonable basis for our opinion.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ Wolf &amp; Company, P.C.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Boston, Massachusetts</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">March 9, 2021</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We served as the Company&#8217;s auditor from 2011 to 2020.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">2</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span><span id="BS" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span id="Section31" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Consolidated Balance Sheets</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">As of December 31,</span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Assets</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Current assets:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash and cash equivalents</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a4db479e-45ec-40cd-af85-0e67868eae7b" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">88,454,988</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f5cc94e1-a319-4a33-9e64-fdebc158c197" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">95,751,160</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Marketable securities</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-39d2f3d0-fc5d-4a2d-aac6-bb145c207023" name="us-gaap:MarketableSecuritiesCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">101,773,781</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inventory, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3a105b4e-1929-474e-978a-2061535024c6" name="us-gaap:InventoryNet" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,259,910</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-53c2c59f-932d-4d21-8d38-1fc5533b8ebf" name="us-gaap:InventoryNet" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,525,377</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid expenses and other current assets</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b7f1babf-2e43-402d-abb7-eac1e83697e4" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,536,484</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-36b9e2f0-0408-4d83-a677-c9f84fcadd21" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">405,370</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total current assets</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-33e151f5-89e1-48d6-9489-a205b88d8b40" name="us-gaap:AssetsCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">193,025,163</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3962c574-6f0a-4888-bd5d-5fd3d4cc8726" name="us-gaap:AssetsCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">97,681,907</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property, plant and equipment, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-74823e5e-fe34-4651-a17e-b15e445f1dc6" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">33,815,119</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-791f209e-7816-467b-9473-6af1f37ed31c" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">26,930,338</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Right of use assets, net</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b7b27d3d-6871-4850-ab74-89fc0d89c04a" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">284,320</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d5c6dafe-136b-4c9f-bb99-3bd2b736641b" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">341,997</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Intangible assets, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-50eaf153-36b2-4bfd-990a-3cad25a08e48" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">231,842</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5a48cc84-ae8e-4fc2-a64c-d7a59d23f7c5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">245,546</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Restricted cash</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b7b9f673-1301-419d-a433-cd8b8f5b7aa4" name="us-gaap:RestrictedCash" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,000,000</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c7a5fdb5-d129-4940-b82f-f91460b00df3" name="us-gaap:RestrictedCash" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">500,000</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other assets</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-baa01d87-dde7-4459-8c84-bcb0abfb4e73" name="us-gaap:OtherAssetsNoncurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">79,548</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-daa5e5da-9120-438b-86dc-eca5c8bef167" name="us-gaap:OtherAssetsNoncurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">76,715</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total assets</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ec7242c1-36b0-4536-b5e3-6cfd0e2a86d3" name="us-gaap:Assets" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">228,435,992</ix:nonFraction></span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-008b4cc9-9649-43e9-8be8-79f300629cba" name="us-gaap:Assets" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">125,776,503</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Liabilities and stockholders&apos; equity</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Current liabilities:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accounts payable and accrued liabilities</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-832eb285-92de-4987-9c5d-ac3e20588dfb" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">4,317,615</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-de25135b-793a-4a96-b88e-2e5a1bf65686" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,176,802</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accrued employee compensation</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-15e18082-e21c-46c6-bc7f-1c69b3a0e0b8" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">874,589</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0abc58aa-c943-4549-bccc-c56700cfcb3c" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">583,301</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Current debt</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-455858ff-4414-4489-95ab-83e9e91cc965" name="us-gaap:LongTermDebtCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">627,365</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1f319edc-fade-45ce-a549-d5f717a5372a" name="us-gaap:LongTermDebtCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">259,939</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other current liabilities</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-077c2fb3-a05c-44a5-bf9b-5f7daa939591" name="us-gaap:OtherLiabilitiesCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">66,269</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-955ea7ab-3964-407c-9cdc-460cdac81591" name="us-gaap:OtherLiabilitiesCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">62,483</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total current liabilities</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9f72ae44-9747-4fa4-a712-e9614e812db7" name="us-gaap:LiabilitiesCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">5,885,838</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-23d31153-1e67-45d2-aa92-dd1f06b99262" name="us-gaap:LiabilitiesCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,082,525</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Long-term lease obligations</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0420126f-df47-4c1e-931a-6b3e3489d08e" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">224,058</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-774b863f-b958-438d-8c75-e6dbbb811f98" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">290,327</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Long-term debt, net</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-da074f30-164b-40af-b94c-e67cd8a9897f" name="us-gaap:LongTermDebtNoncurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">8,523,333</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0306ad20-53fb-4e3a-888e-29c737d3f255" name="us-gaap:LongTermDebtNoncurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">8,528,490</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total liabilities</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e8fa628b-67b6-42fc-a3d0-083d02a5c0ee" name="us-gaap:Liabilities" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">14,633,229</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-14278dd0-4304-41ad-b7c6-b4bfbe648b84" name="us-gaap:Liabilities" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">10,901,342</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Commitments and contingencies (Note 10)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-9b6a89d3-0451-4270-8124-ff3ec68f392a;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a98151dc-30be-4049-88e4-e8cba4435ef0;">&#160;</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stockholders&apos; equity:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Common stock, $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-41396b4b-b0e7-4918-bef4-4b24faa2f48f" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="As_Of_12_31_2020" unitRef="Unit14" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-b56be015-95a5-46c8-967e-ec24381b5a7e" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="As_Of_12_31_2021" unitRef="Unit14" decimals="INF" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> par value, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a301f912-3971-47ce-8b73-6d99e67c62fb" name="us-gaap:CommonStockSharesAuthorized" contextRef="As_Of_12_31_2020" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-055c66f7-7542-47b1-b9ec-1f18f05765f7" name="us-gaap:CommonStockSharesAuthorized" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">80,000,000</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares authorized at December 31, 2021 and</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2020; </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a3974881-05dc-4e0c-8c10-028f9ba55380" name="us-gaap:CommonStockSharesOutstanding" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">71,025,738</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1718fff0-ac3d-4d6e-a7bd-78d9a1b0111e" name="us-gaap:CommonStockSharesOutstanding" contextRef="As_Of_12_31_2020" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">55,497,133</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares outstanding at December 31, 2021 and 2020, respectively</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-aa7443de-55cd-4b27-8207-a2759fe79481" name="us-gaap:CommonStockValue" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">71,026</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f10e0607-9fa1-4d74-8582-06b409aab5de" name="us-gaap:CommonStockValue" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">55,497</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Additional paid-in capital</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-141b8793-b8e3-4b9f-810d-fe1d9a9d6250" name="us-gaap:AdditionalPaidInCapital" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">384,852,107</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7f2cacb4-7963-4039-96b3-c62cee8ab484" name="us-gaap:AdditionalPaidInCapital" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">263,629,116</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated other comprehensive loss</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-60ebe397-2c17-4f93-bdd6-05ee5db5178e" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">255,588</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b37742c1-7a65-4d55-8d13-5dd10ae597c9" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">267,258</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated deficit</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-df897f7e-de0b-4974-a243-2a38e174160f" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">170,864,782</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0236f7e3-edb6-499b-abec-cbab8476675d" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">148,542,194</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total stockholders&apos; equity</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-efe2856f-44b8-4594-9d3d-f86bc7f21f91" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">213,802,763</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1510808c-3ea9-4716-a166-2808e0c9377a" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">114,875,161</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total liabilities and stockholders&apos; equity</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-57a49f07-dd5e-4be5-9eae-824e38688e75" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">228,435,992</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cca5aff4-09c5-459a-8a6b-8724ed590be7" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">125,776,503</ix:nonFraction></span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">See accompanying notes to the consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">3</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span><span id="Section33" style="text-decoration: none;"></span><span id="Section32" style="text-decoration: none;"></span><span id="IS" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Consolidated Statements of Operations and Comprehensive Loss</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.34in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Years ended </span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2020</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Revenues</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Product revenues</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4ea45f21-bfa5-434f-9fda-0d9d3a7e2b2b" name="us-gaap:Revenues" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,174,832</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ee643100-af08-4e22-9002-b6301cad1f70" name="us-gaap:Revenues" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">127,663</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Costs and expenses</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Product costs</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e44403ef-4c14-4880-8c8d-ec49023323cd" name="aqb:ProductionCostsOperating" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">10,786,072</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d39cdeb8-95ba-4030-90eb-a29bf4faaf4d" name="aqb:ProductionCostsOperating" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">6,680,012</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Sales and marketing</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-950ae21b-93e7-43dd-8870-a40198c41900" name="us-gaap:SellingAndMarketingExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,261,764</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-15b08e1a-ae55-42d5-bd15-c54335c6f26f" name="us-gaap:SellingAndMarketingExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">533,428</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5f7a8892-f6d9-4bcb-afb6-60c13746a3e9" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,145,548</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0540c5ef-0d97-4144-a8df-b01ba100646d" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,364,610</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-523b333f-00a6-46ff-b3a5-d17d8024f183" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">9,103,213</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-06e9921c-e976-4e81-8886-3f5bbbfdd759" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">6,797,443</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total costs and expenses</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-80add01d-f7a5-4ada-a59b-29143673b7b7" name="us-gaap:OperatingExpenses" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">23,296,597</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2841b077-7eea-4994-9c68-c8afe7a318a0" name="us-gaap:OperatingExpenses" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">16,375,493</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Operating loss</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-455d8f7d-ff7c-4bed-ad98-af0f4c3a7eb5" name="us-gaap:OperatingIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">22,121,765</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b8c780a6-b62c-47e1-b567-20513eb45fd9" name="us-gaap:OperatingIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">16,247,830</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Other income (expense)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Interest expense</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-86047e16-069e-4a3b-b71d-2982defc2a2e" name="us-gaap:InterestExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">316,442</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bf72f0a7-158a-4738-b002-3a0e71e30535" name="us-gaap:InterestExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">152,367</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other income (expense), net</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8b2fb143-66b4-4678-96cd-64fa64dbd1ff" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">115,619</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f9575adb-0472-401a-a760-fd5615cd4629" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">212</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total other income (expense)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4a0107a3-ad08-4609-99b9-bcd7b041bad9" name="us-gaap:NonoperatingIncomeExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">200,823</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-20c15295-ff22-4b46-bc70-974fe454950e" name="us-gaap:NonoperatingIncomeExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">152,155</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ee4e2f10-66c0-4051-ac2c-3c85c2502c5e" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">22,322,588</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1bb44bef-457a-4fed-bc60-4097213664b1" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">16,399,985</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Other comprehensive income (loss):</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Foreign currency</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-aadb3af0-dea6-40b6-be7a-3b2333e43854" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">51,771</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c1f92a69-d167-413d-aa75-bfdd76b4f3fc" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">92,902</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Unrealized losses on marketable securities</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0fed6436-5405-4cb5-8870-e23bdcf890f3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">40,101</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total other comprehensive income</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c3463091-4514-4271-b86e-b15c7219b17f" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">11,670</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2f16393c-31bd-4447-b95b-48a6aa326b88" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">92,902</ix:nonFraction></span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Comprehensive loss</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-54c608c7-6122-4e0f-8e02-2d424f29f28f" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">22,310,918</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a4432be5-4453-40f7-ba08-e7f5be3cc52f" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">16,307,083</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Basic and diluted net loss per share</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-91cbbf6c-8cc5-4f35-9138-0ba57d5d978f" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal" sign="-">0.32</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bc052c2a-63b2-4343-b6dc-a28ef80e1d27" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal" sign="-">0.45</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Weighted average number of common shares -</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> basic and diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 17.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-02987307-ece4-49a2-a4f4-1a719ad97f78" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">69,428,061</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d832c642-8e5b-4e54-b713-86c4ff3233d2" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">36,347,398</ix:nonFraction></span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">See accompanying notes to the consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">4</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span><span id="Section34" style="text-decoration: none;"></span><span id="SE" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Consolidated Statements of Changes in Stockholders&#8217; Equity</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Common stock issued and outstanding</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Par value</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Additional paid-in capital</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated other comprehensive loss</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated deficit</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Balance as of December 31, 2019</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b01edd26-5bb2-4253-a5f0-8f90adee31c7" name="us-gaap:SharesOutstanding" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">21,635,365</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cae2451d-d01e-4de0-a42d-10ba1e99de28" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">21,635</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5684f2ff-dcf3-47e3-ab53-361a5240f815" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">156,241,363</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0d02baa2-90a2-41a8-b43a-6264e8f2eee4" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">360,160</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c695c153-1cd9-4f2e-a901-0fc2686730f3" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">132,142,209</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3e8922e2-35ee-4f45-9195-5e05336d1e82" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2019" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">23,760,629</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-784a336f-4241-46ff-b361-20226944947e;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-1bb6a9e6-5ce4-42f3-b252-6b5d694544b3;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-f18e4ffc-3dd2-4c4d-bffc-5e004097cfa6;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-d18d1eb7-b31b-4410-9c80-ffbc9b77fa38;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1e20aa1d-3a7f-460d-893c-10ef36901fb9" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">16,399,985</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f2334b3d-2477-43c7-b239-ddce4ebf6c05" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">16,399,985</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other comprehensive income</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-cf4fe521-6340-4877-82ce-2a20e3ddbcd5;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-868b5e5a-c34a-420c-ad32-9cbd544962d2;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a6a59526-a36d-40a1-bb65-7b1a4df8e865;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7f2917a8-acbe-45e2-87bb-93ec4c4fca56" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">92,902</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-5c3c08f2-7378-4208-9011-725686935807;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1fc312fb-03f3-4293-b9b0-361b535c5c9b" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">92,902</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Issuance of common stock for service</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e1d72df2-da56-48f2-b97f-e1246b7e29b4" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">20,000</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-dfea8b0b-7adc-4a7d-9e00-cfd01163c0a0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">20</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-00a6e119-7013-457f-94ca-dcc794e8acad" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">40,580</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-140e6731-d1c4-4feb-b875-90fdf39442e2;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-7d6a578e-1989-4c3f-b810-b250c9fffb38;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1d6d4a34-849f-4193-9d21-fa8ea5aaf4f3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">40,600</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Issuance of common stock, net of expenses</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e3fffbd9-10c2-4167-a892-525eba883ce0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">33,028,000</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-95ab6d5f-b2c8-465f-85ef-cad32e98a059" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">33,028</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3a37085a-3f66-4e80-8e48-2743d9f0076f" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">104,592,587</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-32f45406-b983-4571-872a-500c6d6fa4ee;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-bdea8e6f-fb6c-48e6-baae-6a051816da74;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-27d5d4ce-4880-4592-a1a5-8740e391b903" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">104,625,615</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Exercise of warrants for common stock</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0d6140a1-9b86-4cda-b196-407393235fd4" name="aqb:ExerciseofWarrantsforCommonStockshares" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">713,449</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c7e37eb6-ef8c-4726-8c1e-0a78b89c95ba" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">713</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d49dc8b8-53fb-444a-a4a0-5278286727e6" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,317,996</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-6843bac4-d396-4fd5-bf64-eaadba0c9281;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-4b105fbd-1e83-4e55-98fe-f75182c28eb1;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c2c66baf-0028-4a3c-b264-43cc88615e3b" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,318,709</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Share based compensation</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5f9c31cb-c1f9-463a-a200-6ef24792be90" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">100,319</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2ba4e12a-9ac7-4b19-a28d-cbf2846775e0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">101</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f8c8d574-f4ad-4f33-9ad5-c72d6f45e9c9" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">436,590</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-48c7b8af-c98c-4e02-9b32-50bbecaa0198;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-ce6ab083-ac06-43a7-8908-c67eeecfcb96;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d44de531-20a1-4637-8deb-7fffb5ff0c79" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">436,691</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Balance as of December 31, 2020</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1aeecabe-705a-44d9-b83c-fbc3d0ddd710" name="us-gaap:SharesOutstanding" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">55,497,133</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1f8419a6-00d1-48f7-8feb-b89597ba9800" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">55,497</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8f5207fa-a2f9-46be-9ee2-e1f61431aa25" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">263,629,116</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-701c330e-30cd-4b0f-a473-845ccd5ed93e" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">267,258</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ea2adecf-495b-4200-aa66-28f9339d19e7" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">148,542,194</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-98052bd1-1dc4-49ec-8e19-5993b4879b53" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">114,875,161</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Net loss</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-f5bfb904-39d5-41a6-a26b-bcef77051a83;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-4bb53a14-2a93-4e17-a63b-c2cb1c46e424;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-097314e7-11bb-4ca7-9fd6-6cda76fab2db;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-cb484afc-c85f-4c6f-8d1f-29ef78cae0b0;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-44fc971c-da54-482a-a331-9fb02fdb255d" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">22,322,588</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c148e149-4084-4087-93cc-a022a8082335" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">22,322,588</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Other comprehensive income</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-b59795ba-7292-4c2b-b223-b9e146873faa;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-0f0c9ec5-d409-41d6-944e-59e4d95411a6;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-47847e33-ade6-41f5-b123-5cde2d12e28d;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-790f00aa-2b16-496d-9d89-e0ab791124bf" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">11,670</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-5098dbc5-42aa-46bc-a709-f0801a283dcd;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1de6f5df-5b4a-4714-a84b-2a93dad304c6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">11,670</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cashless exercise of options for common stock</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cfba9c5c-1af3-4adf-93c8-2745e2292669" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">4,354</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-284c509d-d2d3-4720-8fc1-4b47cfb622ed" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5dad8744-1e4e-4934-a20c-58955c7fa799" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">4</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-35042d0c-312c-4986-8548-bc6cd3eb8bc2;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-e8d2e945-1c87-493b-9e7e-e6c30034ab06;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-47b3ae23-1792-4d3b-8c42-c4bb6f520a26;">&#8212;</span></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Issuance of common stock, net of expenses</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-550228db-81f4-4f1b-bdb2-a30eda74d9fc" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">14,950,000</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f5e02a12-9af5-4848-a42f-6b6d5d2fe044" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">14,950</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1c639312-d76a-4652-8863-48cd3b86794f" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">119,105,487</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-ff28a4a8-4f8d-4747-97e8-7cc1e22f4798;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-2e4c5fba-a84c-4603-9ba3-f3d69a621041;">&#160;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d34b270a-5ae9-4e45-add7-1a738e17c6df" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">119,120,437</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Exercise of warrants for common stock</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-07a829a2-8895-4add-8604-3bfaf2ec5880" name="aqb:ExerciseofWarrantsforCommonStockshares" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">530,414</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f4b4d58d-688c-43fd-9329-0a4e684f7bae" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">530</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8d1f4b4d-d973-4e16-b6df-fec1c0094e8c" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,723,316</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-263e3319-a480-4d83-a603-55ac72fed500;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-3fbe7447-b64c-49bf-8eb3-857896bb3d07;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ba010402-e371-450d-941c-dad86ee9da2c" name="aqb:ExerciseofWarrantsforCommonStock" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,723,846</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Share based compensation</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e5ef76d2-0bd5-4199-9bfc-48c5bd1e505a" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">43,837</ix:nonFraction></span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a0703468-8921-4200-9a2d-20f2c93b96fc" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">45</ix:nonFraction></span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e3ab7797-b0f6-48e3-8520-70fcf08b6d92" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">394,192</ix:nonFraction></span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-8d648ec8-43cb-4fa1-ad25-d93da47c90e9;">&#160;</span></span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-aae32a99-c74d-4fa3-a6ab-7f34f49500b0;">&#160;</span></span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b6d28f88-1168-4149-b2e2-21e74ecd0f9e" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">394,237</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Balance as of December 31, 2021</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-694c10d1-3fa3-41bc-9681-95206f30e6c9" name="us-gaap:SharesOutstanding" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">71,025,738</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7f697b12-4530-4f10-acc4-580a474b65bb" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">71,026</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5223a80a-4b8a-4379-b432-c6732e699a8c" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">384,852,107</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6c32a883-23cc-445c-add7-ac4b0394a387" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">255,588</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3766d58d-b0c5-4d9c-8dcc-7c6547303bdb" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">170,864,782</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0284253f-8d06-446d-a841-4dea4aea4998" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">213,802,763</ix:nonFraction></span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">See accompanying notes to the consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">5</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span><span id="Section35" style="text-decoration: none;"></span><span id="CF" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Consolidated Statements of Cash Flows</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Years Ended </span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Operating activities</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-584ed73c-1d41-49f2-bc87-21a8fc784551" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">22,322,588</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ddadbb30-60e7-4385-bbad-b7223e71fdcd" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">16,399,985</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Adjustment to reconcile net loss to net cash used in</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">operating activities:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Depreciation and amortization</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5bd127da-a64e-42fd-81d9-f69dc00eb66a" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,787,564</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1df89acb-fc0d-4f23-aad1-7648429f8482" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,494,596</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Share-based compensation</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-de0e789d-0ab4-4be7-bdd7-f8559fcfe685" name="us-gaap:ShareBasedCompensation" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">394,237</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-35650697-7fad-45ab-899d-2652229a0645" name="us-gaap:ShareBasedCompensation" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">436,691</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other non-cash charge</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ecfbb69a-3979-43d3-8631-645c8dd39adf" name="us-gaap:OtherNoncashIncomeExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">17,386</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0fc70a64-977b-47a3-8fb0-27b13d54ed9a" name="us-gaap:OtherNoncashIncomeExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">44,339</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Changes in operating assets and liabilities:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inventory</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4e9696a6-6cd4-48a9-b328-04544cb909eb" name="us-gaap:IncreaseDecreaseInInventories" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">267,833</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e2e5569d-1c98-4845-86fb-4ba0ac210791" name="us-gaap:IncreaseDecreaseInInventories" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">282,260</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid expenses and other assets</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4c6eed4a-dd2b-44cd-b251-bc1fbc3562e5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,138,691</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-999f77bb-3da7-48e0-b0fd-8dc424fe1bde" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">74,621</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accounts payable and accrued liabilities</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e8b8b125-d4eb-4a37-9ecb-76f5215fb19b" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">230,712</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c640b8e2-cb38-44bb-ace5-b24092bfee39" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">145,607</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accrued employee compensation</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-304a8fd3-fedc-496a-8441-f40ed4d7dd01" name="us-gaap:IncreaseDecreaseInAccruedSalaries" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">291,288</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fa447466-3725-4973-8bda-736f378c04cb" name="us-gaap:IncreaseDecreaseInAccruedSalaries" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">346,812</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in operating activities</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-31da6679-d842-41b3-b7e4-abcbb124e590" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">20,472,259</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fb937b4c-988c-4e7e-96e5-479b55a222ba" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">14,288,821</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Investing activities</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Purchases of property, plant and equipment</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-22460be0-abf7-47a5-9951-9a504605b7bc" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">5,668,696</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-06d2fba9-511d-4358-a35e-0c7c21033b76" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">3,975,135</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Deposits on equipment purchases</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7282ddf8-b08c-475b-a05d-d0552dd8c1f6" name="aqb:PaymentsForDepositsOnEquipmentPurchases" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">45,111</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c61f5abb-c5fd-479f-8a2b-858f5831d8e9" name="aqb:PaymentsForDepositsOnEquipmentPurchases" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">349,847</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Proceeds from sale equipment</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3bb94d1c-ed90-4bc6-8de6-7682309ea9a4" name="us-gaap:ProceedsFromSaleOfMachineryAndEquipment" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">99,816</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Purchases of marketable securities, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c2941b5a-b93c-43c4-9f0b-527c85e697eb" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">101,813,882</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Proceeds from legal settlement, net</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-59890643-57ed-4bd5-8b05-bb349e305a8a" name="aqb:ProceedsPaymentsForLegalSettlementsInvestingActivities" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,014,008</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other investing activities</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a710385a-2d85-4cf4-96bc-efa731bb3265" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">11,010</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a9db394f-3799-4b13-b3cf-0190115cf811" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">27,253</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in investing activities</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-70a772b1-7e78-4939-87a4-da793a95b4f5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">107,538,699</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7df012a6-0f51-45b9-b791-d6b3be9dfe92" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">3,238,411</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Financing activities</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Proceeds from issuance of debt</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-026f2912-1a59-481d-b79d-1cc97365a710" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">606,453</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-85463b7b-6a41-4891-8b50-596eb731bb2b" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">4,221,130</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Payment of debt issuance costs</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-00206ece-c36c-4c16-9414-691e56ce371f" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">91,620</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Repayment of term debt</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4090772a-5e45-4872-9f89-a820596b0670" name="us-gaap:RepaymentsOfSecuredDebt" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">272,102</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-32e13329-03ff-44b9-a2ea-0c10792074ec" name="us-gaap:RepaymentsOfSecuredDebt" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">70,826</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Proceeds from the issuance of common stock, net</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d9409862-5ca3-4340-be16-d82aa404fe50" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">119,120,437</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6e025cb1-952c-4fb1-bf92-5ff1acdaa3fb" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">104,625,615</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Proceeds from the exercise of stock options and warrants</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-35f462f4-1c4b-4be9-8871-b96f2afebaba" name="us-gaap:ProceedsFromOtherEquity" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,723,846</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f5a75f20-c56d-4ef1-a8bf-977ab25bbab3" name="us-gaap:ProceedsFromOtherEquity" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,318,709</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash provided by financing activities</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4e803c86-9b07-474f-9ea9-1e134dbe3ff2" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">121,178,634</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f97c7923-a452-47c8-9079-4dbb1655a348" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">111,003,008</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d28b74e2-7d56-468a-99d4-3fa5d593d91b" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">36,152</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1990b6fc-a1cc-4afc-b0bf-546c3af48fe3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">23,360</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net change in cash, cash equivalents and restricted cash</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4c9b90c5-1afe-4105-b807-7278d654f61f" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">6,796,172</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9449ca1c-5b28-4413-a2c5-5377a88fdf68" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">93,452,416</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash, cash equivalents and restricted cash at beginning of period</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6b56fb8c-9e7b-4ea9-9e0b-b62efdd162ed" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">96,251,160</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2d0df8c4-9916-4532-98a8-8a3bfb894216" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_12_31_2019" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,798,744</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cash, cash equivalents and restricted cash at end of period</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a2bc23aa-7df7-4a16-b3fb-48e7c5b4738b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">89,454,988</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d75a86da-cff7-455d-b327-3df261e40cb2" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">96,251,160</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Reconciliation of cash, cash equivalents and restricted cash reported</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">in the consolidated balance sheet:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Cash and cash equivalents</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-73522370-4d1f-4275-9ca6-01152735756f" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">88,454,988</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-282446b4-25db-4001-92e1-ba1b00e260a9" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">95,751,160</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Restricted cash</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-81a85f4f-376a-42f2-9d64-bbd1f6656a63" name="us-gaap:RestrictedCashAndCashEquivalents" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,000,000</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e476e883-b986-4e57-9cde-adad707a4ce9" name="us-gaap:RestrictedCashAndCashEquivalents" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">500,000</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Total cash, cash equivalents and restricted cash</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-99af16f1-02a1-488e-99f9-0d17a25d2caf" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">89,454,988</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-525b2efa-b067-4be6-a185-83dd8ec8e0dd" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">96,251,160</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double windowtext 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Supplemental disclosure of cash flow information and</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">non-cash transactions:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Interest paid in cash</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0724b367-d9df-472c-8cb8-cd3d3257657e" name="us-gaap:InterestPaidNet" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">299,056</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6f9ca436-d913-4f29-baf7-bccee2919e71" name="us-gaap:InterestPaidNet" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">114,893</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Property and equipment included in accounts payable and accrued liabilities</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-786c6a32-668c-426d-a12e-02e479bfb3ac" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,926,016</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-55b58c64-d53d-4a04-bc2d-d7affad8d889" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">23,600</ix:nonFraction></span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">See accompanying notes to the consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">6</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span id="Section36" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:NatureOfOperations" id="ct-nonNumeric-995a7c34-c31b-4da4-96a3-e8c0fced0402" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-995a7c34-c31b-4da4-96a3-e8c0fced0402-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">1.&#160;Nature of business and organization</span><span id="Notes" style="text-decoration: none;"></span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-995a7c34-c31b-4da4-96a3-e8c0fced0402-continuation-0" continuedAt="ct-nonNumeric-995a7c34-c31b-4da4-96a3-e8c0fced0402-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="aqb:NatureOfOperationsPolicyPolicyTextBlock" id="ct-nonNumeric-f451ec96-17c9-4226-bfdf-74e706ecaf9d" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-f451ec96-17c9-4226-bfdf-74e706ecaf9d-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Nature of business</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><ix:continuation id="ct-nonNumeric-f451ec96-17c9-4226-bfdf-74e706ecaf9d-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">AquaBounty Technologies, Inc. (the &#8220;Parent&#8221; and, together with its wholly owned subsidiaries, the &#8220;Company&#8221;) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm&#8209;raised Atlantic salmon that exhibit growth rates that are substantially faster than conventional salmon.  In 2015, the Parent obtained regulatory approval from the U.S. Food and Drug Administration for the production and sale of its genetically engineered AquAdvantage salmon product (&#8220;GE Atlantic salmon&#8221;) in the United States and in 2016, the Parent obtained regulatory approval from Health Canada for the production and sale of its GE Atlantic salmon product in Canada. In 2021, the Parent obtained regulatory approval from the National Biosafety Technical Commission for the sale of its GE Atlantic salmon product in Brazil.</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ct-nonNumeric-d4d287cf-9a41-4db1-a1d1-cbd0cc1a54aa" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-d4d287cf-9a41-4db1-a1d1-cbd0cc1a54aa-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Basis of presentation</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><ix:continuation id="ct-nonNumeric-d4d287cf-9a41-4db1-a1d1-cbd0cc1a54aa-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned subsidiaries. The entities are collectively referred to herein as the &#8220;Company.&#8221; All inter-company transactions and balances have been eliminated upon consolidation.</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="aqb:LiquidityPolicyPolicyTextBlock" id="ct-nonNumeric-f4503871-48f7-43d0-b30a-452f155b634d" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-f4503871-48f7-43d0-b30a-452f155b634d-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Liquidity</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-f4503871-48f7-43d0-b30a-452f155b634d-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company completed an equity raise in 2021with net proceeds of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-01a890eb-b2a8-4394-bb40-db70561773ba" name="aqb:AdditionalCashAndCashEquivalents" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">119.1</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million and has $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6fa22365-d97c-4c4b-80f0-8f9690e2453e" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">191.2</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million in cash and cash equivalents, marketable securities and restricted cash as of December 31, 2021. While the Company has experienced net losses and negative cash flows from operations since inception, management believes that it has sufficient cash to meet the Company&apos;s requirements beyond the next twelve months from the filing date of these consolidated financial statements. However, until such time as the Company reaches profitability, it may require additional financing to fund its operations and execute its business plan.</span></p></ix:continuation></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.19in;margin-top: 0;"><ix:continuation id="ct-nonNumeric-995a7c34-c31b-4da4-96a3-e8c0fced0402-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section37" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2.&#160;Summary of significant accounting policies</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1-continuation-0" continuedAt="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:UseOfEstimates" id="ct-nonNumeric-3ce76a5d-0b97-4f9e-b468-f7445b7ac7a2" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-3ce76a5d-0b97-4f9e-b468-f7445b7ac7a2-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Use of estimates</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-3ce76a5d-0b97-4f9e-b468-f7445b7ac7a2-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the&#160;reporting periods. Actual results could differ from those estimates. </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="ct-nonNumeric-2f3bbd92-6b1a-4936-ae7b-790e8efbe254" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-2f3bbd92-6b1a-4936-ae7b-790e8efbe254-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Comprehensive loss</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-2f3bbd92-6b1a-4936-ae7b-790e8efbe254-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company displays comprehensive loss and its components as part of its consolidated financial statements. Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) includes foreign currency translation adjustments and unrealized gains (losses) on the Company&#8217;s marketable securities. </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="ct-nonNumeric-2ff42525-1001-4596-a405-8f5de10322c7" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-2ff42525-1001-4596-a405-8f5de10322c7-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Foreign currency translation</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-2ff42525-1001-4596-a405-8f5de10322c7-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The functional currency of the Parent is the US Dollar. The functional currency of the Canadian Subsidiary is the Canadian Dollar (C$) and the functional currency of the US and Brazil Subsidiaries is the US Dollar. For the Canadian Subsidiary, assets and liabilities are translated at the&#160;exchange rates in effect at the balance sheet date, equity accounts are translated at the historical exchange rate and the income statement accounts are translated at the average rate for each period during the year. Net translation gains or losses are adjusted directly to a separate component of other comprehensive income (loss) within stockholders&#8217; equity.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ct-nonNumeric-257e94d6-f812-4ea1-b469-49fc47c19257" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-257e94d6-f812-4ea1-b469-49fc47c19257-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cash equivalents</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><ix:continuation id="ct-nonNumeric-257e94d6-f812-4ea1-b469-49fc47c19257-continuation-0"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents.  Cash equivalents consist primarily of business savings accounts, certificates of deposit and money market accounts. </span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:MarketableSecuritiesPolicy" id="ct-nonNumeric-d6240ebd-8815-4171-99f1-f4b23042f902" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-d6240ebd-8815-4171-99f1-f4b23042f902-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Marketable securities</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-d6240ebd-8815-4171-99f1-f4b23042f902-continuation-0" continuedAt="ct-nonNumeric-d6240ebd-8815-4171-99f1-f4b23042f902-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Marketable securities include government bonds, corporate bonds and commercial paper.  The Company&apos;s investment policy requires investments to be explicitly rated by two of Standard &amp; Poor&apos;s, Moody&apos;s or Fitch and to have a minimum rating of A1, P1 or F-1, </span></p></ix:continuation></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">7</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <ix:continuation id="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1-continuation-1" continuedAt="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1-continuation-2"><div><ix:continuation id="ct-nonNumeric-d6240ebd-8815-4171-99f1-f4b23042f902-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">respectively, from those agencies.  In addition, the investment policy limits individual maturities to 12 months, the dollar-weighted average maturity to 180 days and the amount of credit exposure to any one issuer to 5%.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:InventoryPolicyTextBlock" id="ct-nonNumeric-1afd3c25-4ac9-4fa4-8bb5-1803fdb9b66c" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-1afd3c25-4ac9-4fa4-8bb5-1803fdb9b66c-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Inventories</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-1afd3c25-4ac9-4fa4-8bb5-1803fdb9b66c-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inventories are mainly comprised of feed, eggs and fish in process. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company measures inventory at the lower of cost or net realizable value (NRV).  The NRV calculation contains various estimates and assumptions in regard to the calculation of the biomass, including expected yield, the market value of the biomass and estimated costs of completion and transportation. </span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="ct-nonNumeric-ab7de22e-14bd-4624-9687-bc3569cbaad1" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-ab7de22e-14bd-4624-9687-bc3569cbaad1-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Intangible assets</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-ab7de22e-14bd-4624-9687-bc3569cbaad1-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Definite lived intangible assets include patents and licenses.  Patent costs consist primarily of legal and filing fees incurred to file patents on proprietary technology developed by the Company. Patent costs are amortized on a straight</span><span style="white-space:pre-wrap; color: black;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">line basis over </span><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="ct-nonNumeric-e5c0dd03-a805-4b85-b780-7b6554d1acf5" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">20</span></ix:nonNumeric><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years beginning with the filing date of the applicable patent.  License fees are capitalized and expensed over the term of the licensing agreement.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indefinite lived intangible assets include trademark costs, which are capitalized with no amortization as they have an indefinite life.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ct-nonNumeric-5c46de10-cec4-4c3f-a8e3-2ec30fea4bc1" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-5c46de10-cec4-4c3f-a8e3-2ec30fea4bc1-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Property, plant and equipment</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-5c46de10-cec4-4c3f-a8e3-2ec30fea4bc1-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property, plant and equipment are carried at cost. The Company depreciates all asset classes over their estimated useful lives, as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="aqb:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" id="ct-nonNumeric-4e03a516-82b2-4862-8c33-3458a279b09e" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 40.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 4.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 40.0%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 2pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 2pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 4.8%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 2pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 2pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 55.2%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 2pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 2pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 40.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Building</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 4.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 55.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-45691981-3ff0-47a3-bcdc-e88ddb62b3cb" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">20</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> - </span><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-c45c8b18-5572-48b4-961f-1da580da7352" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">25</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 40.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Equipment</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 4.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 55.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-f3288035-01bb-4842-a97c-df480cbba051" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> - </span><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-0b81982e-d3cd-43d3-8987-08121195c33b" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">20</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 40.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Office furniture and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 4.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 55.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-5468d023-229f-404b-ba43-0703182e46cc" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 40.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Leasehold improvements</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 4.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 55.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="aqb:PropertyPlantAndEquipmentUsefulLife1" id="ct-nonNumeric-324227e9-8920-48a5-b065-2a16c6297c06" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">shorter of asset life or lease term</span></ix:nonNumeric></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 40.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Vehicles</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 4.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 55.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-375fec38-a95e-4164-85d2-625b19534690" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years</span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company commences depreciation on an asset when it is placed into service.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="ct-nonNumeric-f8b6b336-8ba2-4afb-ae08-8ec275920808" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-f8b6b336-8ba2-4afb-ae08-8ec275920808-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Impairment of long-lived assets</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-f8b6b336-8ba2-4afb-ae08-8ec275920808-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company reviews the carrying value of its long-lived assets, definite lived intangible assets, and property, plant and equipment when facts and circumstances suggest that they may be impaired. The carrying values of such assets are considered impaired when the estimated undiscounted cash flows from such assets are less than their carrying values. An impairment loss, if&#160;any, is recognized in the amount of the difference between the carrying amount and the fair value of such assets.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indefinite lived intangible assets are subject to impairment testing annually or more frequently if impairment indicators arise. The&#160;Company&#8217;s impairment testing utilizes a discounted cash flow analysis that requires significant management judgment with respect&#160;to&#160;revenue and expense growth rates, changes in working capital and the selection and use of the appropriate discount rate. An&#160;impairment loss is recognized in the amount of the difference between the carrying amount and fair value.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:LesseeLeasesPolicyTextBlock" id="ct-nonNumeric-a7a05ff6-a820-447b-b187-fe6acf24ff82" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-a7a05ff6-a820-447b-b187-fe6acf24ff82-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Leases</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-a7a05ff6-a820-447b-b187-fe6acf24ff82-continuation-0" continuedAt="ct-nonNumeric-a7a05ff6-a820-447b-b187-fe6acf24ff82-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company leases certain facilities, property, and equipment under noncancelable operating leases. A determination is made if an arrangement is a lease at its inception, and leases with an initial term of twelve months or less are not recorded on the balance sheet.  Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For operating leases, expense is recognized on a straight-line basis over the lease term.  The Company has agreements with lease (e.g., minimum rent payments) and non-lease components (e.g., maintenance), which are generally accounted for separately. The Company has not elected the practical expedient to account for lease and non-lease components as one lease component.</span></p></ix:continuation></div></ix:continuation>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">8</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <ix:continuation id="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1-continuation-2" continuedAt="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1-continuation-3"><div><ix:continuation id="ct-nonNumeric-a7a05ff6-a820-447b-b187-fe6acf24ff82-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company adopted Financial Accounting Standards Board&apos;s (FASB) Accounting Standards Update (ASU) 2016-02 Leases on January 1, 2019 and recognized a lease liability of $</span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1dd24332-1ba8-4fef-b850-dac0381e7350" name="us-gaap:OperatingLeaseLiability" contextRef="As_Of_1_1_2019" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">532</ix:nonFraction></span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand and a corresponding right-of-use asset of $</span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4ebb513f-be43-4449-bfb1-21c6b96db832" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="As_Of_1_1_2019" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">512</ix:nonFraction></span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand. Management calculated the lease liability based on the net present value of the remaining lease payments on the date of adoption using a weighted average discount rate of </span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3e881194-5059-4179-abc9-add51544454e" name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="As_Of_1_1_2019_srt_RangeAxis_srt_WeightedAverageMember" unitRef="Unit13" decimals="2" format="ixt:numdotdecimal" scale="-2">8</ix:nonFraction></span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%. As most of the Company&#8217;s leases did not provide an implicit interest rate, management used an estimated incremental borrowing rate. The adoption did not result in any cumulative-effect adjustment to beginning retained earnings.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ct-nonNumeric-c2ac8508-2c53-438a-ba47-5744ba1b952d" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-c2ac8508-2c53-438a-ba47-5744ba1b952d-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Revenue recognition</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-c2ac8508-2c53-438a-ba47-5744ba1b952d-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company generates revenue from the sale of its products.  Revenue is recognized when the customer takes physical control of the goods, in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for the goods. Revenue excludes any sales tax collected and includes any estimate of future credits.  During 2021, the Company recognized $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f0359a87-4e64-4550-b1e6-24d751a854b5" name="us-gaap:Revenues" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadaSubsidiaryMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">747</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-74f2b606-ad39-4fc5-80c0-f250b26baa7d" name="us-gaap:Revenues" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_UnitedStatesSubsidiaryMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">428</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand in revenue from product sales from its Canada and U.S. subsidiaries, respectively.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" id="ct-nonNumeric-c4c8bf8e-5d83-4fc4-8efd-36916588af56" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-c4c8bf8e-5d83-4fc4-8efd-36916588af56-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Income taxes</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-c4c8bf8e-5d83-4fc4-8efd-36916588af56-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recorded for the expected future tax consequences of temporary differences between the financial reporting and income tax bases of&#160;assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences reverse. A valuation allowance is established to reduce net deferred tax assets to the amount expected to be realized. The Company follows accounting guidance regarding the recognition, measurement, presentation and disclosure of uncertain tax positions in the financial statements. Tax positions taken or expected to be taken in the course of preparing the Company&#8217;s tax returns are required to be&#160;evaluated to determine whether the tax positions are &#8220;more likely than not&#8221; to be upheld under regulatory review. The resulting tax impact of these tax positions is recognized in the financial statements based on the results of this evaluation. The Company did not recognize any tax liabilities associated with uncertain tax positions, nor has it recognized any interest or penalties related to unrecognized tax positions. The Company is not currently under exam and is no longer subject to federal and state tax examinations by tax authorities for years before 2018. </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" id="ct-nonNumeric-4ec694fa-a425-45f8-a210-f9df5ee2f197" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-4ec694fa-a425-45f8-a210-f9df5ee2f197-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Net loss per share</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-4ec694fa-a425-45f8-a210-f9df5ee2f197-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.20in;margin-top: 0;"><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Basic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Basic net loss per share is based solely on the number of common shares outstanding during the year. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and&#160;options with an exercise price less than the fair value of the common stock unless the impact of the warrant or option is anti-dilutive to the calculation. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti</span><span style="white-space:pre-wrap; color: black;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">dilutive and are excluded from the calculation of diluted net loss per share.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2021, the Company had </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d10c8dd2-4151-428d-beee-70f96ebcf99d" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">1,081,866</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> potentially dilutive securities outstanding, consisting of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-471c26ce-de8b-403c-b380-5cbf97819a04" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">418,441</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> warrants and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-10fe1ed3-6337-4f74-9fdd-03a810728e52" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">663,425</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options.  As of December 31, 2020, the Company had </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-db5ebe26-9c18-4ea0-bfcf-9afd0edee65e" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">2,236,229</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> potentially dilutive securities outstanding, consisting of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1cb6503e-68d6-4610-a2c7-e76450364008" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">1,662,304</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> warrants and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-314953ef-2d16-4613-8e28-02a622312965" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">573,925</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ct-nonNumeric-8fbe1762-bc7a-4a1e-9af5-b7f20d37ec63" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-8fbe1762-bc7a-4a1e-9af5-b7f20d37ec63-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Share-based compensation</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-8fbe1762-bc7a-4a1e-9af5-b7f20d37ec63-continuation-0"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company measures and recognizes all share</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">based payment awards, including stock options and restricted share units made to employees and Directors, based on&#160;estimated fair values. The fair value of a share</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">based payment award is estimated on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in&#160;the&#160;Company&#8217;s consolidated statement of operations. The Company uses the Black</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Scholes option pricing model (&#8220;Black</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Scholes&#8221;) as&#160;its&#160;method of valuation. Non</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">employee stock</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">based compensation is accounted for using Black</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Scholes to determine the fair value of&#160;warrants or options awarded to non</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">employees with the fair value of such issuances expensed over the period of service</span><span style="white-space:pre-wrap; font-family: 'Arial', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ct-nonNumeric-98333084-cd3e-4703-8c56-75aaf9ab54d2" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-98333084-cd3e-4703-8c56-75aaf9ab54d2-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Recently Issued Accounting Standards</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-98333084-cd3e-4703-8c56-75aaf9ab54d2-continuation-0" continuedAt="ct-nonNumeric-98333084-cd3e-4703-8c56-75aaf9ab54d2-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company is an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. The Company has elected to use the extended transition period for complying with new or revised accounting standards unless otherwise state. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company will remain an &#8220;emerging growth company&#8221; until the earliest of (i) December 31, 2023, (ii) the last day of the fiscal year in which it has total annual gross revenues of $1.07 billion or more, (iii) the date on which it has issued more than $1.0 billion in </span></p></ix:continuation></div></ix:continuation>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">9</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <div><ix:continuation id="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1-continuation-3"><ix:continuation id="ct-nonNumeric-98333084-cd3e-4703-8c56-75aaf9ab54d2-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">nonconvertible debt during the previous three years or (iv) the date on which it is deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;), which generally is when it has more than $700 million in market value of its stock held by non-affiliates, has been a public company for at least 12 months and have filed one annual report on Form 10-K.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.</span></p></ix:continuation></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section38" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="ct-nonNumeric-6a327775-6421-478f-8200-88af61035da4" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-6a327775-6421-478f-8200-88af61035da4-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">3.&#160;Risks and uncertainties</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-6a327775-6421-478f-8200-88af61035da4-continuation-0" continuedAt="ct-nonNumeric-6a327775-6421-478f-8200-88af61035da4-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company is subject to risks and uncertainties common in the biotechnology and aquaculture industries. Such risks and uncertainties include, but are not limited to: (i)&#160;results from current and planned product development studies and trials; (ii)&#160;decisions made by the FDA or similar regulatory bodies in other countries with respect to approval and commercial sale of any of the Company&#8217;s proposed products; (iii)&#160;the commercial acceptance of any products approved for sale and the Company&#8217;s ability to produce, distribute, and sell for a profit any products approved for sale; (iv)&#160;the Company&#8217;s ability to obtain the necessary patents and proprietary rights to effectively protect its technologies; and (v)&#160;the outcome of any collaborations or alliances entered into by the Company.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">COVID-19</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although the COVID-19 pandemic has diminished in the United States and other parts of the world as vaccines have become more readily available, several variants of the virus continue to spread.  Local governmental authorities in the United States and Canada have issued, and continue to update, directives aimed at minimizing the spread of the virus and the Company continues to monitor its status.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The ultimate impact of the evolving COVID-19 pandemic on the Company&#8217;s operations will depend on future developments, which cannot be predicted with confidence, and the Company cannot predict the extent or impact of the extended period of continued business interruption and reduced operations caused by the COVID-19 pandemic or any additional preventative or protective measures taken in response. In connection with the COVID-19 pandemic, management made modifications to biosecurity procedures at the farm sites in early 2020 to adapt to local requirements and to provide a safe work environment. The Company&#8217;s current preventative and protective measures include, but are not limited to, segregating farm workers to specific locations, rotating shifts, and monitoring worker temperatures upon arrival at the Company&#8217;s facilities. To the extent possible, work-from-home is utilized for employees that do not have fish care responsibilities. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Concentration of credit risk</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and marketable securities. This risk is mitigated by the Company&#8217;s policy of maintaining all balances with highly rated financial institutions, investing cash equivalents with maturities of less than 90 days, and investing marketable securities with maturities of less than 180 days. The Company&#8217;s cash balances may at times exceed insurance limitations. The Company holds cash balances in bank accounts located in Canada to fund its local operations. These amounts are subject to foreign currency exchange risk, which is minimized by the Company&#8217;s policy to limit the balances held in these accounts. Balances in Canadian bank accounts totaled $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-761c654e-3973-4e29-9e39-68dfb00183e8" name="us-gaap:Cash" contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CA_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">224</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand at December 31, 2021.  The Company also holds cash equivalent investments in a highly liquid investment account at a major financial institution.  As of December 31, 2021 and 2020 the cash equivalent investment balance was $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-89b1fe1c-710d-43da-bc13-bb75b1b6e353" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="As_Of_12_31_2021_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">73.3</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fd21c023-745c-4a0d-b833-79eb3703068c" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="As_Of_12_31_2020_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Financial instruments</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The carrying amounts reported in the consolidated balance sheets for receivables, prepaid expenses and other current assets, and accounts payable approximate fair value based on the short-term maturity of these instruments. The carrying value of term debt approximates its fair value since it provides for market terms and interest rates.  All of the Company&#8217;s interest-bearing debt is at fixed rates, except for the loan with First Farmer&#8217;s Bank and Trust, which has a rate reset in July 2025.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company groups its financial instruments measured at fair value, if any, in three levels based on the markets in which the instruments are traded and the reliability of the assumptions used to determine fair value.  Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  Financial instruments with readily available quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgement used in measuring fair value.  The three levels of the fair value hierarchy are as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 1: Inputs to the valuation methodology are quoted prices, unadjusted, for identical assets or liabilities in active markets.</span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">10</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <div><ix:continuation id="ct-nonNumeric-6a327775-6421-478f-8200-88af61035da4-continuation-1" continuedAt="ct-nonNumeric-6a327775-6421-478f-8200-88af61035da4-continuation-2"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 2: Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs derived principally from, or that can be corroborated by, observable market data by correlation or other means.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-6a327775-6421-478f-8200-88af61035da4-continuation-2"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.  Level 3 assets and liabilities include financial instruments whose value is determined using discounted cash flow methodologies, as well as instruments for which the determination of fair value requires significant management judgement or estimation.&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="ct-nonNumeric-90e7ade3-7acb-4997-b933-7d8b3e2953fb" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-90e7ade3-7acb-4997-b933-7d8b3e2953fb-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">4. Marketable Securities</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-90e7ade3-7acb-4997-b933-7d8b3e2953fb-continuation-0" continuedAt="ct-nonNumeric-90e7ade3-7acb-4997-b933-7d8b3e2953fb-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Marketable securities are classified as available-for-sale.  The following table summarizes the amortized cost, gross unrealized gains and losses, and the fair value as of December 31, 2021:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:MarketableSecuritiesTextBlock" id="ct-nonNumeric-35659a38-5aa8-4244-b028-990feac437b7" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 36.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 36.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Amortized</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Unrealized</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Unrealized</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Market</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 36.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cost</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Gains</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Losses</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Value</span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 36.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="11" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 63.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2021</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 36.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Government bonds</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7a273f2b-23e2-4141-b694-dc770d53239b" name="aqb:MarketableSecuritiesAmortizedCost" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">28,453,161</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8eb13e4e-9b5d-4c5a-8a1d-2d0b84903e16" name="aqb:MarketableSecuritiesUnrealizedGain" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">82</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cf88f0a8-e921-4128-b0cd-8841b884d362" name="aqb:MarketableSecuritiesUnrealizedLoss" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">18,255</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c5a9026a-c73b-43d5-a7a9-5916f71bbf11" name="us-gaap:MarketableSecurities" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">28,434,988</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 36.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Corporate bonds</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-90e74fe3-4f3c-476a-a304-22e2e6d87aef" name="aqb:MarketableSecuritiesAmortizedCost" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_DomesticCorporateDebtSecuritiesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">29,874,696</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> -</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5a1920b3-dc64-4379-aad3-dc9d3d55e926" name="aqb:MarketableSecuritiesUnrealizedLoss" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_DomesticCorporateDebtSecuritiesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">21,928</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-539333b1-0460-4c32-8ffc-f16d2483df50" name="us-gaap:MarketableSecurities" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_DomesticCorporateDebtSecuritiesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">29,852,768</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 36.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Commercial paper</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-de34e578-090a-4f29-830e-9f8a37aca6a4" name="aqb:MarketableSecuritiesAmortizedCost" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">43,486,025</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> -</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> -</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a06d5a13-8e70-4cf0-9ddf-d7e9604717bc" name="us-gaap:MarketableSecurities" contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">43,486,025</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 36.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Marketable securities</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-538d06fa-825e-49ea-8eef-92ca15122f85" name="aqb:MarketableSecuritiesAmortizedCost" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">101,813,882</ix:nonFraction></span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-843771ca-1e29-49b7-b6c1-54803a848417" name="aqb:MarketableSecuritiesUnrealizedGain" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">82</ix:nonFraction></span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1802132e-6a47-4718-8221-41d11d43d7a9" name="aqb:MarketableSecuritiesUnrealizedLoss" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">40,183</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-79c809c5-1e02-49c4-8956-ccb088df5645" name="us-gaap:MarketableSecurities" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">101,773,781</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b62d528e-34f0-4e44-bf73-d886c348220b" name="us-gaap:MarketableSecurities" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> marketable securities as of December 31, 2020.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-90e7ade3-7acb-4997-b933-7d8b3e2953fb-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section39" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:InventoryDisclosureTextBlock" id="ct-nonNumeric-2e73f9bf-fe9d-49ea-8928-265a9c842e93" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-2e73f9bf-fe9d-49ea-8928-265a9c842e93-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">5.&#160;Inventory</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-2e73f9bf-fe9d-49ea-8928-265a9c842e93-continuation-0" continuedAt="ct-nonNumeric-2e73f9bf-fe9d-49ea-8928-265a9c842e93-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Major classifications of inventory are summarized as follows for December&#160;31, 2021 and 2020:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="ct-nonNumeric-cf67d3af-d913-4618-a6c0-f693238a1667" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 64.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 64.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2021</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 64.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Feed, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-266694c3-bd45-4c94-9f9b-d246d74c9ca7" name="us-gaap:InventoryGross" contextRef="As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">162,047</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f03a59aa-fcca-458d-96d1-4865f4e03e70" name="us-gaap:InventoryGross" contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">244,311</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 64.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Eggs and fry</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e6a574a3-3a2a-4bf8-b992-f0e419f0d414" name="us-gaap:InventoryGross" contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_EggsAndFryMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">54,929</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 64.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Packaging</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6f3b814e-6c25-4657-abac-9063b4cb2499" name="us-gaap:InventoryGross" contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_PackagingMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">6,452</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 64.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Fish in process, net</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f6a1b71f-6c86-425a-bbda-5792098fc099" name="us-gaap:InventoryGross" contextRef="As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,097,863</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2441ee95-7a39-4e03-9662-05bc648759c6" name="us-gaap:InventoryGross" contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,219,685</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 64.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inventory, net</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-378b85ff-b029-4020-99e8-6ff3759b0b22" name="us-gaap:InventoryNet" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,259,910</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4a8a4225-02a2-45b4-8c1a-d1819cc67495" name="us-gaap:InventoryNet" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,525,377</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In December 2020, the Company reserved $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-07292df6-030c-456b-8410-1bced9bf9c60" name="us-gaap:InventoryAdjustments" contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember" unitRef="Unit1" decimals="-4" format="ixt:numdotdecimal" scale="6">1.53</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million against the value of its fish-in-process inventory, representing the total carrying amount of its conventional salmon biomass.  The Company donated substantially all of its conventional salmon to local food charities in 2021.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-2e73f9bf-fe9d-49ea-8928-265a9c842e93-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section40" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ct-nonNumeric-e20a831a-a83c-47a6-a471-ca1fd4a6dc3b" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-e20a831a-a83c-47a6-a471-ca1fd4a6dc3b-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">6.&#160;Property, plant and equipment</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-e20a831a-a83c-47a6-a471-ca1fd4a6dc3b-continuation-0" continuedAt="ct-nonNumeric-e20a831a-a83c-47a6-a471-ca1fd4a6dc3b-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Major classifications of property, plant and equipment are summarized as follows for December&#160;31, 2021 and 2020:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ct-nonNumeric-4a6060fc-2080-4f23-8910-01cf44aef9cb" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2021</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Land</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ff28c445-eec3-4dff-9674-cc1df5e73dee" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">725,799</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4b3f4717-0da6-4065-9cb0-f91053153fb1" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">724,785</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Building and improvements</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-da394ddd-e669-4156-ab19-9c30f8d8b905" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">15,580,385</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-eccd1f9c-3d54-48fe-bf3e-01eb6795117a" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">14,048,917</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Construction in process</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-436aff8e-397d-4080-88f5-19a00ea8acba" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">8,119,575</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-036f913e-5896-4dae-a6a2-3a449d78a322" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">3,212,287</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Equipment</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-14f661d1-4922-4530-aa4e-d5591a5fb2df" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">15,981,408</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-87794dae-9500-4a71-8931-7ef5a3c67972" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">13,819,210</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Office furniture and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cd6d1e27-afc5-4df9-ab51-9a217ed7e2ce" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">240,939</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7d62a043-1f68-4a60-b259-0f86e5fc0aa6" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">202,596</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Vehicles</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-df9e189e-487a-484f-9afc-a59b5f37456e" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">36,280</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1e619d37-96a1-44ed-b967-b4ee845b2d87" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">28,700</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total property and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d2bf45f8-788f-494d-9a7e-103dfaf0ab8d" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">40,684,386</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8831b1b5-5b06-4e7a-bddf-0bd5c98f2968" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">32,036,495</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Less accumulated depreciation and amortization</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-04a3a9c5-27b7-457d-b073-47559a557888" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">6,869,267</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5748b79b-a5e7-458d-884e-e45489abb3a9" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">5,106,157</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 65.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property, plant and equipment, net</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f871d57f-c504-4bd8-b696-aa5b3e43059e" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">33,815,119</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f1f2a59f-cf78-4bae-90bf-e29be8621e6a" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">26,930,338</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Depreciation and amortization expense for 2021 and 2020 on property, plant and equipment was $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8cdcb10e-3eb5-4f00-9fa3-40cde845ef4f" name="us-gaap:Depreciation" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">1.8</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c548e5b2-f6b1-42ae-9e9b-866534b26c28" name="us-gaap:Depreciation" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">1.5</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million, respectively.</span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">11</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <div><ix:continuation id="ct-nonNumeric-e20a831a-a83c-47a6-a471-ca1fd4a6dc3b-continuation-1" continuedAt="ct-nonNumeric-e20a831a-a83c-47a6-a471-ca1fd4a6dc3b-continuation-2"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In March 2020, the Company settled an outstanding legal claim against a third party resulting in net proceeds of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c7106f89-d59d-4a38-9dde-831da3678afa" name="aqb:ProceedsPaymentsForLegalSettlementsInvestingActivities" contextRef="Duration_3_1_2020_To_3_31_2020" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">1.0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million. The proceeds received reduced the carrying value of the acquired equipment. Depreciation on these items has been recalculated prospectively over their remaining useful lives.  </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-e20a831a-a83c-47a6-a471-ca1fd4a6dc3b-continuation-2"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2021, construction in process included $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bd2062a7-39ef-4f3f-823e-254831765c46" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_New10000MetricTonFarmMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">5.2</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million, $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0fc53c92-593c-44ed-a2cb-f58178340de1" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_RolloBayFarmAndFortuneBayHatcheryMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">2.0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d2e1df87-1026-4ae2-8643-176c5c9112d2" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_IndianaAquacultureFarmMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">856</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand for construction related to the Ohio, Rollo Bay and Indiana farm sites, respectively.  An additional $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-072a3129-e566-491f-ab73-5ca7c6fceb6a" name="us-gaap:LongTermPurchaseCommitmentAmount" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_New10000MetricTonFarmMember_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_us-gaap_CapitalAdditionsMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">12.2</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million has been contractually committed for these farm sites, though if a contract were terminated, a portion of this total would be refundable based on the amount of work completed as of the date of contract termination.</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section43" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" id="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">7.&#160;Debt</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6-continuation-0" continuedAt="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The current terms and conditions of long-term debt outstanding as of December&#160;31, 2021 and 2020, are as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="ct-nonNumeric-8491e564-4052-4b19-b1c2-3b1ed13e932d" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Interest</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">rate</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Monthly</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">repayment</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Maturity</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">date</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2021</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ACOA AIF Grant</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-41653445-9ed5-4981-992f-f4562b8b0ee4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Royalties</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-9c66383e-a218-42db-80a2-601d3e52f409" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-</span></ix:nonNumeric></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0036afb7-cd71-4a1f-b4e2-ccbf66e89ad4" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,261,349</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e13b88c4-7be9-4f95-955a-c75b5ba6e725" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,253,595</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ACOA term loan #1</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f4d889a3-89d4-4af8-afc7-3e23d83550c6" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-95bda496-0a64-4b86-b852-9630658866e5" name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">3,120</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-9da21faa-0b0f-483e-b365-f1e58b643dcf" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Feb 2027</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b4add815-956e-4688-b86c-95df4bf8bdcf" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">152,346</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5925c509-1b67-440c-b2ee-3b73d131f01b" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">181,203</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ACOA term loan #2</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4cfa6684-5298-4f88-80de-7da1773eb7b6" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9efd151d-4f40-42ba-a787-9d22b44dbe81" name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">4,630</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-973027c0-3dcc-4f8b-bd03-61551e529769" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Sep 2029</span></ix:nonNumeric></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bc78f2fb-e8b1-4a87-bd4d-ba5f1cd7e691" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">339,015</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d955ae0b-5f61-4722-8710-4beb6650129e" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">381,451</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ACOA term loan #3</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d5543390-2fd3-4642-9bb3-a8d7a6b7e073" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0fdb5bfd-dab5-4386-a1ab-253b12e7c900" name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">6,945</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-1b872d5a-addf-4fe6-be93-17717ee48bc4" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Dec 2025</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-10c8144d-4e2a-467a-8160-31c4dd84753b" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">196,850</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Kubota Canada Ltd</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f0e76610-fb29-43fe-8d85-42ae4bd17847" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-46bf64c4-d309-4bb3-817f-c9ef04a0c64a" name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">1,142</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-d957b863-ff28-465b-ba2b-99302331c5df" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Jan 2025</span></ix:nonNumeric></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-88dcc8d8-3372-49a4-a28d-8493df6e8401" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">33,283</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-421e6694-84fc-4bd3-8154-18a2d903ad15" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">43,925</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">PEI Finance term loan</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-26af0104-15ce-433a-b345-1deb0de44013" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">4</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-eaa6b121-0f67-43de-aec2-689adabb66c3" name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">16,313</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-bfc842aa-5b88-4736-81a3-8c939c50b792" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Nov 2023</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6695b2be-407e-48ff-8600-ba8d3ab9e2be" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">1,947,510</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-31e3504f-45e2-42b8-877b-c51daa56c19f" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,014,321</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">DFO term loan</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-22a0714c-881e-4f56-8487-0bca4b06e4ab" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-89cabca2-b58b-418e-88df-cec4011e0c7a" name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">2,091</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-856afe73-45a4-483b-8317-b8d8d1fff79e" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Aug 2032</span></ix:nonNumeric></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8264973b-8c65-415d-a23c-8ca993e22004" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">405,700</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td></tr><tr><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">First Farmers Bank &amp; Trust term loan</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d7703fc2-8580-4f1b-b4fd-fe438be1bd43" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">5.375</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-90b2a339-2338-4482-8204-436eb89e5b2d" name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">56,832</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-23db86c3-d1e5-4cdb-b54d-e99cce0788fd" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Oct 2028</span></ix:nonNumeric></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b6332bfe-e3d6-472f-b041-07bbabde44c3" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">3,883,325</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c1aad841-c32d-48f8-85e5-fdf836febf10" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">4,000,000</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total debt</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1185305f-4953-4a56-bb3a-0ee92b6f655e" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">9,219,378</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0e3104dd-a712-4383-97cf-f54156de3735" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">8,874,495</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">less: debt issuance costs</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4add78fd-3df3-4b4c-94dc-989dc5083ea2" name="us-gaap:DeferredFinanceCostsNet" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">68,680</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-657ddfa9-9c75-40c7-bc19-14c2d41020a6" name="us-gaap:DeferredFinanceCostsNet" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">86,066</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">less: current portion</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-87d2305e-7b1b-4edc-ae48-f6105022274b" name="us-gaap:LongTermDebtCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">627,365</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3fbba325-23be-4760-bfe4-95807ed31122" name="us-gaap:LongTermDebtCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">259,939</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 29.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Long-term debt, net</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5d60e0fc-3d12-414b-acf9-94af81881f78" name="us-gaap:LongTermDebtNoncurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">8,523,333</ix:nonFraction></span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-22d24476-b437-4cdf-90aa-9bf2d7172b39" name="us-gaap:LongTermDebtNoncurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">8,528,490</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Principal payments due on the long-term debt are as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="ct-nonNumeric-1a5889db-63d6-4d0a-b582-492b8a8b156b" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Total</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2022</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ae51050b-bcd6-4d81-9d0b-ad6b8f99f079" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">643,980</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2023</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6df9255d-8557-4652-85f9-5a40fae37eb6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,564,347</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1f56cf05-3368-45a2-baae-4f762d9a8ba4" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">729,626</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2025</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8ffd935b-88bc-4b43-9152-f962facb403e" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">750,175</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2026</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0d44e568-99bd-4c00-941f-0e78cb19b93c" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">715,392</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Thereafter</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e1a8de33-0e8e-4f9d-a5c9-ccf14ef5950c" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">3,815,858</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 84.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 13.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-87925379-c610-4b66-9e83-e0a47ea136ce" name="us-gaap:LongTermDebt" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">9,219,378</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Atlantic Canada Opportunities Agency (&#8220;ACOA&#8221;)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ACOA is a Canadian government agency that provides funding to support the development of businesses and promote employment in the Atlantic region of Canada.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">ACOA Atlantic Innovation Fund (&#8220;AIF&#8221;) Grant</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In January 2009, the Canadian Subsidiary was awarded an AIF grant from ACOA to provide a contribution towards the funding of a research and development project. Contributions under the grant were made through 2014 and no further funds are available. Amounts claimed by the Canadian Subsidiary must be repaid in the form of a </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e0aab4f7-f76d-40cc-85a4-1208943d922b" name="aqb:DebtInstrumentRepaymentTermsRoyaltyPercentage" contextRef="Duration_1_1_2009_To_1_31_2009_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitRef="Unit13" decimals="2" format="ixt:numdotdecimal" scale="-2">10</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% royalty on any products that are commercialized out of this research project until the loan is fully repaid. Revenue from the sale of the Company&#8217;s GE Atlantic salmon is not subject to the royalty, and the Company does not expect to commercialize products that would be subject to the royalty in the next five years.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">ACOA term loans</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In February 2016, the Canadian Subsidiary executed an agreement with ACOA to partially finance the renovations to the Rollo Bay farm site. All available funding under the agreement was disbursed through May 2017, and no further amounts are available. The loan is being repaid over a </span><ix:nonNumeric name="us-gaap:DebtInstrumentTerm" id="ct-nonNumeric-4ea73ac6-ab07-4291-b954-120dce6ed51b" contextRef="Duration_2_1_2016_To_2_29_2016_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" format="ixt-sec:durmonth"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">108</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-month term at a </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e64368c4-dbe5-4d40-a5ce-404cbf440990" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_2_29_2016_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen" scale="-2">zero</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> percent interest rate.</span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">12</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <ix:continuation id="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6-continuation-1" continuedAt="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6-continuation-2"><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In November 2018, the Canadian Subsidiary executed a second agreement with ACOA to partially finance the renovations to the Rollo Bay site. All available funding under the agreement was disbursed through March 2019, and no further amounts are available. The loan is being repaid over a </span><ix:nonNumeric name="us-gaap:DebtInstrumentTerm" id="ct-nonNumeric-01a6064b-7eae-49a1-8621-d1a30e253499" contextRef="Duration_11_1_2018_To_11_30_2018_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" format="ixt-sec:durmonth"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">108</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-month term with a </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7f5e9c7d-77e8-4928-9d54-c3cfc5dd0b74" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_11_30_2018_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen" scale="-2">zero</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> percent interest rate. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In response to the COVID-19 pandemic, the Company was informed by ACOA during 2020, that all loan payments to the Canadian government would be deferred for nine months and resume on January 1, 2021.</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In July 2021, the Canadian Subsidiary entered into a contribution agreement with ACOA under its REGI-Business Scale-up and Productivity program to provide funding assistance for the Rollo Bay farm site, and on </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">August 20, 2021, the Canadian Subsidiary received C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c47f6253-da1a-4280-b8f0-78428e343093" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="Duration_8_20_2021_To_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">250,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f9339c70-fc92-48f8-9d50-e9fdfce5e242" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="Duration_8_20_2021_To_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">200,075</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">). </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">All funds received are to be repaid over a </span><ix:nonNumeric name="us-gaap:DebtInstrumentTerm" id="ct-nonNumeric-4bb359b0-a1cc-4e14-a561-0f4eb1fe83eb" contextRef="Duration_8_20_2021_To_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" format="ixt-sec:durmonth"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">36</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-month term commencing January 2023 at a </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fc253903-f045-42de-916a-8337a2121891" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen" scale="-2">zero</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> percent interest rate.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Kubota</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In January 2018, the Canadian Subsidiary financed the purchase of equipment through a loan with Kubota. The total amount is being repaid in monthly installments. The loan is secured by the underlying equipment.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Finance PEI (&#8220;FPEI&#8221;)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">FPEI is a corporation of the Ministry of Economic Development and Tourism for Prince Edward Island, Canada, and administers business financing programs for the provincial government.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In August 2016, the Canadian Subsidiary obtained a loan from FPEI to partially finance the purchase of the assets of the former Atlantic Sea Smolt plant in Rollo Bay West on Prince Edward Island.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In 2018, the Canadian Subsidiary obtained a new loan from FPEI, which incorporated the existing loan and provided C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5abc2e07-ad96-434c-8354-b96e149276a6" name="us-gaap:DebtInstrumentFaceAmount" contextRef="As_Of_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="-5" format="ixt:numdotdecimal" scale="6">2.0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-29d9e1c4-5698-4625-af1b-711cb80af2c7" name="us-gaap:DebtInstrumentFaceAmount" contextRef="As_Of_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">1.5</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million) of additional funds. All funds have been dispersed and the loan is being repaid over an </span><ix:nonNumeric name="aqb:RepaymentPeriodOfLoan" id="ct-nonNumeric-f817158a-2231-4564-a210-541786d1365d" contextRef="Duration_1_1_2018_To_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" format="ixt-sec:durmonth"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">87</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">-month term ending in November 2023. The loan has an interest rate of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-38051fc1-703a-445b-bc3c-83f03ed0eba8" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">4</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% and is collateralized by a mortgage executed by the Canadian Subsidiary, which conveys a first security interest in all of its current and acquired assets. The loan is guaranteed by the Parent.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On March&#160;24, 2020, the Company was informed by FPEI that all payments would be deferred for three months due to the COVID-19 pandemic. Payments on the loan resumed on August 1, 2020.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">First Farmers Bank &amp; Trust (&#8220;FFBT&#8221;)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On July 31, 2020, the Company&#8217;s Indiana Subsidiary obtained a $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c4d23053-7812-438b-ba8a-4e1621a458e1" name="us-gaap:DebtInstrumentFaceAmount" contextRef="As_Of_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">4.0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million loan from First Farmers Bank and Trust. Net proceeds were $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8dfd614c-55ce-4553-a7a8-e29977567d9f" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">3.9</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million after deducting $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-74838b87-216d-4d19-8480-52439dad09a3" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">90</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand in loan costs. The loan bears interest at a rate of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-673266ec-c6db-49b7-a454-183c634cb7c4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="As_Of_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal" scale="-2">5.375</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% for the first </span><ix:nonNumeric name="aqb:DebtInstrumentInterestRateStatedPercentagePeriod" id="ct-nonNumeric-a6c01544-8ed7-4f5b-9d96-6d02f835e842" contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" format="ixt-sec:durwordsen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">five years</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. On July 31, 2025, the interest rate resets to the then U.S. Treasury 5-year maturities rate plus </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-189a27dc-eade-46f3-9299-486ef2b466bc" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="Duration_7_31_2025_To_7_31_2025_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_VariableRateAxis_aqb_USTreasuryFiveYearMaturitiesInterestRateMember" unitRef="Unit13" decimals="2" format="ixt:numdotdecimal" scale="-2">5</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% and remains fixed at that rate through maturity on </span><ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="ct-nonNumeric-bb4b3c1a-6c53-42bc-8b91-16bc0528bf7a" contextRef="Duration_7_31_2025_To_7_31_2025_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" format="ixt:datemonthdayyearen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">October 1, 2028</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The note required interest only payments for the first </span><ix:nonNumeric name="aqb:DebtInstrumentInterestOnlyPaymentPeriod" id="ct-nonNumeric-26a49b31-e571-48f4-9cd7-9a24a1a7b56f" contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" format="ixt-sec:durmonth"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">13</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> months, followed by monthly principal and interest payments of approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-75733d4d-789b-4eb1-85d1-bb2055e63afd" name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">57</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand through maturity. Proceeds from the loan may be used for the purpose of performing equipment upgrades, purchasing equipment and other improvements to the Indiana farm. The Company must comply with certain financial and non-financial covenants and provide certification of compliance quarterly.  At December 31, 2021, the Company was in compliance with such covenants. The loan is also subject to certain prepayment penalties and is secured by the assets of the Indiana subsidiary and a guarantee by the Parent. The loan agreement requires the Company to maintain a minimum cash balance with the bank throughout the loan term. This amount is reflected as restricted cash on the balance sheet.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On October 12, 2021, the Company and First Farmers Bank &amp; Trust agreed to a modification to the terms of its outstanding loan.  The new terms delay the start date of certain of the loan&#8217;s negative covenants to the quarter commencing on October 1, 2022 and raises the required restricted cash balance amount from $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a5796f19-456a-4a74-b9db-99c65aba3490" name="aqb:DebtInstrumentCovenantCashBalanceMinimum" contextRef="As_Of_10_11_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">500</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a3c60da6-190d-4faf-90f3-7d8482094747" name="aqb:DebtInstrumentCovenantCashBalanceMinimum" contextRef="As_Of_10_12_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">1.0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Department of Fisheries and Oceans (&#8220;DFO&#8221;)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">DFO is a department of the government of Canada responsible for safeguarding its waters and managing its fisheries, oceans and freshwater resources. DFO supports economic growth in the marine and fisheries sectors, and innovation in areas such as aquaculture and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">biotechnology</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In September 2020, the Canadian Subsidiary entered into a Contribution Agreement with DFO&apos;s Atlantic Fisheries Fund, whereby it is eligible to receive up to C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1045973b-5640-4918-933d-43064ac14f30" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="Duration_9_1_2020_To_9_30_2020_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="-5" format="ixt:numdotdecimal" scale="6">1.9</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3de8b2b8-2388-4ec5-97e6-ae5e22ba7ae3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="Duration_9_1_2020_To_9_30_2020_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">1.4</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million) to finance new equipment for its Rollo Bay farm (the &#8220;DFO Term Loan&#8221;). </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On February 25, 2021, the Canadian Subsidiary borrowed C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-52812797-84f2-40aa-be2d-e2b31dec4f5a" name="us-gaap:DebtInstrumentFaceAmount" contextRef="As_Of_2_25_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">238,400</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9140d7f2-a175-42a3-88ed-1fa1395124c0" name="us-gaap:DebtInstrumentFaceAmount" contextRef="As_Of_2_25_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">187,120</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">) and on April 27, 2021 the Canadian Subsidiary borrowed C$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c823092e-c574-4c72-af39-0823b2aaccd7" name="us-gaap:DebtInstrumentFaceAmount" contextRef="As_Of_4_27_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit15" decimals="0" format="ixt:numdotdecimal">276,840</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-60a39e73-5650-42f9-bfb9-346d2cfdbe42" name="us-gaap:DebtInstrumentFaceAmount" contextRef="As_Of_4_27_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">219,258</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">) under the DFO Term Loan.  Borrowings are interest free and monthly repayments commence in March </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2023</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, with maturity in </span><ix:nonNumeric name="aqb:DebtInstrumentMaturityDateYearMonth" id="ct-nonNumeric-55266d61-739e-4719-8f77-2a2f290e5a09" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">August 2032</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. All funding requests must be submitted by August 22, 2022.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company recognized interest expense of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-642cb97a-5152-4edb-9bc1-aa22821a67d2" name="us-gaap:InterestExpenseDebt" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">316</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8c3ced33-47c7-4d7f-ad51-2e0517f58544" name="us-gaap:InterestExpenseDebt" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">152</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand for the years ended December 31, 2021 and 2020, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">respectively</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, on its interest-bearing debt.</span></p></div></ix:continuation>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">13</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <div><ix:continuation id="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6-continuation-2" continuedAt="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6-continuation-3"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6-continuation-3"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section44" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">8.&#160;Stockholders&#8217; equity</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd-continuation-0" continuedAt="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s shareholders have authorized </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-86ae3ca8-7e5e-49fc-9531-01e95eb7fcf3" name="aqb:AuthorizedShares" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="-6" format="ixt:numdotdecimal" scale="6">85</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million shares of stock, of which </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f12fc565-8422-4388-902b-892127e292ff" name="us-gaap:PreferredStockSharesAuthorized" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million are authorized as preferred stock&#160;and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2f287235-524e-4b3c-8c54-b19bca0cbb37" name="us-gaap:CommonStockSharesAuthorized" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="-6" format="ixt:numdotdecimal" scale="6">80</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million as common stock. As of December&#160;31, 2021 and 2020, the Company had </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7c19db58-6b5e-418e-aef4-fbd5a7d305c1" name="us-gaap:PreferredStockSharesIssued" contextRef="As_Of_12_31_2020" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-4cadf7cd-12ab-48f4-b861-8db2a01a628e" name="us-gaap:PreferredStockSharesIssued" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-d39314ef-e568-4d61-a711-7bba9f8a2851" name="us-gaap:PreferredStockSharesOutstanding" contextRef="As_Of_12_31_2020" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-4fdc5de2-043a-42fe-9f3d-84bab065c46d" name="us-gaap:PreferredStockSharesOutstanding" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of preferred stock and&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bc12e040-9037-4c96-b44f-c7b0998b8352" name="us-gaap:CommonStockSharesIssued" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-6080e698-a423-46d9-b3b6-a968abf7fee5" name="us-gaap:CommonStockSharesOutstanding" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">71,025,738</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-53c28556-67f4-4e6f-9031-1ad207a6c379" name="us-gaap:CommonStockSharesIssued" contextRef="As_Of_12_31_2020" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-4870a6db-3ea0-4724-80e5-ca312462ffc7" name="us-gaap:CommonStockSharesOutstanding" contextRef="As_Of_12_31_2020" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">55,497,133</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock, issued and outstanding, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Common stock</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The holders of the common stock are entitled to </span><ix:nonNumeric name="us-gaap:CommonStockVotingRights" id="ct-nonNumeric-37e1e51c-681c-4164-a32c-443fe4523cbc" contextRef="Duration_1_1_2021_To_12_31_2021"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> vote for each share held at all meetings of stockholders. Dividends and distribution of assets of the Company in the event of liquidation are subject to the preferential rights of any outstanding preferred shares.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Recent issuances</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2020, the Company completed a series of public offerings, resulting in the aggregate issuance of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-94a5b75a-67ed-482b-81fb-307ab384b10a" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="Duration_12_14_2020_To_12_14_2020_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_December2020PublicOfferingMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">33,028,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock for net proceeds of approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-10901964-cfbb-41d4-8201-4eed2da6d55d" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="Duration_12_14_2020_To_12_14_2020_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_December2020PublicOfferingMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">104.6</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2021, the Company completed a public offering of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9bd1f7a2-4d13-4fe1-9285-3f2a61b5fab8" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="Duration_2_8_2021_To_2_8_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_February2021PublicOfferingMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">14,950,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock for net proceeds of approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d8110305-3271-4490-a65c-2547da3dafc7" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="Duration_2_8_2021_To_2_8_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_February2021PublicOfferingMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">119.1</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Warrants</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following table summarizes information about outstanding warrants as of December&#160;31, 2021:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="ct-nonNumeric-ed3e242a-d80c-49f5-a664-62fcc39eba34" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Number of </span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">options</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Weighted</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">average</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">exercise price</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding at December 31, 2020</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-915b7e4d-dd9c-4d81-b31a-642624a6354b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">948,855</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d4ff3f9b-c324-4f80-b89a-5d70961b61b5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">3.25</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Issued</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-0f1e3a82-3c9a-4af7-8079-b11fbf22c4b8;">&#8212;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-4fe05951-b99a-4a95-904e-ec454df333b2;">-</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Exercised</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c1ebbd77-ffb9-45ff-a106-1d62496396f6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">530,414</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-50c84306-a564-4623-bfd4-3414aea7e0e2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">3.25</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Expired</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-0de592a2-a281-4bcc-b007-54b70b53ad5e;">&#8212;</span></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-2367f287-be72-479c-be0c-a2b3f6b3a182;">-</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding at December 31, 2021</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cd87bd9b-1060-4af0-859c-b583e3560203" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">418,441</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d6b7b554-a37c-49b9-adb8-6efcdfc1c1b7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">3.25</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Exercisable at December 31, 2021</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-23a40f41-c896-4f6b-bba4-017111f787c7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">418,441</ix:nonFraction></span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8298acb3-0327-434e-bcea-2566da9a8c9e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">3.25</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">All remaining warrants have an expiration date of </span><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" id="ct-nonNumeric-24406782-8b9a-41c9-b38a-7bd22b2a6d4e" contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember" format="ixt:datemonthdayyearen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">January 17, 2023</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Share-based compensation</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In 2006, the Company established the 2006 Equity Incentive Plan (the &#8220;2006 Plan&#8221;). The 2006 Plan provided for the issuance of incentive stock options to employees of the Company and non-qualified stock options and awards of restricted stock to Directors, officers, employees, and consultants of the Company. In accordance with its original terms, the 2006 Plan terminated on March&#160;18, 2016. All outstanding awards under the 2006 Plan will continue until their individual termination dates.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In March 2016, the Company&#8217;s Board of Directors adopted the AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (the &#8220;2016 Plan&#8221;) to replace the 2006 Plan. The 2016 Plan provides for the issuance of incentive stock options, non-qualified stock options, and awards of restricted and direct stock purchases to Directors, officers, employees, and consultants of the Company. Total common shares authorized under the 2016 Plan were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-605397c8-a7f9-4fad-bdc1-a8235101d25f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_aqb_A2016EquityIncentivePlanMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">1,900,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, of which </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9ecdb3fc-66de-4482-95e3-d94051e67a45" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_aqb_A2016EquityIncentivePlanMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">916,516</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares are reserved for future issuance as of December 31, 2021.</span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">14</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <ix:continuation id="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd-continuation-1" continuedAt="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd-continuation-2"><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Restricted stock</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s restricted stock activity under the 2016 Plan is summarized as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="ct-nonNumeric-a657ae78-5b23-43e3-86d1-c34d98eda575" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Shares</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Weighted</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">average grant</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">date fair value</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Balance at December 31, 2020</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a80615e3-04f6-41c2-bd15-80598bcd5c4a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">92,653</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-49037f9e-74ef-4a1a-8689-8fcdf343893e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">1.93</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Granted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8247ec61-8463-4dc3-ba5d-11387e1cccd5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">43,837</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c929b05a-48df-4e4d-b3ae-e3fdb2e94a35" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">6.67</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Vested</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d9866cf6-a384-45f4-b66e-f7a52e7cc8b9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">71,390</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5681131d-b2ca-4588-9a5f-dcce177e36da" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">2.86</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Balance at December 31, 2021</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-25649f96-ef52-42f9-b0a8-f1ac456db217" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">65,100</ix:nonFraction></span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b97a08f0-ecc1-439b-a774-efd556590b62" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">4.10</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During 2021 and 2020, the Company expensed $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-74a4413d-18f6-464c-b5ab-bca10103d67d" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">240</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-20c65323-bf90-4c20-bef7-84413f75bd7d" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">227</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand, respectively related to restricted stock awards. At December&#160;31, 2021, the balance of unearned share-based compensation to be expensed in future periods related to the restricted stock awards is $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9beb2b26-fb51-4e2f-acdc-107bb0ac4118" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">147</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand. The period over which the unearned share-based compensation is expected to be earned is approximately </span><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="ct-nonNumeric-85faf8ee-8853-476b-b912-d73faaba26b0" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2.2</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Stock options</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s option activity under the 2006 Plan and the 2016 Plan is summarized as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ct-nonNumeric-34cec40a-a75e-4c58-a8ce-c042fd07a379" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Number of </span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">options</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Weighted</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">average</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">exercise price</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding at December 31, 2020</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0476bec4-d694-43fe-8886-5866616c9a24" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">657,414</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-19b58b63-0ec6-4e2c-a26d-d8895d1c57f0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">4.28</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Granted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e9c28015-4dad-4182-82a1-195c8dae6cdd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">48,914</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2ae366c4-c1e7-442e-ab48-33149d0b6e01" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">6.72</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Exercised</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b91aef62-43ca-4b37-98f9-eb0a2696347c" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">16,667</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f47a8879-43a0-4d77-813c-9587da50910d" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">6.90</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Forfeited</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-059b8f36-7fb4-4aea-ac5e-0665cc5f42cf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">1,959</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-16c07da7-533e-4a28-85d3-c8fb78ee908f" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">6.72</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Expired</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-acace921-83c0-48b8-b725-94cd114189f3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">24,277</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-59a5bd8f-57f0-48bf-86e9-279db00e03fd" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">6.36</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding at December 31, 2021</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-60e9c16d-9b50-4379-9743-2a56c8cbaeb6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">663,425</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9b66d4b4-b50c-4110-a330-c70b49ed14a0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">4.31</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Exercisable at December 31, 2021</span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-60589259-94c6-4172-9d84-7db08e96a2b1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">607,189</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fda9ed6f-c858-40ff-b563-9182815fa3d3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">4.33</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options issued to employees, members of the Board of Directors, and non-employees generally vest over a period of </span><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ct-nonNumeric-bf5b246a-2c21-4984-95a3-ca3f53f133b4" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one year</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> to </span><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ct-nonNumeric-98106e0a-166e-4238-9036-b5f02ae6a667" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">three years</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and are exercisable for a term of </span><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="ct-nonNumeric-3387befd-b08c-4539-9a1a-6765ad48414d" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ten years</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> from the date of issuance.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The weighted average fair value of stock options granted during 2021 was $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f595f7f8-68d4-45d5-8955-51c34058f613" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">5.36</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (2020: $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e0e79846-020b-4d17-bb3a-21c99530962e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">1.49</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">). There were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-aad423e7-f4cb-4373-a518-ea699b08589a" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">16,667</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> options exercised in 2021 (2020: </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a0b34cdd-10af-4cae-88e3-e791c4f968f5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">). The total intrinsic value of options exercised in 2021 was $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-764a5d67-991e-4680-b262-68ea48d804f0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">41</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand (2020: $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-be4a8be1-6b57-44f9-b6cd-5c122c01359e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">). As of December&#160;31, 2021, the total intrinsic value of all options outstanding was&#160;$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f6a3b23d-b26a-4235-aba5-7e2b8cff6898" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">18</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand&#160;(2020: $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6f605343-ef68-4192-b6c9-8be83e95dbde" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">3.6</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million) and the total intrinsic value of exercisable options was $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f6dd678a-d308-4a1b-9b65-8772322274f7" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">11</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand (2020: $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-521698d0-08e0-48a8-8f82-422f3bcecede" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">3.2</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million).</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following table summarizes information about options outstanding and exercisable as of December&#160;31, 2021:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" id="ct-nonNumeric-7f29a991-8eda-4bcf-82f1-e29d4c8d1b83" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Weighted</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">average exercise</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">price of outstanding</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">options</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Number of</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">options</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">outstanding</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Weighted</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">average remaining</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">estimated life</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(in years)</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Number of</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">options</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">exercisable</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-77a8dd47-dfde-4104-bf1d-2ae461f5e7b7" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">1.88</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> - $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-eec376b2-c03f-4e0f-87d5-8b7a55186014" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">2.50</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-158ab179-cd7f-443d-afa9-4ed9b0c7a9f3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">524,019</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><ix:nonNumeric name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="ct-nonNumeric-4e765081-5aee-4821-b1c8-808dc720fe8c" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7.3</span></ix:nonNumeric></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8540d2a1-5c2c-43b1-8bcb-e1b3132104fc" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">493,772</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bb995488-e416-44b3-b5f2-df736dca867a" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">3.30</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> - $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ba0acfe3-d394-4c32-bb9c-3bf671765805" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">6.72</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b40f5354-f5c6-458c-ab99-015733900780" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">53,916</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><ix:nonNumeric name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="ct-nonNumeric-4f19aa30-ab81-42ae-80f3-8611257d5bbf" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">8.4</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-76aff9db-84bd-410e-a7c4-0980164ee090" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">27,927</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-73f675fe-69c7-4492-b6a6-7f3d09af5bb3" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">7.50</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> - $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b3e70389-724d-43d5-a67a-13e249da0c91" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">10.80</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-660b0d5b-116b-4903-9c35-c645c4a42454" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">16,403</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><ix:nonNumeric name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="ct-nonNumeric-794e4de1-36e3-4e55-a46e-47f3b0820e64" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2.3</span></ix:nonNumeric></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ee93887a-9ecd-4810-95f9-e4091b442afe" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">16,403</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7db7b159-eeba-4321-8542-67bb6ef9f8a0" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">14.20</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> - $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3e7708d0-9bc8-4230-b32f-76214a0efd03" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal">23.40</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-507a8b30-39f2-4049-a1ba-8ee76ac69043" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">69,087</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><ix:nonNumeric name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="ct-nonNumeric-1f0a989a-0008-4c83-8302-b23aa18ac815" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4.2</span></ix:nonNumeric></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-08a0ac28-b65e-4307-aca0-567a00aa7efb" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">69,087</ix:nonFraction></span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-48050f3b-2635-441f-8307-e08dc50317a0" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">663,425</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 22.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-92b6690c-2334-4c09-b0f7-29b12d9f8d44" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">607,189</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.3%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div></ix:continuation>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">15</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <div><ix:continuation id="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd-continuation-2" continuedAt="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd-continuation-3"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The fair values of stock option grants to employees and members of the Board of Directors during 2021 and 2020 were measured on the date of grant using Black-Scholes, with the following weighted average assumptions:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ct-nonNumeric-6aa5619f-ec08-4770-a0a5-49f955d6c29e" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 61.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 61.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 61.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Expected volatility</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c5a10cdb-a105-476d-b7bf-afbe7c358e25" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="2" format="ixt:numdotdecimal" scale="-2">111</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">%</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5972fc98-4e6d-48f8-bca8-2dc87880362f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="2" format="ixt:numdotdecimal" scale="-2">101</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7200b5c3-7c4a-4c7a-b071-86cbcb94ea68" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="2" format="ixt:numdotdecimal" scale="-2">104</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 61.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Risk free interest rate</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5d63944e-417c-481b-b4d4-ec84bc89af4d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="4" format="ixt:numdotdecimal" scale="-2">0.80</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">%</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f087056f-1009-456e-ba85-8b179e15056c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="4" format="ixt:numdotdecimal" scale="-2">0.31</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5bd725f5-6f3a-4dac-ba78-0f2208e2efef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="4" format="ixt:numdotdecimal" scale="-2">1.67</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 61.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Expected dividend yield</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-80432ef7-e200-41b1-9901-8f38827908e2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="2" format="ixt:numdotdecimal" scale="-2">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">%</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-55f20e5a-53c7-4607-840a-190590de273a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="2" format="ixt:numdotdecimal" scale="-2">0</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%</span></p></td></tr><tr><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 61.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Expected life (in years)</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ct-nonNumeric-e37a8240-9eba-4e09-a7e1-397e61a05916" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">5</span></ix:nonNumeric></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ct-nonNumeric-56af7640-5d3b-467f-905f-8a3f26ec8422" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5</span></ix:nonNumeric></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The risk-free interest rate is estimated using the Federal Funds interest rate for a period that is commensurate with the expected term of the awards. The expected dividend yield is </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7157b4b6-435e-4201-9f06-0a20af895b1b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen" scale="-2"><ix:nonFraction id="ct-nonFraction-bf285222-c3ab-4269-ab5a-adc8aae112bf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen" scale="-2">zero</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> because the Company has never paid a dividend and does not expect to do so for the foreseeable future. The expected life was based on a number of factors including historical experience, vesting provisions, exercise price relative to market price, and expected volatility. The Company believes that all groups of employees demonstrate similar exercise and post-vesting termination behavior and, therefore, does not stratify employees into multiple groups and forfeitures are recognized as they occur. The expected volatility was estimated using the Company&#8217;s historical price volatility over a period that is commensurate with the expected term of the awards.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total share-based compensation on stock-option grants amounted to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0f5867e8-8c11-4e66-8044-4845118516b6" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">154</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a4f31693-f6ee-4128-ac6a-4a221818d7f9" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">251</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand for the years ended December&#160;31, 2021 and 2020, respectively.  As of December 31, 2021, the balance of unearned share-based compensation to be expensed in future periods related to unvested share-based awards is $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bbd59e93-9bef-40a4-b7bf-6384b7f5081b" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">182</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand. The period over which the unearned share-based compensation is expected to be earned is </span><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="ct-nonNumeric-37887f26-4910-4e40-9fe4-aa8599ecbe68" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2.2</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Share-based compensation</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following table summarizes share-based compensation costs recognized in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss for the years ended December&#160;31, 2021 and 2020:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section45" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="ct-nonNumeric-902238e7-e057-44a5-9435-97e3074cc0ac" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> -</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-60356dfd-2d68-4824-8f80-e5a8ee8469d1" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">497</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-631104ed-4eca-4658-9a56-d17eb554dbc6" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">394,237</ix:nonFraction></span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-12194491-325a-4054-aef1-5371edb9f787" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">436,194</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total share-based compensation</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6525928b-d6d6-4d43-8cad-629a10ba14d0" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">394,237</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-faa92f69-42da-4747-b97f-f7c91a8f7f27" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">436,691</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd-continuation-3"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="ct-nonNumeric-b01f7c85-f255-40a6-8607-0824c713b89a" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-b01f7c85-f255-40a6-8607-0824c713b89a-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">9.&#160;Income taxes</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-b01f7c85-f255-40a6-8607-0824c713b89a-continuation-0" continuedAt="ct-nonNumeric-b01f7c85-f255-40a6-8607-0824c713b89a-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The components of loss before income taxes for the years ended December&#160;31, 2021 and 2020 are presented below:</span></p><ix:nonNumeric name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="ct-nonNumeric-6dc90caf-a182-4569-aa91-8110a435a487" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Domestic</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c52d0585-9952-43ff-80bc-3f2f23348036" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">21,105,065</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-77fbd0cc-31d1-4ea3-9aec-bf8aebed84d4" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">15,768,224</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Foreign</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-62acc7ca-ba9e-4904-ad6d-04440c1168f7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">1,217,523</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3d79593b-1dba-43c9-a4d2-9af048228c8a" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">631,761</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Loss before income taxes</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c2b2e0b4-0abd-46de-9f61-c7c4a4f98332" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">22,322,588</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-03f7301e-a329-4f1d-8925-06c15adc163a" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">16,399,985</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have made no provision for foreign or domestic income taxes on the cumulative unremitted earnings of our foreign subsidiaries.  We intend to permanently reinvest all foreign earnings and have no intention to repatriate foreign earnings for the foreseeable future.</span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">16</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <div><ix:continuation id="ct-nonNumeric-b01f7c85-f255-40a6-8607-0824c713b89a-continuation-1" continuedAt="ct-nonNumeric-b01f7c85-f255-40a6-8607-0824c713b89a-continuation-2"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Income taxes computed using the federal statutory income tax rate differs from the Company&#8217;s effective tax rate for the years ended December&#160;31, 2021 and 2020 primarily due to the following:</span></p><ix:nonNumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="ct-nonNumeric-207fba55-456a-44ab-b104-2f84486d7cb1" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 16.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 16.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Income tax benefit</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-694a6219-7cd0-4b01-8ec0-36b93ab8e384" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">4,687,744</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-da0c20c8-64ff-4a42-9c0f-962b17407093" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">3,443,997</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">State and provincial income tax, net of federal benefit</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5e50d115-5745-462f-9e64-468731b19448" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">1,157,840</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-54581af6-38e8-49c6-a658-064eb12c766f" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">732,994</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Permanent differences</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c6ea9927-4ede-486c-8d04-01d28f891103" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">202,583</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ec53a6d3-dd7f-4516-b745-1e5d61967eb2" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">131,141</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">US-Foreign rate differential</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b42a42d5-6c71-49f4-919f-70ad4da33336" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">39,045</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-63c2c31b-b293-4920-8174-2187af7a8216" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">142,663</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other, net</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-34c2362b-50c2-44bb-b308-675d0ea237c8" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">299,071</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bfbc4f2e-1e94-4970-9e2b-f2d24b28243b" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">145,973</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bd4cf674-f902-4fd2-8abe-96d62b6eb570" name="aqb:IncomeTaxExpenseBenefitBeforeValuationAllowance" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">5,903,027</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-094281c3-ea8d-4761-a605-0f2f4a024bcb" name="aqb:IncomeTaxExpenseBenefitBeforeValuationAllowance" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal" sign="-">4,334,486</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Change in valuation allowance</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-67161561-3724-46a8-b942-a293fefb5cb8" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">5,903,027</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ca93801d-237c-4ee4-8291-c21e97460ef7" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">4,334,486</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total income tax</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-473abf1b-b7a8-48ec-9c21-1b576508b93a;">-</span></span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-6cd9ec42-3e38-47dd-ac50-dd60514278fc;">-</span></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December&#160;31, 2021, the Company has domestic net operating loss carryforwards of approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bd12fb9d-07ac-48a7-936d-f0806b10e8eb" name="us-gaap:OperatingLossCarryforwards" contextRef="As_Of_12_31_2021_srt_StatementScenarioAxis_aqb_LimitationsOnUseToSection382Member_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="Unit1" decimals="-6" format="ixt:numdotdecimal" scale="6">78</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million, after consideration of limitations pursuant to section 382, to offset future federal taxable income, which begin to expire in 2032. As of December 31, 2021, the Company has domestic net operating loss carryforwards of approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4df01e8e-b398-4bbf-a1af-f4d53b50de0a" name="us-gaap:OperatingLossCarryforwards" contextRef="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="Unit1" decimals="-6" format="ixt:numdotdecimal" scale="6">50</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million, which can be carried forward indefinitely. The future utilization of certain historic net operating loss and tax credit carryforwards, however, is subject to annual use limitations based on the change in stock ownership rules of Internal Revenue Code Sections&#160;382 and 383. The Company experienced a change in ownership under these rules during 2012 and revised its calculation of net operating loss carryforwards based on annual limitation rules. The Company also has foreign research and development loss carryforwards totaling approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-eee3d705-90c5-4f6e-9042-ad9a38618d9c" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">11</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million and foreign research and development expense tax credits of approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2268509e-fde4-4049-8532-3fcff6bea675" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember" unitRef="Unit1" decimals="-5" format="ixt:numdotdecimal" scale="6">2</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million as of December&#160;31, 2021, which expire at various times commencing in 2022. Since the Company has incurred only losses from inception and there is uncertainty related to the ultimate use of the loss carryforwards and tax credits, a valuation allowance has been recognized to offset the Company&#8217;s deferred tax assets, and no benefit for income taxes has been recorded.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="ct-nonNumeric-a73555de-c528-4e9c-a165-03c63616ebc0" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2021</span></p></td><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2020</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Deferred tax assets:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net operating loss carryforwards</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0fb6b7ea-f9b6-4069-b550-8194d7d3c560" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">23,216,863</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ce1e0fae-e99d-41a9-9800-aafe012b3fd3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">16,964,199</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Foreign research and development tax credit carryforwards</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9ac68f3d-08c9-4b9e-9288-d6de443603b9" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,428,663</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d2fea393-1ae0-4440-831c-0bb9f0a22cd9" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,679,180</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property and equipment</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-50306c28-b691-46b8-999b-4318a7e58b88" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">145,530</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-092527f5-f574-4926-b686-cff60ae1030b" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">56,697</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Intangibles and other</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-470402d3-5750-43fb-a95c-7aecf8cb3c21" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">2,934,441</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2ff11c59-ef1f-4b32-9afc-09062a7098f5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">3,122,394</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total deferred tax assets</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8a577f3e-ea19-43a7-8ba8-8a2e2fb81814" name="us-gaap:DeferredTaxAssetsGross" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">28,725,497</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e19dcea9-fd04-4ab4-bca1-ca2edeaf0287" name="us-gaap:DeferredTaxAssetsGross" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">22,822,470</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Valuation allowance</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f655ffd5-8760-49b1-9950-dabc8a496be9" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">28,725,497</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4b7c4fb2-708f-443c-a5d8-e6e4e65b257c" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">22,822,470</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 65.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net deferred tax assets</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-1f41823f-8a95-4a42-aa9f-fe1f629034c2;">-</span></span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 14.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-077f0b32-cba5-4513-adc8-5c7bdc6e843b;">-</span></span></p></td></tr></table></div></ix:nonNumeric></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-b01f7c85-f255-40a6-8607-0824c713b89a-continuation-2"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section46" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ct-nonNumeric-0054a6e1-07bf-4bb2-b836-edb28c238306" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-0054a6e1-07bf-4bb2-b836-edb28c238306-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">10.&#160;Commitments and contingencies</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-0054a6e1-07bf-4bb2-b836-edb28c238306-continuation-0" continuedAt="ct-nonNumeric-0054a6e1-07bf-4bb2-b836-edb28c238306-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company recognizes and discloses commitments when it enters into executed contractual obligations with other parties. The Company accrues contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company is subject to legal proceedings and claims arising in the normal course of business. Management believes that final disposition of any such matters existing at December&#160;31, 2021, will not have a material adverse effect on the Company&#8217;s financial position or results of operations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Lease commitments</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Lease expense for the years ended December&#160;31, 2021 and 2020, amounted to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c6df82c9-1054-4f33-9677-65630ca69cb8" name="us-gaap:OperatingLeaseExpense" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">84</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-15f7b68f-d4c2-4cb2-9e33-c7875214f26f" name="us-gaap:OperatingLeaseExpense" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">86</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand, respectively. As of December 31, 2021, the weighted average remaining lease term of the Company&#8217;s operating leases was </span><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ct-nonNumeric-aef12537-0c7f-43c8-98df-e54c98bbbee5" contextRef="As_Of_12_31_2021" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">24.1</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years. Lease payments included in operating cash flows totaled $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-10e98f4a-763e-4d4b-9fce-a8ad9818a9da" name="us-gaap:OperatingLeasePayments" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">84</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2a548141-3ca5-4714-a2a9-b1f1e2c43016" name="us-gaap:OperatingLeasePayments" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">85</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand for the years ended December&#160;31, 2021 and 2020, respectively.</span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">17</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 12pt;"><a href="#TableofContents" style="text-decoration: none;"><span style="white-space:pre-wrap; white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Table of Contents</span></a></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">AquaBounty Technologies, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Notes to the Consolidated Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 120.0%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.19in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">for the years ended December&#160;31, 2021 and 2020</span></p></div></div>
    <div><ix:continuation id="ct-nonNumeric-0054a6e1-07bf-4bb2-b836-edb28c238306-continuation-1" continuedAt="ct-nonNumeric-0054a6e1-07bf-4bb2-b836-edb28c238306-continuation-2"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The table below summarizes the Company&#8217;s lease obligations as of December&#160;31, 2021 and 2020:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock" id="ct-nonNumeric-43929723-5c47-48cb-94c1-0f97308a0cd9" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 51.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 20.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 21.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 51.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.7%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 20.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 21.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 51.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2021</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 23.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, 2020</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 51.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 20.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> Lease Liability</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 21.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> Lease Liability</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 51.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total leases</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 20.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4ad9e48f-f274-4876-a90a-6a82ae99c054" name="us-gaap:OperatingLeaseLiability" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">290,327</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 21.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-72cb756f-7d41-4eab-b676-e79c42d5579e" name="us-gaap:OperatingLeaseLiability" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">352,810</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 51.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Less: current portion</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 20.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8e59b36c-08bb-4559-ac9a-db52c585c760" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">66,269</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 21.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c8fe8209-5a35-4793-b5db-103e1c2e12cd" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">62,483</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 51.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Long-term leases</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 20.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.04in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-875ee1a6-203f-4f0c-8f48-02bd81b6db12" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">224,058</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double windowtext 2.5pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 21.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$ </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1c82df74-d513-4c14-9ea8-e01542fa53d8" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="As_Of_12_31_2020" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">290,327</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company used a weighted average discount rate of 8% in calculating the net present value of the future lease payments. The current portion of the lease liability is included as a component of other current liabilities in the consolidated balance sheets.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Remaining payments under leases are as follows as of December&#160;31, 2021:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="ct-nonNumeric-dd39eaf8-514f-4037-802b-e0e9960edb61" contextRef="Duration_1_1_2021_To_12_31_2021"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Year</span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Amount</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a2b60572-1609-49a5-a458-bf56980e3a04" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">84,080</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2023</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-28291687-50b1-4277-a636-3e2403522b02" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">33,872</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-755dab8e-7e3d-4cc0-b164-d0d386c68c17" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">17,481</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2025</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e4f2f870-00d3-48ba-b231-09999ef635ec" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">18,006</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2026</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a9daaf70-027e-415a-9b58-d76665ff96ae" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">18,546</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Thereafter</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-adecf515-e7c1-40c5-b1f6-b2fa162b19d5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">583,328</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total lease payments</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7861b09b-9c28-4418-bef5-ea5ee1a6ee02" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">755,313</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Less: imputed interest</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-52a5bace-76ed-478e-bc7f-ea458bba9057" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">464,986</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 25.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total operating lease liabilities</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 34.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 18.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-89c382b5-1ca5-4abf-a38f-0476cd3f009c" name="us-gaap:OperatingLeaseLiability" contextRef="As_Of_12_31_2021" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">290,327</ix:nonFraction></span></p></td></tr></table></div></ix:nonNumeric></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-0054a6e1-07bf-4bb2-b836-edb28c238306-continuation-2"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section47" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="ct-nonNumeric-3122cab0-a7b1-4924-a117-4e657b39c711" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-3122cab0-a7b1-4924-a117-4e657b39c711-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">11.&#160;Retirement plan</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-3122cab0-a7b1-4924-a117-4e657b39c711-continuation-0" continuedAt="ct-nonNumeric-3122cab0-a7b1-4924-a117-4e657b39c711-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has a savings and retirement plan for its US employees that qualifies under Section&#160;401(k) of the Internal Revenue Code. The plan covers substantially all employees and provides for voluntary contributions by participating employees up to the maximum contribution allowed under the Internal Revenue Code. Contributions by the Company can be made, as determined by the Board of Directors, provided the amount does not exceed the maximum permitted by the Internal Revenue Code. Company contributions made and expensed in operations in connection with the plan during the years ended December&#160;31, 2021 and 2020, amounted to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-22c20f83-d682-4097-9680-2dd91da869a0" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">81</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-95ad1d0a-6682-4db1-84ef-c5f913def352" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="Duration_1_1_2020_To_12_31_2020" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">72</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company also has a Registered Retirement Savings Plan for its Canadian employees. Company contributions made and expensed in operations in connection with the plan during the years ended December&#160;31, 2021 and 2020, amounted to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e47dd08b-638e-410a-ac75-5e233e75ab25" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">38</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-62fbda06-cda6-4d41-ad44-d4534b745135" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">32</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;thousand, respectively.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-3122cab0-a7b1-4924-a117-4e657b39c711-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Section48" style="text-decoration: none;"></span><ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ct-nonNumeric-71459177-7e52-4fd3-9b71-6c9c21d633da" contextRef="Duration_1_1_2021_To_12_31_2021" continuedAt="ct-nonNumeric-71459177-7e52-4fd3-9b71-6c9c21d633da-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">12.&#160;Related Party Agreement</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-71459177-7e52-4fd3-9b71-6c9c21d633da-continuation-0" continuedAt="ct-nonNumeric-71459177-7e52-4fd3-9b71-6c9c21d633da-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Letter Agreement with Third Security</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On July 30, 2021, the Company entered into an agreement with TS Aquaculture LLC and certain of its affiliates (&#8220;TS Aquaculture&#8221;) that required the Company to file a registration statement to register the Company&#8217;s shares held by TS Aquaculture.  The registration statement was filed on August 5, 2021 and TS Aquaculture completed a transaction to sell </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-300f35b9-9384-4da6-ba52-8a29e4cc2cf2" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="Duration_11_23_2021_To_11_23_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">12,880,000</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock of the Company on November 23, 2021.  TS Aquaculture ceased being a related party after completing the sale.  TS Aquaculture agreed to pay all expenses incurred in connection with these transactions, which totaled $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2d76df76-4546-4ab4-8843-0478bae816bc" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">418</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> thousand and is included in prepaid and other current assets in the consolidated financial statements as of December 31, 2021.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-71459177-7e52-4fd3-9b71-6c9c21d633da-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span id="Section49" style="text-decoration: none;"></span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">F-</span><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">18</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>aqb-20211231xex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.1.0.2-->
<!--Created on: 3/10/2022 8:42:58 AM-->
<html>
	<head>
		<title>
			Exhibit 21.1
		</title>
	</head>
	<body><div style="margin-left:36pt;margin-right:36pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-weight:bold;">EXHIBIT 21.1</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;">List of Subsidiaries of AquaBounty Technologies, Inc.</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;">The following is a list of subsidiaries of AquaBounty Technologies, Inc., the names under which such subsidiaries do business, and the state or country in which each was organized:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;">Name</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;">Jurisdiction of Organization</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">AquaBounty Brasil Participa&#xE7;&#xF5;es Ltda.</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Brazil</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">AQUA Bounty Canada Inc.</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Canada</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Aqua Bounty Farms Chile Limitada</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Chile</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">AquaBounty Farms, Inc.</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Delaware</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">AquaBounty Farms Indiana LLC</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Delaware</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">AquaBounty Farms Ohio LLC</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Delaware</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:53.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 3.2pt 0pt 3.2pt;height:6.75pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">AquaBounty Panama, S. de R.L.</font></p>
				</td>
				<td valign="bottom" style="width:06.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 0pt 0pt 0pt;height:6.75pt">
					<p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:40.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt 3.2pt 0pt 3.2pt;height:6.75pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Panama</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 13.5pt;line-height:120%;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>aqb-20211231xex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.1.0.2-->
<!--Created on: 3/10/2022 8:43:07 AM-->
<html>
	<head>
		<title>
			Exhibit 23.1
		</title>
	</head>
	<body><div style="margin-left:36pt;margin-right:36pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-weight:bold;">EXHIBIT 2</font><font style="display: inline;font-weight:bold;">3.</font><font style="display: inline;font-weight:bold;">1</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:normal;text-align:center;font-family:Arial;color:#000000;font-weight:bold;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;font-weight:bold;color:#000000;background-color: #FFFFFF;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;font-weight:bold;color:#000000;background-color: #FFFFFF;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;font-weight:bold;color:#000000;background-color: #FFFFFF;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;color:#000000;background-color: #FFFFFF;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;color:#000000;background-color: #FFFFFF;">We consent to the incorporation by reference in Registration Statement Nos. 333-258561 and 333-252264 on Form S-3 and Registration Statement No. 333-238207 on Form S-8 of our report dated March 10, 2022, relating to the financial statements of AquaBounty Technologies, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2021.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;color:#000000;background-color: #FFFFFF;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;color:#000000;background-color: #FFFFFF;">/s/ Deloitte &amp; Touche LLP</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;color:#000000;background-color: #FFFFFF;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;color:#000000;background-color: #FFFFFF;">Baltimore, Maryland</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-family:Arial;color:#000000;background-color: #FFFFFF;">March 10, 2022</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 13.5pt;line-height:120%;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>aqb-20211231xex23_2.htm
<DESCRIPTION>EX-23.2
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.1.0.2-->
<!--Created on: 3/10/2022 8:43:17 AM-->
<html>
	<head>
		<title>
			Exhibit 23.2
		</title>
	</head>
	<body><div style="margin-left:36pt;margin-right:36pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-weight:bold;">EXHIBIT 2</font><font style="display: inline;font-weight:bold;">3.2</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:normal;text-align:center;font-family:Arial;color:#000000;font-weight:bold;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Arial;color:#000000;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:normal;text-align:center;font-family:Arial;color:#000000;font-weight:bold;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Consent of Independent Registered Public Accounting Firm</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;line-height:normal;font-family:Arial;color:#000000;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;line-height:normal;font-family:Arial;color:#000000;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">We hereby consent to the incorporation by reference in AquaBounty Technology Inc.&#x2019;s Registration Statements on Forms S-3 (File No. 333-258561 and File No. 333-252264) and S-8 (File No. 333-238207) of our report dated March 9, 2021 with respect to the consolidated financial statements of AquaBounty Technology Inc.&#x2019;s as of and for the year ended December 31, 2020, that appears in this Annual Report on Form 10-K.</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;line-height:normal;font-family:Arial;color:#000000;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:normal;font-family:Arial;color:#000000;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-size:11pt;">Wolf &amp; Company, P.C.</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:normal;font-family:Arial;color:#000000;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-size:11pt;">Boston, Massachusetts</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;line-height:normal;font-family:Arial;color:#000000;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-size:11pt;">March 10, 2022</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 13.5pt;line-height:120%;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>aqb-20211231xex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.1.0.2-->
<!--Created on: 3/10/2022 8:43:27 AM-->
<html>
	<head>
		<title>
			Exhibit 31.1
		</title>
	</head>
	<body><div style="margin-left:36pt;margin-right:36pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-weight:bold;font-size:10pt;">EXHIBIT 31.1</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">Certification</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">I, Sylvia Wulf, certify that:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">1. I have reviewed this Annual Report on Form 10-K of AquaBounty Technologies, Inc;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">4. The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(b) designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(c) evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(d) disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">5. The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s Board of Directors (or persons performing the equivalent functions):</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize, and report financial information; and</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:110.65pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">0</font></p>
				</td>
				<td valign="bottom" style="width:323.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:110.70pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:110.65pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-size:10pt;">Date:</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-size:10pt;">March&nbsp;10</font><font style="display: inline;font-size:10pt;">, &nbsp;</font><font style="display: inline;font-size:10pt;">2</font><font style="display: inline;font-size:10pt;">02</font><font style="display: inline;font-size:10pt;">2</font></p>
				</td>
				<td valign="bottom" style="width:323.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:110.70pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/ Sylvia Wulf</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:110.65pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:323.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:110.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Chief Executive Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 13.5pt;line-height:120%;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>aqb-20211231xex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.1.0.2-->
<!--Created on: 3/10/2022 8:43:39 AM-->
<html>
	<head>
		<title>
			Exhibit 31.2
		</title>
	</head>
	<body><div style="margin-left:36pt;margin-right:36pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-weight:bold;font-size:10pt;">EXHIBIT 31.2</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">Certification</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">I, David A. Frank, certify that:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">1. I have reviewed this Annual Report on Form 10-K of AquaBounty Technologies, Inc;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">4. The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(b) designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(c) evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(d) disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">5. The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s Board of Directors (or persons performing the equivalent functions):</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize, and report financial information; and</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font>
		</p>
		<p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:106.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">2</font></p>
				</td>
				<td valign="bottom" style="width:328.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:110.70pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:106.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Date:&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">March&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">10</font><font style="display: inline;color:#000000;font-size:10pt;">, 202</font><font style="display: inline;color:#000000;font-size:10pt;">2</font></p>
				</td>
				<td valign="bottom" style="width:328.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:110.70pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/&nbsp;David A. Frank</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:106.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:328.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:110.70pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 13.5pt;line-height:120%;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>aqb-20211231xex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.1.0.2-->
<!--Created on: 3/10/2022 8:43:51 AM-->
<html>
	<head>
		<title>
			Exhibit 32.1
		</title>
	</head>
	<body><div style="margin-left:36pt;margin-right:36pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-weight:bold;font-size:10pt;">EXHIBIT 32.1</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">The following certification is being made to the Securities and Exchange Commission solely for purposes of Section&nbsp;906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350). This certification is not to be deemed a part of the Report, nor is it deemed to be &#x201C;filed&#x201D; for any purpose whatsoever.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">In accordance with the requirements of Section&nbsp;906 of the Sarbanes-Oxley Act of 2002 (18 USC 1350), each of the undersigned hereby certifies, to his knowledge, that:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(i) this Annual Report on Form 10-K for the year ended </font><font style="display: inline;font-size:10pt;">December&nbsp;</font><font style="display: inline;font-size:10pt;">31, 20</font><font style="display: inline;font-size:10pt;">2</font><font style="display: inline;font-size:10pt;">1</font><font style="display: inline;font-size:10pt;">, which this statement accompanies, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(ii) the information contained in this Annual Report on Form 10-K for the year ended </font><font style="display: inline;font-size:10pt;">December&nbsp;</font><font style="display: inline;font-size:10pt;">31, 20</font><font style="display: inline;font-size:10pt;">2</font><font style="display: inline;font-size:10pt;">1</font><font style="display: inline;font-size:10pt;">, fairly presents, in all material respects, the financial condition and results of operations of AquaBounty Technologies, Inc.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Dated as of this </font><font style="display: inline;font-size:10pt;">10</font><font style="display: inline;font-size:10pt;">th day of </font><font style="display: inline;font-size:10pt;">March 202</font><font style="display: inline;font-size:10pt;">2</font><font style="display: inline;font-size:10pt;">.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:46.32%;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:07.38%;padding:0pt 0pt 0pt 0pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:46.32%;padding:0pt 3.2pt 0pt 3.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:46.32%;border-bottom:1pt solid #000000 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/&nbsp;Sylvia Wulf</font></p>
				</td>
				<td valign="bottom" style="width:07.38%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:46.32%;border-bottom:1pt solid #000000 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/&nbsp;David A. Frank</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:46.32%;border-top:1pt solid #000000 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Sylvia Wulf</font></p>
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Chief Executive Officer</font></p>
				</td>
				<td valign="bottom" style="width:07.38%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:46.32%;border-top:1pt solid #000000 ;padding:0pt 3.2pt 0pt 3.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">David A. Frank</font></p>
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt 13.5pt;line-height:120%;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>aqb-20211231x10kg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aqb-20211231x10kg001.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &C N<# 2(  A$! Q$!_\0
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MWP?\:/\ AG_X=?\ 0I:=_P!\'_&O0:* //O^&?\ X=?]"EIW_?!_QH_X9_\
MAU_T*6G?]\'_ !KT&B@#S[_AG_X=?]"EIW_?!_QH_P"&?_AU_P!"EIW_ 'P?
M\:]!HH \^_X9_P#AU_T*6G?]\'_&C_AG_P"'7_0I:=_WP?\ &O0:* //O^&?
M_AU_T*6G?]\'_&C_ (9_^'7_ $*6G?\ ?!_QKT&B@#S[_AG_ .'7_0I:=_WP
M?\:/^&?_ (=?]"EIW_?!_P :]!HH \^_X9_^'7_0I:=_WP?\:/\ AG_X=?\
M0I:=_P!\'_&O0:* //O^&?\ X=?]"EIW_?!_QH_X9_\ AU_T*6G?]\'_ !KT
M&B@#S[_AG_X=?]"EIW_?!_QH_P"&?_AU_P!"EIW_ 'P?\:]!HH \^_X9_P#A
MU_T*6G?]\'_&C_AG_P"'7_0I:=_WP?\ &O0:* //O^&?_AU_T*6G?]\'_&C_
M (9_^'7_ $*6G?\ ?!_QKT&B@#S[_AG_ .'7_0I:=_WP?\:/^&?_ (=?]"EI
MW_?!_P :]!HH \^_X9_^'7_0I:=_WP?\:/\ AG_X=?\ 0I:=_P!\'_&O0:*
M//O^&?\ X=?]"EIW_?!_QH_X9_\ AU_T*6G?]\'_ !KT&B@#S[_AG_X=?]"E
MIW_?!_QH_P"&?_AU_P!"EIW_ 'P?\:]!HH \^_X9_P#AU_T*6G?]\'_&C_AG
M_P"'7_0I:=_WP?\ &O0:* //O^&?_AU_T*6G?]\'_&C_ (9_^'7_ $*6G?\
M?!_QKT&B@#S[_AG_ .'7_0I:=_WP?\:/^&?_ (=?]"EIW_?!_P :]!HH \^_
MX9_^'7_0I:=_WP?\:/\ AG_X=?\ 0I:=_P!\'_&O0:* //O^&?\ X=?]"EIW
M_?!_QH_X9_\ AU_T*6G?]\'_ !KT&B@#S[_AG_X=?]"EIW_?!_QH_P"&?_AU
M_P!"EIW_ 'P?\:]!HH \^_X9_P#AU_T*6G?]\'_&C_AG_P"'7_0I:=_WP?\
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M? OPOGU;P_HEMI.I)=0QK=6P*N%8D$ Y[BBNH_;!_P"2+W7_ %^V_P#Z$:*
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M9\UWPOXL^(_PDAT?2K2XA2;Q#]AMS:RPB%)'7S[?@(0K2'(7YN>3BOG+PO\
MM9?M/_M-:7XM\>?!GP[X1TCX?:'<2P6EOKX>2]U(QJ&95((&[:RG'R %@-Q(
M- 'Z+T5\D_ O]LWQ-^T)^RGKWCSP?X*CU3XD:-*=.E\,K,5AEN\IAE9B#LV2
M;\$Y&TC/>O#_ (Q?M)?MD_LQ^&;'X@_$+1? =]X5DO8[:ZTG3]QE@+YVJ7#<
M9P1N!< XXYH ^[_C1\8O#?P%^&^L>-_%ER]MHVF(I?R5WR2NS!4C1<C+,Q '
M/>O+/V4/VT-%_:PFUI-)\(^(?#2:=#%<1SZQ"HBNXG9E#1NI()!4Y%?*G_!5
M3Q]X^\>?LW^$->\/V%@OPAUZSL=2O[B9U^VQW<A\R",#=]W:1G"GD'D5I_#3
M]K3XD_LH_L9V?B7XI>'-%DADM=.T_P  Z=I<JHU]$T#,7N"C-M"HJ,> Q.1@
M$YH _2*BOS-\6_M8?MD?!OP#I?Q8\;^"O"4_@*Y:"2XTNV4I=6T,O^K+XD+1
MEMRC)W8)&0,U[7^T/_P40TGX9_L^> _&_A'1SKOB/Q]$IT+2;DD",X D:7;R
MVQV5-JXW,1R!0!]CT5^:?CO]KS]K3]EN#P[XQ^,?@OPOJ/@?4[E+>YM]'^2X
MM69=WEEP[;'VAB-P8$@C(KU?]LC]N_5_A?8?#?P_\)-(@\2^-OB#!#>Z5]LC
M9DCMI2HA/E@@L\C-@ D ;6)H ]>_:9_:\\-?LO:MX&L/$&D:IJDGBR\>SMFT
M\(1"5:)2S[F''[U>F3P:]WK\4OVS_'7QRUKQY\&?#OQR\):=HNL:;J_VFRUC
M2'#6U_'++;AD^5F4.AC&<$??' X)_:V@#P;XS?MR?!;X">('T'Q=XS@@UV,
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M1M^ZZ]ZW?BS^UIXUL?VZ_ 'P.\#6NF7.FW$,=UXCFO+=Y)8XR&E<(RL A$*
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M//\ @IUX^UOQ=X>/A3Q/<:1<+J.CEBPMID6VC8 GJ"4W#KPPY/6@#]9:***
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ML%:>/2[^*Y:('."P1CM!P<9]* .AHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "OB+XK?\%#O@9;^)?&WPS^+WA74K7^R;V:R:TU+2EO;>_C7(65
M /N[NJY QD$-7V[6#KW@+PSXJN([C6O#NDZQ/&,)+?V,4[+]"RDB@#\H_P#@
MGG\&]3^(GBC]HG6_!6E:CX<^&7B/0=2T+0TOV*B1YW/V=-Q^\8X\Y89QOQDY
M->3_ +,^B_L^^$=$U_PG^T)>>,O WCG2M1E0PVUQ=0P2184!=D2G#A@^21@@
MJ037[EV5C;:;:16MG;Q6MM$NV.&% B(/0*. *QM>^'OA;Q3="YUKPUH^KW(
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M>L-JRZ99KJC+L:^$""<K@#!?&[& ._:B3P_I4NKIJKZ99OJB+L6^:!#.J\C
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M HHHH **** "BBB@ HHHH **** /$OVP?^2+W7_7[;_^A&BC]L'_ )(O=?\
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MWXJ_\]?!W_?N[_\ BJ-OQ5_YZ^#O^_=W_P#%5Z%10!Y[M^*O_/7P=_W[N_\
MXJC;\5?^>O@[_OW=_P#Q5>A44 >>[?BK_P ]?!W_ '[N_P#XJC;\5?\ GKX.
M_P"_=W_\57H5% 'GNWXJ_P#/7P=_W[N__BJ-OQ5_YZ^#O^_=W_\ %5Z%10!Y
M[M^*O_/7P=_W[N__ (JC;\5?^>O@[_OW=_\ Q5>A44 >>[?BK_SU\'?]^[O_
M .*HV_%7_GKX._[]W?\ \57H5% 'GNWXJ_\ /7P=_P!^[O\ ^*HV_%7_ )Z^
M#O\ OW=__%5Z%10!Y[M^*O\ SU\'?]^[O_XJC;\5?^>O@[_OW=__ !5>A44
M>>[?BK_SU\'?]^[O_P"*HV_%7_GKX._[]W?_ ,57H5% 'GNWXJ_\]?!W_?N[
M_P#BJ-OQ5_YZ^#O^_=W_ /%5Z%10!Y[M^*O_ #U\'?\ ?N[_ /BJ-OQ5_P">
MO@[_ +]W?_Q5>A44 >>[?BK_ ,]?!W_?N[_^*HV_%7_GKX._[]W?_P 57H5%
M 'GNWXJ_\]?!W_?N[_\ BJ-OQ5_YZ^#O^_=W_P#%5Z%10!Y[M^*O_/7P=_W[
MN_\ XJC;\5?^>O@[_OW=_P#Q5>A44 >>[?BK_P ]?!W_ '[N_P#XJC;\5?\
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M5?\ GKX._P"_=W_\57H5% 'GNWXJ_P#/7P=_W[N__BJ-OQ5_YZ^#O^_=W_\
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ML_\ _)&/"7_7DO\ ,UZ#7GW[/_\ R1CPE_UY+_,UZ#0 4444 %%%% !1110
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M6,C_ %P,#^=>,45\]7S[&UM(RY5Y?YLQ=:3/?O@7XXUSQAXMU7^UM0DNHTM
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MP_\ ?L?X59HH K?V;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X59HH K?V;:?\
M/K#_ -^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_]^Q_A
M5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_\ ?L?X59HH K?V;:?\^L/_ '['^%']
MFVG_ #ZP_P#?L?X59HH K?V;:?\ /K#_ -^Q_A1_9MI_SZP_]^Q_A5FB@"M_
M9MI_SZP_]^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_\
M?L?X59HH K?V;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X59HH K?V;:?\ /K#_
M -^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_]^Q_A5FB@
M"M_9MI_SZP_]^Q_A1_9MI_SZP_\ ?L?X59HH K?V;:?\^L/_ '['^%']FVG_
M #ZP_P#?L?X59HH K?V;:?\ /K#_ -^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_
MSZP_]^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_\ ?L?X
M59HH K?V;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X59HH K?V;:?\ /K#_ -^Q
M_A1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_]^Q_A5FB@"M_9
MMI_SZP_]^Q_A1_9MI_SZP_\ ?L?X59HH K?V;:?\^L/_ '['^%']FVG_ #ZP
M_P#?L?X59HH K?V;:?\ /K#_ -^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_
M]^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_\ ?L?X59HH
M K?V;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X59HH K?V;:?\ /K#_ -^Q_A1_
M9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_S
MZP_]^Q_A1_9MI_SZP_\ ?L?X59HH K?V;:?\^L/_ '['^%']FVG_ #ZP_P#?
ML?X59HH K?V;:?\ /K#_ -^Q_A1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_
MA1_9MI_SZP_]^Q_A5FB@"M_9MI_SZP_]^Q_A1_9MI_SZP_\ ?L?X4W4-6LM)
MA,M[=PVD?7=-($'ZUPVM_'GPEH^Y8KR34I1_#9QEA_WT<#\JY:V*H8=7JS2]
M62Y*.[.[_LVT_P"?6'_OV/\ "C^S;3_GUA_[]C_"O!-:_:9OYMRZ3I$-LO:2
MZ<R-^0P/UK@-<^*GBKQ!N%SK,\<;=8K8B)?_ !W%>#7XBPE/2G>3^Y?C_D9.
MM%;'U-K&L>'/#\9;4;G3[,#^&4H&_ =37 ZU\>/!VG;DLK-]4D'0Q0!$/_ F
MQ_*OFYV:1R[LSN>2S')/XTVO K\28F>E**C^+_R_ Q=:70]4UK]H#4[S<NFZ
M1I^FIV9XQ,_Z@#]*X/6O%VL>(B?[0OGG4_\ +/:JI_WRH K'HKP*V/Q6(_BU
M&_R^Y:&+G*6[%I***X"0HHHH **** /8?V9?^1LU?_KR'_HP5]&U\Y?LR_\
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M"2VH_P"$)\=?]%)D_P#!);4 >A45Y[_PA/CK_HI,G_@DMJ/^$)\=?]%)D_\
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M_3>5F_0FJ  ' &!117DRDY.\G=F84444@"BBB@ HHHH **** "BBB@ HHHH
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /I']A?\
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M (FC_A?GP^_Z&BS_ "?_ .)KOO+7^Z/RH\M?[H_*@#@?^%^?#[_H:+/\G_\
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ME_,93_WRH4?K7J4\IQE7:G;UT_,X*F8X6GO._IJ?0O\ POSX??\ 0T6?Y/\
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M0'_R"M>5+_D8+_ _S1Z2_P!R?^+]#S2BBBO5/-"BBB@ HHHH **** "BBB@
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MZ]/4]6CE^)RR'U;%PY9KI=/?;:Z/$OVP?^2+W7_7[;_^A&BC]L'_ )(O=?\
M7[;_ /H1HKS#<ZS]G_\ Y(QX2_Z\E_F:]!KS[]G_ /Y(QX2_Z\E_F:]!H ^3
M=<U[2=>_:H\06.E"Z@@OO 4WARWN!I=S';#46O96,7F>6$!^;<3G'.<UB^%X
M;SQ]\-O@%\.K;1]5T_Q/X3U"PGU^&YL)8H],6QMY(I"TK (V^0J$V,V\-D<
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M\_:F^)<_F)%XDDBB;('^BP;P/J$Z_2O.=>\3:QXJNC<:SJEYJDQ.=UW,TGY
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MI21YQ'"P)SATW8]JY)<79='92?R7ZM'HT_#O.9_$X1]9/](LM4=>E4VU"?S
MZE8SC'R( /RI)M0N;A=LDN1[*!_(5QRXRPJ^"E)_<OU9Z-/PUQ[_ (E>"].9
M_HB]M/H:,'T-4$OKF-0$N)D Z!7(I)+VXE4A[B5P>"&<G-<\N-*?V:#_ / O
M^ =D?#.M]K%+_P !?_R2-..WEF&4C=QTRJDTK6LZ?>AD7ZH16-N8="1^-&YC
MU9OSK!\:2Z8?_P F_P#M3KCX91^UB_\ R3_[8Z;PGN/C'PV\94[=6L\_,/\
MGNGO7I_[7%N[?M!:RR@8:RM.K ?\LS[UXQX9;R_%_AM\9VZK:'\ITKUC]LJ,
M+^T-JS==VGVA_P#'"*Y9<45IR^M*DDXZ6N^NOZ!_J)AZ=>. E7DU).5[)/2R
MMU[GEB21NQ7S8T(_OMBI"B!<_:;<_245CT5F^,<;TIQ_'_,]2/AMEBWK5'\X
M_P#R)I>?")-C2J!_> )'Z5)YEKMS]L3/IL?_  K)HK"7%V8O917R?^9UQ\.L
MGCO*H_\ MY?_ ")HM=0K(!O+KW95/\CBI!=67>68'_KD/_BJRJ*P?%69O:27
MR1U1X R..\)/_MY_H7Y+R)<>7N?UW#;_ %-*E_;[1OCFW=]K#'\JSZ*Q?$V:
MO_E[_P"2Q_R.E<#9 O\ EP__  *?_P D:?\ :%G_ ,\KC/\ OK_A44E_%M_=
MQR!O]MAC]!5&BLGQ'FK_ .7WX1_R-X\%Y!'_ )AO_)I__)%G[<W]P?G2_;F_
MN#\ZJT5F^(,T?_+]_A_D;KA#(E_S"K[Y?YEG[<W]T4W[9)_L_E4%%9/.\R>]
M>7WF\>%\DCMA(?=?\R?[;)Z+^5'VR3V_*H**S>;Y@]Z\O_ F;1X<R>.V$A_X
M"O\ (F^U2[L[OT%3#5K@<_NO^_*?X53HK)YGCGO7G_X$_P#,Z%D>5+;"T_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M: "048YR0#7U)0 445P^J?%BUTK4KJR;PYXHN&MY#&9K;1Y9(GQW1@,,/<4
M=Q17GO\ PN:T_P"A6\7?^".;_"L'QK^TIH_@W0IKVZT'Q!:S,K):I?Z9);QS
M2X)5-[=/?VK2G3E5DH05VR)SC3BYR=DC'_:C^./_  KO0?[ T:?_ (J74XR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_0C11^V#_P D7NO^OVW_ /0C17H'R9UG[/\ _P D8\)?]>2_S->@UY]^S_\
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M=/PR_P#?\/QG_P C25UT_P"!/Y'S^*_Y&>&])_DCY]HHHKD/H HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#Z:_8*_Y*+XE_[!2_\ HY:^X:^'OV"O^2B^
M)?\ L%+_ .CEK[AKZ7 _P%\S\6XH_P"1G/TC^1XE^V#_ ,D7NO\ K]M__0C1
M1^V#_P D7NO^OVW_ /0C17H'R9UG[/\ _P D8\)?]>2_S->@UY]^S_\ \D8\
M)?\ 7DO\S7H- !1110 45S^I6WBJ3Q)9RZ?J6CP: H7[3:W.GRR73\G=LE6=
M57C&,QMCGK704 %?EW\<O^2T>./^PQ<?^AU^HE>!^+/V./"?B_Q1JVN76IZG
M%<ZC<O=2I$8]JLQR0,KTKAQ5"5>*47L?3Y#FE+*JLZE:+:DK:6[^;1\ 45]U
M?\,+>"_^@MJW_?47_P 11_PPMX+_ .@MJW_?47_Q%>;_ &=5[K^OD?:?ZX8+
M_GW/[E_\D?"M%?=7_#"W@O\ Z"VK?]]1?_$4?\,+>"_^@MJW_?47_P 11_9U
M7NOZ^0?ZX8+_ )]S^Y?_ "1\*T5]U?\ #"W@O_H+:M_WU%_\11_PPMX+_P"@
MMJW_ 'U%_P#$4?V=5[K^OD'^N&"_Y]S^Y?\ R1\*T5]U?\,+>"_^@MJW_?47
M_P 11_PPMX+_ .@MJW_?47_Q%']G5>Z_KY!_KA@O^?<_N7_R1\*T5]U?\,+>
M"_\ H+:M_P!]1?\ Q%'_  PMX+_Z"VK?]]1?_$4?V=5[K^OD'^N&"_Y]S^Y?
M_)'PK17W5_PPMX+_ .@MJW_?47_Q%'_#"W@O_H+:M_WU%_\ $4?V=5[K^OD'
M^N&"_P"?<_N7_P D?"M%?=7_  PMX+_Z"VK?]]1?_$4?\,+>"_\ H+:M_P!]
M1?\ Q%']G5>Z_KY!_KA@O^?<_N7_ ,D?"M%?=7_#"W@O_H+:M_WU%_\ $4?\
M,+>"_P#H+:M_WU%_\11_9U7NOZ^0?ZX8+_GW/[E_\D?"M%?=7_#"W@O_ *"V
MK?\ ?47_ ,11_P ,+>"_^@MJW_?47_Q%']G5>Z_KY!_KA@O^?<_N7_R1\*T5
M]U?\,+>"_P#H+:M_WU%_\11_PPMX+_Z"VK?]]1?_ !%']G5>Z_KY!_KA@O\
MGW/[E_\ )'PK17W5_P ,+>"_^@MJW_?47_Q%'_#"W@O_ *"VK?\ ?47_ ,11
M_9U7NOZ^0?ZX8+_GW/[E_P#)'PK17W5_PPMX+_Z"VK?]]1?_ !%'_#"W@O\
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M]U?\,+>"_P#H+:M_WU%_\11_PPMX+_Z"VK?]]1?_ !%']G5>Z_KY!_KA@O\
MGW/[E_\ )'PK17W5_P ,+>"_^@MJW_?47_Q%'_#"W@O_ *"VK?\ ?47_ ,11
M_9U7NOZ^0?ZX8+_GW/[E_P#)'PK17W5_PPMX+_Z"VK?]]1?_ !%'_#"W@O\
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M?M[VXM[(22+$7OKA@QM1(8]G[PKE03P.: /L5'$BJRG<K#(([BG4V-%CC1$
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MX(^#OA36&@T>SO+?4=(@M(KM;=KU+H-#;N9%WL3*_F?-\OR\MVK[,H ****
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M7X8\=ZY\>?$_Q=\)PZW9)I]@ZVJ6RZD\RI;-/';P1R91W5MDF #M8C@5]>T
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M(NDO[KPIXDPD$FMZ4H$EU:AU9K6Y0\31':,!N48!E(Y!]EHH **** "BBB@
MKR_0?V??#5EX'\2^$-:MX/$GAW6M7O=5-G>VZCR3<RF5E# Y+*[,5D&&&1@Y
M&:]0HH \V^!?P9'P1T#7-+'B34O%/]I:O-J8O=7(:Y56CBC2)Y!_K"JQ*-YY
M;O7I-%% !1110 5Q?B/X:P:_\3/!_C07K6UYX>AO;40>4KK<17*H&&3RA#1(
M0P]"#UKM** /&9OV8= L_C7H7Q#T&_NO#RV=Q/>7_A^S5?[/U"ZDMW@%R8^D
M4P60[G3[X W D9KV:BB@ HHHH *BNK=+RUFMY,F.5&C;!P<$8-2T4 >1Z?\
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M373JEP;>4G;G:\3RL=Q(S;C@9K[6TNUEL=,M+:>ZDO9X84CDNI0 \S!0"[8
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M4/A)X,N+WQ)=Z9=Z]JFL@:U<74>DVZPV]Q-Y223/;2E6*! D8BW2;3SP<O\
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M,,H89SR,T&-696*@LO0XZ4ZB@!NU0Q(4 GJ<=:-JY!P,CH<=*=10 U455P%
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M/Q%_Z&W4/^^E_P *** #_AH'XB_]#;J'_?2_X4?\- _$7_H;=0_[Z7_"BB@
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9/[+UW7;O4]/<[VMYF&TLO(/ [4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>aqb-20211231x10kg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aqb-20211231x10kg002.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )3 [ # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*2EI* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@!:*** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DH 6BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M)0
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MQD_=1,,9-:V45<\Z52I7E8\E\<?"GPM\3[40WL#)?+Q'<1KAP?PK0^ _P?\
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M_P!H+PQ\4;5'TG4%AO<?O+&X8+(I^G>N?O%M[R$Q-&EU!(NUPXRI!KQWQO\
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M]*^I?#^N66I6T-]97$5Y:2#*2PL&!%*R.A;'3FDIL<R3+N1L^U.K-#"BBBJ
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MAOXF?%']G.5+;6HF\8^$(SCSDR98E^O6HE&QZ,*\9^1^@:L&&0<BBO(?A/\
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M-=]0E8MGXBBO3MD/EOV!Z&K^X-R.E,!S,6.2<TVBBKL 4444P"BBB@ HHHH
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MF^:;NS:U?Q-/>*5W?9K?LJ_>-8:R2W&5A7RT/5CU-20Z?N;S)G\QO0U<50H
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MX+69_M4#,%Q)]Y<^]>S_ &AI%!Z!AFFT*Y,TH7DG)J)IF;..*CILD@CC9CT
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MK\%EWX]C75U^[Y31>'P-&G+=)'Q^(DI5927<2EHHKUC **** "BBB@ HHHH
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MYX'Y_P W*^61]_X++YB<KV(IDDT\84I&)%'+#O7"^$_'45YIZ365RMY9R8.
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M_O0RY'Y5Z#HO[6&F3; -;EA/]RX3^M=%3*:\/A1SPS>C+XCZQ8=>*@N+.*Z
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M=):6_P#!TIU"USDV$QQ*O^Z>XKLOAO\ %*W^%/A^2^N[-KVVN+Q875/O+QU
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M!B*74(S-9RJOWL56\.G=H=@3_P \5_E6A65:FJM-TWL]"HR<7S+='DEUI?\
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M\Z9Z8]:^CZGX];J>N_!&9%L+=II&3_3CE\\_=KW=5F3#J1<Q-_$O45Y3\-_
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MN&X63V-9]*#BIL!JT50CNF4@'D5;CG63H:D"2DH'-% "T444 %%%% !1110
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ME?Y'P-:2J5)375A1117HF04C<BEHHM< HHHHM8 HHHH **** "BBB@ HHHH
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M-P'4U0!2X-037D5NI9Y H'K6%J7C.ULUR&!']YCBBS%<Z2DK*TOQ#;:D@*N
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MOJ>@K75=O3I4@4M/TFWL%PB9;^\1S5W ]*6BD 4E+24 +1110 4444 %%%%
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M$4L&I>(4:PT[(9;=N'D^OH*^B/AW^SGX:^'P29+;^T=0 YNK@9(/L.U>DFQ
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M-52KCKBO<E.X CIC-'/M^5.XN4S;?2QP93D_W16A'"L(PHP*=11NR@HHHHL
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M@>(X$5TQWSZTGPWMEDL;F*4[MEW*/UJ01+;_ !(O%1<!K:,_K4LK;<[:U4K
M@888#!J6BBH+# IBCD\4^B@")H W6I5^48HHI6 \U\<:;J^@ZU>^(-*A&HQW
M%L;>XM?XP.S+70_#&PDT[P1IT,T30RLI=HV&""3GFNH905.12K]P?2@!?2D/
MS=>:**+ %%%%, HHH]^U !39)%C4LS!5]35&]UB*W!"'S']JQVEN]6DVJ"PS
M]T=*5P+U]KVS*0#)_O&J=OI]WJS[L,>>7/05MZ;X92,![GYF_NCI6]'&L2[5
M4*/04@,O3O#\%GM9QYL@[MTK6V@=!2T5(!1110 4444 %%%% !1110 4444
M%%%% !1110 4E+24 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M75]:3TO7_E1JYV?$F @#YK+^3576Q#U1W%% ^Z/I12+"BBB@ HHHH *.E%%
M!1110 45'/<1VZ[I'VBL:]UXRY2#Y!TW&E<#3NM1ALQ\[9;LHK$O-6GO'\N,
M$*?X5IUAHMSJ3!WRJ'J[=:ZG3]%M[%?E7<_]YAS47 P=-\,RS8DN"47^[W-=
M-:V4-I'LB0*/85/2T )2T44@"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *2EI* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,DXJI=ZE%9@Y;+=E%8=UJ%QJ#A5W*">%7O2 UKW6HK?Y4_>/^E9"K=ZM.
MS_3H*U-+\+M)B2Y.T?W*Z2WM8K6,)$@1?:D!C:;X9CM\/<8D?^[VK<CC5%VJ
M-H'0"GT4@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *2EI* %HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ IKH)%(89'H:=10!SVJ>%8KK,EN?*E/;L:YIH[W0YAN#1GU[&O
M1JAN;6.Z39*BNON*8',6'B"*90DX\N3^]V-:RL&7(QCUK)U;PBRY>T8E>I3O
M^%9%MJ%UI4FQP2.A1Z=P.NHJC8ZU!?8&?+?^ZU7LU5P"BBBF 4444 %%%% !
M1110 =\T8S112L 44C.L:DL0 .Y-9-]KHC^2$9;^^>U%P-.:XCMES(VVL.]U
MQYLI#\BGC/>H8+.[U>8]3ZLW05T6G>&X;/#N!++[]*FX&'I^@7-\V]P8T/\
M$W6NHT_2;>P3")EN[-UJZJ[?84M2 F*6BB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6D
MH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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; R:,FBB@ R:,FBB@ R:,FBB@ R:,FBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>aqb-20211231x10kg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aqb-20211231x10kg003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !E H\# 2(  A$! Q$!_\0
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M,Q:[N-,N93-<23?.;4@[=['8N%&%7"CL!0!+_P ))\;_ /HGGP__ /"\OO\
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M&P_4'PW\5'QOX%T776DADDO;<22&"&:% ^2&7RYE65""""KJ&!!! - ''_\
M"2?&_P#Z)Y\/_P#PO+[_ .4U'_"2?&__ *)Y\/\ _P +R^_^4U>JT4 >5?\
M"2?&_P#Z)Y\/_P#PO+[_ .4U'_"2?&__ *)Y\/\ _P +R^_^4U>JT4 >5?\
M"2?&_P#Z)Y\/_P#PO+[_ .4U'_"2?&__ *)Y\/\ _P +R^_^4U>JT4 >5?\
M"2?&_P#Z)Y\/_P#PO+[_ .4U'_"2?&__ *)Y\/\ _P +R^_^4U>JT4 >5?\
M"2?&_P#Z)Y\/_P#PO+[_ .4U'_"2?&__ *)Y\/\ _P +R^_^4U>JT4 >5?\
M"2?&_P#Z)Y\/_P#PO+[_ .4U'_"2?&__ *)Y\/\ _P +R^_^4U>JT4 >5?\
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M+-)X6;6-,N)[:_EA1&D1[F"YV;B2ZF*1;=X\!E$Z[BH!UW_"2?&__HGGP_\
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M],\3+IAU+1;VWC6328)(H?*GM(;A4(DD<NR>:4,GRA]H;8F=H (O^$D^-_\
MT3SX?_\ A>7W_P IJ/\ A)/C?_T3SX?_ /A>7W_RFKU6B@#RK_A)/C?_ -$\
M^'__ (7E]_\ *:C_ (23XW_]$\^'_P#X7E]_\IJ]5HH \J_X23XW_P#1//A_
M_P"%Y??_ "FH_P"$D^-__1//A_\ ^%Y??_*:O5:* /*O^$D^-_\ T3SX?_\
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MX)CU'4[/PRFHZEI.A:K:?V5I=]??84O9I(I0;9)?.O641AUCB\MOG*_-LW,
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MUZ2VE7LUK=V%LUK=ZE)9N5=I'DN=I1 )?*MU8EG4.FPN ?7M%?)>N?M/>/\
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MY0!T%8=W\&?A_?\ AC3/#=UX%\-7/AW3)?/L-(FTBW:TM),D[XH2FQ&RS<J
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M,](ATG5/$-KH'BZV;QWK=M$393+>:=%!%>^4EKNDD#2'R63S/W>U&*[&W%@
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MY)UJ_P#V.?BS_P!2'4:]5KRK]FG_ ))UJ_\ V.?BS_U(=1H /C)_R47X$_\
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M6?A_7/%NG0)9R^)(K>UEU%0\8?#SQJ&4R)('P-H(DR!@BI%^"7P[71[[25\
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M$$4L47PQ\&QQS!!(BZ!: .$?>@(\OG:_S#/0\CFOF3PG\9?$%Y:2^-(O'?\
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MPWK-UIB0Z7"CS7=[]GN;?(0NL(C(<C/F!\$2*GR$ ^_**0$, 0<BEH ****
M"O*OV:?^2=:O_P!CGXL_]2'4:]5KRK]FG_DG6K_]CGXL_P#4AU&@ ^,G_)1?
M@3_V.=S_ .H]K-=M9_$'PMJ'BZ]\*6OB72+GQ191">ZT2&_B>]@C.W#O &WJ
MIWKR0!\P]17$_&3_ )*+\"?^QSN?_4>UFN>\%^*/"NA_%#Q7>^&_B!;:QX26
MVNKWQ.D^MK>V>B:@DJ 'S6=A:EU,VZ LJCR0RHOSE@#US7/&WA[PSJFDZ;K&
MO:9I6HZO*8--L[Z\CAFO9!C*0HS R-R.%!/(H\6>-O#O@+2UU+Q-KVF>'-.:
M58%O-6O([6$R-G:@>1@-QP<#.3BO,?VE6\(^(_#_ (8\,>(?$NF:%/KNJ(-)
MFNKV*&4W*Q2-!-;AF!=TE,+#;GYBOJ*\D\=?&;1?$TOPO\0>-=1T_P 'W.C^
M)[:PDL]:GCM1_:4;.E^\1D8%TB^5 Z\8F;GF@#Z'\,_'SX8^-->30_#WQ&\)
M:[K3[]NFZ9KEK<7)V@E\1I(6X )/'&*7PW\>_AEXR\0+H7A_XC>$]=UMM^W3
M=-URUN+D[ 2^(TD+?* 2>.,&OC'0?BSIFJ:W8:;8>//!OBNSE^*\UU9^#=&V
MMKIS?RL+L7 GF!@0$RMBWBS&&7SESEET+XL:;J>N6.F6/CSP=XJM)?BQ-<VG
M@W1PIUXYOY6%T+@3S PH,RMBWBS&&7SESE@#[1\*_'/X;^.M>;0_#7Q!\+>(
M=:57<Z;I6M6US<A5^\?+1RV!WXXKIM>\1:5X5TR74=:U.ST?3XL"2[O[A((D
MSP,NY 'YU\0_#;Q'H.L>,HO$_B3QOX;/PTT'Q[KE[8W]@\49L-5>:185OKQI
M740S132LFQ8<MY:LS[U#?3'BK4K:#XV:=/K-Q#;Z'IOA>]U.UGNF5;>*82QI
M-/O;@,D+ ;LC"ROV8T ='X+^-GP[^)%]<67A+Q[X8\4WEO%Y\UOHNL6]Y)%'
MD#>RQNQ"Y(&3QS74Z5JUCKVFVVHZ;>6^HZ?=1B6"[M95EBE0C(9'4D,".X-?
MG_\  /XGQ:JWP.L+7Q[X,\57%AIFI-;V.@P 7?AM?L;YN=2;[1-YL*_*A4&T
M!9T/S8 7L?#G[1GB[Q-I7@Z>W^(EL?$DVEZ-<Z;HL5K9-;^,7EF,>H%<(9-T
M6UQMMW00[=TFY3P ?6-U\5?!5EXTC\'W'C#0(/%LB[TT&74X%OV7:7R("WF$
M;06SCH,]*WM*U:QU[3;;4=-O+?4=/NHQ+!=VLJRQ2H1D,CJ2&!'<&OC'PS\2
M+/0?$E_9R?%S3-<T#6?B-J>CZUI6LMILHDA-E,1$&1$V LJ!E8,3M0 J-P?E
M?#7Q)E\%_#:?7_#?Q-TW09+'X2VESHMC.ME-8L\4UPDCHA"N[(X5/EDV*TBA
MT;A: /T!DC2:-HY%5T8%65AD$'J"*Q-#M?#_ (+ATSPKITMKIP6"1[#2OM'S
M^2C#=Y2,=WEH9$7"_*@9%&!M%?*&L_';7?#/QP\#>&(?BRVLV6I/:PW4=\-(
MMH[E+RVN)(9[=$A,TZB7R5616BC'[N/-Q(TA&-X3^.&O^!?AIX"MM%^(5MXJ
MFN/!FK7;Z=)#:3WYOK>6#>P\D)O^SHTX\D(&)B?>SG[H!]RU7M]0M;NYNK>"
MYAFN+5E2XBCD#/"Q4, X!RI*L" >Q![U\;/\:O%$VJ:!I6F?'+3+SP=JWB-[
M"Q\:S6>G/=ZA;G3))I4BD54M2T$ZA-ZP,-SQJX)1U?T3X1^-)O'6H?!;Q7!J
M%KJVJ^(/#5VNN:CIZ1[+R.%8BKR&/Y1LG=@H'"F:0 #)H ^C:*** "BBB@ H
MHHH **** "LV3P[ITOB"+6Y+82:I#;FUBN'9F\J-FW,$4G"EB%W$ %MJ@DA5
MQI44 %%%% &/-XPT&VTG4]5FUO38M+TMI4O[U[N,0VC1?ZT2N3MC*?Q!B,=\
M5<T?6;#Q%I5IJ>E7UMJ>FWD2S6UY9S++#-&PRKHZDAE(Y!!P:^3]!UOPE_P@
M?BJ30;_1G\*Z#\3_ +;K4>E30FWM+5;A)'DE6,[519,2L3@81F/ ->P_ /Q)
MIMUI>IK%JEJT&N:UJFK:%;FX4O=:>9P3<0IG+0L[EPP^7$J'HPH ZZV^+O@6
M\O-?L[?QIX=GN_#R-+K-O'JL#2::BYW-<J'S"!@Y+XQ@U7\,_&[X=>-;Y['P
M]X^\+Z]>I;&]:VTS6;:YD6W&,RE4<D(,CYNG/6O-F^*GA3X3?&'XG6OC'7+/
MP[<ZP]A?:3!?RB.35$%FD!6T3[UQ()(F0QQAGRR#'SKF#Q#8:S\/-0^''BS3
M-+E-[J6CP^$=5MQ"/,BD= ]G+)C)VQ3AT(Z 7#$G"T >Y>&_%&C>,M$M=9\/
MZM8Z[I%T"UOJ&FW*7%O, 2"4D0E6&01P>H--M?%FB7U_'8VVLZ?<7LAG"6T5
MTC2.87"384')\MF56_ND@'!-><_&36S\'?A'ID6EZHGA32H;JQTNZU_R(W&D
M6CR+&]UAU:-2N0-\BLBE]S@J"#\N_"7XP?\ "&Z /#?A+XH^'5TEHO%KVMY>
MVMM:P7-S%?(\-ZLT41B:$1ROS;PF(%9"P;844 ^\9M8L+?5+;3);VWCU*YCD
MF@LWE432QH5#NJ9RRJ70$@8&Y<]14/B+Q)I'A#1;O6->U2RT32+1=]QJ&HW"
M6]O"N0,O(Y"J,D#)/>OB;Q%^U1XGT[P#::A9_%'1K"X?POKT\,VKPZ==&ZO+
M26 17$<]O*L-RA4R(C1)&K-N+Q@@PI<\2_%#^WIK+1M8^.<)ETWX@:3%!J-G
M)I,#21W%E'.(]K0NA19&D\O(+8&&:0KNH ^T]'UFP\1:5::GI5];:GIMY$LU
MM>6<RRPS1L,JZ.I(92.00<&G:IJEGHFFW6H:C=P6%A:QM-<75U(L<4,:C+.[
M,0%4 $DDX%?&6D_'SXA?;O$TGB#QWH.CZ!_:4=GJ<UE=PW-_X-C-U)$9)XWL
M(XK4,HB0"Z>XY)E!:-6Q9\4?$75?#MYXM\06OQHM+C4K?X:)>Z5J%S8V45GJ
M+17%R'O4@8!G.53#1R>23,C;&0HM 'V9'(DT:R1LKHP#*RG((/0@TZOD-OCU
MXEU3QRW]E?$.PMKZ.[\N3PI>VMK-:?V,VG^<NM!E"3M&)"K&3SA#C,> ^&KH
M/V3/C'K/CW5H+'7OB+I_C:]U#PAI?B V]M%:0_9)I'FCG6-(1NV?)%NWER')
MP5#!% /IRLN/PSID/B2;7X[1(M7FMELYKJ,E3+$K%D5P#A]I+;2P)7>X! 9L
MZE% !7+>.OAAX9^)$5H->TWS[JR9GLM1M+B6SOK)FP&-O=0LDT)8 *QC==RY
M!R"174T4 16MNEG:PP1F1DB0(IED:1R ,#<S$LQ]R23WJ6BB@ HHHH S=<\.
MZ=XDAMH=3MA>06]Q'=)"[-Y9D0Y0LH.'"MA@&! 95;&5!&E110 4444 %%%%
M !1110 4444 %%%% !1110 5PN@_"H:'XPN]:/BG7M1L9;F:]@T&^:U>SL[B
M0$/)&X@%P3AG 629U4.0J@!=O=44 %%%% !1110 4444 %%%% '--X+-QXU7
MQ!>:YJ5]! F+/19EMQ9V<I4HTT>V(2L[*6'[R1U 9MH7-=+110 4444 %%%%
M !1110 5Y5^S3_R3K5_^QS\6?^I#J->JUY5^S3_R3K5_^QS\6?\ J0ZC0!J_
M%OX>ZYXXE\'7_AO7M/\ #^M>&=:;5X)M4TN34;>;=8W=FT;Q)<0-]V\9@PDX
M*#@@UE?\(Y\;_P#HH?P__P#"#OO_ )<UZK10!Y5_PCGQO_Z*'\/_ /P@[[_Y
M<T?\(Y\;_P#HH?P__P#"#OO_ )<UZK10!Y5_PCGQO_Z*'\/_ /P@[[_Y<T?\
M(Y\;_P#HH?P__P#"#OO_ )<UZK10!Y5_PCGQO_Z*'\/_ /P@[[_Y<UEZU\-O
MBYX@GTV?4/&_P]N+C3;E;RSF_P"$$OUD@E *[E9=:!&59E(SAE9E(()%>TT4
M >5?\(Y\;_\ HH?P_P#_  @[[_Y<T?\ ".?&_P#Z*'\/_P#P@[[_ .7->JT4
M >5?\(Y\;_\ HH?P_P#_  @[[_Y<T?\ ".?&_P#Z*'\/_P#P@[[_ .7->JT4
M >5?\(Y\;_\ HH?P_P#_  @[[_Y<T?\ ".?&_P#Z*'\/_P#P@[[_ .7->JT4
M >5?\(Y\;_\ HH?P_P#_  @[[_Y<UFVOPZ^+UEK=]K$7CKX?#4[Y(XY[IO M
M^SE$!V(,ZT=J#+':N!N9FQEB3[/10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK10!Y5_P (Y\;_ /HH?P__ /"#OO\ Y<T?
M\(Y\;_\ HH?P_P#_  @[[_Y<UZK7A_[4'@T>/(?!&F6X\-ZOJT6L->6WA/Q>
M'_LW7T2"03P,RH^R:.)WFB<QR!7B!V'&Y #;_P"$<^-__10_A_\ ^$'??_+F
MC_A'/C?_ -%#^'__ (0=]_\ +FO%]&^/6M>'OAOCP-8VMA9>#_"8\4ZCHWBV
M634-0U2,7=Y%<65O=QS@"6-K*5?M3"X#FYMR5Y);0\1?M&_$32HG2*3PQ%=+
MJ7B:Q$=SI%QN9;"S>YMI-GVP$?<"2#)W;P5*8P0#UC_A'/C?_P!%#^'_ /X0
M=]_\N:/^$<^-_P#T4/X?_P#A!WW_ ,N:X[P[\4/BAKVI:/8MJ7@>SN;?1M,\
M3:R+O3[N&&>SO;B5&M[:7[2?+DMX[:7,SJZR-+#F*$$YC^#'QH^)?Q<UO5O.
MT+3?#?AZ\BEN-!U.]@MY2/LUZ(+F!X8M2>6=BA \PQVPA<%71R0" =K_ ,(Y
M\;_^BA_#_P#\(.^_^7-'_".?&_\ Z*'\/_\ P@[[_P"7-<Q^T3X,T7Q)\8/V
M?KF_T;2[_4(?%-ZEM=:A8I<&(KHNHSIC/.%FA@EP"/FB1@05!'E\/[4GQ:A\
M"Q:O=6_@N75+S1%U>SM8;&[2$^7J<-E(DDAN"R^:)@ZX5O)((/G]2 >[_P#"
M.?&__HH?P_\ _"#OO_ES1_PCGQO_ .BA_#__ ,(.^_\ ES7GMC\;OB-KNO2>
M!+6^\(:9XSBOM8B_MJ_TNY;3)EL8[&00+;B[602.-04[_-.%M9F\LYPMSP#\
M;/'WC^>S'_$AT"?Q'I>AZ]H&FW>E7$TL5K<;FOXII1=(LTD*(^&58@-T9*MO
M"T =M_PCGQO_ .BA_#__ ,(.^_\ ES1_PCGQO_Z*'\/_ /P@[[_Y<UXUX5_:
MA^)/B73_ ! +;3=#U"=;?0]6T:\M=-EABO+&_EO0Y@AFO$FNPJV+;),022@M
M(ELZB-9KF@_M4^.M>\60SVWA[1[KP+IEI8KKNM>;':VRRW.F1WHN8I9[I+E8
MO,GBA$)L'8[9#YF]3$H!ZS_PCGQO_P"BA_#_ /\ "#OO_ES1_P (Y\;_ /HH
M?P__ /"#OO\ Y<UE?LS_ !8\6?$RQ\30^,+:T2^TRZM_LMW9:7+IB75M/:Q3
M1R?9I;B>1 2S$>88Y"I4/#$P(KVJ@#RK_A'/C?\ ]%#^'_\ X0=]_P#+FC_A
M'/C?_P!%#^'_ /X0=]_\N:]5HH \J_X1SXW_ /10_A__ .$'??\ RYH_X1SX
MW_\ 10_A_P#^$'??_+FO5:* /*O^$<^-_P#T4/X?_P#A!WW_ ,N:/^$<^-__
M $4/X?\ _A!WW_RYKU6B@#RK_A'/C?\ ]%#^'_\ X0=]_P#+FC_A'/C?_P!%
M#^'_ /X0=]_\N:]5HH \J_X1SXW_ /10_A__ .$'??\ RYH_X1SXW_\ 10_A
M_P#^$'??_+FO5:* /*O^$<^-_P#T4/X?_P#A!WW_ ,N:/^$<^-__ $4/X?\
M_A!WW_RYKU6B@#RK_A'/C?\ ]%#^'_\ X0=]_P#+FC_A'/C?_P!%#^'_ /X0
M=]_\N:]5HH \J_X1SXW_ /10_A__ .$'??\ RYH_X1SXW_\ 10_A_P#^$'??
M_+FO5:* /*O^$<^-_P#T4/X?_P#A!WW_ ,N:/^$<^-__ $4/X?\ _A!WW_RY
MKU6B@#RK_A'/C?\ ]%#^'_\ X0=]_P#+FC_A'/C?_P!%#^'_ /X0=]_\N:]5
MHH \J_X1SXW_ /10_A__ .$'??\ RYH_X1SXW_\ 10_A_P#^$'??_+FO5:*
M/*O^$<^-_P#T4/X?_P#A!WW_ ,N:/^$<^-__ $4/X?\ _A!WW_RYKU6B@#RK
M_A'/C?\ ]%#^'_\ X0=]_P#+FC_A'/C?_P!%#^'_ /X0=]_\N:]5HH \J_X1
MSXW_ /10_A__ .$'??\ RYH_X1SXW_\ 10_A_P#^$'??_+FO5:* /*O^$<^-
M_P#T4/X?_P#A!WW_ ,N:/^$<^-__ $4/X?\ _A!WW_RYKU6B@#RK_A'/C?\
M]%#^'_\ X0=]_P#+FC_A'/C?_P!%#^'_ /X0=]_\N:]5HH \J_X1SXW_ /10
M_A__ .$'??\ RYKH/@]X!OOAKX'&C:GJUOKFI3:GJ>JW5]:636<+RWM_<7CJ
MD+2RE%5K@J 9&.%!)YKM:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *PO%W@
M/PU\0=+;3?%/AW2?$NG-UM-7L8KJ$_,K?<D4C[RJ>G50>U%% %&^^$_@C4_^
M$8^V>#?#]W_PB^S^P?/TN!_[(V;-GV3*?N-OE18\O;CRT_NC&=KGP#^&/BC6
M+[5]9^'/A+5M5OCF[OK[0[6:>X.PQYDD:,LWR$KR3\I(Z444 7;CX/\ @*\_
MX1HS^"/#DY\,E3H7F:3;M_96TJ5^RY3]Q@QH1Y>,%%]!0OP>\!1WVM7B^"/#
MBWFM2QSZI<#2;<27\B2"5'G;9F5ED <%LD, 1SS110!8\6?"[P9X^U#3+_Q-
MX1T+Q'?Z6V^PNM6TV&ZEM&)5LQ-(I*'*J?EQRH]*YIOV8O@X]ND#?";P,T"0
M_9UC/ANS*K%YADV >5]W>2^.FXYZT44 7;K]GSX6WVE7>F7/PU\(7&FW=[_:
M5Q9RZ#:M#-=[67[0Z&/#2[7<;R-V'89Y-=A<:#IEYK%EJUQIUI/JMC'+#:7T
MD"M/;I+L\U(W(W*K^7'N (#;%SG HHH X>']FWX1VZWBQ?"SP5$MZK+=!/#U
MH!.&(+!_W?S D G/4@5M-\(O LFNZ=K;>"O#K:SIMG_9UCJ)TJ W%K:[&C\B
M*39N2/9(Z[%(7#L,8)HHH 7P1\)? WPSDNG\'^#/#WA1[I52=M#TJ"S,RJ6*
MAS$B[@"S$ ]-Q]:ZRBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>aqb-20211231x10kg004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aqb-20211231x10kg004.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '5! L# 2(  A$! Q$!_\0
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M0/@GQ'_;4ECJ4[66B/-'J>H2V4T5K:/%GS%DF90H(V],\Y'J* /1J*XCP_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KQC]K^ZGL_@'KLMO/+;RK<V($D+E&&;R$'D'/2O9ZX3XV_#B?X
ML?#C4?#-O?1Z;+=2V\@N98S(J^7.DI&T$=0F.O>@#F?%'QPOH_&WB?PWX=LM
M)FG\-VD4][-K6H_95GFE0R1V\("G)V#)<\ L!BH_ /[1UEXX\1^&;?\ L_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<YXP^(?A[P"MJVOZFFG"ZW>3O1VW[<;ON@]-R_
MG71U\O?MP_\ 'CX1_P!^Z_E#0!]/HXD564Y5AD&G5#9_\><'_7-?Y5-0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5DZQXBCT6_TJU>QU"Z;4)S
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MU@309\=6DWDYQITR>=]G)QF2,[?-W8&<9V[><9R,8(!OT444 %%%% !1110
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M\DDT.Y6V,[,20"BD<\;1CI7>44 <?'\(?!L>B:OI!\/6<MAJY4ZA'.#*UT5
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M?Q*^)EA\-=&M]0NH7OO-U"TT\P6[KO1IY5B5B">@+ UUWG)M<[UPGWCGI]:
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M,?BGXV>-? /B;7-*O]1M=1L?"^N:0^H:A]D6-KC2;\O&?, X22*0#YEP&7'
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M74BFYE^39&%(4(@C4#8JK@8S@DFL%?V3_ ^WX=!EOF/@?BP)E3_2/G63]_\
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M@=JTJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *@:QMVO%O#!&;M8S$LY0;PA()4-UP2 <>PJ>B@ HHHH **** "BBB@
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M=H>HKMW9MY!MVJV?E/9OE/T/'K0!'X;3R_#NE)MV;;2(;=BICY!QM0E1]%)
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M6&_D0?ZUYY_T%S^\]W_X;(\<_P#/KHW_ (#2?_'*/^&R/'/_ #ZZ-_X#2?\
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MQ:U8^#M86=M1LK-H=5MUB79/(BY!$G)PV  3AAAL5Z[I5\^I:?%<R6=QI[R
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MZ_I?_0C7Z)5^=OQT_P"2M^*/^OZ7_P!"->_D_P#%EZ?J?B_BA_R+\/\ X_\
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M !X^$?\ ?NOY0T ?3=G_ ,><'_7-?Y5-4-G_ ,><'_7-?Y5-0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 <_K4>[Q5X<;R]VTW'S>7&VW]W_>8[E_X #GOQ705@ZQ&&
M\4>'G.W*FXQF.,GF/LS?,O\ P#KWXK>H **** "BBB@ HHHH **** "BBB@
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ME2:3]4:4XSK1YX1;7H;E%>=>(OBIJVB^([G2;7P/JVJB/YDN+=D"2K@989[
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M%=!7/ZT/^*J\.'&<&XYQ$<?N_5OG'_ /QXKH* "BBB@ HHHH **** "BBB@
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MWXH_Z_I?_0C7Z)5^=OQT_P"2M^*/^OZ7_P!"->[D_P#%EZ?J?COBA_R+\/\
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M9^"KJQ^%%OIEIX:L-2N;.:#283%#'>(VV92"!E@0,GH>,'%>D4 %?+W[</\
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M/74%S_:4L+DI^Y\O'#<]<#Z5F>3XQ_Y^;;\E_P#B:Z?S:/-H>'3BH\\M//\
M,%5LV^5:^1EWD>NMH]JMO+"NH _OF;&T]>G'TJGI\/BE;Z W=Q;M;;QY@4+D
MKW[5T'FT>;3=!.2ESRTMU_KYB56R:Y5]QYYX@\#Z!\2/'4\7B'3(M12Q@*0;
MV92H)4GE2.Y/6G_\,X?#C_H6+?\ [_2__%5U>FZ-Y'B2]U'[0C><NWR1]Y?N
M]?R_6M^NO"5L1"#4IO=VUZ7T/&QF4Y9B*OM9X>$I-*[<(MMVZMH\[_X9Y^'/
M_0IV/YO_ /%4?\,]?#G_ *%.Q_\ '_\ XJO1**[/;UOYW][.7^QLL_Z!:?\
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M+^*'_(OP_P#C_P#;6<'1117UA_-X4444 %%%% !1110 4444 %%%% !1110
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M\-"?#K_H;+'_ ,>_^)H_X:$^'7_0V6/_ (]_\31]7K?R/[F']LY9_P!!-/\
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M[7TV6V>'NN[/$QEU5L^R"BBBO5.$**** "BBB@ HHHH **** "BBB@ HHHH
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /7?V5?\ DM6B_P"Y<?\
MHB2OO&O@[]E7_DM6B_[EQ_Z(DK[QKX_-_P#>%Z?JS^G?#+_D35/^ODO_ $F
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M[0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"OSM^.G_ "5OQ1_U_2_^A&OT2K\[?CI_R5OQ1_U_2_\ H1KW\G_BR]/U/Q?Q
M0_Y%^'_Q_P#MK.#HHHKZP_F\**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ]=_95_Y+5HO^Y<?^B)*^\:^#OV5?^2U:+_N7'_HB2OO&OC\W
M_P!X7I^K/Z=\,O\ D35/^ODO_28!1117B'ZV%%%% !1110 4444 %?+O[<7_
M "#_  C_ +]U_P"T:^HJ^7?VXO\ D'^$?]^Z_P#:- 'RH:T/#FG)K'B+2K"0
MXCNKN*!CG'#.%/\ .L\U):W4EC=0W,+;)H761&]&!R#^8K])=W'0_@Z$HQJI
MS5U?7[ST?]H/Q!=:A\3M5TX2-!INCN+"RM(R5CAC10/E7MD\YJA\/]!N/BKX
MJ6/7M5NFT[2]/DN;JY9S)+':PC.Q,_7 ],UUGBH^ _B]J \2R^*5\':S<HG]
MHZ?=V<DT;2A0#)$R=CCH:S/"?BKP?\/_ !]/%87.H:GX7OM-DTO4+R6()*WF
M##2QIV4$+@'G&:\V,FJ/)"+4DNWZGV]>C"IFKQ6)K1E0J5+_ !K5-WC>*?,D
MM$[I<JT+GAW1? ?Q4FOM!T+0+[PWK2VTMQI]U)?M<+<M&I;9*I&%) /*]/YU
M?"/AGP=9_!^3Q=XBL;R^O(=8:RBMK:<QBX_<AEC8_P "@[F+ 9XQ5WPW/X-^
M$-U?^(-/\6+XIU7[++;Z99VMG)%L:12OF3,^ , GY1SS7-GQ-IO_  H5?#_V
MH?VQ_P )#]L^S;3GR?(V[\XQ][CKFE:4G:#?+==[];[ZVV-N;#T8^TQ,:7ME
M"IHN1Q^SR:1]QROS:;M6O<Z2;PIX(FN? /B9+"XL?#6N74MC?Z9+=,_V>1&"
M[UE^\5^8-SSQ5+PS\*;2T^+'B'2/$*2/H7AV.YO+UE<H9(4&8\,.1NW)T]ZP
M]>\1Z=>?!SPGHT-R'U.SU"\FG@"D&-7V[3G&.?8UVOCOXKZ)K/PMC:RE)\8:
MY!:V6M#:>(K;=ALD8^<[.AZ#VI?ODN57UNO371_=?7T'&665).K44$Z:A4LK
M)2;IKFA9:?Q.7W=DG/1#/#?PNL=/\%:3K]SX+UCQI=ZT9)HK.PEDC@LX V%W
MN@)+MV'3C\[MM\$M&C^,7A32KFTOH-!U^QDO?[/O6*7-JPC<F-R,'Y64'/<5
MEZ7XMTOQIX!\/Z3/XRN/!6M:&CVP9O.-M>0EMRG,?W67IR*9X'\1Z#X-^-&@
MZC=>,9_$.G6L$HN-4N(90J.T4@V(&RQ7)7G Y-9OVWOZN_O=_E;I]QWT_P"R
M[X5>S@Z;E2O)RIJVL>?F7QM?$FI>ZMU96$T?P]X!\=1Z]H6AZ7J%AJ6G6$UY
M9ZS<798W9A&6$D.-J!ATV\BMS2]?\+6_[-]G)?>%IKVT76Q%+;KJ3Q^9<>1S
M-N X!'&SI7 ?"'Q-IOAOQ3K%WJ5R+6WGTF]MXW92=TCIA%X!ZFM3P7J7A_Q%
M\)KKPAJ^OQ>'+N'55U**XN('ECD3R]C+\@)W#K[U=2FT[.[2:?7Y_P!=#CP&
M,IRI\\%3C5G"I&UH):<KC=/1=5=_%;5LJR^![35/AGX2O=/A=-6U?7)[ ;YF
M9 I*A!CH,$]0,FMS4['X8^$_%C^$+[1-2U)[>86=WX@6_,;I+D!V2$#;M4D\
M'DX_/(_X3G3]'^&O@ZUL;I;G5]'UZ:_: HR_(""C$XQAL=,YK<URS^''BKQE
M+XQE\8/8V-W/]NN]$>QD:[$A.YXE8?*03GYLX&:;<[^_>VNU^^FWEMT)IQPW
M(GA?9.I:E?GY+<O)[UN;2_-\5O>73J+HOPC\/:%K'Q)L?%3W4]OX:BAEAN+,
M[9&5GR,+TRRE1SD#<3VK#U[0?"OBCX:ZCXH\-Z1<>'KK2+V&VNK26[:YCFCE
MR$<,PR&R.1TZUI2_%33_ !(OQ9U"^D^Q7/B"WA2PMF!8L$D "Y QD(!GMUKF
MO#OB/3K'X.^,]&GN1'J=_>64EM;[3F149BYSC Q[FG%5OBDW>\?397_4BM4R
MVWU>A&'LW"L[M+FNI5'3]YZIV4;+1M.SOH==\/\ P]X/\63:3ID'@#Q#J%O=
M&."Y\0?:9!Y,C8#.J(OE[%8GJ2<=:9\/-$_X1F^^,6D>9YWV#0[VV$F,;]DH
M7/XXKK#\0O#5_KGAK7(OB#>:%H&GQ6RGPM:P3*R.F-R?+\C*Q&2QSQD5Q>F^
M.-$M_%7Q=NI+Y5M]:L;Z+3WV-B=GF#(!QQD<\XK']Y/FT=M._?S_ $T/4E'!
M8:5&2G#F3DN9>S5XNF[.T7>U]N?WN_8\?KZ^_8E_Y%'Q)_U_I_Z+%?(-?7W[
M$O\ R*/B3_K_ $_]%BM<T_W5_(\_P^_Y']+TE_Z2SZ0HHHKXH_K$**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLZ^\1:7I@/VK
M4+:#'4/*,_E3U>Q,I1BKR=C1HKC+[XM^';/(CGENV_Z8Q''YG%<YJ'QQZBQT
MKZ-<2?T'^-:*E-]#@J9CA:>\U\M?R/5J1F"J2Q"@=2:\&U#XL>(K[(2XCLT/
M:",9_,Y-<U?:UJ&J-F[O;BY/_320D?ETK58=]6>;4SNE'^'%O\#Z$U'QKH6E
MY%SJENK#^%7WM^0S7+ZE\:M)M\BSMKB\;U($:_F>?TKQ? '08HK94(K<\NIG
M6(E\"4?Q_K[CO]2^,VLW61:06]DO9L&1OUX_2N5U+Q5K&K9%WJ5Q*I_@WE5_
M(8%95%:J$8[(\NIBJ];XYMA[]Z***LY0HHHH **,@5<L=&O]38+:65Q<G_IG
M&2/SH'&+D[)7*=%=EIWPF\0WV#)!%9(>\\@S^0S73Z?\#XEP;_4W<]TMXPH_
M,Y_E63J074]"GEV*J[0:]=/S/)JEMK6:\D"6\,D[G^&-2Q_2O>]/^%_AS3\'
M[#]I<?Q7#%_TZ?I726]K;:?"5AABMHE&2$4* /PK)XA=$>I3R2H_XDTO37_(
M\%TWX8^(M2P?L/V5#_%<L$_3K^E=7IOP/Z-J&IY]4MD_]F/^%>H6EY;W\(FM
MIX[F$\"2%PRG\13XYHYMWENK[6*MM(.".H/O6,JTWY'JTLHPL-97EZ_\ YG2
M_AGX>TLJRV(N9!_'<L7/Y=/TKI88([>,)%&L2#HJ* !^ I5FC:1XU=3(F-R@
M\C/3(J.ZOK>R"FXN(H W3S7"Y_.L7)RW/5ITJ=%6IQ2]">BH+6]M[U6-O/%.
M%."8G#8_*IZDV"BBB@ HHHH **KW6H6MEM%Q<PP%NGFN%S],TZVO+>\4M;SQ
MSJIP3&X8#\J )J*KQZA:RSM ES"\R\&-9 6'X9J66:.!=TCK&N0,L<#)Z"@!
M]%5)M6L;>0QRWMO%(O5'E4$?@33K?4K.\<I!=03N!DK'(&./7@T[,5RS15>W
MU"UO&98+F&9EZB-PQ'Y58I#"BF+-')(Z*ZLZ8W*""5STR.U/H **X_6OBEHN
M@_$KPUX&N!<MKFOVUU=VGE1AHECMPID,C9^7.\ <')KG_C!^TAX'^!]]I-AX
MDOK@ZGJDL4=O8V-LT\H6201+*^.$CWD#<Q&3P,GBM%3G)I);D.I&*;;V/4**
M**S+"BBB@ HHHH **** "BBB@ HHHH *_.WXZ?\ )6_%'_7]+_Z$:_1*OSM^
M.G_)6_%'_7]+_P"A&O?R?^++T_4_%_%#_D7X?_'_ .VLX.BBBOK#^;PHHHH
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M_BG_ +#EI_Z :[SXA?%#6O!/B3P7IVB?9K&";2-.DO&6!&>\#*%V2$@Y0*,
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M'N"I";F;@ '!.?2FE=V$W97/$?"<W_"[_P!K#7/$)/G^%OAG"^B:;WCDU:8
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MI_PB^M_] :[_ ._+T?\ "+ZW_P! :[_[\O1_:>%_F_!A_P 0_P"(?^?*_P#
MX?YF716I_P (OK?_ $!KO_OR]'_"+ZW_ - :[_[\O1_:>%_F_!A_Q#_B'_GR
MO_ X?YF716I_PB^M_P#0&N_^_+T?\(OK?_0&N_\ OR]']IX7^;\&'_$/^(?^
M?*_\#A_F9=?8?[%?_(FZ[_U^+_Z!7RA_PB^M_P#0&N_^_+UZQ\'_ (K>)_A'
MI%[86_A&6^6YF$I>19%(P,8X%<&.QU"O0<(/73HS[+A'A'.,IS>GB\732@E*
M[YHO=-+1.Y]Q45\N?\-8>+_^A$/_ )$_PH_X:P\7_P#0B'_R)_A7S!_0!]1T
M5\N?\-8>+_\ H1#_ .1/\*/^&L/%_P#T(A_\B?X4 ?4=%?+G_#6'B_\ Z$0_
M^1/\*/\ AK#Q?_T(A_\ (G^% 'U'17RY_P -8>+_ /H1#_Y$_P */^&L/%__
M $(A_P#(G^% 'U'17RY_PUAXO_Z$0_\ D3_"C_AK#Q?_ -"(?_(G^% 'U'17
MRY_PUAXO_P"A$/\ Y$_PH_X:P\7_ /0B'_R)_A0!]1T5\N?\-8>+_P#H1#_Y
M$_PH_P"&L/%__0B'_P B?X4 ?4=%?+G_  UAXO\ ^A$/_D3_  H_X:P\7_\
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M (:P\7_]"(?_ ")_A0!]1T5\N?\ #6'B_P#Z$0_^1/\ "C_AK#Q?_P!"(?\
MR)_A0!]1T5\N?\-8>+_^A$/_ )$_PH_X:P\7_P#0B'_R)_A0!]1T5\N?\-8>
M+_\ H1#_ .1/\*/^&L/%_P#T(A_\B?X4 ?4=%?+G_#6'B_\ Z$0_^1/\*/\
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M#T(((KY]_P"&L/%__0B'_P B?X4?\-8>+_\ H1#_ .1/\*:;B[H32DK,]$\
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M_P#OR]'_  B^M_\ 0&N_^_+T?VGA?YOP8?\ $/\ B'_GRO\ P.'^9ET5J?\
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M73;26\E"]2L:%R![X%>;?#R/X@>./ >B^++KQ5'I.J:LD6I1Z0NGQ2V$%O(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<@$(ZC:&(3)*JS$+G@5SE]^S#X6O=/M]+&I:[;Z#;:H=8@T>&^ M8K@R^:2
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MII;:///J%TK 6Y(.U%5%"$$=AW)ZDFK"?!/PY'X7\$: #>?8/!]W;7NF_O\
MY_,@5EC\PX^888Y'&: /G+XJ>(/%GQ6_91\8^-KGQ&;.QN+R>--!2TB\A;**
M\\A8RY7S/-)3>7W8R<;<5]5^'_%MKJUPEC%9:I#*D?,EUIL\,1Q@<2.@4^V#
MSVK@?$'[+OA'Q%I&KZ-+>ZY:>']3O'U";1K._,=JMPS!F=5VY +#=LSLW$G;
M7KL<8BC5%Z* !^% #J*** "BBB@ HHHH **** "BBB@#.\2?\B[JG_7K+_Z
M:\!^"_B1?#_[-/PJ5O%EGX7^TZ<BCS;07-Q<D G;"F[J.I^5N/3K7T1?6BW]
MC<6KDJDT;1LR]0""./SKRO3/V=M.\/:=X'31==U+3M2\(V,VG66H;896D@E
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MBS%,/-+%@Z*.&+1@D!">PKW?2/@E]F^(FC>--6\6:SK^L:59S6$"70A2#RY
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MA(R*EO+&VU"'RKJWBN8LAO+F0.N1T.#WJ>BB[$1QV\44DCI&B/(0795 +$#
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M?!11X@1YQXM13K 2+ ;[//\ -M^Y[8KB=8D;2=%_::TG[='XG,VAMJ=QXEC
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I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>aqb-20211231x10kg005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aqb-20211231x10kg005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %# E,# 2(  A$! Q$!_\0
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M5;[R[#ZCI32IC.5.W/?L: %\[=Q*N?\ ;4<_B*:RJR@]5[,*7=NZ_*?4=/\
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M 1ZJ>HH F9F5L_==>]/#"0%EX(^\OI[_ $J!9. &.5[-Z>Q]J5B58?PL.AH
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MQZ+_ %/M0!+Y@CP2,D_=7U]_I3<F1LD[G/>H1EV))RQY+&D:3(PI(7NW=O\
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M12^<6X) /KV-,"AB,?*WUI?9N#ZX_G0(>LC)\I&5]/3Z4[S&&&5OHWI3 "N
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M_&E7'0?,:0#_ #&8#/ ].U D;/R\>_>D*\_,<FI%0LN#PM #0W7G)IP#'[W
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M#%847Q9^%DC%+*VCNGS@*MC*Y8^V11>P;FW'XP\.W#I&^JZK>.QVB.$A,GZ
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MQP:R;[]IIY"3:?#;PE;'^%KJ.6Y8?BQH%S'=-XR\;0R8U%-$NH6R2TSHV#]
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M.YU>F_ ;X432G^S=6UF]0' #Q>>/^^D'2G:7\$_!%K));OI&MZKR5$YU.:V
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MR6Z].U0:A<6=K<2W%Y>SZS.S8"68V)@#&#(W4?04"N=IH.GZ3<W<C:VJRP%
ML7V5A'ND/ W,OW5]\50US6[G1]0MK&/0[?0;V4-Y=X +@L@X#"1\@@CNM<U;
MZY!-X=U*?[-_9Z1W$$05LL3D,>6/7I72>#=>BA\/FRU*U76-$:<Q&R9MLL)9
M0V^&3^!N>G0]Q2"YFW%BNI3!KKSM3N.S3LS\^PZ#\*ZK2_A+XVO$4V/@G4A$
M1D2-:E$/TKK_  ZMK\.UN;V+0].\>^'H)?+EDG+QWFG-WCE"GY3_ +6"I]:]
MX\$_M(?#N]MTB:2^\)7&P*OG(984^C+GCZBE9=2M3YITWX-^/6U(0R>%YO,<
M[/+FMBP'/7[PKMU_9/\ BI>6TL\&BZ?$@;"1R11^8WOMW'BOKO0_%^B^(%WV
M/B>UUD[1M-K*A8^V."*Z6UU:"/8XM8DG#9!D8HWXU3:Z(?*^Y\'7_P"SI\48
M9!'+H-A"_0L+.$*/_'JHZQ\(+CPK;1GQ/XAT_1KF1"XM#I49=OH^XBOO?6KJ
M^UKS(SIUK/'R5\\[AG\*Y5?#-S/(!<^$?#DJ'J9HRV/S!J"K'PK;_#WX9W%T
M&O\ XR0Z4S<R0OI9//<*5R*N77PA^'LEFUQI_P <]"8J.(;G3Y@S'V(&*^W[
M3P?X9MV>&Y\&:/,,\B),@9ZXRF:Z"STWX=Z:S30^$;>QOQ&8MXC5E ]0I7%
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M[I]Q-+<7ES-)<1/'8*X4Q9X#S'N=O0#H6/M02>@:K^S3X>US1Y-/N?%L'EW
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MI;1$26VB\P;54G''I3%8]Q\6_P#!.W3?%&N1ZDWQ!:!DC$?EBQW9QGG.[WK
MO/\ @G#I5MR_Q'V?6P_^RKP#XE?M ?$O1_%<"6WBC4;2PDB 0(XVLPZ]NM<S
M-^T9\29"0WC'46&?XF!_I2'H?3T/[ .AV\6I(?B0I%Y;_9]PL?N?,&S][GI7
M2^#/V./"/@59X[;Q6FH07(3[0E];!P[IDJP'08)!'TKXIU']I[XB^&]<TJ\'
MB:\NK:&8236LF"DR \J>.XS7VAHOCRY\37#7VGZB7TRZL+6\MR.0-^_/\A^5
M24K'<R?!K2V\Q#XEA,;1^7L6$@#D$<?A65'\$K33]2@O[+Q9'!=PN75O()&#
MP5(SRI'!%<SJ'B;7?M^F64%U.WE&:=IDVXDAP-ROW)1N1CL3Z5<NO$FJ3;3;
MZA)\H)88&*DLU-8^!NDWEQYEKX@CM4WLXB\DL%R,8'L#TK"U#]G6.XN+:XM?
M&"VES"21*ML23G@CZ8X([YK1B\1ZQ:^$CJ N3/)]O,,BN0"T1CR54]CW!]:^
M?_\ A)?B;X/^)UC:7?C/4-7\)ZS,HTZ[D5<J"QW1/QPZ],=^M&@'L&N?LEZ9
MJ5TUYIWB&'3/-4&>W2W)B$G=H^<JIZ[3TKK?AC\&+3X9^'=9LX-<CNKW5)D:
MYO#%MS"HXB'H,\UX7\+?'GC[XB>-K31HO%$RQF=WG,@4_N4/S #'4CBO2="^
M*,_C+XO,MGJ;V&GV,LEK=Z)-MP\2943Q'')/\2]1UI@K&MXN_9[7QQ/:-#X@
MAM3:H5VM&6!!.:K^'?V9]1\/-(L/BNTGLY>+BQN+<M#,ONN>#[CFN2_:#^*F
MLZ1XHL(-!U.33[,6Y^6$ ;SG[QKS!?C)XS?KXANS^(_PI [7/<]<_93LVO'E
ML/$=OI]NW/V>8;]A] WI]:I0_LFSW !B\46C@G (B./YUP/P^\6:WXJOM635
M-2FO(HK!W D/"MG@UU'AGQ_9S6Z>%M9\07?AB[5=UEKEO\\.X]$G7^[_ +0Z
M4M1Z6N;8_9'NMVW_ (2>US_UQ-,?]D>]5L#Q+:G_ +8FN,\?:G\4?ACJ$,&L
MZK<I#<J)+2_@<26UTAZ-'(!@_3K7*M\9/&??Q!=?F/\ "GJ*Z/7O^&0;_:2?
M$MH%')_=&NE^&_[,]MX.\50:MJ]_;:W';C?%;;=J%^Q;VKRSX3^*_%WQ"\:0
M:=<^*+JWLH4:ZN.A9XTY**/4UD?$;X[>)-6\57ITN\ET;3K=S!!:Q$9VJ<;F
M/=C2U'IN>RZ_\ /$'B_X@'Q5J_B>VN;C[2DPA6,A4C5LK&O/  &*Z?4_@T+_
M .(%CXF-_;0K;V\D36O9G;/S9[=:^</AK\3_ !9JWQ T"SN=;NKBVGNE26%B
M,.O<5[3;>)KG5OC[<:+'<R1Z,FEF0VY^Z),_>HU&K&-XJ_9&O/$FN3WZ^)[.
MV27 $90MC ]:S/\ AA^^+ ?\)A8\_P#3(_XUY?\ $_XJ>)]-\?Z[:6&N7$%G
M;W)BBCB("@#TKDW^,GC3_H8KS_OH468KH]X;]AO4%./^$OT\_P#;(_XTC_L.
MWZJ/^*PL3_VR/^->"?\ "Y/&@_YF.\_[Z%*OQE\:#_F8KS'^\*5F*Z/>O^&(
M[R,9?Q?8@?\ 7(_XU<M?V(Y)%W/XULE Z8A/^-?/'_"WO&,A&[Q#>-[;J>OQ
M7\6]]>NB/3<*0[H^D5_84%U"67QW99/8P?\ UZSM4_X)NMK3QO\ \+!LHFC3
M Q;YSSGUKYYN/BQXL7D:]=CZ-7)ZY\;O'$>H%(_$U\BJHX5\4T@NC[9^&_[
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MPQS\5;B>4Q:#"(R[%2UV@R,G'>GU![(X3PC<?\2IE_NRFMM9"&'^<UZ#X?\
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MG:X_8O\ B[:RLLGAV MDYVWL9'7ZUHB&M$>+!J*]E_X8[^+/_0MI_P"!<?\
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M[I9M:CM;B749(% C1=Q$6_'\1[?2O!?!.K6/A7XI^&[^]E,5G"UP)&(Y),1
M4>Y)P*]8^#6E7/A;P)I%L8O*O/$.HWDETLJ_O,QY\M"?0 ]*!H^3OVG"MO\
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M[(?AO!_XKEO^_"U"W[(7AS/_ "/1_P"_*T7'RL^6JD6OJ#_AD+PTN-WCIO\
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M\OXO>*1TW7>_\U!KW&Q^%>G_  HMWET[Q(NIR7DJ*RR1[ NWD&D\1?L]Z/\
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MF1(-KLEA:!?P#&OA-5.:_6?XI?LY^%_B;X$LO"5_XW72[.TGCG6:#8Q8HNT
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@N_K112&+:_*XQW'-:$+%9, \444AFE'R@)HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>aqb-20211231x10kg006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aqb-20211231x10kg006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #2 F(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4B<5&TH7
MK1*VT9J&W*W#2!AG&*8#C<"E^T+3OLL1_@_6C[)#_<% M1OVA*/M"4[[)#_<
M%'V2'^X* U&_:$H^T)3OLD/]P4?9(?[@H#4;]H2C[0E.^R0_W!1]DA_N"@-1
MOVA*/M"4[[)#_<%'V2'^X* U&_:$H^T)3OLD/]P4?9(?[@H#4;]H2C[0E.^R
M0_W!1]DA_N"@-1OVA*/M"T[[)#_<%'V2'^X* U&K<"G></6C[+$H^Y6=>7 A
MN@@P!\OZT :#7"CO31<+4GV6+^Y2?9(?[E #?M"4?:$IWV2'^X*/LD/]P4!J
M-^T)1]H2G?9(?[@H^R0_W!0&HW[0E'VA*=]DA_N"C[)#_<% :C?M"4?:$IWV
M2'^X*/LD/]P4!J-^T)1]H2G?9(?[@H^R0_W!0&HW[0E'VA*=]DA_N"C[)#_<
M% :C?M"4?:$IWV2'^X*/LD/]P4!J,^T"GK,*/LD/]S]:CNXT@MI'5<$"@"0S
M#UIIN!5;3V6Z60L-VTC%6_LL1_@_6@!OVA:/M"4[[)#_ '!1]DA_N"@-1OVA
M*/M"4[[)#_<%'V2'^X* U&_:$H^T)3OLD/\ <%'V2'^X* U&_:$H^T)3OLD/
M]P4?9(?[@H#4;]H2C[0E.^R0_P!P4?9(?[@H#4;]H2C[0E.^R0_W!1]DA_N"
M@-1OVA*/M"4[[)#_ '!1]DA_N"@-1OVA>U"W IWV2'^X*!:Q#^#]: #SAZTA
MN!5"\G$-YY8X'R\?6M#[/$V?DH 8+A>]+]H2G?9(?[E'V2'^X* U&_:$H^T)
M3OLD/]P4?9(?[@H#4;]H2C[0E.^R0_W!1]DA_N"@-1OVA*/M"4[[)#_<%'V2
M'^X* U&_:$H^T)3OLD/]P4?9(?[@H#4;]H2C[0E.^R0_W!1]DA_N"@-1OVA*
M/M"4[[)#_<%'V2'^X* U&_:$I/M I_V2'^X*/LD7]S]30&H+,&Z5*K9J"=4A
MA9@,?_KHADW"@98HHHI 5KH_(:\%_:"^,GB#X5W6CKH?V7%ZLIE^TPE_NE<8
MY&/O&O>;O_5U\F_MD?\ 'YX8_P!RX_G'7T&0T:>(S"G3JQO%WT?HSXGC/%U\
M#D=?$8:;A-<MFMU><5^1S?\ PV!X_P#^H7_X"'_XJC_AL#Q__P!0O_P$/_Q5
M>(T5^M?V/E__ #XC]Q_,_P#K5GG_ $%S^\]N_P"&P/'_ /U"_P#P$/\ \51_
MPV!X_P#^H7_X"'_XJO$:*/['R_\ Y\1^X/\ 6K//^@N?WGMW_#8'C_\ ZA?_
M ("'_P"*H_X; \?_ /4+_P# 0_\ Q5>(T4?V/E__ #XC]P?ZU9Y_T%S^\]N_
MX; \?_\ 4+_\!#_\51_PV!X__P"H7_X"'_XJO$:*/['R_P#Y\1^X/]:L\_Z"
MY_>>W?\ #8'C_P#ZA?\ X"'_ .*H_P"&P/'_ /U"_P#P$/\ \57B-%']CY?_
M ,^(_<'^M6>?]!<_O/;O^&P/'_\ U"__  $/_P 51_PV!X__ .H7_P" A_\
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MY!HH^IX?^1!]=Q'\[/K[_AZ9\;_[WAO_ ,%;?_'*/^'IGQO_ +WAO_P5M_\
M'*^0:*/J>'_D0?7<1_.SZ^_X>F?&_P#O>&__  5M_P#'*/\ AZ9\;_[WAO\
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M8C/9(98V(+$K]H5D& 1Z"J^NPUNG9?\ !_R_(GZE/357?_ _S/BZO;?V*?\
MDZ?X=?\ 80;_ -%/7CVL7T.IZO?7EM9QZ?;7$\DL5G#G9 C,2L:Y[*"!^%>P
M_L4_\G3_  Z_["#?^BGKHK_P9^C_ ".:A_&AZK\S]%?VIO\ D)Z!_P!<)/\
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M#2?*[?</V>)C[RO]YP=O\<O'-OJWB_4V\03W-_XNM7LM;FNHTF-Y"Q&58.I
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MF_[]M_A7ZA^4G]Q?RH\I/[B_E7VG^N+_ .?'_DW_  #\F_XA7'_H,_\ )/\
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M<?\ /O-_W[;_  H^QW'_ #[S?]^V_P *_2[RT_NK^5'EI_=7\J/[1_N?C_P
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M6L_\@NX_W?ZU=JEK/_(+N/\ =_K36X&=X:^Y<?[R_P!:W5Z5A>&ON7'^\O\
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MD>R:[5!'CD;492Q(Y(XQG !['17D^D_%K4X?#/C36]5L+9WTF_AMX;&UO$9
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M$U"UDR4N86"OY9VN#A_[OU]J6\OK;3XUDNKB*VC9E0/,X0%B< 9/<GH*^=_
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M7[Q^M<SK7_(;'_ *Z9?O'ZU3V0A]%%%2,**** "BBB@ I,#.<<TM% !1110
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M$_+TH \\;XZ7EQJ5Y;67A.YFA74?[+M;J:X$,4TPN/(;<2AVX(+#&[*@YP<
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M<  =A3Z "BBB@ HHHH **** "BBB@#EM:_Y#8_X!73+]X_6N9UK_ )#8_P"
M5TR_>/UJGLA#Z***D84444 %%%% !1110 4444 %%%% !1110 4444 5=3_X
M\9/P_F*AL?NBIM3_ ./&3\/YBH;'[HI]!=2[1112&07?^KJMH_\ K+GZK_6K
M-U_JS5?2?]9<?5?ZT^@C2HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!K_=KEM:_Y"Z?1*ZE^E<OK"YU9#[)51W$SJJ***D84444 %%%% !1110
M4444 %%%% !1110 4444 %4M9_Y!=Q_N_P!:NU2UC_D%W'^[_6FMP,[PU]RX
M_P!Y?ZU1D\93Q^)3IX@A*"Z6U\C<?M+!D#>>%Z>6,X_ \]JO>&Q\EQ_O+_(U
MN!1G=@;NF:'N)'G7Q:UWQ#HFJ>%GT!W?;<3W%W8I&&^VPQPLS0Y(X8C)4C'S
M*HZ$UQ&@?'+5KOP_HMDCPSZSJ=M;2VLMQ"WFRQRV\\AF\L8X5XT7''7!Y(KW
MVC:,YP,].E(9XEX=^)WB37M+L99)K"YMU.CQO=V2.C3S7+Q^8>I4(N6!7J3G
ME<5FZ+\8]?@T:QN+^_TV2[FM[:*ZU*>-X[*RD:>Y1VEC#<%?)5#\R_,RYQ7O
MX4+P  /I2>6I!!48/48ZT >):;\;O$4ZQ:A?:59V6DA$29!',\X=K*2Y\Q0.
MJ?N^%QN(<=".=#X6_$C5/'WBBUDN2L=LEK?Q,EN,0S-'/;A)0-S8.V1A@,>_
M/IZ]@>E"J%P  !["@#PGPI\<?$?BVYL+6SAT666]GMXS/"LS1V6\7!>*49^:
M4"!6 RH^?GC!-74/BIXF\8>7IMC<6>G&;4;-)VLTE\^P1KT0O;3G<,2LHW9&
MW #<8PQ]WTW2[31[&&SLK>.UM81MCBC&%4>@JSM S@ 9.3Q0!\\R?&'Q'HD#
MW4,0N3=+:PH=2E M[4E[W+NS%!\WDQIRPY*]>A]ZT6\FU#1[&ZN8D@N)X(Y)
M(HY/,5&902H;^( GKWJVRJP(*@CT(IU !1110 4444 %%%% '+:U_P AL?\
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M4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4"BB@ I*** %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *3N*** %H/WJ** "BBB@ HHHH **
B** "BBB@ HHHH **** "BBB@ HHHH %IPHHH 6BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>aqb-20211231x10kg007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aqb-20211231x10kg007.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &* _0# 2(  A$! Q$!_\0
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M-'_"W=/_ .?*Y_\ '?\ &M?J]7^4S]M3[G>45P?_  MW3_\ GRN?_'?\:/\
MA;NG_P#/E<_^._XT?5ZO\H>VI]SO**X/_A;NG_\ /E<_^._XT?\ "W=/_P"?
M*Y_\=_QH^KU?Y0]M3[G>45P?_"W=/_Y\KG_QW_&C_A;NG_\ /E<_^._XT?5Z
MO\H>VI]SO**X/_A;NG_\^5S_ .._XT?\+=T__GRN?_'?\:/J]7^4/;4^YWE%
M<'_PMW3_ /GRN?\ QW_&C_A;NG_\^5S_ .._XT?5ZO\ *'MJ?<[RBN#_ .%N
MZ?\ \^5S_P"._P"-'_"W=/\ ^?*Y_P#'?\:/J]7^4/;4^YWE%<'_ ,+=T_\
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M_'?\:/\ A;NG_P#/E<_^._XT?5ZO\H>VI]SO**X/_A;NG_\ /E<_^._XT?\
M"W=/_P"?*Y_\=_QH^KU?Y0]M3[G>45P?_"W=/_Y\KG_QW_&C_A;NG_\ /E<_
M^._XT?5ZO\H>VI]SO**X/_A;NG_\^5S_ .._XT?\+=T__GRN?_'?\:/J]7^4
M/;4^YWE%<'_PMW3_ /GRN?\ QW_&C_A;NG_\^5S_ .._XT?5ZO\ *'MJ?<[R
MBN:\,^.+7Q/>26T%O-"T<?F%I,8QD#L?>NEK*490=I(UC)25T%%%%04%%%%
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M***XSJ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=^.O_0RV7_@IMO\ XBOF2BCZM0_D7W![>K_,_O/IO_AX[\=?^AELO_!3;?\
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M!FKFE?L__$W7-+BU+3OA]XFOM/E3?'=6^DSO$Z^H8+@BJ='#M.71[Z_\'?\
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M#'(>@"E@3]0*W52$M5)='\F[+[WH9NG-7O%]OG:_Y:G 45]:_&#]@'Q)\*_
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M:Z/POJOB#X;ZYHOBNQMIK*XMYA<65U<6Y\J1E]-PPP^E=WU-<W,Y?A_?Y_\
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M_#]EK\^H:#XBT&ZN%M?[3\/WQN8(I&. ')1<<G' ->^?!_6? OPU\;?%_P
MZG\1-!DM/&MGYUCXGT^Z#6<#%YCY3R] V'!/..*R/&>O^#?@C^S,_P -+'Q]
MHWCO6]8UB"Z>;1;D3V]K$DJN27' .%[^M:PK5>>G'=/DZ;W?O>G*O\S.5*G:
M;VMS==K*Z];O_(Y?_AVW\3OMCV?]L^$Q?&'S[>T.I.)KI=N3Y:&+)QT)( SW
MKD_''[$?C_P'\/\ 4/%=Y>:#>Q:8!_:.FZ??F>\L20#B50NT$9' 8]:^DO$G
MQB\(3?MR>$]>A\9Z0_AV#1Q#+J*:C&;6-O*P5+[MH.>V:\X^&_Q)\.6W@/\
M:5M[_P 3:='<:Q=S/IL5Q>H'O 9F(,0+?/QC[N>,5BL1B>3G\K[?WK6^:U-8
MT:'M(TWU:5[]XWO\GH>7?#7]C'QK\2/"%CXD.K^&_#%AJ+F/3D\0ZC]FEOB.
M/W2A&SSQS@TWP1^Q;\0_'/BSQ5X<MQIFG:MX<VF[AO[AD#AC@,C*C CODD<5
M];?#W]H33O%/P,\"6GA?XC>!O!&KZ'%]FU*Q\91Q[SMQAX=W.<#/'!SUXKD/
M"/QST2\US]H"]UCQ[H]Y>WV@/9Z?J"M'9"^D$; "%"WS')P,<FKJ8BO&=1);
M<UEKTM9_,BC0HSA3N]9.-_GNOD>%:3^PWXRUC5-9AA\4>#8]*THQI/KTFKD:
M>9'&1&LH3ENQ! Y[UXO\1/ >I_#'QCJ7AK5S;O?V+A'>UD\R)P0&5E;N"""/
MK7U1^Q/XLL-%\,:O:ZA\0O"ND:=<WH.H>'?%SK%%<18_UD3G^.O"OVHKSP3?
M?&KQ!-\/G$OADN@A="3&6" /L)_AW9Q[=*Z(U*JQ'LI.ZMVZZ?Y_U8Q=.G*@
MZD='?OTU6GYGE%%%%>@<(4Z.-I9%1%+NQPJJ,DGT%(JEF  R3P!7Z2?L-?L+
MG14L?B!\0]/VW[ 3:;HURG,(/*R2J>C=PIZ=^:YJ]>&'AS2-Z-&5:7+$3]AC
M]A<:/'9?$/XAV0-\P$NEZ+,N?)7J)I1_>/9>PY/)P/T!50J@ 8 X %  4  8
M Z"EKX^M6G7GSS/IJ5*-&/+$****P-@HHKGO'GC[0_AIX7O?$'B&_CT_3+1"
M\DDAY./X5'<GL*:3;LA-VU8>/?'NB?#7PO?>(/$%]'8:;:(7>20XS[#U)]*_
M'?\ :N_:PUS]H[Q0R*TEAX3LW(L--!P#_P!-)/5C^G2C]J_]J_6_VCO%3*K2
M:=X3LW(L=-#=1_STD_O,?T[5X%7U&"P2HKVE3XOR/ Q6*]I[D-OS"BBBO7/,
M"BBB@ HHHH **** "BBB@ HHHH **** />O!_P"W#\7_  -X8L] TSQ%"=/L
MXQ%!]JLHIY(U P '921CZUQ&@_'SQMX?^)TWQ AU;[5XKF+%KZ^B6X/S#' <
M$# &!Z=J\\HK+V5/F<^57>_S-/:3Y5"^B-+Q'X@O_%FO:AK.J3FYU&^F:XGF
M(QN=CDG':LVBBM(I122V)E)R;E)W;"EZ\#DT5]V?L.?L.R>+YK+Q[X]LF314
M(ET_2IEP;D]1)(/[OH.]8UJT*$.>9I2I2K2Y8A^P[^PW+XOFLO'OCRR:/158
M2Z=I<RX-R0>)'']S/0=Z_36WMX[6%(846.*-0JHHP !P !1!#';0I%$BQQ(H
M5408"@#  '85)7Q^(Q$\1/FD?34:,:,>6(E?&O[;7[;5O\);.Y\'>#KF.X\7
MS)MN+E"&6P4C_P!#]!VI/VVOVW(/A-8W7@[P7=1W'C"="DUXN'73U/?T,GH#
MP.ISTK\K+Z^N=3O)[N\GDNKJ=S)+/,Y=Y&)R68GDDGN:]+ X'GM5JK3HNYPX
MK%\G[NGN%]?7&J7L]Y=SR7-U<2-++-*Q9W<G)8D]234%%%?2GA!1110(****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBNZ^#GP;\2?'#QE:>'?#EH9IY
M6'FW# ^5;IW=SV J9245S2V*C%R=D'P;^#GB+XW>-+3P[X>M&FFD8&:<C]W
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M9!KTCPUJOQ .A_!^Z^&%MI\_@S5+9;OQ;<0V]N1)<R9:X,Y(^7YBQ^7&#D=
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MB%8!B,3:;HUPO'JLLJGKZA3^-?HB..!P*^>QV.WI4GZL]O"82W[RI\D"J%4
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MJTU?U+A.5-W@[,?--)<322RNTDLC%G=CDL2<DFF445H2%%%% @HHHH ****
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M8YL1B(8>'-(WHT95I<L0_89_8971?L'Q!^(%B&O_ )9],TFX7(A[K+(#_%W
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MF/QI_P"%4^-O^A.U_P#\%<__ ,17W7^PO^PRJFU^('Q"L@71M^FZ+,/NL/\
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M$[7_ /P5S_\ Q%'_  JGQM_T)VO_ /@KG_\ B*_9:BC^U9?R!_9T?YC\:?\
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M5R7BK]F&[\2>+FU1]3T66$WD-ZEU?:0)]1@*$'RHK@O\D9QT"Y]Z2M>*Z?\
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MIDD-Q "H8X7[A!=>#ZUZ17"6/PUDL_'7AWQ ;]632M%ETDV_E$&0NT1W@YX
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M'X(^(_!"Z(_AGQ-8VES#H]KH^HR7E@TPF6#=MDB D&Q_F;[VX=.*H6'[-O\
M8?C5M6M+'P1J=K/>+?3W.M^&EGU-9,#<8KA'0+RNX94X)/L*/=]I;[-_U_R_
M'[A2ND[;_P# _._RM]YWOQ&^)DG@;4?#^FV>A7.O:EK<TEO:V]O*L8W)$\GS
M,W &$//;-<Q-^T')]AT=+7PE?76O7]_-IKZ0+A%:WGB'S!I#\NWC[W3O4/QP
MTGQ!J7Q ^&1\.7,5A?PW]TXNKFU:XMT_T.88D52IVGIPRGG@U>\/_!.\T[4M
M!U6^UJ*\U2UU*YU2_DCMBB7$DP(*QKN.Q5SQDL<=2>M2EHF_ZU_R--$[>7Z/
M];?B)??':>SFO)E\*7EQHVF2I;:IJ4=S'MM9B%W(J]90I8 LO&0?2C_AH33V
M\8-X332KIO$)N%6.S1U):U:,N+O/3R^"OUP.]5]:^"^OW5[K>G:;XCM++PAK
M=W]MO;.2Q,EVCDJ76*7>%56*Y^9&/)P1VKM^SW=KX[C\:0^(!'XCAG6"*3R#
MY(TP1[?L93=S\QW[LYW =N*A:I7[?CI^%_POUM>9=;>?W=/G;?SMTN9_A_\
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M?A+XITSQEH.K:WXGL=1L-#MY;6TM+73S"S(R%0TCEVRX![ #VK3W>;R_X?\
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M $E58G /'%-TSXS>#=7EU)+?6T"Z?&TUQ-/!+#%L7[SI(ZA9%'<H2*\,\-_
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M]^EM^I[?;_&+PE=:EJ=E%J<C/IJ-)=3_ &*<6R!2 P$Y3RV8$@;58G/:L_\
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MM>\3^)K+5+:TM?!^K6-Q)J6J6]Q%YSB)E-O'&Q*1D1MP>>!D"KE&/O)/9/\
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M6EF'!SGR<5.ZO\_N2;^Z]UW\B^5Z>?\ FTOO:MZL^PH84MXDCC0)&@"JJC
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M+^ @Q75Q9QR2QX.1M8KD8/I3]'\(Z%X>N)I]*T73M,GF_P!;+9VD<32?[Q4
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M[UO+ZUB=H0O.0[#*@=>O%)'X5\-ZA?)K,>CZ5<WD@5EU!;:)Y& (*D28R<$
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M/3U[U7*[7'?M_6B?ZHVZ***D9Z[IO_(-M/\ KDG_ *"*LU6TW_D&VG_7)/\
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M<]AVH::M?^NGZ"ZV/5Z*X+1?C+I/B3Q,NBZ5IFKW[J$-S>16H%O:,R;PDI+
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M@AF4^6=Q)P5.<@=16%IO[07AS4]:AL([/5HX)+TZ;_:4MJ%M%N<X$9?=G))
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M-3UCQ!<Z+_:,\FFV:R"V!0XFE&0%7=Z ].E*>B<I+;_@_P#!*46[>?\ P/\
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MY3WL_7[SRW]GWX4GX6^&M62>RBL;_5M2FOYX87#JFX_*H(ZX'\Z]2HHH;O\
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ML'6_7_AO\D?/_P#PJ+QYX+UZ*Y\*_P!A:K:OX>M]$G&J7,MLX=7F9YEV1R#
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M<NS#!(!Z$=J\*^'O@_Q=X\TYM+FCTF'PC;^)SJ37RW$GVS,$Z2K$(?+VX+(
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MM/#DFGND8+R>83PP&,;1Z]O2OH>FS0I<1M'*BR1L,,KC((]Q14DZBU\_QO\
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M %%%% !1110!Z[IO_(-M/^N2?^@BK-5M-_Y!MI_UR3_T$59H **** "BBB@
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M/JGV9F\^^*Q1N@9NI8'(4GD9XKZHHIRDY7EU>_X_AJ7S;*VA\=?!/QO8:/\
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M@<D.AVG&W/ /(^G?%'A+2/&FE/INMV$6H63'<8I,CD=P000?H:P_^%-^#/\
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M*\[KT3P)_P @,_\ 75OY"@#HJ*** /,?%W_(Q7GU7_T$5CUL>+O^1BO/JO\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T?P/_R
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M** "BBB@#T?P/_R 8_\ ?;^=;]8'@?\ Y ,?^^W\ZWZ "O//'G_(<7_KBO\
M,UZ'7GGCS_D.+_UQ7^9H YRBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#J/A__P A:?\ ZX'_ -"6N^K@?A__ ,A:?_K@?_0EKOJ
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MQM=E\._O7_TC_P#9J .THHHH S/$G_(!O?\ KF:\LKU/Q)_R ;W_ *YFO+*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#UW3?\
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M]_S\6_YM_A0!RU%=3_PK^^_Y^+?\V_PH_P"%?WW_ #\6_P";?X4 <M174_\
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M_0./_?S_ .M7-]5J]C?ZQ3[GH]%><?\ "WU_Z!Q_[^?_ %J/^%OK_P! X_\
M?S_ZU'U6KV#ZQ3[GH]%><?\ "WU_Z!Q_[^?_ %J/^%OK_P! X_\ ?S_ZU'U6
MKV#ZQ3[GH]%><?\ "WU_Z!Q_[^?_ %J/^%OK_P! X_\ ?S_ZU'U6KV#ZQ3[G
MH]%><?\ "WU_Z!Q_[^?_ %J/^%OK_P! X_\ ?S_ZU'U6KV#ZQ3[GH]%><?\
M"WU_Z!Q_[^?_ %J/^%OK_P! X_\ ?S_ZU'U6KV#ZQ3[GH]%><?\ "WU_Z!Q_
M[^?_ %J/^%OK_P! X_\ ?S_ZU'U6KV#ZQ3[GH]%><?\ "WU_Z!Q_[^?_ %J/
M^%OK_P! X_\ ?S_ZU'U6KV#ZQ3[GH]%><?\ "WU_Z!Q_[^?_ %J/^%OK_P!
MX_\ ?S_ZU'U6KV#ZQ3[GH]%><?\ "WU_Z!Q_[^?_ %J/^%OK_P! X_\ ?S_Z
MU'U6KV#ZQ3[GH]%><?\ "WU_Z!Q_[^?_ %J/^%OK_P! X_\ ?S_ZU'U6KV#Z
MQ3[GH]%><?\ "WU_Z!Q_[^?_ %J/^%OK_P! X_\ ?S_ZU'U6KV#ZQ3[GH]%>
M<?\ "WU_Z!Q_[^?_ %J/^%OK_P! X_\ ?S_ZU'U6KV#ZQ3[GH]%><?\ "WU_
MZ!Q_[^?_ %J/^%OK_P! X_\ ?S_ZU'U6KV#ZQ3[GH]%><?\ "WU_Z!Q_[^?_
M %J[[3KO[?86]SMV>:@?;Z9%9SI3IZR1I&I&?PLLT5F^(=8_L'2Y;SR_-V?P
MYQFN*_X6^O\ T#C_ -_/_K40HSJ*\4*56$':3/1Z*\X_X6^O_0./_?S_ .M1
M_P +?7_H''_OY_\ 6K3ZK5[$?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\
MH''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?
M_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P
M?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'H
MKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^
MO_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S
M_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM
M]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_
M +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^
MJU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?
M<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_
M (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0.
M/_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M
M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\
MH''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?
M_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P
M?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'H
MKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^
MO_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S
M_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM
M]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_
M +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^
MJU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?
M<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_
M (6^O_0./_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0.
M/_?S_P"M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M
M1_PM]?\ H''_ +^?_6H^JU>P?6*?<]'HKSC_ (6^O_0./_?S_P"M1_PM]?\
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MV%\1/ /BZPT"^^!EUY^J7<MMI3GQ%"/MNP_>4"([<C!PQ[UTOC[]I[Q;\/\
MPCX0NKWX5SGQ5XBOVL(_#IUF,/&P4L#YPC*G..F!]:Q?VK/^2[_ /_L*7?\
MZ+2LO]O&,S:M\)D'B(>$RVO$?VVQ0"S_ '3?O,N0O'N>]<[E.--/FNW-1Z;7
MC\KZ]=#HE&-U9?9<NN_O?.VB\SUCP7\;/$+>%O$'B#XE> YOAIIVDQ^=YEQJ
M4=[YR $L1Y:C&/3O7%67[5?C;Q%Y&J^'O@AK^J>#Y@'75I=0@@F:,_QK;D$G
MV&[FN&^+/A;4_$W[*OC72-#^*2?&#5(7CNY9K66"25(4<,T6V%VZJ#QU-8OQ
M@^-EAKOP?TGQ=\/OC/'X4NM.TZ./_A$K62 33RC'RLC-O!'3A3TJIU'&[;VY
M=-.JW?STT%&FFEIO?OI:UE\[WU/>/C5^T=?_  OTGP5-H_@JY\3:IXI?9;:7
M)>+9RQML5]K%D8;OFQCCI2_!_P#:0N_'WCJ^\$>*O!5]X$\7VUI]O%A<7274
M<EON"[A(@'.3TQ^->/\ [2]MJWCFS_9YC@URXT?6=2E5_P"UH4#RQ2-;QL7"
MG )SG\ZE^!#I\+?VA/'^E?$#5;CQ!XRM])6]M/$=\P!N-/4DL@0#"$,,D9.<
M>U:1DXUIJI\*<OPBGIUTW=^ER'&,J$)06K2?WR:U\K::=3TKXG?M96OPW^+F
ME^#F\.2ZAITLUO!J&N+=A([!IG"QADV'=R?[PJ#X^?M+>-/@G=7UW!\)Y_$'
MA2U2-O[>76HK=&+ <>7Y;-P3BOF"32OBS\6/AO\ $"_TOX81:UI?BR]:_A\0
M2:U!#-"L39B*1,VXA<9'3->J?$CXCGXI?L"IK<L@>^\B&"[YY$R,%<'\0:YI
M5*BH2E>THV>W272W]UZ7ZFWLX*LHVNGI\UU^?;H>CP_M/>,-,^%'B/QSXH^%
M,_AJTTVVBN;."768YOMR/CHRQ_)@$'D'K74^-_VE-&\"^ ?#&NW.G75]K'B2
M*-M,T&R8///(Z!MH)P,#(RV/PKC_ -I3_DRG4/\ L!VG_H"5Y5X^O(_!/C#]
MF?QKK9\GPK9Z:UI<7D@S%;RR0($+GMGU_P!DUVS]V<J=[)2C&_JG\KNR7JSG
MII2I1JVU:D[>EORNSUG0?VLM7T[Q7H^B_$CX::E\/$UJX6UTZ^EOXKR&65ON
MJY0+L)X'?K5_QI^UG9^!_CU9_#N^\/2FQF6'S=>6Z&R!I<; T>SH20,[OPKS
MG]K3X@^&OC!_P@'@WP3K%CXIU^ZU^UN5_L:X2Z^S1(V7D=D)" #UJ3Q)\.[;
MXE?M,?$CPW=G:T_A>T$4HZQR@ JX]P:QC.3:ZV<O^WDHW^_IH;*G!\U]/=3]
M&Y<OY:ZGODOQ=$?QRB^'7]EY,FD_VI_:7VCI\[+L\O;[9SN_"O1*^*/@)X\N
M_&W[4FG1:N&C\1Z+X7;2=6C92"+B&9T9OHP <'T85]KUT1UA&5[WYM>ZYFE^
M"1R2O&I*+5K6^_E3?XW"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ I58JP920P.01U%)10!ZGX#\=B_5-/U!PMR.(
MY3T?V/O7>UXIX,\(S^(KQ93NAM(VRTHX)]A[U[3&@CC51DA1CFO#Q481G[IZ
M^'E*4?>'4445QG2%%%% !1110 4444 %%%% 'F_CSP'GS-1TZ/\ VI85'ZBO
M-Z^CZ\X\>> P?,U+3H\'[TL*C_QX5ZF'Q'V)GGUZ'VH'DOB'P#I?Q*TF;1-9
MT2#Q!I\F))+*YA$J':>"5/H<50\&_L[^&OAW/+/X9\!V6AS2C#R6-B(V;\0*
M]7^$W'B2X!X/V5O_ $-:]:JZU?V4VE$BE1]I"[9\T^%_A;#X+TYK#0?#8TFR
M:1I3!:6^Q2['+-@#J2:@TGX/V.@ZEJVH:=X5CL[[5FWW\\-KM:Y;&,N<?,?K
M7T[16/UQ_P IM]57\Q\DZ7^S;X4T7Q(_B&P^'^GVFMN26OX; +*2<<[L>P_*
MM[2_A3;Z+JFJ:E8>&5M+_5&#7MQ%;8>X(X!<XYKZ8HI?7&E910?5K[R/EW1_
M@MIGA_1;W1]-\(PV.EWK,US9PVNV.4M]XLN,'-)X>^">E>$_#<WA_1O"$&F:
M)-N\S3[:TV0ON^]E0,'-?4=%'UQ_RKM\NP?5E_-Y_/N?+&D_ O1=!\*W/AG3
MO!MO9>'[G=YVFP6>V"3=C.5 P<X'Y5MZ?X!ETO28M+L]$>VTZ*/R4M8X"(U3
M&-H&.E?1E%/ZX_Y0^JKN?)]I^SSX<L-/L+"W\"V<-EI]U]MM($L@$@GSGS%&
M.&SWK6U/X36NLZ_I^N7WAA+K6-/!%I?2VV980>H5L9%?35%'UQ_RA]53WD?'
M=U^RCX%OM=DUJX^&FES:M)+Y[WCZ<ID:3KN)QUKT"U\(WUC;I!;Z5-!#&,+'
M'"0JCT Q7T)12CC'%6C%) \*I.[D?,\GPIMYO$R>(G\-*^N)";==0-M^^$9Z
MH&QG'M1HGPJM_#>FW.GZ7X:6PLKF22::W@MMJ2.Y)=B,<DDDGZU],44?7'_*
M@^JKN?,?A'X0V7@&QGL_#GA:/1+2>9KB6&RM?+5Y&P"Y '4X'/M4FA?"FW\,
MWVIWFD^&ET^[U.437LUO;;6N' P&<@<G%?3%%5]=E_*+ZJNY\>>(OV4_ WB[
M6+C5M:^&NEZGJ=PV^:ZNM.5Y)#ZDD<UU%Q\)+.Z\-P^'YO"T<NB0Q+!'8/:Y
MA2,# 4+C@ <5]-T5"Q=ERJ*L5]7N[N3N?*'@O]GOPY\.9I9?#'@6ST*63[[V
M-B(RWU(%:VC_  GMO#[:FVF^&5LFU.0RWIAMMOVAR,%GXY..*^F:*KZX_P"4
M7U5=SY0TO]GOP[H;:<UAX&M+1M.G:YM##9!?(E;[SIQP3ZUK>*OA/;>.;".R
M\0>&5UBTCD69(;RV\Q5=3D, 1U%?3-%'UQ_RA]65[\Q\RO\ "6TD\36_B)O#
M"-KMO;_9(M0-M^^2'.?+#8R%SSBG7?PIM[_Q)9^(;CPRLVN6<;0V^H/;9FB1
MOO*K8R <5],44?7'_*'U5/=GRCXT_9^\/?$:2)_%'@:SUUXCE&OK$2%?H2*V
M]-^&::-HHTBQ\.BTTL)Y?V2&VVQ[2,8P!TKZ3HI?6WJN5:A]66GO;'S)8_".
MSTWPJ/#5KX7C@T 1M$--2UQ!L))*[<8P23^=3>%_AA'X)T:'2-!\.?V1ID.3
M':6EOLC7)R< "OI6BJ^NRO?E%]55K7/ /^$<U3_H'W'_ '[->X:#&T.BV*.I
M1UA4%6&"#BK]%<]:NZR2:-J=%4VVF<]X[MI;OPW<Q0QM+(<85!DUY#_PCFJ?
M] ^X_P"_9KW^BG1Q#I1Y4A5**J.[9X!_PCFJ?] ^X_[]FC_A'-4_Z!]Q_P!^
MS7O]%;_79=C+ZK'N> ?\(YJG_0/N/^_9H_X1S5/^@?<?]^S7O]%'UV78/JL>
MYX!_PCFJ?] ^X_[]FC_A'-4_Z!]Q_P!^S7O]%'UV78/JL>YX!_PCFJ?] ^X_
M[]FC_A'-4_Z!]Q_W[->_T4?79=@^JQ[G@'_".:I_T#[C_OV:/^$<U3_H'W'_
M '[->_T4?79=@^JQ[G@'_".:I_T#[C_OV:/^$<U3_H'W'_?LU[_11]=EV#ZK
M'N> ?\(YJG_0/N/^_9H_X1S5/^@?<?\ ?LU[_11]=EV#ZK'N> ?\(YJG_0/N
M/^_9H_X1S5/^@?<?]^S7O]%'UV78/JL>YX!_PCFJ?] ^X_[]FC_A'-4_Z!]Q
M_P!^S7O]%'UV78/JL>YX!_PCFJ?] ^X_[]FC_A'-4_Z!]Q_W[->_T4?79=@^
MJQ[G@'_".:I_T#[C_OV:/^$<U3_H'W'_ '[->_T4?79=@^JQ[G@'_".:I_T#
M[C_OV:/^$<U3_H'W'_?LU[_11]=EV#ZK'N> ?\(YJG_0/N/^_9K'U+X5P:SK
MFFZS?>&EN]5TW=]CO);;=);[AAMC8XR*^EZ*7UV7\H_JJ[GSW=>$;Z^MY+>X
MTJ:>"0;7CDA)5AZ$8KB_#O[-7A/PCK4FKZ+\/M/TS5)&+-=VU@$D))R3G'J:
M^N**/KCOS<NH?55:U]#YHUGX5P>(M3TO4=3\-+?7VENTEC<3VVY[=F&&*''!
M(%,F^$MK<>*;?Q)+X81]?MXF@BU(VW[](SP5#8S@U]-44?7&OLA]53T;/EN/
MX):3#XQ?Q9'X/@3Q*Z;&U46G^D%<8QOQG&*5?@II4?C%_%B^$(%\2NGEMJHM
M/](*X QOQG& !^%?4=%"QC5K1V#ZLM?>W/F?2?A5;Z#K&IZKIWAI;+4M497O
M;J&VVR7!484N<<X%07/P=T^\\2/X@G\*1RZW);&S:_:US,T)ZQEL9VG/2OI^
MBE]<>W*@^K+^8^7(_@KI</A&3PLGA&%?#DB,CZ6+3]PRMU!3&.:R_$'[-GA3
MQ5I>EZ;K'@"QU*PTN,0V5O<V(=+= ,!4!' P*^MZ*'C&]XH%ADMI'S#X1^#M
MAX!L!9>'/"<.B6@_Y8V5IY:]2>P]2:L^*/AC'XUT:;2=>\._VOIDQ4R6MW;[
MXV*D,N01V(!_"OI6BJ>-D]X@L*D[IGS,/A/;#7+'61X97^U;& VUM>?9OWD,
M1&"BG' ]JAN/@WIUWXL@\43>$XI/$4$?E1:FUKF=%_NAL9Q7T_12^NRWY1?5
M5W/F;6OA3;>)-4TO4M4\,K?W^ENTEC<3VVY[=F !*$C@D 54\<?!'2?B59V]
MKXJ\'P:_;6[^9%%?VGFJC8QD C@X)KZDHI/&-JSBK%?5NO,SY6\$? ?0_AK'
M=1^%O!=MH"76#.MA9B,28Z;L#FLRZ_9@\&WWB+^WI_ASILNL[Q)]M;3U,NX=
M#G'6OKRBG]<>CY=A?5EK[VY\S:O\)[77KK2KG4?#"WL^E/YEC)-;;C;-@#*<
M?*< =*I^(/@AI'BK5EU35_!\&HZBMN]H+JXM-T@A<8>/./ND=17U+12^N-[Q
M0?5E_,?..C?#Y_#ND6^E:9H36.G6Z>7%:P0%8T7T  Z5@0?L_P#A^U\,W/AV
M+P1:QZ%<RF:;3ULP(9')R6*XP3FOJVBF\8Y:N(+"I:*1\U:S\+XO$/A]]"U/
MPX+[1GC6)K&>WW1%!C"[<=!@4E]\+8=2\/C0KOPVMQHZQ"$6,EMNB" 8"[<=
M,<5]+44/&-WO'<%A4K6>Q\I>"_V?_#WPYDFD\,>![/0I)O\ 6-8V0C+?4@5L
M0?"^*U\27/B"+PX(];N8E@FOUM\321KT4MC) KZ5HH^NRT]T/JJUUW/F"S^#
M>G:=XJN_$UKX3B@\072".?4H[7$\B@8 9L9(XKH/^$<U3_H'W'_?LU[_ $4+
M&-*RB+ZJF[MG@'_".:I_T#[C_OV:/^$<U3_H'W'_ '[->_T4_KLNP?58]SP#
M_A'-4_Z!]Q_W[-'_  CFJ?\ 0/N/^_9KW^BCZ[+L'U6/<\ _X1S5/^@?<?\
M?LT?\(YJG_0/N/\ OV:]_HH^NR[!]5CW/ /^$<U3_H'W'_?LT?\ ".:I_P!
M^X_[]FO?Z*/KLNP?58]SP#_A'-4_Z!]Q_P!^S1_PCFJ?] ^X_P"_9KW^BCZ[
M+L'U6/<\ _X1S5/^@?<?]^S1_P (YJG_ $#[C_OV:]_HH^NR[!]5CW/ /^$<
MU3_H'W'_ '[-'_".:I_T#[C_ +]FO?Z*/KLNP?58]SP#_A'-4_Z!]Q_W[-'_
M  CFJ?\ 0/N/^_9KW^BCZ[+L'U6/<\ _X1S5/^@?<?\ ?LT?\(YJG_0/N/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !6;X@T5->L!:2.4C+JS8ZD#M6E133<7=":35F06=G#I]
DK';V\8CB08"BIZ**0PHHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>aqb-20211231.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.1.0.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/10/2022 8:42:01 AM-->
<!--Modified on: 3/10/2022 8:42:01 AM-->
<schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sec.gov/20211231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:aqb="http://www.sec.gov/20211231" xmlns="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"></xsd:import>
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"></xsd:import>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"></xsd:import>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"></xsd:import>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"></xsd:import>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"></xsd:import>
  <xsd:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:import>
  <xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:import>
  <xsd:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:import>
  <xsd:annotation>
    <xsd:appinfo><link:roleType roleURI="http://www.sec.gov/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets"><link:definition>00100 - Statement - Consolidated Balance Sheets</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"><link:definition>00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows"><link:definition>00400 - Statement - Consolidated Statements of Cash Flows</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails" id="DisclosureInventoryScheduleOfInventoryDetails"><link:definition>40502 - Disclosure - Inventory (Schedule of Inventory) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" id="DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails"><link:definition>40602 - Disclosure - Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" id="DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"><link:definition>40702 - Disclosure - Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails" id="DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails"><link:definition>40703 - Disclosure - Debt (Principal Payments Due on Long-term Debt) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails" id="DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails"><link:definition>40902 - Disclosure - Income Taxes (Components of Loss Before Income Taxes) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" id="DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"><link:definition>40903 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" id="DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"><link:definition>40904 - Disclosure - Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails" id="DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails"><link:definition>41002 - Disclosure - Commitments and Contingencies (Summary of Lease Obligations) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails" id="DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails"><link:definition>41003 - Disclosure - Commitments and Contingencies (Summary of Remaining Payments under Leases Alternate) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails" id="DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"><link:definition>41003 - Disclosure - Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" id="StatementConsolidatedStatementsOfChangesInStockholdersEquity"><link:definition>00300 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationDetails" id="DisclosureNatureOfBusinessAndOrganizationDetails"><link:definition>40101 - Disclosure - Nature of Business and Organization (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"><link:definition>40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"><link:definition>40202 - Disclosure - Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails" id="DisclosureRisksAndUncertaintiesDetails"><link:definition>40301 - Disclosure - Risks and Uncertainties (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails" id="DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"><link:definition>40401 - Disclosure - Marketable Securities (Schedule of Marketable Securities) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureInventoryNarrativeDetails" id="DisclosureInventoryNarrativeDetails"><link:definition>40501 - Disclosure - Inventory (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails" id="DisclosurePropertyPlantAndEquipmentNarrativeDetails"><link:definition>40601 - Disclosure - Property, Plant and Equipment (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureDebtNarrativeDetails" id="DisclosureDebtNarrativeDetails"><link:definition>40701 - Disclosure - Debt (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails" id="DisclosureStockholdersEquityNarrativeDetails"><link:definition>40801 - Disclosure - Stockholders&apos; Equity (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails" id="DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails"><link:definition>40802 - Disclosure - Stockholders&apos; Equity (Information About Outstanding Warrants) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails" id="DisclosureStockholdersEquityRestrictedStockActivityDetails"><link:definition>40803 - Disclosure - Stockholders&apos; Equity (Restricted Stock Activity) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails" id="DisclosureStockholdersEquityStockOptionActivityDetails"><link:definition>40804 - Disclosure - Stockholders&apos; Equity (Stock Option Activity) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails" id="DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"><link:definition>40805 - Disclosure - Stockholders&apos; Equity (Information About Options Outstanding and Exercisable) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails" id="DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"><link:definition>40806 - Disclosure - Stockholders&apos; Equity (Stock Option Grants Weighted Average Assumptions) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails" id="DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails"><link:definition>40808 - Disclosure - Stockholders&apos; Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails" id="DisclosureIncomeTaxesNarrativeDetails"><link:definition>40901 - Disclosure - Income Taxes (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" id="DisclosureCommitmentsAndContingenciesNarrativeDetails"><link:definition>41001 - Disclosure - Commitments and Contingencies (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureRetirementPlanDetails" id="DisclosureRetirementPlanDetails"><link:definition>41101 - Disclosure - Retirement Plan (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails" id="DisclosureRelatedPartyAgreementDetails"><link:definition>41201 - Disclosure - Related Party Agreement (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation"><link:definition>00090 - Document - Document and Entity Information</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical"><link:definition>00105 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganization" id="DisclosureNatureOfBusinessAndOrganization"><link:definition>10101 - Disclosure - Nature of Business and Organization</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies"><link:definition>10201 - Disclosure - Summary of Significant Accounting Policies</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureRisksAndUncertainties" id="DisclosureRisksAndUncertainties"><link:definition>10301 - Disclosure - Risks and Uncertainties</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureMarketableSecurities" id="DisclosureMarketableSecurities"><link:definition>10401 - Disclosure - Marketable Securities</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureInventory" id="DisclosureInventory"><link:definition>10501 - Disclosure - Inventory</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment" id="DisclosurePropertyPlantAndEquipment"><link:definition>10601 - Disclosure - Property, Plant and Equipment</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureDebt" id="DisclosureDebt"><link:definition>10701 - Disclosure - Debt</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquity" id="DisclosureStockholdersEquity"><link:definition>10801 - Disclosure - Stockholders&apos; Equity</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes"><link:definition>10901 - Disclosure - Income Taxes</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies"><link:definition>11001 - Disclosure - Commitments and Contingencies</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureRetirementPlan" id="DisclosureRetirementPlan"><link:definition>11101 - Disclosure - Retirement Plan</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureRelatedPartyAgreement" id="DisclosureRelatedPartyAgreement"><link:definition>11201 - Disclosure - Related Party Agreement</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy" id="DisclosureNatureOfBusinessAndOrganizationPolicy"><link:definition>20102 - Disclosure - Nature of Business and Organization (Policy)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicy"><link:definition>20202 - Disclosure - Summary of Significant Accounting Policies (Policy)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables"><link:definition>30203 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureMarketableSecuritiesTables" id="DisclosureMarketableSecuritiesTables"><link:definition>30403 - Disclosure - Marketable Securities (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureInventoryTables" id="DisclosureInventoryTables"><link:definition>30503 - Disclosure - Inventory (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentTables" id="DisclosurePropertyPlantAndEquipmentTables"><link:definition>30603 - Disclosure - Property, Plant and Equipment (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureDebtTables" id="DisclosureDebtTables"><link:definition>30703 - Disclosure - Debt (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityTables" id="DisclosureStockholdersEquityTables"><link:definition>30803 - Disclosure - Stockholders&apos; Equity (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables"><link:definition>30903 - Disclosure - Income Taxes (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables"><link:definition>31003 - Disclosure - Commitments and Contingencies (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqb-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"></link:linkbaseRef><link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqb-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"></link:linkbaseRef><link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqb-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"></link:linkbaseRef><link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqb-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"></link:linkbaseRef></xsd:appinfo></xsd:annotation>
  <xsd:element abstract="true" id="aqb_A2016EquityIncentivePlanMember" name="A2016EquityIncentivePlanMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" name="AtlanticCanadaOpportunitiesAgencyAIFGrantMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" name="AtlanticCanadaOpportunitiesAgencyTermLoan2Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element id="aqb_AuthorizedShares" name="AuthorizedShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"></xsd:element>
  <xsd:element id="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage" name="DebtInstrumentRepaymentTermsRoyaltyPercentage" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_ExercisePriceFourMember" name="ExercisePriceFourMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_ExercisePriceOneMember" name="ExercisePriceOneMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_ExercisePriceThreeMember" name="ExercisePriceThreeMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_ExercisePriceTwoMember" name="ExercisePriceTwoMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element id="aqb_ExerciseofWarrantsforCommonStock" name="ExerciseofWarrantsforCommonStock" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_ExerciseofWarrantsforCommonStockshares" name="ExerciseofWarrantsforCommonStockshares" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element abstract="true" id="aqb_FPEITermLoanMember" name="FPEITermLoanMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_FeedMember" name="FeedMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_FishInProcessMember" name="FishInProcessMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element id="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance" name="IncomeTaxExpenseBenefitBeforeValuationAllowance" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_IndianaAquacultureFarmMember" name="IndianaAquacultureFarmMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_KubotaCanadaLtdMember" name="KubotaCanadaLtdMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_OfficeFurnitureandEquipmentMember" name="OfficeFurnitureandEquipmentMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element abstract="true" id="aqb_PackagingMember" name="PackagingMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element id="aqb_PaymentsForDepositsOnEquipmentPurchases" name="PaymentsForDepositsOnEquipmentPurchases" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element abstract="true" id="aqb_WarrantsAbstract" name="WarrantsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"></xsd:element>
  <xsd:element id="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" name="ProceedsPaymentsForLegalSettlementsInvestingActivities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_EggsAndFryMember" name="EggsAndFryMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_FirstFarmersBankAndTrustLoanMember" name="FirstFarmersBankAndTrustLoanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_USTreasuryFiveYearMaturitiesInterestRateMember" name="USTreasuryFiveYearMaturitiesInterestRateMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_DebtInstrumentInterestRateStatedPercentagePeriod" name="DebtInstrumentInterestRateStatedPercentagePeriod" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_DebtInstrumentInterestOnlyPaymentPeriod" name="DebtInstrumentInterestOnlyPaymentPeriod" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_DebtInstrumentCovenantCashBalanceMinimum" name="DebtInstrumentCovenantCashBalanceMinimum" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" name="PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_NatureOfOperationsPolicyPolicyTextBlock" name="NatureOfOperationsPolicyPolicyTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_ProductionCostsOperating" name="ProductionCostsOperating" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_February2021PublicOfferingMember" name="February2021PublicOfferingMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" name="AtlanticCanadaOpportunitiesAgencyTermLoan1Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_December2020PublicOfferingMember" name="December2020PublicOfferingMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_LimitationsOnUseToSection382Member" name="LimitationsOnUseToSection382Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_DebtInstrumentMaturityDateYearMonth" name="DebtInstrumentMaturityDateYearMonth" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_LiquidityPolicyPolicyTextBlock" name="LiquidityPolicyPolicyTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_AdditionalCashAndCashEquivalents" name="AdditionalCashAndCashEquivalents" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_DfoTermLoanMember" name="DfoTermLoanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_MarketableSecuritiesAmortizedCost" name="MarketableSecuritiesAmortizedCost" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_MarketableSecuritiesUnrealizedGain" name="MarketableSecuritiesUnrealizedGain" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_MarketableSecuritiesUnrealizedLoss" name="MarketableSecuritiesUnrealizedLoss" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_RolloBayFarmAndFortuneBayHatcheryMember" name="RolloBayFarmAndFortuneBayHatcheryMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_New10000MetricTonFarmMember" name="New10000MetricTonFarmMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_CanadianSubsidiaryMember" name="CanadianSubsidiaryMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" name="AtlanticCanadaOpportunitiesAgencyTermLoan3Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_TsAquacultureMember" name="TsAquacultureMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_PropertyPlantAndEquipmentUsefulLife1" name="PropertyPlantAndEquipmentUsefulLife1" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_RepaymentPeriodOfLoan" name="RepaymentPeriodOfLoan" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_CanadaSubsidiaryMember" name="CanadaSubsidiaryMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element>
  <xsd:element id="aqb_UnitedStatesSubsidiaryMember" name="UnitedStatesSubsidiaryMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema"></xsd:element></schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>aqb-20211231_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.1.0.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/10/2022 8:42:01 AM-->
<!--Modified on: 3/10/2022 8:42:01 AM-->
<linkbase p1:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:p1="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.xbrl.org/2003/linkbase">
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.sec.gov/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureInventoryScheduleOfInventoryDetails" roleURI="http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" roleURI="http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails" roleURI="http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails" roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails" roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails" roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:calculationLink xlink:role="http://www.sec.gov/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Consolidated Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637824985196843283"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637824985196843283" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_637824985196843283"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_637824985196843283" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_637824985196843283"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_637824985196843283" order="3" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_637824985196843283"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent_637824985196843283" order="4" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash_637824985196843283"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCash_637824985196843283" order="5" use="optional" weight="1" priority="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637824985196843283"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent_637824985196843283" order="6" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637824985196843283"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637824985196843283" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637824985196843283" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_637824985196843283"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637824985196843283" xlink:to="us-gaap_InventoryNet_637824985196843283" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637824985196843283" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637824985196853256" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637824985196843283" xlink:to="us-gaap_MarketableSecuritiesCurrent_637824985196853256" order="4" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_637462219409563958"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_637462219409563958" xlink:to="us-gaap_Liabilities_637824985196853256" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637824985196853256" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_637824985196853256" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637824985196853256" xlink:to="us-gaap_LongTermDebtNoncurrent_637824985196853256" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637824985196853256" xlink:to="us-gaap_LiabilitiesCurrent_637824985196853256" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637824985196853256" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637824985196853256" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637824985196853256" xlink:to="us-gaap_OtherLiabilitiesCurrent_637824985196853256" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637824985196853256" xlink:to="us-gaap_LongTermDebtCurrent_637824985196853256" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637824985196853256" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_637824985196853256" order="4" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_637462219409563958" xlink:to="us-gaap_CommitmentsAndContingencies_637824985196853256" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_637462219409563958" xlink:to="us-gaap_StockholdersEquity_637824985196853256" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637824985196853256" xlink:to="us-gaap_CommonStockValue_637824985196853256" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637824985196853256" xlink:to="us-gaap_AdditionalPaidInCapital_637824985196853256" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637824985196853256" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637824985196853256" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_637824985196853256"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637824985196853256" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_637824985196853256" order="4" use="optional" weight="1"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended" xlink:title="00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e" xlink:to="us-gaap_NetIncomeLoss_637824985196863243" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_637824985196863243" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_637824985196863243" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_637824985196863243" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_637824985196863243" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_637824985196863243" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense_637824985196863243" order="1" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_637824985196863243" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues_637824985196863243" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses_637824985196863243" order="2" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637824985196863243" xlink:to="us-gaap_GeneralAndAdministrativeExpense_637824985196863243" order="1" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ProductionCostsOperating" xlink:label="aqb_ProductionCostsOperating_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637824985196863243" xlink:to="aqb_ProductionCostsOperating_637824985196863243" order="2" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637824985196863243" xlink:to="us-gaap_SellingAndMarketingExpense_637824985196863243" order="3" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637824985196863243" xlink:to="us-gaap_ResearchAndDevelopmentExpense_637824985196863243" order="4" use="optional" weight="1" priority="3"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00400 - Statement - Consolidated Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637462219409693877"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637462219409693877" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637824985196863243" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637462219409693877" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985196863243" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985196863243" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637824985196863243" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="us-gaap_RepaymentsOfSecuredDebt_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985196863243" xlink:to="us-gaap_RepaymentsOfSecuredDebt_637824985196863243" order="2" use="optional" weight="-1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985196863243" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_637824985196863243" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985196863243" xlink:to="us-gaap_ProceedsFromOtherEquity_637824985196863243" order="4" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985196863243" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_637824985196863243" order="5" use="optional" weight="-1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637462219409693877" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985196863243" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985196863243" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637824985196863243" order="1" use="optional" weight="-1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985196863243" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_637824985196863243" order="2" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PaymentsForDepositsOnEquipmentPurchases" xlink:label="aqb_PaymentsForDepositsOnEquipmentPurchases_637824985196863243"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985196863243" xlink:to="aqb_PaymentsForDepositsOnEquipmentPurchases_637824985196863243" order="3" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985196863243" xlink:to="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_637824985196873196" order="4" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985196863243" xlink:to="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_637824985196873196" order="5" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985196863243" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_637824985196873196" order="6" use="optional" weight="-1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637462219409693877" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" order="4" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" xlink:to="us-gaap_NetIncomeLoss_637824985196873196" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637824985196873196" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" xlink:to="us-gaap_ShareBasedCompensation_637824985196873196" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" xlink:to="us-gaap_OtherNoncashIncomeExpense_637824985196873196" order="4" use="optional" weight="-1" priority="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" xlink:to="us-gaap_IncreaseDecreaseInInventories_637824985196873196" order="5" use="optional" weight="-1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637824985196873196" order="6" use="optional" weight="-1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_637824985196873196" order="7" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="us-gaap_IncreaseDecreaseInAccruedSalaries_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985196873196" xlink:to="us-gaap_IncreaseDecreaseInAccruedSalaries_637824985196873196" order="8" use="optional" weight="1" priority="2"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Inventory (Schedule of Inventory) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryAdjustments_637824985196873196" order="1" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryGross_637824985196873196" order="2" use="optional" weight="1" priority="2"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40602 - Disclosure - Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637462219409873978"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet_637462219409873978" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637824985196873196" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637824985196873196"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet_637462219409873978" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637824985196873196" order="2" use="optional" weight="-1"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" xlink:type="extended" xlink:title="40702 - Disclosure - Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DeferredFinanceCostsNet_637824985196883171" order="1" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtCurrent_637824985196883171" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtNoncurrent_637824985196883171" order="3" use="optional" weight="1" priority="2"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails" xlink:type="extended" xlink:title="40703 - Disclosure - Debt (Principal Payments Due on Long-term Debt) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_637824985196883171" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637824985196883171" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_637824985196883171" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_637824985196883171" order="4" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_637824985196883171" order="5" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_637824985196883171" order="6" use="optional" weight="1"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails" xlink:type="extended" xlink:title="40902 - Disclosure - Income Taxes (Components of Loss Before Income Taxes) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d8b6d19-6a54-06aa-2077-c10380bd20d1"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d8b6d19-6a54-06aa-2077-c10380bd20d1" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_637824985196883171" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d8b6d19-6a54-06aa-2077-c10380bd20d1" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_637824985196883171" order="2" use="optional" weight="1"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended" xlink:title="40903 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929"></loc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance" xlink:label="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985196883171" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985196883171" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_637824985196883171" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985196883171" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_637824985196883171" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985196883171" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_637824985196883171" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985196883171" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_637824985196883171" order="4" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985196883171" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_637824985196883171" order="5" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_637824985196883171" order="2" use="optional" weight="1"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended" xlink:title="40904 - Disclosure - Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c003e837-c7c9-cd10-ae74-916131fdc333"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c003e837-c7c9-cd10-ae74-916131fdc333" xlink:to="us-gaap_DeferredTaxAssetsGross_637824985196883171" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637824985196883171" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_637824985196883171" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637824985196883171" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_637824985196883171" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637824985196883171" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_637824985196883171" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_637824985196883171"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637824985196883171" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_637824985196883171" order="4" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_637824985196893153"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c003e837-c7c9-cd10-ae74-916131fdc333" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_637824985196893153" order="2" use="optional" weight="-1"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails" xlink:type="extended" xlink:title="41002 - Disclosure - Commitments and Contingencies (Summary of Lease Obligations) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_637806060406526314"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability_637806060406526314" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_637824985196894674" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability_637806060406526314" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_637824985196894674" order="2" use="optional" weight="1" priority="2"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails" xlink:type="extended" xlink:title="41003 - Disclosure - Commitments and Contingencies (Summary of Remaining Payments under Leases Alternate) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637819178487434978"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637819178487434978" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_637824985196894674" order="1" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637819178487434978" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_637824985196894674" order="2" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637819178487434978" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_637824985196894674" order="3" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637819178487434978" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_637824985196894674" order="4" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637819178487434978" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_637824985196894674" order="5" use="optional" weight="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637819178487434978" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_637824985196894674" order="6" use="optional" weight="1" priority="2"></calculationArc></link:calculationLink>
  <link:calculationLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails" xlink:type="extended" xlink:title="41003 - Disclosure - Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability_637824985196894674" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_637824985196894674"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_637824985196894674" order="2" use="optional" weight="1" priority="3"></calculationArc></link:calculationLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>aqb-20211231_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.1.0.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/10/2022 8:42:01 AM-->
<!--Modified on: 3/10/2022 8:42:01 AM-->
<linkbase p1:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:p1="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.xbrl.org/2003/linkbase">
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedStatementsOfChangesInStockholdersEquity" roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRisksAndUncertaintiesDetails" roleURI="http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails" roleURI="http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureInventoryNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureInventoryNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureInventoryScheduleOfInventoryDetails" roleURI="http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosurePropertyPlantAndEquipmentNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebtNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureDebtNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" roleURI="http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityRestrictedStockActivityDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityStockOptionActivityDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRetirementPlanDetails" roleURI="http://www.sec.gov/role/DisclosureRetirementPlanDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRelatedPartyAgreementDetails" roleURI="http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingencies" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingencies" xlink:type="simple"></link:roleRef>
  <link:roleRef roleURI="http://www.sec.gov/role/DisclosureDebt" xlink:href="aqb-20211231.xsd#DisclosureDebt" xlink:type="simple"></link:roleRef>
  <link:roleRef roleURI="http://www.sec.gov/role/DisclosureInventory" xlink:href="aqb-20211231.xsd#DisclosureInventory" xlink:type="simple"></link:roleRef>
  <link:roleRef roleURI="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganization" xlink:href="aqb-20211231.xsd#DisclosureNatureOfBusinessAndOrganization" xlink:type="simple"></link:roleRef>
  <link:roleRef roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment" xlink:href="aqb-20211231.xsd#DisclosurePropertyPlantAndEquipment" xlink:type="simple"></link:roleRef>
  <link:roleRef roleURI="http://www.sec.gov/role/DisclosureRisksAndUncertainties" xlink:href="aqb-20211231.xsd#DisclosureRisksAndUncertainties" xlink:type="simple"></link:roleRef>
  <link:roleRef roleURI="http://www.sec.gov/role/DisclosureStockholdersEquity" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquity" xlink:type="simple"></link:roleRef>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"></link:arcroleRef>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"></link:arcroleRef>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"></link:arcroleRef>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"></link:arcroleRef>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"></link:arcroleRef>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingencies" xlink:type="extended"></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureDebt" xlink:type="extended"></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureInventory" xlink:type="extended"></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganization" xlink:type="extended"></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment" xlink:type="extended"></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureRisksAndUncertainties" xlink:type="extended"></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquity" xlink:type="extended"></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="extended" xlink:title="00300 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637824985196903115"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_637824985196903115" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExerciseofWarrantsforCommonStockshares" xlink:label="aqb_ExerciseofWarrantsforCommonStockshares"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_StatementLineItems" xlink:to="aqb_ExerciseofWarrantsforCommonStockshares" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExerciseofWarrantsforCommonStock" xlink:label="aqb_ExerciseofWarrantsforCommonStock"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_StatementLineItems" xlink:to="aqb_ExerciseofWarrantsforCommonStock" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_637824985196913114"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_637824985196913114" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_CanadaSubsidiaryMember" xlink:label="aqb_CanadaSubsidiaryMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="aqb_CanadaSubsidiaryMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_UnitedStatesSubsidiaryMember" xlink:label="aqb_UnitedStatesSubsidiaryMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="aqb_UnitedStatesSubsidiaryMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_637824985196913114"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_637824985196913114" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_637824985196913114"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_637824985196913114" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637824985196923066"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_637824985196923066" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_WeightedAverageMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" xlink:type="extended" xlink:title="40202 - Disclosure - Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985196933038"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985196933038" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_OfficeFurnitureandEquipmentMember" xlink:label="aqb_OfficeFurnitureandEquipmentMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="aqb_OfficeFurnitureandEquipmentMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PropertyPlantAndEquipmentUsefulLife1" xlink:label="aqb_PropertyPlantAndEquipmentUsefulLife1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="aqb_PropertyPlantAndEquipmentUsefulLife1" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Risks and Uncertainties (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_StatementGeographicalAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_637824985196943047"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_637824985196943047" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="country_CA"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CA" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_637824985196943047"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_637824985196943047" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="us-gaap_CreditConcentrationRiskMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CreditConcentrationRiskMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_Cash" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Marketable Securities (Schedule of Marketable Securities) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637824985196943047"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637824985196943047" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:label="us-gaap_DomesticCorporateDebtSecuritiesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_DomesticCorporateDebtSecuritiesMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesAmortizedCost" xlink:label="aqb_MarketableSecuritiesAmortizedCost"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="aqb_MarketableSecuritiesAmortizedCost" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesUnrealizedGain" xlink:label="aqb_MarketableSecuritiesUnrealizedGain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="aqb_MarketableSecuritiesUnrealizedGain" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesUnrealizedLoss" xlink:label="aqb_MarketableSecuritiesUnrealizedLoss"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="aqb_MarketableSecuritiesUnrealizedLoss" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecurities" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureInventoryNarrativeDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Inventory (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985196982899"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985196982899" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FishInProcessMember" xlink:label="aqb_FishInProcessMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="aqb_FishInProcessMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryCurrentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryAdjustments" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Inventory (Schedule of Inventory) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FeedMember" xlink:label="aqb_FeedMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="aqb_FeedMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_EggsAndFryMember" xlink:label="aqb_EggsAndFryMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="aqb_EggsAndFryMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PackagingMember" xlink:label="aqb_PackagingMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="aqb_PackagingMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FishInProcessMember" xlink:label="aqb_FishInProcessMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="aqb_FishInProcessMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryCurrentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryAdjustments" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryNet" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Property, Plant and Equipment (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_637824985196992874"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_637824985196992874" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_New10000MetricTonFarmMember" xlink:label="aqb_New10000MetricTonFarmMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="aqb_New10000MetricTonFarmMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_RolloBayFarmAndFortuneBayHatcheryMember" xlink:label="aqb_RolloBayFarmAndFortuneBayHatcheryMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="aqb_RolloBayFarmAndFortuneBayHatcheryMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_IndianaAquacultureFarmMember" xlink:label="aqb_IndianaAquacultureFarmMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="aqb_IndianaAquacultureFarmMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_637824985197002844"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_637824985197002844" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalAdditionsMember" xlink:label="us-gaap_CapitalAdditionsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="us-gaap_CapitalAdditionsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40602 - Disclosure - Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_OfficeFurnitureandEquipmentMember" xlink:label="aqb_OfficeFurnitureandEquipmentMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="aqb_OfficeFurnitureandEquipmentMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureDebtNarrativeDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Debt (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_637824985197012853"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_637824985197012853" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_USTreasuryFiveYearMaturitiesInterestRateMember" xlink:label="aqb_USTreasuryFiveYearMaturitiesInterestRateMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_VariableRateDomain" xlink:to="aqb_USTreasuryFiveYearMaturitiesInterestRateMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_ConsolidatedEntitiesAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_CanadianSubsidiaryMember" xlink:label="aqb_CanadianSubsidiaryMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="aqb_CanadianSubsidiaryMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_637824985197012853"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_637824985197012853" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LoansPayableMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="us-gaap_SecuredDebtMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_SecuredDebtMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_637824985197022814"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_637824985197022814" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FPEITermLoanMember" xlink:label="aqb_FPEITermLoanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_FPEITermLoanMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FirstFarmersBankAndTrustLoanMember" xlink:label="aqb_FirstFarmersBankAndTrustLoanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_FirstFarmersBankAndTrustLoanMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DfoTermLoanMember" xlink:label="aqb_DfoTermLoanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_DfoTermLoanMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_StatementScenarioAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637824985197022814"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_637824985197022814" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage" xlink:label="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentMaturityDateYearMonth" xlink:label="aqb_DebtInstrumentMaturityDateYearMonth"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="aqb_DebtInstrumentMaturityDateYearMonth" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_RepaymentPeriodOfLoan" xlink:label="aqb_RepaymentPeriodOfLoan"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="aqb_RepaymentPeriodOfLoan" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentInterestRateStatedPercentagePeriod" xlink:label="aqb_DebtInstrumentInterestRateStatedPercentagePeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="aqb_DebtInstrumentInterestRateStatedPercentagePeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentInterestOnlyPaymentPeriod" xlink:label="aqb_DebtInstrumentInterestOnlyPaymentPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="aqb_DebtInstrumentInterestOnlyPaymentPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentCovenantCashBalanceMinimum" xlink:label="aqb_DebtInstrumentCovenantCashBalanceMinimum"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="aqb_DebtInstrumentCovenantCashBalanceMinimum" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" xlink:type="extended" xlink:title="40702 - Disclosure - Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LoansPayableMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="us-gaap_SecuredDebtMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_SecuredDebtMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_KubotaCanadaLtdMember" xlink:label="aqb_KubotaCanadaLtdMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_KubotaCanadaLtdMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FPEITermLoanMember" xlink:label="aqb_FPEITermLoanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_FPEITermLoanMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DfoTermLoanMember" xlink:label="aqb_DfoTermLoanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_DfoTermLoanMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FirstFarmersBankAndTrustLoanMember" xlink:label="aqb_FirstFarmersBankAndTrustLoanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="aqb_FirstFarmersBankAndTrustLoanMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPayment" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentMaturityDateYearMonth" xlink:label="aqb_DebtInstrumentMaturityDateYearMonth"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="aqb_DebtInstrumentMaturityDateYearMonth" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtCurrent" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Stockholders&apos; Equity (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_637824985197062349"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_637824985197062349" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_December2020PublicOfferingMember" xlink:label="aqb_December2020PublicOfferingMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="aqb_December2020PublicOfferingMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_February2021PublicOfferingMember" xlink:label="aqb_February2021PublicOfferingMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="aqb_February2021PublicOfferingMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637824985197062349"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637824985197062349" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637824985197072320"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_637824985197072320" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_A2016EquityIncentivePlanMember" xlink:label="aqb_A2016EquityIncentivePlanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PlanNameDomain" xlink:to="aqb_A2016EquityIncentivePlanMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197072320"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197072320" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="7" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637824985197082293"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637824985197082293" use="optional"></definitionArc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AuthorizedShares" xlink:label="aqb_AuthorizedShares"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="aqb_AuthorizedShares" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockSharesIssued" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockVotingRights" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_WarrantsAbstract" xlink:label="aqb_WarrantsAbstract"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqb_WarrantsAbstract" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aqb_WarrantsAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="us-gaap_ShareBasedCompensationAbstract"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationAbstract" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensation" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Stockholders&apos; Equity (Information About Outstanding Warrants) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails" xlink:type="extended" xlink:title="40803 - Disclosure - Stockholders&apos; Equity (Restricted Stock Activity) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails" xlink:type="extended" xlink:title="40804 - Disclosure - Stockholders&apos; Equity (Stock Option Activity) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails" xlink:type="extended" xlink:title="40805 - Disclosure - Stockholders&apos; Equity (Information About Options Outstanding and Exercisable) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_AwardTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="srt_RangeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceOneMember" xlink:label="aqb_ExercisePriceOneMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqb_ExercisePriceOneMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceTwoMember" xlink:label="aqb_ExercisePriceTwoMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqb_ExercisePriceTwoMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceThreeMember" xlink:label="aqb_ExercisePriceThreeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqb_ExercisePriceThreeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceFourMember" xlink:label="aqb_ExercisePriceFourMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqb_ExercisePriceFourMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails" xlink:type="extended" xlink:title="40806 - Disclosure - Stockholders&apos; Equity (Stock Option Grants Weighted Average Assumptions) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails" xlink:type="extended" xlink:title="40808 - Disclosure - Stockholders&apos; Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_637824985197201975"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_637824985197201975" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Income Taxes (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_637824985197201975"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_637824985197201975" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_637824985197201975"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_637824985197201975" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_StatementScenarioAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_LimitationsOnUseToSection382Member" xlink:label="aqb_LimitationsOnUseToSection382Member"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="aqb_LimitationsOnUseToSection382Member" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureRetirementPlanDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Retirement Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis" xlink:label="us-gaap_RetirementPlanSponsorLocationAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_RetirementPlanSponsorLocationAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain" xlink:label="us-gaap_RetirementPlanSponsorLocationDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="us-gaap_RetirementPlanSponsorLocationDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain" xlink:label="us-gaap_RetirementPlanSponsorLocationDomain_637824985197213484"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="us-gaap_RetirementPlanSponsorLocationDomain_637824985197213484" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember" xlink:label="us-gaap_ForeignPlanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="us-gaap_ForeignPlanMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanCostRecognized" priority="1" use="optional"></definitionArc></link:definitionLink>
  <link:definitionLink xlink:role="http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Related Party Agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_637824985197213484"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_637824985197213484" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_TsAquacultureMember" xlink:label="aqb_TsAquacultureMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="aqb_TsAquacultureMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" priority="1" use="optional"></definitionArc></link:definitionLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>aqb-20211231_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.1.0.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/10/2022 8:42:01 AM-->
<!--Modified on: 3/10/2022 8:42:01 AM-->
<linkbase p1:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:p1="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.xbrl.org/2003/linkbase">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Transition Report</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line Two</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Interactive Data Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Small Business</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Ex Transition Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Shell Company</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Documents Incorporated by Reference</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Balance Sheets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable securities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment, net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right of use assets, net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right of use assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Cash</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets, Noncurrent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and stockholders&#8217; equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee-related Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued employee compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Current Maturities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">less: current portion</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current debt</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term leases</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term lease obligations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Excluding Current Maturities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term debt, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies (Note 10)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders&apos; Equity Attributable to Parent [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders&#8217; equity:</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders&apos; Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Value, Issued</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, $0.001 par value, 80,000,000 shares authorized; 71,025,738 and 55,497,133 shares outstanding at December 31, 2021 and 2020, respectively</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid in Capital</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional paid-in capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated other comprehensive loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated deficit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders&apos; Equity Attributable to Parent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total stockholders&#8217; equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities and stockholders&#8217; equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, par value (in dollars per share)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares Authorized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, shares authorized (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Outstanding</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, shares outstanding (in shares)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding shares of common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Consolidated Statements of Operations and Comprehensive Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Product revenues</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Costs and Expenses [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Costs and expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ProductionCostsOperating" xlink:label="aqb_ProductionCostsOperating" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_ProductionCostsOperating" xlink:to="aqb_ProductionCostsOperating_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_ProductionCostsOperating_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Production Costs Operating</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_ProductionCostsOperating_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Production Costs Operating</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_ProductionCostsOperating_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Product costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling and Marketing Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sales and marketing</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and Administrative Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Expenses</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total costs and expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Income (Loss)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income (expense)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Nonoperating Income (Expense)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income (expense), net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nonoperating Income (Expense)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other income (expense)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income (loss):</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrealized losses on marketable securities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Basic and Diluted</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic and diluted net loss per share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average number of common shares - basic and diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Statements of Changes in Stockholders&apos; Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Component [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid In Capital [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid-In Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained Earnings [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Deficit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares, Outstanding</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance (in shares)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of common stock for service (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of common stock for service</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cashless exercise of options for common stock (in shares)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cashless exercise of options for common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of common stock, net of expenses (in shares)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of common stock, net of expenses</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of equity subscription</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExerciseofWarrantsforCommonStockshares" xlink:label="aqb_ExerciseofWarrantsforCommonStockshares" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_ExerciseofWarrantsforCommonStockshares" xlink:to="aqb_ExerciseofWarrantsforCommonStockshares_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_ExerciseofWarrantsforCommonStockshares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of Warrants for Common Stock, shares.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_ExerciseofWarrantsforCommonStockshares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exerciseof Warrantsfor Common Stockshares</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_ExerciseofWarrantsforCommonStockshares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of warrants for common stock (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExerciseofWarrantsforCommonStock" xlink:label="aqb_ExerciseofWarrantsforCommonStock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_ExerciseofWarrantsforCommonStock" xlink:to="aqb_ExerciseofWarrantsforCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_ExerciseofWarrantsforCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of stock issued as a result of the exercise of warrants for common shares.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_ExerciseofWarrantsforCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exerciseof Warrantsfor Common Stock</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_ExerciseofWarrantsforCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of warrants for common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share based compensation (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Statements of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustment to reconcile net loss to net cash used in operating activities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, Depletion and Amortization</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and amortization</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Noncash Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other non-cash charge</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in operating assets and liabilities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Inventories</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and other assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="us-gaap_IncreaseDecreaseInAccruedSalaries" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:to="us-gaap_IncreaseDecreaseInAccruedSalaries_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedSalaries_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accrued Salaries</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedSalaries_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued employee compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash used in operating activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investing activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchases of property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PaymentsForDepositsOnEquipmentPurchases" xlink:label="aqb_PaymentsForDepositsOnEquipmentPurchases" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_PaymentsForDepositsOnEquipmentPurchases" xlink:to="aqb_PaymentsForDepositsOnEquipmentPurchases_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_PaymentsForDepositsOnEquipmentPurchases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments For Deposits On Equipment Purchases</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_PaymentsForDepositsOnEquipmentPurchases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments For Deposits On Equipment Purchases</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="aqb_PaymentsForDepositsOnEquipmentPurchases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deposits on equipment purchases</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Sale of Machinery and Equipment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Marketable Securities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchases of marketable securities, net</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" xlink:to="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds (Payments) for Legal Settlements, Investing Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds (Payments) For Legal Settlements, Investing Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from legal settlement, net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from legal settlement, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other investing activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash used in investing activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Long-term Debt</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of debt</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of Debt Issuance Costs</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment of debt issuance costs</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan settlement costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="us-gaap_RepaymentsOfSecuredDebt" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfSecuredDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayments of Secured Debt</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_RepaymentsOfSecuredDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayment of term debt</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Common Stock</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from the issuance of common stock, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Other Equity</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from the exercise of stock options and warrants</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash provided by financing activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net change in cash, cash equivalents and restricted cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheet:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Cash and Cash Equivalents</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental disclosure of cash flow information and non-cash transactions:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest paid in cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment included in accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nature of Business and Organization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nature of Operations [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nature of Business and Organization</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Accounting Policies [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of Significant Accounting Policies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risks and Uncertainties</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders&apos; Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shareholders&apos; Equity and Share-based Payments [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders&apos; Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement Plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Agreement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Agreement</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_NatureOfOperationsPolicyPolicyTextBlock" xlink:label="aqb_NatureOfOperationsPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_NatureOfOperationsPolicyPolicyTextBlock" xlink:to="aqb_NatureOfOperationsPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_NatureOfOperationsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nature Of Operations, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_NatureOfOperationsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nature Of Operations, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_NatureOfOperationsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nature of Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Presentation</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_LiquidityPolicyPolicyTextBlock" xlink:label="aqb_LiquidityPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_LiquidityPolicyPolicyTextBlock" xlink:to="aqb_LiquidityPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_LiquidityPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_LiquidityPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_LiquidityPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Use of Estimates</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of Long-lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Leases [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue Recognition</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Loss Per Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Recently Issued Accounting Standards</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment Estimated Useful Lives [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment Estimated Useful Lives [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment Estimated Useful Lives</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Terms and Conditions of Long-term Debt Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principal Payments Due on Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Stockholders&apos; Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information About Outstanding Warrants</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Activity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Option Activity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information About Options Outstanding and Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Option Grants Weighted Average Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Costs Recognized on Financial Statements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of Loss before Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of Deferred Tax Assets and Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Disclosure [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of Remaining Payments under Leases</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AdditionalCashAndCashEquivalents" xlink:label="aqb_AdditionalCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_AdditionalCashAndCashEquivalents" xlink:to="aqb_AdditionalCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_AdditionalCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Cash And Cash Equivalents</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_AdditionalCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Cash And Cash Equivalents</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_AdditionalCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, cash equivalents, marketable securities and restricted cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite Lived Intangible Assets Major Class Name [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Patents [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Name [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Stock Option [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Liability</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease liability</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total leases</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total leases</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Discount Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Patents, useful life</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potentially dilutive securities outstanding (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property Plant And Equipment Type [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Building [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equipment [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_OfficeFurnitureandEquipmentMember" xlink:label="aqb_OfficeFurnitureandEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_OfficeFurnitureandEquipmentMember" xlink:to="aqb_OfficeFurnitureandEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_OfficeFurnitureandEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Office Furniture and Equipment [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_OfficeFurnitureandEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Office Furnitureand Equipment [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_OfficeFurnitureandEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Office Furniture And Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vehicles [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold Improvements [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment, useful life</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PropertyPlantAndEquipmentUsefulLife1" xlink:label="aqb_PropertyPlantAndEquipmentUsefulLife1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_PropertyPlantAndEquipmentUsefulLife1" xlink:to="aqb_PropertyPlantAndEquipmentUsefulLife1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_PropertyPlantAndEquipmentUsefulLife1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Useful Life 1</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_PropertyPlantAndEquipmentUsefulLife1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Useful Life 1</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_PropertyPlantAndEquipmentUsefulLife1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment, useful life</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Geographical [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="country_CA" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">C [A]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CA_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canada [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Type [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="us-gaap_CreditConcentrationRiskMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditConcentrationRiskMember" xlink:to="us-gaap_CreditConcentrationRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditConcentrationRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit Concentration Risk [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CreditConcentrationRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash in Canadian bank accounts</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Equivalents, at Carrying Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash equivalent investment balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">U S Government Agencies Debt Securities [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Government Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:label="us-gaap_DomesticCorporateDebtSecuritiesMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="us-gaap_DomesticCorporateDebtSecuritiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCorporateDebtSecuritiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Domestic Corporate Debt Securities [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DomesticCorporateDebtSecuritiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporate Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommercialPaperMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commercial Paper [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommercialPaperMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesAmortizedCost" xlink:label="aqb_MarketableSecuritiesAmortizedCost" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_MarketableSecuritiesAmortizedCost" xlink:to="aqb_MarketableSecuritiesAmortizedCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_MarketableSecuritiesAmortizedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities, Amortized Cost</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_MarketableSecuritiesAmortizedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities, Amortized Cost</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_MarketableSecuritiesAmortizedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortized cost</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesUnrealizedGain" xlink:label="aqb_MarketableSecuritiesUnrealizedGain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_MarketableSecuritiesUnrealizedGain" xlink:to="aqb_MarketableSecuritiesUnrealizedGain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_MarketableSecuritiesUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities, Unrealized Gain</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_MarketableSecuritiesUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities, Unrealized Gain</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_MarketableSecuritiesUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrealized Gains</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesUnrealizedLoss" xlink:label="aqb_MarketableSecuritiesUnrealizedLoss" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_MarketableSecuritiesUnrealizedLoss" xlink:to="aqb_MarketableSecuritiesUnrealizedLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_MarketableSecuritiesUnrealizedLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities, Unrealized Loss</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_MarketableSecuritiesUnrealizedLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities, Unrealized Loss</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqb_MarketableSecuritiesUnrealizedLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrealized Losses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Market Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryCurrentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryCurrentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Current [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryCurrentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilitiesInventoryAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Public Utilities Inventory Type [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FishInProcessMember" xlink:label="aqb_FishInProcessMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_FishInProcessMember" xlink:to="aqb_FishInProcessMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_FishInProcessMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fish In Process [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_FishInProcessMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fish In Process [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_FishInProcessMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fish In Process [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryAdjustments" xlink:to="us-gaap_InventoryAdjustments_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryAdjustments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory Adjustments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryAdjustments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less inventory reserve</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryAdjustments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory reserve</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FeedMember" xlink:label="aqb_FeedMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_FeedMember" xlink:to="aqb_FeedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_FeedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Feed [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_FeedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Feed [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_FeedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Feed [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_EggsAndFryMember" xlink:label="aqb_EggsAndFryMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_EggsAndFryMember" xlink:to="aqb_EggsAndFryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_EggsAndFryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Eggs And Fry</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_EggsAndFryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Eggs And Fry [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_EggsAndFryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Eggs And Fry [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PackagingMember" xlink:label="aqb_PackagingMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_PackagingMember" xlink:to="aqb_PackagingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_PackagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Packaging [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_PackagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Packaging [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_PackagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Packaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Gross</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Real Estate And Accumulated Depreciation Name Of Property [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_RolloBayFarmAndFortuneBayHatcheryMember" xlink:label="aqb_RolloBayFarmAndFortuneBayHatcheryMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_RolloBayFarmAndFortuneBayHatcheryMember" xlink:to="aqb_RolloBayFarmAndFortuneBayHatcheryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_RolloBayFarmAndFortuneBayHatcheryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rollo Bay Farm And Fortune Bay Hatchery [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_RolloBayFarmAndFortuneBayHatcheryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rollo Bay Farm And Fortune Bay Hatchery [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_RolloBayFarmAndFortuneBayHatcheryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rollo Bay Farm And Fortune Bay Hatchery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_IndianaAquacultureFarmMember" xlink:label="aqb_IndianaAquacultureFarmMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_IndianaAquacultureFarmMember" xlink:to="aqb_IndianaAquacultureFarmMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_IndianaAquacultureFarmMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indiana Aquaculture Farm [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_IndianaAquacultureFarmMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indiana Aquaculture Farm [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_IndianaAquacultureFarmMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indiana Aquaculture Farm [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_New10000MetricTonFarmMember" xlink:label="aqb_New10000MetricTonFarmMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_New10000MetricTonFarmMember" xlink:to="aqb_New10000MetricTonFarmMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_New10000MetricTonFarmMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New 10,000 Metric Ton Farm [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_New10000MetricTonFarmMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New10000 Metric Ton Farm [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_New10000MetricTonFarmMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ohio Farm [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Construction In Progress [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Construction In Process [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long Term Purchase Commitment Category Of Item Purchased [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalAdditionsMember" xlink:label="us-gaap_CapitalAdditionsMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalAdditionsMember" xlink:to="us-gaap_CapitalAdditionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalAdditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Additions [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalAdditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Addition Purchase Commitments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and amortization expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Gross</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total property and equipment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross property, plant, and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Purchase Commitment, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments to purchase property, plant, and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Land [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Building And Building Improvements [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Building And Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less accumulated depreciation and amortization</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Variable Rate [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VariableRateDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_USTreasuryFiveYearMaturitiesInterestRateMember" xlink:label="aqb_USTreasuryFiveYearMaturitiesInterestRateMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_USTreasuryFiveYearMaturitiesInterestRateMember" xlink:to="aqb_USTreasuryFiveYearMaturitiesInterestRateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_USTreasuryFiveYearMaturitiesInterestRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">US Treasury Five-year Maturities Interest Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_USTreasuryFiveYearMaturitiesInterestRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">U S Treasury Five Year Maturities Interest Rate [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_USTreasuryFiveYearMaturitiesInterestRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">US Treasury 5-Year Maturities Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Entities [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_CanadianSubsidiaryMember" xlink:label="aqb_CanadianSubsidiaryMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_CanadianSubsidiaryMember" xlink:to="aqb_CanadianSubsidiaryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_CanadianSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canadian Subsidiary [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_CanadianSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canadian Subsidiary [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_CanadianSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canadian Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Longterm Debt Type [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableMember" xlink:to="us-gaap_LoansPayableMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loans Payable [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansPayableMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="us-gaap_SecuredDebtMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebtMember" xlink:to="us-gaap_SecuredDebtMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuredDebtMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Secured Debt [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecuredDebtMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument Name [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DfoTermLoanMember" xlink:label="aqb_DfoTermLoanMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_DfoTermLoanMember" xlink:to="aqb_DfoTermLoanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_DfoTermLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DFO Term Loan [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_DfoTermLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dfo Term Loan [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_DfoTermLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DFO Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Atlantic Canada Opportunities Agency Term Loan 3 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Atlantic Canada Opportunities Agency Term Loan3 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ACOA Term Loan #3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage" xlink:label="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage" xlink:to="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Repayment Terms, Royalty Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Repayment Terms, Royalty Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Royalty percentage</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Face Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount borrowed</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan term</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Maturity Date</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity date</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentMaturityDateYearMonth" xlink:label="aqb_DebtInstrumentMaturityDateYearMonth" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_DebtInstrumentMaturityDateYearMonth" xlink:to="aqb_DebtInstrumentMaturityDateYearMonth_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_DebtInstrumentMaturityDateYearMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument Maturity Date Year Month</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_DebtInstrumentMaturityDateYearMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument Maturity Date Year Month</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_DebtInstrumentMaturityDateYearMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Expense, Debt</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_RepaymentPeriodOfLoan" xlink:label="aqb_RepaymentPeriodOfLoan" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_RepaymentPeriodOfLoan" xlink:to="aqb_RepaymentPeriodOfLoan_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_RepaymentPeriodOfLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayment Period Of Loan</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_RepaymentPeriodOfLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayment Period Of Loan</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_RepaymentPeriodOfLoan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan repayment period</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentInterestRateStatedPercentagePeriod" xlink:label="aqb_DebtInstrumentInterestRateStatedPercentagePeriod" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_DebtInstrumentInterestRateStatedPercentagePeriod" xlink:to="aqb_DebtInstrumentInterestRateStatedPercentagePeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_DebtInstrumentInterestRateStatedPercentagePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest Rate, Stated Percentage, Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_DebtInstrumentInterestRateStatedPercentagePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest Rate, Stated Percentage, Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_DebtInstrumentInterestRateStatedPercentagePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate, period</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentInterestOnlyPaymentPeriod" xlink:label="aqb_DebtInstrumentInterestOnlyPaymentPeriod" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_DebtInstrumentInterestOnlyPaymentPeriod" xlink:to="aqb_DebtInstrumentInterestOnlyPaymentPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_DebtInstrumentInterestOnlyPaymentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest Only Payment Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_DebtInstrumentInterestOnlyPaymentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest Only Payment Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_DebtInstrumentInterestOnlyPaymentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest only payment period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis spread on variable rate</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentCovenantCashBalanceMinimum" xlink:label="aqb_DebtInstrumentCovenantCashBalanceMinimum" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_DebtInstrumentCovenantCashBalanceMinimum" xlink:to="aqb_DebtInstrumentCovenantCashBalanceMinimum_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_DebtInstrumentCovenantCashBalanceMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Covenant, Cash Balance, Minimum</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_DebtInstrumentCovenantCashBalanceMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Covenant, Cash Balance, Minimum</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_DebtInstrumentCovenantCashBalanceMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Covenant, minimum cash balance</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Atlantic Canada Opportunities Agency AIF Grant</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Atlantic Canada Opportunities Agency A I F Grant [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ACOA AIF Grant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Atlantic Canada Opportunities Agency Term Loan 1 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Atlantic Canada Opportunities Agency Term Loan1 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ACOA Term Loan #1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Atlantic Canada Opportunities Agency Term Loan 2 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Atlantic Canada Opportunities Agency Term Loan2 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ACOA Term Loan #2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_KubotaCanadaLtdMember" xlink:label="aqb_KubotaCanadaLtdMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_KubotaCanadaLtdMember" xlink:to="aqb_KubotaCanadaLtdMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_KubotaCanadaLtdMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kubota Canada Ltd [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_KubotaCanadaLtdMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kubota Canada Ltd [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_KubotaCanadaLtdMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kubota Canada Ltd [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FPEITermLoanMember" xlink:label="aqb_FPEITermLoanMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_FPEITermLoanMember" xlink:to="aqb_FPEITermLoanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_FPEITermLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FPEI Term Loan [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_FPEITermLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">F P E I Term Loan [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_FPEITermLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">PEI Finance Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FirstFarmersBankAndTrustLoanMember" xlink:label="aqb_FirstFarmersBankAndTrustLoanMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_FirstFarmersBankAndTrustLoanMember" xlink:to="aqb_FirstFarmersBankAndTrustLoanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_FirstFarmersBankAndTrustLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First Farmers Bank And Trust Loan</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_FirstFarmersBankAndTrustLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First Farmers Bank And Trust Loan [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_FirstFarmersBankAndTrustLoanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First Farmers Bank &amp; Trust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Periodic Payment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Monthly repayment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total debt</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Issuance Costs, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">less: debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Year</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2022</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2023</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2024</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2025</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2026</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Maturities, Repayments of Principal after Year Five</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_December2020PublicOfferingMember" xlink:label="aqb_December2020PublicOfferingMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_December2020PublicOfferingMember" xlink:to="aqb_December2020PublicOfferingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_December2020PublicOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 2020 Public Offering [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_December2020PublicOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December2020 Public Offering [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_December2020PublicOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 2020 Public Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_February2021PublicOfferingMember" xlink:label="aqb_February2021PublicOfferingMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_February2021PublicOfferingMember" xlink:to="aqb_February2021PublicOfferingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_February2021PublicOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">February 2021 Public Offering [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_February2021PublicOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">February2021 Public Offering [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_February2021PublicOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">February 2021 Public Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class Of Warrant Or Right [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan Name [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_A2016EquityIncentivePlanMember" xlink:label="aqb_A2016EquityIncentivePlanMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_A2016EquityIncentivePlanMember" xlink:to="aqb_A2016EquityIncentivePlanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_A2016EquityIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Equity Incentive Plan [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_A2016EquityIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">A2016 Equity Incentive Plan [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_A2016EquityIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Award [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class Of Stock [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AuthorizedShares" xlink:label="aqb_AuthorizedShares" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_AuthorizedShares" xlink:to="aqb_AuthorizedShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_AuthorizedShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of common and preferred shares authorized by the Company.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_AuthorizedShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Authorized Shares</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_AuthorizedShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Authorized shares of common and preferred stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Authorized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Authorized shares of preferred stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Issued</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued shares of preferred stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Outstanding</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding shares of preferred stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Issued</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued shares of common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Voting Rights</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, voting rights, number of votes per share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance or Sale of Equity</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance or sale of equity</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_WarrantsAbstract" xlink:label="aqb_WarrantsAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_WarrantsAbstract" xlink:to="aqb_WarrantsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_WarrantsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_WarrantsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_WarrantsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants and Rights Outstanding, Maturity Date</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expiration date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="us-gaap_ShareBasedCompensationAbstract" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares authorized to grant</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares reserved for future issuance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Allocated Share-based Compensation Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total share-based compensation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unearned share-based compensation expense in future periods</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unearned share-based compensation earn period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award vesting period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable term</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average fair value of stock options grants (in dollars per share)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intrinsic value of options exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intrinsic value of options outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intrinsic value of exercisable options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected volatility</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk free interest rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected dividend yield</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected life (in years)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding, ending balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding, beginning balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expired</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding, ending balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding, beginning balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expired</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceOneMember" xlink:label="aqb_ExercisePriceOneMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_ExercisePriceOneMember" xlink:to="aqb_ExercisePriceOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_ExercisePriceOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price One [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_ExercisePriceOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price One [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_ExercisePriceOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">$1.88 - $2.50</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceTwoMember" xlink:label="aqb_ExercisePriceTwoMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_ExercisePriceTwoMember" xlink:to="aqb_ExercisePriceTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_ExercisePriceTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price Two [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_ExercisePriceTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price Two [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_ExercisePriceTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">$3.30 - $6.72</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceThreeMember" xlink:label="aqb_ExercisePriceThreeMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_ExercisePriceThreeMember" xlink:to="aqb_ExercisePriceThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_ExercisePriceThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price Three [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_ExercisePriceThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price Three [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_ExercisePriceThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">$7.50 - $10.80</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceFourMember" xlink:label="aqb_ExercisePriceFourMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_ExercisePriceFourMember" xlink:to="aqb_ExercisePriceFourMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_ExercisePriceFourMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price Four [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_ExercisePriceFourMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price Four [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_ExercisePriceFourMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">$14.20 - $23.40</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of outstanding options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining estimated life (in years)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research And Development Expense [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research And Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General And Administrative Expense [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General And Administrative [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Credit Carryforward [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Authority [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Domestic Country [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Country [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Credit Carryforward Name [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario Unspecified [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_LimitationsOnUseToSection382Member" xlink:label="aqb_LimitationsOnUseToSection382Member" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_LimitationsOnUseToSection382Member" xlink:to="aqb_LimitationsOnUseToSection382Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_LimitationsOnUseToSection382Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Limitations On Use To Section 382 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_LimitationsOnUseToSection382Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Limitations On Use To Section382 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_LimitationsOnUseToSection382Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Limitations On Use To Section 382 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Credit Carryforward [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Loss Carryforwards</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Domestic operating loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign operating loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Credit Carryforward, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign research and development tax credit carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Domestic</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss before income taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax benefit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">State and provincial income tax, net of federal benefit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Permanent differences</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">US-Foreign rate differential</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other, net</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance" xlink:label="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance" xlink:to="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Expense (Benefit), Before Valuation Allowance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Expense (Benefit), Before Valuation Allowance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total income tax, prior to change in valuation allowance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in valuation allowance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Expense (Benefit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total income tax</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net operating loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign research and development tax credit carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangibles and other</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Gross</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation allowance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasedAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Leased Assets [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Payments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease payment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining lease term</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Liability, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less: current portion</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2022</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2023</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2024</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2025</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2026</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less: imputed interest</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis" xlink:label="us-gaap_RetirementPlanSponsorLocationAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="us-gaap_RetirementPlanSponsorLocationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetirementPlanSponsorLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain" xlink:label="us-gaap_RetirementPlanSponsorLocationDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="us-gaap_RetirementPlanSponsorLocationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetirementPlanSponsorLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetirementPlanSponsorLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember" xlink:label="us-gaap_ForeignPlanMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignPlanMember" xlink:to="us-gaap_ForeignPlanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignPlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Plan [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignPlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canada</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan, Cost</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employer contributions to retirement plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Domain]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_TsAquacultureMember" xlink:label="aqb_TsAquacultureMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_TsAquacultureMember" xlink:to="aqb_TsAquacultureMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_TsAquacultureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">TS Aquaculture [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_TsAquacultureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ts Aquaculture [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_TsAquacultureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">TS Aquaculture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares sold in public offering</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses incurred</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_CanadaSubsidiaryMember" xlink:label="aqb_CanadaSubsidiaryMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_CanadaSubsidiaryMember" xlink:to="aqb_CanadaSubsidiaryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_CanadaSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canada Subsidiary [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_CanadaSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canada Subsidiary [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_CanadaSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canada Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_UnitedStatesSubsidiaryMember" xlink:label="aqb_UnitedStatesSubsidiaryMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqb_UnitedStatesSubsidiaryMember" xlink:to="aqb_UnitedStatesSubsidiaryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqb_UnitedStatesSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">United States Subsidiary [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqb_UnitedStatesSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">United States Subsidiary [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqb_UnitedStatesSubsidiaryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">United States Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xmlns="http://www.xbrl.org/2003/linkbase"></link:loc>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase"></link:labelArc>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario Forecast [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forecast</link:label></link:labelLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>aqb-20211231_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.1.0.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/10/2022 8:42:01 AM-->
<!--Modified on: 3/10/2022 8:42:01 AM-->
<linkbase p1:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:p1="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.xbrl.org/2003/linkbase">
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.sec.gov/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.sec.gov/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedBalanceSheetsParenthetical" roleURI="http://www.sec.gov/role/StatementConsolidatedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedStatementsOfChangesInStockholdersEquity" roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureNatureOfBusinessAndOrganization" roleURI="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganization" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureSummaryOfSignificantAccountingPolicies" roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRisksAndUncertainties" roleURI="http://www.sec.gov/role/DisclosureRisksAndUncertainties" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureMarketableSecurities" roleURI="http://www.sec.gov/role/DisclosureMarketableSecurities" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureInventory" roleURI="http://www.sec.gov/role/DisclosureInventory" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosurePropertyPlantAndEquipment" roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebt" roleURI="http://www.sec.gov/role/DisclosureDebt" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquity" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxes" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingencies" roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRetirementPlan" roleURI="http://www.sec.gov/role/DisclosureRetirementPlan" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRelatedPartyAgreement" roleURI="http://www.sec.gov/role/DisclosureRelatedPartyAgreement" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureNatureOfBusinessAndOrganizationPolicy" roleURI="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicy" roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureMarketableSecuritiesTables" roleURI="http://www.sec.gov/role/DisclosureMarketableSecuritiesTables" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureInventoryTables" roleURI="http://www.sec.gov/role/DisclosureInventoryTables" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosurePropertyPlantAndEquipmentTables" roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentTables" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebtTables" roleURI="http://www.sec.gov/role/DisclosureDebtTables" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityTables" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityTables" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesTables" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesTables" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingenciesTables" roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureNatureOfBusinessAndOrganizationDetails" roleURI="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" roleURI="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRisksAndUncertaintiesDetails" roleURI="http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails" roleURI="http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureInventoryNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureInventoryNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureInventoryScheduleOfInventoryDetails" roleURI="http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosurePropertyPlantAndEquipmentNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebtNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureDebtNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" roleURI="http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails" roleURI="http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityRestrictedStockActivityDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityStockOptionActivityDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails" roleURI="http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingenciesNarrativeDetails" roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails" roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails" roleURI="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRetirementPlanDetails" roleURI="http://www.sec.gov/role/DisclosureRetirementPlanDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:roleRef xlink:type="simple" xlink:href="aqb-20211231.xsd#DisclosureRelatedPartyAgreementDetails" roleURI="http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase"></link:roleRef>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType_637824985197232231" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag_637824985197232231" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport_637824985197232231" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus_637824985197232231" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate_637824985197232231" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus_637824985197232231" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_637824985197232231" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport_637824985197232231" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber_637824985197232231" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName_637824985197232231" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_637824985197232231" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_637824985197232231" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_637824985197232231" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_637824985197232231" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_637824985197232231" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_637824985197232231" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_637824985197232231" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637824985197232231"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode_637824985197232231" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber_637824985197242205" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle_637824985197242205" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol_637824985197242205" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName_637824985197242205" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer_637824985197242205" order="23" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers_637824985197242205" order="24" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus_637824985197242205" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent_637824985197242205" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory_637824985197242205" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness_637824985197242205" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_637824985197242205" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod_637824985197242205" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag_637824985197242205" order="31" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany_637824985197242205" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat_637824985197242205" order="33" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding_637824985197242205" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_637824985197242205" order="35" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637824985197242205"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey_637824985197242205" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName_637824985197252246" order="37" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation_637824985197252246" order="38" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId_637824985197252246" order="39" use="optional" priority="2"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Consolidated Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_637462219409513983"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637462219409513983" xlink:to="us-gaap_AssetsAbstract_637824985197252246" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637824985197252246" xlink:to="us-gaap_AssetsCurrentAbstract_637824985197252246" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637824985197252246" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637824985197252246" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637824985197252246" xlink:to="us-gaap_MarketableSecuritiesCurrent_637824985197252246" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637824985197252246" xlink:to="us-gaap_InventoryNet_637824985197252246" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637824985197252246" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637824985197252246" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637824985197252246" xlink:to="us-gaap_AssetsCurrent_637824985197252246" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637824985197252246" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637824985197252246" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637824985197252246" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_637824985197252246" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637824985197252246" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_637824985197252246" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637824985197252246" xlink:to="us-gaap_RestrictedCash_637824985197252246" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637824985197252246" xlink:to="us-gaap_OtherAssetsNoncurrent_637824985197252246" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637824985197252246" xlink:to="us-gaap_Assets_637824985197252246" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637462219409513983" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246" xlink:to="us-gaap_LiabilitiesCurrentAbstract_637824985197252246" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637824985197252246" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637824985197252246" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637824985197252246" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_637824985197252246" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637824985197252246" xlink:to="us-gaap_LongTermDebtCurrent_637824985197252246" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637824985197252246" xlink:to="us-gaap_OtherLiabilitiesCurrent_637824985197252246" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637824985197252246"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637824985197252246" xlink:to="us-gaap_LiabilitiesCurrent_637824985197252246" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_637824985197262181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246" xlink:to="us-gaap_LongTermDebtNoncurrent_637824985197262181" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246" xlink:to="us-gaap_Liabilities_637824985197262181" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246" xlink:to="us-gaap_CommitmentsAndContingencies_637824985197262181" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246" xlink:to="us-gaap_StockholdersEquityAbstract_637824985197262181" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197262181" xlink:to="us-gaap_CommonStockValue_637824985197262181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197262181" xlink:to="us-gaap_AdditionalPaidInCapital_637824985197262181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197262181" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637824985197262181" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197262181" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_637824985197262181" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197262181" xlink:to="us-gaap_StockholdersEquity_637824985197262181" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637824985197252246" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_637824985197262181" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="00105 - Statement - Consolidated Balance Sheets (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_637462219409573947"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637462219409573947" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_637824985197262181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637462219409573947" xlink:to="us-gaap_CommonStockSharesAuthorized_637824985197262181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637462219409573947" xlink:to="us-gaap_CommonStockSharesOutstanding_637824985197262181" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended" xlink:title="00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_RevenuesAbstract_637824985197262181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract_637824985197262181" xlink:to="us-gaap_Revenues_637824985197262181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_CostsAndExpensesAbstract_637824985197262181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ProductionCostsOperating" xlink:label="aqb_ProductionCostsOperating_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_637824985197262181" xlink:to="aqb_ProductionCostsOperating_637824985197262181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_637824985197262181" xlink:to="us-gaap_SellingAndMarketingExpense_637824985197262181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_637824985197262181"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_637824985197262181" xlink:to="us-gaap_ResearchAndDevelopmentExpense_637824985197262181" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_637824985197262181" xlink:to="us-gaap_GeneralAndAdministrativeExpense_637824985197272124" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_637824985197262181" xlink:to="us-gaap_OperatingExpenses_637824985197272124" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_OperatingIncomeLoss_637824985197272124" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_637824985197272124" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_637824985197272124" xlink:to="us-gaap_InterestExpense_637824985197272124" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_637824985197272124" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_637824985197272124" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_637824985197272124" xlink:to="us-gaap_NonoperatingIncomeExpense_637824985197272124" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_NetIncomeLoss_637824985197272124" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_637824985197272124" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_637824985197272124" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_637824985197272124" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_637824985197272124" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_637824985197272124" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_637824985197272124" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_637824985197272124" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_637824985197272124" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_637824985197272124" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A7F5F6A7A92CE7467DC9C567E853B3D1" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_637824985197272124" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="extended" xlink:title="00300 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_637462219409613927"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract_637462219409613927" xlink:to="us-gaap_StatementTable_637824985197272124" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637824985197272124" xlink:to="us-gaap_StatementEquityComponentsAxis_637824985197272124" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637824985197272124" xlink:to="us-gaap_CommonStockMember_637824985197272124" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637824985197272124" xlink:to="us-gaap_AdditionalPaidInCapitalMember_637824985197272124" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637824985197272124" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_637824985197272124" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637824985197272124" xlink:to="us-gaap_RetainedEarningsMember_637824985197272124" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637824985197272124" xlink:to="us-gaap_EquityComponentDomain_637824985197272124" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637824985197272124" xlink:to="us-gaap_StatementLineItems_637824985197272124" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_SharesOutstanding_637824985197272124" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockholdersEquity_637824985197272124" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_NetIncomeLoss_637824985197272124" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_637824985197272124" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_637824985197272124" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_637824985197272124"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_637824985197272124" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637824985197282100" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_637824985197282100" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637824985197282100" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_637824985197282100" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExerciseofWarrantsforCommonStockshares" xlink:label="aqb_ExerciseofWarrantsforCommonStockshares_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="aqb_ExerciseofWarrantsforCommonStockshares_637824985197282100" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExerciseofWarrantsforCommonStock" xlink:label="aqb_ExerciseofWarrantsforCommonStock_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="aqb_ExerciseofWarrantsforCommonStock_637824985197282100" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_637824985197282100" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_637824985197282100" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_SharesOutstanding_637824985197282100" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197272124" xlink:to="us-gaap_StockholdersEquity_637824985197282100" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00400 - Statement - Consolidated Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" xlink:to="us-gaap_NetIncomeLoss_637824985197282100" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637824985197282100" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" xlink:to="us-gaap_ShareBasedCompensation_637824985197282100" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" xlink:to="us-gaap_OtherNoncashIncomeExpense_637824985197282100" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637824985197282100" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637824985197282100" xlink:to="us-gaap_IncreaseDecreaseInInventories_637824985197282100" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637824985197282100" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637824985197282100" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637824985197282100" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_637824985197282100" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="us-gaap_IncreaseDecreaseInAccruedSalaries_637824985197282100"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637824985197282100" xlink:to="us-gaap_IncreaseDecreaseInAccruedSalaries_637824985197282100" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637824985197282100" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_637824985197302045" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637824985197302045" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PaymentsForDepositsOnEquipmentPurchases" xlink:label="aqb_PaymentsForDepositsOnEquipmentPurchases_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045" xlink:to="aqb_PaymentsForDepositsOnEquipmentPurchases_637824985197302045" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_637824985197302045" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_637824985197302045" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045" xlink:to="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_637824985197302045" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_637824985197302045" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_637824985197302045" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637824985197302045" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637824985197302045" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_637824985197302045" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="us-gaap_RepaymentsOfSecuredDebt_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_RepaymentsOfSecuredDebt_637824985197302045" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_637824985197302045" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_ProceedsFromOtherEquity_637824985197302045" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637824985197302045" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_637824985197302045" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637824985197302045"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637824985197302045" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637824985197312020" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637824985197312020" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6378249851973120201"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6378249851973120201" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637824985197312020" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637824985197312020" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637824985197312020" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637824985197312020" xlink:to="us-gaap_RestrictedCashAndCashEquivalents_637824985197312020" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_637824985197312020" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_637824985197312020" xlink:to="us-gaap_InterestPaidNet_637824985197312020" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_637824985197312020" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_637824985197312020" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganization" xlink:type="extended" xlink:title="10101 - Disclosure - Nature of Business and Organization" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_74CDF6F6B8F84FEAFD8CC567E7ED1102"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_74CDF6F6B8F84FEAFD8CC567E7ED1102" xlink:to="us-gaap_NatureOfOperations_637824985197312020" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="extended" xlink:title="10201 - Disclosure - Summary of Significant Accounting Policies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8344F95C9268E6AA0CBCC567E7D72465"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8344F95C9268E6AA0CBCC567E7D72465" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_637824985197312020" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureRisksAndUncertainties" xlink:type="extended" xlink:title="10301 - Disclosure - Risks and Uncertainties" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_8380CCE9474EE5E46C23C567E771CEDD"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_637824985197312020"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_8380CCE9474EE5E46C23C567E771CEDD" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_637824985197312020" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureMarketableSecurities" xlink:type="extended" xlink:title="10401 - Disclosure - Marketable Securities" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureInventory" xlink:type="extended" xlink:title="10501 - Disclosure - Inventory" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_483EB46248640B5AF63DC567E75CF199"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_483EB46248640B5AF63DC567E75CF199" xlink:to="us-gaap_InventoryDisclosureTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment" xlink:type="extended" xlink:title="10601 - Disclosure - Property, Plant and Equipment" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_221B2A2C80A7D19EF7D5C567E742F70B"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_221B2A2C80A7D19EF7D5C567E742F70B" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureDebt" xlink:type="extended" xlink:title="10701 - Disclosure - Debt" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_F373CBE27ECF8EBC06DFC567E67E95FD"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F373CBE27ECF8EBC06DFC567E67E95FD" xlink:to="us-gaap_DebtDisclosureTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquity" xlink:type="extended" xlink:title="10801 - Disclosure - Stockholders&apos; Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_CFCC8451A86DA467C956C567E5F7CBE3"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CFCC8451A86DA467C956C567E5F7CBE3" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="10901 - Disclosure - Income Taxes" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_61B00C7A944D8B23D3E9C567E46B4E17"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_61B00C7A944D8B23D3E9C567E46B4E17" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingencies" xlink:type="extended" xlink:title="11001 - Disclosure - Commitments and Contingencies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B9D317BC55A819DD6CB3C567E3D28201"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B9D317BC55A819DD6CB3C567E3D28201" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureRetirementPlan" xlink:type="extended" xlink:title="11101 - Disclosure - Retirement Plan" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_49C716311259CD0A5C35C567E35B63E4"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_49C716311259CD0A5C35C567E35B63E4" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureRelatedPartyAgreement" xlink:type="extended" xlink:title="11201 - Disclosure - Related Party Agreement" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_34F3DDC7B5C53F191D24C567E3268502"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_637824985197321996"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_34F3DDC7B5C53F191D24C567E3268502" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_637824985197321996" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy" xlink:type="extended" xlink:title="20102 - Disclosure - Nature of Business and Organization (Policy)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_NatureOfOperationsPolicyPolicyTextBlock" xlink:label="aqb_NatureOfOperationsPolicyPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="aqb_NatureOfOperationsPolicyPolicyTextBlock_637824985197331992" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_637824985197331992" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_LiquidityPolicyPolicyTextBlock" xlink:label="aqb_LiquidityPolicyPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="aqb_LiquidityPolicyPolicyTextBlock_637824985197331992" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy" xlink:type="extended" xlink:title="20202 - Disclosure - Summary of Significant Accounting Policies (Policy)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_UseOfEstimates_637824985197331992" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_637824985197331992" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_637824985197331992" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_637824985197331992" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_MarketableSecuritiesPolicy_637824985197331992" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_InventoryPolicyTextBlock_637824985197331992" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_637824985197331992" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_637824985197331992" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_637824985197331992" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_637824985197331992" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_637824985197331992" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_637824985197331992" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_637824985197331992" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_637824985197331992" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6E691D10A827BB8DC282C567E7C2643F" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_637824985197331992" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" xlink:title="30203 - Disclosure - Summary of Significant Accounting Policies (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_39DA3D980E4AFFECF241C567E7AE22F3"></loc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39DA3D980E4AFFECF241C567E7AE22F3" xlink:to="aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_637824985197331992" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureMarketableSecuritiesTables" xlink:type="extended" xlink:title="30403 - Disclosure - Marketable Securities (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock_637824985197331992"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesTextBlock_637824985197331992" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureInventoryTables" xlink:type="extended" xlink:title="30503 - Disclosure - Inventory (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract_637462219409754041"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract_637462219409754041" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_637824985197341957" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentTables" xlink:type="extended" xlink:title="30603 - Disclosure - Property, Plant and Equipment (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_637462219409764039"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract_637462219409764039" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_637824985197341957" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureDebtTables" xlink:type="extended" xlink:title="30703 - Disclosure - Debt (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract_637462219409764039"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract_637462219409764039" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_637824985197341957" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract_637462219409764039" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_637824985197341957" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityTables" xlink:type="extended" xlink:title="30803 - Disclosure - Stockholders&apos; Equity (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_2979080D6E014F175DA6C567E5EA72F4"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2979080D6E014F175DA6C567E5EA72F4" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_637824985197341957" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2979080D6E014F175DA6C567E5EA72F4" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_637824985197341957" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2979080D6E014F175DA6C567E5EA72F4" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_637824985197341957" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2979080D6E014F175DA6C567E5EA72F4" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_637824985197341957" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2979080D6E014F175DA6C567E5EA72F4" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_637824985197341957" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2979080D6E014F175DA6C567E5EA72F4" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_637824985197341957" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesTables" xlink:type="extended" xlink:title="30903 - Disclosure - Income Taxes (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_D069F5E5B093C32FC349C567E4659B19"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_D069F5E5B093C32FC349C567E4659B19" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_637824985197341957" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_D069F5E5B093C32FC349C567E4659B19" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_637824985197341957" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_D069F5E5B093C32FC349C567E4659B19" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_637824985197341957" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables" xlink:type="extended" xlink:title="31003 - Disclosure - Commitments and Contingencies (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C1BBD187005C03A3E16AC567E3C8B553"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C1BBD187005C03A3E16AC567E3C8B553" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_637824985197341957" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_637824985197341957"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C1BBD187005C03A3E16AC567E3C8B553" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_637824985197341957" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationDetails" xlink:type="extended" xlink:title="40101 - Disclosure - Nature of Business and Organization (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_252411FD46C4097C95ACC567E7E045E2"></loc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AdditionalCashAndCashEquivalents" xlink:label="aqb_AdditionalCashAndCashEquivalents_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_252411FD46C4097C95ACC567E7E045E2" xlink:to="aqb_AdditionalCashAndCashEquivalents_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_252411FD46C4097C95ACC567E7E045E2" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_637824985197351906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StatementTable_637824985197351906" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637824985197351906" xlink:to="srt_ConsolidatedEntitiesAxis_637824985197351906" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis_637824985197351906" xlink:to="srt_ConsolidatedEntitiesDomain_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_CanadaSubsidiaryMember" xlink:label="aqb_CanadaSubsidiaryMember_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain_637824985197351906" xlink:to="aqb_CanadaSubsidiaryMember_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_UnitedStatesSubsidiaryMember" xlink:label="aqb_UnitedStatesSubsidiaryMember_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain_637824985197351906" xlink:to="aqb_UnitedStatesSubsidiaryMember_637824985197351906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637824985197351906" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_637824985197351906" order="2" use="optional" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_637824985197351906" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_637824985197351906" xlink:to="us-gaap_PatentsMember_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637824985197351906" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637824985197351906" order="3" use="optional" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637824985197351906" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637824985197351906" xlink:to="us-gaap_WarrantMember_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637824985197351906" xlink:to="us-gaap_EmployeeStockOptionMember_637824985197351906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637824985197351906" xlink:to="srt_RangeAxis_637824985197351906" order="4" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637824985197351906" xlink:to="srt_RangeMember_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197351906" xlink:to="srt_MinimumMember_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197351906" xlink:to="srt_WeightedAverageMember_637824985197351906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637824985197351906" xlink:to="us-gaap_StatementLineItems_637824985197351906" order="5" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197351906" xlink:to="us-gaap_OperatingLeaseLiability_637824985197351906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197351906" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_637824985197351906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197351906" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_637824985197351906" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197351906" xlink:to="us-gaap_Revenues_637824985197351906" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197351906" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_637824985197351906" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_637824985197351906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637824985197351906" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_637824985197351906" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" xlink:type="extended" xlink:title="40202 - Disclosure - Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_C1E6160BBA8F0F68011DC567E798B8D0"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C1E6160BBA8F0F68011DC567E798B8D0" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197361882" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197361882" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197361882" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197361882" xlink:to="us-gaap_BuildingMember_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197361882" xlink:to="us-gaap_EquipmentMember_637824985197361882" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_OfficeFurnitureandEquipmentMember" xlink:label="aqb_OfficeFurnitureandEquipmentMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197361882" xlink:to="aqb_OfficeFurnitureandEquipmentMember_637824985197361882" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197361882" xlink:to="us-gaap_VehiclesMember_637824985197361882" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197361882" xlink:to="us-gaap_LeaseholdImprovementsMember_637824985197361882" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197361882" xlink:to="srt_RangeAxis_637824985197361882" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637824985197361882" xlink:to="srt_RangeMember_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197361882" xlink:to="srt_MinimumMember_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197361882" xlink:to="srt_MaximumMember_637824985197361882" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197361882" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197361882" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197361882" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PropertyPlantAndEquipmentUsefulLife1" xlink:label="aqb_PropertyPlantAndEquipmentUsefulLife1_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197361882" xlink:to="aqb_PropertyPlantAndEquipmentUsefulLife1_637824985197361882" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Risks and Uncertainties (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_AD4A05E3C0064761AE02C567E765F368"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_AD4A05E3C0064761AE02C567E765F368" xlink:to="us-gaap_ConcentrationRiskTable_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_637824985197361882" xlink:to="srt_StatementGeographicalAxis_637824985197361882" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_637824985197361882" xlink:to="srt_SegmentGeographicalDomain_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="country_CA_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_637824985197361882" xlink:to="country_CA_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_637824985197361882" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_637824985197361882" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis_637824985197361882" xlink:to="us-gaap_ConcentrationRiskTypeDomain_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="us-gaap_CreditConcentrationRiskMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain_637824985197361882" xlink:to="us-gaap_CreditConcentrationRiskMember_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_637824985197361882" xlink:to="us-gaap_ConcentrationRiskLineItems_637824985197361882" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_637824985197361882" xlink:to="us-gaap_Cash_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_637824985197361882" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_637824985197361882" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Marketable Securities (Schedule of Marketable Securities) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesTable_637824985197361882" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable_637824985197361882" xlink:to="us-gaap_FinancialInstrumentAxis_637824985197361882" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis_637824985197361882" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637824985197361882" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:label="us-gaap_DomesticCorporateDebtSecuritiesMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637824985197361882" xlink:to="us-gaap_DomesticCorporateDebtSecuritiesMember_637824985197361882" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637824985197361882" xlink:to="us-gaap_CommercialPaperMember_637824985197361882" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable_637824985197361882" xlink:to="us-gaap_MarketableSecuritiesLineItems_637824985197361882" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesAmortizedCost" xlink:label="aqb_MarketableSecuritiesAmortizedCost_637824985197361882"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems_637824985197361882" xlink:to="aqb_MarketableSecuritiesAmortizedCost_637824985197361882" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesUnrealizedGain" xlink:label="aqb_MarketableSecuritiesUnrealizedGain_637824985197371863"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems_637824985197361882" xlink:to="aqb_MarketableSecuritiesUnrealizedGain_637824985197371863" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_MarketableSecuritiesUnrealizedLoss" xlink:label="aqb_MarketableSecuritiesUnrealizedLoss_637824985197371863"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems_637824985197361882" xlink:to="aqb_MarketableSecuritiesUnrealizedLoss_637824985197371863" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities_637824985197373672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems_637824985197361882" xlink:to="us-gaap_MarketableSecurities_637824985197373672" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureInventoryNarrativeDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Inventory (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract_637490202094779843"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable_637824985197373672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract_637490202094779843" xlink:to="us-gaap_InventoryCurrentTable_637824985197373672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis_637824985197373672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable_637824985197373672" xlink:to="us-gaap_PublicUtilitiesInventoryAxis_637824985197373672" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197373672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis_637824985197373672" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197373672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FishInProcessMember" xlink:label="aqb_FishInProcessMember_637824985197373672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197373672" xlink:to="aqb_FishInProcessMember_637824985197373672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems_637824985197373672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable_637824985197373672" xlink:to="us-gaap_InventoryLineItems_637824985197373672" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments_637824985197373672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems_637824985197373672" xlink:to="us-gaap_InventoryAdjustments_637824985197373672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Inventory (Schedule of Inventory) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract_637490200086452374"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable_637824985197373672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract_637490200086452374" xlink:to="us-gaap_InventoryCurrentTable_637824985197373672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable_637824985197373672" xlink:to="us-gaap_PublicUtilitiesInventoryAxis_637824985197381521" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis_637824985197381521" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FeedMember" xlink:label="aqb_FeedMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197381521" xlink:to="aqb_FeedMember_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_EggsAndFryMember" xlink:label="aqb_EggsAndFryMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197381521" xlink:to="aqb_EggsAndFryMember_637824985197381521" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_PackagingMember" xlink:label="aqb_PackagingMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197381521" xlink:to="aqb_PackagingMember_637824985197381521" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FishInProcessMember" xlink:label="aqb_FishInProcessMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain_637824985197381521" xlink:to="aqb_FishInProcessMember_637824985197381521" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable_637824985197373672" xlink:to="us-gaap_InventoryLineItems_637824985197381521" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems_637824985197381521" xlink:to="us-gaap_InventoryGross_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems_637824985197381521" xlink:to="us-gaap_InventoryAdjustments_637824985197381521" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems_637824985197381521" xlink:to="us-gaap_InventoryNet_637824985197381521" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Property, Plant and Equipment (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5E8EA3B073045EE7780CC567E7232527"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5E8EA3B073045EE7780CC567E7232527" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197381521" xlink:to="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_637824985197381521" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_637824985197381521" xlink:to="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_New10000MetricTonFarmMember" xlink:label="aqb_New10000MetricTonFarmMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_637824985197381521" xlink:to="aqb_New10000MetricTonFarmMember_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_RolloBayFarmAndFortuneBayHatcheryMember" xlink:label="aqb_RolloBayFarmAndFortuneBayHatcheryMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_637824985197381521" xlink:to="aqb_RolloBayFarmAndFortuneBayHatcheryMember_637824985197381521" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_IndianaAquacultureFarmMember" xlink:label="aqb_IndianaAquacultureFarmMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_637824985197381521" xlink:to="aqb_IndianaAquacultureFarmMember_637824985197381521" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197381521" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197381521" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197381521" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197381521" xlink:to="us-gaap_ConstructionInProgressMember_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197381521" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_637824985197381521" order="3" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_637824985197381521" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalAdditionsMember" xlink:label="us-gaap_CapitalAdditionsMember_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_637824985197381521" xlink:to="us-gaap_CapitalAdditionsMember_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197381521" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197381521" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197381521" xlink:to="us-gaap_Depreciation_637824985197381521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities" xlink:label="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197381521" xlink:to="aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities_637824985197381521" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197381521" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637824985197381521" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_637824985197381521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197381521" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount_637824985197381521" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40602 - Disclosure - Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_637462219409853997"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract_637462219409853997" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197391798" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197391798" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637824985197391798" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197391798" xlink:to="us-gaap_LandMember_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197391798" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_637824985197391798" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197391798" xlink:to="us-gaap_ConstructionInProgressMember_637824985197391798" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197391798" xlink:to="us-gaap_EquipmentMember_637824985197391798" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_OfficeFurnitureandEquipmentMember" xlink:label="aqb_OfficeFurnitureandEquipmentMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197391798" xlink:to="aqb_OfficeFurnitureandEquipmentMember_637824985197391798" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637824985197391798" xlink:to="us-gaap_VehiclesMember_637824985197391798" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637824985197391798" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197391798" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197391798" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197391798" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637824985197391798" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637824985197391798" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637824985197391798" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureDebtNarrativeDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Debt (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract_637551972229729043"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract_637551972229729043" xlink:to="us-gaap_DebtInstrumentTable_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197391798" xlink:to="us-gaap_VariableRateAxis_637824985197391798" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis_637824985197391798" xlink:to="us-gaap_VariableRateDomain_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_USTreasuryFiveYearMaturitiesInterestRateMember" xlink:label="aqb_USTreasuryFiveYearMaturitiesInterestRateMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain_637824985197391798" xlink:to="aqb_USTreasuryFiveYearMaturitiesInterestRateMember_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197391798" xlink:to="srt_ConsolidatedEntitiesAxis_637824985197391798" order="2" use="optional" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis_637824985197391798" xlink:to="srt_ConsolidatedEntitiesDomain_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_CanadianSubsidiaryMember" xlink:label="aqb_CanadianSubsidiaryMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain_637824985197391798" xlink:to="aqb_CanadianSubsidiaryMember_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197391798" xlink:to="us-gaap_LongtermDebtTypeAxis_637824985197391798" order="3" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis_637824985197391798" xlink:to="us-gaap_LongtermDebtTypeDomain_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_637824985197391798" xlink:to="us-gaap_LoansPayableMember_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="us-gaap_SecuredDebtMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_637824985197391798" xlink:to="us-gaap_SecuredDebtMember_637824985197391798" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197391798" xlink:to="us-gaap_DebtInstrumentAxis_637824985197391798" order="4" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_637824985197391798" xlink:to="us-gaap_DebtInstrumentNameDomain_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197391798" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_637824985197391798" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197391798" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_637824985197391798" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197391798" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_637824985197391798" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_637824985197391798"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197391798" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_637824985197391798" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FPEITermLoanMember" xlink:label="aqb_FPEITermLoanMember_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197391798" xlink:to="aqb_FPEITermLoanMember_637824985197401775" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FirstFarmersBankAndTrustLoanMember" xlink:label="aqb_FirstFarmersBankAndTrustLoanMember_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197391798" xlink:to="aqb_FirstFarmersBankAndTrustLoanMember_637824985197401775" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DfoTermLoanMember" xlink:label="aqb_DfoTermLoanMember_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197391798" xlink:to="aqb_DfoTermLoanMember_637824985197401775" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197391798" xlink:to="srt_StatementScenarioAxis_637824985197401775" order="5" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_637824985197401775" xlink:to="srt_ScenarioUnspecifiedDomain_637824985197401775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637824985197401775" xlink:to="srt_ScenarioForecastMember_637824985197401775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197391798" xlink:to="us-gaap_DebtInstrumentLineItems_637824985197401775" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage" xlink:label="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage_637824985197401775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="us-gaap_DebtInstrumentFaceAmount_637824985197401775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="us-gaap_DebtInstrumentTerm_637824985197401775" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="us-gaap_DebtInstrumentMaturityDate_637824985197401775" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637824985197401775" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentMaturityDateYearMonth" xlink:label="aqb_DebtInstrumentMaturityDateYearMonth_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="aqb_DebtInstrumentMaturityDateYearMonth_637824985197401775" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_637824985197401775" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="us-gaap_InterestExpenseDebt_637824985197401775" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_637824985197401775" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_RepaymentPeriodOfLoan" xlink:label="aqb_RepaymentPeriodOfLoan_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="aqb_RepaymentPeriodOfLoan_637824985197401775" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentInterestRateStatedPercentagePeriod" xlink:label="aqb_DebtInstrumentInterestRateStatedPercentagePeriod_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="aqb_DebtInstrumentInterestRateStatedPercentagePeriod_637824985197401775" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentInterestOnlyPaymentPeriod" xlink:label="aqb_DebtInstrumentInterestOnlyPaymentPeriod_637824985197401775"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="aqb_DebtInstrumentInterestOnlyPaymentPeriod_637824985197401775" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_637824985197411801" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentCovenantCashBalanceMinimum" xlink:label="aqb_DebtInstrumentCovenantCashBalanceMinimum_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197401775" xlink:to="aqb_DebtInstrumentCovenantCashBalanceMinimum_637824985197411801" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails" xlink:type="extended" xlink:title="40702 - Disclosure - Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract_637490222677925095"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract_637490222677925095" xlink:to="us-gaap_DebtInstrumentTable_637824985197411801" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197411801" xlink:to="us-gaap_LongtermDebtTypeAxis_637824985197411801" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis_637824985197411801" xlink:to="us-gaap_LongtermDebtTypeDomain_637824985197411801" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_637824985197411801" xlink:to="us-gaap_LoansPayableMember_637824985197411801" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="us-gaap_SecuredDebtMember_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_637824985197411801" xlink:to="us-gaap_SecuredDebtMember_637824985197411801" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197411801" xlink:to="us-gaap_DebtInstrumentAxis_637824985197411801" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_637824985197411801" xlink:to="us-gaap_DebtInstrumentNameDomain_637824985197411801" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197411801" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_637824985197411801" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197411801" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_637824985197411801" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197411801" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_637824985197411801" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member" xlink:label="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197411801" xlink:to="aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_637824985197411801" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_KubotaCanadaLtdMember" xlink:label="aqb_KubotaCanadaLtdMember_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197411801" xlink:to="aqb_KubotaCanadaLtdMember_637824985197411801" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FPEITermLoanMember" xlink:label="aqb_FPEITermLoanMember_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197411801" xlink:to="aqb_FPEITermLoanMember_637824985197411801" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DfoTermLoanMember" xlink:label="aqb_DfoTermLoanMember_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197411801" xlink:to="aqb_DfoTermLoanMember_637824985197411801" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_FirstFarmersBankAndTrustLoanMember" xlink:label="aqb_FirstFarmersBankAndTrustLoanMember_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637824985197411801" xlink:to="aqb_FirstFarmersBankAndTrustLoanMember_637824985197411801" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637824985197411801" xlink:to="us-gaap_DebtInstrumentLineItems_637824985197411801" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197411801" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_637824985197411801" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197411801" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_637824985197411801" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_DebtInstrumentMaturityDateYearMonth" xlink:label="aqb_DebtInstrumentMaturityDateYearMonth_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197411801" xlink:to="aqb_DebtInstrumentMaturityDateYearMonth_637824985197411801" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197411801" xlink:to="us-gaap_LongTermDebt_637824985197411801" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197411801" xlink:to="us-gaap_DeferredFinanceCostsNet_637824985197411801" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="9"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637824985197411801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197411801" xlink:to="us-gaap_LongTermDebtCurrent_637824985197411801" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637824985197411801" xlink:to="us-gaap_LongTermDebtNoncurrent_637824985197421741" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails" xlink:type="extended" xlink:title="40703 - Disclosure - Debt (Principal Payments Due on Long-term Debt) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract_637462219409993902"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract_637462219409993902" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637824985197421741" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_637824985197421741" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_637824985197421741" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_637824985197421741" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_637824985197421741" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637824985197421741" xlink:to="us-gaap_LongTermDebt_637824985197421741" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Stockholders&apos; Equity (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_2093292A8236CDB152DCC567E5B4B030"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2093292A8236CDB152DCC567E5B4B030" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_637824985197421741" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_637824985197421741" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_December2020PublicOfferingMember" xlink:label="aqb_December2020PublicOfferingMember_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_637824985197421741" xlink:to="aqb_December2020PublicOfferingMember_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_February2021PublicOfferingMember" xlink:label="aqb_February2021PublicOfferingMember_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_637824985197421741" xlink:to="aqb_February2021PublicOfferingMember_637824985197421741" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" xlink:to="us-gaap_StatementEquityComponentsAxis_637824985197421741" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637824985197421741" xlink:to="us-gaap_EquityComponentDomain_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_637824985197421741" xlink:to="us-gaap_CommonStockMember_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_637824985197421741" order="3" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_637824985197421741" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637824985197421741" xlink:to="us-gaap_WarrantMember_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" xlink:to="us-gaap_PlanNameAxis_637824985197421741" order="4" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_637824985197421741" xlink:to="us-gaap_PlanNameDomain_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_A2016EquityIncentivePlanMember" xlink:label="aqb_A2016EquityIncentivePlanMember_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637824985197421741" xlink:to="aqb_A2016EquityIncentivePlanMember_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" xlink:to="srt_RangeAxis_637824985197421741" order="5" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637824985197421741"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637824985197421741" xlink:to="srt_RangeMember_637824985197421741" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197421741" xlink:to="srt_MinimumMember_637824985197431697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197421741" xlink:to="srt_MaximumMember_637824985197431697" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" xlink:to="us-gaap_AwardTypeAxis_637824985197431697" order="6" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637824985197431697" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197431697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197431697" xlink:to="us-gaap_RestrictedStockMember_637824985197431697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197431697" xlink:to="us-gaap_EmployeeStockOptionMember_637824985197431697" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" xlink:to="us-gaap_StatementClassOfStockAxis_637824985197431697" order="7" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637824985197431697" xlink:to="us-gaap_ClassOfStockDomain_637824985197431697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637824985197431697" xlink:to="us-gaap_CommonStockMember_637824985197431697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197421741" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197431697" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197431697" xlink:to="us-gaap_StockholdersEquityAbstract_637824985197431697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_AuthorizedShares" xlink:label="aqb_AuthorizedShares_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="aqb_AuthorizedShares_637824985197431697" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_PreferredStockSharesAuthorized_637824985197431697" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_PreferredStockSharesIssued_637824985197431697" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_PreferredStockSharesOutstanding_637824985197431697" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_CommonStockSharesIssued_637824985197431697" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_CommonStockSharesOutstanding_637824985197431697" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights_637824985197431697"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_CommonStockVotingRights_637824985197431697" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637824985197441672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637824985197441672" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_637824985197441672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_637824985197441672" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_637824985197441672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637824985197431697" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_637824985197441672" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_WarrantsAbstract" xlink:label="aqb_WarrantsAbstract_637824985197441672"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197431697" xlink:to="aqb_WarrantsAbstract_637824985197441672" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_637824985197451645"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqb_WarrantsAbstract_637824985197441672" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_637824985197451645" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="us-gaap_ShareBasedCompensationAbstract_637824985197451645"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197431697" xlink:to="us-gaap_ShareBasedCompensationAbstract_637824985197451645" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_637824985197451645"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_637824985197451645" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_637824985197461705" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_637824985197461705" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_637824985197461705" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_637824985197461705" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637824985197461705" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_637824985197461705" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637824985197461705" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637824985197461705" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_637824985197461705" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_637824985197461705" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_637824985197461705" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensation_637824985197461705" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_637824985197461705"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_637824985197461705" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_637824985197471612" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_637824985197471612" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract_637824985197451645" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_637824985197471612" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Stockholders&apos; Equity (Information About Outstanding Warrants) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract_637545963412769906"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract_637545963412769906" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197471612" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197471612" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_637824985197471612" order="1" use="optional" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_637824985197471612" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637824985197471612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637824985197471612" xlink:to="us-gaap_WarrantMember_637824985197471612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197471612" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197471612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637824985197471612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637824985197471612" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197471612" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637824985197471612" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_637824985197471612" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6378249851974716121"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6378249851974716121" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_637824985197471612" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197471612" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637824985197471612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637824985197471612" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637824985197471612" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_637824985197471612"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_637824985197471612" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637824985197481561" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197471612" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_637824985197481561" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails" xlink:type="extended" xlink:title="40803 - Disclosure - Stockholders&apos; Equity (Restricted Stock Activity) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_AEBC23A3B6D3C7BC1F64C567E504893C"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_AEBC23A3B6D3C7BC1F64C567E504893C" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197481561" xlink:to="us-gaap_AwardTypeAxis_637824985197481561" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197481561" xlink:to="us-gaap_RestrictedStockMember_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197481561" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_637824985197481561" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_637824985197481561" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6378249851974815611"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6378249851974815611" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_637824985197481561" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637824985197481561" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_637824985197481561" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6378249851974815611"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6378249851974815611" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails" xlink:type="extended" xlink:title="40804 - Disclosure - Stockholders&apos; Equity (Stock Option Activity) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1E29C1792D396E7176E4C567E4ED82CA"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1E29C1792D396E7176E4C567E4ED82CA" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197481561" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197481561" xlink:to="us-gaap_AwardTypeAxis_637824985197481561" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197481561" xlink:to="us-gaap_EmployeeStockOptionMember_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197481561" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637824985197481561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637824985197481561" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637824985197481561" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_637824985197481561" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_637824985197481561"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_637824985197481561" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6378249851974815611"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6378249851974815611" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_637824985197491535" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197481561" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637824985197491535" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637824985197491535" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_637824985197491535" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_637824985197491535" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6378249851974915351"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6378249851974915351" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_637824985197491535" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails" xlink:type="extended" xlink:title="40805 - Disclosure - Stockholders&apos; Equity (Information About Options Outstanding and Exercisable) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract_637462219410513559"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract_637462219410513559" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_637824985197491535" xlink:to="us-gaap_AwardTypeAxis_637824985197491535" order="1" use="optional" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197491535" xlink:to="us-gaap_EmployeeStockOptionMember_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_637824985197491535" xlink:to="srt_RangeAxis_637824985197491535" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637824985197491535" xlink:to="srt_RangeMember_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197491535" xlink:to="srt_MinimumMember_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197491535" xlink:to="srt_MaximumMember_637824985197491535" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_637824985197491535" xlink:to="us-gaap_StatementClassOfStockAxis_637824985197491535" order="3" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637824985197491535" xlink:to="us-gaap_ClassOfStockDomain_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceOneMember" xlink:label="aqb_ExercisePriceOneMember_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637824985197491535" xlink:to="aqb_ExercisePriceOneMember_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceTwoMember" xlink:label="aqb_ExercisePriceTwoMember_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637824985197491535" xlink:to="aqb_ExercisePriceTwoMember_637824985197491535" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceThreeMember" xlink:label="aqb_ExercisePriceThreeMember_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637824985197491535" xlink:to="aqb_ExercisePriceThreeMember_637824985197491535" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_ExercisePriceFourMember" xlink:label="aqb_ExercisePriceFourMember_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637824985197491535" xlink:to="aqb_ExercisePriceFourMember_637824985197491535" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_637824985197491535" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_637824985197491535" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_637824985197491535" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_637824985197491535" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_637824985197491535"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_637824985197491535" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_637824985197491535" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_637824985197491535" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_637824985197501525" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails" xlink:type="extended" xlink:title="40806 - Disclosure - Stockholders&apos; Equity (Stock Option Grants Weighted Average Assumptions) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract_637462219410493615"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract_637462219410493615" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197501525" xlink:to="srt_RangeAxis_637824985197501525" order="1" use="optional" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637824985197501525" xlink:to="srt_RangeMember_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197501525" xlink:to="srt_MinimumMember_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637824985197501525" xlink:to="srt_MaximumMember_637824985197501525" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197501525" xlink:to="us-gaap_AwardTypeAxis_637824985197501525" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637824985197501525" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637824985197501525" xlink:to="us-gaap_EmployeeStockOptionMember_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637824985197501525" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197501525" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197501525" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197501525" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_637824985197501525" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197501525" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_637824985197501525" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637824985197501525" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_637824985197501525" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails" xlink:type="extended" xlink:title="40808 - Disclosure - Stockholders&apos; Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_6BE94E89C3146A0689DDC567E4782737"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6BE94E89C3146A0689DDC567E4782737" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637824985197501525" xlink:to="us-gaap_IncomeStatementLocationAxis_637824985197501525" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_637824985197501525" xlink:to="us-gaap_IncomeStatementLocationDomain_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_637824985197501525" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_637824985197501525" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_637824985197501525" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637824985197501525" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637824985197501525" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637824985197501525" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Income Taxes (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6881E83E32FCEC91B3E3C567E40691B8"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6881E83E32FCEC91B3E3C567E40691B8" xlink:to="us-gaap_TaxCreditCarryforwardTable_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable_637824985197501525" xlink:to="us-gaap_IncomeTaxAuthorityAxis_637824985197501525" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis_637824985197501525" xlink:to="us-gaap_IncomeTaxAuthorityDomain_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_637824985197501525" xlink:to="us-gaap_DomesticCountryMember_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_637824985197501525" xlink:to="us-gaap_ForeignCountryMember_637824985197501525" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable_637824985197501525" xlink:to="us-gaap_TaxCreditCarryforwardAxis_637824985197501525" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis_637824985197501525" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember_637824985197501525"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain_637824985197501525" xlink:to="us-gaap_ResearchMember_637824985197501525" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable_637824985197501525" xlink:to="srt_StatementScenarioAxis_637824985197511481" order="3" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_637824985197511481" xlink:to="srt_ScenarioUnspecifiedDomain_637824985197511481" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_LimitationsOnUseToSection382Member" xlink:label="aqb_LimitationsOnUseToSection382Member_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637824985197511481" xlink:to="aqb_LimitationsOnUseToSection382Member_637824985197511481" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable_637824985197501525" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_637824985197511481" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_637824985197511481" xlink:to="us-gaap_OperatingLossCarryforwards_637824985197511481" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_637824985197511481" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_637824985197511481" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_637824985197511481" xlink:to="us-gaap_TaxCreditCarryforwardAmount_637824985197511481" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails" xlink:type="extended" xlink:title="40902 - Disclosure - Income Taxes (Components of Loss Before Income Taxes) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2B16BB0D80A9D03ADB74C567E45771EE"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2B16BB0D80A9D03ADB74C567E45771EE" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_637824985197511481" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2B16BB0D80A9D03ADB74C567E45771EE" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_637824985197511481" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2B16BB0D80A9D03ADB74C567E45771EE" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_637824985197511481" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended" xlink:title="40903 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_637824985197511481" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_637824985197511481" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_637824985197511481" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_637824985197511481" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_637824985197511481" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance" xlink:label="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5" xlink:to="aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance_637824985197511481" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_637824985197511481" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30093A3419EFDC8DD0D6C567E4207FE5" xlink:to="us-gaap_IncomeTaxExpenseBenefit_637824985197511481" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended" xlink:title="40904 - Disclosure - Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_85F281B0F20530DE894AC567E3E90580"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85F281B0F20530DE894AC567E3E90580" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_637824985197511481" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85F281B0F20530DE894AC567E3E90580" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_637824985197511481" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85F281B0F20530DE894AC567E3E90580" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_637824985197511481" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85F281B0F20530DE894AC567E3E90580" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_637824985197511481" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85F281B0F20530DE894AC567E3E90580" xlink:to="us-gaap_DeferredTaxAssetsGross_637824985197511481" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85F281B0F20530DE894AC567E3E90580" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_637824985197511481" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85F281B0F20530DE894AC567E3E90580" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_637824985197511481" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Commitments and Contingencies (Narrative) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_66C6D42AF35DB2CA8DD1C567E3B617C0"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_66C6D42AF35DB2CA8DD1C567E3B617C0" xlink:to="us-gaap_OperatingLeaseExpense_637824985197511481" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_66C6D42AF35DB2CA8DD1C567E3B617C0" xlink:to="us-gaap_OperatingLeasePayments_637824985197511481" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_637824985197511481"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_66C6D42AF35DB2CA8DD1C567E3B617C0" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_637824985197511481" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails" xlink:type="extended" xlink:title="41002 - Disclosure - Commitments and Contingencies (Summary of Lease Obligations) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_637824985197521488" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_637824985197521488" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails" xlink:type="extended" xlink:title="41003 - Disclosure - Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_637824985197521488" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_637824985197521488" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_637824985197521488" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_637824985197521488" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_637824985197521488" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_637824985197521488" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_637824985197521488" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability_637824985197521488" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureRetirementPlanDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Retirement Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F882DE9154439132D025C567E335F089"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F882DE9154439132D025C567E335F089" xlink:to="us-gaap_DefinedContributionPlanTable_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis" xlink:label="us-gaap_RetirementPlanSponsorLocationAxis_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable_637824985197521488" xlink:to="us-gaap_RetirementPlanSponsorLocationAxis_637824985197521488" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain" xlink:label="us-gaap_RetirementPlanSponsorLocationDomain_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanSponsorLocationAxis_637824985197521488" xlink:to="us-gaap_RetirementPlanSponsorLocationDomain_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember" xlink:label="us-gaap_ForeignPlanMember_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanSponsorLocationDomain_637824985197521488" xlink:to="us-gaap_ForeignPlanMember_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable_637824985197521488" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_637824985197521488" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems_637824985197521488" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></link:presentationLink>
  <link:presentationLink xlink:role="http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Related Party Agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_624D106255CBFAECECE1C567E31718BC"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_624D106255CBFAECECE1C567E31718BC" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637824985197521488" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637824985197521488" order="1" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637824985197521488" xlink:to="us-gaap_RelatedPartyDomain_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="aqb-20211231.xsd#aqb_TsAquacultureMember" xlink:label="aqb_TsAquacultureMember_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_637824985197521488" xlink:to="aqb_TsAquacultureMember_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637824985197521488" xlink:to="us-gaap_RelatedPartyTransactionLineItems_637824985197521488" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637824985197521488" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_637824985197521488" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_637824985197521488"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637824985197521488" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_637824985197521488" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc></link:presentationLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566164108744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AquaBounty Technologies, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3156167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2 Mill & Main Place<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Maynard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">648-6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AQB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 234.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,025,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s Proxy Statement for its Annual Meeting of Shareholders to be held on May&#160;17, 2022 (the &#8220;2022 Proxy Statement&#8221;), are incorporated by reference into Part III of this Annual Report on Form&#160;10&#8209;K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001603978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Baltimore, Maryland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566163999320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 88,454,988<span></span>
</td>
<td class="nump">$ 95,751,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">101,773,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">1,259,910<span></span>
</td>
<td class="nump">1,525,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,536,484<span></span>
</td>
<td class="nump">405,370<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">193,025,163<span></span>
</td>
<td class="nump">97,681,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">33,815,119<span></span>
</td>
<td class="nump">26,930,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets, net</a></td>
<td class="nump">284,320<span></span>
</td>
<td class="nump">341,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">231,842<span></span>
</td>
<td class="nump">245,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">79,548<span></span>
</td>
<td class="nump">76,715<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">228,435,992<span></span>
</td>
<td class="nump">125,776,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">4,317,615<span></span>
</td>
<td class="nump">1,176,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee compensation</a></td>
<td class="nump">874,589<span></span>
</td>
<td class="nump">583,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt</a></td>
<td class="nump">627,365<span></span>
</td>
<td class="nump">259,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">66,269<span></span>
</td>
<td class="nump">62,483<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">5,885,838<span></span>
</td>
<td class="nump">2,082,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease obligations</a></td>
<td class="nump">224,058<span></span>
</td>
<td class="nump">290,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">8,523,333<span></span>
</td>
<td class="nump">8,528,490<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,633,229<span></span>
</td>
<td class="nump">10,901,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 80,000,000 shares authorized; 71,025,738 and 55,497,133 shares outstanding at December 31, 2021 and 2020, respectively</a></td>
<td class="nump">71,026<span></span>
</td>
<td class="nump">55,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">384,852,107<span></span>
</td>
<td class="nump">263,629,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(255,588)<span></span>
</td>
<td class="num">(267,258)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(170,864,782)<span></span>
</td>
<td class="num">(148,542,194)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">213,802,763<span></span>
</td>
<td class="nump">114,875,161<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 228,435,992<span></span>
</td>
<td class="nump">$ 125,776,503<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168056360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Consolidated Balance Sheets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">80,000,000<span></span>
</td>
<td class="nump">80,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">71,025,738<span></span>
</td>
<td class="nump">55,497,133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162161608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Product revenues</a></td>
<td class="nump">$ 1,174,832<span></span>
</td>
<td class="nump">$ 127,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_ProductionCostsOperating', window );">Product costs</a></td>
<td class="nump">10,786,072<span></span>
</td>
<td class="nump">6,680,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">1,261,764<span></span>
</td>
<td class="nump">533,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,145,548<span></span>
</td>
<td class="nump">2,364,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">9,103,213<span></span>
</td>
<td class="nump">6,797,443<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total costs and expenses</a></td>
<td class="nump">23,296,597<span></span>
</td>
<td class="nump">16,375,493<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(22,121,765)<span></span>
</td>
<td class="num">(16,247,830)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(316,442)<span></span>
</td>
<td class="num">(152,367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">115,619<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(200,823)<span></span>
</td>
<td class="num">(152,155)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(22,322,588)<span></span>
</td>
<td class="num">(16,399,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency</a></td>
<td class="nump">51,771<span></span>
</td>
<td class="nump">92,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized losses on marketable securities</a></td>
<td class="num">(40,101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income</a></td>
<td class="nump">11,670<span></span>
</td>
<td class="nump">92,902<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (22,310,918)<span></span>
</td>
<td class="num">$ (16,307,083)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares - basic and diluted</a></td>
<td class="nump">69,428,061<span></span>
</td>
<td class="nump">36,347,398<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_ProductionCostsOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Production Costs Operating</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_ProductionCostsOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162539560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">21,635,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 21,635<span></span>
</td>
<td class="nump">$ 156,241,363<span></span>
</td>
<td class="num">$ (360,160)<span></span>
</td>
<td class="num">$ (132,142,209)<span></span>
</td>
<td class="nump">$ 23,760,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,399,985)<span></span>
</td>
<td class="num">(16,399,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">92,902<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">92,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for service (in shares)</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for service</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">40,580<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">40,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of expenses (in shares)</a></td>
<td class="nump">33,028,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of expenses</a></td>
<td class="nump">$ 33,028<span></span>
</td>
<td class="nump">104,592,587<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">104,625,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_ExerciseofWarrantsforCommonStockshares', window );">Exercise of warrants for common stock (in shares)</a></td>
<td class="nump">713,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_ExerciseofWarrantsforCommonStock', window );">Exercise of warrants for common stock</a></td>
<td class="nump">$ 713<span></span>
</td>
<td class="nump">2,317,996<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,318,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Share based compensation (in shares)</a></td>
<td class="nump">100,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share based compensation</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">436,590<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">436,691<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">55,497,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 55,497<span></span>
</td>
<td class="nump">263,629,116<span></span>
</td>
<td class="num">(267,258)<span></span>
</td>
<td class="num">(148,542,194)<span></span>
</td>
<td class="nump">114,875,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(22,322,588)<span></span>
</td>
<td class="num">(22,322,588)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,670<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Cashless exercise of options for common stock (in shares)</a></td>
<td class="nump">4,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Cashless exercise of options for common stock</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of expenses (in shares)</a></td>
<td class="nump">14,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of expenses</a></td>
<td class="nump">$ 14,950<span></span>
</td>
<td class="nump">119,105,487<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">119,120,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_ExerciseofWarrantsforCommonStockshares', window );">Exercise of warrants for common stock (in shares)</a></td>
<td class="nump">530,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_ExerciseofWarrantsforCommonStock', window );">Exercise of warrants for common stock</a></td>
<td class="nump">$ 530<span></span>
</td>
<td class="nump">1,723,316<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,723,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Share based compensation (in shares)</a></td>
<td class="nump">43,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share based compensation</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">394,192<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">394,237<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">71,025,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 71,026<span></span>
</td>
<td class="nump">$ 384,852,107<span></span>
</td>
<td class="num">$ (255,588)<span></span>
</td>
<td class="num">$ (170,864,782)<span></span>
</td>
<td class="nump">$ 213,802,763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_ExerciseofWarrantsforCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of warrants for common shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_ExerciseofWarrantsforCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_ExerciseofWarrantsforCommonStockshares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of Warrants for Common Stock, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_ExerciseofWarrantsforCommonStockshares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162603928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (22,322,588)<span></span>
</td>
<td class="num">$ (16,399,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustment to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,787,564<span></span>
</td>
<td class="nump">1,494,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">394,237<span></span>
</td>
<td class="nump">436,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash charge</a></td>
<td class="nump">17,386<span></span>
</td>
<td class="nump">44,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">267,833<span></span>
</td>
<td class="num">(282,260)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(1,138,691)<span></span>
</td>
<td class="num">(74,621)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">230,712<span></span>
</td>
<td class="nump">145,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued employee compensation</a></td>
<td class="nump">291,288<span></span>
</td>
<td class="nump">346,812<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(20,472,259)<span></span>
</td>
<td class="num">(14,288,821)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(5,668,696)<span></span>
</td>
<td class="num">(3,975,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_PaymentsForDepositsOnEquipmentPurchases', window );">Deposits on equipment purchases</a></td>
<td class="num">(45,111)<span></span>
</td>
<td class="num">(349,847)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfMachineryAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities, net</a></td>
<td class="num">(101,813,882)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities', window );">Proceeds from legal settlement, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,014,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="num">(11,010)<span></span>
</td>
<td class="num">(27,253)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(107,538,699)<span></span>
</td>
<td class="num">(3,238,411)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="nump">606,453<span></span>
</td>
<td class="nump">4,221,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,620)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of term debt</a></td>
<td class="num">(272,102)<span></span>
</td>
<td class="num">(70,826)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock, net</a></td>
<td class="nump">119,120,437<span></span>
</td>
<td class="nump">104,625,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from the exercise of stock options and warrants</a></td>
<td class="nump">1,723,846<span></span>
</td>
<td class="nump">2,318,709<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">121,178,634<span></span>
</td>
<td class="nump">111,003,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="nump">36,152<span></span>
</td>
<td class="num">(23,360)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="num">(6,796,172)<span></span>
</td>
<td class="nump">93,452,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">96,251,160<span></span>
</td>
<td class="nump">2,798,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">89,454,988<span></span>
</td>
<td class="nump">96,251,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">88,454,988<span></span>
</td>
<td class="nump">95,751,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information and non-cash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid in cash</a></td>
<td class="nump">299,056<span></span>
</td>
<td class="nump">114,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">$ 2,926,016<span></span>
</td>
<td class="nump">$ 23,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_PaymentsForDepositsOnEquipmentPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Deposits On Equipment Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_PaymentsForDepositsOnEquipmentPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds (Payments) for Legal Settlements, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in accrued salaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168216952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Organization<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Organization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Business and Organization</a></td>
<td class="text">1.&#160;Nature of business and organization Nature of businessAquaBounty Technologies, Inc. (the &#8220;Parent&#8221; and, together with its wholly owned subsidiaries, the &#8220;Company&#8221;) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm&#8209;raised Atlantic salmon that exhibit growth rates that are substantially faster than conventional salmon.  In 2015, the Parent obtained regulatory approval from the U.S. Food and Drug Administration for the production and sale of its genetically engineered AquAdvantage salmon product (&#8220;GE Atlantic salmon&#8221;) in the United States and in 2016, the Parent obtained regulatory approval from Health Canada for the production and sale of its GE Atlantic salmon product in Canada. In 2021, the Parent obtained regulatory approval from the National Biosafety Technical Commission for the sale of its GE Atlantic salmon product in Brazil.Basis of presentationThe consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned subsidiaries. The entities are collectively referred to herein as the &#8220;Company.&#8221; All inter-company transactions and balances have been eliminated upon consolidation.LiquidityThe Company completed an equity raise in 2021with net proceeds of $119.1 million and has $191.2 million in cash and cash equivalents, marketable securities and restricted cash as of December 31, 2021. While the Company has experienced net losses and negative cash flows from operations since inception, management believes that it has sufficient cash to meet the Company's requirements beyond the next twelve months from the filing date of these consolidated financial statements. However, until such time as the Company reaches profitability, it may require additional financing to fund its operations and execute its business plan.&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169016104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">2.&#160;Summary of significant accounting policies Use of estimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the&#160;reporting periods. Actual results could differ from those estimates. Comprehensive lossThe Company displays comprehensive loss and its components as part of its consolidated financial statements. Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) includes foreign currency translation adjustments and unrealized gains (losses) on the Company&#8217;s marketable securities. Foreign currency translationThe functional currency of the Parent is the US Dollar. The functional currency of the Canadian Subsidiary is the Canadian Dollar (C$) and the functional currency of the US and Brazil Subsidiaries is the US Dollar. For the Canadian Subsidiary, assets and liabilities are translated at the&#160;exchange rates in effect at the balance sheet date, equity accounts are translated at the historical exchange rate and the income statement accounts are translated at the average rate for each period during the year. Net translation gains or losses are adjusted directly to a separate component of other comprehensive income (loss) within stockholders&#8217; equity.Cash equivalentsThe Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents.  Cash equivalents consist primarily of business savings accounts, certificates of deposit and money market accounts. Marketable securitiesMarketable securities include government bonds, corporate bonds and commercial paper.  The Company's investment policy requires investments to be explicitly rated by two of Standard & Poor's, Moody's or Fitch and to have a minimum rating of A1, P1 or F-1, respectively, from those agencies.  In addition, the investment policy limits individual maturities to 12 months, the dollar-weighted average maturity to 180 days and the amount of credit exposure to any one issuer to 5%.InventoriesInventories are mainly comprised of feed, eggs and fish in process. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques.  The Company measures inventory at the lower of cost or net realizable value (NRV).  The NRV calculation contains various estimates and assumptions in regard to the calculation of the biomass, including expected yield, the market value of the biomass and estimated costs of completion and transportation. Intangible assetsDefinite lived intangible assets include patents and licenses.  Patent costs consist primarily of legal and filing fees incurred to file patents on proprietary technology developed by the Company. Patent costs are amortized on a straight-line basis over 20 years beginning with the filing date of the applicable patent.  License fees are capitalized and expensed over the term of the licensing agreement.Indefinite lived intangible assets include trademark costs, which are capitalized with no amortization as they have an indefinite life.Property, plant and equipmentProperty, plant and equipment are carried at cost. The Company depreciates all asset classes over their estimated useful lives, as follows:       Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years The Company commences depreciation on an asset when it is placed into service.Impairment of long-lived assetsThe Company reviews the carrying value of its long-lived assets, definite lived intangible assets, and property, plant and equipment when facts and circumstances suggest that they may be impaired. The carrying values of such assets are considered impaired when the estimated undiscounted cash flows from such assets are less than their carrying values. An impairment loss, if&#160;any, is recognized in the amount of the difference between the carrying amount and the fair value of such assets.Indefinite lived intangible assets are subject to impairment testing annually or more frequently if impairment indicators arise. The&#160;Company&#8217;s impairment testing utilizes a discounted cash flow analysis that requires significant management judgment with respect&#160;to&#160;revenue and expense growth rates, changes in working capital and the selection and use of the appropriate discount rate. An&#160;impairment loss is recognized in the amount of the difference between the carrying amount and fair value.LeasesThe Company leases certain facilities, property, and equipment under noncancelable operating leases. A determination is made if an arrangement is a lease at its inception, and leases with an initial term of twelve months or less are not recorded on the balance sheet.  Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For operating leases, expense is recognized on a straight-line basis over the lease term.  The Company has agreements with lease (e.g., minimum rent payments) and non-lease components (e.g., maintenance), which are generally accounted for separately. The Company has not elected the practical expedient to account for lease and non-lease components as one lease component. The Company adopted Financial Accounting Standards Board's (FASB) Accounting Standards Update (ASU) 2016-02 Leases on January 1, 2019 and recognized a lease liability of $532 thousand and a corresponding right-of-use asset of $512 thousand. Management calculated the lease liability based on the net present value of the remaining lease payments on the date of adoption using a weighted average discount rate of 8%. As most of the Company&#8217;s leases did not provide an implicit interest rate, management used an estimated incremental borrowing rate. The adoption did not result in any cumulative-effect adjustment to beginning retained earnings.Revenue recognitionThe Company generates revenue from the sale of its products.  Revenue is recognized when the customer takes physical control of the goods, in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for the goods. Revenue excludes any sales tax collected and includes any estimate of future credits.  During 2021, the Company recognized $747 thousand and $428 thousand in revenue from product sales from its Canada and U.S. subsidiaries, respectively.Income taxesThe Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recorded for the expected future tax consequences of temporary differences between the financial reporting and income tax bases of&#160;assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences reverse. A valuation allowance is established to reduce net deferred tax assets to the amount expected to be realized. The Company follows accounting guidance regarding the recognition, measurement, presentation and disclosure of uncertain tax positions in the financial statements. Tax positions taken or expected to be taken in the course of preparing the Company&#8217;s tax returns are required to be&#160;evaluated to determine whether the tax positions are &#8220;more likely than not&#8221; to be upheld under regulatory review. The resulting tax impact of these tax positions is recognized in the financial statements based on the results of this evaluation. The Company did not recognize any tax liabilities associated with uncertain tax positions, nor has it recognized any interest or penalties related to unrecognized tax positions. The Company is not currently under exam and is no longer subject to federal and state tax examinations by tax authorities for years before 2018. Net loss per shareBasic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Basic net loss per share is based solely on the number of common shares outstanding during the year. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and&#160;options with an exercise price less than the fair value of the common stock unless the impact of the warrant or option is anti-dilutive to the calculation. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti-dilutive and are excluded from the calculation of diluted net loss per share.As of December 31, 2021, the Company had 1,081,866 potentially dilutive securities outstanding, consisting of 418,441 warrants and 663,425 stock options.  As of December 31, 2020, the Company had 2,236,229 potentially dilutive securities outstanding, consisting of 1,662,304 warrants and 573,925 stock options.Share-based compensationThe Company measures and recognizes all share-based payment awards, including stock options and restricted share units made to employees and Directors, based on&#160;estimated fair values. The fair value of a share-based payment award is estimated on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in&#160;the&#160;Company&#8217;s consolidated statement of operations. The Company uses the Black-Scholes option pricing model (&#8220;Black-Scholes&#8221;) as&#160;its&#160;method of valuation. Non-employee stock-based compensation is accounted for using Black-Scholes to determine the fair value of&#160;warrants or options awarded to non-employees with the fair value of such issuances expensed over the period of service.Recently Issued Accounting StandardsThe Company is an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. The Company has elected to use the extended transition period for complying with new or revised accounting standards unless otherwise state. The Company will remain an &#8220;emerging growth company&#8221; until the earliest of (i) December 31, 2023, (ii) the last day of the fiscal year in which it has total annual gross revenues of $1.07 billion or more, (iii) the date on which it has issued more than $1.0 billion in nonconvertible debt during the previous three years or (iv) the date on which it is deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;), which generally is when it has more than $700 million in market value of its stock held by non-affiliates, has been a public company for at least 12 months and have filed one annual report on Form 10-K.Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169070328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text">3.&#160;Risks and uncertainties The Company is subject to risks and uncertainties common in the biotechnology and aquaculture industries. Such risks and uncertainties include, but are not limited to: (i)&#160;results from current and planned product development studies and trials; (ii)&#160;decisions made by the FDA or similar regulatory bodies in other countries with respect to approval and commercial sale of any of the Company&#8217;s proposed products; (iii)&#160;the commercial acceptance of any products approved for sale and the Company&#8217;s ability to produce, distribute, and sell for a profit any products approved for sale; (iv)&#160;the Company&#8217;s ability to obtain the necessary patents and proprietary rights to effectively protect its technologies; and (v)&#160;the outcome of any collaborations or alliances entered into by the Company.COVID-19Although the COVID-19 pandemic has diminished in the United States and other parts of the world as vaccines have become more readily available, several variants of the virus continue to spread.  Local governmental authorities in the United States and Canada have issued, and continue to update, directives aimed at minimizing the spread of the virus and the Company continues to monitor its status.The ultimate impact of the evolving COVID-19 pandemic on the Company&#8217;s operations will depend on future developments, which cannot be predicted with confidence, and the Company cannot predict the extent or impact of the extended period of continued business interruption and reduced operations caused by the COVID-19 pandemic or any additional preventative or protective measures taken in response. In connection with the COVID-19 pandemic, management made modifications to biosecurity procedures at the farm sites in early 2020 to adapt to local requirements and to provide a safe work environment. The Company&#8217;s current preventative and protective measures include, but are not limited to, segregating farm workers to specific locations, rotating shifts, and monitoring worker temperatures upon arrival at the Company&#8217;s facilities. To the extent possible, work-from-home is utilized for employees that do not have fish care responsibilities. Concentration of credit riskFinancial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and marketable securities. This risk is mitigated by the Company&#8217;s policy of maintaining all balances with highly rated financial institutions, investing cash equivalents with maturities of less than 90 days, and investing marketable securities with maturities of less than 180 days. The Company&#8217;s cash balances may at times exceed insurance limitations. The Company holds cash balances in bank accounts located in Canada to fund its local operations. These amounts are subject to foreign currency exchange risk, which is minimized by the Company&#8217;s policy to limit the balances held in these accounts. Balances in Canadian bank accounts totaled $224 thousand at December 31, 2021.  The Company also holds cash equivalent investments in a highly liquid investment account at a major financial institution.  As of December 31, 2021 and 2020 the cash equivalent investment balance was $73.3 million and $0, respectively.Financial instrumentsThe carrying amounts reported in the consolidated balance sheets for receivables, prepaid expenses and other current assets, and accounts payable approximate fair value based on the short-term maturity of these instruments. The carrying value of term debt approximates its fair value since it provides for market terms and interest rates.  All of the Company&#8217;s interest-bearing debt is at fixed rates, except for the loan with First Farmer&#8217;s Bank and Trust, which has a rate reset in July 2025.The Company groups its financial instruments measured at fair value, if any, in three levels based on the markets in which the instruments are traded and the reliability of the assumptions used to determine fair value.  Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  Financial instruments with readily available quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgement used in measuring fair value.  The three levels of the fair value hierarchy are as follows:Level 1: Inputs to the valuation methodology are quoted prices, unadjusted, for identical assets or liabilities in active markets. Level 2: Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs derived principally from, or that can be corroborated by, observable market data by correlation or other means.Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.  Level 3 assets and liabilities include financial instruments whose value is determined using discounted cash flow methodologies, as well as instruments for which the determination of fair value requires significant management judgement or estimation.&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168966600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Marketable Securities</a></td>
<td class="text">4. Marketable SecuritiesMarketable securities are classified as available-for-sale.  The following table summarizes the amortized cost, gross unrealized gains and losses, and the fair value as of December 31, 2021:               Amortized  Unrealized  Unrealized  Market  Cost  Gains  Losses  Value December 31, 2021Government bonds$ 28,453,161 $ 82 $ (18,255) $ 28,434,988Corporate bonds  29,874,696   -   (21,928)   29,852,768Commercial paper  43,486,025   -   -   43,486,025Marketable securities$ 101,813,882 $ 82 $ (40,183) $ 101,773,781There were no marketable securities as of December 31, 2020.&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169057704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">5.&#160;Inventory Major classifications of inventory are summarized as follows for December&#160;31, 2021 and 2020:        December 31, 2021 December 31, 2020Feed, net$ 162,047   244,311Eggs and fry  &#8212;   54,929Packaging  &#8212;   6,452Fish in process, net  1,097,863   1,219,685Inventory, net$ 1,259,910   1,525,377&#160;In December 2020, the Company reserved $1.53 million against the value of its fish-in-process inventory, representing the total carrying amount of its conventional salmon biomass.  The Company donated substantially all of its conventional salmon to local food charities in 2021.&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169084120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">6.&#160;Property, plant and equipment Major classifications of property, plant and equipment are summarized as follows for December&#160;31, 2021 and 2020:         December 31, 2021 December 31, 2020Land$ 725,799 $ 724,785Building and improvements  15,580,385   14,048,917Construction in process  8,119,575   3,212,287Equipment  15,981,408   13,819,210Office furniture and equipment  240,939   202,596Vehicles  36,280   28,700Total property and equipment$ 40,684,386 $ 32,036,495Less accumulated depreciation and amortization  (6,869,267)   (5,106,157)Property, plant and equipment, net$ 33,815,119 $ 26,930,338 Depreciation and amortization expense for 2021 and 2020 on property, plant and equipment was $1.8 million and $1.5 million, respectively. In March 2020, the Company settled an outstanding legal claim against a third party resulting in net proceeds of $1.0 million. The proceeds received reduced the carrying value of the acquired equipment. Depreciation on these items has been recalculated prospectively over their remaining useful lives.  As of December 31, 2021, construction in process included $5.2 million, $2.0 million and $856 thousand for construction related to the Ohio, Rollo Bay and Indiana farm sites, respectively.  An additional $12.2 million has been contractually committed for these farm sites, though if a contract were terminated, a portion of this total would be refundable based on the amount of work completed as of the date of contract termination.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168979768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">7.&#160;Debt The current terms and conditions of long-term debt outstanding as of December&#160;31, 2021 and 2020, are as follows:                Interest&#8206;rate Monthly&#8206;repayment Maturity&#8206;date December 31, 2021 December 31, 2020ACOA AIF Grant 0% Royalties - $ 2,261,349 $ 2,253,595ACOA term loan #1 0% C$3,120 Feb 2027   152,346   181,203ACOA term loan #2 0% C$4,630 Sep 2029   339,015   381,451ACOA term loan #3 0% C$6,945 Dec 2025   196,850   &#8212;Kubota Canada Ltd 0% C$1,142 Jan 2025   33,283   43,925PEI Finance term loan 4% C$16,313 Nov 2023   1,947,510   2,014,321DFO term loan 0% C$2,091 Aug 2032   405,700   &#8212;First Farmers Bank & Trust term loan 5.375% $56,832 Oct 2028   3,883,325   4,000,000Total debt       $ 9,219,378 $ 8,874,495less: debt issuance costs         (68,680)   (86,066)less: current portion         (627,365)   (259,939)Long-term debt, net       $ 8,523,333 $ 8,528,490 Principal payments due on the long-term debt are as follows:      Total2022$ 643,9802023  2,564,3472024  729,6262025  750,1752026  715,392Thereafter  3,815,858Total$ 9,219,378 Atlantic Canada Opportunities Agency (&#8220;ACOA&#8221;)ACOA is a Canadian government agency that provides funding to support the development of businesses and promote employment in the Atlantic region of Canada.ACOA Atlantic Innovation Fund (&#8220;AIF&#8221;) GrantIn January 2009, the Canadian Subsidiary was awarded an AIF grant from ACOA to provide a contribution towards the funding of a research and development project. Contributions under the grant were made through 2014 and no further funds are available. Amounts claimed by the Canadian Subsidiary must be repaid in the form of a 10% royalty on any products that are commercialized out of this research project until the loan is fully repaid. Revenue from the sale of the Company&#8217;s GE Atlantic salmon is not subject to the royalty, and the Company does not expect to commercialize products that would be subject to the royalty in the next five years.ACOA term loansIn February 2016, the Canadian Subsidiary executed an agreement with ACOA to partially finance the renovations to the Rollo Bay farm site. All available funding under the agreement was disbursed through May 2017, and no further amounts are available. The loan is being repaid over a 108-month term at a zero percent interest rate. In November 2018, the Canadian Subsidiary executed a second agreement with ACOA to partially finance the renovations to the Rollo Bay site. All available funding under the agreement was disbursed through March 2019, and no further amounts are available. The loan is being repaid over a 108-month term with a zero percent interest rate. In response to the COVID-19 pandemic, the Company was informed by ACOA during 2020, that all loan payments to the Canadian government would be deferred for nine months and resume on January 1, 2021.In July 2021, the Canadian Subsidiary entered into a contribution agreement with ACOA under its REGI-Business Scale-up and Productivity program to provide funding assistance for the Rollo Bay farm site, and on August 20, 2021, the Canadian Subsidiary received C$250,000 ($200,075). All funds received are to be repaid over a 36-month term commencing January 2023 at a zero percent interest rate.KubotaIn January 2018, the Canadian Subsidiary financed the purchase of equipment through a loan with Kubota. The total amount is being repaid in monthly installments. The loan is secured by the underlying equipment.Finance PEI (&#8220;FPEI&#8221;)FPEI is a corporation of the Ministry of Economic Development and Tourism for Prince Edward Island, Canada, and administers business financing programs for the provincial government.In August 2016, the Canadian Subsidiary obtained a loan from FPEI to partially finance the purchase of the assets of the former Atlantic Sea Smolt plant in Rollo Bay West on Prince Edward Island.In 2018, the Canadian Subsidiary obtained a new loan from FPEI, which incorporated the existing loan and provided C$2.0&#160;million ($1.5&#160;million) of additional funds. All funds have been dispersed and the loan is being repaid over an 87-month term ending in November 2023. The loan has an interest rate of 4% and is collateralized by a mortgage executed by the Canadian Subsidiary, which conveys a first security interest in all of its current and acquired assets. The loan is guaranteed by the Parent.On March&#160;24, 2020, the Company was informed by FPEI that all payments would be deferred for three months due to the COVID-19 pandemic. Payments on the loan resumed on August 1, 2020.First Farmers Bank & Trust (&#8220;FFBT&#8221;)On July 31, 2020, the Company&#8217;s Indiana Subsidiary obtained a $4.0&#160;million loan from First Farmers Bank and Trust. Net proceeds were $3.9&#160;million after deducting $90&#160;thousand in loan costs. The loan bears interest at a rate of 5.375% for the first five years. On July 31, 2025, the interest rate resets to the then U.S. Treasury 5-year maturities rate plus 5% and remains fixed at that rate through maturity on October 1, 2028. The note required interest only payments for the first 13 months, followed by monthly principal and interest payments of approximately $57&#160;thousand through maturity. Proceeds from the loan may be used for the purpose of performing equipment upgrades, purchasing equipment and other improvements to the Indiana farm. The Company must comply with certain financial and non-financial covenants and provide certification of compliance quarterly.  At December 31, 2021, the Company was in compliance with such covenants. The loan is also subject to certain prepayment penalties and is secured by the assets of the Indiana subsidiary and a guarantee by the Parent. The loan agreement requires the Company to maintain a minimum cash balance with the bank throughout the loan term. This amount is reflected as restricted cash on the balance sheet.On October 12, 2021, the Company and First Farmers Bank & Trust agreed to a modification to the terms of its outstanding loan.  The new terms delay the start date of certain of the loan&#8217;s negative covenants to the quarter commencing on October 1, 2022 and raises the required restricted cash balance amount from $500 thousand to $1.0 million.  Department of Fisheries and Oceans (&#8220;DFO&#8221;)DFO is a department of the government of Canada responsible for safeguarding its waters and managing its fisheries, oceans and freshwater resources. DFO supports economic growth in the marine and fisheries sectors, and innovation in areas such as aquaculture and biotechnology.In September 2020, the Canadian Subsidiary entered into a Contribution Agreement with DFO's Atlantic Fisheries Fund, whereby it is eligible to receive up to C$1.9 million ($1.4 million) to finance new equipment for its Rollo Bay farm (the &#8220;DFO Term Loan&#8221;). On February 25, 2021, the Canadian Subsidiary borrowed C$238,400 ($187,120) and on April 27, 2021 the Canadian Subsidiary borrowed C$276,840 ($219,258) under the DFO Term Loan.  Borrowings are interest free and monthly repayments commence in March 2023, with maturity in August 2032. All funding requests must be submitted by August 22, 2022.The Company recognized interest expense of $316&#160;thousand and $152&#160;thousand for the years ended December 31, 2021 and 2020, respectively, on its interest-bearing debt. &#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168215016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">8.&#160;Stockholders&#8217; equity The Company&#8217;s shareholders have authorized 85&#160;million shares of stock, of which 5&#160;million are authorized as preferred stock&#160;and 80&#160;million as common stock. As of December&#160;31, 2021 and 2020, the Company had zero shares of preferred stock and&#160;71,025,738 shares and 55,497,133 shares of common stock, issued and outstanding, respectively.Common stockThe holders of the common stock are entitled to one vote for each share held at all meetings of stockholders. Dividends and distribution of assets of the Company in the event of liquidation are subject to the preferential rights of any outstanding preferred shares.Recent issuancesDuring 2020, the Company completed a series of public offerings, resulting in the aggregate issuance of 33,028,000 shares of common stock for net proceeds of approximately $104.6&#160;million.During 2021, the Company completed a public offering of 14,950,000 shares of common stock for net proceeds of approximately $119.1&#160;million. WarrantsThe following table summarizes information about outstanding warrants as of December&#160;31, 2021:        Number of &#8206;options Weighted&#8206;average&#8206;exercise priceOutstanding at December 31, 2020 948,855 $ 3.25Issued &#8212;   -Exercised (530,414)   3.25Expired &#8212;   -Outstanding at December 31, 2021 418,441   3.25Exercisable at December 31, 2021 418,441   3.25 All remaining warrants have an expiration date of January 17, 2023.Share-based compensationIn 2006, the Company established the 2006 Equity Incentive Plan (the &#8220;2006 Plan&#8221;). The 2006 Plan provided for the issuance of incentive stock options to employees of the Company and non-qualified stock options and awards of restricted stock to Directors, officers, employees, and consultants of the Company. In accordance with its original terms, the 2006 Plan terminated on March&#160;18, 2016. All outstanding awards under the 2006 Plan will continue until their individual termination dates.In March 2016, the Company&#8217;s Board of Directors adopted the AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (the &#8220;2016 Plan&#8221;) to replace the 2006 Plan. The 2016 Plan provides for the issuance of incentive stock options, non-qualified stock options, and awards of restricted and direct stock purchases to Directors, officers, employees, and consultants of the Company. Total common shares authorized under the 2016 Plan were 1,900,000, of which 916,516 shares are reserved for future issuance as of December 31, 2021. Restricted stockThe Company&#8217;s restricted stock activity under the 2016 Plan is summarized as follows:        Shares Weighted&#8206;average grant&#8206;date fair valueBalance at December 31, 2020 92,653 $ 1.93Granted 43,837   6.67Vested (71,390)   2.86Balance at December 31, 2021 65,100 $ 4.10 During 2021 and 2020, the Company expensed $240&#160;thousand and $227 thousand, respectively related to restricted stock awards. At December&#160;31, 2021, the balance of unearned share-based compensation to be expensed in future periods related to the restricted stock awards is $147&#160;thousand. The period over which the unearned share-based compensation is expected to be earned is approximately 2.2 years.Stock optionsThe Company&#8217;s option activity under the 2006 Plan and the 2016 Plan is summarized as follows:         Number of &#8206;options Weighted&#8206;average&#8206;exercise priceOutstanding at December 31, 2020 657,414 $ 4.28Granted 48,914   6.72Exercised (16,667)   6.90Forfeited (1,959)   6.72Expired (24,277)   6.36Outstanding at December 31, 2021 663,425 $ 4.31Exercisable at December 31, 2021 607,189 $ 4.33 Options issued to employees, members of the Board of Directors, and non-employees generally vest over a period of one year to three years and are exercisable for a term of ten years from the date of issuance.The weighted average fair value of stock options granted during 2021 was $5.36 (2020: $1.49). There were 16,667 options exercised in 2021 (2020: zero). The total intrinsic value of options exercised in 2021 was $41 thousand (2020: $0). As of December&#160;31, 2021, the total intrinsic value of all options outstanding was&#160;$18 thousand&#160;(2020: $3.6 million) and the total intrinsic value of exercisable options was $11 thousand (2020: $3.2 million).The following table summarizes information about options outstanding and exercisable as of December&#160;31, 2021:          Weighted&#8206;average exercise&#8206;price of outstanding&#8206;options Number of&#8206;options&#8206;outstanding Weighted&#8206;average remaining&#8206;estimated life&#8206;(in years) Number of&#8206;options&#8206;exercisable $1.88 - $2.50  524,019  7.3  493,772 $3.30 - $6.72  53,916  8.4  27,927 $7.50 - $10.80  16,403  2.3  16,403 $14.20 - $23.40  69,087  4.2  69,087    663,425    607,189   The fair values of stock option grants to employees and members of the Board of Directors during 2021 and 2020 were measured on the date of grant using Black-Scholes, with the following weighted average assumptions:        20212020Expected volatility 111%101%-104%Risk free interest rate 0.80%0.31%-1.67%Expected dividend yield 0%0%Expected life (in years) 55 The risk-free interest rate is estimated using the Federal Funds interest rate for a period that is commensurate with the expected term of the awards. The expected dividend yield is zero because the Company has never paid a dividend and does not expect to do so for the foreseeable future. The expected life was based on a number of factors including historical experience, vesting provisions, exercise price relative to market price, and expected volatility. The Company believes that all groups of employees demonstrate similar exercise and post-vesting termination behavior and, therefore, does not stratify employees into multiple groups and forfeitures are recognized as they occur. The expected volatility was estimated using the Company&#8217;s historical price volatility over a period that is commensurate with the expected term of the awards.Total share-based compensation on stock-option grants amounted to $154&#160;thousand and $251&#160;thousand for the years ended December&#160;31, 2021 and 2020, respectively.  As of December 31, 2021, the balance of unearned share-based compensation to be expensed in future periods related to unvested share-based awards is $182 thousand. The period over which the unearned share-based compensation is expected to be earned is 2.2 years.Share-based compensationThe following table summarizes share-based compensation costs recognized in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss for the years ended December&#160;31, 2021 and 2020:                  2021  2020Research and development $ - $ 497General and administrative   394,237   436,194Total share-based compensation $ 394,237 $ 436,691&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168968632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">9.&#160;Income taxes The components of loss before income taxes for the years ended December&#160;31, 2021 and 2020 are presented below:             2021 2020Domestic$ (21,105,065) $ (15,768,224)Foreign  (1,217,523)   (631,761)Loss before income taxes$ (22,322,588) $ (16,399,985) We have made no provision for foreign or domestic income taxes on the cumulative unremitted earnings of our foreign subsidiaries.  We intend to permanently reinvest all foreign earnings and have no intention to repatriate foreign earnings for the foreseeable future. Income taxes computed using the federal statutory income tax rate differs from the Company&#8217;s effective tax rate for the years ended December&#160;31, 2021 and 2020 primarily due to the following:             2021 2020Income tax benefit$ (4,687,744) $ (3,443,997)State and provincial income tax, net of federal benefit  (1,157,840)   (732,994)Permanent differences  202,583   131,141US-Foreign rate differential  39,045   (142,663)Other, net  (299,071)   (145,973) $ (5,903,027) $ (4,334,486)Change in valuation allowance  5,903,027   4,334,486Total income tax$ - $ - As of December&#160;31, 2021, the Company has domestic net operating loss carryforwards of approximately $78 million, after consideration of limitations pursuant to section 382, to offset future federal taxable income, which begin to expire in 2032. As of December 31, 2021, the Company has domestic net operating loss carryforwards of approximately $50 million, which can be carried forward indefinitely. The future utilization of certain historic net operating loss and tax credit carryforwards, however, is subject to annual use limitations based on the change in stock ownership rules of Internal Revenue Code Sections&#160;382 and 383. The Company experienced a change in ownership under these rules during 2012 and revised its calculation of net operating loss carryforwards based on annual limitation rules. The Company also has foreign research and development loss carryforwards totaling approximately $11&#160;million and foreign research and development expense tax credits of approximately $2&#160;million as of December&#160;31, 2021, which expire at various times commencing in 2022. Since the Company has incurred only losses from inception and there is uncertainty related to the ultimate use of the loss carryforwards and tax credits, a valuation allowance has been recognized to offset the Company&#8217;s deferred tax assets, and no benefit for income taxes has been recorded.Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows:                2021  2020Deferred tax assets:     Net operating loss carryforwards$ 23,216,863 $ 16,964,199Foreign research and development tax credit carryforwards  2,428,663   2,679,180Property and equipment  145,530   56,697Intangibles and other  2,934,441   3,122,394Total deferred tax assets$ 28,725,497 $ 22,822,470Valuation allowance$ (28,725,497) $ (22,822,470)Net deferred tax assets$ - $ -&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168213064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">10.&#160;Commitments and contingencies The Company recognizes and discloses commitments when it enters into executed contractual obligations with other parties. The Company accrues contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.The Company is subject to legal proceedings and claims arising in the normal course of business. Management believes that final disposition of any such matters existing at December&#160;31, 2021, will not have a material adverse effect on the Company&#8217;s financial position or results of operations.Lease commitmentsLease expense for the years ended December&#160;31, 2021 and 2020, amounted to $84 thousand and $86 thousand, respectively. As of December 31, 2021, the weighted average remaining lease term of the Company&#8217;s operating leases was 24.1 years. Lease payments included in operating cash flows totaled $84&#160;thousand and $85 thousand for the years ended December&#160;31, 2021 and 2020, respectively. The table below summarizes the Company&#8217;s lease obligations as of December&#160;31, 2021 and 2020:                December 31, 2021 December 31, 2020   Lease Liability   Lease LiabilityTotal leases$ 290,327 $ 352,810Less: current portion  (66,269)   (62,483)Long-term leases$ 224,058 $$ 290,327 The Company used a weighted average discount rate of 8% in calculating the net present value of the future lease payments. The current portion of the lease liability is included as a component of other current liabilities in the consolidated balance sheets.Remaining payments under leases are as follows as of December&#160;31, 2021:        Year    Amount2022  $ 84,0802023    33,8722024    17,4812025    18,0062026    18,546Thereafter    583,328Total lease payments    755,313Less: imputed interest    (464,986)Total operating lease liabilities  $ 290,327&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168969464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Retirement Plan</a></td>
<td class="text">11.&#160;Retirement plan The Company has a savings and retirement plan for its US employees that qualifies under Section&#160;401(k) of the Internal Revenue Code. The plan covers substantially all employees and provides for voluntary contributions by participating employees up to the maximum contribution allowed under the Internal Revenue Code. Contributions by the Company can be made, as determined by the Board of Directors, provided the amount does not exceed the maximum permitted by the Internal Revenue Code. Company contributions made and expensed in operations in connection with the plan during the years ended December&#160;31, 2021 and 2020, amounted to $81&#160;thousand and $72&#160;thousand, respectively.The Company also has a Registered Retirement Savings Plan for its Canadian employees. Company contributions made and expensed in operations in connection with the plan during the years ended December&#160;31, 2021 and 2020, amounted to $38&#160;thousand and $32&#160;thousand, respectively.&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169092584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Agreement</a></td>
<td class="text">12.&#160;Related Party Agreement Letter Agreement with Third SecurityOn July 30, 2021, the Company entered into an agreement with TS Aquaculture LLC and certain of its affiliates (&#8220;TS Aquaculture&#8221;) that required the Company to file a registration statement to register the Company&#8217;s shares held by TS Aquaculture.  The registration statement was filed on August 5, 2021 and TS Aquaculture completed a transaction to sell 12,880,000 shares of common stock of the Company on November 23, 2021.  TS Aquaculture ceased being a related party after completing the sale.  TS Aquaculture agreed to pay all expenses incurred in connection with these transactions, which totaled $418 thousand and is included in prepaid and other current assets in the consolidated financial statements as of December 31, 2021.&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566165321320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Organization (Policy)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Organization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_NatureOfOperationsPolicyPolicyTextBlock', window );">Nature of Business</a></td>
<td class="text">Nature of businessAquaBounty Technologies, Inc. (the &#8220;Parent&#8221; and, together with its wholly owned subsidiaries, the &#8220;Company&#8221;) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm&#8209;raised Atlantic salmon that exhibit growth rates that are substantially faster than conventional salmon.  In 2015, the Parent obtained regulatory approval from the U.S. Food and Drug Administration for the production and sale of its genetically engineered AquAdvantage salmon product (&#8220;GE Atlantic salmon&#8221;) in the United States and in 2016, the Parent obtained regulatory approval from Health Canada for the production and sale of its GE Atlantic salmon product in Canada. In 2021, the Parent obtained regulatory approval from the National Biosafety Technical Commission for the sale of its GE Atlantic salmon product in Brazil.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of presentationThe consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned subsidiaries. The entities are collectively referred to herein as the &#8220;Company.&#8221; All inter-company transactions and balances have been eliminated upon consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_LiquidityPolicyPolicyTextBlock', window );">Liquidity</a></td>
<td class="text">LiquidityThe Company completed an equity raise in 2021with net proceeds of $119.1 million and has $191.2 million in cash and cash equivalents, marketable securities and restricted cash as of December 31, 2021. While the Company has experienced net losses and negative cash flows from operations since inception, management believes that it has sufficient cash to meet the Company's requirements beyond the next twelve months from the filing date of these consolidated financial statements. However, until such time as the Company reaches profitability, it may require additional financing to fund its operations and execute its business plan.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_LiquidityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liquidity, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_LiquidityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_NatureOfOperationsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nature Of Operations, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_NatureOfOperationsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168146888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policy)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of estimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the&#160;reporting periods. Actual results could differ from those estimates. <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive lossThe Company displays comprehensive loss and its components as part of its consolidated financial statements. Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) includes foreign currency translation adjustments and unrealized gains (losses) on the Company&#8217;s marketable securities. <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text">Foreign currency translationThe functional currency of the Parent is the US Dollar. The functional currency of the Canadian Subsidiary is the Canadian Dollar (C$) and the functional currency of the US and Brazil Subsidiaries is the US Dollar. For the Canadian Subsidiary, assets and liabilities are translated at the&#160;exchange rates in effect at the balance sheet date, equity accounts are translated at the historical exchange rate and the income statement accounts are translated at the average rate for each period during the year. Net translation gains or losses are adjusted directly to a separate component of other comprehensive income (loss) within stockholders&#8217; equity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text">Cash equivalentsThe Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents.  Cash equivalents consist primarily of business savings accounts, certificates of deposit and money market accounts. <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text">Marketable securitiesMarketable securities include government bonds, corporate bonds and commercial paper.  The Company's investment policy requires investments to be explicitly rated by two of Standard & Poor's, Moody's or Fitch and to have a minimum rating of A1, P1 or F-1, respectively, from those agencies.  In addition, the investment policy limits individual maturities to 12 months, the dollar-weighted average maturity to 180 days and the amount of credit exposure to any one issuer to 5%.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">InventoriesInventories are mainly comprised of feed, eggs and fish in process. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques.  The Company measures inventory at the lower of cost or net realizable value (NRV).  The NRV calculation contains various estimates and assumptions in regard to the calculation of the biomass, including expected yield, the market value of the biomass and estimated costs of completion and transportation. <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text">Intangible assetsDefinite lived intangible assets include patents and licenses.  Patent costs consist primarily of legal and filing fees incurred to file patents on proprietary technology developed by the Company. Patent costs are amortized on a straight-line basis over 20 years beginning with the filing date of the applicable patent.  License fees are capitalized and expensed over the term of the licensing agreement.Indefinite lived intangible assets include trademark costs, which are capitalized with no amortization as they have an indefinite life.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipmentProperty, plant and equipment are carried at cost. The Company depreciates all asset classes over their estimated useful lives, as follows:       Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years The Company commences depreciation on an asset when it is placed into service.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-lived Assets</a></td>
<td class="text">Impairment of long-lived assetsThe Company reviews the carrying value of its long-lived assets, definite lived intangible assets, and property, plant and equipment when facts and circumstances suggest that they may be impaired. The carrying values of such assets are considered impaired when the estimated undiscounted cash flows from such assets are less than their carrying values. An impairment loss, if&#160;any, is recognized in the amount of the difference between the carrying amount and the fair value of such assets.Indefinite lived intangible assets are subject to impairment testing annually or more frequently if impairment indicators arise. The&#160;Company&#8217;s impairment testing utilizes a discounted cash flow analysis that requires significant management judgment with respect&#160;to&#160;revenue and expense growth rates, changes in working capital and the selection and use of the appropriate discount rate. An&#160;impairment loss is recognized in the amount of the difference between the carrying amount and fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">LeasesThe Company leases certain facilities, property, and equipment under noncancelable operating leases. A determination is made if an arrangement is a lease at its inception, and leases with an initial term of twelve months or less are not recorded on the balance sheet.  Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For operating leases, expense is recognized on a straight-line basis over the lease term.  The Company has agreements with lease (e.g., minimum rent payments) and non-lease components (e.g., maintenance), which are generally accounted for separately. The Company has not elected the practical expedient to account for lease and non-lease components as one lease component. The Company adopted Financial Accounting Standards Board's (FASB) Accounting Standards Update (ASU) 2016-02 Leases on January 1, 2019 and recognized a lease liability of $532 thousand and a corresponding right-of-use asset of $512 thousand. Management calculated the lease liability based on the net present value of the remaining lease payments on the date of adoption using a weighted average discount rate of 8%. As most of the Company&#8217;s leases did not provide an implicit interest rate, management used an estimated incremental borrowing rate. The adoption did not result in any cumulative-effect adjustment to beginning retained earnings.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue recognitionThe Company generates revenue from the sale of its products.  Revenue is recognized when the customer takes physical control of the goods, in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for the goods. Revenue excludes any sales tax collected and includes any estimate of future credits.  During 2021, the Company recognized $747 thousand and $428 thousand in revenue from product sales from its Canada and U.S. subsidiaries, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Income taxesThe Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recorded for the expected future tax consequences of temporary differences between the financial reporting and income tax bases of&#160;assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences reverse. A valuation allowance is established to reduce net deferred tax assets to the amount expected to be realized. The Company follows accounting guidance regarding the recognition, measurement, presentation and disclosure of uncertain tax positions in the financial statements. Tax positions taken or expected to be taken in the course of preparing the Company&#8217;s tax returns are required to be&#160;evaluated to determine whether the tax positions are &#8220;more likely than not&#8221; to be upheld under regulatory review. The resulting tax impact of these tax positions is recognized in the financial statements based on the results of this evaluation. The Company did not recognize any tax liabilities associated with uncertain tax positions, nor has it recognized any interest or penalties related to unrecognized tax positions. The Company is not currently under exam and is no longer subject to federal and state tax examinations by tax authorities for years before 2018. <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net loss per shareBasic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Basic net loss per share is based solely on the number of common shares outstanding during the year. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and&#160;options with an exercise price less than the fair value of the common stock unless the impact of the warrant or option is anti-dilutive to the calculation. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti-dilutive and are excluded from the calculation of diluted net loss per share.As of December 31, 2021, the Company had 1,081,866 potentially dilutive securities outstanding, consisting of 418,441 warrants and 663,425 stock options.  As of December 31, 2020, the Company had 2,236,229 potentially dilutive securities outstanding, consisting of 1,662,304 warrants and 573,925 stock options.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation</a></td>
<td class="text">Share-based compensationThe Company measures and recognizes all share-based payment awards, including stock options and restricted share units made to employees and Directors, based on&#160;estimated fair values. The fair value of a share-based payment award is estimated on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in&#160;the&#160;Company&#8217;s consolidated statement of operations. The Company uses the Black-Scholes option pricing model (&#8220;Black-Scholes&#8221;) as&#160;its&#160;method of valuation. Non-employee stock-based compensation is accounted for using Black-Scholes to determine the fair value of&#160;warrants or options awarded to non-employees with the fair value of such issuances expensed over the period of service.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text">Recently Issued Accounting StandardsThe Company is an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. The Company has elected to use the extended transition period for complying with new or revised accounting standards unless otherwise state. The Company will remain an &#8220;emerging growth company&#8221; until the earliest of (i) December 31, 2023, (ii) the last day of the fiscal year in which it has total annual gross revenues of $1.07 billion or more, (iii) the date on which it has issued more than $1.0 billion in nonconvertible debt during the previous three years or (iv) the date on which it is deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;), which generally is when it has more than $700 million in market value of its stock held by non-affiliates, has been a public company for at least 12 months and have filed one annual report on Form 10-K.Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168993768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock', window );">Property, Plant and Equipment Estimated Useful Lives</a></td>
<td class="text">      Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant and Equipment Estimated Useful Lives [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168979208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text">              Amortized  Unrealized  Unrealized  Market  Cost  Gains  Losses  Value December 31, 2021Government bonds$ 28,453,161 $ 82 $ (18,255) $ 28,434,988Corporate bonds  29,874,696   -   (21,928)   29,852,768Commercial paper  43,486,025   -   -   43,486,025Marketable securities$ 101,813,882 $ 82 $ (40,183) $ 101,773,781<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168989800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text">       December 31, 2021 December 31, 2020Feed, net$ 162,047   244,311Eggs and fry  &#8212;   54,929Packaging  &#8212;   6,452Fish in process, net  1,097,863   1,219,685Inventory, net$ 1,259,910   1,525,377<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169075816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">       December 31, 2021 December 31, 2020Land$ 725,799 $ 724,785Building and improvements  15,580,385   14,048,917Construction in process  8,119,575   3,212,287Equipment  15,981,408   13,819,210Office furniture and equipment  240,939   202,596Vehicles  36,280   28,700Total property and equipment$ 40,684,386 $ 32,036,495Less accumulated depreciation and amortization  (6,869,267)   (5,106,157)Property, plant and equipment, net$ 33,815,119 $ 26,930,338<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566245028792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Terms and Conditions of Long-term Debt Outstanding</a></td>
<td class="text">               Interest&#8206;rate Monthly&#8206;repayment Maturity&#8206;date December 31, 2021 December 31, 2020ACOA AIF Grant 0% Royalties - $ 2,261,349 $ 2,253,595ACOA term loan #1 0% C$3,120 Feb 2027   152,346   181,203ACOA term loan #2 0% C$4,630 Sep 2029   339,015   381,451ACOA term loan #3 0% C$6,945 Dec 2025   196,850   &#8212;Kubota Canada Ltd 0% C$1,142 Jan 2025   33,283   43,925PEI Finance term loan 4% C$16,313 Nov 2023   1,947,510   2,014,321DFO term loan 0% C$2,091 Aug 2032   405,700   &#8212;First Farmers Bank & Trust term loan 5.375% $56,832 Oct 2028   3,883,325   4,000,000Total debt       $ 9,219,378 $ 8,874,495less: debt issuance costs         (68,680)   (86,066)less: current portion         (627,365)   (259,939)Long-term debt, net       $ 8,523,333 $ 8,528,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Principal Payments Due on Long-term Debt</a></td>
<td class="text">    Total2022$ 643,9802023  2,564,3472024  729,6262025  750,1752026  715,392Thereafter  3,815,858Total$ 9,219,378<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162576072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Information About Outstanding Warrants</a></td>
<td class="text">      Number of &#8206;options Weighted&#8206;average&#8206;exercise priceOutstanding at December 31, 2020 948,855 $ 3.25Issued &#8212;   -Exercised (530,414)   3.25Expired &#8212;   -Outstanding at December 31, 2021 418,441   3.25Exercisable at December 31, 2021 418,441   3.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Restricted Stock Activity</a></td>
<td class="text">      Shares Weighted&#8206;average grant&#8206;date fair valueBalance at December 31, 2020 92,653 $ 1.93Granted 43,837   6.67Vested (71,390)   2.86Balance at December 31, 2021 65,100 $ 4.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text">      Number of &#8206;options Weighted&#8206;average&#8206;exercise priceOutstanding at December 31, 2020 657,414 $ 4.28Granted 48,914   6.72Exercised (16,667)   6.90Forfeited (1,959)   6.72Expired (24,277)   6.36Outstanding at December 31, 2021 663,425 $ 4.31Exercisable at December 31, 2021 607,189 $ 4.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock', window );">Information About Options Outstanding and Exercisable</a></td>
<td class="text">        Weighted&#8206;average exercise&#8206;price of outstanding&#8206;options Number of&#8206;options&#8206;outstanding Weighted&#8206;average remaining&#8206;estimated life&#8206;(in years) Number of&#8206;options&#8206;exercisable $1.88 - $2.50  524,019  7.3  493,772 $3.30 - $6.72  53,916  8.4  27,927 $7.50 - $10.80  16,403  2.3  16,403 $14.20 - $23.40  69,087  4.2  69,087    663,425    607,189 <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Stock Option Grants Weighted Average Assumptions</a></td>
<td class="text">      20212020Expected volatility 111%101%-104%Risk free interest rate 0.80%0.31%-1.67%Expected dividend yield 0%0%Expected life (in years) 55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share-based Compensation Costs Recognized on Financial Statements</a></td>
<td class="text">                 2021  2020Research and development $ - $ 497General and administrative   394,237   436,194Total share-based compensation $ 394,237 $ 436,691<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169004376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Components of Loss before Income Taxes</a></td>
<td class="text">             2021 2020Domestic$ (21,105,065) $ (15,768,224)Foreign  (1,217,523)   (631,761)Loss before income taxes$ (22,322,588) $ (16,399,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">             2021 2020Income tax benefit$ (4,687,744) $ (3,443,997)State and provincial income tax, net of federal benefit  (1,157,840)   (732,994)Permanent differences  202,583   131,141US-Foreign rate differential  39,045   (142,663)Other, net  (299,071)   (145,973) $ (5,903,027) $ (4,334,486)Change in valuation allowance  5,903,027   4,334,486Total income tax$ - $ -<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text">              2021  2020Deferred tax assets:     Net operating loss carryforwards$ 23,216,863 $ 16,964,199Foreign research and development tax credit carryforwards  2,428,663   2,679,180Property and equipment  145,530   56,697Intangibles and other  2,934,441   3,122,394Total deferred tax assets$ 28,725,497 $ 22,822,470Valuation allowance$ (28,725,497) $ (22,822,470)Net deferred tax assets$ - $ -<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168182904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Summary of Lease Obligations</a></td>
<td class="text">             December 31, 2021 December 31, 2020   Lease Liability   Lease LiabilityTotal leases$ 290,327 $ 352,810Less: current portion  (66,269)   (62,483)Long-term leases$ 224,058 $$ 290,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Summary of Remaining Payments under Leases</a></td>
<td class="text">      Year    Amount2022  $ 84,0802023    33,8722024    17,4812025    18,0062026    18,546Thereafter    583,328Total lease payments    755,313Less: imputed interest    (464,986)Total operating lease liabilities  $ 290,327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123389372&amp;loc=d3e36991-112694<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168986488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Business and Organization (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Organization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_AdditionalCashAndCashEquivalents', window );">Additional cash and cash equivalents</a></td>
<td class="nump">$ 119.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, marketable securities and restricted cash</a></td>
<td class="nump">$ 191.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_AdditionalCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_AdditionalCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162444520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">$ 290,327<span></span>
</td>
<td class="nump">$ 352,810<span></span>
</td>
<td class="nump">$ 532,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">284,320<span></span>
</td>
<td class="nump">341,997<span></span>
</td>
<td class="nump">$ 512,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Product revenues</a></td>
<td class="nump">$ 1,174,832<span></span>
</td>
<td class="nump">$ 127,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potentially dilutive securities outstanding (in shares)</a></td>
<td class="nump">1,081,866<span></span>
</td>
<td class="nump">2,236,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potentially dilutive securities outstanding (in shares)</a></td>
<td class="nump">418,441<span></span>
</td>
<td class="nump">1,662,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potentially dilutive securities outstanding (in shares)</a></td>
<td class="nump">663,425<span></span>
</td>
<td class="nump">573,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Patents, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=aqb_CanadaSubsidiaryMember', window );">Canada Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Product revenues</a></td>
<td class="nump">$ 747,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=aqb_UnitedStatesSubsidiaryMember', window );">United States Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Product revenues</a></td>
<td class="nump">$ 428,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=aqb_CanadaSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=aqb_CanadaSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=aqb_UnitedStatesSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=aqb_UnitedStatesSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162119128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqb_OfficeFurnitureandEquipmentMember', window );">Office Furniture And Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_PropertyPlantAndEquipmentUsefulLife1', window );">Property, plant and equipment, useful life</a></td>
<td class="text">shorter of asset life or lease term<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_PropertyPlantAndEquipmentUsefulLife1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant and Equipment, Useful Life 1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_PropertyPlantAndEquipmentUsefulLife1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqb_OfficeFurnitureandEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqb_OfficeFurnitureandEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566163948824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Risks and Uncertainties (Details) - Credit Concentration Risk [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalent investment balance</a></td>
<td class="nump">$ 73,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash in Canadian bank accounts</a></td>
<td class="nump">$ 224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169152184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities (Schedule of Marketable Securities) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">$ 101,813,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesUnrealizedGain', window );">Unrealized Gains</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesUnrealizedLoss', window );">Unrealized Losses</a></td>
<td class="num">(40,183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Market Value</a></td>
<td class="nump">101,773,781<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">28,453,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesUnrealizedGain', window );">Unrealized Gains</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesUnrealizedLoss', window );">Unrealized Losses</a></td>
<td class="num">(18,255)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Market Value</a></td>
<td class="nump">28,434,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">Corporate Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">29,874,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesUnrealizedLoss', window );">Unrealized Losses</a></td>
<td class="num">(21,928)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Market Value</a></td>
<td class="nump">29,852,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_MarketableSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">43,486,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Market Value</a></td>
<td class="nump">$ 43,486,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_MarketableSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_MarketableSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_MarketableSecuritiesUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Unrealized Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_MarketableSecuritiesUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_MarketableSecuritiesUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Unrealized Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_MarketableSecuritiesUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566169045000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_FishInProcessMember', window );">Fish In Process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryAdjustments', window );">Inventory reserve</a></td>
<td class="nump">$ 1,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_FishInProcessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=aqb_FishInProcessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162087704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Schedule of Inventory) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">$ 1,259,910<span></span>
</td>
<td class="nump">$ 1,525,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_FeedMember', window );">Feed [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total Inventory</a></td>
<td class="nump">162,047<span></span>
</td>
<td class="nump">244,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_EggsAndFryMember', window );">Eggs And Fry [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,929<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_PackagingMember', window );">Packaging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_FishInProcessMember', window );">Fish In Process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total Inventory</a></td>
<td class="nump">$ 1,097,863<span></span>
</td>
<td class="nump">1,219,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryAdjustments', window );">Less inventory reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,530,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_FeedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=aqb_FeedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_EggsAndFryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=aqb_EggsAndFryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_PackagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=aqb_PackagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=aqb_FishInProcessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=aqb_FishInProcessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566163938664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities', window );">Proceeds from legal settlement, net</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,014,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,684,386<span></span>
</td>
<td class="nump">32,036,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction In Process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,119,575<span></span>
</td>
<td class="nump">$ 3,212,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_New10000MetricTonFarmMember', window );">Ohio Farm [Member] | Capital Addition Purchase Commitments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Commitments to purchase property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_New10000MetricTonFarmMember', window );">Ohio Farm [Member] | Construction In Process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_RolloBayFarmAndFortuneBayHatcheryMember', window );">Rollo Bay Farm And Fortune Bay Hatchery [Member] | Construction In Process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_IndianaAquacultureFarmMember', window );">Indiana Aquaculture Farm [Member] | Construction In Process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds (Payments) for Legal Settlements, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_New10000MetricTonFarmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_New10000MetricTonFarmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_RolloBayFarmAndFortuneBayHatcheryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_RolloBayFarmAndFortuneBayHatcheryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_IndianaAquacultureFarmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=aqb_IndianaAquacultureFarmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162057960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 40,684,386<span></span>
</td>
<td class="nump">$ 32,036,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(6,869,267)<span></span>
</td>
<td class="num">(5,106,157)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">33,815,119<span></span>
</td>
<td class="nump">26,930,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">725,799<span></span>
</td>
<td class="nump">724,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building And Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">15,580,385<span></span>
</td>
<td class="nump">14,048,917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction In Process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">8,119,575<span></span>
</td>
<td class="nump">3,212,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">15,981,408<span></span>
</td>
<td class="nump">13,819,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqb_OfficeFurnitureandEquipmentMember', window );">Office Furniture And Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">240,939<span></span>
</td>
<td class="nump">202,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 36,280<span></span>
</td>
<td class="nump">$ 28,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqb_OfficeFurnitureandEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqb_OfficeFurnitureandEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566154938728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2025</div></th>
<th class="th">
<div>Aug. 20, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 20, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Feb. 29, 2016</div></th>
<th class="th"><div>Jan. 31, 2009</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 12, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 11, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 606,453<span></span>
</td>
<td class="nump">$ 4,221,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Loan settlement costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable [Member] | ACOA AIF Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage', window );">Royalty percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">-<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | ACOA Term Loan #1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">108 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | ACOA Term Loan #2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">108 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | ACOA Term Loan #3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | PEI Finance Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_RepaymentPeriodOfLoan', window );">Loan repayment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">87 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | First Farmers Bank &amp; Trust [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Loan settlement costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentInterestRateStatedPercentagePeriod', window );">Interest rate, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentInterestOnlyPaymentPeriod', window );">Interest only payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentCovenantCashBalanceMinimum', window );">Covenant, minimum cash balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | First Farmers Bank &amp; Trust [Member] | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Oct.  01,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | DFO Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug 2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 316,000<span></span>
</td>
<td class="nump">$ 152,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=aqb_CanadianSubsidiaryMember', window );">Canadian Subsidiary [Member] | Secured Debt [Member] | ACOA Term Loan #3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,075<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=aqb_CanadianSubsidiaryMember', window );">Canadian Subsidiary [Member] | Secured Debt [Member] | DFO Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 219,258<span></span>
</td>
<td class="nump">$ 276,840<span></span>
</td>
<td class="nump">$ 187,120<span></span>
</td>
<td class="nump">$ 238,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">August 2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=aqb_USTreasuryFiveYearMaturitiesInterestRateMember', window );">US Treasury 5-Year Maturities Rate [Member] | First Farmers Bank &amp; Trust [Member] | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_DebtInstrumentCovenantCashBalanceMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Cash Balance, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_DebtInstrumentCovenantCashBalanceMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_DebtInstrumentInterestOnlyPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Only Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_DebtInstrumentInterestOnlyPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_DebtInstrumentInterestRateStatedPercentagePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Stated Percentage, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_DebtInstrumentInterestRateStatedPercentagePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_DebtInstrumentMaturityDateYearMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Maturity Date Year Month</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_DebtInstrumentMaturityDateYearMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Repayment Terms, Royalty Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_RepaymentPeriodOfLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment Period Of Loan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_RepaymentPeriodOfLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_FPEITermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_FPEITermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_FirstFarmersBankAndTrustLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_FirstFarmersBankAndTrustLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_DfoTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_DfoTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=aqb_CanadianSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=aqb_CanadianSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=aqb_USTreasuryFiveYearMaturitiesInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=aqb_USTreasuryFiveYearMaturitiesInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566157835448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Feb. 29, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,219,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,874,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">less: debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68,680)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(86,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">less: current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(627,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(259,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,523,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,528,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable [Member] | ACOA AIF Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">-<span></span>
</td>
<td class="text">-<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,261,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,253,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | ACOA Term Loan #1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb 2027<span></span>
</td>
<td class="text">Feb 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | ACOA Term Loan #2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep 2029<span></span>
</td>
<td class="text">Sep 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 339,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | ACOA Term Loan #3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec 2025<span></span>
</td>
<td class="text">Dec 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | Kubota Canada Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan 2025<span></span>
</td>
<td class="text">Jan 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | PEI Finance Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov 2023<span></span>
</td>
<td class="text">Nov 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,947,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,014,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | DFO Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug 2032<span></span>
</td>
<td class="text">Aug 2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 405,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | First Farmers Bank &amp; Trust [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.375%<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly repayment</a></td>
<td class="nump">$ 57,000<span></span>
</td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_DebtInstrumentMaturityDateYearMonth', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct 2028<span></span>
</td>
<td class="text">Oct 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,883,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_DebtInstrumentMaturityDateYearMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Maturity Date Year Month</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_DebtInstrumentMaturityDateYearMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_KubotaCanadaLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_KubotaCanadaLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_FPEITermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_FPEITermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_DfoTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_DfoTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqb_FirstFarmersBankAndTrustLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqb_FirstFarmersBankAndTrustLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566163904424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Principal Payments Due on Long-term Debt) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 643,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">2,564,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">729,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">750,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">715,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">3,815,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 9,219,378<span></span>
</td>
<td class="nump">$ 8,874,495<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566154662072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 08, 2021</div></th>
<th class="th"><div>Dec. 14, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_AuthorizedShares', window );">Authorized shares of common and preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Authorized shares of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Issued shares of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Outstanding shares of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Issued shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,025,738<span></span>
</td>
<td class="nump">55,497,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,025,738<span></span>
</td>
<td class="nump">55,497,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights, number of votes per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of equity subscription</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,120,437<span></span>
</td>
<td class="nump">$ 104,625,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,237<span></span>
</td>
<td class="nump">436,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,237<span></span>
</td>
<td class="nump">436,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unearned share-based compensation expense in future periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unearned share-based compensation earn period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,000<span></span>
</td>
<td class="nump">$ 251,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unearned share-based compensation expense in future periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unearned share-based compensation earn period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of stock options grants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.36<span></span>
</td>
<td class="nump">$ 1.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic value of exercisable options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.31%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=aqb_A2016EquityIncentivePlanMember', window );">2016 Equity Incentive Plan [Member] | Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized to grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,950,000<span></span>
</td>
<td class="nump">33,028,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of equity subscription</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,950<span></span>
</td>
<td class="nump">$ 33,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqb_December2020PublicOfferingMember', window );">December 2020 Public Offering [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,028,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance or sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqb_February2021PublicOfferingMember', window );">February 2021 Public Offering [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issued (in shares)</a></td>
<td class="nump">14,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance or sale of equity</a></td>
<td class="nump">$ 119,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_AuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of common and preferred shares authorized by the Company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_AuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqb_A2016EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqb_A2016EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqb_December2020PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqb_December2020PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqb_February2021PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqb_February2021PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566164143976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Information About Outstanding Warrants) (Details) - Warrant [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance | shares</a></td>
<td class="nump">948,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issued | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(530,414)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance | shares</a></td>
<td class="nump">418,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable | shares</a></td>
<td class="nump">418,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance | $ / shares</a></td>
<td class="nump">$ 3.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="nump">3.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance | $ / shares</a></td>
<td class="nump">3.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable | $ / shares</a></td>
<td class="nump">$ 3.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162452568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Restricted Stock Activity) (Details) - Restricted Stock [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance | shares</a></td>
<td class="nump">92,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">43,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(71,390)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance | shares</a></td>
<td class="nump">65,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance | $ / shares</a></td>
<td class="nump">$ 1.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted | $ / shares</a></td>
<td class="nump">6.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested | $ / shares</a></td>
<td class="nump">2.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance | $ / shares</a></td>
<td class="nump">$ 4.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566168158600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Stock Option Activity) (Details) - Stock Option [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance</a></td>
<td class="nump">657,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">48,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(16,667)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(1,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired</a></td>
<td class="num">(24,277)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance</a></td>
<td class="nump">663,425<span></span>
</td>
<td class="nump">657,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable</a></td>
<td class="nump">607,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 4.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">6.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">6.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">6.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired</a></td>
<td class="nump">6.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance</a></td>
<td class="nump">4.31<span></span>
</td>
<td class="nump">$ 4.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable</a></td>
<td class="nump">$ 4.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566154568056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Information About Options Outstanding and Exercisable) (Details) - Stock Option [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options outstanding</a></td>
<td class="nump">663,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of options exercisable</a></td>
<td class="nump">607,189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$1.88 - $2.50</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options outstanding</a></td>
<td class="nump">524,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining estimated life (in years)</a></td>
<td class="text">7 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of options exercisable</a></td>
<td class="nump">493,772<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$3.30 - $6.72</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options outstanding</a></td>
<td class="nump">53,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining estimated life (in years)</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of options exercisable</a></td>
<td class="nump">27,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$7.50 - $10.80</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options outstanding</a></td>
<td class="nump">16,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining estimated life (in years)</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of options exercisable</a></td>
<td class="nump">16,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$14.20 - $23.40</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options outstanding</a></td>
<td class="nump">69,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining estimated life (in years)</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of options exercisable</a></td>
<td class="nump">69,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum [Member] | $1.88 - $2.50</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price of outstanding options | $ / shares</a></td>
<td class="nump">$ 1.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum [Member] | $3.30 - $6.72</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price of outstanding options | $ / shares</a></td>
<td class="nump">3.30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum [Member] | $7.50 - $10.80</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price of outstanding options | $ / shares</a></td>
<td class="nump">7.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum [Member] | $14.20 - $23.40</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price of outstanding options | $ / shares</a></td>
<td class="nump">14.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum [Member] | $1.88 - $2.50</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price of outstanding options | $ / shares</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum [Member] | $3.30 - $6.72</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price of outstanding options | $ / shares</a></td>
<td class="nump">6.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum [Member] | $7.50 - $10.80</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price of outstanding options | $ / shares</a></td>
<td class="nump">10.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum [Member] | $14.20 - $23.40</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price of outstanding options | $ / shares</a></td>
<td class="nump">$ 23.40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=aqb_ExercisePriceOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=aqb_ExercisePriceOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=aqb_ExercisePriceTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=aqb_ExercisePriceTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=aqb_ExercisePriceThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=aqb_ExercisePriceThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=aqb_ExercisePriceFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=aqb_ExercisePriceFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566163911112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Stock Option Grants Weighted Average Assumptions) (Details) - Stock Option [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">111.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.31%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566165314520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">$ 394,237<span></span>
</td>
<td class="nump">$ 436,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research And Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General And Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">$ 394,237<span></span>
</td>
<td class="nump">$ 436,194<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162087736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Domestic operating loss carryforwards</a></td>
<td class="nump">$ 50.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member] | Limitations On Use To Section 382 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Domestic operating loss carryforwards</a></td>
<td class="nump">78.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign operating loss carryforwards</a></td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member] | Research Tax Credit Carryforward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Foreign research and development tax credit carryforwards</a></td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=aqb_LimitationsOnUseToSection382Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=aqb_LimitationsOnUseToSection382Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162547928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Components of Loss Before Income Taxes) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (21,105,065)<span></span>
</td>
<td class="num">$ (15,768,224)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(1,217,523)<span></span>
</td>
<td class="num">(631,761)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (22,322,588)<span></span>
</td>
<td class="num">$ (16,399,985)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566163904040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit</a></td>
<td class="num">$ (4,687,744)<span></span>
</td>
<td class="num">$ (3,443,997)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and provincial income tax, net of federal benefit</a></td>
<td class="num">(1,157,840)<span></span>
</td>
<td class="num">(732,994)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Permanent differences</a></td>
<td class="nump">202,583<span></span>
</td>
<td class="nump">131,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">US-Foreign rate differential</a></td>
<td class="nump">39,045<span></span>
</td>
<td class="num">(142,663)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="num">(299,071)<span></span>
</td>
<td class="num">(145,973)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance', window );">Total income tax, prior to change in valuation allowance</a></td>
<td class="num">(5,903,027)<span></span>
</td>
<td class="num">(4,334,486)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">5,903,027<span></span>
</td>
<td class="nump">4,334,486<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit), Before Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566154550504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 23,216,863<span></span>
</td>
<td class="nump">$ 16,964,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Foreign research and development tax credit carryforwards</a></td>
<td class="nump">2,428,663<span></span>
</td>
<td class="nump">2,679,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">145,530<span></span>
</td>
<td class="nump">56,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles and other</a></td>
<td class="nump">2,934,441<span></span>
</td>
<td class="nump">3,122,394<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">28,725,497<span></span>
</td>
<td class="nump">22,822,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(28,725,497)<span></span>
</td>
<td class="num">(22,822,470)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162568728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Lease payment</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">24 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566163943304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Summary of Lease Obligations) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total leases</a></td>
<td class="nump">$ 290,327<span></span>
</td>
<td class="nump">$ 352,810<span></span>
</td>
<td class="nump">$ 532,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="num">(66,269)<span></span>
</td>
<td class="num">(62,483)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term leases</a></td>
<td class="nump">$ 224,058<span></span>
</td>
<td class="nump">$ 290,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566163917240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 84,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">33,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">17,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">18,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">18,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">583,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total Lease Payments</a></td>
<td class="nump">755,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(464,986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total leases</a></td>
<td class="nump">$ 290,327<span></span>
</td>
<td class="nump">$ 352,810<span></span>
</td>
<td class="nump">$ 532,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566162200056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Employer contributions to retirement plan</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Employer contributions to retirement plan</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140566164025144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Agreement (Details) - TS Aquaculture [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in public offering</a></td>
<td class="nump">12,880,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aqb_TsAquacultureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aqb_TsAquacultureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>aqb-20211231x10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aqb="http://www.sec.gov/20211231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aqb-20211231.xsd" xlink:type="simple"/>
    <context id="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqb:ExercisePriceFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_aqb_A2016EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqb:A2016EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_23_2021_To_11_23_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aqb:TsAquacultureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-23</startDate>
            <endDate>2021-11-23</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_UnitedStatesSubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:UnitedStatesSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadaSubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadaSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aqb:TsAquacultureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqb:OfficeFurnitureandEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_RolloBayFarmAndFortuneBayHatcheryMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">aqb:RolloBayFarmAndFortuneBayHatcheryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_New10000MetricTonFarmMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">aqb:New10000MetricTonFarmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_IndianaAquacultureFarmMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">aqb:IndianaAquacultureFarmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqb:OfficeFurnitureandEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqb:OfficeFurnitureandEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_2_8_2021_To_2_8_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_February2021PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqb:February2021PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-08</startDate>
            <endDate>2021-02-08</endDate>
        </period>
    </context>
    <context id="Duration_12_14_2020_To_12_14_2020_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_December2020PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqb:December2020PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-14</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="Duration_9_1_2020_To_9_30_2020_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_StatementScenarioAxis_aqb_LimitationsOnUseToSection382Member_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">aqb:LimitationsOnUseToSection382Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_1_1_2019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_New10000MetricTonFarmMember_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_us-gaap_CapitalAdditionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">aqb:New10000MetricTonFarmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:CapitalAdditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:KubotaCanadaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyAIFGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_1_1_2019_srt_RangeAxis_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:FishInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:FeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_PackagingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:PackagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:FeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_EggsAndFryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:EggsAndFryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">aqb:FishInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_8_20_2021_To_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-20</startDate>
            <endDate>2021-08-20</endDate>
        </period>
    </context>
    <context id="Duration_11_1_2018_To_11_30_2018_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="Duration_2_1_2016_To_2_29_2016_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-01</startDate>
            <endDate>2016-02-29</endDate>
        </period>
    </context>
    <context id="Duration_7_31_2025_To_7_31_2025_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-31</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:KubotaCanadaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyAIFGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-20</instant>
        </period>
    </context>
    <context id="As_Of_11_30_2018_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="As_Of_2_29_2016_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-02-29</instant>
        </period>
    </context>
    <context id="As_Of_4_27_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-27</instant>
        </period>
    </context>
    <context id="As_Of_2_25_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-25</instant>
        </period>
    </context>
    <context id="As_Of_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="Duration_7_31_2025_To_7_31_2025_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_VariableRateAxis_aqb_USTreasuryFiveYearMaturitiesInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">aqb:USTreasuryFiveYearMaturitiesInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-31</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CA_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_9_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="Duration_1_1_2018_To_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_3_1_2020_To_3_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_DomesticCorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2009_To_1_31_2009_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyAIFGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2009-01-01</startDate>
            <endDate>2009-01-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">aqb:CanadianSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:KubotaCanadaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FPEITermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:DfoTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyTermLoan1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:AtlanticCanadaOpportunitiesAgencyAIFGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="As_Of_10_12_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-12</instant>
        </period>
    </context>
    <context id="As_Of_10_11_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqb:FirstFarmersBankAndTrustLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-11</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603978</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="Unit15">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="Unit14">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit13">
        <measure>pure</measure>
    </unit>
    <unit id="Unit12">
        <measure>shares</measure>
    </unit>
    <unit id="Unit1">
        <measure>iso4217:USD</measure>
    </unit>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-6843bac4-d396-4fd5-bf64-eaadba0c9281"
      unitRef="Unit1"
      xsi:nil="true"/>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-4b105fbd-1e83-4e55-98fe-f75182c28eb1"
      unitRef="Unit1"
      xsi:nil="true"/>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-263e3319-a480-4d83-a603-55ac72fed500"
      unitRef="Unit1"
      xsi:nil="true"/>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-3fbe7447-b64c-49bf-8eb3-857896bb3d07"
      unitRef="Unit1"
      xsi:nil="true"/>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-ae8d33c1-cd01-46e4-bc99-cd2b4eab21f8">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-89256f51-0667-42c8-90fd-c2b0beb023a5">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-a1f5732c-09df-49a1-b51c-5092f4f69710">0001603978</dei:EntityCentralIndexKey>
    <dei:EntityCurrentReportingStatus
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-dad54e01-7cbb-49a6-9ef9-26fae263ec17">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-1e470b56-62bb-4aa4-976a-9a36f2e03bf9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityVoluntaryFilers
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-40a08545-331d-4169-b4c9-e76073a08e6a">No</dei:EntityVoluntaryFilers>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-5da46204-68f9-4a13-b58a-944d76156d6a">No</dei:EntityWellKnownSeasonedIssuer>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2020"
      id="ct-nonFraction-a98151dc-30be-4049-88e4-e8cba4435ef0"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2021"
      id="ct-nonFraction-9b6a89d3-0451-4270-8124-ff3ec68f392a"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="As_Of_12_31_2020"
      id="ct-nonFraction-077f0b32-cba5-4513-adc8-5c7bdc6e843b"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="As_Of_12_31_2021"
      id="ct-nonFraction-1f41823f-8a95-4a42-aa9f-fe1f629034c2"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="ct-nonFraction-6cd9ec42-3e38-47dd-ac50-dd60514278fc"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonFraction-473abf1b-b7a8-48ec-9c21-1b576508b93a"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-d18d1eb7-b31b-4410-9c80-ffbc9b77fa38"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      id="ct-nonFraction-f18e4ffc-3dd2-4c4d-bffc-5e004097cfa6"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="ct-nonFraction-784a336f-4241-46ff-b361-20226944947e"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="ct-nonFraction-1bb6a9e6-5ce4-42f3-b252-6b5d694544b3"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-cb484afc-c85f-4c6f-8d1f-29ef78cae0b0"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      id="ct-nonFraction-097314e7-11bb-4ca7-9fd6-6cda76fab2db"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="ct-nonFraction-f5bfb904-39d5-41a6-a26b-bcef77051a83"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="ct-nonFraction-4bb53a14-2a93-4e17-a63b-c2cb1c46e424"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      id="ct-nonFraction-a6a59526-a36d-40a1-bb65-7b1a4df8e865"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="ct-nonFraction-cf4fe521-6340-4877-82ce-2a20e3ddbcd5"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="ct-nonFraction-868b5e5a-c34a-420c-ad32-9cbd544962d2"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-5c3c08f2-7378-4208-9011-725686935807"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      id="ct-nonFraction-47847e33-ade6-41f5-b123-5cde2d12e28d"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="ct-nonFraction-b59795ba-7292-4c2b-b223-b9e146873faa"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="ct-nonFraction-0f0c9ec5-d409-41d6-944e-59e4d95411a6"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-5098dbc5-42aa-46bc-a709-f0801a283dcd"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      id="ct-nonFraction-0de592a2-a281-4bcc-b007-54b70b53ad5e"
      unitRef="Unit12"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      id="ct-nonFraction-0f1e3a82-3c9a-4af7-8079-b11fbf22c4b8"
      unitRef="Unit12"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      id="ct-nonFraction-2367f287-be72-479c-be0c-a2b3f6b3a182"
      unitRef="Unit14"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      id="ct-nonFraction-4fe05951-b99a-4a95-904e-ec454df333b2"
      unitRef="Unit14"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-140e6731-d1c4-4feb-b875-90fdf39442e2"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-7d6a578e-1989-4c3f-b810-b250c9fffb38"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-32f45406-b983-4571-872a-500c6d6fa4ee"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-bdea8e6f-fb6c-48e6-baae-6a051816da74"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-ff28a4a8-4f8d-4747-97e8-7cc1e22f4798"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-2e4c5fba-a84c-4603-9ba3-f3d69a621041"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-48c7b8af-c98c-4e02-9b32-50bbecaa0198"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-ce6ab083-ac06-43a7-8908-c67eeecfcb96"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-8d648ec8-43cb-4fa1-ad25-d93da47c90e9"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-aae32a99-c74d-4fa3-a6ab-7f34f49500b0"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonFraction-47b3ae23-1792-4d3b-8c42-c4bb6f520a26"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="ct-nonFraction-35042d0c-312c-4986-8548-bc6cd3eb8bc2"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      id="ct-nonFraction-e8d2e945-1c87-493b-9e7e-e6c30034ab06"
      unitRef="Unit1"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-a110ceaa-099b-45a3-85ff-8dee1d36eb33">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-31e89b51-5185-4a54-86ae-f2e46ceca926">true</dei:DocumentAnnualReport>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-d5f50fcd-12a0-4448-a9d5-fc90348a96bf">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-812b9b51-9e2e-4205-8d01-30beadc493b8">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-b80a3b28-d161-404e-8590-f9d69bb4073a">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-a773f5d0-e746-40d7-b81a-6beffb7009be">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-acc7b983-fd09-4e97-acb9-6d3e8bf2db4e">001-36426</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-fa3d5437-a958-4694-abfb-930717430674">AquaBounty Technologies, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-71c52b6e-6b3b-41f3-8f87-323d70026c97">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-b0bd8b31-6d4f-40b4-bd79-22496f732071">04-3156167</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-16425177-367e-445e-a2e9-13780b273bcf">2 Mill &amp; Main Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-037dbe75-edeb-4ea4-afb7-c8d51cc32cfc">Suite 395</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-e317c2ef-7168-4cdf-aa42-9d30e5a250a9">Maynard</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-58d9efcf-c798-4708-9dff-02d3b7ca96be">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-6abda6c6-2517-47be-a473-088147513ebd">01754</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-0836a366-74c4-4d98-bab0-3a951fb3f3a1">978</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-3922f655-0539-474c-a714-6d8924c8d2fc">648-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-46fa4ecc-f23b-4743-adc0-f4ba715fd4bb">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-5883bb3b-5c58-42bf-ab85-a7f82099dfb4">AQB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-9446b8e7-38ee-4215-9fdb-a3db5842951b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-04528bb6-13b2-409c-8b91-31c0dd884f1c">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-e615527b-4a01-4f40-ae59-498c7b149024">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-5878db1f-6db4-44a8-9e07-d0d1e8afe999">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-2619b13b-ca35-4d68-8fda-0df67e1a7ae6">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-e1cdb6fd-0cc3-42d1-9069-94c89d17a0a9">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-d2f1ced6-89d6-463a-98a1-d89610726ccf">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="As_Of_6_30_2021"
      decimals="-5"
      id="ct-nonFraction-2e8aa19c-9424-4e7a-9cb6-230bf073fb68"
      unitRef="Unit1">234200000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="As_Of_3_9_2022"
      decimals="INF"
      id="ct-nonFraction-b25f3540-0f64-4a5f-aa6c-625c290099b6"
      unitRef="Unit12">71025738</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-0cea20a3-7919-4550-9a50-845b9f2bee44">Portions of the registrant&#x2019;s Proxy Statement for its Annual Meeting of Shareholders to be held on May&#160;17, 2022 (the &#x201c;2022 Proxy Statement&#x201d;), are incorporated by reference into Part III of this Annual Report on Form&#160;10&#x2011;K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-aa2b36db-299d-47e8-b496-9075f6b71067">34</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-2f0d4b42-255b-4527-a6cf-9677e1c9b450">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-29a3b02c-51b5-413d-9390-fec6562d8331">Baltimore, Maryland</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-a4db479e-45ec-40cd-af85-0e67868eae7b"
      unitRef="Unit1">88454988</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-f5cc94e1-a319-4a33-9e64-fdebc158c197"
      unitRef="Unit1">95751160</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-39d2f3d0-fc5d-4a2d-aac6-bb145c207023"
      unitRef="Unit1">101773781</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-3a105b4e-1929-474e-978a-2061535024c6"
      unitRef="Unit1">1259910</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-53c2c59f-932d-4d21-8d38-1fc5533b8ebf"
      unitRef="Unit1">1525377</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-b7f1babf-2e43-402d-abb7-eac1e83697e4"
      unitRef="Unit1">1536484</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-36b9e2f0-0408-4d83-a677-c9f84fcadd21"
      unitRef="Unit1">405370</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-33e151f5-89e1-48d6-9489-a205b88d8b40"
      unitRef="Unit1">193025163</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-3962c574-6f0a-4888-bd5d-5fd3d4cc8726"
      unitRef="Unit1">97681907</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-74823e5e-fe34-4651-a17e-b15e445f1dc6"
      unitRef="Unit1">33815119</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-791f209e-7816-467b-9473-6af1f37ed31c"
      unitRef="Unit1">26930338</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-b7b27d3d-6871-4850-ab74-89fc0d89c04a"
      unitRef="Unit1">284320</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-d5c6dafe-136b-4c9f-bb99-3bd2b736641b"
      unitRef="Unit1">341997</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-50eaf153-36b2-4bfd-990a-3cad25a08e48"
      unitRef="Unit1">231842</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-5a48cc84-ae8e-4fc2-a64c-d7a59d23f7c5"
      unitRef="Unit1">245546</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:RestrictedCash
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-b7b9f673-1301-419d-a433-cd8b8f5b7aa4"
      unitRef="Unit1">1000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-c7a5fdb5-d129-4940-b82f-f91460b00df3"
      unitRef="Unit1">500000</us-gaap:RestrictedCash>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-baa01d87-dde7-4459-8c84-bcb0abfb4e73"
      unitRef="Unit1">79548</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-daa5e5da-9120-438b-86dc-eca5c8bef167"
      unitRef="Unit1">76715</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-ec7242c1-36b0-4536-b5e3-6cfd0e2a86d3"
      unitRef="Unit1">228435992</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-008b4cc9-9649-43e9-8be8-79f300629cba"
      unitRef="Unit1">125776503</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-832eb285-92de-4987-9c5d-ac3e20588dfb"
      unitRef="Unit1">4317615</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-de25135b-793a-4a96-b88e-2e5a1bf65686"
      unitRef="Unit1">1176802</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-15e18082-e21c-46c6-bc7f-1c69b3a0e0b8"
      unitRef="Unit1">874589</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-0abc58aa-c943-4549-bccc-c56700cfcb3c"
      unitRef="Unit1">583301</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-455858ff-4414-4489-95ab-83e9e91cc965"
      unitRef="Unit1">627365</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-1f319edc-fade-45ce-a549-d5f717a5372a"
      unitRef="Unit1">259939</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-077c2fb3-a05c-44a5-bf9b-5f7daa939591"
      unitRef="Unit1">66269</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-955ea7ab-3964-407c-9cdc-460cdac81591"
      unitRef="Unit1">62483</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-9f72ae44-9747-4fa4-a712-e9614e812db7"
      unitRef="Unit1">5885838</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-23d31153-1e67-45d2-aa92-dd1f06b99262"
      unitRef="Unit1">2082525</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-0420126f-df47-4c1e-931a-6b3e3489d08e"
      unitRef="Unit1">224058</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-774b863f-b958-438d-8c75-e6dbbb811f98"
      unitRef="Unit1">290327</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-da074f30-164b-40af-b94c-e67cd8a9897f"
      unitRef="Unit1">8523333</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-0306ad20-53fb-4e3a-888e-29c737d3f255"
      unitRef="Unit1">8528490</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-e8fa628b-67b6-42fc-a3d0-083d02a5c0ee"
      unitRef="Unit1">14633229</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-14278dd0-4304-41ad-b7c6-b4bfbe648b84"
      unitRef="Unit1">10901342</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-41396b4b-b0e7-4918-bef4-4b24faa2f48f"
      unitRef="Unit14">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-b56be015-95a5-46c8-967e-ec24381b5a7e"
      unitRef="Unit14">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-a301f912-3971-47ce-8b73-6d99e67c62fb"
      unitRef="Unit12">80000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-055c66f7-7542-47b1-b9ec-1f18f05765f7"
      unitRef="Unit12">80000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-a3974881-05dc-4e0c-8c10-028f9ba55380"
      unitRef="Unit12">71025738</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-1718fff0-ac3d-4d6e-a7bd-78d9a1b0111e"
      unitRef="Unit12">55497133</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-aa7443de-55cd-4b27-8207-a2759fe79481"
      unitRef="Unit1">71026</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-f10e0607-9fa1-4d74-8582-06b409aab5de"
      unitRef="Unit1">55497</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-141b8793-b8e3-4b9f-810d-fe1d9a9d6250"
      unitRef="Unit1">384852107</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-7f2cacb4-7963-4039-96b3-c62cee8ab484"
      unitRef="Unit1">263629116</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-60ebe397-2c17-4f93-bdd6-05ee5db5178e"
      unitRef="Unit1">-255588</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-b37742c1-7a65-4d55-8d13-5dd10ae597c9"
      unitRef="Unit1">-267258</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-df897f7e-de0b-4974-a243-2a38e174160f"
      unitRef="Unit1">-170864782</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-0236f7e3-edb6-499b-abec-cbab8476675d"
      unitRef="Unit1">-148542194</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-efe2856f-44b8-4594-9d3d-f86bc7f21f91"
      unitRef="Unit1">213802763</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-1510808c-3ea9-4716-a166-2808e0c9377a"
      unitRef="Unit1">114875161</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-57a49f07-dd5e-4be5-9eae-824e38688e75"
      unitRef="Unit1">228435992</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-cca5aff4-09c5-459a-8a6b-8724ed590be7"
      unitRef="Unit1">125776503</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4ea45f21-bfa5-434f-9fda-0d9d3a7e2b2b"
      unitRef="Unit1">1174832</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-ee643100-af08-4e22-9002-b6301cad1f70"
      unitRef="Unit1">127663</us-gaap:Revenues>
    <aqb:ProductionCostsOperating
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-e44403ef-4c14-4880-8c8d-ec49023323cd"
      unitRef="Unit1">10786072</aqb:ProductionCostsOperating>
    <aqb:ProductionCostsOperating
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-d39cdeb8-95ba-4030-90eb-a29bf4faaf4d"
      unitRef="Unit1">6680012</aqb:ProductionCostsOperating>
    <us-gaap:SellingAndMarketingExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-950ae21b-93e7-43dd-8870-a40198c41900"
      unitRef="Unit1">1261764</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-15b08e1a-ae55-42d5-bd15-c54335c6f26f"
      unitRef="Unit1">533428</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-5f7a8892-f6d9-4bcb-afb6-60c13746a3e9"
      unitRef="Unit1">2145548</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-0540c5ef-0d97-4144-a8df-b01ba100646d"
      unitRef="Unit1">2364610</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-523b333f-00a6-46ff-b3a5-d17d8024f183"
      unitRef="Unit1">9103213</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-06e9921c-e976-4e81-8886-3f5bbbfdd759"
      unitRef="Unit1">6797443</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-80add01d-f7a5-4ada-a59b-29143673b7b7"
      unitRef="Unit1">23296597</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-2841b077-7eea-4994-9c68-c8afe7a318a0"
      unitRef="Unit1">16375493</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-455d8f7d-ff7c-4bed-ad98-af0f4c3a7eb5"
      unitRef="Unit1">-22121765</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-b8c780a6-b62c-47e1-b567-20513eb45fd9"
      unitRef="Unit1">-16247830</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-86047e16-069e-4a3b-b71d-2982defc2a2e"
      unitRef="Unit1">316442</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-bf72f0a7-158a-4738-b002-3a0e71e30535"
      unitRef="Unit1">152367</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-8b2fb143-66b4-4678-96cd-64fa64dbd1ff"
      unitRef="Unit1">115619</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-f9575adb-0472-401a-a760-fd5615cd4629"
      unitRef="Unit1">212</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4a0107a3-ad08-4609-99b9-bcd7b041bad9"
      unitRef="Unit1">-200823</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-20c15295-ff22-4b46-bc70-974fe454950e"
      unitRef="Unit1">-152155</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-ee4e2f10-66c0-4051-ac2c-3c85c2502c5e"
      unitRef="Unit1">-22322588</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-1bb44bef-457a-4fed-bc60-4097213664b1"
      unitRef="Unit1">-16399985</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-aadb3af0-dea6-40b6-be7a-3b2333e43854"
      unitRef="Unit1">51771</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-c1f92a69-d167-413d-aa75-bfdd76b4f3fc"
      unitRef="Unit1">92902</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-0fed6436-5405-4cb5-8870-e23bdcf890f3"
      unitRef="Unit1">-40101</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-c3463091-4514-4271-b86e-b15c7219b17f"
      unitRef="Unit1">11670</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-2f16393c-31bd-4447-b95b-48a6aa326b88"
      unitRef="Unit1">92902</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-54c608c7-6122-4e0f-8e02-2d424f29f28f"
      unitRef="Unit1">-22310918</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-a4432be5-4453-40f7-ba08-e7f5be3cc52f"
      unitRef="Unit1">-16307083</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="2"
      id="ct-nonFraction-91cbbf6c-8cc5-4f35-9138-0ba57d5d978f"
      unitRef="Unit14">-0.32</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="2"
      id="ct-nonFraction-bc052c2a-63b2-4343-b6dc-a28ef80e1d27"
      unitRef="Unit14">-0.45</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-02987307-ece4-49a2-a4f4-1a719ad97f78"
      unitRef="Unit12">69428061</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-d832c642-8e5b-4e54-b713-86c4ff3233d2"
      unitRef="Unit12">36347398</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-b01edd26-5bb2-4253-a5f0-8f90adee31c7"
      unitRef="Unit12">21635365</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-cae2451d-d01e-4de0-a42d-10ba1e99de28"
      unitRef="Unit1">21635</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-5684f2ff-dcf3-47e3-ab53-361a5240f815"
      unitRef="Unit1">156241363</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ct-nonFraction-0d02baa2-90a2-41a8-b43a-6264e8f2eee4"
      unitRef="Unit1">-360160</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ct-nonFraction-c695c153-1cd9-4f2e-a901-0fc2686730f3"
      unitRef="Unit1">-132142209</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019"
      decimals="0"
      id="ct-nonFraction-3e8922e2-35ee-4f45-9195-5e05336d1e82"
      unitRef="Unit1">23760629</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ct-nonFraction-1e20aa1d-3a7f-460d-893c-10ef36901fb9"
      unitRef="Unit1">-16399985</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-f2334b3d-2477-43c7-b239-ddce4ebf6c05"
      unitRef="Unit1">-16399985</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ct-nonFraction-7f2917a8-acbe-45e2-87bb-93ec4c4fca56"
      unitRef="Unit1">92902</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-1fc312fb-03f3-4293-b9b0-361b535c5c9b"
      unitRef="Unit1">92902</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-e1d72df2-da56-48f2-b97f-e1246b7e29b4"
      unitRef="Unit12">20000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-dfea8b0b-7adc-4a7d-9e00-cfd01163c0a0"
      unitRef="Unit1">20</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-00a6e119-7013-457f-94ca-dcc794e8acad"
      unitRef="Unit1">40580</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-1d6d4a34-849f-4193-9d21-fa8ea5aaf4f3"
      unitRef="Unit1">40600</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-e3fffbd9-10c2-4167-a892-525eba883ce0"
      unitRef="Unit12">33028000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-95ab6d5f-b2c8-465f-85ef-cad32e98a059"
      unitRef="Unit1">33028</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-3a37085a-3f66-4e80-8e48-2743d9f0076f"
      unitRef="Unit1">104592587</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-27d5d4ce-4880-4592-a1a5-8740e391b903"
      unitRef="Unit1">104625615</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <aqb:ExerciseofWarrantsforCommonStockshares
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-0d6140a1-9b86-4cda-b196-407393235fd4"
      unitRef="Unit12">713449</aqb:ExerciseofWarrantsforCommonStockshares>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-c7e37eb6-ef8c-4726-8c1e-0a78b89c95ba"
      unitRef="Unit1">713</aqb:ExerciseofWarrantsforCommonStock>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-d49dc8b8-53fb-444a-a4a0-5278286727e6"
      unitRef="Unit1">2317996</aqb:ExerciseofWarrantsforCommonStock>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-c2c66baf-0028-4a3c-b264-43cc88615e3b"
      unitRef="Unit1">2318709</aqb:ExerciseofWarrantsforCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-5f9c31cb-c1f9-463a-a200-6ef24792be90"
      unitRef="Unit12">100319</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-2ba4e12a-9ac7-4b19-a28d-cbf2846775e0"
      unitRef="Unit1">101</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-f8c8d574-f4ad-4f33-9ad5-c72d6f45e9c9"
      unitRef="Unit1">436590</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-d44de531-20a1-4637-8deb-7fffb5ff0c79"
      unitRef="Unit1">436691</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-1aeecabe-705a-44d9-b83c-fbc3d0ddd710"
      unitRef="Unit12">55497133</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-1f8419a6-00d1-48f7-8feb-b89597ba9800"
      unitRef="Unit1">55497</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-8f5207fa-a2f9-46be-9ee2-e1f61431aa25"
      unitRef="Unit1">263629116</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ct-nonFraction-701c330e-30cd-4b0f-a473-845ccd5ed93e"
      unitRef="Unit1">-267258</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ct-nonFraction-ea2adecf-495b-4200-aa66-28f9339d19e7"
      unitRef="Unit1">-148542194</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-98052bd1-1dc4-49ec-8e19-5993b4879b53"
      unitRef="Unit1">114875161</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ct-nonFraction-44fc971c-da54-482a-a331-9fb02fdb255d"
      unitRef="Unit1">-22322588</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-c148e149-4084-4087-93cc-a022a8082335"
      unitRef="Unit1">-22322588</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ct-nonFraction-790f00aa-2b16-496d-9d89-e0ab791124bf"
      unitRef="Unit1">11670</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-1de6f5df-5b4a-4714-a84b-2a93dad304c6"
      unitRef="Unit1">11670</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-cfba9c5c-1af3-4adf-93c8-2745e2292669"
      unitRef="Unit12">4354</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-284c509d-d2d3-4720-8fc1-4b47cfb622ed"
      unitRef="Unit1">4</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-5dad8744-1e4e-4934-a20c-58955c7fa799"
      unitRef="Unit1">-4</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-550228db-81f4-4f1b-bdb2-a30eda74d9fc"
      unitRef="Unit12">14950000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-f5e02a12-9af5-4848-a42f-6b6d5d2fe044"
      unitRef="Unit1">14950</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-1c639312-d76a-4652-8863-48cd3b86794f"
      unitRef="Unit1">119105487</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-d34b270a-5ae9-4e45-add7-1a738e17c6df"
      unitRef="Unit1">119120437</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <aqb:ExerciseofWarrantsforCommonStockshares
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-07a829a2-8895-4add-8604-3bfaf2ec5880"
      unitRef="Unit12">530414</aqb:ExerciseofWarrantsforCommonStockshares>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-f4b4d58d-688c-43fd-9329-0a4e684f7bae"
      unitRef="Unit1">530</aqb:ExerciseofWarrantsforCommonStock>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-8d1f4b4d-d973-4e16-b6df-fec1c0094e8c"
      unitRef="Unit1">1723316</aqb:ExerciseofWarrantsforCommonStock>
    <aqb:ExerciseofWarrantsforCommonStock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-ba010402-e371-450d-941c-dad86ee9da2c"
      unitRef="Unit1">1723846</aqb:ExerciseofWarrantsforCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-e5ef76d2-0bd5-4199-9bfc-48c5bd1e505a"
      unitRef="Unit12">43837</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-a0703468-8921-4200-9a2d-20f2c93b96fc"
      unitRef="Unit1">45</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-e3ab7797-b0f6-48e3-8520-70fcf08b6d92"
      unitRef="Unit1">394192</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-b6d28f88-1168-4149-b2e2-21e74ecd0f9e"
      unitRef="Unit1">394237</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-694c10d1-3fa3-41bc-9681-95206f30e6c9"
      unitRef="Unit12">71025738</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="0"
      id="ct-nonFraction-7f697b12-4530-4f10-acc4-580a474b65bb"
      unitRef="Unit1">71026</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ct-nonFraction-5223a80a-4b8a-4379-b432-c6732e699a8c"
      unitRef="Unit1">384852107</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ct-nonFraction-6c32a883-23cc-445c-add7-ac4b0394a387"
      unitRef="Unit1">-255588</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ct-nonFraction-3766d58d-b0c5-4d9c-8dcc-7c6547303bdb"
      unitRef="Unit1">-170864782</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-0284253f-8d06-446d-a841-4dea4aea4998"
      unitRef="Unit1">213802763</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-584ed73c-1d41-49f2-bc87-21a8fc784551"
      unitRef="Unit1">-22322588</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-ddadbb30-60e7-4385-bbad-b7223e71fdcd"
      unitRef="Unit1">-16399985</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-5bd127da-a64e-42fd-81d9-f69dc00eb66a"
      unitRef="Unit1">1787564</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-1df89acb-fc0d-4f23-aad1-7648429f8482"
      unitRef="Unit1">1494596</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-de0e789d-0ab4-4be7-bdd7-f8559fcfe685"
      unitRef="Unit1">394237</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-35650697-7fad-45ab-899d-2652229a0645"
      unitRef="Unit1">436691</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-ecfbb69a-3979-43d3-8631-645c8dd39adf"
      unitRef="Unit1">-17386</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-0fc70a64-977b-47a3-8fb0-27b13d54ed9a"
      unitRef="Unit1">-44339</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4e9696a6-6cd4-48a9-b328-04544cb909eb"
      unitRef="Unit1">-267833</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-e2e5569d-1c98-4845-86fb-4ba0ac210791"
      unitRef="Unit1">282260</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4c6eed4a-dd2b-44cd-b251-bc1fbc3562e5"
      unitRef="Unit1">1138691</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-999f77bb-3da7-48e0-b0fd-8dc424fe1bde"
      unitRef="Unit1">74621</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-e8b8b125-d4eb-4a37-9ecb-76f5215fb19b"
      unitRef="Unit1">230712</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-c640b8e2-cb38-44bb-ace5-b24092bfee39"
      unitRef="Unit1">145607</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedSalaries
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-304a8fd3-fedc-496a-8441-f40ed4d7dd01"
      unitRef="Unit1">291288</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInAccruedSalaries
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-fa447466-3725-4973-8bda-736f378c04cb"
      unitRef="Unit1">346812</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-31da6679-d842-41b3-b7e4-abcbb124e590"
      unitRef="Unit1">-20472259</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-fb937b4c-988c-4e7e-96e5-479b55a222ba"
      unitRef="Unit1">-14288821</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-22460be0-abf7-47a5-9951-9a504605b7bc"
      unitRef="Unit1">5668696</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-06d2fba9-511d-4358-a35e-0c7c21033b76"
      unitRef="Unit1">3975135</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <aqb:PaymentsForDepositsOnEquipmentPurchases
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-7282ddf8-b08c-475b-a05d-d0552dd8c1f6"
      unitRef="Unit1">45111</aqb:PaymentsForDepositsOnEquipmentPurchases>
    <aqb:PaymentsForDepositsOnEquipmentPurchases
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-c61f5abb-c5fd-479f-8a2b-858f5831d8e9"
      unitRef="Unit1">349847</aqb:PaymentsForDepositsOnEquipmentPurchases>
    <us-gaap:ProceedsFromSaleOfMachineryAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-3bb94d1c-ed90-4bc6-8de6-7682309ea9a4"
      unitRef="Unit1">99816</us-gaap:ProceedsFromSaleOfMachineryAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-c2941b5a-b93c-43c4-9f0b-527c85e697eb"
      unitRef="Unit1">101813882</us-gaap:PaymentsToAcquireMarketableSecurities>
    <aqb:ProceedsPaymentsForLegalSettlementsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-59890643-57ed-4bd5-8b05-bb349e305a8a"
      unitRef="Unit1">1014008</aqb:ProceedsPaymentsForLegalSettlementsInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-a710385a-2d85-4cf4-96bc-efa731bb3265"
      unitRef="Unit1">11010</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-a9db394f-3799-4b13-b3cf-0190115cf811"
      unitRef="Unit1">27253</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-70a772b1-7e78-4939-87a4-da793a95b4f5"
      unitRef="Unit1">-107538699</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-7df012a6-0f51-45b9-b791-d6b3be9dfe92"
      unitRef="Unit1">-3238411</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-026f2912-1a59-481d-b79d-1cc97365a710"
      unitRef="Unit1">606453</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-85463b7b-6a41-4891-8b50-596eb731bb2b"
      unitRef="Unit1">4221130</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-00206ece-c36c-4c16-9414-691e56ce371f"
      unitRef="Unit1">91620</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4090772a-5e45-4872-9f89-a820596b0670"
      unitRef="Unit1">272102</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-32e13329-03ff-44b9-a2ea-0c10792074ec"
      unitRef="Unit1">70826</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-d9409862-5ca3-4340-be16-d82aa404fe50"
      unitRef="Unit1">119120437</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-6e025cb1-952c-4fb1-bf92-5ff1acdaa3fb"
      unitRef="Unit1">104625615</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-35f462f4-1c4b-4be9-8871-b96f2afebaba"
      unitRef="Unit1">1723846</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-f5a75f20-c56d-4ef1-a8bf-977ab25bbab3"
      unitRef="Unit1">2318709</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4e803c86-9b07-474f-9ea9-1e134dbe3ff2"
      unitRef="Unit1">121178634</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-f97c7923-a452-47c8-9079-4dbb1655a348"
      unitRef="Unit1">111003008</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-d28b74e2-7d56-468a-99d4-3fa5d593d91b"
      unitRef="Unit1">36152</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-1990b6fc-a1cc-4afc-b0bf-546c3af48fe3"
      unitRef="Unit1">-23360</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4c9b90c5-1afe-4105-b807-7278d654f61f"
      unitRef="Unit1">-6796172</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-9449ca1c-5b28-4413-a2c5-5377a88fdf68"
      unitRef="Unit1">93452416</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-6b56fb8c-9e7b-4ea9-9e0b-b62efdd162ed"
      unitRef="Unit1">96251160</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2019"
      decimals="0"
      id="ct-nonFraction-2d0df8c4-9916-4532-98a8-8a3bfb894216"
      unitRef="Unit1">2798744</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-a2bc23aa-7df7-4a16-b3fb-48e7c5b4738b"
      unitRef="Unit1">89454988</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-d75a86da-cff7-455d-b327-3df261e40cb2"
      unitRef="Unit1">96251160</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-73522370-4d1f-4275-9ca6-01152735756f"
      unitRef="Unit1">88454988</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-282446b4-25db-4001-92e1-ba1b00e260a9"
      unitRef="Unit1">95751160</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-81a85f4f-376a-42f2-9d64-bbd1f6656a63"
      unitRef="Unit1">1000000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-e476e883-b986-4e57-9cde-adad707a4ce9"
      unitRef="Unit1">500000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-99af16f1-02a1-488e-99f9-0d17a25d2caf"
      unitRef="Unit1">89454988</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-525b2efa-b067-4be6-a185-83dd8ec8e0dd"
      unitRef="Unit1">96251160</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-0724b367-d9df-472c-8cb8-cd3d3257657e"
      unitRef="Unit1">299056</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-6f9ca436-d913-4f29-baf7-bccee2919e71"
      unitRef="Unit1">114893</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-786c6a32-668c-426d-a12e-02e479bfb3ac"
      unitRef="Unit1">2926016</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-55b58c64-d53d-4a04-bc2d-d7affad8d889"
      unitRef="Unit1">23600</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NatureOfOperations
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-995a7c34-c31b-4da4-96a3-e8c0fced0402">1.&#160;Nature of business and organization Nature of businessAquaBounty Technologies, Inc. (the &#x201c;Parent&#x201d; and, together with its wholly owned subsidiaries, the &#x201c;Company&#x201d;) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm&#x2011;raised Atlantic salmon that exhibit growth rates that are substantially faster than conventional salmon.  In 2015, the Parent obtained regulatory approval from the U.S. Food and Drug Administration for the production and sale of its genetically engineered AquAdvantage salmon product (&#x201c;GE Atlantic salmon&#x201d;) in the United States and in 2016, the Parent obtained regulatory approval from Health Canada for the production and sale of its GE Atlantic salmon product in Canada. In 2021, the Parent obtained regulatory approval from the National Biosafety Technical Commission for the sale of its GE Atlantic salmon product in Brazil.Basis of presentationThe consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned subsidiaries. The entities are collectively referred to herein as the &#x201c;Company.&#x201d; All inter-company transactions and balances have been eliminated upon consolidation.LiquidityThe Company completed an equity raise in 2021with net proceeds of $119.1 million and has $191.2 million in cash and cash equivalents, marketable securities and restricted cash as of December 31, 2021. While the Company has experienced net losses and negative cash flows from operations since inception, management believes that it has sufficient cash to meet the Company's requirements beyond the next twelve months from the filing date of these consolidated financial statements. However, until such time as the Company reaches profitability, it may require additional financing to fund its operations and execute its business plan.&#160;</us-gaap:NatureOfOperations>
    <aqb:NatureOfOperationsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-f451ec96-17c9-4226-bfdf-74e706ecaf9d">Nature of businessAquaBounty Technologies, Inc. (the &#x201c;Parent&#x201d; and, together with its wholly owned subsidiaries, the &#x201c;Company&#x201d;) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm&#x2011;raised Atlantic salmon that exhibit growth rates that are substantially faster than conventional salmon.  In 2015, the Parent obtained regulatory approval from the U.S. Food and Drug Administration for the production and sale of its genetically engineered AquAdvantage salmon product (&#x201c;GE Atlantic salmon&#x201d;) in the United States and in 2016, the Parent obtained regulatory approval from Health Canada for the production and sale of its GE Atlantic salmon product in Canada. In 2021, the Parent obtained regulatory approval from the National Biosafety Technical Commission for the sale of its GE Atlantic salmon product in Brazil.</aqb:NatureOfOperationsPolicyPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-d4d287cf-9a41-4db1-a1d1-cbd0cc1a54aa">Basis of presentationThe consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned subsidiaries. The entities are collectively referred to herein as the &#x201c;Company.&#x201d; All inter-company transactions and balances have been eliminated upon consolidation.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <aqb:LiquidityPolicyPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-f4503871-48f7-43d0-b30a-452f155b634d">LiquidityThe Company completed an equity raise in 2021with net proceeds of $119.1 million and has $191.2 million in cash and cash equivalents, marketable securities and restricted cash as of December 31, 2021. While the Company has experienced net losses and negative cash flows from operations since inception, management believes that it has sufficient cash to meet the Company's requirements beyond the next twelve months from the filing date of these consolidated financial statements. However, until such time as the Company reaches profitability, it may require additional financing to fund its operations and execute its business plan.</aqb:LiquidityPolicyPolicyTextBlock>
    <aqb:AdditionalCashAndCashEquivalents
      contextRef="As_Of_12_31_2021"
      decimals="-5"
      id="ct-nonFraction-01a890eb-b2a8-4394-bb40-db70561773ba"
      unitRef="Unit1">119100000</aqb:AdditionalCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="As_Of_12_31_2021"
      decimals="-5"
      id="ct-nonFraction-6fa22365-d97c-4c4b-80f0-8f9690e2453e"
      unitRef="Unit1">191200000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-24098f35-7e27-4659-acd3-ff61760293b1">2.&#160;Summary of significant accounting policies Use of estimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the&#160;reporting periods. Actual results could differ from those estimates. Comprehensive lossThe Company displays comprehensive loss and its components as part of its consolidated financial statements. Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) includes foreign currency translation adjustments and unrealized gains (losses) on the Company&#x2019;s marketable securities. Foreign currency translationThe functional currency of the Parent is the US Dollar. The functional currency of the Canadian Subsidiary is the Canadian Dollar (C$) and the functional currency of the US and Brazil Subsidiaries is the US Dollar. For the Canadian Subsidiary, assets and liabilities are translated at the&#160;exchange rates in effect at the balance sheet date, equity accounts are translated at the historical exchange rate and the income statement accounts are translated at the average rate for each period during the year. Net translation gains or losses are adjusted directly to a separate component of other comprehensive income (loss) within stockholders&#x2019; equity.Cash equivalentsThe Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents.  Cash equivalents consist primarily of business savings accounts, certificates of deposit and money market accounts. Marketable securitiesMarketable securities include government bonds, corporate bonds and commercial paper.  The Company's investment policy requires investments to be explicitly rated by two of Standard &amp; Poor's, Moody's or Fitch and to have a minimum rating of A1, P1 or F-1, respectively, from those agencies.  In addition, the investment policy limits individual maturities to 12 months, the dollar-weighted average maturity to 180 days and the amount of credit exposure to any one issuer to 5%.InventoriesInventories are mainly comprised of feed, eggs and fish in process. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques.  The Company measures inventory at the lower of cost or net realizable value (NRV).  The NRV calculation contains various estimates and assumptions in regard to the calculation of the biomass, including expected yield, the market value of the biomass and estimated costs of completion and transportation. Intangible assetsDefinite lived intangible assets include patents and licenses.  Patent costs consist primarily of legal and filing fees incurred to file patents on proprietary technology developed by the Company. Patent costs are amortized on a straight-line basis over 20 years beginning with the filing date of the applicable patent.  License fees are capitalized and expensed over the term of the licensing agreement.Indefinite lived intangible assets include trademark costs, which are capitalized with no amortization as they have an indefinite life.Property, plant and equipmentProperty, plant and equipment are carried at cost. The Company depreciates all asset classes over their estimated useful lives, as follows:       Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years The Company commences depreciation on an asset when it is placed into service.Impairment of long-lived assetsThe Company reviews the carrying value of its long-lived assets, definite lived intangible assets, and property, plant and equipment when facts and circumstances suggest that they may be impaired. The carrying values of such assets are considered impaired when the estimated undiscounted cash flows from such assets are less than their carrying values. An impairment loss, if&#160;any, is recognized in the amount of the difference between the carrying amount and the fair value of such assets.Indefinite lived intangible assets are subject to impairment testing annually or more frequently if impairment indicators arise. The&#160;Company&#x2019;s impairment testing utilizes a discounted cash flow analysis that requires significant management judgment with respect&#160;to&#160;revenue and expense growth rates, changes in working capital and the selection and use of the appropriate discount rate. An&#160;impairment loss is recognized in the amount of the difference between the carrying amount and fair value.LeasesThe Company leases certain facilities, property, and equipment under noncancelable operating leases. A determination is made if an arrangement is a lease at its inception, and leases with an initial term of twelve months or less are not recorded on the balance sheet.  Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For operating leases, expense is recognized on a straight-line basis over the lease term.  The Company has agreements with lease (e.g., minimum rent payments) and non-lease components (e.g., maintenance), which are generally accounted for separately. The Company has not elected the practical expedient to account for lease and non-lease components as one lease component. The Company adopted Financial Accounting Standards Board's (FASB) Accounting Standards Update (ASU) 2016-02 Leases on January 1, 2019 and recognized a lease liability of $532 thousand and a corresponding right-of-use asset of $512 thousand. Management calculated the lease liability based on the net present value of the remaining lease payments on the date of adoption using a weighted average discount rate of 8%. As most of the Company&#x2019;s leases did not provide an implicit interest rate, management used an estimated incremental borrowing rate. The adoption did not result in any cumulative-effect adjustment to beginning retained earnings.Revenue recognitionThe Company generates revenue from the sale of its products.  Revenue is recognized when the customer takes physical control of the goods, in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for the goods. Revenue excludes any sales tax collected and includes any estimate of future credits.  During 2021, the Company recognized $747 thousand and $428 thousand in revenue from product sales from its Canada and U.S. subsidiaries, respectively.Income taxesThe Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recorded for the expected future tax consequences of temporary differences between the financial reporting and income tax bases of&#160;assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences reverse. A valuation allowance is established to reduce net deferred tax assets to the amount expected to be realized. The Company follows accounting guidance regarding the recognition, measurement, presentation and disclosure of uncertain tax positions in the financial statements. Tax positions taken or expected to be taken in the course of preparing the Company&#x2019;s tax returns are required to be&#160;evaluated to determine whether the tax positions are &#x201c;more likely than not&#x201d; to be upheld under regulatory review. The resulting tax impact of these tax positions is recognized in the financial statements based on the results of this evaluation. The Company did not recognize any tax liabilities associated with uncertain tax positions, nor has it recognized any interest or penalties related to unrecognized tax positions. The Company is not currently under exam and is no longer subject to federal and state tax examinations by tax authorities for years before 2018. Net loss per shareBasic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Basic net loss per share is based solely on the number of common shares outstanding during the year. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and&#160;options with an exercise price less than the fair value of the common stock unless the impact of the warrant or option is anti-dilutive to the calculation. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti-dilutive and are excluded from the calculation of diluted net loss per share.As of December 31, 2021, the Company had 1,081,866 potentially dilutive securities outstanding, consisting of 418,441 warrants and 663,425 stock options.  As of December 31, 2020, the Company had 2,236,229 potentially dilutive securities outstanding, consisting of 1,662,304 warrants and 573,925 stock options.Share-based compensationThe Company measures and recognizes all share-based payment awards, including stock options and restricted share units made to employees and Directors, based on&#160;estimated fair values. The fair value of a share-based payment award is estimated on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in&#160;the&#160;Company&#x2019;s consolidated statement of operations. The Company uses the Black-Scholes option pricing model (&#x201c;Black-Scholes&#x201d;) as&#160;its&#160;method of valuation. Non-employee stock-based compensation is accounted for using Black-Scholes to determine the fair value of&#160;warrants or options awarded to non-employees with the fair value of such issuances expensed over the period of service.Recently Issued Accounting StandardsThe Company is an &#x201c;emerging growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. The Company has elected to use the extended transition period for complying with new or revised accounting standards unless otherwise state. The Company will remain an &#x201c;emerging growth company&#x201d; until the earliest of (i) December 31, 2023, (ii) the last day of the fiscal year in which it has total annual gross revenues of $1.07 billion or more, (iii) the date on which it has issued more than $1.0 billion in nonconvertible debt during the previous three years or (iv) the date on which it is deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission (&#x201c;SEC&#x201d;), which generally is when it has more than $700 million in market value of its stock held by non-affiliates, has been a public company for at least 12 months and have filed one annual report on Form 10-K.Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-3ce76a5d-0b97-4f9e-b468-f7445b7ac7a2">Use of estimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the&#160;reporting periods. Actual results could differ from those estimates. </us-gaap:UseOfEstimates>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-2f3bbd92-6b1a-4936-ae7b-790e8efbe254">Comprehensive lossThe Company displays comprehensive loss and its components as part of its consolidated financial statements. Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) includes foreign currency translation adjustments and unrealized gains (losses) on the Company&#x2019;s marketable securities. </us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-2ff42525-1001-4596-a405-8f5de10322c7">Foreign currency translationThe functional currency of the Parent is the US Dollar. The functional currency of the Canadian Subsidiary is the Canadian Dollar (C$) and the functional currency of the US and Brazil Subsidiaries is the US Dollar. For the Canadian Subsidiary, assets and liabilities are translated at the&#160;exchange rates in effect at the balance sheet date, equity accounts are translated at the historical exchange rate and the income statement accounts are translated at the average rate for each period during the year. Net translation gains or losses are adjusted directly to a separate component of other comprehensive income (loss) within stockholders&#x2019; equity.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-257e94d6-f812-4ea1-b469-49fc47c19257">Cash equivalentsThe Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents.  Cash equivalents consist primarily of business savings accounts, certificates of deposit and money market accounts. </us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-d6240ebd-8815-4171-99f1-f4b23042f902">Marketable securitiesMarketable securities include government bonds, corporate bonds and commercial paper.  The Company's investment policy requires investments to be explicitly rated by two of Standard &amp; Poor's, Moody's or Fitch and to have a minimum rating of A1, P1 or F-1, respectively, from those agencies.  In addition, the investment policy limits individual maturities to 12 months, the dollar-weighted average maturity to 180 days and the amount of credit exposure to any one issuer to 5%.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-1afd3c25-4ac9-4fa4-8bb5-1803fdb9b66c">InventoriesInventories are mainly comprised of feed, eggs and fish in process. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques.  The Company measures inventory at the lower of cost or net realizable value (NRV).  The NRV calculation contains various estimates and assumptions in regard to the calculation of the biomass, including expected yield, the market value of the biomass and estimated costs of completion and transportation. </us-gaap:InventoryPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-ab7de22e-14bd-4624-9687-bc3569cbaad1">Intangible assetsDefinite lived intangible assets include patents and licenses.  Patent costs consist primarily of legal and filing fees incurred to file patents on proprietary technology developed by the Company. Patent costs are amortized on a straight-line basis over 20 years beginning with the filing date of the applicable patent.  License fees are capitalized and expensed over the term of the licensing agreement.Indefinite lived intangible assets include trademark costs, which are capitalized with no amortization as they have an indefinite life.</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember"
      id="ct-nonNumeric-e5c0dd03-a805-4b85-b780-7b6554d1acf5">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-5c46de10-cec4-4c3f-a8e3-2ec30fea4bc1">Property, plant and equipmentProperty, plant and equipment are carried at cost. The Company depreciates all asset classes over their estimated useful lives, as follows:       Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years The Company commences depreciation on an asset when it is placed into service.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <aqb:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-4e03a516-82b2-4862-8c33-3458a279b09e">      Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years</aqb:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      id="ct-nonNumeric-45691981-3ff0-47a3-bcdc-e88ddb62b3cb">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      id="ct-nonNumeric-c45c8b18-5572-48b4-961f-1da580da7352">P25Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"
      id="ct-nonNumeric-f3288035-01bb-4842-a97c-df480cbba051">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"
      id="ct-nonNumeric-0b81982e-d3cd-43d3-8987-08121195c33b">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember"
      id="ct-nonNumeric-5468d023-229f-404b-ba43-0703182e46cc">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <aqb:PropertyPlantAndEquipmentUsefulLife1
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"
      id="ct-nonNumeric-324227e9-8920-48a5-b065-2a16c6297c06">shorter of asset life or lease term</aqb:PropertyPlantAndEquipmentUsefulLife1>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember"
      id="ct-nonNumeric-375fec38-a95e-4164-85d2-625b19534690">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-f8b6b336-8ba2-4afb-ae08-8ec275920808">Impairment of long-lived assetsThe Company reviews the carrying value of its long-lived assets, definite lived intangible assets, and property, plant and equipment when facts and circumstances suggest that they may be impaired. The carrying values of such assets are considered impaired when the estimated undiscounted cash flows from such assets are less than their carrying values. An impairment loss, if&#160;any, is recognized in the amount of the difference between the carrying amount and the fair value of such assets.Indefinite lived intangible assets are subject to impairment testing annually or more frequently if impairment indicators arise. The&#160;Company&#x2019;s impairment testing utilizes a discounted cash flow analysis that requires significant management judgment with respect&#160;to&#160;revenue and expense growth rates, changes in working capital and the selection and use of the appropriate discount rate. An&#160;impairment loss is recognized in the amount of the difference between the carrying amount and fair value.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-a7a05ff6-a820-447b-b187-fe6acf24ff82">LeasesThe Company leases certain facilities, property, and equipment under noncancelable operating leases. A determination is made if an arrangement is a lease at its inception, and leases with an initial term of twelve months or less are not recorded on the balance sheet.  Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For operating leases, expense is recognized on a straight-line basis over the lease term.  The Company has agreements with lease (e.g., minimum rent payments) and non-lease components (e.g., maintenance), which are generally accounted for separately. The Company has not elected the practical expedient to account for lease and non-lease components as one lease component. The Company adopted Financial Accounting Standards Board's (FASB) Accounting Standards Update (ASU) 2016-02 Leases on January 1, 2019 and recognized a lease liability of $532 thousand and a corresponding right-of-use asset of $512 thousand. Management calculated the lease liability based on the net present value of the remaining lease payments on the date of adoption using a weighted average discount rate of 8%. As most of the Company&#x2019;s leases did not provide an implicit interest rate, management used an estimated incremental borrowing rate. The adoption did not result in any cumulative-effect adjustment to beginning retained earnings.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="As_Of_1_1_2019"
      decimals="-3"
      id="ct-nonFraction-1dd24332-1ba8-4fef-b850-dac0381e7350"
      unitRef="Unit1">532000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_1_1_2019"
      decimals="-3"
      id="ct-nonFraction-4ebb513f-be43-4449-bfb1-21c6b96db832"
      unitRef="Unit1">512000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="As_Of_1_1_2019_srt_RangeAxis_srt_WeightedAverageMember"
      decimals="2"
      id="ct-nonFraction-3e881194-5059-4179-abc9-add51544454e"
      unitRef="Unit13">0.08</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-c2ac8508-2c53-438a-ba47-5744ba1b952d">Revenue recognitionThe Company generates revenue from the sale of its products.  Revenue is recognized when the customer takes physical control of the goods, in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for the goods. Revenue excludes any sales tax collected and includes any estimate of future credits.  During 2021, the Company recognized $747 thousand and $428 thousand in revenue from product sales from its Canada and U.S. subsidiaries, respectively.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadaSubsidiaryMember"
      decimals="-3"
      id="ct-nonFraction-f0359a87-4e64-4550-b1e6-24d751a854b5"
      unitRef="Unit1">747000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_UnitedStatesSubsidiaryMember"
      decimals="-3"
      id="ct-nonFraction-74f2b606-ad39-4fc5-80c0-f250b26baa7d"
      unitRef="Unit1">428000</us-gaap:Revenues>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-c4c8bf8e-5d83-4fc4-8efd-36916588af56">Income taxesThe Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recorded for the expected future tax consequences of temporary differences between the financial reporting and income tax bases of&#160;assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences reverse. A valuation allowance is established to reduce net deferred tax assets to the amount expected to be realized. The Company follows accounting guidance regarding the recognition, measurement, presentation and disclosure of uncertain tax positions in the financial statements. Tax positions taken or expected to be taken in the course of preparing the Company&#x2019;s tax returns are required to be&#160;evaluated to determine whether the tax positions are &#x201c;more likely than not&#x201d; to be upheld under regulatory review. The resulting tax impact of these tax positions is recognized in the financial statements based on the results of this evaluation. The Company did not recognize any tax liabilities associated with uncertain tax positions, nor has it recognized any interest or penalties related to unrecognized tax positions. The Company is not currently under exam and is no longer subject to federal and state tax examinations by tax authorities for years before 2018. </us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-4ec694fa-a425-45f8-a210-f9df5ee2f197">Net loss per shareBasic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Basic net loss per share is based solely on the number of common shares outstanding during the year. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and&#160;options with an exercise price less than the fair value of the common stock unless the impact of the warrant or option is anti-dilutive to the calculation. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti-dilutive and are excluded from the calculation of diluted net loss per share.As of December 31, 2021, the Company had 1,081,866 potentially dilutive securities outstanding, consisting of 418,441 warrants and 663,425 stock options.  As of December 31, 2020, the Company had 2,236,229 potentially dilutive securities outstanding, consisting of 1,662,304 warrants and 573,925 stock options.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-d10c8dd2-4151-428d-beee-70f96ebcf99d"
      unitRef="Unit12">1081866</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"
      decimals="INF"
      id="ct-nonFraction-471c26ce-de8b-403c-b380-5cbf97819a04"
      unitRef="Unit12">418441</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-10fe1ed3-6337-4f74-9fdd-03a810728e52"
      unitRef="Unit12">663425</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-db5ebe26-9c18-4ea0-bfcf-9afd0edee65e"
      unitRef="Unit12">2236229</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"
      decimals="INF"
      id="ct-nonFraction-1cb6503e-68d6-4610-a2c7-e76450364008"
      unitRef="Unit12">1662304</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-314953ef-2d16-4613-8e28-02a622312965"
      unitRef="Unit12">573925</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-8fbe1762-bc7a-4a1e-9af5-b7f20d37ec63">Share-based compensationThe Company measures and recognizes all share-based payment awards, including stock options and restricted share units made to employees and Directors, based on&#160;estimated fair values. The fair value of a share-based payment award is estimated on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in&#160;the&#160;Company&#x2019;s consolidated statement of operations. The Company uses the Black-Scholes option pricing model (&#x201c;Black-Scholes&#x201d;) as&#160;its&#160;method of valuation. Non-employee stock-based compensation is accounted for using Black-Scholes to determine the fair value of&#160;warrants or options awarded to non-employees with the fair value of such issuances expensed over the period of service.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-98333084-cd3e-4703-8c56-75aaf9ab54d2">Recently Issued Accounting StandardsThe Company is an &#x201c;emerging growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. The Company has elected to use the extended transition period for complying with new or revised accounting standards unless otherwise state. The Company will remain an &#x201c;emerging growth company&#x201d; until the earliest of (i) December 31, 2023, (ii) the last day of the fiscal year in which it has total annual gross revenues of $1.07 billion or more, (iii) the date on which it has issued more than $1.0 billion in nonconvertible debt during the previous three years or (iv) the date on which it is deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission (&#x201c;SEC&#x201d;), which generally is when it has more than $700 million in market value of its stock held by non-affiliates, has been a public company for at least 12 months and have filed one annual report on Form 10-K.Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-6a327775-6421-478f-8200-88af61035da4">3.&#160;Risks and uncertainties The Company is subject to risks and uncertainties common in the biotechnology and aquaculture industries. Such risks and uncertainties include, but are not limited to: (i)&#160;results from current and planned product development studies and trials; (ii)&#160;decisions made by the FDA or similar regulatory bodies in other countries with respect to approval and commercial sale of any of the Company&#x2019;s proposed products; (iii)&#160;the commercial acceptance of any products approved for sale and the Company&#x2019;s ability to produce, distribute, and sell for a profit any products approved for sale; (iv)&#160;the Company&#x2019;s ability to obtain the necessary patents and proprietary rights to effectively protect its technologies; and (v)&#160;the outcome of any collaborations or alliances entered into by the Company.COVID-19Although the COVID-19 pandemic has diminished in the United States and other parts of the world as vaccines have become more readily available, several variants of the virus continue to spread.  Local governmental authorities in the United States and Canada have issued, and continue to update, directives aimed at minimizing the spread of the virus and the Company continues to monitor its status.The ultimate impact of the evolving COVID-19 pandemic on the Company&#x2019;s operations will depend on future developments, which cannot be predicted with confidence, and the Company cannot predict the extent or impact of the extended period of continued business interruption and reduced operations caused by the COVID-19 pandemic or any additional preventative or protective measures taken in response. In connection with the COVID-19 pandemic, management made modifications to biosecurity procedures at the farm sites in early 2020 to adapt to local requirements and to provide a safe work environment. The Company&#x2019;s current preventative and protective measures include, but are not limited to, segregating farm workers to specific locations, rotating shifts, and monitoring worker temperatures upon arrival at the Company&#x2019;s facilities. To the extent possible, work-from-home is utilized for employees that do not have fish care responsibilities. Concentration of credit riskFinancial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and marketable securities. This risk is mitigated by the Company&#x2019;s policy of maintaining all balances with highly rated financial institutions, investing cash equivalents with maturities of less than 90 days, and investing marketable securities with maturities of less than 180 days. The Company&#x2019;s cash balances may at times exceed insurance limitations. The Company holds cash balances in bank accounts located in Canada to fund its local operations. These amounts are subject to foreign currency exchange risk, which is minimized by the Company&#x2019;s policy to limit the balances held in these accounts. Balances in Canadian bank accounts totaled $224 thousand at December 31, 2021.  The Company also holds cash equivalent investments in a highly liquid investment account at a major financial institution.  As of December 31, 2021 and 2020 the cash equivalent investment balance was $73.3 million and $0, respectively.Financial instrumentsThe carrying amounts reported in the consolidated balance sheets for receivables, prepaid expenses and other current assets, and accounts payable approximate fair value based on the short-term maturity of these instruments. The carrying value of term debt approximates its fair value since it provides for market terms and interest rates.  All of the Company&#x2019;s interest-bearing debt is at fixed rates, except for the loan with First Farmer&#x2019;s Bank and Trust, which has a rate reset in July 2025.The Company groups its financial instruments measured at fair value, if any, in three levels based on the markets in which the instruments are traded and the reliability of the assumptions used to determine fair value.  Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  Financial instruments with readily available quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgement used in measuring fair value.  The three levels of the fair value hierarchy are as follows:Level 1: Inputs to the valuation methodology are quoted prices, unadjusted, for identical assets or liabilities in active markets. Level 2: Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs derived principally from, or that can be corroborated by, observable market data by correlation or other means.Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.  Level 3 assets and liabilities include financial instruments whose value is determined using discounted cash flow methodologies, as well as instruments for which the determination of fair value requires significant management judgement or estimation.&#160;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:Cash
      contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CA_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember"
      decimals="-3"
      id="ct-nonFraction-761c654e-3973-4e29-9e39-68dfb00183e8"
      unitRef="Unit1">224000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2021_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember"
      decimals="-5"
      id="ct-nonFraction-89b1fe1c-710d-43da-bc13-bb75b1b6e353"
      unitRef="Unit1">73300000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2020_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember"
      decimals="-5"
      id="ct-nonFraction-fd21c023-745c-4a0d-b833-79eb3703068c"
      unitRef="Unit1">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-90e7ade3-7acb-4997-b933-7d8b3e2953fb">4. Marketable SecuritiesMarketable securities are classified as available-for-sale.  The following table summarizes the amortized cost, gross unrealized gains and losses, and the fair value as of December 31, 2021:               Amortized  Unrealized  Unrealized  Market  Cost  Gains  Losses  Value December 31, 2021Government bonds$ 28,453,161 $ 82 $ (18,255) $ 28,434,988Corporate bonds  29,874,696   -   (21,928)   29,852,768Commercial paper  43,486,025   -   -   43,486,025Marketable securities$ 101,813,882 $ 82 $ (40,183) $ 101,773,781There were no marketable securities as of December 31, 2020.&#160;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-35659a38-5aa8-4244-b028-990feac437b7">              Amortized  Unrealized  Unrealized  Market  Cost  Gains  Losses  Value December 31, 2021Government bonds$ 28,453,161 $ 82 $ (18,255) $ 28,434,988Corporate bonds  29,874,696   -   (21,928)   29,852,768Commercial paper  43,486,025   -   -   43,486,025Marketable securities$ 101,813,882 $ 82 $ (40,183) $ 101,773,781</us-gaap:MarketableSecuritiesTextBlock>
    <aqb:MarketableSecuritiesAmortizedCost
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember"
      decimals="0"
      id="ct-nonFraction-7a273f2b-23e2-4141-b694-dc770d53239b"
      unitRef="Unit1">28453161</aqb:MarketableSecuritiesAmortizedCost>
    <aqb:MarketableSecuritiesUnrealizedGain
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember"
      decimals="0"
      id="ct-nonFraction-8eb13e4e-9b5d-4c5a-8a1d-2d0b84903e16"
      unitRef="Unit1">82</aqb:MarketableSecuritiesUnrealizedGain>
    <aqb:MarketableSecuritiesUnrealizedLoss
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember"
      decimals="0"
      id="ct-nonFraction-cf88f0a8-e921-4128-b0cd-8841b884d362"
      unitRef="Unit1">18255</aqb:MarketableSecuritiesUnrealizedLoss>
    <us-gaap:MarketableSecurities
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember"
      decimals="0"
      id="ct-nonFraction-c5a9026a-c73b-43d5-a7a9-5916f71bbf11"
      unitRef="Unit1">28434988</us-gaap:MarketableSecurities>
    <aqb:MarketableSecuritiesAmortizedCost
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_DomesticCorporateDebtSecuritiesMember"
      decimals="0"
      id="ct-nonFraction-90e74fe3-4f3c-476a-a304-22e2e6d87aef"
      unitRef="Unit1">29874696</aqb:MarketableSecuritiesAmortizedCost>
    <aqb:MarketableSecuritiesUnrealizedLoss
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_DomesticCorporateDebtSecuritiesMember"
      decimals="0"
      id="ct-nonFraction-5a1920b3-dc64-4379-aad3-dc9d3d55e926"
      unitRef="Unit1">21928</aqb:MarketableSecuritiesUnrealizedLoss>
    <us-gaap:MarketableSecurities
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_DomesticCorporateDebtSecuritiesMember"
      decimals="0"
      id="ct-nonFraction-539333b1-0460-4c32-8ffc-f16d2483df50"
      unitRef="Unit1">29852768</us-gaap:MarketableSecurities>
    <aqb:MarketableSecuritiesAmortizedCost
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="0"
      id="ct-nonFraction-de34e578-090a-4f29-830e-9f8a37aca6a4"
      unitRef="Unit1">43486025</aqb:MarketableSecuritiesAmortizedCost>
    <us-gaap:MarketableSecurities
      contextRef="As_Of_12_31_2021_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="0"
      id="ct-nonFraction-a06d5a13-8e70-4cf0-9ddf-d7e9604717bc"
      unitRef="Unit1">43486025</us-gaap:MarketableSecurities>
    <aqb:MarketableSecuritiesAmortizedCost
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-538d06fa-825e-49ea-8eef-92ca15122f85"
      unitRef="Unit1">101813882</aqb:MarketableSecuritiesAmortizedCost>
    <aqb:MarketableSecuritiesUnrealizedGain
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-843771ca-1e29-49b7-b6c1-54803a848417"
      unitRef="Unit1">82</aqb:MarketableSecuritiesUnrealizedGain>
    <aqb:MarketableSecuritiesUnrealizedLoss
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-1802132e-6a47-4718-8221-41d11d43d7a9"
      unitRef="Unit1">40183</aqb:MarketableSecuritiesUnrealizedLoss>
    <us-gaap:MarketableSecurities
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-79c809c5-1e02-49c4-8956-ccb088df5645"
      unitRef="Unit1">101773781</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-b62d528e-34f0-4e44-bf73-d886c348220b"
      unitRef="Unit1">0</us-gaap:MarketableSecurities>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-2e73f9bf-fe9d-49ea-8928-265a9c842e93">5.&#160;Inventory Major classifications of inventory are summarized as follows for December&#160;31, 2021 and 2020:        December 31, 2021 December 31, 2020Feed, net$ 162,047   244,311Eggs and fry  &#x2014;   54,929Packaging  &#x2014;   6,452Fish in process, net  1,097,863   1,219,685Inventory, net$ 1,259,910   1,525,377&#160;In December 2020, the Company reserved $1.53 million against the value of its fish-in-process inventory, representing the total carrying amount of its conventional salmon biomass.  The Company donated substantially all of its conventional salmon to local food charities in 2021.&#160;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-cf67d3af-d913-4618-a6c0-f693238a1667">       December 31, 2021 December 31, 2020Feed, net$ 162,047   244,311Eggs and fry  &#x2014;   54,929Packaging  &#x2014;   6,452Fish in process, net  1,097,863   1,219,685Inventory, net$ 1,259,910   1,525,377</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryGross
      contextRef="As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember"
      decimals="0"
      id="ct-nonFraction-266694c3-bd45-4c94-9f9b-d246d74c9ca7"
      unitRef="Unit1">162047</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember"
      decimals="0"
      id="ct-nonFraction-f03a59aa-fcca-458d-96d1-4865f4e03e70"
      unitRef="Unit1">244311</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_EggsAndFryMember"
      decimals="0"
      id="ct-nonFraction-e6a574a3-3a2a-4bf8-b992-f0e419f0d414"
      unitRef="Unit1">54929</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_PackagingMember"
      decimals="0"
      id="ct-nonFraction-6f3b814e-6c25-4657-abac-9063b4cb2499"
      unitRef="Unit1">6452</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember"
      decimals="0"
      id="ct-nonFraction-f6a1b71f-6c86-425a-bbda-5792098fc099"
      unitRef="Unit1">1097863</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember"
      decimals="0"
      id="ct-nonFraction-2441ee95-7a39-4e03-9662-05bc648759c6"
      unitRef="Unit1">1219685</us-gaap:InventoryGross>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-378b85ff-b029-4020-99e8-6ff3759b0b22"
      unitRef="Unit1">1259910</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-4a8a4225-02a2-45b4-8c1a-d1819cc67495"
      unitRef="Unit1">1525377</us-gaap:InventoryNet>
    <us-gaap:InventoryAdjustments
      contextRef="As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember"
      decimals="-4"
      id="ct-nonFraction-07292df6-030c-456b-8410-1bced9bf9c60"
      unitRef="Unit1">1530000</us-gaap:InventoryAdjustments>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-e20a831a-a83c-47a6-a471-ca1fd4a6dc3b">6.&#160;Property, plant and equipment Major classifications of property, plant and equipment are summarized as follows for December&#160;31, 2021 and 2020:         December 31, 2021 December 31, 2020Land$ 725,799 $ 724,785Building and improvements  15,580,385   14,048,917Construction in process  8,119,575   3,212,287Equipment  15,981,408   13,819,210Office furniture and equipment  240,939   202,596Vehicles  36,280   28,700Total property and equipment$ 40,684,386 $ 32,036,495Less accumulated depreciation and amortization  (6,869,267)   (5,106,157)Property, plant and equipment, net$ 33,815,119 $ 26,930,338 Depreciation and amortization expense for 2021 and 2020 on property, plant and equipment was $1.8 million and $1.5 million, respectively. In March 2020, the Company settled an outstanding legal claim against a third party resulting in net proceeds of $1.0 million. The proceeds received reduced the carrying value of the acquired equipment. Depreciation on these items has been recalculated prospectively over their remaining useful lives.  As of December 31, 2021, construction in process included $5.2 million, $2.0 million and $856 thousand for construction related to the Ohio, Rollo Bay and Indiana farm sites, respectively.  An additional $12.2 million has been contractually committed for these farm sites, though if a contract were terminated, a portion of this total would be refundable based on the amount of work completed as of the date of contract termination.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-4a6060fc-2080-4f23-8910-01cf44aef9cb">       December 31, 2021 December 31, 2020Land$ 725,799 $ 724,785Building and improvements  15,580,385   14,048,917Construction in process  8,119,575   3,212,287Equipment  15,981,408   13,819,210Office furniture and equipment  240,939   202,596Vehicles  36,280   28,700Total property and equipment$ 40,684,386 $ 32,036,495Less accumulated depreciation and amortization  (6,869,267)   (5,106,157)Property, plant and equipment, net$ 33,815,119 $ 26,930,338</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember"
      decimals="0"
      id="ct-nonFraction-ff28c445-eec3-4dff-9674-cc1df5e73dee"
      unitRef="Unit1">725799</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember"
      decimals="0"
      id="ct-nonFraction-4b3f4717-0da6-4065-9cb0-f91053153fb1"
      unitRef="Unit1">724785</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      decimals="0"
      id="ct-nonFraction-da394ddd-e669-4156-ab19-9c30f8d8b905"
      unitRef="Unit1">15580385</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      decimals="0"
      id="ct-nonFraction-eccd1f9c-3d54-48fe-bf3e-01eb6795117a"
      unitRef="Unit1">14048917</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="0"
      id="ct-nonFraction-436aff8e-397d-4080-88f5-19a00ea8acba"
      unitRef="Unit1">8119575</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="0"
      id="ct-nonFraction-036f913e-5896-4dae-a6a2-3a449d78a322"
      unitRef="Unit1">3212287</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"
      decimals="0"
      id="ct-nonFraction-14f661d1-4922-4530-aa4e-d5591a5fb2df"
      unitRef="Unit1">15981408</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"
      decimals="0"
      id="ct-nonFraction-87794dae-9500-4a71-8931-7ef5a3c67972"
      unitRef="Unit1">13819210</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember"
      decimals="0"
      id="ct-nonFraction-cd6d1e27-afc5-4df9-ab51-9a217ed7e2ce"
      unitRef="Unit1">240939</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aqb_OfficeFurnitureandEquipmentMember"
      decimals="0"
      id="ct-nonFraction-7d62a043-1f68-4a60-b259-0f86e5fc0aa6"
      unitRef="Unit1">202596</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember"
      decimals="0"
      id="ct-nonFraction-df9e189e-487a-484f-9afc-a59b5f37456e"
      unitRef="Unit1">36280</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_VehiclesMember"
      decimals="0"
      id="ct-nonFraction-1e619d37-96a1-44ed-b967-b4ee845b2d87"
      unitRef="Unit1">28700</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-d2bf45f8-788f-494d-9a7e-103dfaf0ab8d"
      unitRef="Unit1">40684386</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-8831b1b5-5b06-4e7a-bddf-0bd5c98f2968"
      unitRef="Unit1">32036495</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-04a3a9c5-27b7-457d-b073-47559a557888"
      unitRef="Unit1">6869267</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-5748b79b-a5e7-458d-884e-e45489abb3a9"
      unitRef="Unit1">5106157</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-f871d57f-c504-4bd8-b696-aa5b3e43059e"
      unitRef="Unit1">33815119</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-f1f2a59f-cf78-4bae-90bf-e29be8621e6a"
      unitRef="Unit1">26930338</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="-5"
      id="ct-nonFraction-8cdcb10e-3eb5-4f00-9fa3-40cde845ef4f"
      unitRef="Unit1">1800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-5"
      id="ct-nonFraction-c548e5b2-f6b1-42ae-9e9b-866534b26c28"
      unitRef="Unit1">1500000</us-gaap:Depreciation>
    <aqb:ProceedsPaymentsForLegalSettlementsInvestingActivities
      contextRef="Duration_3_1_2020_To_3_31_2020"
      decimals="-5"
      id="ct-nonFraction-c7106f89-d59d-4a38-9dde-831da3678afa"
      unitRef="Unit1">1000000.0</aqb:ProceedsPaymentsForLegalSettlementsInvestingActivities>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_New10000MetricTonFarmMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-5"
      id="ct-nonFraction-bd2062a7-39ef-4f3f-823e-254831765c46"
      unitRef="Unit1">5200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_RolloBayFarmAndFortuneBayHatcheryMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-5"
      id="ct-nonFraction-0fc53c92-593c-44ed-a2cb-f58178340de1"
      unitRef="Unit1">2000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_IndianaAquacultureFarmMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-3"
      id="ct-nonFraction-d2e1df87-1026-4ae2-8643-176c5c9112d2"
      unitRef="Unit1">856000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_aqb_New10000MetricTonFarmMember_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_us-gaap_CapitalAdditionsMember"
      decimals="-5"
      id="ct-nonFraction-072a3129-e566-491f-ab73-5ca7c6fceb6a"
      unitRef="Unit1">12200000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-165717fe-60e9-4a3f-9c59-c9a6ca0d94f6">7.&#160;Debt The current terms and conditions of long-term debt outstanding as of December&#160;31, 2021 and 2020, are as follows:                Interest&#x200e;rate Monthly&#x200e;repayment Maturity&#x200e;date December 31, 2021 December 31, 2020ACOA AIF Grant 0% Royalties - $ 2,261,349 $ 2,253,595ACOA term loan #1 0% C$3,120 Feb 2027   152,346   181,203ACOA term loan #2 0% C$4,630 Sep 2029   339,015   381,451ACOA term loan #3 0% C$6,945 Dec 2025   196,850   &#x2014;Kubota Canada Ltd 0% C$1,142 Jan 2025   33,283   43,925PEI Finance term loan 4% C$16,313 Nov 2023   1,947,510   2,014,321DFO term loan 0% C$2,091 Aug 2032   405,700   &#x2014;First Farmers Bank &amp; Trust term loan 5.375% $56,832 Oct 2028   3,883,325   4,000,000Total debt       $ 9,219,378 $ 8,874,495less: debt issuance costs         (68,680)   (86,066)less: current portion         (627,365)   (259,939)Long-term debt, net       $ 8,523,333 $ 8,528,490 Principal payments due on the long-term debt are as follows:      Total2022$ 643,9802023  2,564,3472024  729,6262025  750,1752026  715,392Thereafter  3,815,858Total$ 9,219,378 Atlantic Canada Opportunities Agency (&#x201c;ACOA&#x201d;)ACOA is a Canadian government agency that provides funding to support the development of businesses and promote employment in the Atlantic region of Canada.ACOA Atlantic Innovation Fund (&#x201c;AIF&#x201d;) GrantIn January 2009, the Canadian Subsidiary was awarded an AIF grant from ACOA to provide a contribution towards the funding of a research and development project. Contributions under the grant were made through 2014 and no further funds are available. Amounts claimed by the Canadian Subsidiary must be repaid in the form of a 10% royalty on any products that are commercialized out of this research project until the loan is fully repaid. Revenue from the sale of the Company&#x2019;s GE Atlantic salmon is not subject to the royalty, and the Company does not expect to commercialize products that would be subject to the royalty in the next five years.ACOA term loansIn February 2016, the Canadian Subsidiary executed an agreement with ACOA to partially finance the renovations to the Rollo Bay farm site. All available funding under the agreement was disbursed through May 2017, and no further amounts are available. The loan is being repaid over a 108-month term at a zero percent interest rate. In November 2018, the Canadian Subsidiary executed a second agreement with ACOA to partially finance the renovations to the Rollo Bay site. All available funding under the agreement was disbursed through March 2019, and no further amounts are available. The loan is being repaid over a 108-month term with a zero percent interest rate. In response to the COVID-19 pandemic, the Company was informed by ACOA during 2020, that all loan payments to the Canadian government would be deferred for nine months and resume on January 1, 2021.In July 2021, the Canadian Subsidiary entered into a contribution agreement with ACOA under its REGI-Business Scale-up and Productivity program to provide funding assistance for the Rollo Bay farm site, and on August 20, 2021, the Canadian Subsidiary received C$250,000 ($200,075). All funds received are to be repaid over a 36-month term commencing January 2023 at a zero percent interest rate.KubotaIn January 2018, the Canadian Subsidiary financed the purchase of equipment through a loan with Kubota. The total amount is being repaid in monthly installments. The loan is secured by the underlying equipment.Finance PEI (&#x201c;FPEI&#x201d;)FPEI is a corporation of the Ministry of Economic Development and Tourism for Prince Edward Island, Canada, and administers business financing programs for the provincial government.In August 2016, the Canadian Subsidiary obtained a loan from FPEI to partially finance the purchase of the assets of the former Atlantic Sea Smolt plant in Rollo Bay West on Prince Edward Island.In 2018, the Canadian Subsidiary obtained a new loan from FPEI, which incorporated the existing loan and provided C$2.0&#160;million ($1.5&#160;million) of additional funds. All funds have been dispersed and the loan is being repaid over an 87-month term ending in November 2023. The loan has an interest rate of 4% and is collateralized by a mortgage executed by the Canadian Subsidiary, which conveys a first security interest in all of its current and acquired assets. The loan is guaranteed by the Parent.On March&#160;24, 2020, the Company was informed by FPEI that all payments would be deferred for three months due to the COVID-19 pandemic. Payments on the loan resumed on August 1, 2020.First Farmers Bank &amp; Trust (&#x201c;FFBT&#x201d;)On July 31, 2020, the Company&#x2019;s Indiana Subsidiary obtained a $4.0&#160;million loan from First Farmers Bank and Trust. Net proceeds were $3.9&#160;million after deducting $90&#160;thousand in loan costs. The loan bears interest at a rate of 5.375% for the first five years. On July 31, 2025, the interest rate resets to the then U.S. Treasury 5-year maturities rate plus 5% and remains fixed at that rate through maturity on October 1, 2028. The note required interest only payments for the first 13 months, followed by monthly principal and interest payments of approximately $57&#160;thousand through maturity. Proceeds from the loan may be used for the purpose of performing equipment upgrades, purchasing equipment and other improvements to the Indiana farm. The Company must comply with certain financial and non-financial covenants and provide certification of compliance quarterly.  At December 31, 2021, the Company was in compliance with such covenants. The loan is also subject to certain prepayment penalties and is secured by the assets of the Indiana subsidiary and a guarantee by the Parent. The loan agreement requires the Company to maintain a minimum cash balance with the bank throughout the loan term. This amount is reflected as restricted cash on the balance sheet.On October 12, 2021, the Company and First Farmers Bank &amp; Trust agreed to a modification to the terms of its outstanding loan.  The new terms delay the start date of certain of the loan&#x2019;s negative covenants to the quarter commencing on October 1, 2022 and raises the required restricted cash balance amount from $500 thousand to $1.0 million.  Department of Fisheries and Oceans (&#x201c;DFO&#x201d;)DFO is a department of the government of Canada responsible for safeguarding its waters and managing its fisheries, oceans and freshwater resources. DFO supports economic growth in the marine and fisheries sectors, and innovation in areas such as aquaculture and biotechnology.In September 2020, the Canadian Subsidiary entered into a Contribution Agreement with DFO's Atlantic Fisheries Fund, whereby it is eligible to receive up to C$1.9 million ($1.4 million) to finance new equipment for its Rollo Bay farm (the &#x201c;DFO Term Loan&#x201d;). On February 25, 2021, the Canadian Subsidiary borrowed C$238,400 ($187,120) and on April 27, 2021 the Canadian Subsidiary borrowed C$276,840 ($219,258) under the DFO Term Loan.  Borrowings are interest free and monthly repayments commence in March 2023, with maturity in August 2032. All funding requests must be submitted by August 22, 2022.The Company recognized interest expense of $316&#160;thousand and $152&#160;thousand for the years ended December 31, 2021 and 2020, respectively, on its interest-bearing debt. &#160;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-8491e564-4052-4b19-b1c2-3b1ed13e932d">               Interest&#x200e;rate Monthly&#x200e;repayment Maturity&#x200e;date December 31, 2021 December 31, 2020ACOA AIF Grant 0% Royalties - $ 2,261,349 $ 2,253,595ACOA term loan #1 0% C$3,120 Feb 2027   152,346   181,203ACOA term loan #2 0% C$4,630 Sep 2029   339,015   381,451ACOA term loan #3 0% C$6,945 Dec 2025   196,850   &#x2014;Kubota Canada Ltd 0% C$1,142 Jan 2025   33,283   43,925PEI Finance term loan 4% C$16,313 Nov 2023   1,947,510   2,014,321DFO term loan 0% C$2,091 Aug 2032   405,700   &#x2014;First Farmers Bank &amp; Trust term loan 5.375% $56,832 Oct 2028   3,883,325   4,000,000Total debt       $ 9,219,378 $ 8,874,495less: debt issuance costs         (68,680)   (86,066)less: current portion         (627,365)   (259,939)Long-term debt, net       $ 8,523,333 $ 8,528,490</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"
      decimals="INF"
      id="ct-nonFraction-41653445-9ed5-4981-992f-f4562b8b0ee4"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"
      id="ct-nonNumeric-9c66383e-a218-42db-80a2-601d3e52f409">-</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"
      decimals="0"
      id="ct-nonFraction-0036afb7-cd71-4a1f-b4e2-ccbf66e89ad4"
      unitRef="Unit1">2261349</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"
      decimals="0"
      id="ct-nonFraction-e13b88c4-7be9-4f95-955a-c75b5ba6e725"
      unitRef="Unit1">2253595</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-f4d889a3-89d4-4af8-afc7-3e23d83550c6"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-95bda496-0a64-4b86-b852-9630658866e5"
      unitRef="Unit15">3120</us-gaap:DebtInstrumentPeriodicPayment>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-9da21faa-0b0f-483e-b365-f1e58b643dcf">Feb 2027</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-b4add815-956e-4688-b86c-95df4bf8bdcf"
      unitRef="Unit1">152346</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-5925c509-1b67-440c-b2ee-3b73d131f01b"
      unitRef="Unit1">181203</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-4cfa6684-5298-4f88-80de-7da1773eb7b6"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-9efd151d-4f40-42ba-a787-9d22b44dbe81"
      unitRef="Unit15">4630</us-gaap:DebtInstrumentPeriodicPayment>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-973027c0-3dcc-4f8b-bd03-61551e529769">Sep 2029</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-bc78f2fb-e8b1-4a87-bd4d-ba5f1cd7e691"
      unitRef="Unit1">339015</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-d955ae0b-5f61-4722-8710-4beb6650129e"
      unitRef="Unit1">381451</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-d5543390-2fd3-4642-9bb3-a8d7a6b7e073"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-0fdb5bfd-dab5-4386-a1ab-253b12e7c900"
      unitRef="Unit15">6945</us-gaap:DebtInstrumentPeriodicPayment>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-1b872d5a-addf-4fe6-be93-17717ee48bc4">Dec 2025</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-10c8144d-4e2a-467a-8160-31c4dd84753b"
      unitRef="Unit1">196850</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-f0e76610-fb29-43fe-8d85-42ae4bd17847"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-46bf64c4-d309-4bb3-817f-c9ef04a0c64a"
      unitRef="Unit15">1142</us-gaap:DebtInstrumentPeriodicPayment>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-d957b863-ff28-465b-ba2b-99302331c5df">Jan 2025</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-88dcc8d8-3372-49a4-a28d-8493df6e8401"
      unitRef="Unit1">33283</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_KubotaCanadaLtdMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-421e6694-84fc-4bd3-8154-18a2d903ad15"
      unitRef="Unit1">43925</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-26af0104-15ce-433a-b345-1deb0de44013"
      unitRef="Unit13">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-eaa6b121-0f67-43de-aec2-689adabb66c3"
      unitRef="Unit15">16313</us-gaap:DebtInstrumentPeriodicPayment>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-bfc842aa-5b88-4736-81a3-8c939c50b792">Nov 2023</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-6695b2be-407e-48ff-8600-ba8d3ab9e2be"
      unitRef="Unit1">1947510</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-31e3504f-45e2-42b8-877b-c51daa56c19f"
      unitRef="Unit1">2014321</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-22a0714c-881e-4f56-8487-0bca4b06e4ab"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-89cabca2-b58b-418e-88df-cec4011e0c7a"
      unitRef="Unit15">2091</us-gaap:DebtInstrumentPeriodicPayment>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-856afe73-45a4-483b-8317-b8d8d1fff79e">Aug 2032</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-8264973b-8c65-415d-a23c-8ca993e22004"
      unitRef="Unit1">405700</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-d7703fc2-8580-4f1b-b4fd-fe438be1bd43"
      unitRef="Unit13">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-90b2a339-2338-4482-8204-436eb89e5b2d"
      unitRef="Unit1">56832</us-gaap:DebtInstrumentPeriodicPayment>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-23db86c3-d1e5-4cdb-b54d-e99cce0788fd">Oct 2028</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-b6332bfe-e3d6-472f-b041-07bbabde44c3"
      unitRef="Unit1">3883325</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-c1aad841-c32d-48f8-85e5-fdf836febf10"
      unitRef="Unit1">4000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-1185305f-4953-4a56-bb3a-0ee92b6f655e"
      unitRef="Unit1">9219378</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-0e3104dd-a712-4383-97cf-f54156de3735"
      unitRef="Unit1">8874495</us-gaap:LongTermDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4add78fd-3df3-4b4c-94dc-989dc5083ea2"
      unitRef="Unit1">68680</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-657ddfa9-9c75-40c7-bc19-14c2d41020a6"
      unitRef="Unit1">86066</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebtCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-87d2305e-7b1b-4edc-ae48-f6105022274b"
      unitRef="Unit1">627365</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-3fbba325-23be-4760-bfe4-95807ed31122"
      unitRef="Unit1">259939</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-5d60e0fc-3d12-414b-acf9-94af81881f78"
      unitRef="Unit1">8523333</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-22d24476-b437-4cdf-90aa-9bf2d7172b39"
      unitRef="Unit1">8528490</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-1a5889db-63d6-4d0a-b582-492b8a8b156b">    Total2022$ 643,9802023  2,564,3472024  729,6262025  750,1752026  715,392Thereafter  3,815,858Total$ 9,219,378</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-ae51050b-bcd6-4d81-9d0b-ad6b8f99f079"
      unitRef="Unit1">643980</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-6df9255d-8557-4652-85f9-5a40fae37eb6"
      unitRef="Unit1">2564347</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-1f56cf05-3368-45a2-baae-4f762d9a8ba4"
      unitRef="Unit1">729626</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-8ffd935b-88bc-4b43-9152-f962facb403e"
      unitRef="Unit1">750175</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-0d44e568-99bd-4c00-941f-0e78cb19b93c"
      unitRef="Unit1">715392</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-e1a8de33-0e8e-4f9d-a5c9-ccf14ef5950c"
      unitRef="Unit1">3815858</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-87925379-c610-4b66-9e83-e0a47ea136ce"
      unitRef="Unit1">9219378</us-gaap:LongTermDebt>
    <aqb:DebtInstrumentRepaymentTermsRoyaltyPercentage
      contextRef="Duration_1_1_2009_To_1_31_2009_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember"
      decimals="2"
      id="ct-nonFraction-e0aab4f7-f76d-40cc-85a4-1208943d922b"
      unitRef="Unit13">0.10</aqb:DebtInstrumentRepaymentTermsRoyaltyPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="Duration_2_1_2016_To_2_29_2016_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-4ea73ac6-ab07-4291-b954-120dce6ed51b">P108M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_2_29_2016_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-e64368c4-dbe5-4d40-a5ce-404cbf440990"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="Duration_11_1_2018_To_11_30_2018_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-01a6064b-7eae-49a1-8621-d1a30e253499">P108M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_11_30_2018_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-7f5e9c7d-77e8-4928-9d54-c3cfc5dd0b74"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_8_20_2021_To_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-c47f6253-da1a-4280-b8f0-78428e343093"
      unitRef="Unit15">250000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_8_20_2021_To_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-f9339c70-fc92-48f8-9d50-e9fdfce5e242"
      unitRef="Unit1">200075</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentTerm
      contextRef="Duration_8_20_2021_To_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-4bb359b0-a1cc-4e14-a561-0f4eb1fe83eb">P36M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_8_20_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-fc253903-f045-42de-916a-8337a2121891"
      unitRef="Unit13">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-5"
      id="ct-nonFraction-5abc2e07-ad96-434c-8354-b96e149276a6"
      unitRef="Unit15">2000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-5"
      id="ct-nonFraction-29d9e1c4-5698-4625-af1b-711cb80af2c7"
      unitRef="Unit1">1500000</us-gaap:DebtInstrumentFaceAmount>
    <aqb:RepaymentPeriodOfLoan
      contextRef="Duration_1_1_2018_To_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-f817158a-2231-4564-a210-541786d1365d">P87M</aqb:RepaymentPeriodOfLoan>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_31_2018_us-gaap_DebtInstrumentAxis_aqb_FPEITermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-38051fc1-703a-445b-bc3c-83f03ed0eba8"
      unitRef="Unit13">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-5"
      id="ct-nonFraction-c4d23053-7812-438b-ba8a-4e1621a458e1"
      unitRef="Unit1">4000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-5"
      id="ct-nonFraction-8dfd614c-55ce-4553-a7a8-e29977567d9f"
      unitRef="Unit1">3900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-3"
      id="ct-nonFraction-74838b87-216d-4d19-8480-52439dad09a3"
      unitRef="Unit1">90000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="INF"
      id="ct-nonFraction-673266ec-c6db-49b7-a454-183c634cb7c4"
      unitRef="Unit13">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqb:DebtInstrumentInterestRateStatedPercentagePeriod
      contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-a6c01544-8ed7-4f5b-9d96-6d02f835e842">P5Y</aqb:DebtInstrumentInterestRateStatedPercentagePeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="Duration_7_31_2025_To_7_31_2025_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_VariableRateAxis_aqb_USTreasuryFiveYearMaturitiesInterestRateMember"
      decimals="2"
      id="ct-nonFraction-189a27dc-eade-46f3-9299-486ef2b466bc"
      unitRef="Unit13">0.05</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="Duration_7_31_2025_To_7_31_2025_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-bb4b3c1a-6c53-42bc-8b91-16bc0528bf7a">2028-10-01</us-gaap:DebtInstrumentMaturityDate>
    <aqb:DebtInstrumentInterestOnlyPaymentPeriod
      contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-26a49b31-e571-48f4-9cd7-9a24a1a7b56f">P13M</aqb:DebtInstrumentInterestOnlyPaymentPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_7_31_2020_To_7_31_2020_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-3"
      id="ct-nonFraction-75733d4d-789b-4eb1-85d1-bb2055e63afd"
      unitRef="Unit1">57000</us-gaap:DebtInstrumentPeriodicPayment>
    <aqb:DebtInstrumentCovenantCashBalanceMinimum
      contextRef="As_Of_10_11_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-3"
      id="ct-nonFraction-a5796f19-456a-4a74-b9db-99c65aba3490"
      unitRef="Unit1">500000</aqb:DebtInstrumentCovenantCashBalanceMinimum>
    <aqb:DebtInstrumentCovenantCashBalanceMinimum
      contextRef="As_Of_10_12_2021_us-gaap_DebtInstrumentAxis_aqb_FirstFarmersBankAndTrustLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-5"
      id="ct-nonFraction-a3c60da6-190d-4faf-90f3-7d8482094747"
      unitRef="Unit1">1000000.0</aqb:DebtInstrumentCovenantCashBalanceMinimum>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_9_1_2020_To_9_30_2020_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-5"
      id="ct-nonFraction-1045973b-5640-4918-933d-43064ac14f30"
      unitRef="Unit15">1900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_9_1_2020_To_9_30_2020_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-5"
      id="ct-nonFraction-3de8b2b8-2388-4ec5-97e6-ae5e22ba7ae3"
      unitRef="Unit1">1400000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_2_25_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-52812797-84f2-40aa-be2d-e2b31dec4f5a"
      unitRef="Unit15">238400</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_2_25_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-9140d7f2-a175-42a3-88ed-1fa1395124c0"
      unitRef="Unit1">187120</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_4_27_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-c823092e-c574-4c72-af39-0823b2aaccd7"
      unitRef="Unit15">276840</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_4_27_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="0"
      id="ct-nonFraction-60a39e73-5650-42f9-bfb9-346d2cfdbe42"
      unitRef="Unit1">219258</us-gaap:DebtInstrumentFaceAmount>
    <aqb:DebtInstrumentMaturityDateYearMonth
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ConsolidatedEntitiesAxis_aqb_CanadianSubsidiaryMember_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      id="ct-nonNumeric-55266d61-739e-4719-8f77-2a2f290e5a09">August 2032</aqb:DebtInstrumentMaturityDateYearMonth>
    <us-gaap:InterestExpenseDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-3"
      id="ct-nonFraction-642cb97a-5152-4edb-9bc1-aa22821a67d2"
      unitRef="Unit1">316000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DebtInstrumentAxis_aqb_DfoTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember"
      decimals="-3"
      id="ct-nonFraction-8c3ced33-47c7-4d7f-ad51-2e0517f58544"
      unitRef="Unit1">152000</us-gaap:InterestExpenseDebt>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-9ef26341-8fee-4f84-8ff8-fac6fb993fbd">8.&#160;Stockholders&#x2019; equity The Company&#x2019;s shareholders have authorized 85&#160;million shares of stock, of which 5&#160;million are authorized as preferred stock&#160;and 80&#160;million as common stock. As of December&#160;31, 2021 and 2020, the Company had zero shares of preferred stock and&#160;71,025,738 shares and 55,497,133 shares of common stock, issued and outstanding, respectively.Common stockThe holders of the common stock are entitled to one vote for each share held at all meetings of stockholders. Dividends and distribution of assets of the Company in the event of liquidation are subject to the preferential rights of any outstanding preferred shares.Recent issuancesDuring 2020, the Company completed a series of public offerings, resulting in the aggregate issuance of 33,028,000 shares of common stock for net proceeds of approximately $104.6&#160;million.During 2021, the Company completed a public offering of 14,950,000 shares of common stock for net proceeds of approximately $119.1&#160;million. WarrantsThe following table summarizes information about outstanding warrants as of December&#160;31, 2021:        Number of &#x200e;options Weighted&#x200e;average&#x200e;exercise priceOutstanding at December 31, 2020 948,855 $ 3.25Issued &#x2014;   -Exercised (530,414)   3.25Expired &#x2014;   -Outstanding at December 31, 2021 418,441   3.25Exercisable at December 31, 2021 418,441   3.25 All remaining warrants have an expiration date of January 17, 2023.Share-based compensationIn 2006, the Company established the 2006 Equity Incentive Plan (the &#x201c;2006 Plan&#x201d;). The 2006 Plan provided for the issuance of incentive stock options to employees of the Company and non-qualified stock options and awards of restricted stock to Directors, officers, employees, and consultants of the Company. In accordance with its original terms, the 2006 Plan terminated on March&#160;18, 2016. All outstanding awards under the 2006 Plan will continue until their individual termination dates.In March 2016, the Company&#x2019;s Board of Directors adopted the AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (the &#x201c;2016 Plan&#x201d;) to replace the 2006 Plan. The 2016 Plan provides for the issuance of incentive stock options, non-qualified stock options, and awards of restricted and direct stock purchases to Directors, officers, employees, and consultants of the Company. Total common shares authorized under the 2016 Plan were 1,900,000, of which 916,516 shares are reserved for future issuance as of December 31, 2021. Restricted stockThe Company&#x2019;s restricted stock activity under the 2016 Plan is summarized as follows:        Shares Weighted&#x200e;average grant&#x200e;date fair valueBalance at December 31, 2020 92,653 $ 1.93Granted 43,837   6.67Vested (71,390)   2.86Balance at December 31, 2021 65,100 $ 4.10 During 2021 and 2020, the Company expensed $240&#160;thousand and $227 thousand, respectively related to restricted stock awards. At December&#160;31, 2021, the balance of unearned share-based compensation to be expensed in future periods related to the restricted stock awards is $147&#160;thousand. The period over which the unearned share-based compensation is expected to be earned is approximately 2.2 years.Stock optionsThe Company&#x2019;s option activity under the 2006 Plan and the 2016 Plan is summarized as follows:         Number of &#x200e;options Weighted&#x200e;average&#x200e;exercise priceOutstanding at December 31, 2020 657,414 $ 4.28Granted 48,914   6.72Exercised (16,667)   6.90Forfeited (1,959)   6.72Expired (24,277)   6.36Outstanding at December 31, 2021 663,425 $ 4.31Exercisable at December 31, 2021 607,189 $ 4.33 Options issued to employees, members of the Board of Directors, and non-employees generally vest over a period of one year to three years and are exercisable for a term of ten years from the date of issuance.The weighted average fair value of stock options granted during 2021 was $5.36 (2020: $1.49). There were 16,667 options exercised in 2021 (2020: zero). The total intrinsic value of options exercised in 2021 was $41 thousand (2020: $0). As of December&#160;31, 2021, the total intrinsic value of all options outstanding was&#160;$18 thousand&#160;(2020: $3.6 million) and the total intrinsic value of exercisable options was $11 thousand (2020: $3.2 million).The following table summarizes information about options outstanding and exercisable as of December&#160;31, 2021:          Weighted&#x200e;average exercise&#x200e;price of outstanding&#x200e;options Number of&#x200e;options&#x200e;outstanding Weighted&#x200e;average remaining&#x200e;estimated life&#x200e;(in years) Number of&#x200e;options&#x200e;exercisable $1.88 - $2.50  524,019  7.3  493,772 $3.30 - $6.72  53,916  8.4  27,927 $7.50 - $10.80  16,403  2.3  16,403 $14.20 - $23.40  69,087  4.2  69,087    663,425    607,189   The fair values of stock option grants to employees and members of the Board of Directors during 2021 and 2020 were measured on the date of grant using Black-Scholes, with the following weighted average assumptions:        20212020Expected volatility 111%101%-104%Risk free interest rate 0.80%0.31%-1.67%Expected dividend yield 0%0%Expected life (in years) 55 The risk-free interest rate is estimated using the Federal Funds interest rate for a period that is commensurate with the expected term of the awards. The expected dividend yield is zero because the Company has never paid a dividend and does not expect to do so for the foreseeable future. The expected life was based on a number of factors including historical experience, vesting provisions, exercise price relative to market price, and expected volatility. The Company believes that all groups of employees demonstrate similar exercise and post-vesting termination behavior and, therefore, does not stratify employees into multiple groups and forfeitures are recognized as they occur. The expected volatility was estimated using the Company&#x2019;s historical price volatility over a period that is commensurate with the expected term of the awards.Total share-based compensation on stock-option grants amounted to $154&#160;thousand and $251&#160;thousand for the years ended December&#160;31, 2021 and 2020, respectively.  As of December 31, 2021, the balance of unearned share-based compensation to be expensed in future periods related to unvested share-based awards is $182 thousand. The period over which the unearned share-based compensation is expected to be earned is 2.2 years.Share-based compensationThe following table summarizes share-based compensation costs recognized in the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Loss for the years ended December&#160;31, 2021 and 2020:                  2021  2020Research and development $ - $ 497General and administrative   394,237   436,194Total share-based compensation $ 394,237 $ 436,691&#160;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <aqb:AuthorizedShares
      contextRef="As_Of_12_31_2021"
      decimals="-6"
      id="ct-nonFraction-86ae3ca8-7e5e-49fc-9531-01e95eb7fcf3"
      unitRef="Unit12">85000000</aqb:AuthorizedShares>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2021"
      decimals="-6"
      id="ct-nonFraction-f12fc565-8422-4388-902b-892127e292ff"
      unitRef="Unit12">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2021"
      decimals="-6"
      id="ct-nonFraction-2f287235-524e-4b3c-8c54-b19bca0cbb37"
      unitRef="Unit12">80000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-7c19db58-6b5e-418e-aef4-fbd5a7d305c1"
      unitRef="Unit12">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-4cadf7cd-12ab-48f4-b861-8db2a01a628e"
      unitRef="Unit12">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-d39314ef-e568-4d61-a711-7bba9f8a2851"
      unitRef="Unit12">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-4fdc5de2-043a-42fe-9f3d-84bab065c46d"
      unitRef="Unit12">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-bc12e040-9037-4c96-b44f-c7b0998b8352"
      unitRef="Unit12">71025738</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-6080e698-a423-46d9-b3b6-a968abf7fee5"
      unitRef="Unit12">71025738</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-53c28556-67f4-4e6f-9031-1ad207a6c379"
      unitRef="Unit12">55497133</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="ct-nonFraction-4870a6db-3ea0-4724-80e5-ca312462ffc7"
      unitRef="Unit12">55497133</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-37e1e51c-681c-4164-a32c-443fe4523cbc">one</us-gaap:CommonStockVotingRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_12_14_2020_To_12_14_2020_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_December2020PublicOfferingMember"
      decimals="INF"
      id="ct-nonFraction-94a5b75a-67ed-482b-81fb-307ab384b10a"
      unitRef="Unit12">33028000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="Duration_12_14_2020_To_12_14_2020_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_December2020PublicOfferingMember"
      decimals="-5"
      id="ct-nonFraction-10901964-cfbb-41d4-8201-4eed2da6d55d"
      unitRef="Unit1">104600000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_2_8_2021_To_2_8_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_February2021PublicOfferingMember"
      decimals="INF"
      id="ct-nonFraction-9bd1f7a2-4d13-4fe1-9285-3f2a61b5fab8"
      unitRef="Unit12">14950000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="Duration_2_8_2021_To_2_8_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_aqb_February2021PublicOfferingMember"
      decimals="-5"
      id="ct-nonFraction-d8110305-3271-4490-a65c-2547da3dafc7"
      unitRef="Unit1">119100000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-ed3e242a-d80c-49f5-a664-62fcc39eba34">      Number of &#x200e;options Weighted&#x200e;average&#x200e;exercise priceOutstanding at December 31, 2020 948,855 $ 3.25Issued &#x2014;   -Exercised (530,414)   3.25Expired &#x2014;   -Outstanding at December 31, 2021 418,441   3.25Exercisable at December 31, 2021 418,441   3.25</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      decimals="INF"
      id="ct-nonFraction-915b7e4d-dd9c-4d81-b31a-642624a6354b"
      unitRef="Unit12">948855</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      decimals="2"
      id="ct-nonFraction-d4ff3f9b-c324-4f80-b89a-5d70961b61b5"
      unitRef="Unit14">3.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      decimals="INF"
      id="ct-nonFraction-c1ebbd77-ffb9-45ff-a106-1d62496396f6"
      unitRef="Unit12">530414</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      decimals="2"
      id="ct-nonFraction-50c84306-a564-4623-bfd4-3414aea7e0e2"
      unitRef="Unit14">3.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      decimals="INF"
      id="ct-nonFraction-cd87bd9b-1060-4af0-859c-b583e3560203"
      unitRef="Unit12">418441</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      decimals="2"
      id="ct-nonFraction-d6b7b554-a37c-49b9-adb8-6efcdfc1c1b7"
      unitRef="Unit14">3.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      decimals="INF"
      id="ct-nonFraction-23a40f41-c896-4f6b-bba4-017111f787c7"
      unitRef="Unit12">418441</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      decimals="2"
      id="ct-nonFraction-8298acb3-0327-434e-bcea-2566da9a8c9e"
      unitRef="Unit14">3.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="As_Of_12_31_2021_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember"
      id="ct-nonNumeric-24406782-8b9a-41c9-b38a-7bd22b2a6d4e">2023-01-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_aqb_A2016EquityIncentivePlanMember"
      decimals="INF"
      id="ct-nonFraction-605397c8-a7f9-4fad-bdc1-a8235101d25f"
      unitRef="Unit12">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_aqb_A2016EquityIncentivePlanMember"
      decimals="INF"
      id="ct-nonFraction-9ecdb3fc-66de-4482-95e3-d94051e67a45"
      unitRef="Unit12">916516</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-a657ae78-5b23-43e3-86d1-c34d98eda575">      Shares Weighted&#x200e;average grant&#x200e;date fair valueBalance at December 31, 2020 92,653 $ 1.93Granted 43,837   6.67Vested (71,390)   2.86Balance at December 31, 2021 65,100 $ 4.10</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ct-nonFraction-a80615e3-04f6-41c2-bd15-80598bcd5c4a"
      unitRef="Unit12">92653</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="2"
      id="ct-nonFraction-49037f9e-74ef-4a1a-8689-8fcdf343893e"
      unitRef="Unit14">1.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ct-nonFraction-8247ec61-8463-4dc3-ba5d-11387e1cccd5"
      unitRef="Unit12">43837</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="2"
      id="ct-nonFraction-c929b05a-48df-4e4d-b3ae-e3fdb2e94a35"
      unitRef="Unit14">6.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ct-nonFraction-d9866cf6-a384-45f4-b66e-f7a52e7cc8b9"
      unitRef="Unit12">71390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="2"
      id="ct-nonFraction-5681131d-b2ca-4588-9a5f-dcce177e36da"
      unitRef="Unit14">2.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ct-nonFraction-25649f96-ef52-42f9-b0a8-f1ac456db217"
      unitRef="Unit12">65100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="2"
      id="ct-nonFraction-b97a08f0-ecc1-439b-a774-efd556590b62"
      unitRef="Unit14">4.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="-3"
      id="ct-nonFraction-74a4413d-18f6-464c-b5ab-bca10103d67d"
      unitRef="Unit1">240000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="-3"
      id="ct-nonFraction-20c65323-bf90-4c20-bef7-84413f75bd7d"
      unitRef="Unit1">227000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="-3"
      id="ct-nonFraction-9beb2b26-fb51-4e2f-acdc-107bb0ac4118"
      unitRef="Unit1">147000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      id="ct-nonNumeric-85faf8ee-8853-476b-b912-d73faaba26b0">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-34cec40a-a75e-4c58-a8ce-c042fd07a379">      Number of &#x200e;options Weighted&#x200e;average&#x200e;exercise priceOutstanding at December 31, 2020 657,414 $ 4.28Granted 48,914   6.72Exercised (16,667)   6.90Forfeited (1,959)   6.72Expired (24,277)   6.36Outstanding at December 31, 2021 663,425 $ 4.31Exercisable at December 31, 2021 607,189 $ 4.33</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-0476bec4-d694-43fe-8886-5866616c9a24"
      unitRef="Unit12">657414</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-19b58b63-0ec6-4e2c-a26d-d8895d1c57f0"
      unitRef="Unit14">4.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-e9c28015-4dad-4182-82a1-195c8dae6cdd"
      unitRef="Unit12">48914</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-2ae366c4-c1e7-442e-ab48-33149d0b6e01"
      unitRef="Unit14">6.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-b91aef62-43ca-4b37-98f9-eb0a2696347c"
      unitRef="Unit12">16667</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-f47a8879-43a0-4d77-813c-9587da50910d"
      unitRef="Unit14">6.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-059b8f36-7fb4-4aea-ac5e-0665cc5f42cf"
      unitRef="Unit12">1959</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-16c07da7-533e-4a28-85d3-c8fb78ee908f"
      unitRef="Unit14">6.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-acace921-83c0-48b8-b725-94cd114189f3"
      unitRef="Unit12">24277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-59a5bd8f-57f0-48bf-86e9-279db00e03fd"
      unitRef="Unit14">6.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-60e9c16d-9b50-4379-9743-2a56c8cbaeb6"
      unitRef="Unit12">663425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-9b66d4b4-b50c-4110-a330-c70b49ed14a0"
      unitRef="Unit14">4.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-60589259-94c6-4172-9d84-7db08e96a2b1"
      unitRef="Unit12">607189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-fda9ed6f-c858-40ff-b563-9182815fa3d3"
      unitRef="Unit14">4.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="ct-nonNumeric-bf5b246a-2c21-4984-95a3-ca3f53f133b4">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="ct-nonNumeric-98106e0a-166e-4238-9036-b5f02ae6a667">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="ct-nonNumeric-3387befd-b08c-4539-9a1a-6765ad48414d">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-f595f7f8-68d4-45d5-8955-51c34058f613"
      unitRef="Unit14">5.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-e0e79846-020b-4d17-bb3a-21c99530962e"
      unitRef="Unit14">1.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-aad423e7-f4cb-4373-a518-ea699b08589a"
      unitRef="Unit12">16667</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-a0b34cdd-10af-4cae-88e3-e791c4f968f5"
      unitRef="Unit12">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="ct-nonFraction-764a5d67-991e-4680-b262-68ea48d804f0"
      unitRef="Unit1">41000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-be4a8be1-6b57-44f9-b6cd-5c122c01359e"
      unitRef="Unit1">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="ct-nonFraction-f6a3b23d-b26a-4235-aba5-7e2b8cff6898"
      unitRef="Unit1">18000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="ct-nonFraction-6f605343-ef68-4192-b6c9-8be83e95dbde"
      unitRef="Unit1">3600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="ct-nonFraction-f6dd678a-d308-4a1b-9b65-8772322274f7"
      unitRef="Unit1">11000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="ct-nonFraction-521698d0-08e0-48a8-8f82-422f3bcecede"
      unitRef="Unit1">3200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-7f29a991-8eda-4bcf-82f1-e29d4c8d1b83">        Weighted&#x200e;average exercise&#x200e;price of outstanding&#x200e;options Number of&#x200e;options&#x200e;outstanding Weighted&#x200e;average remaining&#x200e;estimated life&#x200e;(in years) Number of&#x200e;options&#x200e;exercisable $1.88 - $2.50  524,019  7.3  493,772 $3.30 - $6.72  53,916  8.4  27,927 $7.50 - $10.80  16,403  2.3  16,403 $14.20 - $23.40  69,087  4.2  69,087    663,425    607,189 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"
      decimals="2"
      id="ct-nonFraction-77a8dd47-dfde-4104-bf1d-2ae461f5e7b7"
      unitRef="Unit14">1.88</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"
      decimals="2"
      id="ct-nonFraction-eec376b2-c03f-4e0f-87d5-8b7a55186014"
      unitRef="Unit14">2.50</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"
      decimals="INF"
      id="ct-nonFraction-158ab179-cd7f-443d-afa9-4ed9b0c7a9f3"
      unitRef="Unit12">524019</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"
      id="ct-nonNumeric-4e765081-5aee-4821-b1c8-808dc720fe8c">P7Y3M18D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceOneMember"
      decimals="INF"
      id="ct-nonFraction-8540d2a1-5c2c-43b1-8bcb-e1b3132104fc"
      unitRef="Unit12">493772</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"
      decimals="2"
      id="ct-nonFraction-bb995488-e416-44b3-b5f2-df736dca867a"
      unitRef="Unit14">3.30</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"
      decimals="2"
      id="ct-nonFraction-ba0acfe3-d394-4c32-bb9c-3bf671765805"
      unitRef="Unit14">6.72</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"
      decimals="INF"
      id="ct-nonFraction-b40f5354-f5c6-458c-ab99-015733900780"
      unitRef="Unit12">53916</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"
      id="ct-nonNumeric-4f19aa30-ab81-42ae-80f3-8611257d5bbf">P8Y4M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceTwoMember"
      decimals="INF"
      id="ct-nonFraction-76aff9db-84bd-410e-a7c4-0980164ee090"
      unitRef="Unit12">27927</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"
      decimals="2"
      id="ct-nonFraction-73f675fe-69c7-4492-b6a6-7f3d09af5bb3"
      unitRef="Unit14">7.50</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"
      decimals="2"
      id="ct-nonFraction-b3e70389-724d-43d5-a67a-13e249da0c91"
      unitRef="Unit14">10.80</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"
      decimals="INF"
      id="ct-nonFraction-660b0d5b-116b-4903-9c35-c645c4a42454"
      unitRef="Unit12">16403</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"
      id="ct-nonNumeric-794e4de1-36e3-4e55-a46e-47f3b0820e64">P2Y3M18D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceThreeMember"
      decimals="INF"
      id="ct-nonFraction-ee93887a-9ecd-4810-95f9-e4091b442afe"
      unitRef="Unit12">16403</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"
      decimals="2"
      id="ct-nonFraction-7db7b159-eeba-4321-8542-67bb6ef9f8a0"
      unitRef="Unit14">14.20</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"
      decimals="2"
      id="ct-nonFraction-3e7708d0-9bc8-4230-b32f-76214a0efd03"
      unitRef="Unit14">23.40</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"
      decimals="INF"
      id="ct-nonFraction-507a8b30-39f2-4049-a1ba-8ee76ac69043"
      unitRef="Unit12">69087</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"
      id="ct-nonNumeric-1f0a989a-0008-4c83-8302-b23aa18ac815">P4Y2M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_StatementClassOfStockAxis_aqb_ExercisePriceFourMember"
      decimals="INF"
      id="ct-nonFraction-08a0ac28-b65e-4307-aca0-567a00aa7efb"
      unitRef="Unit12">69087</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-48050f3b-2635-441f-8307-e08dc50317a0"
      unitRef="Unit12">663425</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-92b6690c-2334-4c09-b0f7-29b12d9f8d44"
      unitRef="Unit12">607189</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-6aa5619f-ec08-4770-a0a5-49f955d6c29e">      20212020Expected volatility 111%101%-104%Risk free interest rate 0.80%0.31%-1.67%Expected dividend yield 0%0%Expected life (in years) 55</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-c5a10cdb-a105-476d-b7bf-afbe7c358e25"
      unitRef="Unit13">1.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-5972fc98-4e6d-48f8-bca8-2dc87880362f"
      unitRef="Unit13">1.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-7200b5c3-7c4a-4c7a-b071-86cbcb94ea68"
      unitRef="Unit13">1.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="ct-nonFraction-5d63944e-417c-481b-b4d4-ec84bc89af4d"
      unitRef="Unit13">0.0080</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="ct-nonFraction-f087056f-1009-456e-ba85-8b179e15056c"
      unitRef="Unit13">0.0031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="ct-nonFraction-5bd725f5-6f3a-4dac-ba78-0f2208e2efef"
      unitRef="Unit13">0.0167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-80432ef7-e200-41b1-9901-8f38827908e2"
      unitRef="Unit13">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="ct-nonFraction-55f20e5a-53c7-4607-840a-190590de273a"
      unitRef="Unit13">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="ct-nonNumeric-e37a8240-9eba-4e09-a7e1-397e61a05916">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="ct-nonNumeric-56af7640-5d3b-467f-905f-8a3f26ec8422">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-7157b4b6-435e-4201-9f06-0a20af895b1b"
      unitRef="Unit13">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-bf285222-c3ab-4269-ab5a-adc8aae112bf"
      unitRef="Unit13">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="ct-nonFraction-0f5867e8-8c11-4e66-8044-4845118516b6"
      unitRef="Unit1">154000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="ct-nonFraction-a4f31693-f6ee-4128-ac6a-4a221818d7f9"
      unitRef="Unit1">251000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="ct-nonFraction-bbd59e93-9bef-40a4-b7bf-6384b7f5081b"
      unitRef="Unit1">182000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="ct-nonNumeric-37887f26-4910-4e40-9fe4-aa8599ecbe68">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-902238e7-e057-44a5-9435-97e3074cc0ac">                 2021  2020Research and development $ - $ 497General and administrative   394,237   436,194Total share-based compensation $ 394,237 $ 436,691</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="0"
      id="ct-nonFraction-60356dfd-2d68-4824-8f80-e5a8ee8469d1"
      unitRef="Unit1">497</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="ct-nonFraction-631104ed-4eca-4658-9a56-d17eb554dbc6"
      unitRef="Unit1">394237</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="ct-nonFraction-12194491-325a-4054-aef1-5371edb9f787"
      unitRef="Unit1">436194</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-6525928b-d6d6-4d43-8cad-629a10ba14d0"
      unitRef="Unit1">394237</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-faa92f69-42da-4747-b97f-f7c91a8f7f27"
      unitRef="Unit1">436691</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-b01f7c85-f255-40a6-8607-0824c713b89a">9.&#160;Income taxes The components of loss before income taxes for the years ended December&#160;31, 2021 and 2020 are presented below:             2021 2020Domestic$ (21,105,065) $ (15,768,224)Foreign  (1,217,523)   (631,761)Loss before income taxes$ (22,322,588) $ (16,399,985) We have made no provision for foreign or domestic income taxes on the cumulative unremitted earnings of our foreign subsidiaries.  We intend to permanently reinvest all foreign earnings and have no intention to repatriate foreign earnings for the foreseeable future. Income taxes computed using the federal statutory income tax rate differs from the Company&#x2019;s effective tax rate for the years ended December&#160;31, 2021 and 2020 primarily due to the following:             2021 2020Income tax benefit$ (4,687,744) $ (3,443,997)State and provincial income tax, net of federal benefit  (1,157,840)   (732,994)Permanent differences  202,583   131,141US-Foreign rate differential  39,045   (142,663)Other, net  (299,071)   (145,973) $ (5,903,027) $ (4,334,486)Change in valuation allowance  5,903,027   4,334,486Total income tax$ - $ - As of December&#160;31, 2021, the Company has domestic net operating loss carryforwards of approximately $78 million, after consideration of limitations pursuant to section 382, to offset future federal taxable income, which begin to expire in 2032. As of December 31, 2021, the Company has domestic net operating loss carryforwards of approximately $50 million, which can be carried forward indefinitely. The future utilization of certain historic net operating loss and tax credit carryforwards, however, is subject to annual use limitations based on the change in stock ownership rules of Internal Revenue Code Sections&#160;382 and 383. The Company experienced a change in ownership under these rules during 2012 and revised its calculation of net operating loss carryforwards based on annual limitation rules. The Company also has foreign research and development loss carryforwards totaling approximately $11&#160;million and foreign research and development expense tax credits of approximately $2&#160;million as of December&#160;31, 2021, which expire at various times commencing in 2022. Since the Company has incurred only losses from inception and there is uncertainty related to the ultimate use of the loss carryforwards and tax credits, a valuation allowance has been recognized to offset the Company&#x2019;s deferred tax assets, and no benefit for income taxes has been recorded.Significant components of the Company&#x2019;s deferred tax assets and liabilities are as follows:                2021  2020Deferred tax assets:     Net operating loss carryforwards$ 23,216,863 $ 16,964,199Foreign research and development tax credit carryforwards  2,428,663   2,679,180Property and equipment  145,530   56,697Intangibles and other  2,934,441   3,122,394Total deferred tax assets$ 28,725,497 $ 22,822,470Valuation allowance$ (28,725,497) $ (22,822,470)Net deferred tax assets$ - $ -&#160;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-6dc90caf-a182-4569-aa91-8110a435a487">             2021 2020Domestic$ (21,105,065) $ (15,768,224)Foreign  (1,217,523)   (631,761)Loss before income taxes$ (22,322,588) $ (16,399,985)</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-c52d0585-9952-43ff-80bc-3f2f23348036"
      unitRef="Unit1">-21105065</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-77fbd0cc-31d1-4ea3-9aec-bf8aebed84d4"
      unitRef="Unit1">-15768224</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-62acc7ca-ba9e-4904-ad6d-04440c1168f7"
      unitRef="Unit1">-1217523</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-3d79593b-1dba-43c9-a4d2-9af048228c8a"
      unitRef="Unit1">-631761</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-c2b2e0b4-0abd-46de-9f61-c7c4a4f98332"
      unitRef="Unit1">-22322588</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-03f7301e-a329-4f1d-8925-06c15adc163a"
      unitRef="Unit1">-16399985</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-207fba55-456a-44ab-b104-2f84486d7cb1">             2021 2020Income tax benefit$ (4,687,744) $ (3,443,997)State and provincial income tax, net of federal benefit  (1,157,840)   (732,994)Permanent differences  202,583   131,141US-Foreign rate differential  39,045   (142,663)Other, net  (299,071)   (145,973) $ (5,903,027) $ (4,334,486)Change in valuation allowance  5,903,027   4,334,486Total income tax$ - $ -</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-694a6219-7cd0-4b01-8ec0-36b93ab8e384"
      unitRef="Unit1">-4687744</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-da0c20c8-64ff-4a42-9c0f-962b17407093"
      unitRef="Unit1">-3443997</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-5e50d115-5745-462f-9e64-468731b19448"
      unitRef="Unit1">-1157840</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-54581af6-38e8-49c6-a658-064eb12c766f"
      unitRef="Unit1">-732994</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-c6ea9927-4ede-486c-8d04-01d28f891103"
      unitRef="Unit1">202583</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-ec53a6d3-dd7f-4516-b745-1e5d61967eb2"
      unitRef="Unit1">131141</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-b42a42d5-6c71-49f4-919f-70ad4da33336"
      unitRef="Unit1">39045</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-63c2c31b-b293-4920-8174-2187af7a8216"
      unitRef="Unit1">-142663</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-34c2362b-50c2-44bb-b308-675d0ea237c8"
      unitRef="Unit1">-299071</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-bfbc4f2e-1e94-4970-9e2b-f2d24b28243b"
      unitRef="Unit1">-145973</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <aqb:IncomeTaxExpenseBenefitBeforeValuationAllowance
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-bd4cf674-f902-4fd2-8abe-96d62b6eb570"
      unitRef="Unit1">-5903027</aqb:IncomeTaxExpenseBenefitBeforeValuationAllowance>
    <aqb:IncomeTaxExpenseBenefitBeforeValuationAllowance
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-094281c3-ea8d-4761-a605-0f2f4a024bcb"
      unitRef="Unit1">-4334486</aqb:IncomeTaxExpenseBenefitBeforeValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="0"
      id="ct-nonFraction-67161561-3724-46a8-b942-a293fefb5cb8"
      unitRef="Unit1">5903027</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="0"
      id="ct-nonFraction-ca93801d-237c-4ee4-8291-c21e97460ef7"
      unitRef="Unit1">4334486</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="As_Of_12_31_2021_srt_StatementScenarioAxis_aqb_LimitationsOnUseToSection382Member_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-6"
      id="ct-nonFraction-bd12fb9d-07ac-48a7-936d-f0806b10e8eb"
      unitRef="Unit1">78000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-6"
      id="ct-nonFraction-4df01e8e-b398-4bbf-a1af-f4d53b50de0a"
      unitRef="Unit1">50000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-5"
      id="ct-nonFraction-eee3d705-90c5-4f6e-9042-ad9a38618d9c"
      unitRef="Unit1">11000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember"
      decimals="-5"
      id="ct-nonFraction-2268509e-fde4-4049-8532-3fcff6bea675"
      unitRef="Unit1">2000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-a73555de-c528-4e9c-a165-03c63616ebc0">              2021  2020Deferred tax assets:     Net operating loss carryforwards$ 23,216,863 $ 16,964,199Foreign research and development tax credit carryforwards  2,428,663   2,679,180Property and equipment  145,530   56,697Intangibles and other  2,934,441   3,122,394Total deferred tax assets$ 28,725,497 $ 22,822,470Valuation allowance$ (28,725,497) $ (22,822,470)Net deferred tax assets$ - $ -</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-0fb6b7ea-f9b6-4069-b550-8194d7d3c560"
      unitRef="Unit1">23216863</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-ce1e0fae-e99d-41a9-9800-aafe012b3fd3"
      unitRef="Unit1">16964199</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-9ac68f3d-08c9-4b9e-9288-d6de443603b9"
      unitRef="Unit1">2428663</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-d2fea393-1ae0-4440-831c-0bb9f0a22cd9"
      unitRef="Unit1">2679180</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-50306c28-b691-46b8-999b-4318a7e58b88"
      unitRef="Unit1">145530</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-092527f5-f574-4926-b686-cff60ae1030b"
      unitRef="Unit1">56697</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-470402d3-5750-43fb-a95c-7aecf8cb3c21"
      unitRef="Unit1">2934441</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-2ff11c59-ef1f-4b32-9afc-09062a7098f5"
      unitRef="Unit1">3122394</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-8a577f3e-ea19-43a7-8ba8-8a2e2fb81814"
      unitRef="Unit1">28725497</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-e19dcea9-fd04-4ab4-bca1-ca2edeaf0287"
      unitRef="Unit1">22822470</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-f655ffd5-8760-49b1-9950-dabc8a496be9"
      unitRef="Unit1">28725497</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-4b7c4fb2-708f-443c-a5d8-e6e4e65b257c"
      unitRef="Unit1">22822470</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-0054a6e1-07bf-4bb2-b836-edb28c238306">10.&#160;Commitments and contingencies The Company recognizes and discloses commitments when it enters into executed contractual obligations with other parties. The Company accrues contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.The Company is subject to legal proceedings and claims arising in the normal course of business. Management believes that final disposition of any such matters existing at December&#160;31, 2021, will not have a material adverse effect on the Company&#x2019;s financial position or results of operations.Lease commitmentsLease expense for the years ended December&#160;31, 2021 and 2020, amounted to $84 thousand and $86 thousand, respectively. As of December 31, 2021, the weighted average remaining lease term of the Company&#x2019;s operating leases was 24.1 years. Lease payments included in operating cash flows totaled $84&#160;thousand and $85 thousand for the years ended December&#160;31, 2021 and 2020, respectively. The table below summarizes the Company&#x2019;s lease obligations as of December&#160;31, 2021 and 2020:                December 31, 2021 December 31, 2020   Lease Liability   Lease LiabilityTotal leases$ 290,327 $ 352,810Less: current portion  (66,269)   (62,483)Long-term leases$ 224,058 $$ 290,327 The Company used a weighted average discount rate of 8% in calculating the net present value of the future lease payments. The current portion of the lease liability is included as a component of other current liabilities in the consolidated balance sheets.Remaining payments under leases are as follows as of December&#160;31, 2021:        Year    Amount2022  $ 84,0802023    33,8722024    17,4812025    18,0062026    18,546Thereafter    583,328Total lease payments    755,313Less: imputed interest    (464,986)Total operating lease liabilities  $ 290,327&#160;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="-3"
      id="ct-nonFraction-c6df82c9-1054-4f33-9677-65630ca69cb8"
      unitRef="Unit1">84000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="ct-nonFraction-15f7b68f-d4c2-4cb2-9e33-c7875214f26f"
      unitRef="Unit1">86000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="As_Of_12_31_2021"
      id="ct-nonNumeric-aef12537-0c7f-43c8-98df-e54c98bbbee5">P24Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="-3"
      id="ct-nonFraction-10e98f4a-763e-4d4b-9fce-a8ad9818a9da"
      unitRef="Unit1">84000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="ct-nonFraction-2a548141-3ca5-4714-a2a9-b1f1e2c43016"
      unitRef="Unit1">85000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-43929723-5c47-48cb-94c1-0f97308a0cd9">             December 31, 2021 December 31, 2020   Lease Liability   Lease LiabilityTotal leases$ 290,327 $ 352,810Less: current portion  (66,269)   (62,483)Long-term leases$ 224,058 $$ 290,327</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-4ad9e48f-f274-4876-a90a-6a82ae99c054"
      unitRef="Unit1">290327</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-72cb756f-7d41-4eab-b676-e79c42d5579e"
      unitRef="Unit1">352810</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-8e59b36c-08bb-4559-ac9a-db52c585c760"
      unitRef="Unit1">66269</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-c8fe8209-5a35-4793-b5db-103e1c2e12cd"
      unitRef="Unit1">62483</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-875ee1a6-203f-4f0c-8f48-02bd81b6db12"
      unitRef="Unit1">224058</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="0"
      id="ct-nonFraction-1c82df74-d513-4c14-9ea8-e01542fa53d8"
      unitRef="Unit1">290327</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-dd39eaf8-514f-4037-802b-e0e9960edb61">      Year    Amount2022  $ 84,0802023    33,8722024    17,4812025    18,0062026    18,546Thereafter    583,328Total lease payments    755,313Less: imputed interest    (464,986)Total operating lease liabilities  $ 290,327</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-a2b60572-1609-49a5-a458-bf56980e3a04"
      unitRef="Unit1">84080</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-28291687-50b1-4277-a636-3e2403522b02"
      unitRef="Unit1">33872</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-755dab8e-7e3d-4cc0-b164-d0d386c68c17"
      unitRef="Unit1">17481</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-e4f2f870-00d3-48ba-b231-09999ef635ec"
      unitRef="Unit1">18006</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-a9daaf70-027e-415a-9b58-d76665ff96ae"
      unitRef="Unit1">18546</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-adecf515-e7c1-40c5-b1f6-b2fa162b19d5"
      unitRef="Unit1">583328</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-7861b09b-9c28-4418-bef5-ea5ee1a6ee02"
      unitRef="Unit1">755313</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-52a5bace-76ed-478e-bc7f-ea458bba9057"
      unitRef="Unit1">464986</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="As_Of_12_31_2021"
      decimals="0"
      id="ct-nonFraction-89c382b5-1ca5-4abf-a38f-0476cd3f009c"
      unitRef="Unit1">290327</us-gaap:OperatingLeaseLiability>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-3122cab0-a7b1-4924-a117-4e657b39c711">11.&#160;Retirement plan The Company has a savings and retirement plan for its US employees that qualifies under Section&#160;401(k) of the Internal Revenue Code. The plan covers substantially all employees and provides for voluntary contributions by participating employees up to the maximum contribution allowed under the Internal Revenue Code. Contributions by the Company can be made, as determined by the Board of Directors, provided the amount does not exceed the maximum permitted by the Internal Revenue Code. Company contributions made and expensed in operations in connection with the plan during the years ended December&#160;31, 2021 and 2020, amounted to $81&#160;thousand and $72&#160;thousand, respectively.The Company also has a Registered Retirement Savings Plan for its Canadian employees. Company contributions made and expensed in operations in connection with the plan during the years ended December&#160;31, 2021 and 2020, amounted to $38&#160;thousand and $32&#160;thousand, respectively.&#160;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="-3"
      id="ct-nonFraction-22c20f83-d682-4097-9680-2dd91da869a0"
      unitRef="Unit1">81000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="ct-nonFraction-95ad1d0a-6682-4db1-84ef-c5f913def352"
      unitRef="Unit1">72000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember"
      decimals="-3"
      id="ct-nonFraction-e47dd08b-638e-410a-ac75-5e233e75ab25"
      unitRef="Unit1">38000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_RetirementPlanSponsorLocationAxis_us-gaap_ForeignPlanMember"
      decimals="-3"
      id="ct-nonFraction-62fbda06-cda6-4d41-ad44-d4534b745135"
      unitRef="Unit1">32000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_12_31_2021"
      id="ct-nonNumeric-71459177-7e52-4fd3-9b71-6c9c21d633da">12.&#160;Related Party Agreement Letter Agreement with Third SecurityOn July 30, 2021, the Company entered into an agreement with TS Aquaculture LLC and certain of its affiliates (&#x201c;TS Aquaculture&#x201d;) that required the Company to file a registration statement to register the Company&#x2019;s shares held by TS Aquaculture.  The registration statement was filed on August 5, 2021 and TS Aquaculture completed a transaction to sell 12,880,000 shares of common stock of the Company on November 23, 2021.  TS Aquaculture ceased being a related party after completing the sale.  TS Aquaculture agreed to pay all expenses incurred in connection with these transactions, which totaled $418 thousand and is included in prepaid and other current assets in the consolidated financial statements as of December 31, 2021.&#160;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="Duration_11_23_2021_To_11_23_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember"
      decimals="INF"
      id="ct-nonFraction-300f35b9-9384-4da6-ba52-8a29e4cc2cf2"
      unitRef="Unit12">12880000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember"
      decimals="-3"
      id="ct-nonFraction-2d76df76-4546-4ab4-8843-0478bae816bc"
      unitRef="Unit1">418000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>77
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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ML>!(+/AI8C8R@;E :,O-/##X$L\/-:N%D]X5LVP@G-C&FO9%.3Q&.7Q1E-^
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M*E^ABN_8J38_Y/,_>6]08O65LM;N/WKN9:,5*D_:R*8?# @:T7:_[*5WQ-D
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M@VT&92!HE.G_R]N!ASV%%[,[%+)!(8NX>T<1Y84,<G[J[$8XEH8U?HBA1FV
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M+PN!A3#61WD<^>_-AA6,446OE .$KPI95G8Q$IX/])TX*2@@O>$$Y;1=Y58
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MU=+%W9K#-/;K)[4Z TDMA#=,#^ (Z,<'8?XI5J'H!FGDFGQ3HXA8.)6K.,U
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M*+&]T81X2<,!+=4VC[0^]PJ@ [-(BN;)]R>T:T9Z^&8&PPJ?DIK8[QXA:52
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M\X+-JYSJ2 4_A(<V-!W.'HFS)<@FWW^7S[(?SIW^]&2J4#Z;.#L=G8.=]L.
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M9)Y^+XY3N M5UYDE8Q;D2+!8)#" G)H&81C2GT^(0>FJU/UW+)9!'"V#9+[
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M43@=C_RGD/;!JJW[LKI0UJJ-^[D6''6/"/!^J91M'TA ]ZG]ZK]02P,$%
M  @ [$5J5!%XH4:S!@  $1   !D   !X;"]W;W)K<VAE971S+W-H965T,34N
M>&ULM5AK;^.V$OTKA+LH:H"-];(E;Y, ^VC1!=K;8+-M/US<#[0TCMF529>D
MXJ2__IZAY->NDRT*-( 34>:<>9V9(7.YM>ZC7Q$%\;!NC;\:K4+8O)Q,?+VB
MM?(7=D,&WRRM6ZN I;N;^(TCU42A=3O)DF0V62MM1M>7\=V-N[ZT76BUH1LG
M?+=>*_?XFEJ[O1JEH]V+]_IN%?C%Y/IRH^[HEL*OFQN'U62/TN@U&:^M$8Z6
M5Z-7Z<O7!>^/&W[3M/5'SX(]65C[D1?OFJM1P@912W5@!(4_]_2&VI:!8,:?
M ^9HKY(%CY]WZ#]$W^'+0GEZ8]O?=1-65Z-J)!I:JJX-[^WV1QK\F3)>;5L?
M?XMMOS<K1J+N?+#K01@6K+7I_ZJ'(0Y' E7RA$ V"&31[EY1M/*M"NKZTMFM
M<+P;:/P078W2,$X;3LIM</A60RY<OS.U79/XH![(7TX"$/G]I!ZD7_?2V1/2
M:29^MB:LO/C>--2< DQ@RMZ>;&?/Z^Q9Q+=47X@\E2)+LO09O'SO7Q[Q\K_A
MG_COJX4/#D3XWS/(Q1ZYB,C%/XS<L])<:R_]1M5T-4(Q>7+W-+J>7WS]53I+
MOAN@0S3ZPXH$EAMKR 0O[%*TUGNQ(%0D"7V\%6]$P/9'4LX+XI0(!)36"W(]
M\BZR0IF&'Q*A !(M, &[%URE+\7Q3]S.6]]"D0^Z?B&^R5*9)E.9S*9C@64Z
ME>6LDEE6C%$J* 0C\%)F:2FG63X&R#<S:"YGZ?BG)VQGT$SF^$RKJ@>=R7P^
ME_,*.GXGL5+W!.(W)(R%P?9>Q[[ +B\'G7AL!AM/XX)]'):Z6W>MXBX@.N-H
MK0.[C%@9;>YB9&UW0//=PNM&*Z?)7P@V02-$"%N ?D)#X'RTC^A,VMQ#J5!M
MNQ?>@W*<H^FP.LK'7@0(1QL5G%:!/A?:Y9&_\$1JT>*Y"YVC"W'"#>9%QTYT
M'H*]##7D5"M\4*$+UCT>A4(X5M?HY9+ CZ6SZRCR!BC*/'[]586,?0?BX/O8
M+ \R_X19&Z?1YS5"U'3$+O<NM6 8C'V"9 ?WP!)#2QU A4+.JE*611&)D<NB
MR.5\7HYO ]O&"B,A3*WA^,%=*0RF&M*ZB\F &,F93DM9%4DD9YEGP"O&-[NT
M#C$B4R/(;!=8F6-G"B_3(OWU]ML=SX\BRKF%$I'/95),&3<M,CF;Y>-?X+GK
MK0'-0>JD3,?]AJF<EWET"T])+I.LC*M"YGDABVHV?K-2YH[))^Y5VZE^EG$0
M%:P38B\&O+W0!QM.(O%"?"OX\RJR_'SBY#$7P%E_**881G >RL&RV'YJY=PC
M6+%5KHF@:H,</"#C@9#Q%V6%:=6V,%8*M0SDP%5,\B:"P -N8QH5&%=>;#KG
M.X7 @R9^&-AYE4E>V^72PX"^ /:YA%>Q+GHGI=BN=+U"AN]T+"]ZV.C88N!;
MGEU\XKGX=YR>)@>G>WMJ96!3%-0HF4$69N'@H(UFL8O8X0?ONJ!;_=<^1#6Y
M@(.56&D<!-QYHYC^7"ZUHP;</K%1BI7=TCV33WON:'\@MAP>94R'(':>3M+
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M<VAE971S+W-H965T,38N>&ULK59;;]LV%/XKA)L5+>#Y(LN.FB8&DG3#!J1
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MBE +!04_7)N7QR2YK)D"O<J9&M)V@IQ7J&0J1H=F09]K5_^@3PAXJ6D#MV!
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MRQ)C.%DFP/W:&+_?L()^L%_^!U!+ P04    " #L16I4B?]&;6,#  !)"
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M+=)T_/:G]$/R<0!?>^Z_EP@K4]5"GZ$4#@0X<93ZP"M=<)%<2W/-@B0'7[:
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M/IO(\0'L5Q;#QO#"!L8/L;._ %!+ P04    " #L16I4-:>BO\T3  !E.@
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MNX;DB'7?_6-Q?ORC+&;10D8N]W-87-N!,N2$L.*Q<5?D. 0$T*A5XTJ\[/Q
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M=_9W+U(([WOXM=&^O2O(^2(8_W<V>==1#38AG(16QEM$VJN1P'BDRI+LZCA
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M^V!# .YWQOBG21!8/B2;?P%02P,$%     @ [$5J5(8_=[,0!   H0@  !D
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M%BHK0.MS*<UV8!7T+[?IOU!+ P04    " #L16I48#V1<1T$  !S"0  &0
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M3!TD^(FE)'T/X&HB-1OTQF:!!A%7)!D!'WX R$.P)Z#E[>Y>C_MJV/TWS$;
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M4]+=?,).3\[8"1.:?:],[8C4#6,DD;Y47+2"KAM!Z1%!$RC.6=;[P-(D[1V
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MXN9;=+18YY?'F=!X%<V;*_Q; )E-P.\+(?1;)[N/5O\?P[]02P,$%     @
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M0R%25B .LYYUC:\&.-" ,N)W"AO1:",M9<K8L^[<)CW+T1E!!K'4%%0]UC"
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M>!W,/99DP?._:*JRJ1,[("5K7.7JEF\_DB:@T-A+>"[M?[!MUGH.2"JI>-&
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M22!- +Y?"Z%?)F;7&P^Y\@]02P,$%     @ [$5J5$M00KB=!P  /B@  !D
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M$H1]W0+X!FT+9? +HX;R#<K+;,6%&8>^H0?TH"^JL;F& O=3Y!S@).Q9>?%
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M @2TF]".=B3 O8E"6B4Z3-%G3NBZMX/Q+$@_3LO*!&;EGT[H ?\O2&AB69K
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M=,:P2$%^ \M=P6"UF8C=BCKNJ>D&//R+Y5.$YV_^\<LOQ",^A,J27G#V;>K
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MW8'_M32A(CY'O#!BN3"C!C.RF-$.S VE/Z(9+"AC1O09R0B+ ?U&V]A78E3
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M-\S-3P!*:V#V9T+HS<02U+\5D[]02P,$%     @ [$5J5+(\YZYH P  ]0L
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M^+\8&&X;:#+=X*#%/7;C_I8^_]?G'[:4QOV6^T<L[(E[OOU._I6]OO(/-=V
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M6GA893%*BXT62SN-9D+C;+/+!#\_0!H'?#\70F\W)D'U0=/[!U!+ P04
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MH497#C/ZM4!E#]#^5$JSGMANU_RLQ'\ 4$L#!!0    ( .Q%:E0%RIJ)A (
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M13>U?A3;;]#EDUB^0M3*?='6^XY' 2HV2HNF QL%#>/^3]^Z.NP!<'H$0#H
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M2#5=S*0X$&FB4<T\V+6QV>B&<?,:5UKB*,,\O?C$"]$"^4)?09&K%>Z2<M<
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M3DB<^YF]EMD[SA2:EG6#:+N&C][;HV=I2C#QTW'TM[E%1_EWH-0U8M5ZHZ%
MC)OD06EO5XKV0KA*NDDO/U!UO--@\1DU*%V3])+QWAL:]R(29RVX:7S[=B2-
M<QR]MQM[[%)B/@/^?>7#G:%A1_PW*I>,*Q/IP@BC3F;>+UE/S7JCQ=K-D9G0
M9BJYY<I\:8"T!N9\(81^V]C1U'Z[#%\!4$L#!!0    ( .Q%:E02BLV[;@(
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MX?9.;3Y#5\_0\16*&_]+-FWN$!6+QE@E.C#&@LGV29^[/NP ^J,#@*0#)/N
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ [$5J5 K8\$>/!   524   \
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M,>2>&-D],*8_;L:0A6)D"W63B_]JEI" 8F0!?9_^,%4=/9GS]BC7.F]\3$A
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M?UE^[QS=XQ>< _QO\?@%4$L#!!0    ( .Q%:E2/X;=ITP$  #8A   3
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M:X8B:X8B:X8B:X8B:_:?LKX;L_SK-_GM-:UUV1SR6?>YQ.034$L! A0#%
M  @ [$5J5 =!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " #L16I4I71<[NT    K @  $0
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M=#(N>&UL4$L! A0#%     @ [$5J5,E18416 @  # 8  !@
M ("!>A4  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( .Q%
M:E2Q&XKMR@0  .40   8              " @088  !X;"]W;W)K<VAE971S
M+W-H965T-"YX;6Q02P$"% ,4    " #L16I4@LGV/R0&  #I(   &
M        @($&'0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%
M  @ [$5J5"1+VLI%!P  B1P  !@              ("!8",  'AL+W=O<FMS
M:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( .Q%:E1:# ZLK 4  -L,   8
M              " @=LJ  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"
M% ,4    " #L16I4[#(B6)$2  "@,@  &               @(&],   >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ [$5J5*?"/CQ "@
M?!D  !@              ("!A$,  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM
M;%!+ 0(4 Q0    ( .Q%:E03>)&E$@,  , &   9              " @?I-
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ [$5J5($K
M"P47 P  H08  !D              ("!0U$  'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6Q02P$"% ,4    " #L16I4=X)QM:$$   Q"@  &0
M    @(&15   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (
M .Q%:E3'; ^;*0T  #TA   9              " @6E9  !X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L! A0#%     @ [$5J5.'];B4."P  =A\  !D
M             ("!R68  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"
M% ,4    " #L16I4$7BA1K,&   1$   &0              @($.<@  >&PO
M=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( .Q%:E1[]8) &@4
M .0+   9              " @?AX  !X;"]W;W)K<VAE971S+W-H965T,38N
M>&UL4$L! A0#%     @ [$5J5(G_1FUC P  20@  !D              ("!
M27X  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #L16I4
M5*'%N&P#  "?!P  &0              @('C@0  >&PO=V]R:W-H965T<R]S
M:&5E=#$X+GAM;%!+ 0(4 Q0    ( .Q%:E1\YU -NP4  )0-   9
M      " @8:%  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%
M  @ [$5J5#6GHK_-$P  93H  !D              ("!>(L  'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #L16I4&))WAWD"  !5!0
M&0              @(%\GP  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+
M 0(4 Q0    ( .Q%:E3>S@#LKP(  +P%   9              " @2RB  !X
M;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ [$5J5)$Y1)%H
M @  ( 4  !D              ("!$J4  'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6Q02P$"% ,4    " #L16I4F%EH3@4#  !4!@  &0
M@(&QIP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( .Q%
M:E2&/W>S$ 0  *$(   9              " @>VJ  !X;"]W;W)K<VAE971S
M+W-H965T,C4N>&UL4$L! A0#%     @ [$5J5'SKS%O_!   Q0T  !D
M         ("!-*\  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
M    " #L16I48#V1<1T$  !S"0  &0              @(%JM   >&PO=V]R
M:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( .Q%:E05,FNU^P(  -,&
M   9              " @;ZX  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL
M4$L! A0#%     @ [$5J5+!&2,,F @  IP0  !D              ("!\+L
M 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #L16I49^&A
M8.D#  !O#0  &0              @(%-O@  >&PO=V]R:W-H965T<R]S:&5E
M=#,P+GAM;%!+ 0(4 Q0    ( .Q%:E24CW^=/P,  #D.   9
M  " @6W"  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @
M[$5J5 1#\.Y3 @  U 4  !D              ("!X\4  'AL+W=O<FMS:&5E
M=',O<VAE970S,BYX;6Q02P$"% ,4    " #L16I4<)7,OCH#  "+#   &0
M            @(%MR   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4
M Q0    ( .Q%:E0C1\.E^ $  !\$   9              " @=[+  !X;"]W
M;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ [$5J5-"+:!'; @
MW@D  !D              ("!#<X  'AL+W=O<FMS:&5E=',O<VAE970S-2YX
M;6Q02P$"% ,4    " #L16I4G5IE+M@#   4#P  &0              @($?
MT0  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( .Q%:E3D
MPSZ_M0,  !@/   9              " @2[5  !X;"]W;W)K<VAE971S+W-H
M965T,S<N>&UL4$L! A0#%     @ [$5J5)!R!+]9!P  U2L  !D
M     ("!&MD  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .Q%:E2?Z;K"T0(  &((   9              "
M@1/U  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ [$5J
M5+(\YZYH P  ]0L  !D              ("!&_@  'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6Q02P$"% ,4    " #L16I4-H[:APT%  #-'@  &0
M        @(&Z^P  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0
M   ( .Q%:E3[=C'&)@,  )H+   9              " @?X  0!X;"]W;W)K
M<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ [$5J5(#=:JCE @  W @
M !D              ("!6P0! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q0
M2P$"% ,4    " #L16I48"0XBKD"  "X"   &0              @(%W!P$
M>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( .Q%:E0%RIJ)
MA (  %X&   9              " @6<* 0!X;"]W;W)K<VAE971S+W-H965T
M-#DN>&UL4$L! A0#%     @ [$5J5%/RBZMI P  3@H  !D
M ("!(@T! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #L
M16I4U/\[#Q<#  #L"   &0              @('"$ $ >&PO=V]R:W-H965T
M<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( .Q%:E1-N,8/@P(  &8&   9
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M970U-BYX;6Q02P$"% ,4    " #L16I4(_GL!QP#   N$@  #0
M    @ &<(0$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .Q%:E27BKL<P
M !,"   +              "  >,D 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M .Q%:E0*V/!'CP0  %4E   /              "  <PE 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " #L16I4##^0_.4!  !_(0  &@
M@ &(*@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #L
M16I4C^&W:=,!   V(0  $P              @ &E+ $ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     0 !  '<1  "I+@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>159</ContextCount>
  <ElementCount>374</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>65</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00105 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00300 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00400 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>10101 - Disclosure - Nature of Business and Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganization</Role>
      <ShortName>Nature of Business and Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>10201 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>10301 - Disclosure - Risks and Uncertainties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureRisksAndUncertainties</Role>
      <ShortName>Risks and Uncertainties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10401 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureMarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10501 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureInventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10601 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10701 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureDebt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10801 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>10901 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>11001 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>11101 - Disclosure - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureRetirementPlan</Role>
      <ShortName>Retirement Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>11201 - Disclosure - Related Party Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureRelatedPartyAgreement</Role>
      <ShortName>Related Party Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>20102 - Disclosure - Nature of Business and Organization (Policy)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy</Role>
      <ShortName>Nature of Business and Organization (Policy)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>20202 - Disclosure - Summary of Significant Accounting Policies (Policy)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy</Role>
      <ShortName>Summary of Significant Accounting Policies (Policy)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>30203 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>30403 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureMarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureMarketableSecurities</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>30503 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureInventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureInventory</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>30603 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>30703 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureDebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureDebt</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>30803 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureStockholdersEquity</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>30903 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureIncomeTaxes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>31003 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>40101 - Disclosure - Nature of Business and Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationDetails</Role>
      <ShortName>Nature of Business and Organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>40202 - Disclosure - Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Risks and Uncertainties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails</Role>
      <ShortName>Risks and Uncertainties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureRisksAndUncertainties</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Marketable Securities (Schedule of Marketable Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities (Schedule of Marketable Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureMarketableSecuritiesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Inventory (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureInventoryNarrativeDetails</Role>
      <ShortName>Inventory (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureInventoryTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>40502 - Disclosure - Inventory (Schedule of Inventory) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails</Role>
      <ShortName>Inventory (Schedule of Inventory) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureInventoryTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Property, Plant and Equipment (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>40602 - Disclosure - Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureDebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureDebtTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>40702 - Disclosure - Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails</Role>
      <ShortName>Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureDebtTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>40703 - Disclosure - Debt (Principal Payments Due on Long-term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails</Role>
      <ShortName>Debt (Principal Payments Due on Long-term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureDebtTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>40801 - Disclosure - Stockholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureStockholdersEquityTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>40802 - Disclosure - Stockholders' Equity (Information About Outstanding Warrants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails</Role>
      <ShortName>Stockholders' Equity (Information About Outstanding Warrants) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureStockholdersEquityTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>40803 - Disclosure - Stockholders' Equity (Restricted Stock Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity (Restricted Stock Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureStockholdersEquityTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>40804 - Disclosure - Stockholders' Equity (Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails</Role>
      <ShortName>Stockholders' Equity (Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureStockholdersEquityTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>40805 - Disclosure - Stockholders' Equity (Information About Options Outstanding and Exercisable) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails</Role>
      <ShortName>Stockholders' Equity (Information About Options Outstanding and Exercisable) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureStockholdersEquityTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>40806 - Disclosure - Stockholders' Equity (Stock Option Grants Weighted Average Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails</Role>
      <ShortName>Stockholders' Equity (Stock Option Grants Weighted Average Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureStockholdersEquityTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>40808 - Disclosure - Stockholders' Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails</Role>
      <ShortName>Stockholders' Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureStockholdersEquityTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>40901 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureIncomeTaxesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>40902 - Disclosure - Income Taxes (Components of Loss Before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Components of Loss Before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureIncomeTaxesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>40903 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureIncomeTaxesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>40904 - Disclosure - Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureIncomeTaxesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>41001 - Disclosure - Commitments and Contingencies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>41002 - Disclosure - Commitments and Contingencies (Summary of Lease Obligations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails</Role>
      <ShortName>Commitments and Contingencies (Summary of Lease Obligations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>41003 - Disclosure - Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails</Role>
      <ShortName>Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>41101 - Disclosure - Retirement Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureRetirementPlanDetails</Role>
      <ShortName>Retirement Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureRetirementPlan</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="aqb-20211231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>41201 - Disclosure - Related Party Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails</Role>
      <ShortName>Related Party Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sec.gov/role/DisclosureRelatedPartyAgreement</ParentRole>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="aqb-20211231x10k.htm">aqb-20211231x10k.htm</File>
    <File>aqb-20211231.xsd</File>
    <File>aqb-20211231_cal.xml</File>
    <File>aqb-20211231_def.xml</File>
    <File>aqb-20211231_lab.xml</File>
    <File>aqb-20211231_pre.xml</File>
    <File>aqb-20211231xex21_1.htm</File>
    <File>aqb-20211231xex23_1.htm</File>
    <File>aqb-20211231xex23_2.htm</File>
    <File>aqb-20211231xex31_1.htm</File>
    <File>aqb-20211231xex31_2.htm</File>
    <File>aqb-20211231xex32_1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>aqb-20211231x10kg001.jpg</File>
    <File>aqb-20211231x10kg002.jpg</File>
    <File>aqb-20211231x10kg003.jpg</File>
    <File>aqb-20211231x10kg004.jpg</File>
    <File>aqb-20211231x10kg005.jpg</File>
    <File>aqb-20211231x10kg006.jpg</File>
    <File>aqb-20211231x10kg007.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="571">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="50">http://www.sec.gov/20211231</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>82
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "aqb-20211231x10k.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 159,
   "dts": {
    "calculationLink": {
     "local": [
      "aqb-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aqb-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "aqb-20211231x10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aqb-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aqb-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aqb-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 469,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 39,
    "http://www.sec.gov/20211231": 4,
    "http://xbrl.sec.gov/dei/2021q4": 7,
    "total": 50
   },
   "keyCustom": 0,
   "keyStandard": 374,
   "memberCustom": 0,
   "memberStandard": 62,
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://www.sec.gov/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10401 - Disclosure - Marketable Securities",
     "role": "http://www.sec.gov/role/DisclosureMarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10501 - Disclosure - Inventory",
     "role": "http://www.sec.gov/role/DisclosureInventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10601 - Disclosure - Property, Plant and Equipment",
     "role": "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment",
     "shortName": "Property, Plant and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10701 - Disclosure - Debt",
     "role": "http://www.sec.gov/role/DisclosureDebt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10801 - Disclosure - Stockholders' Equity",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10901 - Disclosure - Income Taxes",
     "role": "http://www.sec.gov/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11001 - Disclosure - Commitments and Contingencies",
     "role": "http://www.sec.gov/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11101 - Disclosure - Retirement Plan",
     "role": "http://www.sec.gov/role/DisclosureRetirementPlan",
     "shortName": "Retirement Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11201 - Disclosure - Related Party Agreement",
     "role": "http://www.sec.gov/role/DisclosureRelatedPartyAgreement",
     "shortName": "Related Party Agreement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aqb:NatureOfOperationsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "20102 - Disclosure - Nature of Business and Organization (Policy)",
     "role": "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy",
     "shortName": "Nature of Business and Organization (Policy)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aqb:NatureOfOperationsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00100 - Statement - Consolidated Balance Sheets",
     "role": "http://www.sec.gov/role/StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "20202 - Disclosure - Summary of Significant Accounting Policies (Policy)",
     "role": "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy",
     "shortName": "Summary of Significant Accounting Policies (Policy)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aqb:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30203 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aqb:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30403 - Disclosure - Marketable Securities (Tables)",
     "role": "http://www.sec.gov/role/DisclosureMarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30503 - Disclosure - Inventory (Tables)",
     "role": "http://www.sec.gov/role/DisclosureInventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30603 - Disclosure - Property, Plant and Equipment (Tables)",
     "role": "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentTables",
     "shortName": "Property, Plant and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30703 - Disclosure - Debt (Tables)",
     "role": "http://www.sec.gov/role/DisclosureDebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30803 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30903 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.sec.gov/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31003 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "aqb:AdditionalCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40101 - Disclosure - Nature of Business and Organization (Details)",
     "role": "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationDetails",
     "shortName": "Nature of Business and Organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "aqb:AdditionalCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit14",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00105 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.sec.gov/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit14",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)",
     "role": "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_1_1_2019",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "aqb:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40202 - Disclosure - Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)",
     "role": "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails",
     "shortName": "Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "aqb:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40301 - Disclosure - Risks and Uncertainties (Details)",
     "role": "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails",
     "shortName": "Risks and Uncertainties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CreditConcentrationRiskMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "aqb:MarketableSecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40401 - Disclosure - Marketable Securities (Schedule of Marketable Securities) (Details)",
     "role": "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails",
     "shortName": "Marketable Securities (Schedule of Marketable Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "aqb:MarketableSecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_PublicUtilitiesInventoryAxis_aqb_FishInProcessMember",
      "decimals": "-4",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryAdjustments",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40501 - Disclosure - Inventory (Narrative) (Details)",
     "role": "http://www.sec.gov/role/DisclosureInventoryNarrativeDetails",
     "shortName": "Inventory (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40502 - Disclosure - Inventory (Schedule of Inventory) (Details)",
     "role": "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails",
     "shortName": "Inventory (Schedule of Inventory) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_PublicUtilitiesInventoryAxis_aqb_FeedMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InventoryGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40601 - Disclosure - Property, Plant and Equipment (Narrative) (Details)",
     "role": "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails",
     "shortName": "Property, Plant and Equipment (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40602 - Disclosure - Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details)",
     "role": "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
     "shortName": "Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40701 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2009_To_1_31_2009_us-gaap_DebtInstrumentAxis_aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember",
      "decimals": "2",
      "lang": null,
      "name": "aqb:DebtInstrumentRepaymentTermsRoyaltyPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit13",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40702 - Disclosure - Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)",
     "role": "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails",
     "shortName": "Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "role": "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "lang": null,
      "name": "aqb:ProductionCostsOperating",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40703 - Disclosure - Debt (Principal Payments Due on Long-term Debt) (Details)",
     "role": "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails",
     "shortName": "Debt (Principal Payments Due on Long-term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "aqb:AuthorizedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40801 - Disclosure - Stockholders' Equity (Narrative) (Details)",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "aqb:AuthorizedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40802 - Disclosure - Stockholders' Equity (Information About Outstanding Warrants) (Details)",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
     "shortName": "Stockholders' Equity (Information About Outstanding Warrants) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_us-gaap_WarrantMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40803 - Disclosure - Stockholders' Equity (Restricted Stock Activity) (Details)",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity (Restricted Stock Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40804 - Disclosure - Stockholders' Equity (Stock Option Activity) (Details)",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails",
     "shortName": "Stockholders' Equity (Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40805 - Disclosure - Stockholders' Equity (Information About Options Outstanding and Exercisable) (Details)",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
     "shortName": "Stockholders' Equity (Information About Options Outstanding and Exercisable) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unitRef": "Unit13",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40806 - Disclosure - Stockholders' Equity (Stock Option Grants Weighted Average Assumptions) (Details)",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails",
     "shortName": "Stockholders' Equity (Stock Option Grants Weighted Average Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40808 - Disclosure - Stockholders' Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details)",
     "role": "http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails",
     "shortName": "Stockholders' Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40901 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40902 - Disclosure - Income Taxes (Components of Loss Before Income Taxes) (Details)",
     "role": "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes (Components of Loss Before Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00300 - Statement - Consolidated Statements of Changes in Stockholders' Equity",
     "role": "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity",
     "shortName": "Consolidated Statements of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40903 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "role": "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40904 - Disclosure - Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41001 - Disclosure - Commitments and Contingencies (Narrative) (Details)",
     "role": "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41002 - Disclosure - Commitments and Contingencies (Summary of Lease Obligations) (Details)",
     "role": "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails",
     "shortName": "Commitments and Contingencies (Summary of Lease Obligations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41003 - Disclosure - Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details)",
     "role": "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails",
     "shortName": "Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "As_Of_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41101 - Disclosure - Retirement Plan (Details)",
     "role": "http://www.sec.gov/role/DisclosureRetirementPlanDetails",
     "shortName": "Retirement Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_11_23_2021_To_11_23_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41201 - Disclosure - Related Party Agreement (Details)",
     "role": "http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails",
     "shortName": "Related Party Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_11_23_2021_To_11_23_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_aqb_TsAquacultureMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00400 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10101 - Disclosure - Nature of Business and Organization",
     "role": "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganization",
     "shortName": "Nature of Business and Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10201 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10301 - Disclosure - Risks and Uncertainties",
     "role": "http://www.sec.gov/role/DisclosureRisksAndUncertainties",
     "shortName": "Risks and Uncertainties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aqb-20211231x10k.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 65,
   "tag": {
    "aqb_A2016EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Equity Incentive Plan [Member]",
        "label": "A2016 Equity Incentive Plan [Member]",
        "terseLabel": "2016 Equity Incentive Plan [Member]"
       }
      }
     },
     "localname": "A2016EquityIncentivePlanMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_AdditionalCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Cash And Cash Equivalents",
        "label": "Additional Cash And Cash Equivalents",
        "terseLabel": "Additional cash and cash equivalents"
       }
      }
     },
     "localname": "AdditionalCashAndCashEquivalents",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_AtlanticCanadaOpportunitiesAgencyAIFGrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Atlantic Canada Opportunities Agency AIF Grant",
        "label": "Atlantic Canada Opportunities Agency A I F Grant [Member]",
        "terseLabel": "ACOA AIF Grant [Member]"
       }
      }
     },
     "localname": "AtlanticCanadaOpportunitiesAgencyAIFGrantMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_AtlanticCanadaOpportunitiesAgencyTermLoan1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Atlantic Canada Opportunities Agency Term Loan 1 [Member]",
        "label": "Atlantic Canada Opportunities Agency Term Loan1 [Member]",
        "terseLabel": "ACOA Term Loan #1 [Member]"
       }
      }
     },
     "localname": "AtlanticCanadaOpportunitiesAgencyTermLoan1Member",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_AtlanticCanadaOpportunitiesAgencyTermLoan2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Atlantic Canada Opportunities Agency Term Loan 2 [Member]",
        "label": "Atlantic Canada Opportunities Agency Term Loan2 [Member]",
        "terseLabel": "ACOA Term Loan #2 [Member]"
       }
      }
     },
     "localname": "AtlanticCanadaOpportunitiesAgencyTermLoan2Member",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_AtlanticCanadaOpportunitiesAgencyTermLoan3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Atlantic Canada Opportunities Agency Term Loan 3 [Member]",
        "label": "Atlantic Canada Opportunities Agency Term Loan3 [Member]",
        "terseLabel": "ACOA Term Loan #3 [Member]"
       }
      }
     },
     "localname": "AtlanticCanadaOpportunitiesAgencyTermLoan3Member",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_AuthorizedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of common and preferred shares authorized by the Company.",
        "label": "Authorized Shares",
        "terseLabel": "Authorized shares of common and preferred stock"
       }
      }
     },
     "localname": "AuthorizedShares",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aqb_CanadaSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canada Subsidiary [Member]",
        "label": "Canada Subsidiary [Member]",
        "terseLabel": "Canada Subsidiary [Member]"
       }
      }
     },
     "localname": "CanadaSubsidiaryMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_CanadianSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Subsidiary [Member]",
        "label": "Canadian Subsidiary [Member]",
        "terseLabel": "Canadian Subsidiary [Member]"
       }
      }
     },
     "localname": "CanadianSubsidiaryMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_DebtInstrumentCovenantCashBalanceMinimum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Cash Balance, Minimum",
        "label": "Debt Instrument, Covenant, Cash Balance, Minimum",
        "terseLabel": "Covenant, minimum cash balance"
       }
      }
     },
     "localname": "DebtInstrumentCovenantCashBalanceMinimum",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_DebtInstrumentInterestOnlyPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Only Payment Period",
        "label": "Debt Instrument, Interest Only Payment Period",
        "terseLabel": "Interest only payment period"
       }
      }
     },
     "localname": "DebtInstrumentInterestOnlyPaymentPeriod",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aqb_DebtInstrumentInterestRateStatedPercentagePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Stated Percentage, Period",
        "label": "Debt Instrument, Interest Rate, Stated Percentage, Period",
        "terseLabel": "Interest rate, period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentagePeriod",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aqb_DebtInstrumentMaturityDateYearMonth": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Maturity Date Year Month",
        "label": "Debt Instrument Maturity Date Year Month",
        "terseLabel": "Maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateYearMonth",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aqb_DebtInstrumentRepaymentTermsRoyaltyPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Repayment Terms, Royalty Percentage",
        "label": "Debt Instrument, Repayment Terms, Royalty Percentage",
        "terseLabel": "Royalty percentage"
       }
      }
     },
     "localname": "DebtInstrumentRepaymentTermsRoyaltyPercentage",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aqb_December2020PublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2020 Public Offering [Member]",
        "label": "December2020 Public Offering [Member]",
        "terseLabel": "December 2020 Public Offering [Member]"
       }
      }
     },
     "localname": "December2020PublicOfferingMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_DfoTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DFO Term Loan [Member]",
        "label": "Dfo Term Loan [Member]",
        "terseLabel": "DFO Term Loan [Member]"
       }
      }
     },
     "localname": "DfoTermLoanMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_EggsAndFryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eggs And Fry",
        "label": "Eggs And Fry [Member]",
        "terseLabel": "Eggs And Fry [Member]"
       }
      }
     },
     "localname": "EggsAndFryMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_ExercisePriceFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Four [Member]",
        "label": "Exercise Price Four [Member]",
        "terseLabel": "$14.20 - $23.40"
       }
      }
     },
     "localname": "ExercisePriceFourMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_ExercisePriceOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price One [Member]",
        "label": "Exercise Price One [Member]",
        "terseLabel": "$1.88 - $2.50"
       }
      }
     },
     "localname": "ExercisePriceOneMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_ExercisePriceThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Three [Member]",
        "label": "Exercise Price Three [Member]",
        "terseLabel": "$7.50 - $10.80"
       }
      }
     },
     "localname": "ExercisePriceThreeMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_ExercisePriceTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Two [Member]",
        "label": "Exercise Price Two [Member]",
        "terseLabel": "$3.30 - $6.72"
       }
      }
     },
     "localname": "ExercisePriceTwoMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_ExerciseofWarrantsforCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of warrants for common shares.",
        "label": "Exerciseof Warrantsfor Common Stock",
        "terseLabel": "Exercise of warrants for common stock"
       }
      }
     },
     "localname": "ExerciseofWarrantsforCommonStock",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_ExerciseofWarrantsforCommonStockshares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of Warrants for Common Stock, shares.",
        "label": "Exerciseof Warrantsfor Common Stockshares",
        "terseLabel": "Exercise of warrants for common stock (in shares)"
       }
      }
     },
     "localname": "ExerciseofWarrantsforCommonStockshares",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "aqb_FPEITermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FPEI Term Loan [Member]",
        "label": "F P E I Term Loan [Member]",
        "terseLabel": "PEI Finance Term Loan [Member]"
       }
      }
     },
     "localname": "FPEITermLoanMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_February2021PublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2021 Public Offering [Member]",
        "label": "February2021 Public Offering [Member]",
        "terseLabel": "February 2021 Public Offering [Member]"
       }
      }
     },
     "localname": "February2021PublicOfferingMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_FeedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Feed [Member]",
        "label": "Feed [Member]",
        "terseLabel": "Feed [Member]"
       }
      }
     },
     "localname": "FeedMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_FirstFarmersBankAndTrustLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Farmers Bank And Trust Loan",
        "label": "First Farmers Bank And Trust Loan [Member]",
        "terseLabel": "First Farmers Bank &amp; Trust [Member]"
       }
      }
     },
     "localname": "FirstFarmersBankAndTrustLoanMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_FishInProcessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fish In Process [Member]",
        "label": "Fish In Process [Member]",
        "terseLabel": "Fish In Process [Member]"
       }
      }
     },
     "localname": "FishInProcessMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryNarrativeDetails",
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance": {
     "auth_ref": [],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit), Before Valuation Allowance",
        "label": "Income Tax Expense (Benefit), Before Valuation Allowance",
        "totalLabel": "Total income tax, prior to change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitBeforeValuationAllowance",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_IndianaAquacultureFarmMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indiana Aquaculture Farm [Member]",
        "label": "Indiana Aquaculture Farm [Member]",
        "terseLabel": "Indiana Aquaculture Farm [Member]"
       }
      }
     },
     "localname": "IndianaAquacultureFarmMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_KubotaCanadaLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kubota Canada Ltd [Member]",
        "label": "Kubota Canada Ltd [Member]",
        "terseLabel": "Kubota Canada Ltd [Member]"
       }
      }
     },
     "localname": "KubotaCanadaLtdMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_LimitationsOnUseToSection382Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limitations On Use To Section 382 [Member]",
        "label": "Limitations On Use To Section382 [Member]",
        "terseLabel": "Limitations On Use To Section 382 [Member]"
       }
      }
     },
     "localname": "LimitationsOnUseToSection382Member",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_LiquidityPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity, Policy [Policy Text Block]",
        "label": "Liquidity, Policy [Policy Text Block]",
        "terseLabel": "Liquidity"
       }
      }
     },
     "localname": "LiquidityPolicyPolicyTextBlock",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aqb_MarketableSecuritiesAmortizedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Amortized Cost",
        "label": "Marketable Securities, Amortized Cost",
        "terseLabel": "Amortized cost"
       }
      }
     },
     "localname": "MarketableSecuritiesAmortizedCost",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_MarketableSecuritiesUnrealizedGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Unrealized Gain",
        "label": "Marketable Securities, Unrealized Gain",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGain",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_MarketableSecuritiesUnrealizedLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Unrealized Loss",
        "label": "Marketable Securities, Unrealized Loss",
        "negatedLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedLoss",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_NatureOfOperationsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature Of Operations, Policy [Policy Text Block]",
        "label": "Nature Of Operations, Policy [Policy Text Block]",
        "terseLabel": "Nature of Business"
       }
      }
     },
     "localname": "NatureOfOperationsPolicyPolicyTextBlock",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aqb_New10000MetricTonFarmMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New 10,000 Metric Ton Farm [Member]",
        "label": "New10000 Metric Ton Farm [Member]",
        "terseLabel": "Ohio Farm [Member]"
       }
      }
     },
     "localname": "New10000MetricTonFarmMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_OfficeFurnitureandEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Furniture and Equipment [Member]",
        "label": "Office Furnitureand Equipment [Member]",
        "terseLabel": "Office Furniture And Equipment [Member]"
       }
      }
     },
     "localname": "OfficeFurnitureandEquipmentMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_PackagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packaging [Member]",
        "label": "Packaging [Member]",
        "terseLabel": "Packaging [Member]"
       }
      }
     },
     "localname": "PackagingMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_PaymentsForDepositsOnEquipmentPurchases": {
     "auth_ref": [],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Deposits On Equipment Purchases",
        "label": "Payments For Deposits On Equipment Purchases",
        "negatedTerseLabel": "Deposits on equipment purchases"
       }
      }
     },
     "localname": "PaymentsForDepositsOnEquipmentPurchases",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_ProceedsPaymentsForLegalSettlementsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds (Payments) for Legal Settlements, Investing Activities",
        "label": "Proceeds (Payments) For Legal Settlements, Investing Activities",
        "terseLabel": "Proceeds from legal settlement, net",
        "verboseLabel": "Proceeds from legal settlement, net"
       }
      }
     },
     "localname": "ProceedsPaymentsForLegalSettlementsInvestingActivities",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_ProductionCostsOperating": {
     "auth_ref": [],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Production Costs Operating",
        "label": "Production Costs Operating",
        "terseLabel": "Product costs"
       }
      }
     },
     "localname": "ProductionCostsOperating",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aqb_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant and Equipment Estimated Useful Lives [Table Text Block]",
        "label": "Property, Plant and Equipment Estimated Useful Lives [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment Estimated Useful Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aqb_PropertyPlantAndEquipmentUsefulLife1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant and Equipment, Useful Life 1",
        "label": "Property, Plant and Equipment, Useful Life 1",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife1",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aqb_RepaymentPeriodOfLoan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment Period Of Loan",
        "label": "Repayment Period Of Loan",
        "terseLabel": "Loan repayment period"
       }
      }
     },
     "localname": "RepaymentPeriodOfLoan",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aqb_RolloBayFarmAndFortuneBayHatcheryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rollo Bay Farm And Fortune Bay Hatchery [Member]",
        "label": "Rollo Bay Farm And Fortune Bay Hatchery [Member]",
        "terseLabel": "Rollo Bay Farm And Fortune Bay Hatchery [Member]"
       }
      }
     },
     "localname": "RolloBayFarmAndFortuneBayHatcheryMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_TsAquacultureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TS Aquaculture [Member]",
        "label": "Ts Aquaculture [Member]",
        "terseLabel": "TS Aquaculture [Member]"
       }
      }
     },
     "localname": "TsAquacultureMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_USTreasuryFiveYearMaturitiesInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Treasury Five-year Maturities Interest Rate",
        "label": "U S Treasury Five Year Maturities Interest Rate [Member]",
        "terseLabel": "US Treasury 5-Year Maturities Rate [Member]"
       }
      }
     },
     "localname": "USTreasuryFiveYearMaturitiesInterestRateMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_UnitedStatesSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States Subsidiary [Member]",
        "label": "United States Subsidiary [Member]",
        "terseLabel": "United States Subsidiary [Member]"
       }
      }
     },
     "localname": "UnitedStatesSubsidiaryMember",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aqb_WarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants [Abstract]",
        "label": "Warrants [Abstract]",
        "terseLabel": "Warrants [Abstract]"
       }
      }
     },
     "localname": "WarrantsAbstract",
     "nsuri": "http://www.sec.gov/20211231",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "C [A]",
        "terseLabel": "Canada [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sec.gov/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r110",
      "r224",
      "r228",
      "r233",
      "r433",
      "r434",
      "r437",
      "r438",
      "r483",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r110",
      "r224",
      "r228",
      "r233",
      "r433",
      "r434",
      "r437",
      "r438",
      "r483",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r238",
      "r272",
      "r354",
      "r357",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r518",
      "r572",
      "r574",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r238",
      "r272",
      "r354",
      "r357",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r518",
      "r572",
      "r574",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r238",
      "r272",
      "r310",
      "r354",
      "r357",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r518",
      "r572",
      "r574",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r238",
      "r272",
      "r310",
      "r354",
      "r357",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r518",
      "r572",
      "r574",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate And Accumulated Depreciation Name Of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r120",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r120",
      "r124",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario Unspecified [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r172",
      "r173",
      "r284",
      "r286",
      "r573",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r172",
      "r173",
      "r284",
      "r286",
      "r573",
      "r585",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r120",
      "r124",
      "r218",
      "r355",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r494",
      "r496",
      "r499",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r33",
      "r208"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r51",
      "r52",
      "r53",
      "r563",
      "r579",
      "r580"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r50",
      "r53",
      "r61",
      "r62",
      "r63",
      "r112",
      "r113",
      "r114",
      "r436",
      "r575",
      "r576",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19",
      "r397",
      "r486"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r394",
      "r395",
      "r396",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustment to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r360",
      "r391",
      "r399"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share-based Compensation Expense",
        "terseLabel": "Total share-based compensation",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r104",
      "r160",
      "r163",
      "r169",
      "r184",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r433",
      "r437",
      "r446",
      "r484",
      "r486",
      "r542",
      "r560"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r47",
      "r104",
      "r184",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r433",
      "r437",
      "r446",
      "r484",
      "r486"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r361",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building And Building Improvements [Member]",
        "terseLabel": "Building And Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalAdditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual obligation to increase property, plant and equipment either through construction or future purchases.",
        "label": "Capital Additions [Member]",
        "terseLabel": "Capital Addition Purchase Commitments [Member]"
       }
      }
     },
     "localname": "CapitalAdditionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r92",
      "r93",
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Property and equipment included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r30",
      "r486",
      "r582",
      "r583"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash in Canadian bank accounts"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r30",
      "r89"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "terseLabel": "Cash, cash equivalents, marketable securities and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r83",
      "r89",
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheet:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r83",
      "r447"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalent investment balance"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r102",
      "r104",
      "r125",
      "r129",
      "r130",
      "r132",
      "r134",
      "r139",
      "r140",
      "r141",
      "r184",
      "r224",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r270",
      "r271",
      "r273",
      "r274",
      "r446",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class Of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r282",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class Of Warrant Or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r43",
      "r217",
      "r546",
      "r567"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r219",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Issued shares of common stock"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "verboseLabel": "Outstanding shares of common stock"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18",
      "r486"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value, 80,000,000 shares authorized; 71,025,738 and 55,497,133 shares outstanding at December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common Stock, Voting Rights",
        "terseLabel": "Common stock, voting rights, number of votes per share"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r287",
      "r288",
      "r358",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Retirement Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRetirementPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Plan [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r56",
      "r58",
      "r59",
      "r68",
      "r550",
      "r569"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r174",
      "r443",
      "r444",
      "r581",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertainties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r150",
      "r443",
      "r445",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r148",
      "r149",
      "r174",
      "r443",
      "r444",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress [Member]",
        "terseLabel": "Construction In Process [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails",
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.",
        "label": "Credit Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk [Member]"
       }
      }
     },
     "localname": "CreditConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRisksAndUncertaintiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r101",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r252",
      "r259",
      "r260",
      "r262",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r103",
      "r110",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r265",
      "r266",
      "r267",
      "r268",
      "r459",
      "r543",
      "r544",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r235",
      "r265",
      "r266",
      "r457",
      "r459",
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Amount borrowed"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r40",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r41",
      "r238",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r42",
      "r103",
      "r110",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r265",
      "r266",
      "r267",
      "r268",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r42",
      "r557"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Monthly repayment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r42",
      "r103",
      "r110",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r261",
      "r265",
      "r266",
      "r267",
      "r268",
      "r277",
      "r278",
      "r279",
      "r280",
      "r456",
      "r457",
      "r459",
      "r460",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Loan term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r34",
      "r248",
      "r458"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "less: debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangibles and other"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r410"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r417",
      "r418"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r417",
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Foreign operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "auth_ref": [
      "r415",
      "r417",
      "r418"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "terseLabel": "Foreign research and development tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Employer contributions to retirement plan"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRetirementPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Contribution Plan Disclosure [Line Items]",
        "terseLabel": "Defined Contribution Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRetirementPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanTable": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan [Table]",
        "terseLabel": "Defined Contribution Plan [Table]"
       }
      }
     },
     "localname": "DefinedContributionPlanTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRetirementPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r87",
      "r206"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r87",
      "r158"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r177",
      "r311",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Domestic Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Bonds [Member]"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Country [Member]",
        "terseLabel": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "verboseLabel": "Basic and diluted net loss per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r447"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Accrued employee compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unearned share-based compensation earn period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options",
        "terseLabel": "Unearned share-based compensation expense in future periods"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r61",
      "r62",
      "r63",
      "r112",
      "r113",
      "r114",
      "r116",
      "r121",
      "r123",
      "r138",
      "r185",
      "r276",
      "r281",
      "r394",
      "r395",
      "r396",
      "r420",
      "r421",
      "r440",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r575",
      "r576",
      "r577",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r181",
      "r182",
      "r183",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r261",
      "r275",
      "r439",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Patents, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r199",
      "r200",
      "r203",
      "r204",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r199",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite Lived Intangible Assets Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Country [Member]",
        "terseLabel": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r352",
      "r353",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRetirementPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General And Administrative Expense [Member]",
        "terseLabel": "General And Administrative [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r205",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r106",
      "r424"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r66",
      "r160",
      "r162",
      "r165",
      "r168",
      "r170",
      "r539",
      "r548",
      "r552",
      "r570"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r106",
      "r424"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Operations and Comprehensive Loss [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r210",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r406",
      "r408",
      "r414",
      "r422",
      "r425",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r122",
      "r123",
      "r159",
      "r404",
      "r423",
      "r426",
      "r571"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Total income tax"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r402",
      "r403",
      "r408",
      "r409",
      "r413",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "US-Foreign rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "aqb_IncomeTaxExpenseBenefitBeforeValuationAllowance",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State and provincial income tax, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedSalaries": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in accrued salaries.",
        "label": "Increase (Decrease) in Accrued Salaries",
        "terseLabel": "Accrued employee compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedSalaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Potentially dilutive securities outstanding (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r97",
      "r202",
      "r521",
      "r522",
      "r523",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r198",
      "r201"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r64",
      "r157",
      "r455",
      "r458",
      "r551"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r72",
      "r256",
      "r264",
      "r267",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r82",
      "r84",
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid in cash"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryAdjustments": {
     "auth_ref": [
      "r46",
      "r195"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.",
        "label": "Inventory Adjustments",
        "negatedLabel": "Less inventory reserve",
        "terseLabel": "Inventory reserve"
       }
      }
     },
     "localname": "InventoryAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryNarrativeDetails",
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryNarrativeDetails",
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory, Gross",
        "terseLabel": "Total Inventory"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryNarrativeDetails",
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r45",
      "r486"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails",
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r46",
      "r98",
      "r137",
      "r195",
      "r196",
      "r197",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r180",
      "r540",
      "r555",
      "r584",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land [Member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due",
        "totalLabel": "Total Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesAlternateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r104",
      "r164",
      "r184",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r434",
      "r437",
      "r438",
      "r446",
      "r484",
      "r485"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r104",
      "r184",
      "r446",
      "r486",
      "r545",
      "r565"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r104",
      "r184",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r434",
      "r437",
      "r438",
      "r446",
      "r484",
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Loans Payable [Member]"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r15",
      "r249",
      "r263",
      "r265",
      "r266",
      "r544",
      "r561"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Year"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedLabel": "less: current portion",
        "terseLabel": "Current debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails",
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r110",
      "r222",
      "r254"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, Repayments of Principal after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r110",
      "r222",
      "r254"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r110",
      "r222",
      "r254"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r110",
      "r222",
      "r254"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r110",
      "r222",
      "r254"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r110",
      "r222",
      "r254"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtPrincipalPaymentsDueOnLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails",
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Amount",
        "terseLabel": "Commitments to purchase property, plant, and equipment"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of items purchased under a long-term purchase commitment.",
        "label": "Category of Item Purchased [Axis]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.",
        "label": "Long Term Purchase Commitment Category Of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased [Domain]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r42",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Longterm Debt Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Market Value"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r4",
      "r37"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r142",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Business and Organization"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureNatureOfBusinessAndOrganization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r83",
      "r85",
      "r88"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r54",
      "r57",
      "r63",
      "r67",
      "r88",
      "r104",
      "r115",
      "r117",
      "r118",
      "r119",
      "r120",
      "r122",
      "r123",
      "r131",
      "r160",
      "r162",
      "r165",
      "r168",
      "r170",
      "r184",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r441",
      "r446",
      "r549",
      "r568"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Restricted Stock Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r160",
      "r162",
      "r165",
      "r168",
      "r170"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Lease liability",
        "totalLabel": "Total leases",
        "verboseLabel": "Total leases"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails",
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfRemainingPaymentsUnderLeasesDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term leases",
        "verboseLabel": "Long-term lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseObligationsDetails",
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r468",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Lease payment"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r465"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right of use assets, net",
        "verboseLabel": "Right of use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r472",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r220",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.",
        "label": "Lessee, Operating Lease, Disclosure [Table Text Block]",
        "verboseLabel": "Summary of Lease Obligations"
       }
      }
     },
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Domestic operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Business and Organization [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r431",
      "r432",
      "r435"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r48",
      "r49",
      "r51"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized losses on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r55",
      "r58",
      "r431",
      "r432",
      "r435"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Total other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r38",
      "r486"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Expense",
        "negatedLabel": "Other non-cash charge"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r75",
      "r77"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payment of debt issuance costs",
        "terseLabel": "Loan settlement costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r176"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities, net"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r361",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Authorized shares of preferred stock"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r17",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Issued shares of preferred stock"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Outstanding shares of preferred stock"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r28",
      "r29"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from the issuance of common stock, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Proceeds from issuance or sale of equity"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Proceeds from the exercise of stock options and warrants"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfMachineryAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sale of machinery and equipment.",
        "label": "Proceeds from Sale of Machinery and Equipment",
        "terseLabel": "Proceeds from sale of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfMachineryAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r33",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails",
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r212",
      "r588",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r32",
      "r207"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment",
        "verboseLabel": "Gross property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails",
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails",
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r209",
      "r486",
      "r556",
      "r566"
     ],
     "calculation": {
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r31",
      "r209",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r11",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r11",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails",
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryNarrativeDetails",
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Public Utilities Inventory Type [Domain]",
        "terseLabel": "Inventory [Domain]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryNarrativeDetails",
      "http://www.sec.gov/role/DisclosureInventoryScheduleOfInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r335",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses incurred"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Agreement [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r335",
      "r477",
      "r480",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r475",
      "r476",
      "r478",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "verboseLabel": "Related Party Agreement"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRelatedPartyAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedTerseLabel": "Repayment of term debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r401",
      "r520",
      "r604"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research And Development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research [Member]",
        "terseLabel": "Research Tax Credit Carryforward [Member]"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r95",
      "r541",
      "r562"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r10",
      "r89",
      "r95",
      "r541",
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r281",
      "r397",
      "r486",
      "r564",
      "r578",
      "r580"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r112",
      "r113",
      "r114",
      "r116",
      "r121",
      "r123",
      "r185",
      "r394",
      "r395",
      "r396",
      "r420",
      "r421",
      "r440",
      "r575",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r353",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRetirementPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r353",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRetirementPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r99",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition, Policy [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r65",
      "r104",
      "r155",
      "r156",
      "r161",
      "r166",
      "r167",
      "r171",
      "r172",
      "r174",
      "r184",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r446",
      "r552"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Product revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stock Name Of Transaction [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares sold in public offering"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r42",
      "r110",
      "r265",
      "r267",
      "r277",
      "r278",
      "r279",
      "r280",
      "r456",
      "r457",
      "r460",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Principal Payments Due on Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r360",
      "r390",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityShareBasedCompensationCostsRecognizedOnFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r360",
      "r390",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]",
        "terseLabel": "Share-based Compensation Costs Recognized on Financial Statements"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Summary of Remaining Payments under Leases"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Components of Loss before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r25",
      "r26",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureInventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Terms and Conditions of Long-term Debt Outstanding"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r33",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentNarrativeDetails",
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureRelatedPartyAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r361",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]",
        "terseLabel": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r368",
      "r379",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Stock Option Grants Weighted Average Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r282",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Information About Outstanding Warrants"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt [Member]"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails",
      "http://www.sec.gov/role/DisclosureDebtTermsAndConditionsOfLongTermDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Compensation",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation [Abstract]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares authorized to grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares reserved for future issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Issued",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of stock options grants (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r370",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
        "terseLabel": "Information About Options Outstanding and Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r359",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityRestrictedStockActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r361",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options",
        "verboseLabel": "Number of options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options",
        "terseLabel": "Number of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Exercisable term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r385",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionGrantsWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Intrinsic value of exercisable options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of outstanding options"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining estimated life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r283",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r96",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r102",
      "r104",
      "r125",
      "r129",
      "r130",
      "r132",
      "r134",
      "r139",
      "r140",
      "r141",
      "r184",
      "r224",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r270",
      "r271",
      "r273",
      "r274",
      "r276",
      "r446",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOptionsOutstandingAndExercisableDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r44",
      "r61",
      "r62",
      "r63",
      "r112",
      "r113",
      "r114",
      "r116",
      "r121",
      "r123",
      "r138",
      "r185",
      "r276",
      "r281",
      "r394",
      "r395",
      "r396",
      "r420",
      "r421",
      "r440",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r575",
      "r576",
      "r577",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Balance Sheets [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements of Changes in Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r138",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Issuance of common stock for service (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r17",
      "r18",
      "r276",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, net of expenses (in shares)",
        "verboseLabel": "Issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Share based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r18",
      "r276",
      "r281",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "terseLabel": "Cashless exercise of options for common stock (in shares)",
        "verboseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityStockOptionActivityDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "terseLabel": "Issuance of common stock for service"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r17",
      "r18",
      "r276",
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock, net of expenses",
        "verboseLabel": "Value of equity subscription"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Share based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r44",
      "r276",
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Cashless exercise of options for common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r22",
      "r23",
      "r104",
      "r175",
      "r184",
      "r446",
      "r486"
     ],
     "calculation": {
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets",
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information and non-cash transactions:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Foreign research and development tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r178",
      "r179",
      "r181",
      "r182",
      "r183",
      "r261",
      "r275",
      "r439",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r109",
      "r311",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "U S Government Agencies Debt Securities [Member]",
        "terseLabel": "Government Bonds [Member]"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r151",
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityInformationAboutOutstandingWarrantsDetails",
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails",
      "http://www.sec.gov/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.",
        "label": "Warrants and Rights Outstanding, Maturity Date",
        "terseLabel": "Expiration date"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/DisclosureStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted average number of common shares - basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.sec.gov/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6283291-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 5))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r605": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r606": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r607": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r608": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r609": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r610": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r611": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r612": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r613": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r614": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r615": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r616": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r617": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r618": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r619": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r620": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r621": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r622": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r623": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>83
<FILENAME>0001603978-22-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001603978-22-000011-xbrl.zip
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M5:OO-,L\MTMDMM[YDXXTSS_^'U!+ P04    " #L16I4)0P><Q01   J_0
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MXA=,0N9^:_*SG$PL4'IVH8T-@F>D)C';%NVHE&M).J7MR(6FW'U(V7M\Q03
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MXCD"  [?-69DXB0//-^.)]/=,O8E".96Z]GQ\GPQ ,?Q%C]A5W[T9/NY9V?
M=VP!E[\\MK1Y470F&TM:57MV<%M/', QO7+-Z)D/Y*R/9H19^LG+!G99VC=H
MQ0M/N+LO>JY;-AIK:+AG![OK$&7/4MY+OC4<PTZ1%C^NDA:_H>Q_C) V [F6
ML:7.V))G1/09(8$]RJ#/?Z%3F5NO6[V[>XREA)VN[EGGBEB]3DUHN?D%X4QD
M:^@("MZZ(V>4=:V,J.K4A."X+J')6KC&!?3"<$UZG(^.#H^.8;C,F\=:Q#I
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M#)N"85,P; I ;PK$]B'&EMPLW'WLLS488[%I<5[,YSR^=[E[DCXCU$P1,'9
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MR\"WJ3S/BLVH"S[4<Y)+A$6!G>[2M)S%7,-')_=PC: PA)E+1]M4^,"UIFM
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MJ<&#.$ZC3M@N7A"2S9>KJH+(7(+IO8(F:2,<C\<G1[ LIXIPB?C31+#[F*0
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M-.0O5O>W4.3>B S"\B]$9?]'4M=;@V)*,0RBUN^!KY.TE[3C*#/;01M[+WC
M=?SZ0NWTO:3]#MRAMW=/1+1D/L,;?T7IZ[^EN _CK[!6 <XKBATT+IM3]*9
M3E&42!3U-^03#?E$0SY1[Q;C(9]HR"<JJE3;MT=WJXTRITA>OC^;_YKRBA2B
M@X?SD%LTY!;U506'.PK!!P2&.PJ'.PH;'-S#'855.![N*.R9B@YW% YW% YW
M%!85'I/6#-M^0'#3=Q2*>MK'\_$-3W-"P/9<25_:19I[<$_A<)'F/E^D6>QU
M/) *.ERD.5RDV?>,TN$BS8HBZ5;%]](1-5RDV?UM:<-%FL-%FB_B>K3A(DV
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M5B&3P!WT$NW*V];D5NMX,Z/+EOBT7:%U;T_V-G<HO..1W\.R>5XB>IWBBM(
M6U=N3! R&Z]($V!V.J54I9"P^CD%K,_[T4LFK?@@^-WV'^-5BLT0VJV"B>.6
MT8_*(JV^,_YMNW?\^_\#4$L#!!0    ( .Q%:E2YDQ %<V@  ,[Q!P 4
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MX)W0#!-U *T#VH@''-O]5MR18U776O<+[I&Z<S$ [])D@]-\=T> Y421Z+3
MAB[)R3O.FBR@PM,$?K-]EJ>'%;Q&2.P;(6Y\@9AYU@95#A;HP_"=<7U3/ K\
M304?U_ =&(LX"W]$Z;LEA?3HA8,WF!3[/GQZSF]7'TF_C*JSA#=='E#B9T2
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MH<M50+ DW1A-#WM=A*M_IH[[P6$?[(6!<-N/, ]/6MO;E#01I$_)IN3O</I
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MIW!U%-\W*;+A.WO_B?ZQ?%D94.^O7W: =?<L!?4@[QSTM)T0TZ[<O-14 FG
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M,342>WWE8YRWJYLD?B)]Q_4%7IJL6$HS@E(;<RIDZY3MN6"I20<\_<Q'B$_
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M()2J"_SR"D]=>O=T17=/IS$BV^I=.T#4-#JEA__I/P0G$]VT^1JP*^_*'),
MG^*F0TOV#VQ"P(C]/PI\#SRAX^$Y27-Z9\4U.UJU;E%$*P,@]-&>&K&[9I[;
M/>U4]<DL<%G/V! WBP/=6+!@8@[YA0>"RZD[5J.3LZ\I"[2N+]G,ZFM'*65I
M?6219G-"?JY(KR_'[,7=:])6QT\A*3B?CCO;O??^.TG/(R_+3K^$,OWI9@&4
M %F0(RI0A^RP),@&F&V8<5_%J]:UMW+*>+E#S"%B'M$GZE,QO',CLFJ*/GAK
M?)'0L5=WJB56YA)A*I(,HZS-Q&PB30GNN&A#LF@30XUZ19^XW\DG5*;A2:9*
M"QNBQKPGU\MI7^4]7B]Q*F%T/PTH66D%V+CH5DP 2Q+:BVY;D0MKZ!.W-WD@
M3X5NQ.@[C?,P"*,MW<Y37\-_^<6/M@$.KDA%IBOEV[S88K[_;N;9KMV HHL^
MK$=0RC "^:+.#.@.EFJ-083U7*%@&HE/A;@SF&A'KQT]&&2;0?2JQP>Z/'.(
MHQY[MK)@<*J[/Q4+"P<[\\6MC,K._'X:4$'?"E",\$8"6.'<7G3;6EM8<Z8S
M/Q6Z$:.O.C%:G^Y71J(J/:BHU (7(U2:&%:TZF'8UNWZE+5X;8,K<3P<[HYP
M[0,[2W,AJ,E_[0<T^=.O]_1&I99Q]/YO( *U%1 -RL8/, *PO<BVE8Y9&G!T
M9U[76IN*PU]AU;?#9F#O)V!UKB>I*VK=Q)(^$*H!!T1&T53>;%1<;"2-*UDZ
M,!&F!%K&6FLB.%&G+K[U\&'_\BL70M$9J).=J"O/^^TD?4]Y:A Q:PA:?C"N
M2@HC?DU!V%;M@Z-NE>FI!TE#(>;'UJ*Q8":Y%TT!\Y$Z1I'FN$DO&#N?4!P;
MY8ABS$]>-N'2<YC)-L[I_1(2?@RR@9)G4QI$G=;E@278QFCL=4QQ6)EZ8?>9
M3*WB@]-0H4V5:)W8J/HQPZMM=!.N9#)@F!64%'2APVP?:IT/EB1T0C3(3LH%
MXIX0=36U-(Q"1[%C;8&V''BD!#ZB2ES'?LKN%/6B\V2]3N+B=:\\3\/EEIUW
M>4P.;[ZN7RF0;4[KQ3 HA>F/2E%_CK<*2YUZQ&L;K$(1$"]#]5J?4 KZ[LA%
MN9>$7^0FO0%?*-W4<N< OW<)%</0BZ(=JG;C"(?J$N$!D6_"&&6LA-\ZH9?U
M%0]W:4*ZD_GNCK"0TZ=6?M^&&TH0N\Y!PGZ'[*"TKRLM[1>PJ//"TK'.J*RC
MJ3"_0,P!?W*G=%%<DC+Y5@,H;(QY6D=&Q-GND3A7[/LWRPE*/SJ0T3COH\\&
M2S6Z !HD1!:(^G%IC[Q<,(AKY39YLYSSB)-#,HSBI,XVDSAI 71LG!1A<MIH
M27B4.+)O?DPVE*KAT@;ZLVT8T2&$<M_N02)0:M .40S\9@I8,2XINVT%+LU-
MOD%D>GQC;J0O)4*]??X@%:@XE(!L;)5O)H$5B;+"VU9584#F2"Q.B=#ZKLW;
MU2KT\=4VC4-ZVZ@G-/RMT6::!T3L=2*@O&Y3F\&]N-3=MVD.R7IO%O. *A?[
M<RKCA'";/DV#?Q+XRFLW)Z@#IQU)&+'+\0M^#OT(J^_!.4@$0O34$,7^1C.%
M>[*FZFY(RFY;=TMSDX?J]/A&W8%("O><1,'U>I,F+WSI4!F2ZAR@XM, ?'/+
MH30YK,@U 7+4AFEJ&XG&G0EJ)Z$/?#RK>-] >BQK_W<0,2P%5A[#:OP((S[E
MQ;:MDN5+'5.'WY3(AHXN[XLZNO9^AQ-=;<"JZ!)_!!1=K<6VKH/<FAO1-1$R
M%Y:8;\(87^=XW7DGAI@11%QVI\)H?;G*!2.2+? ,M%&).D+,T^0]6R!DN* 7
MVI,U9CGGH1CJ<S4&V6:B&7T>(U%OPG#H5,VX;&PJ-G#-1F]';5H7WPP GK1,
MU1MF Z$ 76DH5^%,\K@7^[J%N$ZHAA< =#+1@MQKXT&Y,C<R&</J8$^]IW.J
M*'&>LD"Z#[/?5 =FI(E!**09Y,;S=JTIW5-#54](@\&VFC?,(FK7E=,M#@$>
M>$[R@31_;/7A9YP\I=[F.?2]2'*UIBHMB.@U ES.6TH3PHA=,PBV-5DT./4-
MG0_X:1]CZRD275HX55@'N*K"LH2 JK 6@FT5+BRC9E6>^ #(L) [0NT<MQGV
MOWM*7KYG%^>D.QZZQ7^PR&4Q6_SAU_/3/?"-'T!$XR$4&GKU7V'$64MYK7LX
MI#&8+'CZQ.'%7N"YM:AUT"G5GBM6YP 181W *T==4,\/FP#I<3CBVEGAPX&8
M[HRP.@?L.J\^$ZQ(#KS.]WCJ55KG'3GYZR;V,2,^Q4&8']"@W&BLRP,KZDT(
M:,2]*@.PR#>"8EW_F774-@OGR)YC=_%/V>;?:#9M*3/ BGTM=&6#?P-S<Y8!
MCCYGW&_<V8GE(O(Q(]W+GF7,\)]@1:\ IQ&GY._ (E(LL?T<2O8\>8#U!02%
M,6*30J$7HZ47_X8\G\TWN?$\ "TBW8KPXD7T)-%I?NZEZ2Z,GW[QHJUT*5Z7
M"5STZ2G8CTMY#G@1:X#EJ! 0["^01SJ2A0O$?+@0ZD,S@"O[1 ]><):S%:2E
M1VSZ;NS%>>^EOV%VZ6_]&K9J.XXJ/:CPUP(7(U^:&%;0ZV'8UO;:,A+>EG?I
MMM6K,"9!%WK1=9SE*=O(J5@)D:<&5<DUH/>>N6A+"JN"ZT#85N_*+JH-N[3L
M\9AZ<;8B+=YI'#S@]"7T23MVNVJA(Z,SN%G[3\IUDIY=@ JC(>@58Z]/^[ "
M=A#DME%>%89=;E05!]VN4)L 9&PU))/_[,H:D5,DVU(UHII^?/@Y><%IS)J/
M)TQ*B[,+O,SKGHUR=:E#=E JV)464>%,\\)2K\ZH;(/F(WI M2M4^D+46:/#
M[<BZU&C$"*2<)7'@V!581-3(F#_TSY-TD]!W 3NHB&E>4!+2B1!1/XPRPA*/
M;I!L Z3T@BHWSHK&.(34/#@H&/1!+IS2WM&=M\&I>A.+)"TH05 ";JY=MR2$
M%?!J"/;UN;2*F%EGPMD9N!//IM]H=J/H\H"*9R,"=#/K-S"WI9A!Z7F&_::O
M+1JM=URT03I=)VD>_@L'YTF6[U%AF@=$G>Y$0'FUA3:#>W5:=Z^%.:1>Z_8"
M54X0]3+1;1:O [WR#HOA*:BQ^DJLO0K9QSC%7D2]_GRX[&&<";24M5.@TK)F
MCGF(F013S_%<>T'4C4-R-D?\G06M9Q+VT!ZYZ\]"TVZ2;'_$89QI)IHF4F"F
M:33'W#2M@6FXF*9NG-2T&>#_D>./\9.7$T#3T;"'%[NQF;D->(<Q.A3!,X&K
MFUIQ3]RZSJ@,$\I33Y8.B%2WVWK$0+V.7T@SEJ2[\VV:DG^I-AK+TH(*525@
M,59;$\(*5C4$VSI<65V@PJXK=_ZY@W?,B\^WRRCT/^9AQ"2J*JUB*[4F"ZAX
M-H'?N.-<D1Y6=!LA.;K2N[2G6H98>Z.,4<995'OU_3+Z7/,(@1YO7.$N4.4#
MU9'AU*TS(U A:$(O>X-;I]"NPNSY.KY+$Q]G[=OQY*E 1+ &9#DKUI+$O=C4
M38.I0-C60FJ3!"$JK$[]UO6,("HGZ-W .<7(^$:S6Z@U(0@ITD-M'1#?P-P,
MI"A_#RWBC3M7TC@ =(HX/0W^>\N/\VLCM9D49JRVP&V-5B$=T'AM0W!\11:L
M3K=(-"C6&]JFAA5@4G2<ODQ^R<? GU6+TGYD@G$@'Y"(/X(0E'9(U?"C^L4]
MT="..@[+;MU#):8F'V' A*,>38R.R3KL+Y^>Z"GMJW0G#?Z6)& D0 :O%(+]
MW^')@12!;8VC!ME]!,3D1)HP*"8G%&)JA/:/D'K^;]Y3&#])Y>(P!1BUD("K
M7A%M_@Q/*V0 K%</2GM3=R+  U,_Z3DANBFF.GY.#[<22Q.!$!<UQ-:)#9;"
M/8DQFM)HEKV'G2G,H#-#^W[@/28YNY.H,#K9ZX3WV(LN,_H0(^D^G/JD!=E&
M=$+G F]2[(>L+;G F9^&&_K/VU7Y^*_D$<YC[8$(Z-Z(*U]"/,H8#)GH#Z9M
MR'WPUA@E*U0:G?IA4!,V:)EK&J3OAAYA:E8!IZ*K2ZRUV9E7F"D1VD88=8RX
M9S8:%7PCT3EBH7@KAJ(##YM.1MNA, VW!>D^B:+DS-M=>>F:3D$D:;Z-,?G#
M_^?E_C-63 2:YP0A*19DE#,!AMG<$PS=#$%78-8Z0?T@8A=13WSBBOMB?RR]
M33VO\$KI4,Y&P./$6BJO8_J:BG?Z^];SMU&^33$MBE0?-<G!B*()[%()56GA
MR9\1&OOY#&8<"=9YU9Y8Y&8-6BEEKB*W%JP/^//)6_+_WN,\#?W')%;JE3HU
M&+DR %VJE2(I/+$R 6,](,&?T<G;!;&.N'E$[#NA5@.C9K:GPJP4JR&!WSZ'
M29_BU-.*T'G";NSW:0"PW?E/J>S8C&$6$*+6!?[><ZO2].[)FVHER0B);647
MC1?G,YCYR:-\*O3NG4ZY2>*G1YRN[PBWSZ38]!+>D&VF/=N=>SE^2M+=[8IN
MTR]3!(H#X?;60,G%D:2)2F)I"I;(' O2.@(+VW3"EUI'E7F73J/+V9%PHSRB
M;F]M)B%H1)I9""I-S24$S4#:AB#UBZCC*O90[1I5 7I[&*".G(>?DK@WN82X
M!5))FTL/;IU[FS#WHM,@"&D_2#.DD"4&)4UJR,U7I]M2PA(6#0;[IIN9195=
M=\8,XP!N"WO'Q@[B8KV$K+TDH.*X#5[CX2KA=U@QVUIRVXHK&ILZ-@<#AKPX
M0!Z_RI[_ 7_9X#ASX_+%<C/+'4&:G\;!Y>_;<$,%0[6_6YL)5+":4="XPTJ9
M U9 &V*QC832_ (Q!RP8*A>.[!D?F *^AWQ3[AJC#.#2P\#07W"Z3"8%SZQ4
MX!=H0]TL3$EP8BKE=)ULX_TWC3ID R6&IC28S8+P/+ $T1C-0,-S[F5J31R<
M!7%HDB=H4U(!02I(D923$8T$L,+_ %HCT*M?@87T8;FM@Y=61U?F$\;'-6*4
MG6W#* CC)](G*?]YO2;J\(*9:"@#T#0OJ-CL1(@8MD89845T-TBV05&:9ON:
MJ_\0'3DC!1,0TI&'$:5#>F9Q$V'Z#WIP2)B0D0Z!)%SW:!Z4 /5-JZA1?=F&
M)6.]H[8-;-D1P 6JRL(ZXF)I%FAO<F?1G-T9YTK#1YTR.L,QNPO1$X@.5+/$
M3@CI!5[FUVPKVEKS,$][2E#RI@#;7+LY2 9+=%0 ;.OV@_^,@VW$SL?6\QO4
M$ZI=9:X\TN,R R-&]R]>&M+2W-.SU/*=F2W)0,6U#*88U/MI8$6TM/2VE;DT
MB*A%ES8\BDB5>QE;$X*MMO(=B(>IX%;=GK:_[55>1S8#.@#4^L3BQX?'%'O9
M-MU=A2_XG]A+WWMY\1[E=4R@XRRG99 >8NQL $2DVE-3'G7LEMN]R-:=?K3$
M9QL0'Q]0Z0]1AV]VQ".J7:+2)XN8B<Y&CLT)VB,%_5-%RN03FA-7FS^_V:?'
MD)6!;R&C)\*2* SHQ,%EG+.B2>[V4R0%(:LF<,M;PF3IW)/*-CDP0F"_P%X;
M1J7EJ2_3:T,KO2Y/F1AT56Z_\DZ>$G9U[JF[*ZG0#EQ)YR!HZ[[^N1=[]$Z4
MA^TR"\D_%%?-*9*"B$X3N&5/79;.O<C4]<FU2*RK:F$8U9:GOH=DCEB5/6?'
M (^\?Y=.N=,9=_K@L.:J@9:D(#3+!.[^WMS]=.YIEG+SG@K!\7MPJ=E%\8ZV
M._/<^Z"UY_9;$X.NT>I3]X<I8=?J'H]^UPN/O%8[,@$^(.+#2';I'/M-XL79
MG;>C4_7J;>-M"8'%L QJ,W[W4T&+76GY[6LQ,8D*FY/W)!T".F*</F!_F])-
M8LM<&:9MZ4!%J12H&*0'B6#%J+SXUAM\N$7>LKH2H9/#G&PSHF)\UYH05(3*
MH<IW(L(;V2G*;UM[]_;;N32D:Z*ECXDH!W6*Y("K\B%L>86NTT*NUBTH^JK<
M[$$:5X9W8Z%>F,*V7@&Y6"7TY#/MJ4J7/MK2@ A+)<!RL>,@@7L!J%OED$.P
MKH=7M_PV0FISZH6- >"MDO'A*=<RIO^$UA)RFM/30Z'/5DV\V\V&O8G#]W8\
MX=C?E<!^D"J,A0DP F1+3ZE/7?/#DR]KA+:A43I$W"-JN$3<IQ [/TPM@(X3
M-!H_2@4=GZ3SVU.AEOR;"0V3#<%NPAC3^V_-IA'$U""$UA"T?/Q5)75//LV'
M7X<@>IM:H*;9!<JJ"88I!E]38[8?>35@W..-MV,'-(F@9/?)SHORW1TFW)%V
M\VG_(+)-?A!Q;$U,-9KKDMF]6->.]*S@]38;43ED[5Y&_L!]HMKI5&/$UTZ,
M>G0Y*CLE]HT!]LDZ1%>>CY6772J2@Y!24]CR/E&=UCVA-.\4M:#H+>RI[7'N
ML#2XW'8PV-P,6B9IFGS&@8/!3(7,B)4B(>  %J$J;FHAJ2 ';:/\O84KM>K6
MZ*47G&SZ(5=BFRPRB[.ENPLO-[M-:2\#X$AM@RZ/6#$UY,AMQ=%;!)?6T<7P
M9]H[AG*OP"N<@1)G3Y,/8M'9 ?0DSI^UPPA9+A AVY&$]NF%UBSN!6^W204U
MJ+XFUQJ!7-S20!TY,7TP:PHZ3!0,PT./VC9(ET6\=.,AIV>1I?.P5@9 Z*,]
M-?(NCBJW>ZIIWN4QPM5;%ZAQ@\T"<8<.S#-.P$U%1>J*DI0ENN2OGE$N)#2U
MIP2E#0JPH@BT)(,5[2H 1U?=PNB"G4&8.G8'1=K+2X"MHYEJ08-H2Y@$MRLZ
M(]+2NY&E Q%U6J#E&*4UD7L1IQN5J&%8KTU5"W7<+'U1FQJ>:-PQ*Y#*D<4P
M2-G49UK!W3#;@\^7J#HU')YV:&5D HPNV=+3/JVBSP]/S:P1CC9N6!1BX<0,
MS"LFJ,/\S @L-898B[$%]C:.=G=BLV%,25M.X'(J)4.MH@?9YB*><F#]2P+U
MA>X:G2JG='+>7%A(8O^$5/@3BK_/'N<@L]AG7A9F#YL4>\%M+-['?V(T;Z?,
M#D)(;6F1SU_+\[HGJ>:SUP:H>M,0Y@MQ9R2.4.-1AZDGOT:CA;.052R\E"P<
M/XUMT+<Z3UYP[)'_];+G,X] \/'[, [7V_T==!VS@A %&SK:NU?R?.Z)0;?^
ME0&RW@2A]$7^1;RAPMT"%0Z=Z&.]'CXZ]+,&)*7F8,TM(I]RL>1>ICC ?GI]
M]7-*DMB?7S^P $8M+<DQ/KW>S Y/.VT!VD:'T=%LXA,QIZX>6)^$%'2-"EI@
M'%COFR1Z7KVJ&4[<"')R_(T@)S.45 D]G6\$.9FMJ,H0#BH@]5T/)V!N!)F&
MH-'XZ>=&D-Y(VKL1Q(2&X47VW?$B^V[&(OON2)%]-WN1W4<XDLB^ R.RTQ T
M&C_]B&QO).V)K D-UB+[7]MEDGL<VTT>2)54E@Z,7"J!EIK8F@B>\*EAV-9+
M;K4,76)W:OF:&4RE"KF#U5IJKNXNK[57\;8F B,R<HBEPARF@"<O"@RV%9&:
M=.<^WB$ HCMTB2; J%25 8#2#WD5QG0E8YS;>:_"-,NOO'1-@)YY\6^G<?"8
M;K-<+3,FF>#(CC$%E0QI<P"4)7-,UE%,7:#"!Z).$/&"F)LI3UFX -T-09N$
MB'_WUIN_%U0X?$4NWR<8^L6VP3WZ3/. 4,5.!,@WQ.UE<$\3S7?!R:#TMK.C
M=%#NG'5KMUO?\-E-$=&N/IKE1+S3YS,?BU<Y);3L)0$5S6WP]I^2+7^'%:NM
M);>MF\U'5(>.PR3W(E4<]@KMD7I#@1+6J.WK"J<I#HH!SWF2Y=D'+&]99:E!
M1:$&=+,U;4T**S9U((YK0;-LR\;*S.P"$<-#!>R/'&J,G^A!ND=]^SD,[ AG
MV4\LA%%8@O>I<2<B6E2KLUUYD]/IDO0C/-^D36W-!"J^S2B0M;N'.6!%NR&6
M?MKF!;H*,Y^T:/QRM/+>L$^EN\F?HAB8#0K;N; O4(8XJZYTR&Y7=VD8^^'&
MBZ[C#_A+_O@91R^8C0)D+\X<:Q.L:%@3*-.4S@;A2HX]U+X4J2Z!\.I#AI(5
MJDJ!PAC1<B!>$'ZKHZ+]'E^KQJ>1",L[>%)&!?CQ<]('H[6I^0K7'EW6>E78
MF;%,[2,<69U8?XKX!Z5)?7%&A.$'H%)$W,NNH+4V-G,Y$BD[3I"HI;E+4@/C
M)*)$2P!/EGKAC<C$GV *TQ7Y!GUQ6=B:MRR)A!VE2M30S$6I 7$*3:(% "=)
MO;!&].'/0!4I?.FMIU38FKDB"80=ITC$T-P5280XB2*1 L!3I#Y8(_KP%VB*
M=+HB9/8G2OOFYJI+K;192E/#UFS5J1WEF +ET1* U*A^N7M\QBEF9#@A5@_^
M,PZV$;Y=/3Q[*3XC90S.DS5]CX%M%S]-4X(3,T[.=G6:8CO@Z6<O#1[I%742
MGONT#TK.>B=6U+?>C,,2O/YAVT9Q61*J<<S/&_KW (FE06)QT'+72%C>DLO*
MA#ZQ4DV^:>'U\CNFXFZ761B$7KI[\!C5>>+_=OHEE.V&4*6'I8@ZX V%DR4&
MIEA:&-81XA7102VB3]2F(_6[!OK!6Y-_/I(HS3R?ANQ%LO;"_2-HG3+"JO'&
M5#2JOC87L!@PQW-4,-R6P4"]T/\2_*!/W-/T3>Q(9-3*H 5^Q.W1/CNR1WYX
M>[==1J%_NUIA,FQZDAX?-L@"(L*[P*]OB5:G=R^J];=#&R*RW^G/'2#J 7$7
MJ/0Q]64'HZ&?$KSFXF?'O[_]W0AXF6Y)KXW^8"AM!EG 2)LI_.I6!$UZ>-)F
MC,BV:I<.:-4^<4W:1D,_)7CU?0BN?_\11W3GD9=EMZM_>'2^);]-[\.GYUPQ
M8Z%*#T("C8&+PS9I8O?$3S5:T\.PK?',,AV8%+91DB)FW:79BU;XRFD+=0[X
M]5T^4:%(/H,ZW]-HG-?ZV[K6WU:UWI$IB>'1M\9\+_,2/47]'8%'IV,4C=I>
M$E!QW09/#&3Q=UB1VUIRV\I*C?')0X<:I!*AL@TZ2 2R>LI;FF8*F%6T)T45
M*JDC[<>$ .V?2'CW]N0OE[]OPWQW'=-WL<,73!W+'T3090 1<>;0J\<.E*G=
MBT3MTP9F>.PWH9[\!7'SJ+*/6)6>^LF"88&?3H]<_1B!P]]]Q-X$WZ)#W"AZ
MNOMI0"B;$J#8E6@D<$^_5#V)]J);1RS;&47-N=3=M=]X5K,3!T:=YH%<@0J7
M(>EN[&D9P ^LX!V4 >NM(M0A.M-LK3PKME86"9M;*P49H==:NS<\<9+XHJM0
M[$YU:2KL'F=Y&OHY#MC^H=8!D2XM* E4 A8UK#4A+!%20["MS+75<L_9Q!U^
MY^".V8$B0U\F:\6TOG9[N2(]J#C6 F_T1V2)8<6S'L;1"S?.[2\7H9HLS#83
M@JK2<J@MR[!"*EB56%'^HQ==3?= C[K2VC_2GG=[CS66EW6\;\(87Q-AD[99
M?1@&I03]4=EI5*ZU"DMI>L1[U(A;<YA1<Y:1%@:QTDPN:*^(4/NEQFW^G*3A
MO\@@A!9A7],D24"HDPI>M8"X][M[BJ%=,I0AL*VRC\\8Q5MVKH$TW'ZR7I/J
MZL4!VJ3%TQ$H8YZ05[FF53A_QJR*>_'NNZE6$?OFHC;((W2RR["'1E=\4>D'
MI]TW)WIM=V696(^2$U'CD.T!T64"H6?=*&AL4%+F<$_SE!N6S+!8[^^IZCRS
MORCB'M4NIN[5#$Q JRA 40+Z[%(G%:@R@%> )G1=]//4\"-_#T??4<_-NQCQ
M/0'G9@!&^NTVSW+220GCIPZL-7.!C_D6$G2!+V2!'_UM8/J6 ,&'BSK0)P6"
M+<<5X9P-4DP;?GEJ4 J@ =U8=&E/"BOB=2"L%R7X"+<1Y@M'FOJA,!^T\\4P
MW\F0_B7)B02Q@WC20]S2U%!#N@VT)*3%I&!#NA5$/R'-3?.3G),_7S<PY(Q#
M?N&04V9[(<S?DA](P&_(?[#8=R+4[]+$QSC(KD@LE \EWZ;\[C&^]5#: 3+(
M"$H S*EH=NQUN6#)0@<\]MU[[@)1_NOGN9,4E1?2<4=3R\7H5(0"%5E!!=90
M8;W:6)RSSR0/;TN2@(AH%;QRM7'_=_>B5+?:*$5@6QE+@^,]CBU;/)P!-.7R
MX;3X1NQ>5$#C@/>UA'F-\JGS"R^7O0G0(3L(8;*E1>QPF.9U3]!4W8[.J(Z.
M%+JJSEV)\XK5$R4[1-U-W049C9;++YLPY=NA B7NZ7>%MO=7C#.!$@HS"@QV
M:CK;R['8A=E7HRG=$#A])V%B!EP.?_V6T0]LQJ5XFD2_(VD(/W,0F>.)[F4'
MN<S)+*2L!_B3;8=>H _5U*9S.[,<Y;NQ43=/T!/MW<U*;5^\,*)/*%TEZ<\4
MW,#?I\7=J]1>&>U#2/"^K]>IQ%(6G!+DLI1HE:3H9[7:P%+F8?C/$/D_G+X0
M;BECJRT98^-J8MX)I3Z-F/7BZ,$!DV0D3_XIFU$SS@Q*1;M1TKCDRR@G+(7K
MB,EZ=WKI1O[N8N%J:LD9B9#')/<BOK9?D.$;C:E[(>$%I\O$"1H>) 0@K*L-
M(XKHY7H3)3N,'XC6ASYN9^1#$K_@C!#&VI^,?5_Q]_,DRS\D^3]Q?H_]Y"FN
MSH,Q2SS3;?Z,T\=G+[[=T"RR3513E@>4U$_^X<368[+"P&J0IJ?)>EFD*#DJ
MBBYMZDC?NRP_[XQGBV932(J.=CA'=>$7#6,\$V((4$X@H +#U(TGW(_W,<9>
M&I=;;14M$@KCLJ>_P6F8! K2Y]!&W3&09.!4_(FF.QG[\\L*\;4UTGZB49J@
MUA)\;7<,N)F^L:%E;FUQ>,'9U(90]-DV,<-\)X-VA?Q>-"5.M"36<V[L__N%
MT![&3YQ,63O1LPM0K< 0]/8R<=]B'Y:"#X)\P@EZ?H]44:Y"C:=67Z<XY@2]
M% 2Y)J%+/4O+?9;JG76<(]57Z,D^//'LD]@#Y>S#.$#9[!7VA)HI;$UU2#"=
M8/?R"T[],&,+O*38:W>4TJ8]*>9]V&IN=EUP] ],]SV37O\+3KTGS'ZD.YZO
MO##]Q8NVLH7.\4L!3W7'_TB]]&KMB@!0P2<@9T*=+TJ^X-M4,CHIRTN_0&7Y
M40& )V$G-!#%@!@()]H%0-^L8M4K6%U1*E^H;;J%B!UG1PDO&]^IF*%OR%<)
MDBCR4N$D^[>S:'>*QA177X!-,5W'>1K&6>@/V=@8NGY5+4R7S]%GLV+B]W6U
M)9T8<:$!J0HLMB%5>>?16(SR46K.JE:A; ]PX=^AV9DCV!2.58XB^"I_KTKE
MM<3W*>U29Z]+S_4TN"#BC4/9,Q/OX;Z 0K$3D]LS(<RH-UM .OG5)%&Y1#F4
M0WBJ/2CUO4S":[T!U.UA>7!!N(5BNBG<;GZ"%N7&PO1^HML-"J&W7<U=G6;9
M=EU2NL'TB=1?DHB8B<)\=R^_$&@<S_"T?)R/T4M?W-PM0'4?B9 )9;Z>;D="
M>=DJ+2LQJHN,[AVX00G"9ZFX>ZGLSD_G[\/LMZL4TW83DR^=CZ7R$K^O5^-5
M'V(PA6]S^HKU74F'@^I.RXMH@5%9XOF)^R#?A!&WHL2%)7&IX_?K'=<T7H0O
M88#C8.Q._)[?UROOJ@\Q> =>=/J*Y5U)AX/R7G5 RP+/3]T'^205;T')VR[$
MD4-+HC9372KV'G&Z[GUZW<0A/#T?E/I>IM>UW@ J^+ \N"S=C\K]WXY/KP__
M"2J>HG"%V3;&'?;2;!Y;%X7UY/LDBJZ2E/XX_.)UTQD\C1Z,\H%VK0B> &KS
M<!RXL.PIOMCYB182%:5T]1+QJ<FO+ZN<Q=KF(5D<X/ ?I?+S6@6X2?1 VLN=
MO%K9W8/OF.*65]\.++7\//IE'(PDMSV1WB *\R9JZ47J&VU[).PA]](<,&5+
M_!3&L1%K@%JJYG&SG],DDUU..8RG5]5:*<@>[DPL<_.Z6BP5 2ZT68=G6UD9
MH0\1AJ!]E%?@#:Y-=I$;9G,F9Z_J6S$JD@;Z$NV>7E4[I""[WT.T!VY>5SND
M(L"%=D@H7]T8#:6U/W*^8_Q$;Y\?]E1L_[0SF[/1VNI$P:"S4VU^7IG.2H@>
MX*J"VLEKTU@9?#<45C@&-<KLU%AW#O1(N&!Q%OHJ3!OMW=]3WM=PEX8^ILLH
MJ[$6:<T+\JH4VOY3#;3 8%B*UZ7Q1_#C0B/0F$8^N,6LA( 8!O>?G7;YJQU<
M9E9>4(,VU-5K:EVF_:A?VQ'E1YF@\?C:8JA(@=9,S&R)>]!O])H6OL<C$NAR
M>';,]:N]-+"]EF!>C6S_'Z=30]N?^YDUM@,0,V2#F_5XQ_2HS>[Q0S*'OA2H
MU6D=;P<7K4[1,G0MQ.MJ'*P^4:_M0Z<2O+(FPHX;)UJ)UHNDY]Y0C/N]2FNS
M:2T.-B!,TUYT+<9K:S&L/E//;4:G,KRZ5L..'4?:C9;=5:^AY1CWF\UT9]8$
M:SOFWN?53O3[40;:V_6*6H6>27%A;:>Q#PQZ"^#(]YG-MK'+W[=AOKN.LSS=
MLA;V-G_&Z>.S%Q>,5J_>#WBOAVTA7D=3<-0GZJ5%L"K!*VD8CN-FPO:!%QP)
M)4>LZ"@G9:];CZKXY1YB>E\&,YO-Y9:1"3\A\"M'S)D;YK"'A?^O;8;JPXS<
M7+RJ0R/6M !L)$#O$1O]0UW.:6/8Z.R=P=P-9LU?<Q_%Z)_OP/W7%E7Q6<9I
M4)N^O[:G2E;<;T[W]X;-=V35\R<"M>_+FK1?6.LY60-PX/YK Z#X+.,T $W?
M7QL )2ON-P"\X+.X%V7LC\3-S;P%J(90>XM<K/V[(-^RNL[>B56;CJ7\VIX<
M_Y%'GLCK4L2OK5,?Y+G?B F3@@>[#AA&1$&*[XK,X/X!1[_ZP>4$3^P#!/0#
MK.@'>%$_CO[*6DV':\77]M'^<[K6*'YM":T9FV'S]TK6S(;_QJ]T.6UX8E_W
M2IM[O8;NY?O:=3CFPTZQF/>U$S$P;>[W) RNBIBB0^',LN'PW_HUKBNZU]QU
M+]_7YNZ8#SO%TN77YFY@VMQO[O87/[\V=V-_ZSFLH1;4727I"H?Y-L6#[9A4
M>GH=+9">[#Y/)K>X>26M@@$!+IPX%LHWBSTL ])>V(2BMKH+.%HHFN+VH>[%
MF)=.#_29>KU]J&,99J;P0[$SI/P;WS[4JO_P[YYP[9LYUG;XSSC81OAVU4XD
M^VMVNLV?DS3\%PX^Q@%.'_+$_XW3=T=8( PWW^>@U#_26S9DWVQHI[#:A5$^
M0:,5&-0C,,T?APMKA2^*5]W?T*+VB_)FA[J4:$N+B5@Y"X5'K*0+VAKL/2#$
MBHL^L0)/OX?OZ_<P_!XFK83W^Y(I_\F[0O?)'WYM<',;X_>XY98'94(0^JJ'
M2C51GLH]'0L2GTTULEIF_+UZNVNWJ)[$,/K$30^M%FW"/4N@4ED<$.T?3[[[
MV]_0&_3'=]_]^>W0,O/X.3&3&3$A3)DY@-HJ,U4JX#)SB*.GZ".&G9*9.0 U
MEYG^T/[QA^]^>$MEYB_?_?7=X#)#$AKV9YI)@4K-(=QVL:G309>;%B1]Q2$U
M[9;DS 1L!]GI$?$?_TKZ-51X3MY^][?!.SA7A!4SX6FDA*D[AV!;9:=.!EQU
M6H#T%(?4LE.:,P^HYHK3(]X_GOSINW=,<=[]\-V?CE2<0=>&C2;1#J?0;L(8
M7^=XG75:B^G!&0B5'(=R_6KNL9[<T^KN:[:]<=#WRFRWN>'VB6%:2L2*.?UL
M_5?VG5#X94^?0'BPN5@>5ZV%5R<+S_C!PA-5+7&GB/!:$W>X:V^#'"D?P);+
M->;<4]P%$K#5NY4@;$N:R\<]N(<&EUQOV'=*5B@1OE'"R^A.Z]A7!X5??7V[
M.OP>8W2/E-[AM6GC?93!ADQRUP!;HA%)<;&1J9_):6ENG&A- 'R@FL2B#1#;
M!7?:@]':Y7N\]D+:%)\G,;LB;^M%CSA=OW.BUZ J';SVQ G:)AX>28L&L#UR
MB#07VRNS05&%#0G@$$7G1),V@V]\,#9**\IQEH=K>KP11>$*HV_"&.VPEV;?
MNM,2]MVG$%Y8G6!DU.H=7DLVWD<9?&1TZ!I@2S0B*2ZV-'6G7BCX2",CHJG+
M9(*QT0"?Z'!LA%U[CKHZ>G.YWD3)#N,'G+X0:B1G+"-6&/*OV]4]]I.GF!+-
M3U">)UF>F1T![-<7++4?DO#V W\].@*FY(-2T,=QLK)<J"B8XGQ973J:L2Y?
M<6@;L1*Z=Z+O*_,3J/IU["=K_)"3@0C=[WA3%/_T2RCKFZMS@%)8 _"B3BJ2
MPU([$R"VD<-MH\HX*JVC3]2^T[7^(J&#\VZD57GF4/.;!!C4?9YA%K5_#\H
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M:)$4U/#:PUPCP;?C0M,[5<P@&Y,-<#I8,A?&%QQ^\:)M]?S 9R_V]X=4=A9
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MP.7&#%NOBO/8?I+;G0-$(Y,$^WCW 5EW*971?'='Z,A/X^#R]VW(<)BRK3(
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ML-*,2)<7UMX7*+AF)LL'[C_5,X95O(ZBXZ<DE* $9J(;$P]"]4/<YJJK[IG
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MLT$:/B<O/C3_C><'O$*O3,(I\O_)!'Q7#;)+>$"8W;J&UV_R86*NXS]$2E*
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M&5)5U:W^AZ>O<0>\&HI=H1E0R<>'"IX!R8('D$A#H4U0)[D)XH\WK,M>J.S
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M661H"3YZI35O1%EQ?!(]#,AW5IMPTM^8=UAE/'U'QCORSW2LP(S<;8)$6P[
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MHUHQ)V$EQ!T>F$#9GU7X4#00J(B)CE/T='JES3%:\*%HR&A@2#.)ATP:I45
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M\'?R6'B*>Y%@"])CIR2>'/ SJ-1@ D=#S5Y)?L<;,W'UG0G"\AJ6'IO5LNH
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M0!MFK;<TD]$_0I/*?_Q_4$L#!!0    ( .Q%:E3L/U[E49$" %KV*0 4
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M.\S   ,8AZ;FMQ5'TPV@J,=T3].9WO6V2KE=LQ6<MMVQVPX%K-GH:NE@)NA
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M6^NE%1*EO%_+&C>A^N"R-5Y%W@.UP/MW!R ./[([%L8CO'1_I/T*\Y/8D+;
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M: P6=EDM->K@0U-6]"!$_ :75+HRKV54KE"(:_>-2N[*M*4K(U&W55=&](7
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M+AMEPF'TIU!:AO=X>B5,K#_@!C)@'"0Q+?.(G2 N,TS@C?5<]B5)*"(%6C*
M9(!7LJD3Q@\*(#<DS$WR("/?V1C33=,XBE@HP2G!N5WI7.P'E@*X2+DN\I>H
M^U<>%&?9>+)S=,?2C.^Y2*1*I#9B?[L\ D6\/.'I3.7!K/L@#/FAJ8@P,(;[
MW"[@!\OX?B"BG=?HX$_XGWPX2C.:9.027E4>7\5BLDF6CU+2 T>R'BO\G\L/
M-_AE&2*4["#98<OL4)[NJ?$"/TZ9XCF;V034<H\F82#1$W$^1*2E@FGLB9S
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MVP -L^7VBY=W++D+V/U^$K/1ZKJ908<-;($_3-IS[!Y%RX,&Y#Y.0A[D+(Z
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M+R+EL43>,PR&J6AV5TV+\)9+,W< =XLNW7PT93,.4"\.R^[QD5T+]*%0OI/
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MWT^ /DZ1VOR#RWM,?O@;O+W(F2Q] 'Z(#\<$?]BUS1C]>/%N3''0XXZ&N6C
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MDXZQ,GF^HAB<PGEWFA,\+< C<]'(@/^+:;,>7+#U?CQCT!+@0GH2 !H9ZHK
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MB=+)\GPDRS, 7 ON"1!C]']J H"+(P J XN/T@0G_;$1TUM+BTBW:0&F9]D
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MQB0(;;NFAMY;6K*6',6WKILE9?%C7^2%<0@&,;9%Z=X5FJK:DZJTNG!<1].
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M69E&!+G[P1> XIO31>>,+&%2E7E?E+DU3D4JIC3GT-TC7XC\$Q9#'2;R10"
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M49)'Y*F!YD0)B:LXO@ G?*1H+9H7:-?%S* %FN9@)4LN2L2K*JHPD:3TJ.2
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MSZ#G2H8B<:[%SUP=$":@79RYE;OAJP2 &^>RR9W10%]C."F7^]0V64D*'Q7
MQ#?^:^V;IY.L+\O!*$(03][5?3I/IQ#I1'>-AY=HZ4B3$Q3C!Y2(YK9U_W Z
M 8?),&3@.$  GH'NRD!XX.63"WL4J&2UK),OA!42)!W"KPZ8JJ/"TVZB,NU"
M7K'U"3REH8TH^H L#=#26X&]HI:9LP"[9#C2.ZMA(4;#71 /8B1[ LZJ[QIE
M9NG25@E9<'+W#05PGK.VKT"E=Z"2-[.>FC <'45>Y ,";\E?KIV,1%K@6(&Z
MK(63K: A5!D@NKVSWB5+:*T!I(P2H6M H*(<I*4;1_G2 EC-O."\DQ&Y.64@
M*I"]%=RF4&Y$F6%:DD@Y.;FH+!N[I@P87,]^R';M/=.@Q)%A*7C2N01%5UE0
M%=W2TI+, 5>69PO'S[B/VZ=FTE_5GXC9A6_#>I6*YVY@'H1T=M\8S?5G%ZAI
M[Q%;OE#Z1/+IBES+T_3=3N'F=*5F_S*P;%PN:N62Y6N4*J5UR S@K34=M_TM
M&&4K]!VR^+NBD@XPVBLVE2,&GWE?,!#X-B(H\LE*/E:W+#4R((X-0 #>4I:8
ML3$>;DB+1)F6-&YZ-6Y$M(P_\?WL&IIYY=KQF#U4A9QBA)L<ZGFZ3I?.)!T:
MM^F[-&  4R;^E@VDY6SZQZ(08A5-[(>Z1GSY'8DG ]NI$M=0WLDS)]D6&RRC
M.3U_?N0%\,EW^&/X#@.JL4,I3S:Z+:H/XX9 *4%LDW93%^7,:A0LP[0N8.GR
M&9<FZ,<-8V38;N#HIE^N :*?NQ)GRS7])7<MS4[J,4-V9]F!P:N/VPZ4R3_W
M#:^!B2G5[\^,M39FDK5;#).X9:TL<8,K]M6 &RKZ-@ZBU.0,M%QWGKQ!)CD=
M/X4*5 T?90?H/)M,V+'MR3^("?O%?;)' .GY?B<$20=6@@/W-:KAO(.E=5 W
M2RCVCU@!(D&.P@U8'I3#+6 >]@@M'O?>^$U?]K1!CF*#O/>@!R*'UKT<5^CF
MY" >"*"T*@*') 5.^9E0)Z;DC(/>@]GAJ[RG(W0[!H[D>W?7@*]#6EQ34QW5
M&Q7@1H0?P'OH/'G5<<J"CK>",P(K)5F) A?9?C]OF\M!/@.H!I&B/#."!6$P
M!^1CYE$5]+M5CRY%US0U,BJ<:Y?HAR9W09\&BI>N9GPH<I>9/Y8#N[A#H;>1
M]B4PADB'(JC8!R>\\=OZI(H7G]W6&KHQWV-=4A@E7<Q!^?7F0Z9@)LCO81$Y
ME:A7$=6QS;.R<GBF& ]EOU/RA\!;DL?74"I*AM)(?Y<T3N,ERN//E$/7B&]B
M3^6#[&MR@MG7/Y(Y/:8&D+M\BVNR4GT'8$?LFVL&8KB!RQ1.Q"+9"1>099TE
MBQ[J8O6[[1)RS6ZY;&>159#=_]8))E-[2="H[4(&-5:*'H<2XKDX3OJYH=26
MY&E#Z! % 9PAKD EY1\'%F1@$69LND%LI+<)+-N*^#=%"(E0WA-AQ \QCC9F
M.P'/H=!#JG/R_T]TH4^&X,@ZP:Z%)X6/5/ ]5*5Z0Y[]ZKJ<IR#,\&)\6,+?
M- 5\E:]RI)Z35RT<K%GRG/Z>IR)85+&CT9B:BA&S[)H-IB( E$LPHI8K561K
M9$>R1LG6BFK1I)+Z4*T7H%@CO\YK""Z,1X_+0*E2BPR3&UP_-1>"G45O4K@%
M*<9IB]$A.VGV4RAH(B/J"AYK;$>9X>'JV2+F"M%4C#E<_ADK)8H@+PZ5&)JJ
M 2W>R)2JNQ5YDWK=-"+?'OA$,L<VXR&I%5&<T$06"R=LXL,7J$UG S]N3N=#
MO_%*B_RZQ-WD;R_ :YXYG0*S[U*&[HWU9FS?-2_']0^KM@@B6&M9S,3.U:)1
MZNF7'@<G" R>S.TQFMOOG21-17 K:ATAUVF7KG_NN"G"BLD@9ORP/DWVQ(2H
M1VRRV;9_5]Q4RCKW4OR--H%Z'A*0K5*6KPIZ6,6.,I\VLXB."6Y(']';L4@
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MFDF]*:K"Q$<&WI"T*"C9D&JJWW:KZ2RX]V?!+YF?X^'0&9%_L:S!V:ZLP5
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MG'Z_+.LY;3K)W$N'1%.-^NIW.MYMLV#\==^*Q,MZ@*=#AI0.-)PJ VKG70H
M_C4 <U5[[#OE#[Q)+GZ'J3D*_/2739T:\XM?J0<V3+2I$CXC(M+__1OIKLKV
MGJT2TZ!(3_NP+Q,'2MI@9W*)T+/!S&P3D4/ B<D!&<K>/4Q;MHU8X@#?Y6Q+
MT+(SKVZ8E+ GC.X^R.=R*[=0P*]<V;F&@>DE\Y>0PT)?PE- ;52G5"EH<KZ7
M?P/:E ^54\Y3C"80J:.Z>;NH&V8!$8_I)R\X&!JU]36:,Q.RKEJ3U/<&V2RX
M)NRI0C,Q>O_U;=7U334P7QZX'M@56!86D\J9'5TU3J92EF#LD9*SLH:W9 \\
M3(J#=_]\%P0T;?C?!5LU3>MO,*U_WV__RN*M.V" M,FPBN+3.*N+^DOI-W"F
MG:?IG#UQ;WLMP&)2)FNY]?1+VN@^;,?DG#-Y]6M\PE5+CC1$P4'"@]VA<M<C
MBG=2<S4IA:1+WSKNW*0?-K2MM?S'%D"4MN+H5$ ?,PY$L.1P$(A1D1^8ZR(8
MA)A<5DJX,'G0^?/:@4)/)G6G7'A'6@.7M!:Q2[^!?H?3U;Y]1BZXM\?!RV9X
MEI"QFO; 8K;2*<3&'%D+<>@04)M(\[-!%W1<X/2V\ED<+T9P,=%Z]O70OF5J
M@_S9""F3T)+CUFE4<%OMU15MP^#0HC>;HU93/>2/R</R:=/204B+-I]IUB"Z
MOK1X[[MZ,-V!4DXHI=NNZ'KMQY52 C^_S*K/J>!(3'L(B>D8%DP(HX2N5C/'
M]?.FWGC9S4!5)>'V[M!"39KG3I9&(+,:M!\+4DA+[-%CZR-%)1"_,4S%#,1J
MX.$)JYU>M"P);HKQC&NABWC4^WRXFX>S&7Z#Z0CVQ"2V1$%@5D"+F*GV\C6J
M]5TC-5ROW1*8<FO/&,::+(U#HW>Y]2QW U(]/LQ]JH3>V6(Q;.E*R3T8\.RV
M]+WH+;!I*."7P9+ Y:M1Z0GKW1 !:2"U;8WEI_-ZSGW'('SK)KHIFO[3Q4XG
M>Z9-KL+OP^DQ1 &]9SL;*"56<XR(#^-\1L1=T"*I-R*(#O3.P5R/TB%Q:+*'
MK5,"&#JGYWS.Q&"3#<P.$L?,F(%G>OGB.N*;BCDT-N3>TX-,S6Q'W(-Q9S/;
MX_N4ICJ!ES$ULTW-;%,SV]3,-CE7[YWM'796<3]\8C66J&%@,B,!HD ;?[N)
MZK_K]*WSJ.)6\A!@P$I;!GN/ LK.H8>$Q4.55C40@5MDC\C)L@L1OQI[>Y)1
M:3NW:86"*V^,%,0\N84F?!J*J3GP,4=MH+3K/">G1;0:%S;M3B9#TTK[LB ^
MU<*^)7^14QU*I)NJ8$+("VNU']4L@>5Y?)$E0G:)T ;5>AE+N#& " %5$<B]
M(LY8!3RX!<7AW8"EE097]>'>(V**3LDJ"H:O#RK_DD)#)J)R#,$7KIBHKMZ7
MI>9^&F?<,8RP*&A]MT-*7P%3,I5,ST)8V5MVOD4\QG%[@1'[@YO7W7#2KDUD
MH5*P3@O.E%>4UR[-5OPY(*R'#ZED<#2 R]G5Q05-!GQZ^HX\LZS&9LV+)*\9
M?2[S$MAT^>;<69#D@;:DHH,EZ6Z1JD2/1[<Z_9A[JEP>K:7_WOFV&]8W$) 0
MDQ4BQRD+O<W(*FI&$)3) EA.F2+)FQ)_.+2KOD.]RQJ@XM!8^G*8"M!W+P;4
ML:0+1X7'VSCUN&D*>I#"A^1R9NS) JYC2JA1AG>,]-R3D_R/__/%U>639VTT
M2DE11LG-UH'\&5:G:"51KS3F2#"P=3G8L!F3-*KI-\@XIR_)FB^T]) &^:GW
M5B &*>2@6.W+OYPWV#G)9CO4G#7727$VCW6N9W'6)'KYTDNE9>#! A#/85#_
MCANO]+4(WW#K@>1,OL[M7[-Q^L2\C0&PW+_UJM("@KXQ4ZAHXZ6MA7(/UHKN
M*A+D\KZB5::CB.1)C&)SI&(16+QW<2E>03+DH!KH2(X:VD:GL'DO7'N(YO'D
M3XTCB#&F:?VMVX%X3S92\8LJ3X:B%]'4;*!J+^(/&H$4]0@NR289/>MI5;BX
M( @Z-=K!BJW8V67[55B2**WL>Y>@FT,+ ;(T/;<>>@VH+-V03UMZ?24I3$5=
M ?YYX(UC \LG%)(+-[1:I#>UZM@ZUF#:7ST>'"ST<HN<'L[1T]VX@+8AUQ*E
M992A!&XM_:I[TM>^&5(10\LF7;?B(@>9*3VIAR@=N7*JA'4EE%NM9,H'H#@2
M CB&!V$-6J&E: @,-/;L9.DPBLT*![/T;.EK4MCT,_FA;SQ:/3ZQG^T#!D6Q
MJT:KOG7;JI\VOSAJU=*"]<_*[#9201+P40KLCV+3P;R'0P'G"ZOL9F_/Y.33
MR_^[XHK?&P0^-'?/TRK-TUA!PD,.GNW"EAAO[$7Y@N5_%MZW2>]52K?HG](P
M!3]O$/'L2+]KB)SU+4S@RB,-44X*@2S:-U7H[F!SY55:YK3@%T7(@E0TG!CU
M,6R[D'Y^9NHW4\7Y@M-\4]-*/K+>K)<:Q46+=.OQ4/.^*/?%.(A]N]$>P#:0
M@&8+_ME"UC0.UP*0KWSIF(PG6OEIA#,YM N0.!3II,,W7G 4&X;/KI$1!N&L
M&8'48G2+LQ2RE+OC(85ZM](!K0MX&)5V_Z@/ \8/G(="E][A*L*3K$'R4!Y1
M;R.X)&TX]U<^.*]MMG(0N:=8N*_B5/,VUKR=^8#VEN,V31Y:ME;2$7>:IMG0
M"?,1:!1R&C9YE-%EE<GA6]#6^#86D9R9SP<G3#A?E(W"#^S61HM.^R@MHFH^
MTH0OTHT;XV#1Q+R_<]&R0^P8>\Y@A5L/\,O#9 !FN8@RI(J0/#C!DTF>3/)'
MH"6L\IYV_S96-03M4-16X=*F$H(8QZVSG!O2/.&B[-'<*HZVRJ?4><$B<1S0
M>GW9:3E/R_EC>!C?-#59]A&8W6.(=;$7@^RJ[X!1RSY:Q&$-:W(!O@24%5RC
M20;Z/1IS*M7_:<@W+RI/\:4[(>7L ?(:W!H^WWKEQB@CK^+.FCSPV\OQQRGD
M_,!6)%\06 ]T?@/VV%(7DMWA.N18KC>5<B3=N-_@F1]>_'F ";>>=\TEFUH"
M8"#:6C13"*^T)M.UH'-T5O==DFVS4J0[+7MDPXIK).$F(N#-&GP<@^M0HPD,
M?0[RSJRN.D4VD]WY..R^M]PU[Y*W;@LGF[9J!61KJ$+A#RP-STCU^#/*UQ0<
M=_+L66A-5K;$"J' %%^]\S47D",,"5BT?X]3FYQ \TW%A]H>K=8R4*2?QR,3
MK;;&OB0PD=LJ8"].<SE-V^W(CGF0O+1]QM(ZDJ1O8](+$[5TOGK(*=RY1TQ)
MF:5&N&7]6I+_Q2[U32U2@/"T&M56-K%#T.ZCVK"G9[ZLKZP>T59F+#SOY#WW
M0>V:5:0MP<SA.CI=I,;<(<2VN-07?1<C$+Y8 N--Z14YKSO5TO2Q>3#6C4 G
MRA5:E_4,7QHSEG'3CUMNN?EFC\3U[J.R4N6B(/\B/*IU.&D])> -0)8#D)<7
MW4;5A:X5+N(-7Y*NX4^D]">4H7HPL@[*87%&/_QVU)4NC<[O8:+SM_3]39%@
MI@XM2SVH(X($",X+R#VKZMF-Q8>+?!M#8B'&LC(&:CC"],.5J+DDF92V%*F/
M5=$,>?0 50 3GFG$>W<W&A3-/K33=2:B"<1?OJ:=LDJN:7W0(YU'*26\Z-%;
MGLGX9O$9)9 N>^HP=0PNXWP3<_7$:ZKF_%S!5$IZWD2CY7XP51IM^7[=H"EE
M+PU E#OTJ#UQ@$,YT@NP%U$><9&V*U7\]#JETI'F$7TZ]=&K&^2S&G9)F9BH
M5^E:D0T]<-Q:L9'S6V%=#1C*AS>Q1![WN-X4>8^,88R\K!MY,>+3?WO]9O=5
M!UR&^?#[QJ0!2R1Z/9K</4Z*5D';MP5(@I.64UDT=2.^U:DWY\@@Y7?VYCRY
M3R[+";R,J3=GZLV9>G.FWIQ[,/.?9HZ?CP*$V/V)G"9VW6:1$[(3%#!O17!3
M.5RJ ,6M^S;"T7'HF*6!N<0:D-6KBS@I!,[&Y 8?X"XQH"K<GWN%,K?I(@3<
M?3I[IW3*$6^IN[*7XR8 -/,@VBE:CR"4<,)R_\SF.2W.>[TX[QFK\W,CP&K<
M,FURZR!#TJR N8PD?$1X"[:6+?H!3G.AH7':QP,R(5[4+-.RWB"37[HE%!2Z
M0DDS(G:*(:T%M-Z%W@*8$MT](\Q*ZX7-(^ZD:W*YWZ9*R><JJ=F-*3,.[4ZO
M8A2U?"H%(D!1ONN/^96KK3U?#:@*JY*CV[&+D(3,K..357JW01:B83&:15R,
MT*NF>4WA1TL''_)B0T+" 5"(KK<JYD6G:<Z4>P$/,\]S5@DOPZ9N2!@T'KRF
M[R13U<O#C)]@+Q0X9BMFF,]Q&[>)8OA#)NGR\7%9N%]X!N]A33>^JB!!PJI5
M2@5L,BV1E(KBAO_*N7DL\"$5G#12'_F:_U6O\X^RYB^.;,W?/9EOAHM=F>]G
M42Z\9*(J5+04TUEOP&?@TK,,[(O^&\A6W_0ECD0U_[973#[/8^>9DF!=M"T?
MS*&-UA--X>=JJ K(+3$_I$@I)E8QT7M+D=#3VP96!2]Q4*N@61R<*L>_2OQ%
M@&$FA,"$H#RQ[ELF->R;T:;F&I^X)D:>&=R*&PHCN0^'(U>:.=3&BJSUS5'5
M3)6EA$U 9:6*2G!0L\&]6+/)FXW\OAB+7[4/_BC&XM@.R/?0W)6=)[40 @N!
M9 N;;%/?WN%$AJ+GC'O*7&[-7;R]!TP=>O6VT[HK.= LU\C.I'<X=X[BP$D9
MTU'2UFL=[5]D@3S-K>J(164]+G[GTD00*9^LZ:]+X/^\,3/*V[Y3E5*U(%4M
MK0%!;!@^O[^CU9 O+R[^'&K,1[Z'IP/_]TES?*16Z+O<W6\M0F0=4%KN8.JU
M?8'4)YT[@*$O&R=P.>15+:P<IU:5_G$?6.4D>]M.DU?FOB_W]P/6]JUKAA6]
M+!IRLEZJT_=E6DG3_W>-N']"/+5&9S(\LL\>TKE0EH70Q71,%F*964&VI'&*
M:K##^&38J4_$,%4,"!AM_I J8XIT,;,_^\1/0<?5G$XXWT%?%BS>38^P=*I#
MJAW55DCQ9"?<X^Z'O$J9=$OUE9N:G/PT$Y3+Z HSHY>GKP&'(VPF],5!*S\3
MK-G5P2;3=KM4:T&X(DR.8&LP"<*(97)K_F)<8U6ZF8:[8;I=<;3)WDSVYCCL
MS;B+=NM!C&UL$TR_/&J#44&XN=O6GL+'MF9 AH_PGXJVJ^.+GR?)-?3;P &G
M$%JO[QU&L"/;F^1ND>('1C,H$>*.\1SJ[XIR'0"02H=!5@QX8+9J VLE%QUZ
M&MSD*6'P&I(& O_+E9-JDV[QE.BS5:4!GB$)%D+F.(@ZD[_.88:B#^5A3#Y8
M='\612EM=;LBPOLTSKT^@5=WI$C<S&9@5_&B%>/996JSO97IUKFW._0M@L@U
M 7;<!09W,(UU,].6UF'W J\#MHGTG$LCD#3@8J_L^S2E1KWOWY*<<6I@6[J$
MMA#:X'3=A6I"+^F51:^K-("A(VD@41(T[')R>@9G,LC'E\]7B#QM'BQIIGV+
M2).X9\#@]TA==*NA'=B+;/;X\=-\0W^0%7S/"N_?.UV23/V5 J]4U,P_P<Q;
MNGII<&59WPI6WS/TCKLIXF836^_8)2QG-V#-X#Y/9CNN=IILF#=L-F1Z&&K1
MT9?E\-#<O+2T!&'DP.58II5'PVM+BK45101@LZ!5NXN#EZ%Y]<&83,P+"!H-
MXRY_HZ<_]$E#(<%<@P[$#4,+5MFS>3A/KJMMW&FDXV _0>^O[P93K/R;\1SO
M^AC#(S0.D2I/6F>$=:Z!2%'*'&8JM<,!T62=[K=U.K::P <<LIK_LY1?)ND#
M;:GRG+*:!8C[A\;>]I"4-C"J<CRQ53=7[<.B+X][I4_I\].KE[]2HB@*!)%"
MJ[G9K*^DAJ3QJ\= ^8XZRZ;%C8\I_0>'L.^.M ZVF/;(52NN)^WC%Y;3DE%N
M&?#+1BP/>3T<3'*8QCN1Q\,;[V\GO"9.=..</[H(DW)7\U7!_8)_2\XNSJ\>
MT5<^:.;RHB6?A9ZCJ'AX<]"'#C-G;[9K.@I^^]X9&^_%L]LB[U9XU"M^5C1S
M/+Y\?/7 MW,<JU4HVEC][%A'&6H'QS[2!*FJ#HP[7+B/]#LDUY>3S]VY@>8X
M)^-6Y*J0'_'):+.GC7O?-BX7U8Y]E!&OQK$/-4%ZVF>$N6P:.2#/R+^9]N:T
M-S_LN&JARG'\FS,D=(Y]J$E9> :>XPJ=SR^?OG<?_N$C@&.NQ+P'.!JG@XJ*
MA2)"HR^304<(F.,.3J=5.1VA]^4(#27/8Q^I(K"7C:A"<@VE;[(54R?%,I@'
MTV6[G \3P='QO. ["8Z^."J#=OHO8R(XF@B.?N9A.!$<'<O>_0,2'/V!/><C
M#NH^K4+E%(O<LUBDKV+%VB!(*QTF469J6E+3DOK0\!:H(845!F">U\M.NTYH
M"P(/$7DQ 88QK;1II7UHZ3Q&:C(KE*>D]KB<QI62I5@5&VVAB#"I?Y5<!4,T
MN2704V#K'[U(^K0LIV7Y8<M2911;%@3VXL:<E,#*7+-*#P/&%#VA_ A5S0K!
MZ$5BRLYB0.+)DK[3&IS6X >MP4#(83(=;X]]R .%D:-:Z%/(?-+HX>^]^*@0
M3D*\KBUNW$@@Q#>GF2K+4F7FR7_(N#/D< ]P ,>76_]=QXC@?>CCT RT6U@)
M\B$JI[K&,WHP\U!'QE@+AATN>"YTKG CT<(*.=4RZFV9*66 U^4:]0[M>7Z3
MW(+[W\5?A8Z(^/J+.NM;T]"QNX[::X;MSAE6)'XPTY"LZR8%B!NL"=S:W#B+
M)QCPR0CMM&%I(-S3>!1$AI,>O%7VAL8!)8X!#%S$F<V=[]SQ^D6TS9R7.V;!
M7*]<,ZBE<T^Q,+,,FWLISLF395WGW$2%&:[JZBQ=8QP_\5H!LT*U9.I660SZ
MFI6G*.(\1%-&T<@$N]:4B5*E8VTB^>=P%DB3FK*QZ9=I?IJEDTH_VK!T,/R8
MO%!:ITZTM' '!HG12&?:4H*KE+BF=FQIVWARVV#+UXM%:]*$+*_<-Z;!9/SA
M<BN[]\QZUX?]X"K9%E:1K)MVU/+F6[3&6LG#%H! QL'3+7155=N;[G 0K1E<
M&JW_HTYUF=EQ1UO8\AY\UW"^!;<5J<;0VFKM-NB]BWKW=+6: !%:W*QU/MZ-
MINPU9N-0C@$>V+@/:-BH'JDM>SGFE#Z(X<Y90J=NEC1;/^E&&K1!')A^SZ8P
M:N ]?D;9J>GA_IWW[VF.4UYIVM',WX[-8=P9:@"&AILY&89]N-B+H7%63PPF
MJ#/AL:+)A:_SV+W9:8E_4-?@@^-:XN]IB*N2JXN+IWS.D=OAR"<C*Y_0&5%U
M@=#5$T(^)V<M3Y/7@[ZYZR5YOEN/&D^#LH=JH9'70W\% 0DJS9]=G3^5XI.Q
M<-VF8'3(H]:[B+>&A^)=9C]&UJ:D,36>V<N85U[01\!O+O=X<#FC)[Q\=)Z\
MAGM.EYB[9<%\-4( WX7MR,\;*'9"*Y^?B/&3B7\ EC'NVL<=F)E%.&]W:728
M*L<\[QJNR8+FZ_+BSTE3;].RVWK1:[F&^<J56S)9[?#0CSEH(MV\B$HK^58>
M31^!.__O8(LWK<+(>^2GUK&=\,;[PUBG>W0 OQ[XM<%#9#)E\>%#4&K:07M=
M1U!RJ6.N/! AZS]"+T/9@0/!A$V#*<@C,#CA-_M'6?['YG_>/9G?,9?Z#W43
MT;_XS&>\9@>:Y)&\.>QYD#0IZXP#9AQ(1>[L?!KH>-!1+0$<1=0_]D9=9HFL
ML'_H'Y84&B1EE,R,8G+FB$8R8V^18WBU^,1ZR<6,%&PN_G(BP;I7=T2H4^C9
MJW$@S(HG<HC2-_]]_N8\R>NR3)O X[XSNUG:KD(&B^^]<F4^O@!,$/V*O:&"
MUH[^^CQY P*!H:_O4R.2R]#C6"=)K!-SYR6Y P%^E9I6E%#',>^G2*ZMQ'>(
M!T)>C>1">))E042B/DM(&INFSU 71U[JFCY@O@J<-YJ:P%OJ&453F$"Z -:L
M)+EHZ$JBH)_3')2E$1=(;<19-/9K&D<^#[U5NRN_F(&]Y2B*]05*SH'4\))H
MKPRF(Z2 #JPB'BLF)"+N,0]JQ%$BV1*7[S]18@X?TYB6Q<,+95'6MU/,-AT+
MGR0MX2.AL,G#&<!!D](*UVGE24<V::OD]ZQUL?.QN"+A8[$A8<D)O\EIN1^C
M%^15(<(2WKOXZ0@J$&AG;AQA']X6G+-K4/* ?@VR%S=I4W!78Q3I_R#%G>!O
MV>^T&=)<L-V(6H^].T0F B'X_D>Q@LZ![8@G( ]E UFZUG4#Y9F!5Y@"MJ1<
M'!Y0DD$2PU/P5DY\$<\&NS,'FG$QK1_.0?AQ#7VGF)Z0AJ]@%<Q'X0N K@3Y
M&#(I3(=;104UY%WH S>NK#>!U"]2(MI?IAE6OE)Z6QUB/\XC1=.[5$^"7P&(
M HM<7 "=JS#]3.+$1(K\69EX\I/HAISU%5\MS5"PT_<E#-&B/VM^EN33 -JA
M92?,@S(X_3O*DY[766^@G,Z27^9TU[ :*Q_3"IE60J7X^(&PRLF4WW]3_O#R
MN$SY^_(Y4<H2:[X"T[6OS *!-/#ON_0=ZSX7Y+%(;*!FSHQ?^DY-(C.W[5H
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M=6#G'Y<+VZGL-G@"!,N>8W &K?@<Q#KX=F&NRV+3.VB&FBDJ&58T/8&"L*K
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M*L>_E L=K+7* YU&\.U7.M3+J<[__*?QV>CE\7@03$83^.^U*H)5'L,3X5U
MK"WA%[Q[-@NR*@^^G4R&QWP-O&P29VF0PBJ2K"@&\)U9 ;],UZAWCFAED89-
M"F-8%'Q3I:CHLO CW5>G!?\Y7,#K81'_#&X_G#3OCM>8?$F$M[[.\H_X/J%:
M(67BN_.EQR<OX"6SJH!+AL$EW!]W"EL#9%NRM'!N!=N%;PS;HX,RLQ_@5V #
MLJ@*><WU1JJ2MN!#EB19\(-:T]K>PE-4JH*9RI=! ;11T)^SJBSB2,.+ID65
M\)' GU5T%1=9O@YF6A?#X,(>WBS+M]X,CP)75Q_'YCIA:W5\A7*=GPI[O5*@
MW_4GW%T-1[)2H)E5 M?6A].XA0K#K$I+.'2UQAOQ,L,PKW1]'_XC'&:=MXK3
M*YV6\"I#S\DMY.31S9P\/AN>?$%.'@]?;'/R#OXM8#&AN>;X[.XL/+I_%G8W
M -28SH-9K),H*'/@)7CE O@EUXDJ81'P8+QEI)>PN)(7R;>"5;R'^RX5/04^
MNM*)92EA?ECF51SMEFP[^5^EC?3Q0?9-8C6-$WKS6T@"R]$[14F+V+QGUE$]
M",-;1_<I4U^QM!2S1K-H_?9T^"PP$@F5;J[3[$HDB[#RECP8D!HO<Y$G1LIM
M"1-[ 7&0>V?YZILL+ZM4TY<7J@P7.E\/@F]/3JW4HS6!J,W@-M36J'^OXM42
M&#-8@9Q<**.-OQV/QL/G@7T7^/^H%\R74)S"OGS4Y/4%A0YA-Y"RABUR<_I
M6R.'MDZ&HSO35F ._78DQN182W @@Q&K64M!K/Q"K2,1,$@7A4J()FIR8B)J
MJNB8;8#FY0JHIRP3S5?-<TT_>3JZ#SKZ59."#4O6LU%<5KEI9V8C ,[B-_B\
M< T</*=9A5\-P"R*,S@I,!6NT=M8PMF$NDE,8O"]6\09T=TP"."Y(!" /DNP
M!U#[++&;&@FE289DZ<"3I_1,_#RGYFMRU5[4U Y?^?9X8G\?X%*3BHPW!6P
M>W>EB<I760D/92LJ1:4'RXV- V>OYQ7*SL"]9X3CB0N,"[,CM#CX2YY5\P4\
M!=Y]"E\S;TPV*_RX((,(_B_24R#:X#6_K+&CZ29DGL5+_!NND?^^7"7:W(R>
MFP(UX#?YHT^;)Q3$:$6!1.=-C>+9+ [!]6-;N9K^)N\B[>M3LF#1.@W2"LUW
M?,X,3-4L+]SMBW01SU/3Z#X(9@F<3<4OP,=#DK[4:)K"YXF:PBL4"] TBB[
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MS3R\Z/(X_YJ,YIO>\30U8GQO79T''^K2>O57ZHNH5?"F&5GF<&(<P*2^M%P
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M*NJ;0(%!0:'SH#A57T=DBEI5P?'HLZCU_QV$90!3[Y>I/P0VMG?E#J"NZ10
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M$Z90QC*,#(^)HYBJE#'BBWJ\$"/C1:K:,-5?17UI2+>Z3S%<?81I<G>Y&6$
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M&P:38)0EO- \XEF$EUIL>TZD+ R:BVA((A='YO;9]+*M3CQ(_PS>K7D/%2!
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MWK K29%1$6=(D3A!G#!ER$@2H;Q0*HES7K!".LP\MC9H/*-AAO<P:WR8YU)
M"F57*OKO<:W-XOU?K;H=UN::1D_->__0G18$C9:3NFQ+_8#-UT-&&G";W1<%
MAHT0=],H;G,9S[=3XT*KF+,811Q'B,L\0FF:8*0IRY4LT@P7;%TB8S<B'7\6
MY<B:8,-J3L5(GUX9XF7ZLN^=V!R'!-^?)G%3A@^>1#Y,\^2W P./!9  3@-)
M&I>(S3<0]/UW*27T^5[.3!_XT0@0YN_C#+&[FL>=.O(41H,.FC@="%[<S0-
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M!4@ )(#K&KCK4B151.<)RAG)$><$HTRF&!5%+K,\20K!4G!=?J$4#!8@ 9
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M%5JD.<Y1(I1$7"0*91IC) N%"8F9Q *O23?^1XPFVBVV\8"#L8!F@#<!;P+
M &  S0":L6V:@;&(-2$92C!AB$=)@3(N!5)2)AG7J9!".4LSCLVSVF\3HP^B
M5&_&)^*B;,5H4\K!<1BE0#O NX!W 6  ,&#_X8#:& G'.DX808I(CGBA<Y2G
M280R7*B"99Q3_:!-^0.$*33N@\$"3P; @(;\07NR1,4B2E*-2)9FB$M6&$]&
ML#V $\NL*(H<3H'Q"*5@OP 8  S(#$-3_=YROT3%B@O&4<JS G&2,90I2LR]
MIEI$0A2\8/O+_6Z4KXW7Z4:#B>9^> 2WVNK#8*Q;^Z+^>J''C6X.;^\6\(^=
M\ \_P0*<!#C)BBY[9B-[E2&")36<)$Z02#.*(AKI7*0IDWK=MK=IE[UYJNY7
M ^JN9RS$-'UPA[V?YL)KWP+.!- !Z "J 52C!ZJ112*/552@G,H4\=C\E$:Z
M0-).L==9*G"T=$+NJO2'&TQC_;3)E&8 Q0 G D[D4-$!R0U@', X]L4XF& )
M3B.!6!''B.L4HU3S%-&$,Y45&"=QX1SCV%&3/<$\C#(:1FD"%,1O)P->!= !
M%,0!"N(!6@;:S,AHP2..8Y1G:;?-CJ TH0)%&,M8Q87@6L-T8;!S8.< + "6
M73A%Z/!WSBGF2HM4QP4J\E@B;GY$N1 :Q0)')"6Q$@D'IPAV#NP<@ 7  LEJ
M2%;O,UE-$Q4I+K5QS"DV(6M&D2 B,G$KQYIE),_P@W8'/"Y9O5F".:91&),(
MINO[Z [ZT9Q77W4MRZ;;!O!%U+48MTTW67]Q3X#?N\J 9.R$9 P?&$ H@%"L
M&#6G8L*Q("C+TQAQJ03*269^P@G+&&51H:X&Z(L_\V=S2UL5_YG966-F%_K?
MFJZ_?SAM_0EA(><9S)7SQUF =P D !* )SCCAGW@"3+1+-%YC'212L03&J-4
M$HVP2-(\S606Y>(A/&$@[?B&'@ U (=PD [!:R1 1@&8@GN.V >FH'BFI.$$
M*&)%CCCG @DN,(IHDM(T3FBB8U>8PH[:Z&G(2!)F60S<P1^/ 2X"D #< 1KA
M'73*F_;\Q2EGN9 <*693_X6*4%[$'&DA5"ZPS&A*8*JO-R@%^P7  &! ,[O_
MCHWG!$=%KA#1=H>7CB*4I85&11*1E$J:ZAP<FS\H!?L%P !@0+87LKW[JPM3
M&<>Y*!#&-$5<,(ER:D)'SJ1,TYA$FN4[R_9NEJ%-PP2OT?CUF 'USX*F&I5J
M;G",=;7"&(K*0XOZ#G2I&WP<Y*+1RG:EVZGT';0WV>$T;)@!Y=@-Y? <-8?
M1YPXJ-S#@]6C(I.,R!Q)4F2(QTP@03%&L2XH3S*:Z^QA@^R[/U]8HWZR8-/_
M45?-@'K@"<:&#CVL!]YS(P.N"5P3H 90 X0&"(W+A(;F@FM"!<J$3&RY(S.$
M)E5(Y@5->9PDT=HG\W3S %SE,P^9,$" R(!+ I<$J '4 )&!2I$K5*5(9:JB
MA*.""X5XP9@A+2I",J$J+GBD,_F@DWUZHBH[VC+ 61Q&V7;/%AR:.3DOE1KI
MPW!"X'6 JP!7<9*K> ";H;9KIC+)4U$@F=DA QI3E.6,H@CGN99"8)*EVYP]
M/' ,@^4#RP>H =3 ]H8#]9=2QR+'*4-"XAAQ)A*49CA%,DZTUK*0>1:#OP3+
M!Y8/4 .H<26^A%SXP>?"%>=*1XP@:D?O\I@9QZUTCI*B*/*H*+!,>LF%;Y:_
MCK,U2N_[&NI_M_V K1,#Y,DOQ$B,I0Y$8^?[O]2RJ[4$C(2!!>V^M]_U@RS@
M(;OA(1XA!#@'<([[.0<16DN1:Y3@2"!#0#*4ITRB(I=,8:540I9;!;M-#N\G
M;=.*L;W:339QW/S^OG!E%T,4A3Q+0L+ZG]B[+_U?NV#NE$/81//!)P!KZ-O6
M_NU H -T NC$"CI1I)QD(D88*X)X6B0H+71N.$4694DNLA3?O?/@K!H97#=3
M9K!?/K%^.F-*)H!(^.HT@$< C^C;R */ !X!/"(M(HJ3P@YBZ$8RY!IE6E.D
M21$3SH@0--HSC]A1BS^-61C3+"2D_W,!@%@ L7##._@/"2 6AT<L\,")Q0\>
M,(L$$\D8UHAAJ1#/<8$$3QA*>22EBK3*F-XWLY!R<CX9F;>J]^V9MH,OS4*>
MZ7%3?M9OQK(ZUQNRC* Q"/OY";)T(PEIE-Y+-5R5[(^^6B^HU@ 9 C($9&CO
M&S2 # $9TH(*PQ$*Q+,H1]P.O10BCA%-BXRQ3)%,)WLF0[_I5AB$J5>B'IM'
M:;;&? A/PXC3D&0<V(\KY@K8#[ ?8#_ ?@XN%00UIM[)3Y;BB.:*(*(D-PQ(
M2Y1JDJ$HRUC.TR3+([8I^=E@8B7A89I$(8D?N7WF6UOIMJ7;>]U!!SMI'J4K
MN4'L?9KR3K?!J&J:3;9E#A)+?C,+=_?P#A,L,!K*P5$71907>88Y8IF*$"<B
M1H+&.<JE+I($1T2D;)NC+H8)7;!S8.< +  6<(H'X11Y;@)703BB(K/'6Y,$
MB9CE2%*9$\ECS2D'IPAV#NP<@ 7  D[Q()PBSA)&N$X0(7F.N!0)R@H5HU@J
MD<2%R*G*P2F"G0,[!V !L(!3/ BG*'.><E%()-.H,$XQ+E"J2(%HIHLDE4+C
M'(-3!#L'=@[  F#9A5-TM#O;[=:D5=T,+K1EK[J_-?J2."]DEA")E(@X^G_L
MO6MOW#BV+OS] .<_")G9@VZ@Z)%(2J+2>QIP;K.SW^Y.T$GOC?.IP9ML39=+
MU5)5$L^O?[DHJ2Z^ENVR2Y)7@"1V722*?+C6PW7E@DHB&8O<>56%-#>*QK&Y
M&)?TBUTTB6(_W5K<-]HJ[AOU)3R;T@ES?V/1Q]RTFU;TQMCLD<@M#--&M88<
M"#G0TQH&>@4.Y$!/R8%TQ(6->$9X*#C\DY*,:4UD2*D4H:",7:K_<W\.A/3E
M$+T8,'"\_P;(FY#C:U6X;;91K"(H_ 9\ZO0BI#<CH#?#!P;Z.'KHXU!QEF:Q
MDB2E&25<4T44I8RHS/&+1*0LE_(N/H[APQ3E%\HO! 8" Q7;H!5;F(<ZLSHF
MAH?NG!R9A&2<6Q)GEILLYE$D[]3F=_@P1?F%\@N!@<! Q39HQ<93P5/+&)'&
M)DZQY3%1D3NQQ=I8:B)JJ3"HV$:#4I1?" P$QG/QJAZ%O.^5KVYTK?;;F;=+
M_?/,'1Q#*0E5D=.N66)(9D1&;"A5FD41Y2J_Z%F]KBHY.%I_L8L/^6?Y[6-9
MP?6/%XNJ4,N%5%/[N?PH*SM;/&8\VN/73O\QBB9)&AZ\.0N&> TRQ&N 4$"2
M@<!X8/CZ") QT--S'&;"*!T33IV2YXG21*9A1O)0A)&D@AF-I^?QH!3E%P(#
M@8&G9SP]/\GI.3(VR6.3DUAQIUW3B!,IN/*EMHPT+.0Z.>3I^?%/N5AJ>ASZ
MX1 ;[+6L3Z>VK@/[S5:ZJ&U0YD$Y!Z#5@$T()CXK8>"E_N/YI<(@'WD4/C).
ML#P'CG(59OI+67HPVETRJW(E,QUK$LF<$2X=E\F8%H2F/+:49C1)LBN[7KRO
MZZ4UCG^XNWUT0R_-IU-'4&K_YH=&B+]MY;IY3)/_:Z\D_&VO-NW33=;S_I=W
M-_(>/F'Q]0W!GH\\0>6#R@?!@F!!IH),I1],A0JNXS SQ%#CF$I*0R)R'1&N
M>.I83$*IO50'YQJF\C]RNK3](RJ[6V>0H:#20:6#8$&P/"N&,AYR<H>2-#T8
M[@[L)#;2B)1S$EEN"<\8)Y*&FL0BBV.=YC+-=K6C'(:='+OGA:O)Z4=9F/>S
MUW)>+.1T;P7]'M)EO0<0> YE_5!GHLY$L"!8,,^REZ[T1XX497'(J7&4A454
M.P8C$B)B+HC2B3;,*J$T?8;5_S$1 B4;JD%4@X^B!C%AHG=JT I#;<9C$FF1
MPD%>D<RFEMA$LS!D7*KP3G5TQ@E=E',HYQ L")9G9'S'9(M'-;$_O$R08M)2
M1J(4"KL:I[>%YI1HKE22QS24M-';@D;T6L6-Q<Z')X$/ 5?PVLB9]AD+FUD*
MDV!F%_"B_3:WL]K6X\Z,0\W^*)I]^,! +?X\M?@.CO(XI%08IYVCG!.>1XHH
MHRB1++1&IMQDN;Y3PH%[)O_6H_:YVV^20<0G61Q.G%3!,D*]D J#LYX/$ K/
MB3H@$I K'%P9#Y\KY+$-J8PHR60>$RZX()+3G"0J,;&AN0TYOTM073^HPAV*
M,'B>@!RA%]( .0)R!#0O] ,82!F0,EQ3D4DG+&..,I@T@7J',25"),R1!VV8
M$DF:\4OUC ].&1XG]O['*,HF41A/N$B10_1"/""'0 Z!'*(?P, @]!Y&W^4Y
M%9)+07@N#.$I3TF66D%2K2-+:<[33&"YXM&@%.47 @.!@6'EXU=LU'(=YTI"
M?6#MSJ4A(YF2C.3,))E,:!3R"!7;:%"*\@N!@<! JR]:?9_$ZFL85S0-)8FE
MS0BW/";N"BF)9,J$C5*=F">P^C[04DO#"6<[6&JQY/XX5,$A]M+;C4K[7V55
MR=D"2^TCY< ,-:0A!Y=-PZ<A82H%S22XG+,8BND;(I*0$Z9RF5.K8R'"CH;(
M/]7+3AJ7^?^VLMB)XHWXL=H'N \GKCUFCL)$6)QVY H%-0BB ]&!_ +YQ5/'
MPW/%32P,2830A+/<D(S1C(22VT3P/%72WH5?#"0,WM$*I!2H-%!I/%=TH 4#
M&08RC*=@&,)$GF00DZ6,<!LE1"4F)[G5D0[#C%NA^\(P'BMJ?I)2-F%1@IQC
MW%H%U0BB SE'#SC'"- RU*C$A%G&HHQ(+D+"C6!$0FAB'$N=TMR:. RQV"W*
M.91S"!8$RV,H10S5[YU29+FR*>>I._E"J'ZF<B*L8D3$J<@2I9@)4U2**.=0
MSB%8$"QHG4;K]%-9IY4,HY"'E%B61H3'H2$9CS2!WJN)M9F1]/&LTP^U* N^
M@T7YMOKS+X.ZG!:F$S9.LL*T#V5K8T#_WG>-KX$<*%E; S'\4'3>@WC73+!A
M PJ)Q>,0BQ$A!-D$LHFKV82-;9XFAI)0F9CP*,N(.^MK*!47*Q/9.(SEG2K1
M^W]?@2A^O2&)_UF5]8!B^+EC*KMD(8Y$6F#A.-0@SYEC("205/1':P^?5,@P
M#1E/!!$9C0BG84@R20VA84YUQE26[-S>QE<BZ"NGV-WZP6,D$_T2$D@FD$R@
MP:*O"$%N@=SB&H,%DRI-LY2H,$\(%Q9B$FA(TC#7>2A48C(Z &[Q2''[+..3
M**-(-OHE-9!L(-E LM%7A&!4?@\#$(5)G'+7@G"F%>&YC(@T-"8F8T;R5&>A
MS>Y;*WC@>$6)AA(-$8((P:#[D>D\*2VC,LN(3KD!G0>9:%*1-&<\YUD<ANI.
MF6@CPBM*-)1HB!!$"!J5^V>U';Y1626&BEP($D6).W%&/".*6DIH9%-NM0GS
MS!["J/PP0S!]K$+Z+P-3+M74K@0!/8H?)@BNEBP8BM]+%GS39GLEIW*F;2!K
MJ*[_QFKOT A8- D T ])Y!H+ZL;-5)Z0FCP;P"!Q0>)R-7%),JZCT$2$@;&
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M/F$LPP"&,:J!P^R8UZ=R=N+N5,R"C93RNK:+VJ=;3 NIBBFFEP\<7.CJP)3
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MSJPQ4"B,?CEL?0&AA(IH3 RWBG#)4I)9K4B:Y#&-XEQ%V0[1+YV8_MA(::B
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MD(Q'G"199.-$6Y9&^74EP#[D<$+MSJVO@=0_5?OP:)+0/E8_'5)R)QZPAW[
M_M7.UT?LA:W., !@?-!"*_XS(43]YD(C+_'%PRQ,4RI);'E,N$@IR7*1$2EH
M&&>)"I/TDO-_)7X=$_+]RZUY0H\_3>DD"K%Y>>\%#FHGU$X(%@3+,Z(R:-OI
M@VV'41LQ1C,2LCPGG"M'9ZB5)-11F&8T3+G5>^$T>[/KI.%$T*2'E&;?9=P'
M*6_0AO/HR1R+4[N5T*'+L[,2QEWJ/[#?_;#QA5ZL43*=84=-'%ZU/M!P8S(>
M9B*A)-:2$<YX2)2-$F($E9*'/+?QCED;K[VL_02B]LF:^&63B(83SM([)6X,
M?S^CH$=!C\! 8(R" 6#RQ<%-'8D-::Q51+*8:L)S]Y/*,T<*\CR2VDC)\AV3
M+W9F 7LS>D0AGR0TGB11?+_LB]'WL43#PY,8'NPW6^FB]H8';W$(RCF@L [D
MS*%'5I6<W9RW,7HD(C\YC']F^,#I,7]!"\9!+1@LSGE"<TXBS17ARF9$B-01
MF"S)J<RMDDK>Q%U\Z]VW?RZ+Q?E3V2TF*643P:_WU#S//8[* 94# @>!@ZP"
MK2)]L(KDL4SCG(9$QXDAW.81D4+E)$M3J6BL'+-@>V$6>[.%T F+Q"0-K^],
MNW.(Q:C:-Z(%Y!%VT"]V$6A9GP;SMH-AH,Z#_ 'M T8%N7&3D@/Y7L:%D!ZS
M#[1I'#:=QHJ0:9&03(4IX2EWI,/*C$0V8MPHR_)\UW:RJWXNN[:3W9^9 TIB
MI6*2,'[O\(QQ;7CL1(\Z 5D#(F2LK %M%H>W662I3C/*B.0Q=<Q!"Y*%:48<
M:U!1$L>2<?%8S&%_(1U1- E#YOZ*QPGIV%<,%QHT!J\H1@\5I!2(%&Q2A5!!
MH8)(0:0@4OJ+%%0_#X'*(1RZ&,8^="?NVSRWVA= M-_TJ9R=V, =ZFW0_%P'
MY<S[>">-I]?^N2R^R"G4M_!![96M%U6A%];X]P]ID,.(LQ%$G(T+)#VVU*)_
M][!9]U2HE%M*4A,GA"="DBPSG+!<QB;.F,FB2_EVC:3^D+]MY?2O3DQ_F('A
M%OZ^74OF7U="&=XXGIGM%S8^^42.8)9,HOCZ2HOC%P2H+5!;($@0)*.F%%BR
M\/#>WRC+0I7DFLA(:\*E^TF%*B<Q3S23.1>YO12Q_N2\8E]NXJ!VR/K'"_+B
M1\HF+,%^%@.U^Z%=Y[&"\QM[3K$O$\[HD3AN#H:^BN= Q/K-P<;>!D-G*@MU
M3"*96\*C,"9*A"E):2I,$O,\N=P.[$%,ZZ-[S-*\G^G*RMJ^L<W_[O?I$@:^
MR>D:GO<T)I\U-4LF:99,HA0;;0Q*O&&F FI"Y$R(E.?!F3!SH0>VJXSS3,M(
MDUA103B/&)'44:F8I:D4(C=Y<BESH4_<:7_=6=F$QW3"HQWJ0V'0SPCTRY/O
MQM<[FX,"N0B4==>8N2]#E-#<;YKGXW 9-;M!K]SHB0T&^AS4()2H.,F5T"2S
MJ2(<:CAD-E1$)=3FQD3N/[-74K/-48[KWS_D^R$ER83&T22ZP<TV_GV.5A$4
M_\@1$"0CXPAH_#BX\8.:T.1"<Y)E44)XS"C)A!1$2*8<?\@XC9(GXPE1]I *
ME&DF)BG?H>33_7IQF'*IIG93$-"C>*"U7-"XL7=.?C?3AG4O[V34>%ZX?'Z,
MYHE1^E?$VA"($1I/#FH\D51IRJ0DJ<E3PJ5C1HKEBG!A4QTKGC)Q*4OJ\8PG
M#TB $MF$QWR2B1W*63U?03!JI=.C0 *$S7!@\T1<Y6:T(5L9!%M!,\[!S3@F
MC:5(C"0Z!\82Q\8Q%IH29G*:1):'6EVJVSUX=\]M,2C["UR[3I*@G68HW&1<
MN!@W]T!88"$SQ 6*"X0%P@)A@5ID6+@X9"D%C) ?MA/Y5^M.U;J8%C[! SS$
MNQ=0<+_/R\K]UH=<+XR#&XR\&CTZ4)TA/%!X(#H0'8@.5"T]@L=3^6_P5-0\
MV5$HUI[:H1V-BEFP.+7@=?0>> G''B6G<J9M4)]:NWCYU!8:5$2#D32C0@(J
M'80""@5$ B(!D8#J ;TWHSNG]/F(<@N>@N"US_";F4L^F^=G'1FU3AIZ,M\P
M(=7C*'C,V3MHSE[*8DI9&A)NHIQPFL8DTS(A813%U+V9QLF5%;"/9Q=#VX\7
MKV55G;N;_X^<+NVCY>:)1\G-&^:^'K6J0#<+HN/@1.(1,^V&":H>4PE,J#MX
M0AT5E/-$<4)CHPAWZT8R:B.B9*3"T-(DE-G^Z<1#$N?B2;JOQ+G!%SU#X\;C
M&#=^Q;;K8X43EE8<%85 :\1!K1$BDB+.>4Y8FDC":4Y)9A).E#)1GB1Q(I-+
M_5 O)=\_49&@:.+.'? 7"RRC?$?YCJA 5 Q5ZZ/AX."& \O3Q K!B,I$0KB-
M4Y)I8XDTTJ1A*KFVEPP'#]+\#[ 9Q+OJ?:R8C!:%Q[$H?"X7<OI$;<)7B&QM
M[0.&X[BIR=!C*\8$M!ZS';1Q'-3&D64RCY(\(B&5$>%"6/=2GI'01*FDL:%:
M[K?G^%"K)(] "HQ:W?0H/@,Q,Q#,##]J8USGLS[S%+3*'-PJ$]-849M+HL(D
M)5S9A,A(Q$0P8X35PH9F?.TPL3[RP)7,@4ST>\?%-IE!XH&8>'),8%8D@@(%
M!6(",3$&3&!-Y&'A K/J1X23)_9$?%K.YU-[Y@[5<NHFM=;3LEY6MBN.'.33
M\FM0S)HS,QS_Y0Q+((\+=E<96_MAKQ\F6,:MS! M*%H0+ @6!$O?P8)ZZ)'/
M6(.'2(_/4X.NINP6C_C3TZ*2L[IQ(-9801F%33\,?:B&$!E]0 :*# 0& @.!
M@;JD-T>:49Z$>WS,Z?,)Y];LPO>SA84$PF N"Q,4LP>G$ X27<]/6PTI67"8
MD.IQN#VF!1XT+3!,*5<L28G)3$YX2C416@FB#3.,QFD2I_9BJ'TGIS\Z,?V+
M76P'S[]95MZQ_WOT>Y/I]_OG<B]Y?S3+)F&<8/GE<2L(=-,@.@Y.'[#\\G (
M!.;K'3Q?+\DS+3E+'(F(&.$YS8B2>4J4UM;2+,IL&CV(1(1;).(!"7E1Q"<B
M8_W)QD/#Q0@,%Q^K<NXF_MR70(*22',(@ V*F9XNC?6F#*FU4PJ+.IC+<PE!
M\?!1]V*U=.]/"ZF*:;$H[(U]IP://^0FAS1M#!\^/68A:,8X;#\ID>A$,DJ2
M1&C":6*(C*@E(;4\S52NF-27*P;,BX6<OOTVMS-3+):.C;R?Z6556?-JN?BE
M7/P_Z]G)4]DW)AE-)F%T-PO'\#?UJ'4">F,1"4.Q7 P?0#WF!VBE.+B5(HY5
M+'3"B8F9(5R&G"A-#3&IS'-IA!'BBB91^^ (>S-?4#9)=JX _?<%'#3=_Z;X
MTL,]T3-U.I[Y>?*]]\E:;]\X<^.#SFGNXPMWXT49+$XM; Q?94Y"4>B\F,F9
M+N34/8=[ <PD]=$XE^&16!]LYO_[?P+WYS_]OG;_!'HJZQHFRLU[]=I=6;I'
MK_JH"&_0@=J"17BW">X3^M^1W75CC\;=@48O_LM*Q];>>?!\E"?VQ8_)D';D
M&#!T>8O_YVG5K=#<K<FKRLH_5O/?7B42\T4 -P\<TX%/$04?>QDLJJ7](5B_
M0F3NIN5E(*=?Y7GMUO[O6W+CU /@2>0&=51X#ZL>T;FGRS(XK8!&_>4S4)TR
MAV=HZCEN'AP=?2H;0M8>1!Z C\UCW+MW!SG&77JFY<PM'\RS>S _$5!MHYN*
M%;+D,+;SX/;NW_X2)>$/CR QZ0-VSU&474YWW'JQ-]*3/M Z?/SG4KX"W]IY
M\-GJTYG;H">%K2>!.Z@]!K7$9=EI67[9/ .\WCP#O%N= 3ZMS@"X3H=:I[RL
M_!*=6UG5@9V!O_J-U?9,V:H1;2R:!.#:\"YKL%]<)BN73B6CT#)H;<#YN6GS
M=Y,$ML9/UIOB6'([]6P?L['A_;(\<\/6%\R.OT@P-7[(/\QM\VW':-<6S?8[
M),MBF6K&B6:1(MQ(3K)$,F*%#G-M3<A#>D?G)7RXF"VM.5[<YVZD_;YL8LM[
MZ_".CAK1ULPST&6UK!U.ZJ:+65F=R%GQ;_\46X=[6 .OV'9>Y;]O+7,#;O?2
MYCS=<V4OSO5^UR[JH_7HIDWX'"15<B_;2.%T^LQ/'P4OU(NK18_\4UTA=CXZ
MUJ;/FW\_NXN]FI;ZCZMD4<[CR.HL(5&J,\(I38C*34Y2;M,PL5KFV5T#*6[
M\RYW&XHLNBR#;I(=_8+;-1OR=@$WM 6\62#<> 0-O@-Z_;>_"$K#'S[*RNU%
M_TOT ^B:B3LBG5CWB2KX6BQ.@V)1N\-!.9V>!^77F>/B]5+5A2EDY2^X<:G7
MC;^EO=;WP5=90\1I6<U!%S51IQV1#Z(LB^ %^+X_=0'>WMBI_.H&%'1G@/G2
M?;ENBK66,[-TE&9V CT]W=E GWK5:.P7.RV;^%;WL<;!<^86U1_HOK2!K.?P
MG@P@$6(./\XKIS2+6>T_6\[<P_TQ<X\72-"WBR*OK/VW77WJR,T;C#AIGK>9
MLZ!4WCQI_&OVFYZZW?+%!DXRV5GMQPE+5?N'<;>VL\;UM*C<8[@U@,I)\.+W
MP;*&BY2!KBQ,A R4N[V!8>:R.H/Y#+,?*EG QXX74QB@#FHY=0-W]Y8+=_/3
M0A4+>+RO;LE@MNOF'9A,6+ %?$G"(N:R=H=">'<&P_GBGL2A&?Q?_H)'D/7L
M#E51?/6S5O9D.96+LCH/Y-S-SQ?WS;PJS_R'?SOZ=!2\*TOC5^9-M3P)CLU9
M,2O<0S<;;[6P5>E7LZFW"_?VBPQ@@SGQ,15NL';FT&UM!0_^Y_+8?'&/(4]L
M]_#M58+O6@3^\^W%^5F!L84:N+?=Q3SB&FI5^*>]9F6O?=K_LG+J9OJUG$DC
M=WFJRT-;C=Z-H+G.43/U-+K'U/\BVV5\592US&VW\V$B [<SSXJZWER W<?V
MJI+_+J9'FSI@4P[V40O<GW1TYYU7LB[J#_EQ$R3O-O/.O,-P0T6J<Y))'CEF
MJR(B(Q,1K4RH=21C+N7^>,<N=^N3VKJ)=_@Y;X2S$_!NHV^>=D9,/8:VAC=3
MC\^[1%ATF2A>%*TR4=S2WTQ<O+R^B8\<!7![4&F0NN*UGW8?!5.(8PGG3H3F
M%D*E0-LZAF,+K_$O<YBCCA =3Z=NK$YADC::9*OBH1^0DDYT:G>W4^FTO[)V
M%MAIX;2>?_KEO)QMS(?[UC.1I'!\^ZGX<^F69G%^EU-;R$0*_8#SE'!F0J)8
M* F/:1[%L4H8W^^I[=:[]6GGW20]5W/],$//_::D7Z!]F%7F(!*SE3MP')E/
M+0@.-U9(W'."T#/_AJ?2R)_)'$$&AJ;=*<%+S;^.(!@VC*3(0JN(HE(XX&6<
M*,5#8E0:QDF4IDS)%QNRY=A=OJ&\;2_-O77[)O%-(:]![1BU&T,"N;O9471M
M[&M?UR)P]YMV1Y13I_[&@)XDEY2R)"8F2S7AFBLBPCPD(L\2ARK*8W:I:LP5
M#5H=C#Z=EM7BLZW.WKNS<;TX>RHL9=$1'2Z6VMIH'E/^![N>U$G@OOV']<'?
M06WULFK9V0S.M%T#W/;[=6,':JU$G:?W*/C?TV)J6]=](RH!NO;;W#V6=?3+
M>*$X+>NZO?+,GDA@?>LN/W5S6BY7MN2@=C04)*NV<W@!!CJ3)YZB.B(W+>R7
MSHY2+/S]ZF6>%[J ]YORUV5P9MU]-\;U-SDOZQ]J]V1N!JJ6[BI[7LX:0]$,
MNHXMOMJI&YH[:2].Z_4A/B^F8#<RK3G,O53O$JX<_%?YU0VUF@1P5G5O+;4;
MFH- 1VZ[*:NLU.Z:H#OR8M%:QB;P<&?RO!MQ(%>2M;N=&Y-[TGS9TN^-&?3Y
MY=_<FKH1PULKK]7<D>*M8)<KV.ZE5X;BWWD,?UG48X9R(:+LX.>6AP00;/K&
MT[WXQC\5)[/"B04Y6URP%SDI=^-IA_(P$SF+26JI(]M)G!&I#2-Y[@A/$M*,
MJ6A_IYU=[C:4TPYM_>6?EF?N$]ZZ7Z^7H3,I@.":MPOQL&/1?>9NOVO12_\W
MNKX?U0K]6VT_Y&]KI\JE#_&XC$NF;9K(V)!090Y'>6:)XHD@><IYK%*I4[G'
MB)M=[C84"?);XU:TW>P^3#[<;V;ZA=<C&M[/;-*F(*BIU'\<*(_\L_>^V;EL
M_8S@.[W:[@SXAA,96%:\,6535U3N+%#,I[;Q0E;>!^G>=\>#QGU]V84(-FL/
M =GQYWKS% $'!/F'7<.L*;-4U\NS><.@&S=MGCM*XB_O'L(=0,$ =+:RBKO/
MVT7SU8W*3(V7\$)+4P^Q$[CUU5]J3UC^F^MCQ@X6>]F>7ZX:'QS#9G#P,NYL
M!X>%4]NHY^;#?FK=')7&G56.]6+IKNSF:3E=@/]].37N(=P$5-U!"#S^JPD[
M"FX^1?1K#SU<YL-9K;*G$$+PQ;Z?Z?+,[FP]ISE3RF24)"J2A&<L(=*FBJ19
M:(7-E:4QWR.?W.%N0]$&6[/NS0@/Y(OWFIM^87GH^J"S>C@).9_*<Q_K<V&1
M5QY%>,N=^+R@@Y)XU:(+CMC!_'(9//Y;1=U(Q\XPU43R^LBJ[9$4?I<'W\&'
MOC\*/MSVD<Y[ZD.+W'0XG08%(&:Z]4Y.VT;6YE_+UH#I;[V<559.W0R;X$1"
M[--WC;GL^Z"<;5FP_B)HE/Y07VVV>V[R^%TSQ:_;&?Z\X?X]GIG/Z_FN=Q+0
M.:<QC4GD3E>$QYD3"SR,B<AC8Z.04:K3?0KHV^\V% '][@:D/U14WV>6^@7S
MH8OJ?#G3K<EYM< M,VVCX(K&DOW;I^!-.9W*JHGTN.%[/J2N<,__J8L/.>\N
MLGJKN53PW>N_?K_BMS=<TMT</M4$Q*VO"ZSZ\O#>M8%V5XQC<BTW=R2^PS4P
M[,6:2=MO^E0Z8M\&=[JSB&W.#,V'NBB4H#X%?P1HJTGG/U[%UUQY^>#4Z:FR
M\G&"6S=9S4BK>U8:[[8+RB_NY-1=!.(-P>O0'@ V3@@^P>_( 6RQI;4:U>2^
MU?ERO$<"-)F%<T+EGMD=RMRY2CJEY,][=JV]8:5NU;#^V%? QG!2^M3)'%O5
MK<YKI^P6QT6_]OX>CAQ7.M!W46=Q:C-N$I*+B!)N9016C\SQW5SS5$>9^\ >
MU=D.=QN*.GM]P4<ZH##'JU7-#GKVD9:O)RIL'<'C1 Z(E$!.ITZXGIPZ<37U
MP5E.#*U""AK;TQFDVC2RW^N8RJZ<PB !P9'ZU<DPR(-PDKE-$U#VDHO]* @N
M(JH[@H!1RPV[F)YO9176\HL;?KV2Y9- 0RE#\)^T9BUCYV5=++P:<&.RY^UY
M8/65C9/ P3V"3R$F?UX=ASZM3D.-D+PR#CRA/+3*$"&BF/ HC4B6Y1')N:(L
MY#3/]ID+N\O=AB(;?[[JV/DPCG^?Z=GO=#^U^^[.&Z+'X0=7 F(50GY2.KXY
M:V)VRID!2=:EG#4O-$%)ZYRPN71<U$G,SY>#=M8"NO$;GZ^-^INRNQ'"]ML<
M7,M 1YO\-N5XZ=<29.>GA;NGK$SP-WGFINUC65;M+2;!SV5I5C=T4OY=L6A3
MV2 H'6+(90 Y4V?+,[@NL&5P,D23X&/D/T_<CW>-K,$J?7VKTC3"*GUIKPMF
MC!!#6*4/J_3M#!>LTM>KO8M5^K!*'R[+I67!*GW#6*>]5^E[C!C<?<=#TQ<_
M-J>GQ[ XH(7@_LK4'=#G79+W9#.,S''9F?91"U!;H\MLF;1^K8N'?4C;]D&"
M;I$+ V%J&P9:)Y,BVEIGV] [[^IKAPC^K];QU7[)>ZDB$08&@D\Z;UH3-N=C
M]2KKA@-FA"9\#WQ:L_/ ,<V@J.LE%&DI@_@_GIDSZKTO25-6N\2[13(W3%.W
MOR04;<HE)T*IF+A)9[E1F4H2O3\;ZRYW&XJ-M9OE6RRKO0;73EZGH2W:S7)N
M8]F\8_S,G;RG3=9XY<M#0=RSM682V).31N;D17T*X0(^7[QV@O#=]@M>#/H-
M!T$,9U:"+(*J%OYR36!8%XSK7B[<\]5U$U_MKN,^<.KN<K1I3&TR,VLPV+J/
M@%R$V('&'NIO:EIIUUVV"6"X^LK!TI?26H5H-W65SN8^47+A*QS]N?3RO>^Y
MLILSU$[SYN2WP1/3\JL3_#Z2NUZ N1>B!YNX/7]$_R*G2QM\]\NO__-]:\)V
M/P9:3O6R#:#0C4&F=A^MBG)9WQ![[E!0V1-8EZXUSL9UVJ"7=ETFK;T=IAW"
MO7W*[GEAIZ;1A:UOL!G>]E>;)-$5A.#!ZN8)?:V#+A7=!X% N'A3)>69.1??
MNT6;G11NB8]];) [[3CH_N08C;G>QRA5:BREED3<,4WN*"?)$@%MSEF<9%I)
M:?:8/[C+W?HD2F_6?]UTM[%8#_,OWF]J^H7A(<<0OK&YWR^.P7_QF3H75G?E
M+)S+Q2H>NBG4Z'7'1_]R*YJN#)R8.CDY;16JUSU.S?K++KMZ4CD4*.BNWY30
M<U>P"P@\7'06IO.N7F7K+ESKA*/M0?BPMS-(GOEWHX=!B582)F-W17=Y9?8V
MXW?P7O4 '[ ]@-) ?3EW2 MV2>O>D, 7A/-OM<V7TY^*W%XEE&VL0V-"1J0(
M'>U4(B8J%2%)51+'W$12Y_&=A/+O=;7X_5>(RSS^5M3^MY\;__#/WMSR>SOB
MWZ\?<?WJ_&?YK[)Z#9X;?Y7N.PWHZN9*6[5*2&WU2T?5P,(S%#FP862Z(,<'
M,?S6FJ:L>W,&0L8'B5U=&01J@#H)YDEA(W6<'/NI$6F-</+5[YIVH5Z(-+4Z
M?*:>:;8!7&9AJ[/NDNO2M?*DLM[$>K!>B.-66.\=.=Q193FI;RS0ZT8S3, (
M# $C%U:W*0Q6=DJC30'R8>GG;5@)E.G9N&UNGYEIZ6,%E6L6YQ^AUNWQS$"P
MLR\<O8.I*=8\@700HJWFA&N6._EN&:%6LS"WDBN]1ZJ]R]V&0K6[69_XFD!-
M/*GM9OYAM/M^T]1K6/?8^'3C0K;RJ'*,UR>"@*S:M@H9ZQY %XTA8CIMQ%P3
M2V+KE3XJJ@U3P=(3+2\A:TB:<0\^A4)>+Q]!*?6F)LI^HX*N*\UZK2SLRHV8
MCN6ZN??1(3>*1VY#)N,H(8(J2KA(*!&:,<)X+"1-,Q5F]F[BL0DUVHS':?RE
M,.ONS28<]-+*J[(R$++DXW6:7PA4 );SVLUE]]-]UE4N%^4/7PNS. 5LA/\!
M"PM-S1=F=6]')Z#!P,R\;!RUW0":VZP7=#TTN-55K_M[7O6& ]76R^W"KYYD
M!8754W2_K^#9O=#B\PN$_6LY[=S1S96Z)^7>]WVUT+RP*/<32R/==K[I_<BA
M<200&8B,*Y 1QT<4H7%/:/S=*Q54+-=BY+5[1U7%)B NQVP])2 V8WO#\.*X
M4'0\B5)!5(P8%?=7*,\<%K<HD[^\?OWV[;MW@T3(66',U#[9.:4'-5.?W.#S
M:EE,X;<=I<V0T?2T1YO#@NEZ$;3WE+1Q@F5;]#SZ:><QT7(O=\G-_F\>)UF4
MB8BP/ \)3R4C2AM-K!#&J(0JIM7C^+^O'?"K\\_G<[OE]^YDVSX<W\/S=1_(
MO4UV"KRX)^XTC[50D2!QG(()6D$,5I23R,A8A$:F++Y;P8VK<">_(>[BP>'.
MAU7L1(X'KXV0"#\"@-Y><E=?06X&"!UDO4_!>@<(#&2X-S&-G%$A0A:3,%+*
M,0U.B82V<R;G(M1*R3"^6RS0HS#<U7O#I1K#8QJ/RG!#)=S!BEIBF#;0FY41
MD8F4A"*B493%FK&'GZP>S'!'@+L!'JUVI[BC-,(@[7T$4'V 9I=0$;N:%0O(
MV;PZ='.\AC[DQV@51LZ\%^X2\T28D#)":983'G)%E.2,A&G((L=I>*+O5JKA
M3MQ$_JE^;Z39NTZ8R8U/#I>IL!$3E<'+ "0ECP"@GZRL+71M"(JS>55^N5P(
M; 3V%R0>:)A[CB3CQLR4-<&(KFR%2SFEJ<V(R&A(N) Q46$2$RJC1"<T2W68
M/![#Z#Z[$D_O-Z13RR_Z*U3K4^CI6:UZC?KLT*8%A7L<GR-\4Z8>VAH&L^OZ
MBL#_L:>%GMH;%?E(T(3*':T*J/#W8E5@:9Q;S02166P)CQ).1&PH26BLHBQF
M/,G"Q]?YG>Q",T(OS A_][G!JQK#%YZH7]G_>ZQA\CAB=;33=> F<6=.EFAW
MWU55!%]R$2HAM@S<]WTK?./3N1MU4R*F#-S0OA3ZN55N<8<I650@?C]4;XIZ
M7M9R^B'_J9R=^&I738VK':JXY$(EBK&$""4IX3)71-I0$&$U36-W;A2AV%\5
MEUWN-I0J+NL5\-7P2J TOG#1/LHGWF^B^@7RL8BFRGXI[->Z+0=;5>=0#FQ5
MUA7*HU]:_$EP6S&KB7<=SV\L(.,%7BYU6YU1%Y5>GD'A8!"3]?+DQ-90(K>I
MDPO-*,^A"5OA<6G;"L3; _959NLE%,MJ^RU#C9JV/Z<UJ^\VM]XN=.P.#D7M
MJPY#R5KHK9E#Y9FFMOS%:_I&G6YHL[:"S85A' 7'L_9F_DFA"_$D*/*F3X*;
M] E(>:<&RI.9K^55S"Z4BO?5YHL\M]"/VKKG7GRU[9!7]VH_O>IC[>ZV7K>-
M$6-%MT-5= .HU$OU+VC;[53Y!B(6 #Q?W=H)N"E4'*V"L])]/(?^@^X3[J4B
MW_P&]"C0<E%"GUDH_>WQWP"JZVG8M+2NK[K/<E% U3CWW> JF+MQR.EY[9N:
MR\6Z!V+M#I>^1:R[E)M+>=+T __7TIPT6QAJT+6]&)JQ+,KF?R=5K%.2FS4(
M W<\_PJ?AXI0DZ#I/.YK4G\MJS]@E&UYNQ6D:SNU>E4O>EEOED+TQ5:A.F+W
M//ZZL/.: 5S8?GO><.O-]LR(V4].\EGKC=Z[\"^9RC#.\X1( 39ZGBJB(I&2
MW"92YY3GN=AC4]Q=[C84_M5,\0.K5-]C/O8[O_WK<3-DE;-)V[RCIO9-O&7A
M>923\ O?T&Q-N[8)E^__!W9+#1QKVG0 =)]L>LXV%W0"U)$[\/\4LQ96M1/]
MQH(Z@K-J58'8;E02J)/&8>241M-(1]MYTW#'%]QNQNBUA"]&Z@;HQ/NJ NU7
M._URJ?\Y*,U9N?#2NC+KGA1*3F'807UJK2]]N_)4U9X;=N53R[;7 ?2;^+:P
M;AC0N:I]H*;U1#/FC0-WY5XH9VY"SE<3VA'/U81_+:93=T7H*0SWA;>;6QT%
M[]P=+D[D9*7VMC7/5F5O<K%.]7IT,.+MGL6^S<:J3F\[K<V'O[-')T>3=1=A
MW^)(GOO/?>^7PJTZ:3X+71C*F;]"]S7WO&ZB8':_WZPV>V)G[IF G;0=X-WP
MH0U8;><2E.WT_'(;$%@YK[5MH\+GE2/X8-_VTV$*3TK*[H+^<BV"KANDK'V'
MI NOWZ)VUZ; K=>Q(7*/3+HC;(@LL"$R-D3&ALC8$+FO[OD^[5ULB(P-D7%9
M+BT+-D0>QCH-HB$RW7-#9+9[0^3^&XN>I&(PAF<,P)@F33G?EK#'>M6!]%/;
MR[0.7I7NO[_)>5G_4 ??O3O^].K[JS_XV]PW;OKN^--OW[N='R4DI(W!RG>*
M^V_I(%^=!UX^1)F7#QLFHLZH-BVD J.>[T?WUT'U7VM]".^\]6=+/'0OD<@8
MRAFC)%)2$)[;G"@1A\1('3(1V93%X8L+WH</G9'-S^5/W?QL>Q".Z]\_Y*W[
M(,I>.)9?-&_\YGZ(7@3N!%"XH;OSFQ-GF[%[+V?+,U,NVO?=_M(2)MG)O)C1
MS@3?C?_'0:T'=$=?UKX=+/QU0ZK ;5?.X"-!$^Y:Y@1<;$TTTA@1QZU2<<0<
MSBQG3B/QC*C<:3@:Z41EB5&"T9L1]RN,Y$/^6]UTV7M\W$5CP=U1\//:?]QU
M'6YMQ!>EW58K:FB'[!ZIAN]M-1NN+-BM5P;WE;V[^V+7.L_+=D!$TUA:!LW(
M0<Y^<6M[<L&##%\9U!3O 'QFA8BBC),X=!2/1ZGC>4J[?XR)H]AMA)C;B\!O
M'+W;\'_33M2O;IYNPOX596;^MYWTXV;.N\CI[3W"-C<)W66/.((+1M<A;Y'_
M. J.Z^#,=__.-SU.JWB.UHUF"N/=*Y!F5IBFO1_T1=?@PX(3%,1+ 80GF[$:
MR]IW@MR(="IFNO+O.9JCG!XHOWH=X*,G@!2M-DQW0W?AY13N$?A0UN69[QC^
MQ1*;YQ#:(LV_EO7BK'7MK)M95M;;14W@3DCP0OW,8B5^;6)@?FV8'3SC#A$3
MFDKM:) @5,=.23$AH6Y"2N*4<R4CE<74["]B8I>[#25BHIWNCDG#:!\6/G&_
MR>DUBGN<DK)Y'FL\SV 'Z^+(?!BFCPF3TU5@JI.$9JD7T-"[6_QM9_LJSE,[
M 56>@8-=_N&N.C\]K[U3&E:O*J>=Y#TI2P.1FDU8?A/NU4;$Y>#4;J)D%Y6<
MU:VVG5=0,:F+,6V0="ET %S?_LLE#,XZT0FWL-^:$+B@LR3YNQ^M'L6]#P$-
MM9>Z\-CN O*;[VG7^->!RK=1#\V'.AD/CY,O?04G)^I-X6?(B0D0RB 2)ENC
MVYBO.U#^WI*=/&1Q)D7JZ'[""8_=D5)%-B&4FS2.I(BYBB^2G7;*Z[L7T]LT
MT+YUD@ B<%85:%X[-6SDIZ5RX"C<@?]JUG.ODT'*TP?0GCX<0L> M93G5"5A
MXI@T<\0ZUS$1H0Y)3N-0T41)F9HGPAI R1KO&*@?!7&</H1H'QIQ3MYNJ9)6
M=;1RU;\$&J79L1Z?OQU].H+H[68FO6.LC71V\GMZ_LRX[/N9=OKSL_RV"X7E
M6JA<6!(;P6!7<")L;@A+LBB)A9!Y?+?"'#=3V!WN-A0*V\PRJ/F'AO[>;U;Z
MA=JQ>!>6<'KWAJZ5B>O,.LEDO'EJ[3\ 'EAL(. H^,U'["Y.(0;7?\-G7MD*
M<IB "W9Y)A!KVUZ[L$T([2I\MF.7#0F%%QIFV'#)6>WS3723.[6P9_.R M?$
M.A>BWDJ&R%<>DLJZC[9)+&9CW-Y\!U=KLYVN&2*P #>*,ROK9>5;?\.E_$!G
ML@D?===J#@'^R_)KFYT"7UL]C#<X>#;=V")6C'_S 4#R5Y R<^Q-B,V>D=!9
MW$<4N]EUS%FJ:5&?-I=T UKJQO9XU7RWSOGV@'!A+)65D&ICMF-CVT;FF\M]
MLG2J'.Y?V1-9F>[Q-XZODVYZP+8RZ<R@<I41 X;+:0D?@,5;SE:QRVZH\[(N
MFD#HXN+*U:OH 3?&K8_"Z6@&\=(7GJEYO;V0>X"J2<5Q YK+JAOX1;.57S_K
ML#;K$.FSBMIK-NBPS7HT+W9QYSXTVUVQP>WVP\"%X [420O(EYH6?SAEW.3B
MS<J%?ROZH1WV<GYJIZ:->W>S#':KLNI2'IL%:HQ;_AG<C2!K2'>&N/KBS:_,
M(;IJ7K=-V,TMF@T&6]FN0+B-D;6]K;V'/]3!$+9V3EV7D#\.QUN( +]FV2<@
MH'Q(=K'8<B[.SM?60O>)N=MN4W_ARDZ[E5C.-KZQ==GM$1=-P+=>5E63L]9,
MM?TFSQJI ._[_%'WZD8F7&[AL-PD>OE9\S>!K[59!VX&FR>72R?VJN;)09(U
MT1;*YK#X-(S$4?"\B-C;UI;ZT5:?3MUNV(&/<:N3C.>22$YC=R+.!9$T<J>4
MS.2QM32/LG1_?&R7NPV%C_UBV^S!.> 7IOMAK.Q^<],O" ^9E;V2M=M0C>J<
M+D'8S2ZM<""_R*))CG*2"@IWE/!@;F]!E3_'([Q054"(-OR8"L3WE\)K\=4U
M088Y:7G)X>C.V*HIOM=='F[L%,1R ?GO_B)FN5*L(/..@F;L5XRWZ-1-74Y!
M%W:.T_O<Y-T2TGUNF)R5O7'[%MVU\ZT)<T.KEWXFE_-V5*L$*O?1KSZ9K"&'
M#1WH<K>ZC+'5IQLSZU;:_86$]X:9;-Q[.6L_;K>U>G?;P"=M=2EN[H6"^.<&
MZVQ+\+KU]9KZ$R2W;1E./1U8D>#U;(&><NP29JTH3=WQ-NO8NW^YA/CRPEN?
M-Q?F0K$"&-%#')E[VS1W2-/IP19?K6%WPFC-Z&;M0MA85L#$]6CO<>6$X?AU
MCKU8Z")C@RXH=ML'<2K-':(N>FL/-E&HA3&4\"B."*?"$*<H+$G#/$NLTGF6
M7;('OU^[XU][>>!I77V\6%2%6OK29I]+_]HKD/(?FS"7XW4>[MTLR1=MP733
M&/S^EW<W68-_C":AB"8B289G"5Y)W4Z_@8RHK3NZ-(>+#;4X:<1P4SGC3N%
MO04F3R--$VV)L4(1'C)-%!,AB;7*LU1$F0SY@8&YJJYX[):I6Z%/JP5ZVXKQ
M=TZ*@]18-G:0#_G% ]&K\ZLOL%7!\7\;#G"U>^1.6X)'8L)Y-+P-L<F^Q@#Q
M*,QM9 TC"6,IX7G*298;0T(F112F5-CX4G3GF"'^]FP^+<^M_01L^(,GNGN
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MF[O+7OW\19<NJ^S&0$P;*SV?GC<:;.;6K:Q\I@VHJ762S$8"5+VJEP<O3.&
M]05.Z.L;74P;VKR#.S?4=GV-RZT(5FT(2M\ZJ(D^7C2%.GT)AZ(YUC6*$PAA
M<WD8VE7/<,W(?93Q>N;] ?RHQS4;A[DS??>-IN37[5NTVZ$-K/S"RVI:V*;$
MTG?%]Y?B/MC$O>Q>]UF:TGW.R/-N8^0%),'[ 'G?K,KWQR@6'F.+LNE7!5V\
M8!#UJF*)#R_Y:W3D-IAR8_>&HZ;'E[]5>Z_&(G7AHD6CJ'Q^FX]VA\NLKN*&
M@+TOR,#[%HRP]T6&O2^P]P7VOL#>%WVMRMVGO8N]+[#W!2[+I67!WA?#6*>]
M][[8L:?$_1I6/(8%#RUN]U=^T(&TG'VQU<(WRS96+38ST>=@<"F78->J;(<Q
M![COBB_7')H+L,0YF="5JY'N#%^=6+#8V*DO) H6*/=36Y_$QULLIVW-(_?+
M.E+5X_5M5YD38F_=:1Q T_G[/[U]W7FSNUZ9ZSZ9;B!=5U$XR&^<X-,P#,[6
M)W@W,W_8C8+F$#W4A!GYBC7J'#BG8^!NU$73+GM5=$!NF_/.FW3SA:\2O7!;
MN^NG"@]R*K]8_^3&]]!L[12-&1%F\)U;)[>BY/_#3.<]X'JCPKTI;=L+U0<#
M!6V=U;:QN[?O3 *U7/C/G#LD-.6KBB]V<K6=T0';+Z8,(,H(7'1=Q2L U*+>
M+#*T#ON!;;,VO6IH]^ C+&XQ(!W4(X==>1YO?D#SM:9_)FX_[[9/>)-OTY$T
M0'7SS5^+^H\WJYID-_HS$\EHFJ8Q23B-G,85.1$T# E4)DRBD,5&\OWY,W>Y
MVU#\F>RH85@PV8V47U4  P7V,%?F?29JOQ./3<#Z)6[&I* ON'HW"M)55V^F
MKD)/Z]]5A3N?MM:"\Z; S)]+J9W>7?K22&8)8>'>OPKA.M==M*VAU!" KMW]
MM#@K&F_E2_!0-7N\4^K>X=I6V?,7G$\=EX.8Y[:,L;%?[+2<>^Y1+Y:F8[(+
M8 KU#]ZYU5P2$J9JSPU\M'I;HNK=FV/@"K4;A*/.F[4256F:,3<^SL!S$WC(
MQD?:ED3V/=WGT)FDK>H'$P>UFZ L8ENQ'V;]F@XG[HOSLEX_3S/B;LA=::?V
M>L#JYPM?.;.]:O>M=@A=FWJXKY^$*^[8%6(%[[C_MEL.4]1->IUMG/&UG4X;
M=@V?R8O%+3?[P1]1UF.^X9ZE:BHV^@9'VM8UU%R=RX7M\AYA1MPL+^!UO]$\
M!5RQQ*D?QP)F'LC?8L.&]8/__G>; RF7"U^=M9TNZ" @5;G!$=WAI6@#RWQI
M2(AH@*/4^>;<#>>,<$V,5C_U^>L/__/^#8D.YCX;DX _GD+!]Y,F@+*;6+>O
M'!3.''6%,[1Q(F[6%/IM-V!3.;^Q*S:;KY%T<UDM5A:"KV4U];D;7YSX@;">
MYCBFK-]8_J!?66G<XZ[K!TZ<!/GBZYQ^D4X.S]97^U)4RWK%FV!GUW/X^E$0
M_%1"L,$)Q'7.VB9-FS50KQUS6[G>CZH[8#:">'V3I6]+"8*N:L2(^VH!9A.Y
M"&!6SHI_=T:89CS;X[T@2U>7]J+)J<EB 06LO25#+I;U<.1%CQ$-E*7++;I0
MQ]!^*:=?8+TN [W-=[JH@#8, SZ>QMBYG?GLJ+8F^ :-J#OKEG9,P_$3Y0US
MIDEZ\ZK?+7]>&*BP/;D,C>9+[3?6L5>^ZN*%Q^ABLM81S*L#A6-(;0R=+UE<
M+>>KVM==3-S&,VGIFYUU6NORK%1!T^RUL8+(J3<U-A6UW:Z!8LB-3H7?5NF4
MJ]K73<-,*"/^?@9#G+4Q=*N([4MWW&K$YNG6F6-3>:'; 8.*+<JVVH?7Z.Z)
MFAS.11L#7IT%D!3F-SX$,9U[8[JG6T;./>^:>HFQ%1'HEZ-<=XIS]"3W,NP/
MI^#=9BZ]:-D*F5NGD[4T<VMN6DIR:7)NH;(@ 4^@O'E3WQZ>!@8!152]S'-<
MU,V&?X*V:+6[1_/A^K3( 80^*K*1+3XPSW_=%ZJ'=?>#\,5%9071@]-@N_72
MZJERJ=L"VNZIRTU .N)9%UY:P[4)4&UR"D(=LOH6A:_E[BG>.D;?!UR:TC]L
M:V*M8:-X)>!!4JC5W08C!8?%FC;M3EYF^$97_LPUF!GOL=Y9^UN+F3L5+3<B
MC3=+%JV.T!NR'^)TUXO1%2V"Z%YWP;G_&JR7K$\G_M\ ))?;NHW2::*@P3OB
M@U+6I9! 6D$F+5P3^F&X%T^ZTLM7GBE]4@7<"H)&%VVO6,B&5W+:'':\Y#YU
MT^&&U'F)-A^[6"Q;L53,(),7+G!QQ,U%SD 4M16;\HTZQ5D(D:3M8ZTO<N4#
MWGRE2#27ND9HPZA6SP51Y" '/5;L-VT]V742VQ^:O7B^*BT8ZEM?O)13.TK.
M_NB<$G4CJQORW%).J.>_A,=KWYU>S#NNNU8934#W9A\ QYN+DUFK<_3YNB<>
M+'/'0/QJ>W9ZZVJ#.H3':\PUW4-XGUK#G&N[>A0HJ;U^2O\PCJ1?>%P?X#N2
MSGAI$NDDYI:P+&6$6YJ1S+(,BF_E*@PCP>RE:ENO'1JN;/6[W9IL%93Q3UN>
MN%DXA>Z*ONI/8R\Z__WU\:H T"6?P:OSS^=SNU4DZ+67()<^N<=^9I0.L#;6
MNH/>XG))97=ZW-S.;CK*S3V]%EJM)&ID.@34=T)P6KC/F(VWNXT ]P/7X[^V
M'(H;,O+:BHKK")"V]O9U(^FV:_#5G;+'L-U$IJ+<1IJD46@(9T82I2-&E$IC
M%:G$LIA=M=W>KI7+\>*UX[60D?(_$"EPRT9\FOT5[[*_DA<_INR(#6^#=3$:
M8^E0F1L:Z9 RDO)8$RX=$I5@[M?,*I:&+$R$WB,(PYZ!,!P< F_H,MGKL\R@
M3H]7GFX&,]4]/C9^]BJ^D18KTM_$FZT-[EL%BSJM7Y]::*V7^X1+Z)$-IZ-Z
MTO28<YRDK7BP::!?.41]5[[FC+4B[G-Y[L]7WDOWK;&?;I14V&K05I^Z\1&H
M;M$=OSI/96TW$=(<EU;/MZX.!=_T88P;=ZO]@6CCEK5O(%,L.K-<\[!M)"!<
MHFY/B6US-M_[$'C5='J=W[3[+%&VZ</G!U%X^V%>?(.4X29Z$ Z!\\6J%^2T
ME*W=\EU1N5N]D]491.ZVEWWECT!N+)^K9;WHCF'@/9'^@B"B+'"WX+^7C44R
M'HZ@ZOGNZ=C[255"RKC'T)6VF%7G3%CK%<HF0>&=O)-FLT$ [12,^A=:$C:H
MJ]?YK+Y-TL;5X:#N5+)IV\PW%<K6_4N[&FAUO3QK*[UXV_M6F9CUJ!R*WZTW
M0K%.G)=U&_);^-Y*[E&^EDL(@+6M%&BNZ3WQ;LW\3O>&>A )D"< >=RY!1?]
M>G!-BC!T/P5[N?](2Y"Z3J;MI@,/7P$V*?_$C=%@H^.F#S2&H5\Y_VWXPP6?
M7_#GLESX0(;"]U2M_)YKYGA#%F@P-&QT/_4!'K)S[6]?8QU>[)TV;1@HG-C<
M<QNPK]O&RM4\DY_*4D$5F&Y"O&#TMJ2M;_QK:5K?A%\["$OVXVEL]1MK![C<
MPE*7&;U^H-/"C;'2I^<>.;+N&IZ^1+GP<+GP$\QZ$+T,WL_FRW7_V74OVZ:*
M6AN65%T X<01:6G^Y20Y^(1]DV%@:6"AZ1K:NM<V6XS"!FH=/8V<N"U@^&(F
M!^:7']I\/[[\\B@<4L3U&$"$">:88+XS7##!O%=[%Q/,,<$<EP43S >Z3H=*
M,+]/OM)^\Y_H $Y(F/\T9#L"W<V.T(9V7C!&Y1M90CL:#WZXXA)K"\0NU^NL
ME:M"EQ!XV=SD!Q]0W#R.XYO>8+@9:0:&M;;6IOMN:W9S)+4J?0*,#RB:K,QE
MTV[08/J3$&L$'[5=K_"J=3R<63GL5DT[%<6XG^SJ-_;9[C:TY6P#%3X=S.E3
M'[P]6W3?WC" ;MB-(8NCN5L':?CZ-J:;O76U9?^KKVRZ82MO#>JFK5AOBKHK
M8^_#:?)I^75C^)YF2G<9;S2OMRZ]-D;[0AKME5=!M!O/T\:3UUN/O1'.OC8>
M0VATTVD%XH N'#PNVPJ'<=J[*>?]_3IZZOWLC56+XYGY>171"9$3B_.-WG<S
M\[I)_OQ<2<#CL<?$CGGR66A3:2PCJ=2*\"Q+B<H@?L,(Q2S-8I:K/=;]WN%N
M0\F3YT?!>E$V*KP\L-;W/69HOS/>_P3YI#&#]543_'QE\#6(?&]Y=+*N[=+4
M^?2(DYH$$GQ;5UCCVO*9<LU5EF?N5K[9FG>*GD&1[G_[]B/@/6_* B]GE95-
M,LF)DP6M3G#OV'J=/K4A?^75T90'\Z<-\9QPDQ!?HV M&FZ4Q"Q.XDPR06(I
M!>&4<Z)"*DB6A;F5FK-4I7>3Q(VY>],FW)S987+=FPVX+JVP\H[MUF;<_$)\
M1O>\=C/6_72?Y9/+1?G#U\(L3F$IPO^ ]5M4[J]9W5OJ/R P869>-L:";@#-
M;=;+MAX:W.JJU_T]KWK#86?KY79Y5T^R6O#54W2_KU#8O=#"T%<:<V>-SB32
M7*E[4I8<<?^H5^RF"XMR/XG5F]VU9X?0PHP=&M%1BLA 9%R%#'J4(300&B@T
M$!F(#$0&JA.$!@H-1 8B Y'1 V2@.D%HH-! 9" R$!E[0 8["A$:]X3&W[T'
M!;TH#\7(89V4FPD68?BH>3;/0)Y<KVEZA8S[AE$C6)[H+#-:M#QQJ-1Q%['R
MW+"%@@@%$8(%P8)::X!:Z[=51.5S Q=*(I1$"!8$"ZHM5%L# A=*(I1$"!8$
MRY,ZJ$:+EB=66TV^%+JWT+WUA-+H9> +]'0#<UH!AC,4T* .0]3@&:R/RNQU
M65]69<\%7RB54"HA:A UJ,M&H<O^"=5$GBW 4"RA6$+4(&I0F8U"F?WD"V(]
M6X2A7$*YA*A!U*#/;!3:S/?+W8/+;-A(0]_9GL63NR.\^(\74?3B4 BZ^H*/
M#:6$'24HM!Y7:%TJ.7M7 ?:7UZ_?OGWW[G&\_H?!W3,484]>EOF?I5N#F:\H
MK\J9V?40.$*T/78EAF<!MIM$W%^?,;9Z:\0Z"OF-C:S\YP8#L15Q&\1HVTKI
M[ZJV3_:Z^GGW$DDE35E.%:',4L(C'A&59)P8G::AB1EEF7K1UEB7?ZJ7/U]1
M7WV59PSQ%]NUTH_KWS_D&\71?V_KM/^^ZLOV?M7&Y/A;4:_>_^W36G$<GUCW
M45M#3X[U77_V=.9%L)P5S;U^<S\XYFRL+MPLU?]X$;Z QBAG<O&/%\6WQ<O9
M\LR4B_;M%S]2,>$QFT1)U/6,Z";EQV<L1]#H]/A&I^>%&^0VR&V0VPP 8J/C
M-L*JB%EN2:9B0[B.)1$R,H2:4 F>A<Q&R6W<9IW6!P$Y@R$W@B*I05*#I 9)
M39]E.)*:80FE@?&9[\9&:'0N1!Y*06P&K7LC*H@*M2%"\$BY?PQ+Z.Z$!H*R
M!D-H(C&A<7PMJ1G$"G__C,4=4C"D8$C!^B>3GC,%ZVVH'-J5^DW#8IF%-)%$
MITP1SDQ,9"HS$F=1DJ>14CE$<-W>EW@PY M<98Q/,B%NMRI=%46$=4)0#]W*
M<EZ7U;RLY,+>'B<T>#P]/UKS-&1X^,#HK5D(.4FO.4D6VI3GEA&>,TUXZMB)
M9"$GE%IJ$R-2:?-#Q/&\*=T$.<"OI/N>F4DV$2F?)%ER)W_7\.4$VE-0A2"W
M0& @M^B=M@[(N&&$J@<E#*H>!,8H5,]XM,[HHAUB&64T5(P8G7#"69H1*0W\
MFAEFXMAF] [AFWN,=GCL,VTTR>CUEO9!+.^-H0[#%V=(@5#3(05"8&"T0>\T
MS^@L^S'+&&,J(B%/0L(UHT3DN29YE!C*!3-Y'#YAM,$3&/1C.DF3>X8:W!:R
MA#67!J9>#A"'<'9F*]@!P5S.;?60 +EAHPVYS.-PF9&CIK>V'B0ZO28ZQC)N
MXU20, LEX3G-B&"A)5DN)$NEEHGDAPAA6"N$CZ /'LIP.)MPD4Q">GTVRS,4
M&FA1066#% 51@Q1E3!3EQDB(D6,,-1K*)M1HB!K4:*C1QH$QU&@HFU"C(6K0
M7SXFC38V,[(,$Q/+B!%A4_"7YR')C,F)26V6A#R-4J6?T%]^0.OQ;:GX+P-3
M+MTSKR0$/8H?)B&PC<=8O>+K'1+4JRVR:\#66(#V_)A,GZH1C1)1>&Y'EG,?
MEA,S8<(DET30V!*>6?>3M3G)J)91'%&:BWB/SO('%&X,HXF(V$3<L23U*'<[
M6E">(#S\&: %V0:R#60;O076Z-B&X"Q-(RU)9&GFV(9*B4IT1&(N0B8%%SQ*
M]]E)X\D:7XQRER/+0):!+*,OXA59QA $T, (QNB*/43"J7U&+4DD3PE/(T$$
M]4TN3!09SDPJLWT6>WB !R:<1((]D_(,HY%)R(F0$R$GZHO\>7Z<"*-9T/)R
M'UZ49EJ$F8Y)9$-*>*8Y$5F<$*U5*(3)XX3'#X]F>9A[)TW9)!4[M%'W 2E_
M]R-S_YOBRX_==WY9GKGIU4^[/Y)'$:^'B<_X?&HKNSOX#S/(X*L;Y!VVZ&%&
MN<.N5 DU,166,)Z'A%O.B<I31HP0B6;<G5Q"]>!=&=ZT*]__\FYK7Y+::MB;
M7YVBJ^WLQ8^S\@%'E /!X^RJ(*- UD&9!V^L]J%S 8LF <S.T99X<8\*4UG,
MEK)YUMXIVLNRY,*8-X#6BD-?U5\:RT@JM7+2/TN)RIC[U0C%+,UBEBNR>0T2
M'51&W:3L_O:7* E_6"W:I06#91S HOG)A95RNQ@&SK+MLX';HE 6R;W34L\7
MJWVWI>HN2(?WLR_NN%=6YV^*6D_+>EG9S^YRKZ:E_N/%%<B@-F5YIG*2V\RT
M\1\9%80FL724@5.;L6WI\F;9#.OWZ/<VA/5SN44!VN6PYGAQG[MMXS#L+0[C
MHP:)JQG?A.0F%0% WKY%[S,U^YWJJ(_'BGLSI\>Q6B"MO&_8[[_**M!36==%
M[HZW #BOCHMN]P324;IZ>>8N )97T-9Y.9V67^'_:J6VFSW7ZNXHD#/CE?C+
M1UBDWF!XOQ"^27M\TJ?6+*?V0[Z2:J^75>5^^@QLZD9-HO,D-4SFQ&01(SR)
M!)&)#DF>9(PR(:,D2>^F27[\3W>TN\9@YMYL"-ZEI6Y,--OV&G=&G\IY[2:O
M^^D^"RF7BW)EB D;.\SU90/]NCY.G],G3:!*^"-;,4>ZSVY(LQL+-.@CY\L@
M,H:*C(@?480&0N-*IUB,R$!D(#(0&;LC(SX2"(U[0N.6\N978*3S;7\M9J;\
M"A,\L*(/CWYF&:V!JQ,F[IP,+_[C!7WQ7$ 3]C6T8D^Q78<PDE_TMD7W5UR#
MQ]<-]&8\^$*IA%)I<%(IW$M+F'TQZVLABZQI@)ZO=]::23"SBX>48!L\M![;
M4CQ.9-T[]'GT>+K)OCR:..B>!S[W--*9)DF2<<V(,CPF7&><9'FFB*$\,:G[
M7<OT8DSERMO]SVKW]KX?EVI:Z-\6Q=3'%ZZNX<OVR3_5[R#Z'UJG+TKH).3I
M7EN\#'_W/[*AN ?:I!^E7Q$IB)3G@I0;7 R'9A1QWQG%CL#JZP!W8!5YR&2<
M24ERK27AL3 D2TQ$N$CBG-N0V?12]]P[L(KP:5D%Y7S"HETSK6XH_3M(;R+:
M.1YA#[T].:E].&Z^$0D_Q@;LXS9E]*, P""!@3:)Q[))_.TO@D;TAW&C!T\J
M*$>> 1)0P> 1M7_L=0Q'5)O(..62$2:I.Z*J7!"59=0=72V/LCPT/.)/<T2%
ML\#QS+RKSA]Z4(WY)*/9_<ZI3V6RPK/KT,^N'QU4I'OCI \64#S,CH!KC!(L
M>, ]X %WG(@:]5$'Y0VB Y43'H[Q<'SXPW&2,R4B;DFB:4QX$J=$NHU LO^?
MO6]M;N-(LOV^$?L?.NS9B7$$BJ[W0YYU!"69L]H[MA26=F[L)T<]1=P! ;H;
MD,SY];>J&P !/D" !(CN9DWLRB0(-+JK3F:>?%0FY,10:S!5ZGF<XZ6S\53?
MF \HVV)*R</36SM^0B*[Q(<H6Q]6Y\5P7%R6$^NKZL$*]EXA*GO%AX_ =QXD
MV1O.)>CW%8MQC8Q (9(-R0'%3 -CG 9,* R5#!8^B6SL4H(>U?B[\8=&B3^Y
M%GT E1A(?O_0DOX+?:]=TFP*,BHR7\@!BO;QA?X'*#"ER'O%@-!$@511#A3G
M&$!F+*=2,&7Y,Q68[Y<S8*0&7++#Y/"7<WU6U,+>1OOD _A]B&0L ?[D4_C]
M EN_@QS'\ R?="2_7^#*P9$<'+F'Z! AC60A  /3#/A(38!27@(> HDLQT"#
M\;U$YQ<_/=@$L@%F:J 0W.M9^YZ)=:\=W1:EX#-L,FPR;'+$)$=,[B<25$M-
M,68 8HT!988":9$&#DFDK.6"JELC3;<F$AN')CY$)!AF R*V:-K3LD&FG?/&
M-F/HQJ3 /+[K"3&4Z[F923@&Q?3<%V\F%_%^KXK2QR_]XEWQIQYH%2BPPBYP
M  FT4:MP R1%$"!CO5,F*,OO;_1QZO[?K)I>Q%^.%8T%=)-N*JIH;..-\ZBE
M3MC]>=RV[E\1OV^4-DY_UL-Q-:UA^$6/9KZ>)3>MBA"7"T29FM<M7<^7&T28
M7B:DIHF'G^L/3B=3/2JL+LNK])*^B,QJNKA0W+WTR?AE\3V5'EW$;S7#^'15
M=5(4GU;@[^);IA']U<Q44QT_HD>CJR+^L^E2TTDQFL3-B LY<84]U_,AM<-Q
MW2;[)0RE?=R$RK9"LZ=C:2G<RUC:J+\N(]>_^C"* G(Z=C_]/AM>)CVYY9A:
MCZ&6))*[^&_4RD)SH*E P&H4'-7<66+V-Z9VFV_KRIA:/A]3N]B!07&9]J!N
MU>,7N_"TT;6/6:[]+G\>7?MP+"%SW\<MXKVC:R\W250>9_M,(X[RZFQ:G4?9
MY(V6..I?R&&(] U*"&C )+*VZ!]!9 .EVD<':4=+G,?\MJ$\C;,\S#5/W\MS
M&3,R=LO0W#N=*$/C94,C*XV,C(R,C(S=S G*T,AC?EOCL[RT@U=YOF9KP\==
MGJ^9I_[V'%]9*V6MU#FME*?^O@02=9RDX=_UV+6A!5\N^>\4J/+ W\=$FH]]
M%B ?*#QNMZ6 I:64 >\M =2% !07%%B+7&!>$.?]S8K=>W/?.W5?NN\BKZ\^
M75WZNH1W\=YD$)[:2T%@-A!JBVD(+THQ]-_0M.-L649*^Y'R[#SWQ9.2>_,5
MQR8E^8#BT8\244,"%4@ Z#0'%'(&E#40!(4@(XB18- >B0D\(C&A _'8%D^=
MSUKF ,H!Q.OU;#AR]:FLL2N&%Y?EY(NOS]7U>\)?KRE*.QI)=A,8.?R1PQ]W
MLPRGB:+..> Y5X BQH$V2$6J06"03AH%;[5!>/;PQT*=Q[<M?GRWHM2?W&62
M#9B$ [(-!^F56NA@<GE7A9 M1*8.F3KD($4+G906D(>G3XVVUJ&@+"".44!E
M\, $X@%$WG"A&$)"'SU(<6CZ0 >0RH%"V[9L>A&3IG-88_\"^68RKJ;E;"Z-
MR_%:;8BB9[;2 [;23[#DX$<.?MR38B%<AR ]($HX0%-+ BD# TAI"+V6VII]
MLI?'!3]6E7[=RNUSN8?)&G* D!HPL5O(HY\*(H=!LOW(9".3C1PN:;/STP*Z
M\?3VL(0'A8@'3"H.J-,>:*XQ()I2Y834Y/;TBF</EQR&<) !1GB Y2.#))W7
M##D@<@"1^^E6"\I>QN S \G)F1S:R*&-'9@&HH%SY!"@"J?Q%@0"K:D'CC&%
M- L&NW#TT,;R;WNHX% 2#2B4N8*C%?+?N=!%GZ&02<*+!D8.2>20Q/U$00JA
MZD"$8A "J@4"4A$$A ],$\N%$L</2>R/*)"!1&J MYG3F6LU^F$[CB-Z[T,8
M6E^$61D1.BO]/2,S7DQ@/-.3G$7)<8T<UWAB7,,Z[I#' NA@66K7H8 V# &E
M,1+>"8_M\=IUI(E[C=X_6ZA]O?+.IY(73.% D79V\&B+,6F5[6A_V..EP2-S
MC0R6'![)X9&M^89P'&M("4"!RWI\%3"8*0"#Y)X%"[7F1PN/')IO0#Q@BC^]
M8*/S#75SA.0 TO</?SZT([]U3X[.HRCSDL.G:+H/DAS[R+&/>WIU!.615!Y0
M*73\AP:@=+! ,V58(((R?OQ6I0NM_N1Z43[ <HLL36_U0(YQ9/.0.40&28YI
MM,EI:0&+>'), WF.E","**X1H-0[8!07P%#O)64&.RF.7O*Q+QZ!Y4# EE=[
MY.DM?8IK?)I,]2CUYJBQWKZZC]Q"O5-@RU-=<J@DATIV#95@$R@+$@@I Z"*
M.J"T\ !!XH(.4!OI]ADJ>3P_H7# )1T0N46>Y44)=_^-1;^R]ADIG:(5>3)+
MCI_D^,GCCLQ(@@PR## #.:!>:&"<"P :QZR2 2LN]QD_>4(2!0\@X0.J]C!=
MI?-1T1SL.,2H6E]5A;9V=C$;Z:EW$9KQENQ0U\*38A_Z8A)WY5_U"R\G M]K
M3I+3-#V/7[2;86P,7?SE^ 3CB;$+2#71RC* A1& ,N& @8( *AA3FC$AY2UZ
M<7JM@=^N*.#X\\BG'R+C.%W1P_>RD4-%.?A <C7 _/[N7^W<KN]>CC+*]2;9
M1F4BDT'2LW@)['B\I 5\YLD!$R:H-$(9H)E/C$8Z("7UP%-&I=+&1+YS%$;S
MA- *&R#(!XBUD=%LWK#;G.8QM2^O"C>9F9%?U5KXA#U-:^5"F#[%AA8R.2@N
MDU2N5\(,BK%_4CE,OP#8;Y[5N=J8GH&KM8&F7"ASY&!3D (Y)@*P#%) C9/
M<,6!ULP03PED:OLS1;_X@P602&K<QM+0FKV6R?1,SOMO1-I1,Y-ATS'8=*N
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MF=YCIBJS>]1U]V@1#-CH(?423FU6VK#C2OLOK=?:#P?M+/+&."% "$8!RD(
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M;6UXM$\E_^P=V'J)E,P']J^ FL:546UG5;V;JL[K=-\ZW3;_+U%9]=RLM6+
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M$D"U75#!F-5M]K_@<B- RM1^ FC (&IK_>?GUGJJ\G/XM<IK> TP!:-KY_<
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MYA]6&5N][<#SJ_ID?9&&0P77QPJBN]/[[]]EI;F"'V?-^?2'_P]02P,$%
M  @ [$5J5"FMBU&Q;@  A:(  !@   !A<6(M,C R,3$R,S%X,3!K9S P,2YJ
M<&?LO'=<4]W:)KQI(EV4(C5*$92F2),6%0$1$4%ZBXK42),ND""**%5 B(*
M@O02D5Y#+R(@O8D0BM1 0@F!M,ESOG>^><_YS;S/.?.]\YO??/-LLO[89+5[
MK7M=]W6MO7:HD]1YX,0M/0,]@(Z.#DBE_0'4&4 '8*"G_^-#NQAI'Z;C3$R,
MC$RLS,S'CK.SLK.SL;*Q<7">/,'!R<W)QG:"[P3W*1Y>7EYV+O[3?#RG3_+P
M\OQ1"1T#K0PC$PL3$PL/!QL'S[]\45L [N-T.?0K#'1B #TW'0,W';4#  $
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M"L1"*A&89.(E@G/W E>''']+X"_>)+P&M%3*^*=3>'- H?=/%T9/IA:UQ32
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M]$>G=,8ESDQS(A<!U0'3I+EG1A#1%A<8E1"I:>SSV4X^)R=55BY/MSHN7*I
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M6Y9/O\</YA67#B1!NGMS%N?8<K3]LEF&H&"98%IU>:;WX[J@59I?BL'=!^]
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MW'1+,A*^LBMQ$ZL8>/$T+UK)\G:H2CZ^W)@*T'0*YA5E-.PL@6:65I._+;,
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M6!?/&38=SKJ@#(YS.#Y4)5/,-L=M,_/+]N;#-#ZNMP]&165J\C8A6PG?PM5
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M4=4GR<SQPX=NC\&Q]BY4H&OCQ^I'+AI\1X8L;!^=3T-2V&B\ES +PB)#[:F
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MN11?;D@%Z."D)*7%FM0';^-^^GTK5"J%JH>M/H(4<5O-O/.3@"EY.HZE[Y:
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M756+)8]60-_#BYW)X0>[",#,)4U*:J0N[KUN+Z@N4_JUL*B(\7N[_"M/IA8
M]P$S$\M5G7A?9/BQGSP+8<*,K61P/F-U.M7P6+:N,;7,)N.IE;F=N !)2,+5
MK2 $=CIG!7GC_-'D^55L[W'6S+G4L=]-4FQ"YK%^M\O9UX*8.<U87P>B6$34
MWB=B,L#J!C)8RH)^/(BM\P,>M&<_+GFV/:\N N)UN/P2(K9F&;:^W[Y^H!-S
M^]F'"99)_%_MIL!/\D]7X?PEY[PNBDGL4* ZMQP_G ?2;>(LRMX@KQ<X\"3U
M"D0XCNA4"@I0%22'D#)8RU'T3RDX*$2FGYPR'.6$5Z.NG:E,KDRYEE4'RB_-
MZ?,\3HH;Y-1@WR>3V+9(_5<A)L.W.9H?@]@1Q=89-Z/VQCLGQ[5YO 4\?G/F
MU1TLMNU)*K\%A%81GZG?%YK]C&FY)"QKK6SGHJ.M])O/L]^@-ZA1X<<%GA_9
M+(LJ.GF&6%) RCI%%&C/7A2L^D]QKD<.K?Q5O!(&&8601N%C56LFW0]9[D -
M&VIC8([?M"H?;7/=XU\6] QEH0^5&?%3!OA_:_LL2N(4)(6] ,14(VF<", I
M25VO"@ZN+VQVK[4X>^A^/#0&B).IT*"><_RIZGDVTK5,;(K0N60Y"A3+PW=:
MLFNL0"]>/B9R[(HR\B /BULG#XO9+,JEX<,7G,EN7**T9AJ;@N5EK0)\SI/*
M,ZD<S# O*'1_;"B O>R^V'T>29Y7EEVP=HZ]4+!X*R76(@2]5@^M'O<Y"[A2
M;W?-[H9*$7/(:%9#;XOKV#]DR)S(=^?LXS[+-Q"*K4W[L$")'N]V[X "B[GW
MR>2:L) 0/MFI-,F?QAZ*O:8]>,$S.:<+ "E8&3._*/ALLH9:T(0QV<3I>=C/
M?(U0(I%Y> &?]V,J5(U9*D!$C6%;\A_B)7(6'!1="F1HYLH4FD$5]E/_RBZX
M,M!5^2)S#LW[6[['Y]=8U1;/-LXV>PZ2U1=<FZ*[EQSF-QXZZ'.]D#M313#[
MF@:EKC&.?*(&%:)7"8K'IO_=R;ZBHTB'96H3.+"KE78:M8+CBX2A+$X,I/QJ
MM\ OO0527]V3$2H;,E2,8&&682G7N>P=\RN0]F2LZL,9R0J,EF:WPIQI\]SK
MEJD^:*IA O\X7Q*R]&X%_Y*_V]&FY)_AX!G$C8>2M>$DV@F23"A7?_2&N^MC
M3KW&!66O(F;;_1>2:DHTCVA,=_AS:5C>'%N-"A% &Q#:0[:S<AKAK*Z3= *P
MRH P,BGRO@Y^I3_QO?Z5I%V?LQ7JS\F9Q\Y_BJ#?-=9I#IJ@UOH3GCK.DY.3
M6DY6ZY G;UX JB 1B>VN).CIRGWGM#EZ0<8W)9]#IX_[1U]28=7>=M^E;GMP
M)-AW*]F<KQT2$8]%HK.3T0*@-XFT@]8._B#-HC09-TZ3M8R,5#BY.&>69^;N
MOZJNK]\)8IHK[Q[<8X]%C4,V/#?231%)@CS1["-W[]OT70!,N%(WO&B<UYJO
MG(EOY% 1[IGC1SH;4[]%)$J]D7ME00]@HQ2PSY2Q2YN%1<E$W:0[S^ )EH@Y
M?O"OZY+C\2W8N67,>N<OU8X3Z?A"U$2[I)\FW> W=:I^21?=>JM&T$!V/J@W
M:!18)1*)6U5^^2!\)ARA?VQ?!:%SHBCQF-X5$VX>@&<R ?>']XDZ!4CM6Q)B
M  E+-]S=Z1^NJ>0IGE(]??57TK)*MR\*:N%4NS@TMONGJO=8!MU!NZD!SBF/
M.>\SDI&^W3-\JIT:043. 6V[#(/TE;8?>X7GM#B%6-'#+&^]MG'8B^K07O5)
MX+ Y+P5X\9/2;=G,6_:N'[_. G0NP_GI7\& I MB;<?10:X].4'9>*,7O9;-
MZCSI!LK&2O)5!@+$U58]OCVAV#0OH"=:5:!'VE.38X#QU=J,QLY,%@S3.R!!
MV47UPVZ(H&G,G%WF?;?5C37Q^,I?A_V )$^+X3\'&/0X500<<VEXQBX ]FV4
MG5CK071M==O\\R?9^RWQZVG"NZ6S0_N7<.KVD+=JO;7!K92&7:CW"K*C09X:
MH1#6J0\//>B^6?!M<:VQ-H_U_0D->$],A"FT,^@J\Q>)D,R]C?_PH6?_J1T0
M?K_:Q!'0E3;@,&;D!IB5+X:3:5(D4RIF;JU87S#)B.2#6)P1+U=3[DO=EA&D
MP,!JQH!GJL%U,[>ZMF'@AZD,!TP@4&^JK+I)R[1G6[_F.^8+VRO_O'7@ Y+4
MM83\%DOX%K67=MCIN3RGN"I&971="US<&5M>]2F696,>-]."^%EXKH:W62D/
M?@Y:CE N:(LM]9D57I(USM<R>Y(QH.QQXLKC,HTV?SLH]/%AIQ3S"F=5^W-9
MH.D8A,$1R=:L)1W9G9V_NOQI4Q?Q,/81DLYDF 'K*J])(L'?"'5,#GYYZPD7
MT<.M1]]+'5EWBS&)T9"KH"QHSVF7*=?6TJWQZF'(EX@E#HM%GL0?KGR['7T'
M=RN)<_U#Y0;(O!2!]F,03F,$$B?WY25:3@RAMH__R$9#+]7D7+MA&QI@^VHN
M.O@WE0$#C?(KP5^8O?7@^=U+"MBE>.SJDQ;<H.G7[3GV3-1ERP&A5#CNF.F(
MM==^O</X4I45,-['Q4]I>;[N1$]T](L!O70?!XPM57"08]*MQ[G%%N#?J?T8
MWBW_SB:H^4XC0T^@(#J\(561DB<YJ2#BJ5':-J3:M^0#'&(P^:6EV/%XIHW&
MMG64>_I6>-DNB+\P6\IG?[1TW'6?IN]:96I@+ITCR8\'@JN+ :M,T58X2!17
M6*^T)D9.00=[SBKZ8GR)-C-FH=UE1N-S;ZN.TE!7"8V@VVJ(T3DE#@J9:N7>
M&%5<C47YF=3C$HKSE_&Z*+0QRN>UZ:H+WK@S/OQV5W=M1>#;[&"@[L9SPAN,
M*PA$S7M*K=*]N&H6ZW ]/'G@?M\NBXEV/2@/0H,/P$C'MC(@[F,QFTPW!YGB
MV(RPA'CG43)-+9^M=+(E/=]U:-=^Q8+:</V*?>OT^(Y=Q82P<&%CRC'<2FVM
M\17@X)X.92V A<=VA6@88/HN)J]<L#]O2Y#9/AGU_AJ3#)]3C]QF@9^5',/@
MH='W"T P KA:#[9!9XA(NM]4)7:60@EJNGLQ/-7($$Z.LY$9#FS"G?4RY= 0
M;FXWIJ7>? :=4&D,2G;+>0[=G%5RRR>0;7G! 730R=X5PVNZ&H@90E-5&'D,
M_/U\I'#";J]N]=0M"9-%)3\*>VWQJR1EWWCN]<DIDMZ8C:F 4#DV7@"BVAR&
M%;KD2<,TV[!D&?"Y)R57#D?<?8[3RB4-,VO&J^W&C*7ZHUUV)*J20\S=7Q"D
MMS+=H_(RUWMW2O"<O;W>CE50O_YK*M,.&B:WU>\\-;BUP'F'>4%M+?2*OVIN
M($P9$2G=RP'5P:NO#,8NTYEOIC\_+BX-03TS5WT_7RIU<M-?G6?$5<"0GY;'
M6GC<%8SUN@"$M+& 1J*,.#D;<"/QNPB!(J2#DY=3IJU8-_WS[?X&AZ3WR>ZO
MTLW#]=W30[NH.P% DR4+Q<*O(S#ONXJNQ)*5@[<[WA7U6P< B(H.6_0F3"=<
M06R4K_>$W##J.[NW+?N%7$@$!3@426D#M]<,\%-EVXV0B'.Q@/*:I2;1\SN&
M2UP3TPP'-RPCMG_T2]T\@5.R6(1_'AD2AU*V+\_+<[S1:QEOUBXUV1Y'<(^[
M'<K=_A#7Z0GVK;O]0J?:MB'NA0NQFNB!+2V ?$'2J(_S%AZ' 3*IHGI7EEE>
M7MNP8!/;DC*L&.%H69S.M6Z ";TQ/Z\D$5%3FA08UL8!NW_?\P\8;5H8[@)V
M=\JCYIWKKA;,N;$E2+FUPS<LT2S@<+OY9V]J)6]<.;M=2"Y-&7\YQ:]BL&<I
MG$D+>YQGAP&-"^TL!60I:=4T1DQ? /0>*]8(<\*79'CT-/W)G=*#F6VRI0WQ
MFV5.!)[):AG83Q0HXQSVSFS6R=N,OX%5J\,T0X*SX[%M]>>&,U3J @5QL'SQ
MQ[FT FB^4YUI^%&7;YIAA>3!PF_M>OR3C/;6SP%$/&=&O006_##&;%&O)T";
M<W&[\<=<9)0P2/MZ3;4@8Y:-2YT*9=:[>P.ZJW6Z@F(FX(YZO@)W&H3&=+/=
M"L=S>ES!<@(*)!HA_?Q#/6]M#&C\Z";MC9X2=F=K<;*<$ZV746%4)'WD7WVE
M/SD;^I[X5MWI1G5!A?15O,KBQ$MI/!3)"LM3SJ57]UB=@NYBD9ULYBH8:1QU
MZTO49ET//>^,6LQ7A>I;5$9L+Y*YXC_7BO2"J0*=+ENP$3?.>>G[-GJZCN&M
MMZ;7&/_C.M(&V9E<]FG0QX"[7L70K](G5YL$LV ZTS4[$IV^2.A4#9N6R(0'
M1/X8%B'7F[O01343=DXR#FL"LFOSYCL4*Y+/OB<J6TW6]SW\_+-^Q'3\UT<1
MR5@IO(%W><LK4TEYB=J 8AA'Z)+D&:AO,/WGPW[V[#4C$7)&W*O DDB1)J0A
M+]UW([DJK<D?1V^8W7W.ZD5+O[/EU]<FV\;W>*;:\0 [2F>Z3WMC0<BK6YP/
MIEK9FED=.E$.78WF>5/3D,I-[$WW6ZV-=>G]R=SQ[QG'JC%26M]&2J['*N&8
M$F&+2I]9K\QT 66UI]QJ>@*-.L55?0Y,V^G=W2*V-&V-?.PM;1/NE9+)R( V
M& /-E1$PM&C<TN\T)!RA@-'RMI@Z?P0K)W%F73PJ9;P71CU<U5%14VU%-FZH
MLL#\Z?YB2)PA))0@"%_OYI2"4)CA,>J2Q37#4A(E3D9)SF6W,[]L?@\1B2_5
MS<ED_F)P]9':PG, 38V;"%=U79K_>^.\:,WF. ^&A_T\I]8E&Z?=Z5&2)7+:
M6HTQ9]K-T0YUC2&=O4(NXJ7O8:2TWA"@.>(ICK$P;W-.(0;L'H@>OB/4K$P,
M%: 2E"_Q=X);UH4^LKD[9#7X>LR@ )SPNFQ7@<7Y G#] F!%0[/=* M^T%T8
M(3GU(LIKZ\NG'H\7[%+,J[>"/9,\8P"G&C'X-^KXAK*O&W[W(/AUX_@C=UHP
MX_*\:5;-BTQ0J:^U<LS^^H_?N/V-U7 A;!ED]%(&)92:O_*:K<K@#RX+N3X^
M'/8.'C/246L:$?]^WD0YWD9/FDF,U!*[FSZ\;ZU/]T)!QI+>!W V%U->. @^
M#:Q.UZ40L;CC9$U^FSTD=:1BV/C_Z)FS_VGX%0,0R-9PLY]M<&->+9_.4098
M0Y=HQINUO-^-(-WL7JHV,4T'/,M5?^S.J4;^G<W6*JP75&FCE\M *JJ8\&J+
MGZCI*=VC8&V+!Z.X][$U4R:!S+;Z1;EDE:4Q!L%V<HHL]"Z05SLL%F]]"G4?
M,C<JA!VVD)M.'YG)>G,<5SQX9J'V9;AE_$ZT&BDZZ+%N2,(KN%'[*23TAT/5
M.&J(5@LFMQKAZV6;J9*BE*+>;F^3$ 8VG*(G"BN'\ZGCI&K0O_1U0\I$? 33
MFRL@8B^<)%3&]OBOLX0V629YUB</N_^U0/-5M0XQ W4[RXYQ$!#[)!D=N^-[
MH%TKIH5:HMQ>_/*%TXI5A8(4K3([:FGIF;GX+IBUK^S> +,#.&[4QM#..K?R
M\/[FDW?!;#5*=/3$S]_"\IW7V*D2(CD$)G5(#!B,B!YR!NN,E8BGZ6@<\OSN
M)K6M4<\WZK#DY-'3L1H_M\^+<0[L$T6YU[V5\<AW<&3'B05G98WC85-.M7]%
M=>D0XL0O_3L?N#IQ.0YG:@$<=6D6S=L\5<EB>FECX\Y12F%<<>,=J8[ZVENB
M_N_5CKE40/PCGS3<9QSTX5Z92,ZO#/9A088$$K[7 \59'TU"OP7WS^4>,K3\
M21?T31B5[PZP!%+T_6[8;).4*YM8?/TJYZN['XNN 4AR20H>Q !^H]&X#&L=
MAD<AHT0Q,'K M+*+G6)[7]_>MG'0?:Q*,NYFI]\#QCJ2$2M9GIS&U'<I,C<Z
M>[D>) UL;94R<UZ+6?I=2D6*N#<&)CM]>\RU>Z(SQ2G=.@G3+&QLJ-^?++5:
M\U)_2AK.0:9=C))5(-_TE1>8;%9F:& MRR-E/*&K2F&Y+6)#I/Z9>RA(]=F!
MV=/_\!*H?[;Y^$,@7SON9<\22YR3*21JSZ7Z[)%UZ)(4FXT.G(3K,GNH27!,
MA(A%)<(I!'N9$ KHW""N"\#H?!%R69- C^Q\>*Y\ <BKT[D M*:?\[\+IL$[
M J/:#J6V@"?CE^44B!U5N('<<)U4V"NX %SCSR4AL))C1']1-T;^.FQ#JYY+
MTG1!3ME@-&>;R(Y+_GL!B C!QUX E-SR+@"!HGC=ORWXVX*_+?C;@K\M^,]8
M(.@,I#\W684K5!XM^N[I3RSL0?U?NPHUAWW>^;U'7'S];U!+ P04    " #L
M16I4CNT42S[*   AVP  &    &%Q8BTR,#(Q,3(S,7@Q,&MG,# R+FIP9\R[
M=51<T9<F6@1+<()[@D,A"5"X)"%X<"DH++@4$B"XA1 @N$,H H3@4GA1.,$]
MN%MPET(+G_QZO>[IF>Y^Z[WIF=6S[_W^.N?N.M\Z^^S]G5OG/LP\_ &0*,LK
MR0,P,#  *7\OP,,\0!: ^>C1/^Z_AO7WQGZ,C8V%A8V'BXOSF "/@  ?#Q^?
MD.@I"2$1*1$^/@DE"2D9.04%!0$Q%34E.?53<@KR?SC!P/S[#!;V$VSL)^2$
M^(3D_[_MX1> ]/$C;<P*3 QFP"-2#$Q2C(=. !, @(&-\4\&^'\,X]'?,>+@
M/GZ"A_^W X($\ @#$_,1%N8_1OVWU?]O.P"+%/OI\Y>O<<@TS7"97<@%@N*S
M'[.\J6RCT!H]9A4T=_W\!(^2BIJ&EHV=@Y.+6P@D+"(J)B[[5DY>05%)65M'
M5P^L;P"QL+2RMK&ULW?[Z.[AZ>7M$_PE)#3L:WA$0F)2<DKJMS38SYS<O/R"
MPJ+BJNH:1"VRKKZAO:.SJ[NGMZ]_;'QB<FIZ9G9N975M?6-S:WMG%W5R>G9^
M<8F^NOX'+PP )L8_V[_+B_0OKT=86)A8N/_@A?'(\Q\=2+&PG[_$>?I:$]?,
MA8Q9(.@Q^9OX[,JV)RR"6L<4YJZC>)2L0BMLJ']0^R=F_]^(??Y?8O8OQ/X[
MKSD  2;&W\G#) 7( .ZT?T9P OZSR*]V+-"VO*G!.'$^<+^16T;CW$F^7)E]
M2YO4U[*Y$W#VZ@QS87J8D:EA4E+%C"^/*9*/;7*,O<Y+R3F)WPCYRO[H("-O
M<:>5'F$8&6)&N.#2Q*> 94$/!OT9?FI[3SUB@^_M=>3ML..27R/#4Q:P!_1X
MU")!"M%UT8I6^"F3YQI53AS26ZC;UB:>J(2T/%S:V3XSY9=@4KD?> #4L&>7
M[AY[V9C6B5@[\9:QRKQ@02N5ER6M@S>6]_<(EQ H:$?%;.A"*K-\CQ5]HFEA
M^%AS:57-GD93 U,JZK=QZ, I9ZDX4LAI.F-Y4SR"L]SH=IOS9P3@_S9P<=EQ
M8MC^IQTE"@%JH@W$'P#A9T=$'9LF"Z4FD5G?[BDVI9G1YQ3?S!SB7S/9.3$E
MHC68MWKX@VAENJ-97_L$# 0"V)=0X$UU9Q=3P:P99,\(R\X(U >J3X:PMI)^
M;_H*.@9RGK/&<F6="KNIX'68N=6!'N$L>(6XTPQ]MS?T?/=^FL$!F_YM?2Y"
M.H=OU6$8F'/N0Z9&U:#*8;,QLRW]Z'YH#MR6KE=WBI,-'WS).TO/>6;ZVF2A
MI ;<[P,^ -FQ<,8:SM\/#G3Y" >C=IP?766JKMN4M'?()+N_^6Y7I@ADZ>RV
MJ*0)\39WT=[\WO  ,":V_5EQ*[5Z(-*IL3FU\BZX]-V'CF-X?T[4?_5,_A^;
M7>4M/\?5I..6&)OVIA.&^.>B ^"W/N#/ 6-C$CUV5(.Z[[W),6_?P!84.%9+
M"'T[HUE1NQY[WOP&;&)/SB@V?<+V'P"KA.9Z*4>=*2>)NVHRW*?1% AHT;M4
M2,:@9L*'G[)[AF/HSYO= EES B]-5Y:40-.T/HSN[RRY!E+=:H[+][<<<W?[
MV.M]B?)H:!291?LNRQTKC^\SG',9!"1$I[I2[8*=^Q7R_ :RT3]7+ZY8(U97
M6"-SG$&'#<87.2)?+%O%@Z\*O]R-*NU4CBL7U(:)BP9^S:IN22NV?SF4/4R9
MR$(P0!"V(?U'CS+]1GSOVF& %QG.NV(VW-]#D;9&_-2H[0,?GU-!@KPH;]-F
MM4.3\450;.T[F8-L"N4LX<(M>$0TS0G(;4F28R4C4%;'%VXR9_CM2BE;0NEZ
MNLF+JJN@4]B9_D;NH'6 4SO.?^_TM)-I+IRTKF+2:=:GQO'Y'7"G=39FU;GF
ME14!X^KTQ_1P,9;Z,N^NGNQQ^1K[;I1TXL]X'XU!<E<7 X9'H[IL3?L9_JJD
M2ZZ8]Q\QG"+D'!>"89#_\C#[WQIN\MO0H19!M+RQKUS,R:3D?/J[1&KZ*L:?
MS=RPT1("TOA73)D!DL?P@Q:GFIG+5ST"W#$:EZM-?XJ='$^JAL8)337]3.*V
M6Y^"'L,IM'#PAHBDC3(174M>OAU+S'VM53<\6_<0#J98BEG:<%YUYA;"OE-M
MR;!7DS&QG@WNO!B'S24[_,1[>E6WP/I6XOLH%C$'W^GO0\?.ZG6F9[R&]EDK
M<9C&AY$K,PX!#,9HL\-)ZWCETER_ O886Z3+RII)Q(>$D>- *BC)7M8N'6G1
M\-#"-%\)<R\.<2UPYCGZN8V3SI+]E>:D!<"ZME22;669^/N\(6B_ [U.TW9K
MW_PSHDHLDQ)AYZ8NFW!,'%J.X+S=VQ[TD(VSI.9@"/%W/E9O%[!+J;)/+$C>
MXNLEB3*3"J1%+6,/NJO3[+PP^AGI+!JPHL 4[:\VA'CS[''D+]TR[X'OYX6:
MT=2SE.L-^FBFE\55[RS7)S[JV3$PCVG*Z7[R4;;8T5MI #LP$FK^3'QE/S;E
MY\G+9")G&+/">C2D^'14247Q403GC_]2)*0D?*+\SSJ)N\C+M0=<":Z%W28=
MR-Y-W.O^GHU)7@H86:)+54=]@93K\Y/S!<YAYGU(\2_^,C0 5,S"ZLZ] [ZW
MJ]UC)%"6L]&_FSR'9]^7'Q?7195$BH(/VX./2WT[Y^OPEAIVT%,,J/6QA;</
M &(TZG?BWSH1XJ_600#=//H"PVJ8COI1IWT3*;,D=O^F)9Z#_7/GSPCN3_^R
M:EX#Q^%LY!CF=#_K"(>,E"A?)XN5-KB*15<54*1C:D64,,QL;^&4AF+9"'V"
M</[\A/=OD&L1! - N&4$F3IKO#LF-+"2M'61/MJ%_VF!]O^&W+S<']C_>4<Q
M!GK2^9\D92_R$(+;#8) <O>,"H6Q)A'5)AC]DT0/";AOU@'O!ZO1LT\XN)G+
M_4WJZAB5F?;Q/#L?][:-N!:#M^6<X)T!^E=ARFV5T08*_4!7"=O;ROAW<OA[
MO<G2%^H(-_&,_:JGSZ/6'P"D99F[2S*'P?HB_>2U.)PTVTS5?GS(ZP'%6=<2
MV*4RBG]VZUX&$7NIUUS[^7,$9_&_&6X1I6=L_#!"00Z($4"7%^=V DMGKMK5
M+Z.5#"0IK* EUW'I9V7P+N(":,J1_PMT/ EKA4%L-EZA2LPC1TND:7JX7.=S
M+DHMNBZ%IQ*>TF;HHQL38MR],2_/]@O4DKVF<%\9ZP9I:P.NFY%<P<%+%'][
MPOS27DKMZ:SR+R$K!094_,AJ"V2*K;X5);<W+)+J#IH_C/_]8CZ6=3K?*ZXV
M^GC4X<BJ-@+E3)&BZ"0Y[MFSM-<-7&MIAN1N7L$MKA7N=/N/R2MFP/*"26>)
M=K4W-3=\O7?8:'64A"HZ8Z5FDD=MFMH@6\K"6?D0$W.IA?/NRSFTJ.EUV3RN
MA?U[\'MQG"'_PIP-BC,T9)A4'L2DC2)Z-F"6; UZ4;/<4'O2T-SRMD93SCU+
ME%Q3#O!_!$DU28":_V4'BHH,MAAVI6T^9X76?Y.BZ;=)A>1<,?8B8)"U85FV
M5W&4BJN:;6D6I<E0@9>-3@.2!D9GQR"=K<99P4B'.EVE3(3;3]TS5J4/-U4Z
M"WB8-M2O.?E#NR254'@#;16?.H8;S4[:B7>A$<<Q=<OSM/"-M=2Z),F07#'6
M+="6]+.6NHGSR,CTSZZ#+L/VN5^E$CN6:UCN*K4UQB<,*;NWTY/+?4?/H<;.
MJJ&'OW5A3W!DN>Z *P-6Y79HS-4K'G?/4>ND;WSRVTD79O="&(>I&:KO[7$)
M)IN]O\-^33Q>F/BT'?#4[]78+=VJ?-4DZXM .W/1?)F/(MGEN3V#V4']F:&M
M4M+LBXZP4:UW[PH^M*W[@.=-\=S#R^]IT &'=[%SK CCKH;O+J\./603(SZO
MGD@$4&^T-@"%3\&.K<]G,F:FF=;X28SUO0(ULU34931B*&UEW5(P@\#4IT_Z
M>(=ED0TQ*Z[PX+OQJ;SRI #*^^DYCW(OF$@4W+ #LBK<P1KQ5BTPSY\W?P]E
M(DL?SFST:@W(8TFB,)48"4G*3:N4$Q"CE.NO75'_829'KH'QWZ'YGL+0&60.
M;*\C'I\JT=1^#Z+H((BQFTPIZW6EHW"2J)@A;#O/G?Q4+0<RE-J9?/:/F:9@
MZ#17-%:7IQ:Z*&U6@:@8=0</!J /WA&'M=J6S\I"QOTTW5>)\0R$"PJ,%:U3
MAJ1O';Q%&4.;4J;_'$5*Z@KIT:H'.Q]P6-^M3S\+,<WWP;MC381DS+/8Q[[B
MBBP:9EJTNBWI+4D:+^)@W<_<ON/'7L4Q^]+1'K5"4U?"/K^#&%M8>0!89P7M
M'+NU5\FZ[KF4+)D=YID$W\6?E5N7^?28SK*SFQ#3A3@K< ]FQR.YMJ'C!<I"
MYMD4/V5DNM: UA1;$9W*IXF-K'^+Q>]7_]>E\=S\OF=1EK 2WA6K*WE<^ L>
ME1=1OM>Z8GRTLL/*L2Y.!4))O+\@RIQP %<JY8Z[,ZL 81]S\GO?S^+:V]E!
MQUG=PY^NLX+.!^ *JDC?#$8;_F_=$)[O?V*53T3&F1M[X^5]K%O5W*'ZARR=
M7ZN ?J6E H3>J1'2 +1LYXGD\'N>+2>_ 0LDJHN9.'B^/8- /=9^YC@@T3L7
MG:5:;_HGS>ULR%_"^X;#$&<H$\$*G;6*!6D$#(ALOS9V(HT)&Q#ZE:4UP0L?
MJ:GNSK@R,V(O6NUL;A#V>?O4WK.\/5<EWGA!IIHTX97S^16[YJ2F^GFY\G'K
MYX_$@+FO9S<Z!I6G[Q8: X0X%X@9CYWWY]WA2WSPU:N+4(F0))NL;*F294JH
M(_<84,7]$:<&,W,F.5%RNG^94(0N=6 #H3EHO#$E+G['L-B&P>B=6272W<?:
M0?%&(=]'SVJWG3D^I,VE9NO1C^=9FY);><95QV?(K]WJBV\[:$#P)-UA<5UN
M<'(L&ZJG/0O?3QU!LO2KSZ])P85VI>T6*/M'INT!0'7+W=IP/XYZG=71>M+>
MK?YMK9+U;KF]6?! 7#W$@LN1.G.OT7UKJ<+Y''A@-J"HKS#!?8QMOBS<DZ-V
M9C$D["Z\3';V^%9>Z'6)+%$NV.?5 =+K8AAR"'=_FX0=F-SL2XM>6U-HLVUR
M=,$ILO/FRRA]]2W"RASC" T6_/, F./O8<(Z>CXFZ6;%7IEC8V_*SU>R2]<L
M6\#BX[XBE7:Y>KL0DUF3O/D ( K@LV4BJ4$?"1&J 3M9-C_5LJJ;([8I+T?5
M<C+@VU )_>6)2CER;>I_74O_ H/53<@?71*WP/.-84\Z5;3M;^&MT7U<EN9S
MPKT@^$3^]2T7!F7V2R0BX=63N=P_[CM&.B(JWK1#=&'@=1(WXZZ104N+9\%9
M_2VOJE&']7]:2>Q?SC8LV6UNREX8Q*I_NQN?*\.JWBX&#C@$2-N=R&,?)GL[
M<OA_$I],DY:T35>*Z;^7WV_1 T(3+<:@SNW7GXV[A&SG.]5KOJ.RE*^0G8$T
MB&9S#N0X+Y5*2#?!&'U?K+/R1>LG5#+:W]88ID2ST!3=9Y&97_5MK7[[3%/.
M4O]_HO>_#5I:8QJ/1O^C1NL<.^%S%HI>K]35Z1 _#I=U>Y^-O-)% JLVEEUN
M*S8&RWVH6K+RV$8>%<>ZAV\1%'8\''.F3L7ISZ*-;#&R_+KP5 9OFZ#EBR8-
ME\/ANQ5NUP^P:N,^VUP&+ONO_R),N;AI^+0D3Q-?D9'%J%/H0=MZU51?LPYS
MR8@P)C,(8:8AW<6$YCA+*K#)-=_]LU"WI%(V4)@J/NBQ1[HSYWJ;8UL.%S*^
MN2U9@*4+"MA9Z_=P<(P5&IMX!WK7EO\HG1\R!C,+UE=/5>77I[AZ'O+XZ(V&
M#XN/AA5YW)C@)T=NG$OMX>SN'*8??6?\F9_P6ZT\7BXSTRH=6X78?NFEYL(I
MMUZ1[BR0^;.\_EH\1".O@6]6S9\K->7$H ^1^%Y*:J=0<G,K*&)LBP,86;W0
M"@4UM^Q(MKZDBH/BZZ'D-DN'R $=@+4G$Y/U^-RD="XC$3'=<M71GYE/=X$B
M=-4C!5^CGD/M+67-!T(#OYV#LO%YWJ>MZ__$%#,'E#]'M][(S:(9O86:N9@;
M)Z]E/H;M[4*W',&KULVKT##8 T K[?*I'\*\6*H".).=,EG"Z!^_.MT#49ZK
MWHZ-9J*IB<5;DK.RBKR3=?)@L2+QO9G.-+E].\574S?\U0]$T"#7MO8[-A1W
M)#/Y3^K3/A>?W[\A>@$TL:WTTU7&?-D%?KR3YI.2VV6=<969WE_"/S1_L:C%
MS0LP [\LUT*H&8@6+BT?^PWOWC+A;(@%X!+2UN1HY<DQ6A_YUI2ME:O,6RL1
MMY>$?PG@0AN7J.0MR;N!(E5J@.Z_SBEV @D#'>QJX$I^4BC&KIJ];?74"_3$
M%U9/LWN*7P'#D-+85:6##C+\=H,PLR.3MC7^T&OB6)XE7OG?8I;X09S4+H>$
M_HPXR*EMKN;A[KHL0!7!F)=H8W=?.>M4SV@F \H_L[Z@R]O"DS+;ZEF_*CX.
MQ8CLA\1"3C?3#(N.0)) FSO5<WZ<I:$BVQ^'"7U]9K%O6B? S;=,=V62,FM%
M/\?/8]$%H.4&L[I5$6=S'W]"]W[<,-KXS,%KCXC!ZJD$'=5U@8K^WH)G4PD5
M\:X%+',YCH1R/R.X/OWKY:.='/$].,*10N"1FY=D=6M0\/"**=6>OC/)+H<D
M71C+*>A\$RZ2[ 06Y>_R"R]].P)-[=]#?!F*"ZA956&OCOK@ D,RERTE0\9_
ME&C[STW(N_]:;*0'C\L\FE7OV'M&_'Q>)L-OP"V9T%3VEM &>3STW3GY*>5S
MP^:WM32[?Y.&N<9_1=+ 6%VN>0!TJ<2&M!(Z.?/@+,H?M QA9JUP%)5_N<4T
M][.Z0Y;8?]XR; F&PF$JX>P\']17#DPM[N<"<%M0-NW5+@7=IRKY@QQ>$Y;)
MA]"_M0)C:7E'?-TGY NAFU31XCHPF?7B>KK?VIV-_IW./6/8T0)Q6 Y/#$*9
MD'MAKCDS'7BF;C%6!DHO_Q(@'7UFF'8 >4X/QVQ17K?L7D)<4_QA(NM98WJ\
MX]/ -^J.5\^(WCHO[R_903A:="7 1Z 9>H=.FFJK!K'*=Z_1$BOUMUS'RV_&
M^6+XGB--7_H_V:(83]9)*E;E_W(B^@!XHAQ*A2^>H%8]V@(W+/?WR=B]&U51
M;/VH";MF0079"2H.!>GR@52@;+Q"J$Z9.1?Y&\PJL-5<A)T>J$\FQ$VDE53(
MT"@XD$9F_]3@Z:W62'+K=.,=R51EGIA#E+$]U)OA>ZHJ!^8&).B;J])J70H:
M^9.?^ML=996D)DIKZE0Q@?!%+T?B!D\'G1R47DI^K#*I4BC!^=OT1 O0KL&I
MB*TH0DE+L*;_RWL8T@8E\J8! .IXTU,3&8$V7<V+[?Q+F% X$<KCXX#_M2G-
M.U /U,\?+<WI914X5GK$JGM_:]@-W&9)>J.A)C!QG&D'$4!_E%'A]5/*-UGK
M:PDYO1^!8R>S=O> F?:_3V_ZQQY(E=I5.4X(=?7NQ5F YK9-$9,)%D-4M6_=
M7[:LZ.OT[<G9W5NC?K,$!@A+W^>6I]\2HTHT4?+ISKX%)HWS[]I(%O(%W"*N
M6=3([B+(/K85<.,?[,!0NR/)./6S>Z.=LB3I0>81G*5J/XIINW/G'!OJ:!9<
MP'OX7<NH+>*;LY15*^LZ$67#@!,?-WWQC(E*Q7;__K!LS2[YZB8!*^HHO2]@
MU**\19V<V#F]WAP+7GB?[>"WLH.&V#14MX^V;IY=<&)"8(C]QE9HPN9;+[:3
MM</6%;F+'*N5NG:+H2QZGZFF_AY8Q6GB9?BT^FD.N-Z92_P[;'"BR<"Q ),P
MX@DKO=/! V"ZE%#6H&6:[;&2?G5[^:,,Q_P>(A6_X7%8"!7OT$+1R+B'JIF_
MU$;'D&?]Z;A42W(V:V4Q*76W@IONP1^)%C.]_!"_E@!90S9'8G%W!OD-\PJ)
M<0;@H(RM>GC)<?DOMX7VCAOY_2O*CM&O&ZUXYQ*&KITA#G_%A.#%]?BYQ-<F
M"=Z,&J2X?X6;"RN+:W=/M46>YY^B]GSF%T650]IIK^MR-N6G\IL;$C97]6#>
MU(V-] FJ]I!=FAY0V[PI0TXB9"IUZ?P:E]N8."N)J&>0:*6;6#)B80*!+]%(
MO8J@BN6_/<TT'NW:JP$30PMOIH;*?N"\@)X.>N*.=(*3[=U<5!=+F)!6)D"+
MDUM"23[FB!)N^]'D@P*5'7AC1GGP.8-L^PG^@$0P8=N?M6S&T.;&OQJ4EK<\
M-V)9C\GRVS$[TX<[?^!6I)1*;#-$XW?U!Y_I$>W^#V@_25MM/<V]B=M$H>'*
MV5KQ?!D*8+^_.- A-3FVYN#H9]T7(6*&3@+IDY6@,J:>+"Q)(.J12 9\KD=G
M_L38\+;.64MB.M0+W-/0^H6=T$XL85YROM>UX!:X<,N @BJ@6./;M_:IOKC1
M%WSVC_:J^]Z21ZC5 &K?)"D\&\T,S$%?KCKO+W^L;8@0B?#C:0K;B+*7(M9$
M3X\O/WD V/(3^&DB%,;<L4,OF9HJZ]Y7<5U[E@6@'(^>OQ2R<\>*1'1$%>$T
M>78_ *J-X><#]DLD,%5,_=BMV/WAK[,-]Q1KRKACVET?TRXV6GXF?G@ L.BV
MS):'^M'=J'LA5Z3.?(@[%_D,(RW;\XM(^GJ*SLM+FLA0+(JH_'2&B_#"CL+9
MNN'>#M<;TKG*#1N?A(0&B0AN.FC=(3@X]/Y ]?7K?]D54R@8Q1C40-=#K9%I
MV>\3^75$=Z63/JVV"$$3T6Y*X^4_Q+P.Y<%2\N)@4O<"+]]5+?A&S5[!;DB
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M_;D)Q(Z(/ #D+ZFZ4HZYQ-,!KH/="P[/J %N?:>'++)#(B?G3!1&K$:[)B#
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M!++>0K^HY)\S(-86DD5ZL-,#V8/V2XW1\/;H@C#YEN'&N9:$4Y\XB<ZF7C?
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M%Y]^6>*5X%N&<?+S?O<<!-D5+#*NJ* ;1W\_HRC/\PI8FDP^#!QCVTO9YG;
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MLMNQ6\J9M,C=,?M>%Y:G"H[T[\"CT-3IC)VT$SCL6G@_N?IR_C'4N4QIFB,
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M#::VF8W3%CUY0X:ZC!%)J:8IK9^B";1X0R,VS^(%$ YJ<=XV\!)UG6_2-Q^
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MX^<\+9^9=YKR2D#<V:&+';^.0=XD5NKJ<GR=#XD%N1C^TZSZ7T'%#&4D,R=
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M#QJ"T#-P=UHX^00),$D/]EAR9Z=!\;KW)LW.'CT01@^L*"/8HVN,[KPEI5-
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M,:HO77UW5F-=+,4O;B>J1J5B\<E_YQJ"A[^0'W[M(R^@$7> GVN)-SZLM]]
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MNY&6_M&4#Y'X^)D9EP-&?<5VHF:DUP3#EW$DZ:$A(#-)O@$"FSV4WSJUU"N
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M,CO)\KAIU-BG\#.4!^9F>?-:82GA<#=9L<O$ \ G_%)^J^P)!M5&SP<+]&/
MDI4*SGW'KQ[JXJ$Z);LB>O[]L\>N69-:;;*N_;3O1H@$H:)+76%A].GZUR-Y
MR89)"1F<N>E7,^LKT?LV\P6'\P.0"N@!D4'A472L?4=Z<VVBW%A#N4"*4@<Z
MK<N>PL5Q3E;]^[ZL5^C,T%G8WL-%%;//0Z^VJRY5EXPUG0<8ZH?W76HR8^5>
M(ELMOPY.C, >[PVKXFZ-*"19F%^F7K(F'^^!.ZAYPC/(C5Z4ZW$[^HNLI!M,
M_+:B_G.X'_PP/CNH_M'[*< *WGR69::"P.<BPX H9X/;?^)STFNO<SR].0C&
ME;WH\Y!2V*FIIR=K&1T[^D)>.JG9[Q,PFDX[E3Q.DM;^/\#EKA<MSZT?[XHM
MHUT6'NE#GA[[';_?G4U>B- 0I*1YLZ799L>\N&L0JOM:HQ0KVAELC1N.4APH
M'V6M/GJYYK\L\LR0=T&J+)UP+T&)YF>V>+EA-QCRXUWY'8"$AXSB'A(.1BJ!
M[/JGQQ0;_8,H":@30CGP"9Z81JJ27K'AL'P1AL3[J8>R97^4F.B@MD?]WM&M
M9QC.H YW)V^?7Y[ -.[V&!*WT#P6.+AO/=CW7!K$[A81](AY(WF;ZHUFM&+#
M9U^V>[[LQ'T3R6R9C:3J__00A2^@ :13S'JCI:^TSP1E+_1"9Y\&]\)L.JSM
MSZR%<CGY+^04=7'.SNM*V0%=MT?Y;E>^\X78/QUI!J=D%3D8<Z9[^WX6MYM;
M^D/MQ=QC:O!!#5R>]X?7Y-X?.E(8]N= ^E9T#[C(&/[#)+1_[7GT?YJY]I\%
M"SN5- &U*^F]X'P/B_D+'N!^]AD=H=.$F.]ZA-#[M5/73>B0C:B)0EQ!KKGD
M=\1G44)PZ_=))?^O(Y^1E:L?2/E>??0%@74. T0LR\3UBUJ&_Y@E'\C%0A^^
M!7\[%6C<92NL QL%[."S[J^>[D'2;O*+[OT3TOU?8U=_1Q^Z<4!QNW'^9?CG
M'8 T%*QXA5,KW#[-=3;1OL>Q/#VV%LD7N0\/I%_/MF+Q3I^3T.5903VZ S1K
M?PRC>;1O:@L7EMXSE ;VQU0YBMAX=&MD:!MQ#O^:$V5O73TU?C!M7>[8DR=#
M-M:J5$E.A>\_79MN<-CPY5IF.>3L4D+<0E#^F+#U^Z,5N-VFBN\]5V"*'8<K
M9Y;9(2IU>MP0K%%=5EWA,;5F(6?2I#E=3R'^ZSA4*V_Q9E(\9Z^A0%*90R]$
M4=OU6#0JBKS8XZ3Q_/#=#C1O*Q8$F6M,D1T9?2JNVU<.(R4.%GPLT$#R-.;=
MS(/A4ZEO$Q.W3P]O$-]=]79Y,BW1/YZV3-"?]6ZG_P$&2TBOY)U%:'ZHKARF
M5Q5T6:,$[R><%D52M%F(Y%:9LGHYZD"@?K<!O>R#"'L9:[_@N&DC?1N=+D<'
M#H.W*R\&5ZFOE!:UGO4MHBUH4LU-8OM<2?P&Y@F"FX^LJOT2Z9,(J]-9Y/%Z
MB?,DMSM:C(.%C?"'[04N-SYD\B<J4.1I&L-Z/?H9M\2R*J;+$;9:')#.W-\P
M<EF;^CR:EA5?VI+=#R]^X,A\.+S&AZY$N+WB$VZ?_:>;1*WU,::B)5CR'1R!
M%M\%T4D6I9#(%BZ(,M49:#_YS=9XGM-RF\._778[F5N5T7(-OK1W%1B8JXOS
M*S,"-#RGF>]2O964\Z\W-(:H*DW<:MEL6+;^?(2[7G*KHCW>*JD^J_X:"]^2
M86S^UQ2@R+C_)Y)(1GOQ;*9H"VA5")WSZ(G[NDHG3*V+^WY'/:C79R]A-[.8
M1]#Z -@3_A2!T4DUR9S=5J8[SO6J<2U"J [9[>JN&0[<K-..&A#0";?P]85P
M/Y:Y/7 V%$3&"47OAN!$F6@.#^)H#,DP_$=*%?]I28O_"I 4S.N]\:52@!-(
M>H\EL^&&COF N.H_E4O91"WM<T2D%3LCZKOX.L4*7,DVWUFB+6T@_ZV[*P]F
M0UOC094JTI3TU=K>6UM"JXNMU$/?X*HUL=PKEJM4;44M:0E*:+F-[998FA9)
M:@M%B:*6MO9=;4FL27&U@@1%J/7QYMTW\Z;]P[OO];V9]\?OFS-SSLR9.>>;
MWWSGG-_Y/JD*XBODR/9C#[1!*SQR6\^P,3QPM="Z<Z^'FKKCS-T&%$Y1C?DE
M\T+9>U_8EL-L,9^AOKXO$MSO$]\HD)K_A?J*;#,F5ZI2-9T27 2-[3SE?C;!
M#WZH>R0) XU0O&2[N)U96U!Y@;O#OYCO^_*9Y]#>/,25%'"?7W)4-61XAHH(
M=$_E+.$=[RNK^F.@!#,5FA+XT<7DY!H!Q#5% [ZCSJ%O?AEYVZ,N8[IA]?KR
M5%.FF,O3X"3(5L%YM2W#-Y*AU*4L:L[2>DO)1.XN("_UU#I+M;=KGK +2 QZ
MC5UE68PL^\2,Y()Y5S5\C^PL-&O."NOTMV\UBZ]U+DF8Z=#)X7V%XLM-9QH0
M,;&KAK$])XK+@H-;@E99CFZ+"U/-[YI*8BU^FA6_@;I5:E?=./V:M;V$D"<I
M;?@)P^YARQ]M-T_%"2"P%C!]T;\ELH9X0%/H)4)X)^ ><8U+D;B0Z= D,[XZ
MUY^]2']JYZ<SZ"S;3W3[67]OBR%ML->/IHLE73+5EW<!3E9C@D&L!=40=,3/
MF48SBMD#M9>%BJ5]Z1TZ4$KT^-E!)<^"9[U6Y1&>^=8 P;U(&/XUXOPJLG.R
M\;P''?P? -=S-#;R(M"SGE*K+#2A#&2[<B3%9Q3P0$W<R++^$_G >_%#^S7Y
M9)*/: SM+8B#/6=I[%P[R"&L.4"S\G[,1J=YRR6S]YZ%2A@QB=O:S>#6>N3=
M[.X7;'MIV -?YL9XW23+9;ISQC.BCXB!C/U#A&<8VJ>O"/A])_X.$^'OYT!;
M1FE$-MERSR>LS:6]<-[4$ORH7OBA2C^'K=Y6!24--B13Q2VF.2U>/.U7YD6P
MA5\2D$?UDPXZ5+W(,_Q$K4ZPA[?2W<-3853),@.NC_),T^-A"VZ[ &GF"HGT
M:^MT0^'3R2PX;)IQ[,I1N;J<]3*^D45/_G3X#S.:(O;R]>%1'+K8DK\7S9P3
M2TEL>\@W'H?:Q*W-U5@&IH$^2CNCNZT& L$#"+6VFQL6BA(J\'[+OP@HY!I=
MO)J348&>,SD"K:.LJ&%,$J.8=+*RZF*'#6-G4Q7^[EH-169\V5O;H0" I)-5
MVR''1F(2-'%99HOS:R;2EM/RCB@J)P,_.I0O$YP4'D1-/YES&SKLT3N$!\D!
M[VB;VOT!%?PW#T*^BO0<8@34D5FQUI>2>CYLDR9;$.3H==6ULJLO09>M6)6-
M!^J4TN3)?[:/:'M&1H+[;&>/.2I<>&U^&T7),&ZDCD3O5_BYB9A67K&KDS.=
MD@W1I'!1$K+BP3U,^AG7!@>AQMQ9>O2DUGTA$3YIBA%:5K0<^T5>^GUG$JPS
M:-&*[>X6)Z?;JH-ZM!7?;5V:&!Q 0@1A>^%'<!;6I0X5)<?$/AH%"S!?V)6P
M>Q7=9/JYNT)/BY;#=(6&-[L'Y\,81:+E /AQ0+M&01H*:^,T73:.M9&B$OSR
M-:S'\)G@D'X>Q!H"PY@VI^LP;04J4>7O >]69A0MC1=KC!Z>,^O;[F">93F_
MC)/Y 11&XHK/7;^I%:K=(A/.YA2U35DY%*BA>P7"_OGR\5_!-[FH//#DQ9'Z
MWT4;$O;.G)(<TL1/Q6395Y]RM&O$/^"TQH6O5ZFXT4I+#/)]O%VJ39.(U9L8
MIX 3TJ<QKD<T/OVVL^:"Z*A/.W-R]7F&78/2JQ #611V8=U&OX* S#$JK3]#
M,,R[K3D+C4]XR<LY'%JY,V<]3['_0L3+4'%1@5U[*PJ_]-S3^!B ;7J#X474
M20*E[GQFZ;\=P$UJN7;%5[Q80+8^@0#;\N+6\IW(-90/VN:%ZGH.)S(FJFXM
ML@^5;:Z0JDZB[J$#0D?'3O;N D20Q<_VQ5,B_(]]YL<]9XL9UXWAW,ZI_R;?
M_K?)_:N$#TT@9(_.'GUH)3)<0]E0X+D_6*OLY]P\(>>^G*F)26AUQ%$JC#>;
M)"57P0P0KI5R1=T[WY422@JO+7^+Z=\X2NDR U:B2NU3V&G!S]I.>?%*24'9
M69,F$^>"3S' /_+@B8]%VS6CXZ-(;,COI>VMV2_Y;[7V,-1=I3RXW!)6KZ[9
M8&C0O*YP/5MU7!,M#JY$1"E;VJPPA(P#8IY^]J!),>T%/\ON<2:4D(AWC*Q8
M80@61-#.5NT"_"M8MZZ3XY1@$7LA%'JE61?4R-U @%W-GX<B_I@:_0L<."G'
MM\9^T@^7IC*(<$T,H3C$9O'I78G,P<_>VXV]-"-]0'##-ED_/5I(3/I-(/5#
MUB1_\?GD>VSS7IHATD7H-U=9W;F$U4[/3%"0/^>-YBX@H*J@2D*O,O!T(LP4
M=^.!NA:O]&H[8O8N*C!:35ZLA58(:D46&K=\O#PW9,D]S:[NQE9.H'SRE0)#
MBJ[ISO.;L1G]E?OO*KX51HE/Y.WO%#5;Q$:<A_H<OI-%&!V*T&7(K\6[HS$(
MR($_,!\$<'B_!?>-ON2]YO^5[;^)4>"1MR5'NPHND;P;<7T5#[Y[8"VJP"%B
M\EX<C_3P=R=F\\C%X13P_RL+W!W^*U!+ P04    " #L16I4I3I^[BM<  #M
M:   &    &%Q8BTR,#(Q,3(S,7@Q,&MG,# S+FIP9^RZ9SR<W1<V.J)'[RVZ
M(&KT1)N(Z!$BT5M$':-$M!&C]QX$01!=, 2CA EA=-%%&5%F=(F801@,CN<]
M[WO.[_S^_P_/.5_/N^>^/^TUL]>U]KVNM:Y]S]7\U2J 7E];3QM 1$0$>'']
M 5PM C0!Q#=N_'-=#Y+KBY2"E)2$A/0F.3D9!?5-:FJJFU14-+2,]#2T#+14
M5/2L] Q,S"PL+-1T;.RLS.R,S"S,__P($?'U=TA(*4E)*9EIJ&B8_U^/JV\
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MFY@?#?"_(Y"O>_[RL13+&GU[9F1U;6@H]^/@LHF+)*AG#02)[D]Q[5PQFB
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M)R]FLW35FV:7[4U,R<Y)#IN5%J+19O&.R6?=[]&(%R4.7'R>=O=85'EO(EC
M&!IIV[CN,VJKY1POB:,+?359TB]-X7>>,IO$+'&2W@[X1$R2;#ZR+(OOPQEA
ME)!A\0Q#9:!"UHDZA['TJF7K;A7#&RM4UO&<[,VL&38UPLY.X=>:*TV(<Y-@
MBQ4W:L39QQ<]G8*R'7M3N"^S*Y.\H8M]\A[EU+C4.\7.X64C]&1*?YS>1D4Y
MXS4B/&1)"UI<&SJS+(7URG%6;)".]=ZO\T1H>I-F-==8#@4&5ZY00?*DE;%U
M2"XVR$+;_,"HZ1@*E;-'B>MZ,KW><BWRHX^XS8TFFU/,_OY5E#,0F<];6K-O
M1"U]?\LAT*8!7](=M@ZE,&X$A/AH!8ET7P'H(:6]]@SJMX=JW -\W;)/6IZ"
M4'Z*4Y22FA;=XBYF[VJ(-UUO*&SY#(V1%[@!&3HE%J\ +A:+N^ILG3F]//=G
M_?PZ9R3^I!T[(P1VUIY2%%T(DOT\W'QX QVPGF-,5R5:G[$7!O).#&QY4SN%
M#].;A#5319#'>OVIG=HU^,2X@<XF@;?.\%C'H:H#AX[ED[,/;T9+@':N '#R
MWJ5GR#==:;6ID3@40:EI[@J YOX:"2E12KG=G468R7L03O'!X^9&N,:F%!4]
MW6?1^IS%M2M ;Q$EOMI-U8 N5H%;>,[J<CB#FZ=_4SP_3<X C#^&9S86)]=G
M/YD[#/2BHE7\,$YS.<'+Y;]-4'#T0:=1;9N'\LV8J'@://=[U9(Q;^3+7#(V
M=;S:1D<2Y?M3:S.&W6*$B9U\UL]\_)H0+@4@TQBE7D/@TYG]HT5;QE_=RE[E
MBFE@L P0G&>)'+J5HLCBR\'UV$-_[S26-C3\XXU$T8\W$#7'H"M AG_-%6!^
M"S-^H>O/^=?JH'ZA\E)OMOX*X%B4!/S+/^,&P ]= 6ZSK1I=I 8"S]+ "O7E
ME]>+4AV)%^AO&>*]T=SJ:R:1!N =F)^X1>'N'5JG5).&R-W>&Z:-M/=KTY*+
M#IZ&DORSA.\5H.JXR<*.%EO+0W]1I?K@!38K-HVUH9BK;-9O],&(5-G0JT['
ME=Y)\:"/PZS"TL+T]TA"?@#^KM!#C![AO"+4X^K<4*%-)38" XKY559EQU.B
M?#%N/UGXZ"E( EABJJ!L^) :"-@ NW<2H2H7C+ZX0Q@%ZK5-[JW#F[Q"W4KN
MM,@=*HF1+ZLW#X9.\5)+=@J![-CI=;S!F *@*9LR3^-DE$+,%%(H?A@_^!#7
MSZU#_3$JW0Z$(^[- ^YQ@+%3NYL]5%UT"_A,(T,#G<ZT4:V9_.^6DA4IL;-W
M25^81IR6/>M^^H!GCNWW(;::(OHI00X+]4DP>Y7TT8IHDT0F;B#G))+QX]_N
M ?TY[%Q/$0E>VCCRNN6ZI)V0%]^6N (T8=JG_=HD-U+G0J\ _);,##P8ZQ>G
MKWV3YV+QTIBYY'IIX8FC I5OG?0=T_L*:@;/#=[E>M3!,#^$(DUC39WN2$TX
M9:!+?3H??7^AEY6I@Q_%&=G%Z;=F;W6'<O]0U:AWSU/\X#S]9Q\&4T?>'MN7
MN9PDRMVP>"X6P;K4"!SM?4&\(!U*25"=J9S9[,"RQ4I5_)!:Z^K*\.190OW9
ME'WLJZ\//;CC@FS1_?DJJ.I:*$6$T<#S(WP<L2<]+;[5/T6S5[1:4L(_>'YP
M$O;A0U\!$,J;"+N!XR)<W@ :%O@<NP$KBMV'.ZCB%E C$)<NAN$]DD"&X<<J
MB.:#Z F2=[H4^0&"GDPX:PQR:#5?/'@_+C #TGBA6J"_(+5^3E/6PF0ST#YC
M<([AH636%TEQ,D739\*)9YSP;*M@-651."_E-@_GC$2MEX3\5X/'DWNE^8_U
MHO;/@4,'-\:^/W\A(\*W/B>(73FVQ7;%0L7#2O!%2'7B.<^ZK=C ADD"/VM^
MI5QOF="X^\$83UA!DXQ'.AP@,YY;N:>"<P=SZ_MAU>HSJVT'0.C\\!;KI<O9
MV0/Q!ZC&7.R-@BF%0FY$HY*C_R(0Q8M9SXL6?(8]B3X2#U'GIOEKH-V6<;9K
M*;6_T=B6PLD!?:\/]T!N%7F-PMH:9,*#YPAWBN*N (LBYE> :"YD&&K%R]9H
M[PJPP'H9AIIQ\%(=S4=,4!(==A0VIU=#.3XW33I/J'(XH[M(\;ZFA>8XTH+4
MR!KAXEN)K(8IS.D2KV77.;AO#ZJ1R=D ]WC1(48#O/2=M]R,R&,5NFB>^%/E
MU]-!2G7 B^"%XBB_X/SOJ/<_'S8D/HS.1H:@<!W<CK8MDSKQ"%'Y(G)(E 6V
M/II1]_=JH:'BD+U)-A-W\^=<U;9PSPZ&M_06A7KR1,?9G]!?16PF7"?^2DJ-
M/YWTXCN71_DOM1MX2U@,9$]^%AM)O:LM_KX!SX2=,TAZDCJ.WHKQ%)SV!L(E
M,F@8%TAAL\Q!.$"1T/M'7',TT780%O2RRD69NCC$UPQW=&84=12\0NO&.C=[
M?!9;KJJ8WORWN?VQGGB0T$&<O?RIP*SL1_Y#2SV'G4+U&8*!)_8$J:B\6>IZ
M?!%FW3CM3P7CY/ 43$4%O9[LMS)_U0=(^DY-*?WE(2,SP"^0ERB48VG[4YD1
M]E>/+^@.Y"QR7J\8!:?R0]+<2ZZ8Y+_%UH]1F6GE);Z\9:<II,1+1Y!6E=7R
MI!H03O$8GEQ,MBXFO6_1%>YGA.Z#D!R_$>GI2E4JO!VGVS0'[RBP_ WSIV%U
M)"NOL$-6W+45VR0[=6T^,$;<ION39_0E5LH-7XH1B;\4@ICU3_<QNK47Q QA
MQY/\\J\ -"'7:ULVWWMK]5/P\:6/C=-]L3H-=9-W'^G*I4)I\3</C.CU?%;3
M:(U$XDW-+8/D\P.4WS_+8A.JW ]733GM<X.X7B==#('-)P08AU J<Y-;"0H#
MYSQN2%RH4VU>Y'W_5"/D_Q3*]H($?7P$IHL#RH>;BY(_-Z*$*.,M()G/9F*J
M;8,"Z1?MAIB$R.Z\"%,8HI/8RQIYT=OSD+P!*HWOAOWJ8H =B:=7AO4(!E>6
MM9/^+6_ZGK/[5GML)YAYZN%HM@=2X,$N,_/AN^P'=/XEG0_QZ17N-;B:?A[1
M'W"C&_@Q-3I3[%YV=OMQY'A@6;>/,GG&,KH\;/G&[U<U[%*F)S3YG&&Q)W;B
MV-8D>4^VGIQC4,E V!K7IZ,]RSJ7X!V!+AZKYH$\?>@4W;+LXP?2!QG: /66
MDD[-MHL*=>$==0Y\$,P^K$<R4/@K6?ZG7>4G627+NL?9@8&LQZ=*='[I_<2Z
MZ_>I_^B:AL>O9S3#5^(+Y:;XI_R-Z%';/%(MWMR_ B:9G&6709,:+/OOLCO*
MWLK'#3D= @.;V>OZ?UH 0@RO6R*1/6[<PT6#AHS9Z6X[@1#W1<T?\N>_PIJM
MK%&+]LM4 9&F*W(& EXFC<3TWA].'5UF=^6+V,$YI=UV(C\X>R$-4'/?U0MM
M6^$[GGO^5,_S-N365>LTGC%^[\@=9N"C:5[AX]6<U&(&/-4RGQ'2_2UEIV=%
M8O$>7B5K_&(CKNW7 ^9]5>E2=U9[Q_8I"2]/]2GIT'&%1M4P-\:@$MLR1TCF
MUM)<X/UQ!?M^=5+L2J\A[[E(GQW/%,*P/"A):=X_2;1N=?D+:E'(Y O'O7N#
MH]##<[:=X[/;_1UN\K]L98-ATD^Z8K<,B7^?_47$OLY#%,DX^*L'# MQ=2>$
M!C%'*GLGY1G&I72Y>=_ :_9G!YP5A>_[@<^KY OT%3(&GOX0S.!.D/ (^#Y$
MF?TH)2N<_P/U1S&BW;,Y)) "DMD3<,GZ W&GQ+V0O=5BBIOUY$DL6'16)KZG
M9]B8%.!(G/JCJ [*B _$I!#K3307 ?".9I/R,0N5H%:4 GQVUB!<AMHCQI$=
M /WXBA0ZXGU=EKO(UG'-1>'2\J*=MW9"[UQ^_]R,F';M-! *5@!G-3/8Z"0%
M&Q2,BP$>^21$[AVTS!6/XL 8[:RU4=]O[=E-J]L$O:H19V"42YIVVX$_%:O(
MWNO!V'.IB>K.U>1BG>P5I??,@&#_N7""7 B:#O_H#U2E["?$>M#:_O=]CY=@
MZ=L^+4"^NM$H8JIDZIN#S7@1[)\!HTD/3R@I.A^LQKA1+U\#\0,[IQFUN5!/
M/RB68<H&9!M3"BH<KA#DS?LY<GK9LE&L.8&N%\6L:>6+2/3.FL"!P5 )D9=7
M,U5P\+I%L=D2TZ/:PVIO,Q/8F_'C./P7X6**&8(:6NWFBE&<9HC)9)U09WNV
M0<>I1YV@=JR],".,Z^[IUF(3V$OB\0ONRH@P9SHZMY,W:Y!6':Q.DN1? >BX
M2#<690B%[BN-SG"49WEM4C/'+;";V,1PM1W12*\&(E/H3!IFY%?B+EFG_U)1
ME$5.[<YIM21:0U8"CE)^$&EY[K^E( ]V_51__Z*D4QB2@ZZ/)RO]"/%&*L/Z
MBJ*;4Y[,GI@'F6T(1\"2'G'0OXNN(7M!Z^2D<4#Z\Y4+?FA-7)I^81%?\QC;
M"1/.P7!\=/X\O;E<[:?3%;^(R%0<,MZ/'H*?)BY0LNI/D-=K8LG1,9TYM/EL
MR#1*G4I-OY,&*^$X=_Y4](S@]T\;J[K#-[*)A:A=OMC' QOWHP@:Z/E:J S:
MFP02L L4%CX/C(;MU]9Y.K[$S$)8BEVC[]-6-XK25O]<C=JZ)M,+7'!?]EEH
M@G\)Q+NG\_8LTMX-E=V8KN>J4-5\F*W8"I]Q??6]^X>3G-2ZGA #-%:YH1I_
MTO_:!K]OC+BNU$9]G-3J(M@]6%V^/\FT!HBY9Z@0XBQEYD(CBX"D2MQ=:5N5
M! 3;Q6&+]*8OV5!XX5TN[\\ZM%/MC\B-8CF43B-@CCK""T^QCC=[!YI?]2;/
M%(KBY5;#XNEWPK"Y>"--W-?9?+HL[V",I!CJP'F0ZSU;VDV+*A$W8R.OK-5"
M@8M*=0'0&[)/&$DY(VQ+0\72#FIC-K=2OY6UE=.FW:^#0UJ(3J2@S6M0%XU"
M/Q.ZZ[/+0XY/QYP7T1%TU(7B=-IF$0K\X+#?$)=4#I;:E^VZ\[J_OP\[B=IX
MTL$5>\<FB.9^V9-#B3%&]-:_VKLB"$K5X("=6Z]VS=L-$7,R$JXRU<.#%J2J
MX73DY=;8+220' _4Z)PXXKWI]D8X"3IV\L8KOU+3V_/56(?-$*>HN<1'XK>O
MR6B@J+,G<1@C;@(7=B!E[;J_*$H@ /UA!K15)6#),#OGUE<BYK=O.T4/XQXM
M&#-[$ _;MJ$&^NJ9"538M%0)54'T5SK-MJGFCKG6*<,?FYU-W:31SP9;<"Q-
MUO=8.'F[9%(EWFF]?OF0Z,C]<JSK)BM0,I0=+Z^SH4,[^='*<22E5?O]P>7N
M9^K2CX("&48+XVC5N4P[()*.[.O/::Y<5V\Z%(?0N\Y#0:6<C,5OG@,?DO_6
M@;]= =@(AG50FTS-60F8_#Z=O=7IF1SL7>J<BD#*>A_*4,BY.V")NJ%;()H4
MNB$Q-/2KB+U38@A']702/H_@J 1-XJOP[C^7K)>61AN.T$'<TXTC]+??R/-!
MSS_?-NQX3SRS#W3UCK%*K&K'.Z_^"F\<53YM)RW=RS"AKI/C77Y=;?'7L_1^
MG\\5@#;,^2M;SPD//X_0-((#HV)K)]S:9FU$T><H5<IEL,DZ\WY$;%GOR_/8
M!<XH1#379]4MG8M:5>]Z,)!NK*!R.[!%>0.&4(XI6; 9. [>J:V38@I!YSCI
MC][$""5N]#".#7TA!FI=E'4*+^'UET.TH"*>=;^LU%,^[=!;@'):\YT0H!][
MA&+E_#@!FF&#Q1)R;YGC?J<7='ZM_[R=M9(W)+]^"GHFK_ORT@E)YK*( '+V
MM%BJ@ZVZ>SMF>Y<4A/M-EZ-W(<0]V +%66MQ7FGM%OO&Q9&.T5@)D<&TKR=B
MJ]Q[;U^#-[J(+^>*6*$.Z(XNEK 7(,K2G3/-)=N%@6*;B.,TL9^/V(R#^YI'
M1E23)];A>D2T:Z_>^EGE[)'CNHRFO23WH??1:L3FTT>VCJ;MGD9R>C*-;MST
MBU;+C[,O/<PIN]NSWA7,\Y&^H@N)6Y5&J@2K).EV<D.>B!LDW9ZNB)!7,<Y
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M"",7^A F&616MFW>'>VC:$"/W#GMXDQ?&<.S0CV'G2??9!T9J]45$0KZLIN
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M,&MG,# T+FIP9]R[!51<0;<NV 2"$]P))'@@!'=-"!Z"NR4X-$U#<+?@%B!
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M2TP.:<#=Y)RI"((A#'0/J'VH9V 23[?Z=K%K.W^P$!O4Q6&3"I-'UA$+PZ;
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M+*A*F1V"76J* W\?N]&YV+E./57_P'>&!;D&JX)A>56&]M.#.)BTR9K4OX;
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M?RS3MT^_Z_<!>]72=HQS="R=C1&2?VH;T9T]].5?CQYIY@+=482E475 G<%
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MSI ,'P!+A(TMR<1O)U1 ];7;XY;)LYOD&7>_.E7[N%<-^&S?$TX/ 1;NSI!
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MYEIOM%&P E[5I3-0:)CI@L3_*QB L>62&P_HMQT'S3?B >,/]1:%49Y[97@
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M\._%KC"1S5H[6\^=A;O-UCK8[IK506).1=,7U4JC#@5[_=HI[M^T>IHF/NQ
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M8@RKBG\IW!3C M8@$Y&(GW]=@_R07RQ&[ B2V!<F)VJ(E"'%BK)TSP'#(-_
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M  5$LLC 1N9Y'0H6ZLAOC[4H,BQ/IJM<>^^P;TQ$_IQ0V< H\9W^/9YMX->
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M/ FZO2</^&R&4I4LAI]Z3QWOJH#KK"\4(D[\@2K=;1\*<N>IHG6J/T/%6?[
MID\V\  "9HR5U7)9&5,(U85E46BY,$^:>/:$^0LY!H3([(\@(OW[ CZ,SUU,
MX_['5D_0!'"EZ47P..TELLW^3B IBG*9R1U;19.866FETO+69[+ ,Q::"=YA
M5K6;)[74+Y\-DZ>(P.:(62(6;60L3"U_H 7."O;A*ML-%O7[0A;[%4Z36JF-
M83V]WE)ED2Y4J[_NMPKVH6:^NNQ"__!5/ /.I>'T5AWGKUY,SM5)S4G--8YI
M.!P-F@F8&,$7#+WI!^16[^XV;\ =WUS/D+-AZ]WQW0F3IQ.%H6(B?IVJ30M9
MSG9ZPWG#^;^VY?LR#<]W@'8>6=R741E$T@&2#1+Y8_U$HS\4&B1K]FY9]9-'
M8GMG71UJ..CYU9:Z3$33%-+DNHHH&;UM-HNYZQT.P8V#UB=+>Y0Z24Q(52R4
MSF-S.R9S.HM0AN^1PL:\$<W9W?9;VYF@T&9UD5B1\'>:-D>#ZB^XZZ'-;:LL
MQK'=_/X9 M::<&O$=;>6BHNV-':KAD5/\W_U,XXNG'M=SI[>^-L'0C^T%M5N
M)A<<7X8@I4?4=,YL78F8:-80&W"F:\Z$L%-#2+MM.3_3[!267H)81#=N%M$<
M5_S58JZ8.]WEH><1-B+1U,ZW3)TEHR:L)VCGD8N+X_M%J?8<UP8I/."NP4P>
MFFZI:O)3"*]'% ]RQ/>$LF9C?&/\Q+V_?Y0?^NZT[4ST>H!:J:3=;XV>_OC5
MQ'69Q4\O*NTLDYBRANG#!3A V?[J1M&1]9&UEQLB;Y3W^K7/=>SAZX;GM)YQ
MNQ5Y<Q607Y79Y <I5;4GVWT3)=LH3(%3MJ@G%=(!XOWEU1HX8'K,N]:[=H%P
MK6"4EQ=V<1ZN4VV7Z-^7Z17<?D'<'<N@3OW-[7<=155@/MWLCV(VI77%?75#
M$%8PK"OV@HH7#S@XAF)UW'T<H]>\XL\T+E^)IK?XQ9TE[Y]@H89+E1 V^]=/
MI@K//& %QU+VG[22/G!?&JRL< E5SC/#/7;FI YPM)LKHU<D'L!KGHG6!G5)
M^XE?JT2U/CR Z?K;RL8Y*T>=C,Z7%D?,]NQK<%]L\(#E:R%B&<$#5C+;Z/&
ML2*+OT51T3HS7D8=%Z)!;C._QHXQM7"1[P/F86+/7A(>^H>M&U%H#U0HE2FK
M8D<B:#U(28$VKZ(L^':X@*U/*IGT,5H68#_]<3]77T^APVT)G9$4I\)FKD#O
M SHEKM\C>V_*MJ-@+O*O/ZY6S2,*FN[7A;S7?_WBFQZ=Q9Q(E%M[D2J9YP,A
MS=[JWBZRF.S@$Z(L>:77&G!YLANW$:^_WLT5?D?-^#,_:&1Q^F7H[16 PPTA
MTB_IJS&S)<79MY]4-]0!Y C?A8Q(U9)&I6=F%GXK=UC.5,IMB!#/OSSD!@R?
M2._X<-Z &/J7$_Y$YD0E']W[TWX.;3TY*Q#11;HUL-^.'HC.=0CV8DS9U1I_
M^> JDW\Q  GT[L+F;:S27TS4OH"PL\M;?YM[%YO,^/.X:/SE_1XKIUO0V=4@
ML>4.1LULTN IBX+[!AUVQ ED#WK(L4?1-\#27I3"% 2$5+JGOWZ:!W&:BP^Y
M9.N([[87&<'E;.Y'W(ZGZ7L=_>H+AB3IGP3DBOGY*XXO/3)WO) KIF"66Y2;
MIJR880>G9H;'3'5*D\A'-ZIBLW= RHV=6G_6P1%YH7IE/ %6N:9+1MOU2.DI
M-+RSU?0-0"\5D[<JH-!V]R'_BV;_4O-#/*!=#[IJ:E=N-Q?VC4]J][*$CTZ*
MAY[[BCJ[E'*6Y(X=KWIBCQ4EMV^M'O<!#$=@I3%5>6)7V-C:&+_Q:>>0'G=S
MS)^[CD)/Z0C9)/DK-X+S_C_F:)06_.$.&NHC>-G/,=&ZN0(-Z@LY'I595SA-
M_$TDAP=(P:K)=P^,&SK-"+V'4I''(.:L8_T_[L E/(!\I-6VL4P;VAQ;.> L
M5;9+205V.B+AS&TB+_I;)M+_<P3 ,X][L!O?$#BIA(II*,3X]F8Y>G.8R#\P
MTOCV9;V/OC*?C!Z;;B6\DKCH9=;+>'>R-I+3'7RKOJC$X+<)/V\==<,1SJ%=
MN5&\[VV4B_'/G^*=_6;[6$?_>PH1,=04FUS%[*DMG]6-_ 2"' 7VD Z3B[VQ
M(4C(QR6JNJ=V^3;;B)"C3(0DW*NG-:6=7X3\=^,..4OF>>41@E T]:S#Y!,>
MT,WX= RB5V8#.[UFH) ) T85R\]R;_9*(8S9OKXD1TC159UYT'WA@X>VJ?82
MT?4MA$F>%SY-T89$ 'N]M: ;8)EI]B:TBBR(8*>- H4'A "K[ \^A;JZLJVJ
M"PJ\X/!^\M$"0!#E"A/NYW:W%),QJ:AK"[":,$?_(1%[*P\L%RE ^L^ZVLZ=
M,7''\CB]F<^,_=@@LC\EVI45%!@H.\U/0.@,FLBM7 EXLFC+5"N]&30<D\44
M4GERIWS_>+U.M8$PE)>G7I2:(WTSBL"4A[_;G",4^Z#@*IBXR]/5.,5O"8,Y
M8C,0667B$UF%&E8YH:4=< *B,=":R*=0NZ5?YY"5:I&#/JBQQC.I_ S8D=%T
M2^[6IANG<G)-F>5PV,;X+HV61JJ/+3C/Q&]\*_,>NF"T^ZYGCPPYM*8JLNO%
M=G*6Q61.O;R1R-< Y'A5BR=]O/>P>1?8V(\-H[ BK=*%[B!J0HCS635-LW[Y
MF"2&<(Y\2$7(N<E!#Z->!GV3Z\!Q3YTD6)R"Z^$F1N<RGQ8RG:4VB<5&5PT9
MJ3$IA1TK-) 7B"QR/*!3+M_H+8Q*E7*\(7,Z[>#6^WO:%Q_2B\5:6;RVW9<4
M0&.],4[*=3Q3X$'328TT]?FS[-52U8*!(LJ!5OBQ@B?KN-=BWTIL%-C!807V
M"4UBTU M^["WP?SC&P-:0._+Y2P?> TFVK\$-T:=2>K+( $D,=Y)%J%^;#C'
MWE]MYE;^9][XUT(Z>LS%5*<,JV\T;->)-,_KR<?X=C7<<;'*[WKQN5N187:-
MY=F>PF(?I6X7XM4?K)D3W55@<X:RJMR>J>,]AI_(I1AX\VJ=PG0!ZP%CS*+A
M]I6;1)+WJT1]7XFEP\,L2:7+;7FNAH(YQS-U \?I$77]&A.@/K1.39,TG-GX
M@N<^,%&KS+#@X#2IR-NS9O#R]:C(T*;C!@<MUK;"9[PU<71XY_/18(+=UC64
MU?CYWY.TA45<90#M8T.9:DR;T%E=C#)3=;P<!HV8L'*S/C(?U:'ESOW2BJ;[
M,<JB3.J&0U<1>("363#H%HZT?V6)TLXP,:9T;J/ YVGLF^8?WEK&D+CZM:@8
M[>"87*A*E.U\(N$5EU0^#H'3)CCTQ#X":H898<@1JKI3*J>\"KVIP^LU@W1O
M3+G8R:)KHZ*"S0PU 13OR4C^A]9JM*,=T^R*Y6U.TSILUON;!&/3+USU( .;
M :R@DDG@;A7N564:3EUXM;DJACFW+C-+FEQ6ZW,!<<!&T4]IZR/B"DM_Z&)L
MP^5,YNR#O=F*#7)#E+\6(KE;'V0S2HQYBG1C$.QZG%B? Q)Z49NL-V'87EK"
MTT;)O,123'+S05VU':Q2^$WHH@&5:$:<RNV\WLTG_N/Q1.I--R#J72(R;&U7
M175.]#NXAU-[M4I"I ZD*DD&2-J<JUT5YT/N$>4@#X+:%V*5I90Y!^)&5E 0
M2VJ=^&6IZ (UQ!.=IUF%J4.HDZHB5/E7<.'96\X[>5I3%:^/=IRXG%^3[)5:
M1-J&DC8-BMVDK%A9BFG(9+C*K"7_9O:P-C+ZX>'RR^29>H]-MS<VW1K*%I^&
M;#OB9I78;CX8X>D7'OW:QHI^$[?:B#5?SL*\A;B7F)JPAR&4W&DT1]7J/PWG
MO50)=_ KYWD>(STTF)X.*\"J8;PK,=!3LVD(J7LQTP.O4M5;O %++VX[\5OH
MF#_E#115#$[833#Y7/)J+'IF!Y=AAA4?I(%!UA)FX<>XN#E,\&ILB!0_8MCW
MY=1^84.:[-@UKGHZ=2!5,3-37Y"BYQJ<@:S[]O+.$]VL+VU/BF(J<..,7RJW
MQH0A>N\&R^:>\4A]OJ&=H^?H,FU$)B# T]?&@"$W1IT%^BF485:[?F$&>]M$
M4NBZ?73*T=X:</O#^!E!%D*W"*DU1[J4G\%&( !6$,$?=F$6P5M'V%:/FFU;
M6@&3+YGQKL]D?*H*_"#HR$*VG/@*^>N^J(^YN$:4Y<")[B[4%Z1;!:&T8ANJ
M#3#R@)XTB2+OK((?8_E1P'"(E67E5I*(H>$;MV%F.ZJ,$RZ#Q-<"BOKW#U]P
MEM&L/HGWT0$Q^ODTUUU;V# L<='.8_X08;MH+O<*3VT8ASJ_\I=?)60N-9Q)
M5O[M'U=T5.Y[40Y;^^A%2GFC249[0 \A#&6$$_MG7KY=29.SPT7;5FSR:\C-
M#=_X>[+P;QU/9:6FRZ!W,)&=9O1MS)@16,>8UY!7I$I5L'+ZJ&/6QWB:.=$@
M)Z%0Q9_?U[^+O)&E[7%Z_"-OO[]P8K_"G[+-Z!KC//_!/;@8/>$T<@HSR^RK
M$(TD#\31[RRRHT6@3F";9H?:N01;0__2GK9I/:_.LNJ6]XS:@5[+>L1%.-CB
MO2DKU$*S-8XK9K/[M'#W94."$K.JAJQ))]O2X7<Z%P%[D^QZEV$7B=$.ID?6
MH"J(&8E;RH=I]\'\B(E314M]<\6-EH<+WI:_K^98)(IW7M)[5 YY,6DRU884
M72NEFD>X!Z/W,"^W)80R;2WW\],$N L_-\8(F703'&ESK2 Y./S-DF;J,QUP
MEHTPB+9.K:GO 3CYG$$X"TFYO L.0R)F.5KK:AZGIS[YE3J5!IMZJ/6@3O%'
MQB$U#8$2S:98?Q&H<\_DU5'WXWO)*QDF$-="F_X2V956]8&Z^'TNN@^*U>?1
MC.UX  _#K#%3LAAQ)X0.Y=0K0XG*ZFA5.WBC*J>'PD%+[-J>C)LW?QOX!'E$
M\$QMB,7CV^][HF3!';_!.BCJ$/?!@T@<&R8.H?)Z@KUE,F?L.)ICV*"@H29Z
M",PZ\A6<PAHFJ?V]-"]>E9(M+&3.<PF<$7]9!WT?UI"1H LO2L(#"L*P7)B<
M4D,YCA _.9&*52B5C6>X'7A70B;M\?8IM2 .[=!Q2[]<\3?IK0]$I/?5&4<A
M/K 1#8Q<MUX67:T9M34C?2N*.L.%!U-OX\YI63=CKC_P*O?V0O" VLS#Q%>E
MMR6;]5JNH(M-:$J;PG0?'(A76BIZZW^Q]]Y133==NW"L* @(@DB-4A4$1'J-
MBH" $$$A]*@T(4"DMT!L@'0! 04D2$<($6E2H_0BO7=(Z$42:H"4+_?]O.<]
M]_,\YVWK.W^<[WO/'[-6LM;,;_:TO:]K9L^>AY]2DL%KQ5B" ?1&0!]=$78<
M(>N \/UBJ$L,RJ'#@E5#;0A,D04=B?@D_O(+WFMQ]?DM5RF!X))6=( FQRX<
M0, 6CXT?37WZ/;-H*%+O[>U*![^<RWPO_RTON/]E>@J;OMFOII1M,WTYN4R&
MW _\@;38AI]'.-373%U,=*LPVMG.:6P+?IU!@9D-O*_00;UMG2.,&UKL6::7
M?(%=M)"L2C]<57U69^?BN*Q*Y5P2$"3U1U9+\DSXK^REOGRYRT257Q@9V5=)
M_)G^&Z?_,1:2&,GSJCKKCD00^&.3(^<7)UT/3%-=X5KRX6[K)Z2W2.?>N6"3
M0Y97^7U:7NGGLN<WQ7SH9OOXO][_E]#7(DSGX*[Y..W%&\J^%KT1N6O;'  )
MJV?ZR=+N'9F@NGND7B6.BO0&A4HH/XKR=70#GH)>("NMS'Q>J'9+]"^R.G,=
MG5W]G@8X!TL+3)@@%N_US.9F*:1O6=DTPGVCLB]?A&8IDASJ8.#^#;E4;SK#
M4WT&(=E:!0>7.U?96V/?'#ISRU^5GM%PW!=:M/9LK X+<T-\NC.6(?8;^PB9
MY27_"6HT8V;I;-H#]SYN=6O*-LY#XA?B(0&^.?G,(S!5E\Z(;\.7D2K#G G]
M%@)N$F(%^M-9FU)3R-ET$VOP"[4_MBJ1 8PKO><'L/MUYP-1"^8^&ER#\/*V
M'52I+C->@=O>6(%E/2@DZ.S<QNF)QH#["@I9\U&([H :7]O?SE\&%TPM/]A_
MYWI;T&446$+'6MO2S>RWV75XWD0#3$PN 5A>H;0XEX ^_QKS]_\CM^3_QY/)
M_P6,L]T)C9D^%C,NHB%:UI'!L( $[SM#25"-8W1REC) /4!21:LU,)8'P,D>
MWB.8! V0\05)XD/^VLPO9J!R];Q +CN4T0#U4!H@/.L?_Z_N8N,HOT 5W["'
MC'DTP,M6<O=AQ/8P)2.8/XL3SCE:P!]# U!%$Z@\%^9&*,Q)(-(^#7!!_V_%
MD!/*CI23 W3+@*<Z?NZS\:<!F,\2UJBAG4!RX)^U_5TIG:$UI-#1!Z3+ FKG
M I@&.!%[D!ZFY;]$EA-KQ!SR7D<2-ZFBL:1GX##HCH(9?7AFR 9 ")H<^_L)
MI30)V6L (K. %@/X.9=0A%X4"W;9I80&:,624D!SGS7XD;UC?VRV((ER03:5
M6Z"JL+UN<_H<E:,!"$HTP,=E+T@ZLO$.0H7>:=]::0 !&@#WC 8(?4/RI@$T
M[6/_C$G7MQLPTT9=!/X?TB[-HSMD99MZR:_ 2&2(0,/_JE7O(9^0C9H(^N_/
MU8W;< )=--ZY5@KS,##UCR(8>I'8(UM)^ISX@)QUIP%D^YYAZ%T0&DJB_]'T
M#EN<F=,ARRDVQA[R%H$4: !&]1#H/-*3=2.JDOKJR=\FQ.M6GC>F"C>N)W6J
MZAV9I *O\"U6]50&CBCB,='4$T-H]*F\B.L.SR9+ 9;J&HE0+:)D<OAU@\4$
M;X$LEV^74O017R$ _KR8[X+UX!LQHHE.A@^<Q<?')C9+=CX&@Z2;M>7R(6]R
M-S/?6QXE5 T'_<U%63W-UW>?Z>1YU7MC/X3X-<HF8LO&?Q':ST4*\A?)I,/:
M]K8JY<O4>^QY)PK*]S8#-*8VS9^/S5B9Z_LD_7X<-9>:"V(LW O'+KU'[;=_
M'GGO,C[)>;4N>K,RL(^>N[.^K'X @2VSK/9_[8%/!S':1RFFA/P(/<,_?SF-
M+09E@7'5<--7C1QKF1SI'?G#.=IMOT@W!7?61C'TUK)>7-DNIYJ/;[^9.FZB
MJE(SU(T&2+;9272JZ+=D*(T82D&Y[6=M3.^^7OKEMY5-7V@&%EAZ?<)WOU=Z
M.?*&*N,)GR$)AKK/PM:S GG^)6^"+=R_ #P_,5'3'CVJYDX:E!8FU@AI7K97
M EW+V5AP@ST3Z% LJ?J7EB)MZU7\ZXY4*2A57]]N]P&TJ7F>#^.5!.%91&XJ
MYNKXVO-'F7N*?W,W71.G#N_?_Z#E[K8\[P;P;)W31L$""SKZZ%551S<)*)&=
MCIRV/<QGRD/6Y]Q@R\[_XB)^P>!FR6GNFRP:*X62CH@*I@#7F?5UG]#--'R>
MA5YM3J!DZ(J6FY<&4RB$R+G0'EV;]!;S,48V$5=3/5L/G)ZLR%*O";7TY$Z
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MBQ(=OW8:07&'BF%$XYZ5:Q(KTA21=!J !C@S3>^A6S729 8P766SU8E17_I
M22RH.0LY2/.VQM*N8TD.N?"W+':.MQ^YS$7'$B]6J!S(!D6Z/NF5ZJ0!C@V0
M);0CE%'/]^2PB4$MOF2A ##E^#J6P ]J0%N839AI&X]/2WC9QG_-> #&<*IS
M5*6*R\UQ^35+OZ,/8?3_.R\P"2%3HD/<Y]=[4W<N?4!VJD^@J =\ [IU;]_C
M3_G7"-E$;$O:XNV+S UNMNB';HC\',6^6SJ L!8A=$9VT1W[N>-"-,#U#>V?
M![N@3W">FX'+_IRE+O+J@@>HY(-T?"$)I=?[/G5M^3%H4C(91&#K>EX]TM+Y
MK%(TV6Z?>=SR=0ER,ZZ=(M$V%BGC(/)AUT%9-+Y:Z \DSECA;I/[?D3\:&9W
M2X49UEJ]6%?E)IVN9$DUFZ!N( W!.!@J,V)*N$PGTCA[5<.IYNM?W,4WINFH
M/*,/<:IX+=5BNAD?CETH;_T]LCM//5[3Q3N;QK819'R0IXZKY(50#]5H /%N
M$R'^L1F=8V\Q14)YOI_G(W(^B+_Z%7"56[0ZFG6NN Z]\02VI\1*+J\^ (FL
M(L7WIH -AZ:O,LQ&&T\@>PRJ/&F XVK#:$]]-G+^?OY\G,5P(IG>_L#/9.[^
M=9_ZSW(I;S[I!;71-5X[>:VJ9&##J^VD0A)QXBXH5)Y1O(NSYUJ'9>E,5FA6
MF&D.+]*:KG+R5?[=J?M'^L>]?0H[IGLF!K5E^H>')+2?!EC6KB.C2-]V*.!F
M\@,:("X82$8>P914KF;6?Z7"_S-O1:G[[IG0<?=0)@U010<9F<*86MCLYC\<
MWL=VT0#37'FK/2LSY[#S!@^I]71Q=%_0F1\.B [YZU$RHN;('=D&^M/5<8/G
M,*+>FO(=.P_\,PKI7C0 D>]TS4 D^'T%Z)4]\49F#9R)S$U,CBIK'O1"LYN[
M6.%4P[/OF6I26_9XL8R+M;?GIL -U=G5;AA;!530145-E;FO 6RKK/FX3/DK
MUY0*)#YYWU#Z(I=E@[ZFS3Y6UA\<:ZL2<17-<OE_:I34=5^@W1$D3GK,]R X
MN+'41[;2]SZ^_$KV=).<:7E/2+DJB'EL;6O"I1\C&N@GI8CI7ML/E8T[,#40
M$9&,+##T2GD8"=%=&UM%9=&[*__7U<QJ5D:2U';S</7Z7GPC^[,]UOQN4>&+
MT?=.2AT[J-I\V7P_.[.X*[^OX&U*GJXU=@#:MK2VMCF:3-4"LB-'#I'+)=#+
M(R,S)=+D" UAND[>H2O(I[6U Y0Q<FPO0H,^B!1I7>3*]4/Z[,!$@(K^PTGR
M[Z:V0;)YUO+!D4T6_ +K[$P5]DJ7AT5>"UI\0L+>U3U@9OJQ$'0$U5]\@\ZR
M1:RL&4%\_>KLJ<+AC%QQB>>]'92.UX(>D7X60^U=WUP\@UQ*V83_H@%"/"Q"
M2Y"%&FL3[;]C*7(>.@O]E3$"UN;S)MWYK7KN<(+ZDBDI=HXBY-$>7-H&6OCT
M=9MUI77-R@%-K)J0R%WY&21<_8>7:Q89UOD,C==F"@+S%,/#"[*AXEN*Y7#^
MM>KAA>^#=G0U8*YY5$Y1H<J_GDQH5S?@,&T7*9DWS%Y5[9HZH$^[^R_^-L;E
M3W*FG>-/EI:EK-0)WAED%A.S,\FL"9*>8ZE#EA>?5&!#':P?I6Y!B<6-^B3)
MG(DGF&+'.N3O@JV!G:7=HD]F.@4KQIWN)A71R>DH IC;1.KGHXNV?8_L4E;D
M8L-4J"7E624POUAR696&&3E6; OCU5^KG/LLXF)+"R]R+U$#WH-V,F5O0HJK
M?U'F,RW/0VIV[L2^NJ%3OJNZ_V$_9M05N-^WM,,Y\8S*W%>FQJNNP?$.V:G-
M.[.M-CS$V2,>G[2^MSS[=4?CC 1EG0ZD?FW\E]YZ^]_A$_3OI_\-OCS_RONW
M-C>::8#+?X8@P=*Y7!EL5?S =P]' [Q#_N'B0@.,RQW;^HQF97%J+_*+U/OZ
M#J=:^#W#-NUY-P<-H-(C+X(>3%)\,-DP(1HR?!>NS7"9^A2KZ^O>2V5YD\53
MT&4-A=;N(,=9F[@LPIHV((;L<CQN,;B&COZ;IDJV6B<6;,;4%O,1H%XW#7%2
M@>U(N67N0%F=AGYJ89*G<,EX@VR)[.Z/G2[O='&-$Z2Z?%;V3EPBP:?4(YR2
ME3<UUB[G>O7!N;B;/DK+,-F&8'$"D@Z6@&#.D.[/!22;(X,$_4%ID;?"Z,5S
M<B5Y]G1]L,2-4;CI'"LL.!B_<8B"VT2).V XP]'<#PJ,:0">(46_Z6O;PF6&
M*QYHIG3^/@0#T1BVP7"G5[I6$2U95LD3-)B\\;Q2DB=I3#PN1/A$QP[5&R$T
MAV(P)P,3FJ<%2VKK:\/,8%?1Z#R9R-C)4+-1NHUZ715Y+%T&@E $O0X^/P4E
MO083GY+R3(ZN5QS:?T*GQ;DX<6 ^RFH ?H@M\&U;C1$54NDTDA,!VOM,H?/8
MLZP3&EUE2^U;"IO=,OO?UU),WW_*F)$<"=RM/YRP=7-1OW1T_[Y3H#UCBI0.
ML+0].ZA58MNIQK2N.Q[.Z"<(0P%('Z]+74?(%UOKVR)S];UZ]OS97FV:!Q.A
M'Q35B(]J90FY_0.XUK=>L>>S8S_[^:BF=@Y#KMJ%G+9M9-'>:!^8_KJ[R;8R
M@F)0$\O2]  ^+!V4%DT'9%\:VMM0;E'>DQ\G;>+JPXO(DM%%.6(M//,7*RQZ
MQ_TB)GQXA6V75%4$7H\G;\8O0(;7!JR!4T%!#-SVB<*K@P\,4T+T)41$5XJ?
MF3N1#:&^=FD[FFJ*A.I6,,$T 3-)DC8CYDR7V:5(J)ZUBV%2.O'$M_JX?N63
M@=CNC<J?DCR@*!N._F)7Z8Q>[R-N:63IIEE.5^&9R0^34<#$]WS[G,DYI$I]
M8MX+!"B[!R\1>PIFP:/^U6$[NGQ>I/+:+Z1W<I[@QUDDV[(&,ZDO8U711@;5
MI.)=Q!X9;8SCOI-59LS\EO<Z1,3_Q_PP?"+PL.9HBFJZLL]/-PS?-D-LNEE2
M$R7:.U(J2I86H;Q0=F>;U2ES,P-@X_0QXF# 7LCGE8"0T)P\,P-_QZ))ZR1%
M![8D=LWH_$M>$VWH+FDHH1R[/N,HLA^26U=F[:(E6;T*!GYTG_=4F%4ZZ5Z:
M\QQX!F&02X(WJS1/YWA(NB[UPUWQ/L:^]U;>V!Q;A3W\&9 <1M8BI*PU\-1C
MN<*DYH8@QA$X'$.2\H7.T<ZMX[XL];O>U\K6?_<[[1[0 -8L:J=OIA5L_WP8
M;=Z0[?I,)$\B>J#/&X+D+'<IE'ZY(0\.#6:O&YCS&BH/\@@\5N]@QZCWYM+R
M#?"#FS#/AR4DVSG01= ;Z3(#?>- _Y!/,V\ODEM6I&[YW+LU4:ZK)F (4HLE
M&7I1_O!61+NX)2U!^G97,./'H["7+V==B'I2,J",[O+HF6N-J+67CK(GOAX=
MG>K96ZMC6[>#E5Q131=YLO7.,-AEUB'5$XL-A)4?K50F39W-XU,4](/:K5HD
M'AQ(=K9O6J;J;R-,]Y,-,Y>Q9\CJGV% =A?$H_V'$R3GJ_:AN%\;<8DH(::!
MZSDZRB?<U0M9;7H1$KC8T.K8"#7%;"N_@+5[=:'CJ_V6%54QSQ;:=,XU7OFF
MS*\R_![+*4<#L$LW?[IS""ZQ(KV:YOA:\=CLJRZ Z9W,NQ>.E1:+M:HX=976
MV<VH':??=P,^41;>)PT?&=H]<I#RC#H7F.)N4G]-,;!UP!XY&#%T<R+(YLV3
M]4D)U;*JXARC@?WT@C'M3NV!TOHP:SJQ;)QF)=J-&WYD>*&FF6\Y=6FVBL@P
M;B=P/_I%=W[DPKJI6($8OQ.*50Y,TH;7RS@).'[:8V;9&]6-@H]=M:(J%7\E
MWR$,4:OFT![2;Q53+K[,:W;):QC^>K\HYL,D2KJMH\FNI(>;LWFE7JE/DFQ"
M]%G57[ ,<FXYE%3?4Q!S_'#S6"LWWW9$ZW["8M^$(85, QBP&AO]?)*CK?=\
MT5#_8Z"\7[5;=Y]O^=[2?LV>6G!]/24<.6]$%*,@\ZB1G%O,_T3.K 8H0^18
M4./F ;!_)YD:WY--MTVDK,.F__PY<BFF5BMGY06E\$'%:W[-#MF#AT/K?X;"
M&.W+_-ZY&1G,7]H6X^\V0?W0Y'Z0!E'.1[BO7O?"9%GI4AA(PQ'O9S1?Y=J&
MY-6.=$+;=IVU'W_1/Y_A+5K+^X!4@I-8?_,]IHOUF1 WN=O $S(^_/F+@MNF
MFQ28(O<N[L +;<J_ZYCZ4#4'.->,_7%XP8A8')(S;[6:M-I(,MFOG)>UJL\A
M%NI6MI56?*^%&Y^$':0C]8B(8[U/(\8>1$QNK3J:A2/.ZA"I]7CL8+TL3-'\
MXCO+,6F'GW%8&Y#>@K<T)XRG0FLZQUT<-3MM@KSRTOR1Z1>VF+:MU:>%PZ3%
MT<#]S CQ[@=_XJ6HEY#K7C"*P:MQ<RLKU*$CM]!VAGMDPC?(M3[KI$^$U";%
MT9NW.>,%MMMD#\Z-@//(K.'/X;N*GE.2>$:0+&K!7.6=-?A.NG5$81G/[L"V
M6DI.17G*UJTD0KLJ:BY:']A?MPDF0>>Z0 SK("=W,N0<=&?E$*(+A[GF-9A>
M>EH1KGU/BQ% EA![:\VV^K!='(0SD#9 MA&L%>=BWY9?!WZE)+(2K;Z"!S K
MUC:I!%"6,T]ZD/$8:,^6RKEZ,3EIGQ".SHM9O/ CGNM<'I&#M!CC.FU9N/$4
M7?;ZE<KK3;..LIFXU?Z.&U^'(<D8\HF/_51N4J"^>.=3*3M@JT=SS\+ 3G'2
M):'**&&CHGLJXE<!P<<3':*S_88&VSY,9FS)#@AF_1'BAM%-2O"%(EB^86F[
MR"JM4MW"JZ#/-(^C[NQROB3<==,DNI9HR#'[(4T!))Z>/?JOL^S+OD4(.JG/
MW?/<J6K_8B[0_0$T1G*3H[R6V/WE^7VW2ZP=+T0S"UOS+3I5;R7?J.W\&6UW
M*FPN)<D\ZZ7OO36>^7,E/]J7KQ[;,=$MA_'ZG_.8GF@6W-5)O U\*;<6I-=-
M[+CM??+W:;W6R[:Q-LRJ,E:E6I#*04DX=Q+3!P?[5:'G3<$F3]\U1#SMXHM7
MD2A4L?5X==9JIVT#3"<#^%U,A(74:Z)$H\WI[UR2Q;"]$8A/^J,GF68;#1_/
M1:.257_P\:4L46\$]PLPD(!!V:-^\8>SJP'9)3IP6UN7@8Z+NB?U)?!O8OU/
M>+(E_&C'E3U:$HVW?+>J?:UB3YU.5(HZ__M U.P<N<1#XU'JV>0F.IG/O6>D
M)5[@PYA1*O#B7 I [YH9I_"-<9T'?CG/ICADA<33W[PZEJTJ4P9QS25I-&S.
ML53B('0YG,Q7GUMHA5%FDE9UVUK%U-<BMR:7SK2><)_=V<V/&DS5SPTS<9&\
MK^;4@713Z^S?"(YRY9@MZC"[)J[RE8_1,/M8>Z'RW<RTCKZ*8>.\OE!F <OM
M+<438J]_[&9<;^G3XFCZLT6[^^OT7A:,#0>M44 [9IAWL+\GI#:&3M1UJLXR
M%8ALHR9G8W>2@J[0.Z89.'SE[W?ZVD7OA5H/,13R/3BQ7#01R^ZD4+5=+G&/
MN'9SZ6#8I+4)PSSAJ)+M ;R7B#I@S.%6CWM3V!_6+%?_;&6YF&4)K_":Y:Z3
MKS(-X'"==7#8H*?UJO^11H(0T-SAQ,$)TP*#'661#W-"=5H'5)T"(QM);R(&
MDBS(I'I/_>SDTD%$:S7I,TZ_-G:#53A DQVS%C7TY8*R2-I<5OE,)[DGP[F\
M.\?)L:MY\ 9R1/<X#2 +5;0F)9C6TP"QT8:_H?NY+DB5;GC:0@Q^=7(XDG4J
M[6$/UVC>?NER8,_;>KZ2MB!CKB?D&PL]R\Q/IA%.?4_:*BNKJT"_3P(+,!R9
M98^$!G'IGN')#?'J"OOXD $["R=W;76'=R7D%YRO XF63;X?F7SYOZ7WWF58
M]8"]HQ>8K= Y221]07'J; UL24^37C\<+-U#:Z\B]OP-05*)FO6!?5I.)<W7
ME%7;)Z]F)G)F*VE)(<>X,^*NHB6@YU;W9U;E:JJ"FJXS+&JYC)&EB"*S#.N"
MQ];DOF!S/8T7.&L40P7*P:',Y!CCB!T8Z)5%V@=%Q;VO+',GE*F)E4Z$.PUJ
MO)_T<' C'G'6-?/J7FO#47N_*DIDP"AQ5;9;=:3>G'R-,)7.9%[>3@/D;I50
M3DL$=#96VZ0 *@8V/K?>B;L*2I=0?!M[UU=3N(BJ+$*B+YKM3^DA!<["3)9,
M'[=[L^_K+$69[B8WS+#;/$X5J7PX[6^"O)U@0P-H.1!9,]7/V+U/;E6@ 5BW
MU4);9X,&9J>=W>^":D[:QRZZ6_.'_:QC'#GMZ>XW16Y7>$V2DJC)+/5V.$P/
M4:MD C^#CCP4:/QY*/7QM6NNI3:RUO8<4M9B]?,M $#]E"1G@NOO +8WC]&<
MCS,CKEWD;"2;D=0SZ$/F4H:\H/!9*A;N56D\:C[=[LJYR/&2[^B,-%!Y(JZ-
M<Q(20QT$ECE\.E(DG99\&J@XZ.VJC2QQ2JJ!=CB][3[X='N,A_7CVY/O;IPV
M@.D:/M1+7_3FX^!-;XWWX_I1#?RY.?%JH ')?-E5J+$R^$(2#="4(EG4O?>N
M0X3)5:I%6#AZ(,K>?].0E(H#DY[.1%7WQ,Q75->0'/%-_O*\EH^<F).^O[50
M-!JU"AE'3G"K/<3:@R)19XIVCU*9D/RL7 @3XJ>^FJ%=[0&I#"[/+^Q?F^MO
M"(6*G#+2798='"#;SWU'NDI'!5\F-!]4@4-L3NFZY/I]S.*)J1+DG,R+0G\I
M$:*43D*R?W\)WM5X5(Z%@K"VW:9>F[J%,_I>U*2E+&HGZ)Q\+"/)%T)$1?T$
MG:^%>\B[/M$5-O\,7-YS6O[:<H<&J+6H1>WE]9*9<;'CG7/:'XDB930 Z6YJ
MXV%9?"[:=P\&5Y*S,9>LTO[]?;%.<\^$%(UV'M>H)&RVQ&SB9XX;5KM2&@M.
M/*@04JB, !L)/W:D9 3!WI.:YX*DFU$5,PWZ_/![9<->PX3A;SUPI$MIXW<Y
M)1$SSK8-\]L=\O/SA^IU<I6=MDXBXC)&UJ;4ZLFU>OX5$*/&>9)$<\#,3S1C
M:Y-AID+- $(HH#)A2N^F4.S',P^W+[3SV>U]L0!OB.&FN%KK.0C[3<B0;3_!
M@6:(I'V.\P/8C=5K>Y]"AL\.<=YW^<%WWLPNZ![VZ+;%%(*5DDZ&%R)$"<VA
M"9CLL^+%T;DM1:=WS46W^G0^]+58OU!>@5Z9@=DP$,6:-U]>((%PP)A@46>A
MYJ2'SLGC\]N=MLYZ2N-&<<;7PI<+^TR^%#PT>9\GZ3MBN5R_6=N=HZ/5P@26
ME,3.[ ,A9%M*?CDH#,15UA,Z+4!@WHQ6TR]T@HY?E)FP$69+VC;GMG<P%HHV
MT><^NW-I2?YA"ZK<M&:6V?&' -]0\*55B( ,T0'EK?(LP)4,885[7A O$KVE
MP'$EDEOW&(?=Z_Y"FQ8:@$! R^\I]) @WZ*/#$%XDGN*;U/;)'5RYE2:$ </
M2P73*26@<)#!75OPE"'(OK[NHYN)^F+.7OS*%(<K$D8#<.KB"FF L"WRY<&P
M9DM/OI)EA<-L8[.ZU +!C<V*4S$RT=F<W3@ 0UH \@<V&DOX+JFFZ93_C$N
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M<*3E",4Q&=R(95HDOH\'<NA^\7/'3*5Q.2H:>31Y/Y5!(4;2@WMH@(L:Q_S
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M\>GQ2P[,0O9OVT]4/GQ 27.7B0_R'NDA1]KTFSEI%:<X+5 =$_RRFONH@S3
M)0V.SEDDR]J[E>D+P\@*;VD.YQ2[)!F=,W<TNM@2-57O/6=\^;+,,0HW$U$.
MCP2Q@YPQW&1U0FNLSNO::SDKIES;5LU/F)M_75\>O:<9B[=-NNYW!K &-1N)
M\E.<R\5F40=GV!"NWJX\?H'F?3MK^LI-'>;S;Q4_,#H*">05PZX.1W^*-[6
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M=7%R,F(7-2XQ!PJG0[=?>U26/DG!JA&\BNEC_V$Y2A.A%J7*]YPMME[I"PW
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MR)84$HPP\70(>9Q=9[/CB$[EA)1V)E7MCN&I[>4T[-WFV >K.18+76')NM4
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M\1=<PQJ'6!16E!G^]6#I$C^^DJ?F>NU+E*8FRY,64PYB_ L^TJ#1 (&=U"L
M+=%H-7_JD;"N=D2'AD5%':JZW<&38@#+ O#1VX\AEB8U4:M#Z-JO #1$GT*"
MZ$IMU'$@_17 N3;FD2"84D,WJ>?66^.]^U[J,5_#[X;=?*'IE$W&?!PKNF(1
M^Q8];-F5)E>&+-YA+4R=4SC<9GK6!DZZ.VF@=DN%/<+--\FQ T&'6PM@PJD'
M46[,*'!Z0_T*+Z\ &X=<AL;$SOA/;^,T6/YZPA8!>&AW#D.K+2<S86ZCZ]VO
M'O0!?$)%6[,IK#+JL,]X,.508?R5C_],?\^"T50 )QY:5NJ2*F[BF#"0>/@
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MB'FF@H1):,G(YR.Y!62_4$DTC1-U"BZGEBDFNDP7R^J!]K[%X.$;:;-9//.
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MW\2OV[$O?AN0ADB\$%S+X>1]CQ2=G<8PG,:8#L$)D(8020LET;Q/S]3R]:X
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M[R18V _'X. ^P<5]0D9$2$3VOQWW;0#2QU@?'FEB8S$"'I%B89-BW7<!@
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M"LS/_3AH9=8(D\$.O" [CI>Z&EQ>Q+].P1,CBU_'DM/P4=^R0)N:7N]T7A.
M#=YC;8^^6PD@.Z(L^[>\2-^2]XU"=, 2\Q52F!]">"5E@5X?/Z'?K;/E)9$*
M?TO@U(&\'L[<O1[#TE8J!WE=6:CBZF8N^?M"D+L 6]']G>Q<^2)*=/;.6S5
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M@F:4KM^[Z[$;?=$<%]$_O9C<0M/SKZNE&0\&I/3GTSQ!IM+O^B.I'=/_X:N
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M,]5;^V-BHH:PBU]SX5VP6P,HA-M/7)S0/9I!ZW5$A%Z:OX]ZP60#]55JLJ/
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MGU#EB'MG0,ML,TBJ,N0SIY&_O-5KJEP-5PHOI)## RR_@*3V*56M@<#_!3M
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M/V9K[4HS:+<0IJ*.85R208VZ8[TE*X-6,&\6Z*M^^#J1@_-U%-N-/>QF,$H
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MX.?2G'S!GII^+GBRXAG:)-"=D;:W_$GML=^>!TXJK;_%CQ1-GRFT,/P&*:1
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ML$DOV:VL/LPE%I"B_*JD]>^?4DUD)H]TA.S7"A Q_P >:C]*7+H#;N=]X?\
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M1!_!0*[9;C+#N*\W^%ESM\)(W9[B1L^O.*[1+GY=P.0/UJ1'R3^UQ<:WX?\
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M'Y.>KN6Q8L3(,3)8&4^_$G6K7#M-Y"6[A^)DS4:4RZK]43D#MOP3 1BB=^]
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M<D+ZOQ:=C'%$#5=0!2F29,W#II].,-.Q/W,2R1QW41\X+JTV-+N27HZ633@
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MF3CNJI>,P: $1%<6RYC]S7%L732T9 H7=B/)-!Y<8X_<KL*7 #E,%W4M'%;
M!R72,X&#,@5*I3'\XU(\F*%W_"(%WL@["2^;0W 7"SRNL"A7ARO&9O$'/. C
M(<L5P=/HGOBJ4A\86]GLC@Y=L6/1O_<4P'&S/K4GAND])6_'EJ[0._(O!,?^
M78*H2$KKT/QV7SG9:CE>FZ^<\0U!IJ)H+U;,,U96_)FA)?N;PI8>^+0D[K73
MPF>BW$\\[YG")A3[]X*N:J!=A'S>BMC'54;.]SP0W=+LMH3)XB_,J_\>.L>(
MZ&F)HT7"'$1/ 5 OQUV(TN;0327B,R^*!NXYDE+:11/X24X@<9*[_12;GF I
M2F_/*[DSA<#+H%Z\)"WR!.$8)QZ#@\JR&S^3+@!^CJ \!BT\]7+?FH>_?I'M
MWK#G4Y25)37J*'U1QB$GRZN.3?XKD\; )<:IB<Q'GUA)Z?9H*\]DPZF#JT ?
M^=VBF$+)\G$-(#F@YH_LC<JH7)ZJQX]2'[V90N^7DLA..'%HZ,S@>65 PT#_
M_DM&UL./[2<,>I]=)=X8H4#%TX[#<3^?XB62YZ^JL=L;R#J5V!+M6#^674O0
M;DJ4']"GJULQL,CY7/'!>-L0ZKJ<;4]",BT$A]7W^TI6RSV8/-:VLB8&H9#S
M,!,_QT]FLG?F!8=,_6P-/1^ IV.PD\@ET,QC7?8W!FFRO^?-C.<MEAM"(TO#
M?=<4>ZFBC2;(&8;7!D/G4]9$IVK\C"CJR BU&Q]&81]S'T_6?M(<J]'=/'A<
MRG2/$V.+0P&QB#8DOY<R;K6X?,OG4W?!GY0@QQNIEBN]LVUK&1.7W"1AGPFC
MY,"W568:3O(FU14'EF-*V-40M=ZK='%A3/D#;AS4355@L^6^U\ZN_YU+AW4-
M8WO5;U\X*5#+*Y&J*;-I<?8[_@IHQ=TD(0&GJ(^1_>Z%A1S"+\\-Q$:/^A3Y
MCS-,9 +;)CE-O7)"YWA?JOD9-S@)/BM&-IZK>?I,"5'@!JPZ!634+BC)"O80
MIN^HJ,3VS1*_J0HL:UPWXR$Z3($Z?H*(?[7U*!)^A$5\P5[@82I5N6RJ&]=Z
MT2Q6XN]>BP60H@<RG-TP69 B2UCAU-D@/#"9AO0N <"%W6IOMAWM5[M/;JV,
MP+U<M\R94T2.1LE W,4&PIYYH!&!GB.3";]*(68)>;X7[CZ?E4>1FHU A!I'
M^Q2F*O/MQ=XS?U+:LF-./0/X+L0)/Q*I<87ZG!#2#>9!%YM\3E[@(PZ0AB_\
M^[I=C3KO(KX0WETQ"&L@BK;YG (Z$5QFMEDW?L?W[.3;7HVYUY<?SR^8Q_89
M^ 2RI-LX#S,FX++&Y/V?]32G:]5QP.R)W]M3-5M"1-AA\: >E.?2A0&E5N[J
MU%W!_C >TY91C_CO;%FKS54=)(PR@I,NNJCMU#(M75:*L=V<-@<]MN7E7($+
M/[,D>E1V9="*3VC0# ^D,Y%WNY,HKX=19*E'W1_F.F:_H9R!*GX@3)-4IO-+
MXO(."9,:=9?H"IS67JN[MIX&59T40:IAO3T[6T_1W_(QJMVH?U<K[U1FBU 4
MD39;7> F*=_%31Q\(;CL:HYKK6#OQG5ZAF2_C*1BPKIU@-O:1-O"2[2(SPV[
MF)\7;I0.7VRBY-9'6:R.KU(9-R!&<_0SV^5-_*FB&\!8-XL_RV-DB90>R9+>
MFQ$OQ\R$EN%%A=K"Z_5&/Q 5+5F0;EYET5]2>S&YYW2)U 6;2)12I?^A7Z$1
MFW](VC$B$%1Y'*W!L'Z258 K456U@MHF&2^L6-G7V;-_-%2!G\ED:UC"YQ;1
M$?O2<K<)CLAACPHE,$.@_I>=G+6ZNH@6,8,+B1\J^(!!WFO=_64S'IE7[*VM
M/R$>3;;\3B!)D,MN)-&'1OGPDIE::JMG8=>_K95?<;4:JLZIF_BXK%4@XTG"
MQN"M78Z:2,@THV$] =D)%+ CQ:R8"D[E&)"FODBN9#[?*#]Z,3VU4I"E+;'9
MA9EO93\%V$!XJ-)D96]LLT^/()QS2Z!*T-=PEWO\5FC0S8"V7F1F.>C3*2"B
MMK*R%SO%8KGFL&WI?C(9&ERM'7$QMSF%SK>'&Z:QV)[1J<LI((KK3Y7Z$])'
M<C$.*6R'&=F:6>G)GQQ[_,GV3U_(']'H><E>F#MQ"_<J#J_K"@;S+G9SERU7
MB-D]9,Z)!N!'&V6G%IQ;%"?Q'V.E/R& NWUGNVX-3\I2:(U<D/YZF;VV.G"]
M38"YM=%^?;&:L<LD["8'N4DO 7 U&8@U@1+'T%T?R(64 R#6_$EV/47_\A%X
MRXR-&#=3Y7E^^ W!IJN5TPO]=GS[J/F3PRM)B+B7*(+QHT2& 9CRFJI'# E0
MTRQ"YT#K5*Q*:Z^\Y."X%^^LZPWN:$BG<TJ_5\3FCP5^\W6PVSD%V&L>E%(E
M?<=[\[^:S!O"HRZXJ55ND1+).7([3OR;4BI?.JEW=A%G[=2]K]"1"'?*_/&E
M.X1L$#^PE#;[UW+>"EBKO64LJEHU"L%[1I^A;%S:\5G/K]%G%2.U^MW*O8>B
M5,E05[UD!;2'CPI]I/4J$1UQ=(Z,).NC=RX1^8Z('MEP[E, \X'>Q(V:>W8^
MSZDP\G<?<B65?E8X17V B]+O 5:MA;FKOR>]H#U6]?[(R^;OK,QVGZ2XWZ'H
M)T]X=<^/HD(>%0(VRW&.L\?>I;\-X2U>AUR"F6']&)=>Q<A&5I\"=D"L<[>J
MF][Q>SVY!U'4_G54MNY_F0HB7R^8)_\%$!/EX06?8R2&[8D6U[7N+ZAOH15J
ME!&5]SYX<L7US+G-7GM @\)).IC""90H'L1JE\)A3G;3Y@KN &=:7'[F&0EL
MG!(NYIZJ.U-0QE!_!9C6)&Y2G 6J$:=BO$&(U&13N2!2OP>Y/[?*4HP3M8W6
M>J-^]QGR%XJ!\ C%0BSIF#D.<N+M$OEO$O4G>]S"_M_UD'N]ZYU%B@>\4=*3
MZ)XT6J-P/T^.RG_J&2,2%9FK^L8O#_2"R].Q>YW-<%Q*N/0AD'6J9H?:*E_Q
M[U-=#"H>I/EZTS;>A[<M3*D6<6L97?P!.6&'C$(]RJ'R8Q0_9IL^*2/ODFQ%
M=/4=/_S-^P).80+YV(M R+X&N>N-P&]4;K^BSR("$\ NE>CT8JW&VG($<4^Q
M'6\I2HD84]]:C8FXR@(*%[D3>?G"N-@UOU?PLAL+?];*D0M&-Y-M16SS/^WK
MB/+86(S'^Z11ZK#SJWEGR[L[BG\1KJ.!YBX=[;0-LK"KEPLZ[H$>[&ZZUOR&
M[K8RD;^= MI S%3YDHTOH5;))C>EK\V5"P6YB8Y\LPV7,, Y1:;P:DB1OYZ\
M);"SKM.!P7O@9*[S_R*[>"WF#I$9V_X@V--&35;<@VAOUA4)LD$AN;-]8TG8
M%?_&8KOQ?5D1GUL;>'>@KT/G!N05VT,DTZC]HVAQ]+LW8*PNLX&Z))@\AL]$
MT^](?@6_?_>:)ODS :<<45JMRH@:M_:-TGLY.2R)_6[$,#@;G?GP9+7>Z=+G
MNXN*$T=DJ[_5RQSS?U#\[(3'14WW\!MIFS5;$9D6G3-*)6XY(CCZJD*0_S+3
MSP +B.;KD]'SGV?(G>8)CC3CE6"59.XVV!=:MOMB<(MPLHFZL3[<+7CAKU?'
M'VTY-_K5$\P+&T[Y*VB[6[T6;0S<Q) >B" P',@ASC-D\NRW^,)L%G/Q/P3]
MO&V.DKLQ:$>6:+3S7H?J\%.U5535"YBD_);VDRXY:SZ;[Z\TSLUWN9P7LV&J
MYA*DQPAXKU7?5&.FYODI[^##[00//W5LZPP#[L)*;:PXT6PY7M?U1I^)TQTF
M@-L)IJ"N&\EK$LQ:/L>SSH:%*-@Z]^9!"3.JCE#?W"*G5]F84FWG,:',\OF'
M^:_77:AOB?FSL&:?=>67COA_[X[("/S3&<$N@T=-/S_<1ZJ/[18]H$U.F+\:
M6ZB6/IY?T+IH(:RLK'"9)/W"9+QFF'5F'F+'8;K3%-HU,-T^;%SE2N3M]O07
MJX]VNK*@<+6E*P;^086Y^-,%]'>]_VY>G>\J"YH=\I/\S]<MI#LMPK%3H5XP
MC'9KD]W234.,2&JVLI,([.)E=OW#'GQBP.Y-3.BAB1(UM[W6+CY* !.%BY7C
M)1T2@3\XIJDA9=[TG_%/))%R;-E"+CL/HU'4+\3&903'8I8/(Q!K9'Z-_!<?
M5S1OVHU3[?Z,M;Z0X>QR6&YKI7SU)W/V*<"-#<K9-2Q=F/"3\9Q>6QM[1T &
M.!1NQQY>6\?3RQCESC318Q*TABC0]:8\A[V[6Q_24[=)_N=EWIKD#0SC4USY
MH48].R"/N9'75E-Y;<:!5> =81Q<Y,*8XHXC;DWOM^WEW39KG')/A_/].U]
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MA^I)LJ<)_L #Y42F]\S9EQ:9[42D)JKG15]\'X9[]0O(W!]Z8+$.Z)48,9B
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M]FM]/OK&:**YFC!C@G(PC$]JV_&5X^E^'_#L,=U U_I]LT%T\&&$[Y_UA/\
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M!GTYO9U'^/,<W,5^!'EPVXGVNFN2:*73^6&^L/=T\)/?X7HMKY*%LZ)NF]1
M^%!4A,\--V"A\]8C<36@<8\7WSX$#YZ'UYAR+-GN<!ZE-1[X[+IMQ9, 4#H'
M"?!</.Z$JK[MSWOS0V2PB*M]5NMW7^2BLG4@@Q:4*3SM]:A$ZK2-!S2^EP2T
M/H*1 &(F''<.CBN$S']5AI, PT8\)01O#(ME/1D]!$-) )C_"/2#!&R8^),
M5:_3/E<2$-Z$)0$$-1* N4@"L _A_V0'RRE,[.PA :MMP7,DP**L[X0V8R;
M#R]/@R !Z^PDX&4$"8C*)G)1=)*  UH2T*1. MI-W_1K_=MR-"?#Z?!?5L2]
MR<9_P@3"C/% 2$ ^E'@61!2MTXR"E.Z2@&,LJ HR4KQ'#%D]2I\F ?2O%DG
M21@)F.,C 0OY_XK6>$'6B(!((0%];PC-Q K[C'UV2-WA#NXY(X@$#$F1@#.,
M)(!5ZU_@HIBR$)N!C<1 K6W&@R)E$O"YFK"*AO\/ \@"MUTF 7L+$'<XTGR5
M0-6WHU+[+UX;_2O<HC:'[%,0&44&TVDHP:D/\EL2[K]%ACXZ W$[H8+_-6BL
MC@JK9(&-:.5^T#81,=Z1Y\S=H[746:G<SG;0O9K^8@_*(1&DBK$G:C.^@6S$
MDB$FCO[P8("^;GW,\GO0*+#';CTXLJEZQN[]L[ADR;H\'ATEA2!OL" $\[ O
M=J:!BP0T6\*QW9#YM0SR??U\(YX530*NH-XZH,368? EK3428-T&5P(WD("(
MW$ WXE$X&:+)+-X3@7MAWT$"=F!N)(#*A01TBBUQ"I^D@XXO!ODQX3=/3HD\
M'["-IS/_@R6R_ZR@>C"EM5>VL?.OYH3_=<$&U2Q$P3P)B*<9]0#][$,U_HO!
M[']9\)@Z"IP70;P#^M\$/TJ3\ D^EPEB)4H$/L=DO)9;S(3;KH]JTF9\6]NZ
M4NLK$XBLFUO6<L*?HEP(4?"E-2(W?$RU<?_!B-S7=_QW]51M?DS$2=85=DBZ
M]F8?R"PJ=#!>#)2I&WS<KY?;4S6^?'I/4#WI)IE(D/Z=>#D$ E*?\_>MN*%^
MF$L"WJ:_(@%6 B3@5QC,V/_F"]GENY)&IF!^<*_'6&!WA:AQ#D>1N= 2PHY<
M9Z78U:/RO^U^:Q!F!*Q,/$SYJWRB49Q9-<$HK6,C,B.XK$#WF:3J#J$X9Q /
M/$#W[Z703RX%V\6^'<>_%5,-ME#XI!ZTK$I ?X#_NM.P-PZ?+P[T)VS]O4#9
MM?X%;$=^]OH^/(GF<(:,1)7YM.]_"@A1U$]\")KT3R%0ZNZHI! Y.SLS9@;^
MSA+>\%8SW-[IQ-^H1K+.*0I,1F\(_W\E=G 7!M1&;]H^R_@4R_#Y$;'?^#U"
M4*64N&D'ZR+Z-$.V^!:I?($U GQU[ __H3!>1.WBQFUK$O!;L,["X"#V0&ZA
MF^DPP60\HV)YN/!ATZ\"1>NJW%D_VR'X_)= VXT\,E#IOW-I/!91DD$&TOF'
M%,6S,LH0MHWIUGT/_N51-I%3JP-< R=2_&'J;U$J'P-HE&O3R9;H^1=!UF06
M/X/X&\W*(F*"O$D GII,F?YV+ $W#QG\_50,_G$Z N<(XC@A4PZ.CLRRN]W"
MAQZ;5W:W7V3\TV009@ L?3!(SA_''R^7WQEM+HXI+D\=0/YI.N2?/"KJ$<X>
M[_SJU5.]#O^G^>0S31O7.6I 3K#MG],IV4BK#/%H-<5KB 3\SV*"L.=I[I-<
MK<;1+,(C \T7>NA%\>.$A/GWD*0S)O,Z<]L'K#N5+DFLNZ#FOF/A"<CI#@G(
MFFBH*3W-JG;*8<\<U*FLD'K:KZ/AE?:6G*0B5"+\.0*'QW2>IH!^WCKIWB%8
M!Z:=/H5WKH9#IJJ('J.#F%E\S%H@"=A/#@[J;-PU> +9ZB-("OVL"0KK* AR
MLW.\9.#C<;6=16=X/ X 1984=630^AB<'4-V9 ;DZ+>XE?6XV04FZE&^%W+.
M7^*A?P1[MF'T#<OVP>,+M<M]I?<SPT9^EX0?EY^9_6A:A0N=Q^$BG1T7SN^+
M!-(O5!_DBTL^J=%D0WMJ^R<Q=7@R"M"%XE8:'W8\60Y',CQ[QT.P)IY.]@JM
MP&_:^;LHM]*:)D@:FTRSUFP\^UB7%CLRD0%1OUR5>C.1ZU,(HN FTNTRS&2O
MB2A0WR]''8F2N&RB3LMV+XF^F=?W:D,8[D-N:P'^5F-M345=AF%_Q9A$]I";
M=_YS71&7$GZF5^_W$/5;#V _#Z$,&U!.N?<N$E"CLK1["2/./0_3NL7EMPWG
MXE[O63'U+ANU=W /HT93SSN[U!,[T0_"YC5O/,C?+ZNO1%PSU_&<&:U7DGHQ
M8]_CSU/^K %5,Y1HCJUHC! :V"_-<9IA(0[61HF=BT]?:NE=<:-PY\WO8&1-
MG.>RW+HU.Q^7-K]%/6F$&2E[_LU9@?%)8N07R3LM.N>4Y*54XZ-06PC?[4^?
M4%A'9X5Z])%-1F3&2>$G?;.1FOKR<'2=R>CDK*G?H#5/RG&:K.DOA8E-. /Q
M2KO??&T0^/:,:'U9U/K"@.(X,OR<X0]&RC.]9$G6V<O9IXJK0$V865[+*<$M
MF_%S&>NV%3<QM I@K7'/X2.BIV!=H5X7>-*7[1K7VG1)B.!)'&@R0/_9QTLF
M_5X%<O9!P>Q![*H-/#C^!:F+#I4UV3JY:_(I&=@5'\LAM#/J9"4O067CS=!S
MNP'4]O/ML\6'N[+WJ=R;;GR\PM2\Y(OZ#+X*TW3CA"VV</YX <Y>8*2V<:RL
MQ- +)#QJV1+6IN0S453DJ1AP)-+V@WG6TB5N,<]PG>HYF,OU-J3P%'E1-;XK
M+EJN!L2D%9_[MOL;]4XQ)^E95>JX((MG2C90M0V=_4/SL.'$,*Z.Z[Z>KMO!
M.W*+;%G%!^C&2D+?NSV-(,&3W'A;H;8M>_5^D^[M3KW2^,QAV2$#P9U>ONG'
M+LTR;\<.Y/Q:3\"QBXSL@>"1@VA:K2$?;NJ5K?FH:4H_4R-IIL2++66V0FY
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M&%0S.ICZU_S0ZC G?$LW9W!D5_,]F(VMNW)X<C)FN/&,NM\"*MSO%E52*"S
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MY:,0]C1P'^>&M-1B#;L>QT8_%YOT3]&])4[W@]"^F=ZS+DTUTS(@" T_'*(
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MK:AX-BQ2BD=;Z2,).+<XN"HJ4JQ\R:"L<4:W32^WMBBHV6;RE(4$= WB;Y&
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M'PB(?/@O,)EHSLR2P](Y!/D-(K<5+W>(K(3+A'2IXZ6,H^_9FUAX'WG_-6B
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M.VRQ_04\QEL/HA/782WI?+.$<]LAQZ?NF:> V3CK2]%79F<U_>+&/S,:9S7
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M>XR;;U[3N^[?N14?1K%[Y==AB+-34SMUO.W&R_B]1'P4CAZ;9\H /HWCG;$
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M/:*37_P4LX<E)5$F;%0G?3BP"'*EW6^$%)2B\2AQUYT '5G<E@,Z@!496YB
MJ3M T+%[@:WJSI7!)U.FP==C"$@8YWSGD=+9^P;!DV ]@<9'0D][.XA2O#[X
M4HRNM<!_\!<Q-GV< MN1+J#!]LZU:W@5]FT8C^S\BQS(9,;]ZQ(LDG$4[@">
M]#4;;FN)N&"T$ZQ!@*?84I7LV>>5>GMV;QZ.WVI5%"72'?/UV;F;;-'BDMC?
M'.9'>B<_.;B>YZ%^5'[\3&.$OQ73 *@(V1; 8UV]O<E.[F(RJ28R>4(< ![&
M: 2+$:S,&L/)1EQZPJUOQT%02PJMI/1% A@D?MA 2:]IQ&7A.=##KNH:DEP"
M,X)9:4PQ5)6J$_1\4U@KI_<7R]*[.!?\!-15SI6W]F'ZQ+%TQ3&-H$3(UEX_
MS]H4>)5\Y'LLPK Q=ZIYD]>Y=VV(=?%)>Z+J6A/*IY'TNB9X:CV:'RN19:"X
M/_32G-T38':M92[TX;MB1'=#DOR7N)W,$]SAMT$#'G.5PD/SCK#D DC'%43>
M-T2IZFD^U>+3]XY.;D$WRSW#)_XBPZC$*&NWM!?(8KU%<,[PYY:L?)^*'<O$
M;JECW>>U3M(4N,18#_89P^:^'KQFU<=?*^E*^V2!R"DR5':GKGK<!P39<JPG
MNIV"6 %W@,1@K2=IG_"IV2;&VQ"X?J:SF=9]9[Q*-7/:/3'*:BG>]6=%."LW
M')J,E-!D[6RPZ0.T=E'.">,>='4 O@H&.L S+?IXZMJPK@K6W_XF]/ P*#6A
M:W(Z@3B0*-'D)2%V*!;B<\O1E@AJ\1%FYXOC]:0]DL#95$DS(>EUO(T%\\X8
M!]$,#=#YHG#)G"'N]IF6FCYD1U-%KX\K[53>+AS)]'!1@8(CV,[KQ,=JY.<S
MXY6)9@BY=]8[=T9D!U$\:(RJDN@"9?_7;RGO5R"!:G@P?1]+Z$N$Z2O>(#:J
MRRYQ\D99L^H^3H[JT+",,4U]SX+BAD<R@G&=+/L_:KSG:1%!?#6Z S",Q;=?
MB2&8X"/*](3C8D7$.B?+FB($N9X(2?R,'35>2?R+:;ECM?F6),^S9.1\=AQY
M*M&3&+=*%KQOL0G,.6\O>\D+7'$Q7F[%B-MVNRR]%R*TJH'+%</-!X-*/XOO
M8(#SR)ZMULDN '_FJP_DX<2>I%T42AX-U=82&0J<Y>!=S\])8S7 K=VAZK5@
M>K/M7N_$)_'=MQ_[GM"L<QIS/GX9%-JKWP&B"4X9R^3<=-48XE6F&.(Q?&;P
MDVU:.5+,TM-^911XDV8YRF421ZRM+Q92*PO >-*$=9*(\B!&XH<;#<L%E_LJ
M%]J%J8)M[WJ2LB7\BH+18ZTQ4=V8X4!%@6[AH\?AS++_HV]^8;? V@E0N>W9
MN_P#@X$>DJ;HCVJ2O+) ]2V3DTX'7I3UU=K<R1*C< H:F1J+J,=H)DY;.#$8
M<LK.X\V>_$N55Y[Q8!SKXX%Q&V?0DN5 N!VT4T'1E3W;K,;)9C*];4%N<?=<
MB-+*NAK'=J50'A@QI>YBBE-[KF5!E.*R;+2..GD[2HIU2@1 ,COL[2ANYIY\
MFO;8K=]LHE6\@>M2TSQCNRP^6&!(U07#P8F>NK.?84Z1W# <.^&^X6-"%++J
MZ \M].-5XD[Z_#O3!O3O>LNJ;G0(@N84FZ5U9F&X5I&[W+Z'1E[^[TR^&,<X
MB1?8! =FM:T@"3L4:X9G]Y<5/<Y=60L!S$OAK7^F_]#5_JB#%E7_Y6+!YW$/
M\7SZH\^3KJ9VOQ=S_77]^0#DZ=Y31F.SB#/Z/7OD0"SBNGZ=ESM,+Z?)D4^L
M59C!A"<J!:"= <T2%\3O+*ORT&J'Y\9#::I<KY.11O%#UV*O*$6H!E-X9D/[
M &8QLJ[PFJ#<O9$>TKP\Q"Z/W*JZ8KZFAA8U.08FYF(J1K2Q+2YWAZD]L4JO
M1;CPJDIY_9".%!51?3WMHD15L*=&&1*%8R.R(?HG_;E@P_/Y8ML"_5=J)"'>
MH6,MC[\@3"D0Y'AK[-PS963=;-O507R]AWEA#Y+7PG".77V /M(0,U2JXP/;
M"6";+VWLIMO(]RG/7#)>GJK(I-_,PO"IOO1ME3&5E ;E]M#W-O@4]I;4<0=)
MX]5_$NG1']K:[3SG1UD?O1WQ^M#P0FCI*%CO105DT"\B8I1<L%R6N'C[I?DG
MPC4[P+>;U4>VBBH72P*E*><U5YASINGJ4-9VEM)S)?[0L:*J_/Q7,N<<T4VO
MY5\>(KT9/\^T'\U9(7R:N)KX'74S"Y;\+P%^I!@^#D]K:?!&.%OFMJS@+JUV
MYN]*SF+3Q9,.DM8V&<K%61Y,A11(E&?.&(*M.2*3N$&#MA)"[3K2+#/"O4/"
MWXLF>HUAB\3A(.U56>S00.R,7UYAD(0_-DOF/T$$:GLK8WJ+HL][L_:CU/)^
M:>_,'<!?ZU6KQXU-6J_,=F9X;- ?M/DW^%\OS!CN#FJ-^4WI^?R^^OUE.$LV
M][_$HO\Q+KW2XBKF=#63Z-.@[APJ#&<I(/^7C,D_0>.OB*%1O3KZ$GW>K_'&
MNN3KT-'T?-VO&=FO1#6^^TW/ZIN\4#H6SL3IWGG?L;88H32RO$2^Z*^GB#*/
MM]Y)M(=<)P)UQ)9N& <?[\U@NJO$O5.4J6#%<H1Z"=IY3N;VE-R^IH.*??"1
MPDIHGQK/*2OLPS1!AK?39.E/R<Q9A@Z)RH(YB*(M1R?'9C]5S6FOQ4FWL%84
M&95KVWKX.4(P<@M57%2-8M6 ^B)U5>F=8GDBN)@3.K%]W+P0)\I_JM?D:[RK
M3K_QWB![*Z'+8KN5_,<%ORTPXOI&4+&^!)G9,)$7M591$9M7+V]MBM=FR*CR
ML_^4=XOD<.7Y$0!U![Q1@$9"+BXG.H(99MT*;)(5[<HWM-9TTU5X 8Z1YQNB
M+LZN/R5^5'#=0@8,=1R!N4B0_E28%/-9C=#A?-GS-K'VF!<2*<,G+UX'EIJ?
M>69F[-_3*I'6_'[G>;X> $#3[B_&W)Y.Y2V_.O<)!R+LHF/>G+;()\;&)V_>
MI$<6KIH.5WFBB<HJX>O1)N"*'Y[&=!R2E#LSK[/3#94;9+;E3QK^(M?\N+EJ
MRZ&S.,M-;AXP;XKKLZ0TAN1_1_YVOV2MNOH#%,;232*?4?1,:@A (2*F@CG,
MZVU\3!.&NB#SN%Y(T1:;^J4*!Q+\;KZQDIA6*)[2J2.NV8O6:]2>:8+_'; H
M.0XG;!D&IH<I\ZA^E&8%7O@SEWG5?"M^R/KP.WWJ/U'Y7YUT@1+4FRK)99*Q
MLD5)W;R*QU<LF=G&O^9CE/\ =/V_)>@*JB4O3N[M(O.77:1+NW+^8F2PO.C!
M&_62/-C@!B^AD&D&4]5'=PUPB<Q9+EU4J2Z7EOWU\IB?_:S?L-P=H 7_0ATO
MMXBV4>FVGW8A+\-&YW:IX@Z0%O7[OIVL:]_^6R^A^RTJ17[FT0>C-XF2C7+O
M"RS_NA^-O.:ZW%XZ;[L#8)?<B^7/M&^1E!@YZ7\32-;NMVYE^2UA_F2MO1?3
MSII>5UE1)OK]>9_E[]T6+MW+?^_P_YI"Q?^BD.T-@A]/T7!.,\Z!NO4P4,>]
MS:[L1:]3EKTJ+,'59>/-N8U].:Y+EM'$.UO!@LFYVPO^8>2>Y!_M17T_>F>1
M=3M@>*^Q]O\GK_#?*Q3<;.'US&\)(ZMYXDE#91R_B4XPYC<;NMRR<QNS<IPY
M8BO*!)<"DW*=%Q^B.@G\E?1OYRL-2CMN =:4G4(V[ZLF[SO*O@/,G1F>CK;>
M;Y/Z&U4U[/?+;Q"2%3WG5B.Z_YVA_V"_ _SUN.I-J_D=0!QX>R&YHM%ZW\H]
MZ;.D)BK_)I _NTGZ^=W^]RULFK_+K]G]W*)0U8;_)J#]4ST2R+TX^EZO7_R1
M_)^J+?#?U:CY3\%K?9O1AOM76G@',"\[M^[/8T'^^F"O[P#0R8O41V\VD,,D
M^8BN8LND7\J-^W;SJ+:D 0LW_7]%J5[#_^:3EMTDMBYD_S\\]/_S&F495-K!
M?HV^L/6>&UFO#%_RD^9$1&S;(6<)PIBIU6$_! JAJJHR%F14&KWC5MD\UU8Y
MF3'M<*M,?Z#B?S'WW^.W*E4IK'FU4=D_5WK]6V"S9#R(^^5H6/T71^0\?1;.
MDH&><;/[GU,T?P#%NOT?C=W-_@]02P,$%     @ [$5J5!8?D4@9-@$ 1F0!
M !@   !A<6(M,C R,3$R,S%X,3!K9S P-RYJ<&?LNV=84]VV-AP%1$%$JE*#
M4@4!17J+B(" @'2D146D1$ $)$!(%!2D"PHH"E%Z"Y'>B70!D=Y+Z+TDE!!(
M>WF>L\^[SW[V=UU[?]_U_3AOF<GZM>98<]UCC#G&/49F:*.T&<!Y UU]7<")
M$R< 2<<? &T"H V@.WGRC^_QH#_^,IQF8*"G9V!B9#QU^BS3V;/,3,S,+.?8
MS[.<8SO'S'R>^SP;!R<7%]=9U@L7N3DOLG-R<?[QD!-TQS+T#&<8&,YPLC"S
M</Z_'K0? +;3)R+I]NA.7 :<9#M!QW:"U@(  @ G&$[\.0!_&R=.'K_C*<;3
M9YB8CR>4GP></$%'=Y*>[H^W/KX;?'P?0,_&P'[INM8I#M.'C)>].>5>Q7\[
M+7RKN)'+K \G<N/1\Y S3-P7+O+PBHJ)2UR1E%=05%)64=6^K:.K=T??P-S"
MTLK:YKZMTV/G)RZN;NX^OGXO_*$!@:&OWX2%OXV(3'C_(3$I^>.GE/2,S*SL
MG-R\_)+2LO**RJKJFJ;FEM:V]I\=G?T#@T/#(Z-CX[-S\PN+2\LKJVOXG=V]
M?<(!\?#H#UPG '0G_G/\/^)B.\9UDIZ>CI[Q#UPG3OK_,8&-GN'2]5/L6J:,
M#[TY+LN].LUY*_Y;<>,9X1MF.*Y'S_N8N$7D9T7Q?T#[$]F_!RSD_Q.R_PGL
M[[C& 6?I3AP;CXX-  )0S-,CY\O!$4FVQAG>+J)9S74R]THV&RGNLV<L7D1>
M-H]6>*_&*Q5* [RIS:$!>A)[J&I4>433U  -L-RY3 ,(T "\(VO[B \]$^9;
M_A^L&6D 9G\3&@ IA23[DUW_42[8$;T37I$SN2U1Q$KEWD+2 )K6(.(VL>\?
MA8[JP8NL'B;5TZ;V0++T%(@**T+@L?B,?Q#9#\1T"HXC?>K2JT!$NQH$^=">
M!IC'S.O]5XD_7DRC7',Y0.<9 E?I2P,<[E33 .V(MKA_$!E:HP$D@MR#?^]$
MSM  LYZK-,#NH@\-$$L#Q #_4:Y@B'J/,$A*7>1JI '^40V@OPA:%Y"_;>8=
MJ'7^"_5IHJT/M?^O]OZO]I;J;LQ'@3FF]3T8ZGK+O _?9+9=?Z<&#%R%7-&]
M]R)!(?I#8J^I#A<# Z?IS?^V%U0O&K/@-D@#K)=:UXZ\AG91=5--J+4*@1=E
M8X[X;=!O+@Z:Z@0Q?N2T\G];7H!@65&-1;V84X/P!<B(.(U9&@(7P;SP'A#[
MO@=H7NQ-4 &QP0-B@B=?8)?YK$#\)+\ZN!7#)O?B9+ZNQAKG0&X>#>#PM.&%
M\P[FR?+$$<*;L,BUBXU!0)[@L-'J6EDK5+IA==-,HB_74'D43[S9^,T;I0]Y
MO)ZS"B;6SX+'58&<$"1KV6+OXTI-F7X[2WV67J]2@-Y/W<9:M*/FAPRS&Y52
M6"HSY>*B\3UB\G[.8<98+IJIAI+EQU-W8XYB<ANG/CXT$NX7MY%3ZF"LK#XT
M5M5=/\)TZF9CCV-Y(_$SX<OGN>2- [RQG9'B;F.#>&_9JOKHHP;]<>G.%S5&
M@J>@F_VEB= V]I3AKL^+$&I66_27#X[)+PZGVX?EK9==-OKP)Y=&YC ATGO;
M?,0Y0R.#T51;;+MQCX>WV.1&F4C@G@IY'>NW/:$\ZLZ;N)6,.[ 9KF/-FM)(
MI0$B'U;=CA37&UU\)"SS]> G2B/S:=$!9F;S("!^8V$J89-(;=#K'[1.A ;-
M;\9%-(@Z$JW:C=R$PK7"':+,=MM$8V_]$.NN$U1=QAC,;&.>=MFQGB(Z@359
MZVNH4\/.?>DE9376B8_O3=@XW_1HO=E^L<<6MHIPA&'27N]44@)\X+;(.WW@
MR[";E.]U1J"F'@'%Q)E4O69!Q5Z+,YN>,I<_%<Y[U7IW;CXX\7O2V@YW0$C&
MT\-9B'Y^\R:,#FX><U?,6O>OH(6%BF,,[#DMZ)Y^$I&]F,4;_]DM *Z& "]L
M+#*RD&D %AH O6M]I!JYBPVG 2YPS%V(57?^-K9JPA4>MAS95ZZM[%S]Z;U/
M>O:T8DBUB@:DV?.J'PTP_GY>/%9>'%]1/[/-1#2PV7P4WFPMY>'MK7;2O^Z-
M_C@ )&O CZQ)1_LADA&MP?/WB%]243G=2%M31[59$+\#D;5]_$(3RB (P^[8
MD=T5J$"JMGSLK-U4(_FR.V[NYY&U%(HZ.EP##-F7/8]Y(U/$WM7R'!JT\7TJ
M5"0ZUOP7^'TUT!^+4C([CEX%N53/IGO)7FLCY,2># ETJKH1Z3Y$D-.+Z?XT
M67:HK78.5!Z<?,?NYZ_Y3JE2D,RUV=*1Q?; C'G$A)&Z<"&+)/;'06#2-V=Z
MG_5G%3D,U0/:)PUBCK>>#0!J_V(_ST^HW.N(!G@U4FF6J-)U&X->]Z2P9KNB
MTXZ7>6!WWYW*/U!W8X9BV'H@*-0_838P7Y(J["),O'BM*<ZJHSTK -O&.L'1
M<H"DVX3ISV#..:X<U:QAQFI2NJZ:*:9**O(*5Y\.;G_Y[/KM?%TEC,ENY7'X
M1]V;-3!WD\$L(GZ29")W*1?FQ/*QC(_Q+^IG#^LT\IH?2@^..[1T25VZ.=HE
M =CZH<XZASY%5,)A6C'\\BRR<]D%>.V6(V-T\ W[L=7 IRLI3Z^%"^GB.-5V
M3G2(JP]5#$Y*5U"M)_9)T?W&_)O;Q?O=7+O^D1@(*8;1;"@L"D<#V.!=PN49
MKZT+7JJHBI78'-,\M/DIBCNASF8-,R+9Z[C-H>BT<96A?JP\)D5NIFL51L[/
MXSUCXG3/8F0857IFS7GC$XQE$3L>P:MJH,NI*M(C?^S[%0.I)0P0/EXA> [O
M/!SG,JN&>B)P56BX*/E>".OW4J%'D7&_,D\M>TH-P9SQMB-Z1*D\(NGNR:5Q
M#6GT9I*Q$GOU/03[#;.U1O-$NQ4,FN@YD]?1>6WM-S7RT&5FI!')36PVPFVW
M=-O-Y41R.#;L;#L/7$X#;6 D*NYJZO[^_%S)17T)[8ZM2![=DO538PVO^8V:
M46,.JZC!6UBS%=[IG+B?=%FN\_1ZO-7BST-W5Q*B<=1 O2N%MVAY@-.Z1U"1
M4B1RK)IH=)W:[/9)=\=KU>&&H59A=GR9,2)A.E<-/<'O3H1B-8?B,N&3BD??
M<+^_T@"L^P6RS) +4=D-U=[RCY1E1F=TSY^T?PS\')MZ13?36<9BO[[!OW(Y
MI^A5AY2/+Q:'641_VZ-P[;I$(IZJ;0H[XL,2T\D*0W4&U(L?F;NB#,ON) ED
MI9@9+)QGG (L#Z.( X1?O65@5N*C[>9QD6GQ(3^2:9!7-J5$ZE8\@BU Y%!+
MX/ITSH16>PH%(X 1/Y"K_S"P"#FBIFB^36^0(F:17* 9%GUDUCPH77/R-YE]
MW;+!K[M?G]S(X JZUFKC\_)V:.[E>N&Y"YNO:(#3,M]R5OJ@DLOF^$NEL22+
M@7,Y#!B"KT<:,X;]6N.LCN PMT=#!5GVP [= [$G/*^O0Q,GMC'[04A=4[ :
M!%FA^_EIPQG5"V_\9-DQD3.IF]*;8CJ?1*,1!4+1_&FH-$;UH1A60E.?IR8_
M,;0E</H5XNM:C< R(7@Z9.?J .7K%Q'W'P!]99Y6Z[+8!O"R5QK*8XIYK+-C
M K&^Y](K;]V)X&A0=Z]I;T)6$C\W-DC@N#94RS,?#?=8QEYQUO-*?-VDR&""
ME^D-7H?,@393<X@76OUYN9-GH^+8BY(YG[L?N.5J>Q"N=54Q6"]93730"=2[
M!=U!8>W@9\B5AZQC^IDC^RY>R/7>(X/(PXDV<(5T4EP^%-[5[,B.P4/6DB"Y
MU6%K:@BQR2_<]PYW+R*\(2L"FCAW[FOV^>JW'I]CUPJSCYXA#4?LBHWH.2E6
M>\!KDB32(Q^IQ;U&[ C6'@=A)QK@&RJP-0#4!#ID=: !1HII@-[A^D=UZF#\
M_?6'F#!.4QWO5"T=SGLG_KM>CFSSLH>\?J"CC:&M_5E!.1H@/L><!BCJ=@QC
MGH>'<TO-ZBIPFCHV+@DB\ .-JM@61-A1>%B9VF<[_?(+D5(11:GOF(/7G)DL
M;;8D3PM4KSMJS8-'XYI5/3]]6P.?+0N6;8;?Z)=%H2\WI 4DJ< JS=86O)0?
ML.J@<U8**5\"JH^FU(X\=N27$ZL#(42D,.P>41POW.B!!UKA,!'R:B:GB9%G
M_%B,IW?&]3WG/[O\NM1V@7$0V?05AVP"\D(+9I,;$3Q0.NM^WRF$7I_5T/SP
M?/Q7Z&- @N))_[.^\^M@L#Y[-Y_(6X&+#PK.ANJSU+WHS;S75GP[@^GM5PG!
METP?^TT'^J>MELA7-RSR56RI_KOUF)^'C#:4=^H!!3 5O.![4(2O'0IR#\^T
M#O5-4Y-JW:F0-Y<D=\KYO)'N#<3UG*2V:8KCT,TT0,01AP/4LW^^-?#YQ'AK
M5L1\166R&_WYV8\R=Y9%2-:C'RQ(I^\7>*)V2L )VH2!@0XL'K,$0\X"QPKF
MXMZ6RS)HXV4=<<VNFFR^26W8YF*3Y;N=52?UWLDP"N3S8<>\YMXDQE;/>%QH
M30.:A-D.;8SX R$5'];N72WY)*B,WV%[/Q@/MC.U5?5^7[N+2=T,.ACCX$V(
M--"0]I)R'"9AIV%]<UYCS>V"0.*;;&CH;,Y;>0?5J3+E,F;B?I7(N\+K[RON
MA/AYFM"_NJ]JLO%MKAO4#&(I&_-SN#PWW^PHKCJTT+AHF7)9O\7IX>'ARC.-
M];7Q*VU,<DOK033 PB0V+;/3OF]QIW*VZ] 5MCP7-Y9LC7>)IDJ!)]VMK(Z\
MHLH^;DC#*EZD7+!L6W;XZJ3Y>E@\#@XD(F]2WNVS2+6/IT512F>);'OK4P(B
M.QD[S[XO0\^"Z;Z<&&[(R=V2?E3[)CU-)$5L+4'"&?2J<-%P\EE4>3_8IP:>
MO]B6E9TC&J1&/:.PLA%WB?)!G<5[!AVJ:I$2%5 S7-9=L,:>V.CVI-EGSR$#
M5V3>!J33%(&:SSF6S\N^#J2^<A*KXR"9&.(YY3XRYRHG\EXSWAH5LNZ+#%%@
M*BB_^0/P@,EV/--B(;.L8CJU_NSL%1WY_09J+79;TPWO\@,=N0O-:$J3ZZVS
M^]H]S\RG?[6<1\'PODY!V[)(6][[^%%VS?(>Y)AXFP=NRX$IV$NO;G ![X:G
M3T;41ZH(RWD)>[9)+I/JX@@%Z^Z2PL;7D^6H]8NRW?8Y2J(N%->1A1XA8@0N
MU ;OWX8.%Y0MJRZ),L*-3T959?NS8S[F7WC I+7BDR#5!E>EMJKV1#>(N3?(
MX+HQH?NA!4^5N!ND8]?/RT5[1GQ57XX.4;,>+;/HC!9)".9#P.=C]&\1UA)(
M%9H!.,3&;A$1,>=U[,'L(() 8MBK;UW9DV-N/==,I608$WA,.JB[3ZIKT6/B
M+:KAS:"WFL#/E@,/!_W0;!U%JP/"=_K$P,^O8H2$L9[P\GU+KN<A2>@>?$+R
MTAN>3FF%1:(4_.X\67B6$DB:+>-5BLT<\%*(0#F.'Y8E>C_]L:C[@P90FFIW
M/$2SX:P;@3$(YJ7P)BH//CGLN*)VS&I,4/'R>**:6*<3=7&>;D'SY?O)D8%!
M\P\6.3TCNV)RWN'BVHLL$((;,2^[,E)=:1;$380#3Q+3[S\>!)6AG"'K"/E'
M6N>PB57BVVP.R-<(%V8,/?D!+JT^QV%<*6Q/]EP,IXZP<O4+NA,5FQ-Q1*Z@
M1:YK(3F>CLB%?K#(5.271?F!]:.RB?T7>JW8BXB'FSXM( Z%'D[HDXG&P$'5
MP:8Y5W4[@=$@%Z;\VQXG&AGI=]1&!BIH@'.;^ZRO.V:ZK::'3XL-P!N]N5YZ
MB<I]U'3<>L8JK#[BIG/7M4E^2J1^6,7B2V;V@5XW\ASU/-D3QW_D$L;1EL:'
M_,'-+J'?G=EN[DKGTMD^R0.4>1XX<D-I X57[=$=I +=X-*X(YCLH.?C%&UO
MR)7!=+WGW;SS"QK>"9#UE"LU;NO2"+ C"6$;DB<QI6<R,+"M+JQ'0?I),\Y5
MU*-M[4>+POUF<^75E&WU=N,S;KVLFHBI5Z%'NB]\)ECCU9$GR<"9YCPW;<L^
MF!YWL7RZOGIRA/,+R9PG_@]KHUWJ@_5US$*,CY-=:_=AA,4'7_!(;=<AD GJ
MWP1B5[?$A\[#DV>,O&[WI]?41@[<HPZ'Z'E)]^9!/ZE>X_DAS#A>XQ6!^!X]
MGA,.XTWC_WQK2$'CY \;?:\YUVR2Z,^UQY2.252:]T\T>K8D9/J^<^3IN03S
M3P+G3]( YM/9A8FG=R3J;2L:DLD*@0$IG75?)I/W*P^%%SY0WI/!7CA_[7[?
M(1PBG/PP R)N66FDX(DH%=$ !,]T?#DQT)]+AE!BR.9X8*M5VO674"4;/%?W
M:\6:5.3;RS7<D,N//PFYQF[Y1%];D=HPD,S2Y<".X!;)T?-FIA-'PS3 IUW0
M&\03)-L*]0I1)_]G __ 0]P':\/<^ZNRRA$I%I+J+]?T>835WN8'8C;B4<00
M4$1ZL'M;6S#"SLA)ORH4%G;J%L_M? M__DVQALQT5*,A&-R:<YCU,+_$8!KY
MA@;H1EZ#=LUXM<E&(E@F#/!Q;\DWO M9=(?G)'SW4J3NS$=$.%5_*%5C)=PL
M4IIGW5 K@L;-B67-'4\F*MGREK2-6%&E#0LG?K[E.# ZL:"H,JEF/2YO81 M
MBD'/)*\H#W^Q3&KOP'+0 ,XT !#:K(/;BLDTF:E7,ZHHB1U_D3 ]8Y)3I>)2
M&@_W>L8?&]+P%;>5+!;^==1M9[)^HZ)7Q,A;?/K=JYCV=5MYJV+[NN&UK4=8
MN<B-PF.&<UV@_:_\!SDK3@XO.J[(1FF %8ACL:.@++%P_SNVF4DBO>KWU_1(
M"<!_TXM.O-5*-3MKEK3N<<&,^G/H\=LH"%;4F0WTR/05?2!^&G-=4PX^ BRK
M; 3R.A"#6FR'OICKMC0K]TO750^HJZ9^B:28HJ]0TD$NB'/P/D&FS[K#E\^#
MV[(*_90' RKZ7P@/!5OL4R"ES+:<B^[Q1C=2ZE4&XZJE;NR*4P45\ /4,$,@
MF7,"@>=$-+<UJ")Z.XXY9LAG+^KE.L0\L!'##F/%)XZ$P_1<'Z6(:5HVA2[:
MB[MH3_+.0M:<M%E%LBX6! (U)(?2-Q9ZLC&S\V !T,KC8Z,T&E72 &QZ9'7(
M? [E;!*(>.4X3,U)+=E*-J#T#B],FE06D'NV-5-H@/ 8F.\QJTUHIP$8%+%D
M'2 .CXY%[LG9T  SV1,TP%OT)]>,M4%$?'#CYAH-<(/T[ZTC<50.7  _"PK$
M_*+NKJ*)T)%VDR.>JPB<N0<-T&)Z7';Q$E=I &W1."J3!X88>9@4J?GGFPE.
MHW=!=4>0?Z&=!N?TN )3JLX!X_]F2$ V("?6B4C6Z'7@&QA$H3XG^@-\;M;T
M42PQZ,1+X*CU:*W>5_1R6-O1_-VZD*W^ &G/K]XBYK<6!2[RAYFIT ON'^60
MV*D3WV&VW\MQ_C&>&97X-S7T(?NXJ-S<&:"6>"Z_8(: 5'/;3#!R^XJTV@L-
MF(P4\L!/2;-K7(-Q$2Q"'4N[0MS&I4V1[\^P>/*AF;X"(<4><F><2VD +]$S
MCS4I4NN!D4OC?%T!'EN7]6<2#?3Y(WGNWVFD%_P:N>-F07ANYD[-R3#CQY>\
M  DB_JI@_7_2UQYX(I0 _#R[.;0<"V-QW85Z6LDYKO:=['YL8@6VH%KB&8(=
M+CXL:$X[#_;>+7=VC*YV%C] &OU5C7%_,8SUKS(K&L J@QRU=9VPC_A$61X
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M0SKY/SSC. HR\!,W6D[,V5U&;'#\AZ7]"F9O\K7R*@L+36N_0V YA[E#7RR
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MPZFBF%Z%S4<3)D-7,Z]WT]?H?!<B""\LL/U4.)H%JU%'P"6Z,21=Z..I\<Q
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MG&=Q^N%XN63$5VK5=]/XMY:(><LS+8&X7(W61WU6_>Z_7H_[ZVWT;$20'-R
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M@5B@XX?9^>PECN/#]!A',464*+C(6@87T2S')77GWS::Z*F/F[*D]H$%0$I
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M"V2@$ZJ_X+7FM;]N9=QC)%#K4<?R^5S'MX*?;+T\FQ5V,AD/,L^2%0@U[30
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M[O]0%@XR*ZI:K?^J7.(@L;VVS3,VQI^W>93BW>7MZREJ*#58[NPO(1ZIH:]
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MWC,,\4D/2_./0MZK+]]>#>836A#Z38-K-*UYMMYR2]KSV\W9V:,NU/LI(QO
M#1&ST@SC^8!VSIZ59(%"26<"K'.<J)YF87$!P,WA8-<P]CF1\?];^=!;\P(0
M#RT\=],^OVZ07G9Y5]V7F[">EQ3\M ] JZ/\KT6WB.# XX7.ND[0%4:QT["N
M=N0NQ^H+IH9Q9(&/T\"V7VTN.!^S0[XZV_^K0%NQ_C-32<*;I/;$5YO<3M?X
MBKLM_>[Y1RZ0A ,8< -=VN1"X40]BG:,W]^JCU#A"-23[I6&;0:U6APISJK
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MS;N3:9(D;SM[S4H\ W<\#X\1B[H W)G>D&  F!!R]O7K()N$<EXU[H]C3#/
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MIE7NE XW(CB3$%XWGU\M3#-8=1Y"#FB+2B&T!,\P%X"@.9S1R\UERS^WUE3
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MDO0L/[T73U0('K2+^&SN^]A/>?T8@&8L:) \^A)H6 "QSP'VWNQVOZI_)D)
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M)M\E[J,)&;V3\)>)6SZ^QMT-9_1"H9OO,LL&[CZHTIE!RMH9S=Q?8CT><,O
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MC%D9FXOM8@"XE%EDMENZ!18>P+RU!HD-L7?8IUZJU73$7)\Z:<+6L2Q6K]
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M?Q[^WFYA=J^X=4+=X%:^1P.-N]_#TA"_]Q97EUAE1!VS?NV(^_']N*-PR!%
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M]B)CBQ7)+=ZZ:++X;=)JTPPY;0_7]+$P>7QGS#7RXUM. U=QHJ6M"264K$W
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M9FP1VJ4L,C7Y V</>J'20<]!X>/'*#YR+<UDR7!I7UX$Y5[1#"\6^[7E1O;
M:=-AM-RYZ,/N#,!7B9KD-%2S)$^#[<7TUR@(5#6U^+R^L,/1JQ^VA#>S0N/C
MPIVV Q*H<AW9R1Z(%T^??A1SS3?3@9?].H!,3_H,=S3GC!X$LW>]L2QRG^T_
MDK45"<7=*.D8V5VAB<=1!*@F9O"G9&R8LJ0+?K@&Y);3<=U,Y^+/]Y)Q"J=/
M)TU99O(HG-V#O">?HB%#0AF IU,,P"X+2IKB@\_O0 1[^JGV6#\?I(D3"N]-
MYG$\+Y>3G&E;;9-)O0QZ:>!MYKFCEP"*H[&\T$L6]VF=D'<SG^GVZ478(8[#
M2AKKI/KA4B2ZI<]#$KU:)++*R"Q9'7OYE5:*SSFV[;H5SL$*YU#D?C>:06'I
M5VM^%M"9Q\[W23XM&<@6/!]<UU2S]N/8G9='=$]NY2._I%?;$Z*8">HH:]$4
M6U]"1WX8>,!,/HSN 5R*WQ^("&+;7D@A [#!7#B9U<UA6W,R>;U4<GN,'ECX
M7=!/K;2@]BH#\ U=X#=@I5!!"28@CL&4)I>[([EO5E!5.J?,IHPGI!B )T0B
M2:3:69#>\X:FU .7X<W"%]Z>;:U:NDR"&3<,VL?=5K6QEW^0YRKGXXYZYT[E
M]J#>A9L_(9>#@AH\]-\))XZI#J]2L59I\JA;E%B"#@B_NJP]&7,6LAMI2%$R
M^,D E"PKW^53J7$3O)-D8'3D&W2X307">N-M[JWO-./J/AW^ONS"B[F%#B[!
M6I<*$W$[?B;.=P;J3M.<R&VO:[0XXHF<0<DY 0:3W,X^>Q]YED29WDP??+LU
MB67Y3!]2E7+F@A6-W*8H>1$$V)I,U,<9 &/TX*?;X?F5*>UV:[JCJ0>]/8K<
MZJT4!J]@' I%;WVA?/,3HK@9%5?6Q@V.:PJ'_-Q!"GM%I<@+9@(=UH]0?(C.
M7'?(LQ8D3)0'^^4^O?ZQHAH5R)FPS:/-7F].*UQ^>80),.A6J&K:#NH0W=:2
M@*.']',$_4P&6CP64OKH+-O 5W1QNW%E"@1*A.C)8K62AXL>.=TTB;S4<63V
M[-.:MDGG97/)UFPR>QY,D:@^X$ZUJ2W^FKRA!*Y??#<J$'[*DQB^A@R;.'[E
M*L8:P3H'Y%AZY PW?=)34#KPED6N\J#1%9? J&%1 4BR)80 ;&0 HB8XX \)
M$Z$O8,RWUC)(2[UF"Z1QX:\;MQLXC*(5L199WBML:G[@%/,)Z*B!U7/]<".O
M]%U,G(]YIYMOVR=+OV$$]Q6:"W1RONZ 91O!/,70BS<=KG5D)DC*8&>MG'@N
MNA)E!,8=7,,2D@*4.?,H^AN=&LW>[MCB$C"SK![?H=:;]T'4^I@L+P8@O)(!
M"/"'/8A&DEYCZ#'>>J]'Z:,3;,Q[MYTQ&USZN@9[8V,[J4ETIFZZIA37 X/I
MWIX(Z@ZB,TTN"N2@<UN2;T&5C^)&8@ >4&+SYG5*]"$^0TO+R]W;\#9F-Y^G
MY71>>J\QB*L4PZ7A]G$<YMDB*!A9GO71JBHI\A4RH>U83O829Y87\U(3F:T)
MP0J'DC6:5*4'EY3E"F5+L=HBJ!>)^2[<ML<*IH[PF."7-X!<?BJTY^2VT.^5
M)-269A^Q7PA86?F>^Y@^)LREWU@J5_)YE@^:65(#0O>&N-GJ*O?JF"=J>2\Z
MMT!R[@R ;/5P>5CB>&B!10=^'BZ7:S\_6QB)M?)$'F!V#*>>"G@8JBMER0 T
MQ(0S$;8#N)N%=.CM8QXJZ&':JM*>><)8M<-FJTOX#G^][ D*TQ:"8D/6;3#5
ML+9632F\XJ#WWE:X&/J4V3(205[8CAE*7!"?\-_R/(Y^?PP7/!765/5>BWFM
MZ-L$[A[G$JJ52L,2_=J$ZXYV>B R^O:U&9O@MA4#@)_8 <PS )L-H 3881\&
M(!0QQ93# & /T1_.$OWXTMZ!7[]'<(&F'E;1Q%O$<?0+B&_Y'A23\(>3#$#(
MGE8+W.[2I_!5^<9_T37AWQ);ZA&QRRSY-&&R7'"-$IX!.*1-A-HV"SK'0G@_
ME0=Y68LFJC-';@N(CXA/(7!]3=[("(2=9&"5<0R!#<GF('>$I):'4Q>..Z81
M=SONP+=#?C+!)N(-&OG:VGXY:GRM%EV6W C7-95[DCB.[48DVR8G'UR;Y-OF
MGUF>U!ZC377T+![E;@RZ=/)9NI2%,K+\U.L:Q7,#M"<D3S-2=\"*,)M@A<?1
M'!MCD) 6X,$#KN_?B>.5G+B8_7:^AA\FW;E9@87K?Z;LJ@ M0W;INPO#!GI"
ML(4\35Q=W4"O7S]2@': "/17+/KUP@E[OW,#FT-Q@TWW^YP,? *%N");,XN)
MH\>,#7(O=@IOZHA[]L WH872/RL,(U,?#\;5U98AXK"6CEVKQ-!E 0]2+9P'
M&%(C0E>H)9M7#8TT^96_9PV?#'GVV)6_3M'8\Q7"046C.<E/[*='-V "!F[=
M%4D2R9-6BNA_?_6I?OVCA!<L\D!WH@P1>5:9LT@:5*(7(C3H!)<I^IS,]+G^
MU739&_-6W9.I)Q1X^NB=BA"8WM8K\G8P'(( A<'='7LFL<[\,S5?NV2#F-@"
M(_WU[I5U7TXXAWQT$7VWT%EG;->1_;9T;F<AE)?N"@&+B]OW;WB!''Q5)8?+
M]2(D,Z%&_I6].EC5%_)K-6/I-;;.>(,6Z@-3"[\NV0F>#[WP'A?6XGF00\-Z
M!%3*JUHQY)"MLU/"6E>P4S'L&_Q@LDJ/!E&DVNZH,#^/]567.9?PETG<#$"C
M-0/ RI?S'4I\[9S(,U=^FON\4-]LUIGH?(LJL9&D#OP, ]"+I!]L-"+JTG!K
MXW3(./I7FO=XH<68"(3@18H)":-%5B!-)6>7Y'F).7]H<^7":416B[[_LO>3
M4\G'>*()$9&(X:)S-Q A/B)E[- KO4/2U3@Q(69WFR\*Q"*E7UZ%9VOTB9P\
M?GW)L@F3>LQWB$$D7>162@J+!]\2(=HG,B_15E[XP@L03D9CZS&VYA;>\@X!
MVX3AG5O$%]['Z129V8N[)[&==!5G9KMP@N]9.-)Q*D_+WD,42/5<KT,5-6Y9
MU+Q>J71F )S]+%77/>_M5=9HC@N&ME2U-8QIZ)&$M*?K:B$%:BZE3CC^]J$"
MKVV>N8DS"'MV0WS75[R >".=):GM3.AK(7MH(;&?MS/ _^AT[*O)W7!*GPX)
M'.;..3S29"4UJ*R?"PO$8[>2&0![BI:1VLD'.Q^<.*Z;,@7<:O$]3T:U" )[
MZ"IPKD&1_B7W3J:EM1K/),/,:U=LU"?2P@#6 @MO,_L-7V['S?O(^'I#^F;N
M%B1)/]QP+BQ]N=F'^K:JRD?O0Y(28#C085A3XYD8?^4G5T0(_/S#<833/T^
M/*]/2FVU>$P 5:]ROL(<\P#QR29ZQ#[K$2OAWE':_I:;1C7G&TM/RV]4]B7L
M<1,UEI^0JD8:Y!+IYP3YS2,Z#0W[GG'?.NGT4?]8?H+H.7+ZYA!] K,&H5]B
M (H2,;OZ F E=VM5-#IOIJSSO.[5JL#AK+6U/3_KNBM^V,%]&8(_G-R[/MNX
M/F$*2<SW\4#PC*LV<%T^'>ZH5,\LFC!O%4A 1>I3/ F2@32)(\DRA\@G#3H$
M%D:A7$&G@5?[JD'Z5CPHRO.V5G I<U,:MT&8GC5B<C'?*[8Z7RV0MOB&I%KK
M:TN]19,A<53>T$;!U%:6SF@PWQ@Y0'WM-N$*I3D4[7T*7!3=%KWHG!"_4]?*
MNWT6JXFJS5S=*1KQ5)H0H ^!N929"(OL!ZF3-EADGF4'-$N!?%)HN9IS_,$%
M)==K+]IJW>M4]W)JS/>-8:/J\:I:BHD"V20,A6L$<:0]OT;^8E"_TW@]1W[^
MU68!&%="U\;4@ZBL^]9FKK0 ,])Z0[:0])XY+#2H ]*,@'Z]>84!<)^HZ7A3
MXY.^V34MWZ>7O-RID8V-:=_=_#GWUMK#9LNB:G45OOQI7<6Z <&O?'N<E\P<
MIGH1QN$<DOPR'I@V8^&@/[[S[< 5C<0,OHU5BX=)RR;[2,GK#"JT[BAD-R=P
MY@#6..E! $OR#1K$Z9;HD--,A7.$*F\_38=ZF8+5_$D7$VUE-S@5O?*HT"9
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MI9A@V=VKN7D.QH*GS;7W] .M1M6@H15"_A;$Y-VGX6 +^T=JS .HFI@D=T0
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ME[*BBAA^H94=KBS@0\Q5_9GCA1]>BHM*L\!ZQ%S\$'WLOC[ZD=^S-T 6'['
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M-$JSO.V&^H>(F91T6$;%1I*Z^.I:C2UO_CB&=X7(V"/]=Q0*3,"DA;3/42U
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M- ",$<KYSN I*(H#2'$'J1P\?+PH.'Z81J>"EE*7GG<X@I0DJ-S4$GOO;BG
MMOE_#R(-I[<791Z4$ 0),B8Q>6;*XFX7]J%ZN9E-7-@F#_<;8E:7S/Y&J[8"
M_DQ8^=&&[?AQ%9_6$;L9>>YLJUK*C]R.K_T+-9]_3125E@/<2':WJ5T85V"
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M3BN.M:4^(I6RGO^*G77[3^+_"U!+ P04    " #L16I4BD\3'^<'  " +P
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MN)H*Z@@BQ7@1'2X4#A^KTVVL;A./O9-Y;F%V_Z'[8Q=X1Z5%D.169YPHFEO
MF=(]PBDW48T9H%CRJ502A0$B\JYI:0<Y>#GD>/!O=&VDBRX2W%0KRDN3 [G6
MI1!AJ$WD%'")XTQDR P4 (P6D=/.H"Y(BCU(L8-D#AX^7!0</DS#8R;F7)6.
M=\B#(HZ1N<DY;&]W)&#K^+\'D?K;W4F9 R4&@@0)D^@\U65QMPK[4#U?]1:4
MV,8/UQML6J?,;J-5IH ^8Q)^L&X[?%Q%Q[7';GN>*MLJEW(MN_&U?Z+FXJ\.
MP]*0@QO!;I?85-L"#73D!F$VA*1O)8(E9!_=-28&5L%'6]TKW5&N"%>74\GN
MCE>\9L=>KX3;56Y 3.:P+2+'\<XD%?TN47U?"U45Z5O]V\^WTBN@GZ7@R9,+
M(7<,M]H+[37C$ $VT;@F'X+3WHYMWTXNU[IQ9)B%-G85H-T#R$Q3611"W$?P
M'S5R .IP+J&ADW($T()/+?$U_E*B6^\U\:V46(#;5F46NGK^^+78>5:Q0V<J
ME,BY=PL82]5H* 4 4 775=&Q$/R:HJ5/I%R\="F@.QVLSU=VP>J>5-(7"+Z.
MWT%2/,) *U8<=3<&J]018X C9'AM'[0M(K8M4Q@9R_9'.E6 V'D8]4I@SRY(
M*/#&!A30AG.%HRW@PYW95D!J^Z EL[E6<T&1:_7*F)#DAH@T5WHIT+I(M*<W
MO@%3P.IE(GOW8*UYG[OO>%,]*5R1%0JE<AY1<?6AU6^Y>YOSL+YW;P0_M/PK
MP58M:(IM(TPGU$KQW(I1?3'V,V A_2YF&3??I7M-_>(*XR]P%;%Y-<=4%X5.
M6]O*_M9UBZRF+'0^"O("*,D$>WO^GOZQNM'-<V>KEW]WNW_!?[NY,@\M@ V[
M _Q>78T3_SXSP&I7KGO"6\ -,6/"'QTXCQ(9 4-W(.3Q+WXJ=-3(<%]$1/LZ
M8CAXUSUY=41ET@:85U\V/,VN0=#O_OYJUT?:%5?F1^.2IUOWA0CB'%%WY&U^
M^W=-'O=)1!C09O2V[WYNR__"39B\F+2@_P)"VFS0'[R G!^:6U\&F(,F, ^/
M,=WK#E8Y^ #,]8Q]W+,];]_-KY?N@>B/0*>-__]_%VPEY#\$+;R\@;\[)>S>
MU']5!GT&'C\E4L3L8E73_MN?">Y#";B@2O'T@4]U'^_S>U?PP!%&':PA\T,K
M:)VRQDH>_VTV"X;=$ZR!9N[4J>H ]>LC%^66=?=GSI/$5!H/5_BM\HKW[J?%
MG+Y8$2F\57MC;8GS2"6LY[Y<)]GN,_C_ 5!+ P04    " #L16I4 9@D>!$%
M  !)'   %P   &%Q8BTR,#(Q,3(S,7AE>#,R7S$N:'1M[5EM;]LV$/Z< ?L/
M-Q<M$B"6)3EOE9T J9.@P985:#)L7VGQ9!&E2)6BXWB_?D?*\NRM>7.3SLMF
M( A%\H[W]ISNQ/X/[?;[JXN?@.MT7*"RD!ID%CE,A,UA@,:ZR1-1I5)78X-P
MP10;H=\:QT$4A$'<;A]]_UV?. UFM%HET.U$82<.XQ@.DIUNLAO!\46],;>%
MI/\;_1P9=X.-OA56HA]NG-[D8B@L=(FY7^O,%_N=AJ(_U'QZU.?B&BH[E7C8
M*I@9"=66F-FDNU?:WFS"B%$^FVDM$4P$MWD2A>'K%G'T)Y7+S)*0B"S>V#:3
M8J02SZJ7:67;&2N$G"97HL *?L8)?-0%4_5:)7['!"(B;AAO]-U"PYR+JI1L
MFH!04BBLB2;HY1QJR1>X."8D]NEO[\_?G5]YD_0[;KF1N%,^B^SQ@NQOU+ J
M>\OG]3MDR*-;SWVDB;[>0&]>W9R=GIWUYL9I1%T7 :]RA$Q+J2="C2 E5(E,
MI,P*K4!4,$0W73".8#58VGR)Z=@(*T@TICB<WJ0Y4R.$@2X*456.KM(2Y938
M&BC'IM05[=69HW1L:[>]#??<G.?(S) IK-H?;B1.X3BU;B4.PQ@VHP/X);@,
M!@%$W=UP*X"KG*3ZFYA*6R??$($C90 .#$IF;'/"1RRUL=NTS;C=A.'9MIJ&
MG!2'T:"7"8F\?CCI>?&9FC8JP"1GMM)XC2986V^N0[@MRG.N@*6I-IRI%.O$
M[?QA\/-8&)^JORHR+@=U6&P#LC1OJ,:*HZDHMY"#<S0XG#8!@]6V<[D+H4]*
M3\C;(Z09<FRR+A9[K =])A6DL9J]2YY;P$VQ118C"QXK-69RABUZL<*9-@7Q
M;?_HH>,\,45F $DX#C-]'G?6":98#-'4@;$2BVZT30&S$FF\$E6T$M4VI1>1
MYK5E*TNUBJ]C''B*DBD?N=E84E9U$])EWUO15-5H(FALLBT@5T2[FWQKCJD_
M\_<\=\^ %;WM[A"P=IN4NW]0./+] TWT6SV7[]<V+/\%N/' 0=I \"CJ5U=*
MNYAPB4JH_U'U#*C*F# $FM)@Y>"Q[>S,I*2*QJ(19&A:* DO[L7@*B&AZ$WE
MYLDS7'@?N2J'=HUEC2Y=HO'.\T_'G\?LG1XK.X4K3'.EI1YYL)ZK],%EPMJ#
MY;GE.?&]&:OJ'$4H6"U&5@M(RJ*<3=W1*Y%?,$-YF]K);XB&?[0 ?6@@W=+1
M]BT;2J2*3,J2<4[MQ6$K;/GGJF1I\^R;P\-62IA TVH8#:F41--.J6%A985)
M,^C5)Y B84"G]!9[[EK26CEKZ@&-.%S/SAAJ:W716A9V9R_HQJ][,Q$=$^@&
MU'W"?-3+ZTH\HA/GYEO!#TML>IKZBXRZL207G!+"DI<63GFPG[[DIL9%_A,&
M?ZA%POV@>[!LD86_;VV-!:_./P6LIM?Z>?JANM'(K!K8,R356UR8N*Y=<'@5
M^A_<:8^[3;#P<:>&[PIIZ-&9J%-U:D-=3N6U8/#K6&;/&>ZK1\$7/F<]61"_
M6*^>L&M2XSB ,\/4ISL<^P28L+I\ ::["P=K).8@%YA1)TI=J177"!^R3*1H
M_K/0?1G!=P]<UTC2.O[.YGW?_?$WSS T<*7LT1/=.<0/J\'OZ=Z:3H)X'K:B
MUA$L:/+X2R:(NL$NZ>!.;C?E2TP%]B.5NN>^II^;F<3=.3BHM-<F>?76_UK@
MY26-G,!_:0Y(M]S4MW">6<=?P3G>_C[O#U!+ 0(4 Q0    ( .Q%:E0.X'WL
M? X  .>:   0              "  0    !A<6(M,C R,3$R,S$N>'-D4$L!
M A0#%     @ [$5J5"4,'G,4$0  *OT  !0              ( !J@X  &%Q
M8BTR,#(Q,3(S,5]C86PN>&UL4$L! A0#%     @ [$5J5"DDQ7?2)P  \ \#
M !0              ( !\!\  &%Q8BTR,#(Q,3(S,5]D968N>&UL4$L! A0#
M%     @ [$5J5+F3$ 5S:   SO$' !0              ( !]$<  &%Q8BTR
M,#(Q,3(S,5]L86(N>&UL4$L! A0#%     @ [$5J5' P&F/,30  &@4& !0
M             ( !F;   &%Q8BTR,#(Q,3(S,5]P<F4N>&UL4$L! A0#%
M  @ [$5J5.P_7N51D0( 6O8I !0              ( !E_X  &%Q8BTR,#(Q
M,3(S,7@Q,&LN:'1M4$L! A0#%     @ [$5J5"FMBU&Q;@  A:(  !@
M         ( !&I # &%Q8BTR,#(Q,3(S,7@Q,&MG,# Q+FIP9U!+ 0(4 Q0
M   ( .Q%:E2.[11+/LH  "';   8              "  0'_ P!A<6(M,C R
M,3$R,S%X,3!K9S P,BYJ<&=02P$"% ,4    " #L16I4I3I^[BM<  #M:
M&               @ %UR00 87%B+3(P,C$Q,C,Q>#$P:V<P,#,N:G!G4$L!
M A0#%     @ [$5J5'2YC_1$Z0  + L! !@              ( !UB4% &%Q
M8BTR,#(Q,3(S,7@Q,&MG,# T+FIP9U!+ 0(4 Q0    ( .Q%:E0MG?K:6\H
M %3+   8              "  5 /!@!A<6(M,C R,3$R,S%X,3!K9S P-2YJ
M<&=02P$"% ,4    " #L16I4D50L<L=C  "^<@  &               @ 'A
MV08 87%B+3(P,C$Q,C,Q>#$P:V<P,#8N:G!G4$L! A0#%     @ [$5J5!8?
MD4@9-@$ 1F0! !@              ( !WCT' &%Q8BTR,#(Q,3(S,7@Q,&MG
M,# W+FIP9U!+ 0(4 Q0    ( .Q%:E2DK])^6@0  %,N   7
M  "  2UT" !A<6(M,C R,3$R,S%X97@R,5\Q+FAT;5!+ 0(4 Q0    ( .Q%
M:E0H<="_+0,  +,.   7              "  ;QX" !A<6(M,C R,3$R,S%X
M97@R,U\Q+FAT;5!+ 0(4 Q0    ( .Q%:E1()&*LBP,  )X/   7
M      "  1Y\" !A<6(M,C R,3$R,S%X97@R,U\R+FAT;5!+ 0(4 Q0    (
M .Q%:E3')7_:Z <  (PO   7              "  =Y_" !A<6(M,C R,3$R
M,S%X97@S,5\Q+FAT;5!+ 0(4 Q0    ( .Q%:E2*3Q,?YP<  ( O   7
M          "  ?N'" !A<6(M,C R,3$R,S%X97@S,5\R+FAT;5!+ 0(4 Q0
M   ( .Q%:E0!F"1X$04  $D<   7              "  1>0" !A<6(M,C R
F,3$R,S%X97@S,E\Q+FAT;5!+!08     $P 3 ! %  !=E0@    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
